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Amyas Ames
Amyas Ames (1906-2000)
Amyas Ames, whose home on gently rolling lands was off Moores Hill Road and who regu-
larly walked over our laboratory's grounds, died January 24, 2000, at the age of 93. He was
a member of a distinguished New England family whose name still graces a more than 200 -
year -old farm-tool-manufacturing company, once called the Ames Shovel Company. It was,
however, his family's mid-19th-century investments in railroads, particularly the Union Pacific,
that gave his family its great wealth, as exemplified by large country properties at North
Easton to the south of Boston and a palatial villa on Lake Como in Italy.
Amyas was an old English version of Ames discovered by Amyas's grandmother, whose
husband, Oliver Ames, was a governor of Massachusetts in the late 1800s. In turn, that
Oliver was the son of Oakes Ames and the nephew of another Oliver Ames, the strong-willed,
crafty investor brothers who amassed their family's formidable railroad properties. The name
Oakes passed on to Amyas's father, who became a distinguished Harvard botanist, direct-
ing first its Botanical Garden and later the Botanical Museum and the Arnold Arboretum.
Oakes's specialty was orchids, of which he became our country's most renowned expert with
his various treatises illustrated by his wife (Amyas's mother), Blanche.
Like his father, Amyas was educated at Harvard. He graduated in 1928 and two years
later, married Evelyn Perkins, the daughter of a physics professor at Trinity College in
Hartford. Soon after, Amy and Evy moved to New York City, where he rapidly moved up the
ranks of the investment banking firm of Kidder Peabody, eventually to be chairman of its
Executive Committee as well as twice a governor of the New York Stock Exchange. Before
becoming our close neighbors, they first appreciated the beauty of the Cold Spring Harbor
community through spending time on the Fort Hill properties of Nan Woods, whose father,
William J. Matheson, was our Laboratory's principle patron at the turn of the century. Living
there in much more seclusion than Amyas and Evy was Charles Lindbergh, whose enthusi-
asm for Hitler's pre-War Germany kept him on the sidelines for most of World War II.
The Moores Hill Road property of Amy and Evy was once part of lands along both sides
of Stewart Lane belonging to the Laboratory's ill-fated Eugenics Record Station. Milislav
Demerec closed down the station as soon as he became our Laboratory's director in 1941.
The selling off of its lands-almost 100 acres-began soon thereafter. One of the first buy-
ers was the Cold Spring Harbor School District, which used its purchase as the site for a
much-expanded West Side Grammar School. Demerec also bought land, first for use by his
sister Vera and later for use by himself, as a site where he could build a house to move into
upon his retirement. The monies coming from the sale of the land were later used to help
build the greatly needed new research building of the Department of Genetics that was com-
pleted in 1953 and now bears Demerec's name. Amy then had just become president of the
Long Island Biological Association (LIBA), having become one of its directors two years
before. His being also a director of the Carnegie Corporation of New York must have been a
plus, since it and the Carnegie Institute of Washington provided the funds needed to build
the (now-named) Vannevar Bush Auditorium.
Later, Amy played an important role in the purchase from the irascible Rosalie Jones of 23
acres of her family's land, to the west of Bungtown Road on the way to the sand spit. At that
time, this land was not part of the Village of Laurel Hollow and if not purchased by the
Laboratory, it could have been the site of dense residential construction. To help finance the
purchase, three building plots off Moores Hill were sold-one to Al and Jill Hershey and
another to Jim and Jan Eisenman.
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Amyas's ever-growing involvement with the New York cultural scene led to his resignation
as LIBA president in 1958, and the eight-year-younger Walter Page took up his mantle. By
then, Amy was already a director of the New York Philharmonic Orchestra, later becoming
its president (1963-1970) and its chairman (1973-1980). He also helped lead Lincoln Center
itself as its chairman between 1970 and 1981. Equally important to Amy's life was his iden-
tification with environmental causes, helping form in the early 1960s the then Long
Island-centered Environmental Defense Fund (EDF) in response to the reputed DDT-induced
decline of Long Island's osprey populations. After DDT became banned and the osprey pop-
ulation came back, Amy built a platform-topped pole on his Martha's Vineyard property for a
potential osprey nest. It soon found users, and when Liz and I also had a summer home on
the Vineyard's Seven Gates Farm, we needed only a five-minute walk to hear the shrill cries
coming from the Ames's osprey tenants.
Pesticides were long an anathema to Amy, who led strenuous opposition to our village
mayor Bill Smutt's wish to spray the mild pesticide Malathion over our village's trees during
an early 1980s' outbreak of the 17-year locusts. The strong feelings then generated by argu-
ments between residents not wanting to see their cherished old oak trees put at risk by a
second year of leaf defoliation and those residents not minding the occasional dead tree as
long as birds were around to perch on them were not easily forgotten. Many once close
friends no longer wanted to speak to each other. Trying to defuse the tension, the Laboratory
held an evening meeting so our neighbors could hear scientists on both sides discuss the
issues. After it was over, however, neither side saw any reason to move closer to the other's
view. Though I was once solidly on the environmentalist side, I was then badly bothered by
the EDF seeing recombinant DNA as much its enemy as pesticides. Though I soon warned
Amy that his organization's ranting against DNA risked alienating its backing by serious sci-
entists, he saw its good features more important than its possible bad judgment about DNA.
In contrast, I saw its well-intentioned trustees, badly misled by staff, creating more of their
kind through the pandering of irresponsible scare stories. If what the EDF said about DNA
was nonsense, should I trust its views on pesticides?
But even when I so strongly disagreed with Amy, it was impossible not to continue to like
and admire him. There was no one in our community more committed to our purposes of
education and research or who more enjoyed walking through our woods and telling us how
much he valued our existence. To him Cold Spring Harbor, unlike, say, Greenwich across the
Sound, would always be much more than a commuter's site for sleeping, where residents
were always more involved with where they worked than where they lived. To Amy, it was the
mind as exemplified by the achievements of science and the arts that reflected human beings
at their best. In working so long and effectively on behalf of Cold Spring Harbor and the cul-
tural scene of New York City, Amy never doubted that benefits would flow out to all the inhab-
itants of our globe.
Noblesse oblige was never better represented in our times.
James D. Watson
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Jack Richards (1925-2000)
Jack Richards, a master contractor whose
keen sense of how a good building should be
put together underpins the whole fabric of
research and education at Cold Spring
Harbor, died on March 4, 2000. A Long
Islander virtually all his life, he grew up in
Stewart Manor to the west of Garden City
and attended Sewanhaka High School in
Floral Park from 1939 to 1943. With the war
then raging, Jack enlisted in the Coast Guard
as soon as they would accept him. Upon his
return from service, he completed his high-
school-equivalency exam. Knowing then
what he could do superbly-work with wood,
sail, and ski-Jack had no desire for more
formal education. After his postwar marriage
to his high-school sweetheart, Cory Scala, he
worked for 10 years as an employee for the
Nassau-Suffolk Lumber Company in
Huntington. The first house he built was for
the two of them, located on a plot of land in
Huntington along Southdown Road just after
it turns right to go north toward Lloyd Harbor.
This land previously belonged to his employ-
er who, though knowing that Jack and Cory
then had no savings, gave them a clear title to the land. He knew that Jack would pay back its
several-thousand-dollar cost through deductions from future salary checks.
Soon after he joined Nassau-Suffolk Lumber, Jack first came to the Biological
Laboratories along Bungtown Road where he obtained a small order for nails and some
lumber. Then, the Biolabs had a reputation for paying their bills very late, with many in the
Huntington community believing its eventual bankruptcy would prevent many local mer-
chants from ever being fully paid. In 1959, Jack took the plunge to move out on his own as
a self-employed builder of residential houses-sometimes for designated clients but often
"on spec," depending on later finding buyers who would let him take home genuine profits
from his labors. With his skills as an honest contractor soon becoming known, Jack never
was without at least one new home to build.
Jack's first contact with the Laboratory as a builder came through the New York architect
Harold Edelman. In the mid-1960s, Harold had several commissions in the Huntington
region on which Jack worked. Then Harold was also working for John Cairns, who, as the
Laboratory's Director, was in constant need of advice about how to keep the Laboratory's
old buildings going for science or human habitation. Initially, none of the renovation projects
that Harold asked Jack to bid on were given to him. In particular, he missed being able to
rebuild Osterhaut Cottage in 1969 to serve as a residence for Liz and me. So, Jack was
more than reluctant when Harold asked him to bid later that year on the addition to James
Laboratory that was to provide offices and a seminar room for scientists working on tumor
viruses. Jack made the lowest bid and was asked to do the job. Soon after, our then super-
intendent of Buildings and Grounds, Don Eckels, decided to return to California to take
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charge of the City of Davis park systems. We asked Jack whether he might like to build the
James Annex, not as an independent contractor but as our Director of Buildings and
Grounds. Initially, Jack only perceived trouble in becoming our employee. As self-employed,
he could go off on Fridays for weekends of skiing or sailing. In response, we told him that
that is how good scientists work and play and he would be a perfect companion to our then
two chief scientists, John Cairns and Ray Geste land. In the end, Jack gave up the indepen-
dence that all too often gave him clients who never used to pay for late-made changes in
construction plans.
From then on, until his official retirement some four years ago, Jack was in effect the con-
tractor for all but the biggest of the Laboratory's construction contracts, using often the
same subcontractors whom he had trusted and enjoyed working with as a private contrac-
tor. Though official Laboratory policies often forced him to go out for bids, Jack never liked
the process, usually knowing what a job should cost and what would be reasonable profits
for his subcontractors to take home. At the same time, Jack proved of inestimable value to
our young architects, making them aware when they had unnecessarily overdesigned pro-
posed buildings by showing how simpler, less costly architectural solutions would do equal-
ly well.
In his early years, when we had far fewer employees, Jack never questioned the need to
drive the snowplow or to man a lawn mower when special occasions demanded the
Laboratory look its best. Never the person to get his way by loud shots or nasty retorts,
Jack's way was to hire individuals who justly took pride in their specific talents and who could
be counted on to work through the night-say, in the midst of an ice storm.
For the next two decades, Jack would regularly appear in my office to point out alternative
ways of moving ahead. Many of these occasions represented differences in opinion between
him and the architects, and he wanted my concurrence before seemingly forcing his opinion
on the architect. One such case occurred this past year during the construction of our new
Samuel Freeman Building. The decision to give up having a basement then suddenly resulted
in a proposed flat furnace addition that looked to us like a square carbuncle. With Jack and me
holding firm, our architect, Jim Childress, came up with a new solution that pleases all.
Jack's seemingly instinctive knack for knowing how to behave stayed with him all through
his four-year-long fight against prostate cancer. Never one to seek help when he remained
capable of taking care of himself, Jack, until the last month of his illness, drove by himself
into New York City to receive the radiation or chemotherapy treatments that largely kept him
out of pain. But they weakened his body, and finally he could not hide the heavy tiredness
that increasingly took over his body at times of intense therapy. Always the best way then to
bring back Jack's spirit was to talk about buildings in the course of construction or designs
that soon must be made. Though Jack was finally to need a cane to move about, his face
until the end was never that of an old or sick person. His brain remained functioning at high
capacity, and his advice was as sensible and to the point as ever. Luckily, his end came swift-
ly and painlessly in Florida, where he went to enjoy the sun and its warmth after still one more
round of treatments. For a week, he could enjoy looking out upon the green surrounding him.
A bacterial infection then swiftly filled his lungs and his eyes and face sparkled no more.
The respect and affection that he felt for our Laboratory and its purposes will remain an
indelible feature of our history. In turn, we shall miss him more than words can ever convey.
James D. Watson
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REPORT
In the waning years of the 19th century, the Biological Laboratory at Cold Spring Harbor was
expanding its summer program of research and courses that then focused on organism-based
biology, encompassing the fields of botany, zoology, bacteriology, and embryology. At the same
time, events in Europe would soon have a profound influence on the science at the fledgling
laboratory and shape much of biology in the then new 20th century. The hybridist, Hugo de
Vries, professor of botany at the University of Amsterdam, completed his extensive, decade-
long research on plant hybridization that uncovered quantitative laws of inheritance, research
that he first published in 1900. Sparked by the circulation of reprints of the de Vries manuscript,
Carl Correns and Erich von Tschermak published accounts of their independent research on
plant hybridization in the same year, coming to the same conclusion that traits were inherited
as discrete, quantitative units. All three had independently, and to de Vries's disappointment,
rediscovered Gregor Mendel's laws of heredity that had remained unappreciated for over three
decades. The Darwinian disciple William Bateson, upon receiving de Vries's paper, immediate-
ly recognized the importance of the combined discoveries. He soon presented a synthesis of
the new field to the Royal Horticultural Society in May of 1900, almost exactly 100 years ago,
and, in 1905, coined the term genetics.
Charles Davenport, who was by then director of the Biological Laboratory, was aware of
these dramatic developments and quickly seized the opportunity to bring Mende lism to Cold
Spring Harbor. Davenport was already concerned with understanding inheritance and how it
related to evolution. By 1902, he had outlined a plan to the Executive Committee of the
Carnegie Institution of Washington for the establishment of a Station for Experimental Evolution,
a proposal that was in competition with a rival scheme from the Marine Biological Laboratory
at Woods Hole. Fortunately, the Carnegie Institution executive approved Davenport's proposal
in 1903, and by 1904, the Station opened with great fanfare. The now celebrated Hugo de Vries
was appointed as an honorary associate of the Station for Experimental Evolution and spoke
at the opening of the new laboratory. There, he echoed Davenport's belief that understanding
the process of evolution necessitates direct experimentation on plants and animals.
Remarkably, de Vries chose not to mention Mendel, probably because he considered his 10 or
12 years of studies on plant hybridization to be more extensive and superior to Mendel's work
with a limited number of species. Although Mendel was not yet celebrated by those present,
Charles Darwin was much in the minds of the assembled, and his revolutionary ideas and stud-
ies on evolution of species, by now 45 years old, heavily influenced the goals of the new sci-
ence. The very name of the station indicated that the principal goal was to understand the laws
of inheritance and, thereafter, the secrets of evolution would fall into place.
Evolution and the new science were not only on the minds of the assembled scientists, but
clearly were of concern to others present. W.R.T. Jones, brother of the late John D. Jones, one
of founders of the Biological Laboratory and governor of the Wawapex Society which owned
the Carnegie land, suggested that the new experimental station would revitalize Cold Spring
Harbor and its environs, making "our village" well known both at home and abroad. That pre-
diction was more than fulfilled. But Jones also raised concern by stating, "I trust in going back
and investigating, as far as possible, the origin and order in creation, it will find nothing to inter-
fere with the doctrine of the church just around the corner, erected largely by the aid of family
relatives, in its efforts for improving morals and explaining to the best of its ability life hereafter."
This not so subtle plea reflected the tussle between Darwin's ideas and the doctrines of the
Christian church that, unfortunately, has not disappeared after 100 years of enormous insight
into the nature of life and the process of evolution. Recent pronouncements by misguided edu-
cators in Kansas, who eliminated the teaching of evolution from school curriculum because cre-
ation was not taught, make it clear that it is still a challenge for some to separate religious beliefs
from scientific reason and progress. What is not appreciated by many is that creation, if it should
be taught at all, should be taught within the context of religious education, not in the schools
as an alternative to evolution. But the very fact that this debate still exits suggests that science
will always be a target for attack both because it often challenges accepted opinion and dogma
and because it is sometimes difficult for the public to grasp complex new ideas. Thus, it is easy
for a vocal few to twist the scientific progress to confuse others.
One of the first appointments to the Experimental Station at Cold Spring Harbor was Dr.
George Shull, who, in 1904, set about preparing the fertile ground for the planting of a variety
of species, including species whose seeds were obtained from de Vries. His goal was to con-
firm the Mendelian laws of inheritance in as many plant species as possible, but within four
years, he would clearly state a principle that would change the agricultural economy. By con-
tinual self-fertilization of purebred types of Indian corn, the plants reached a state of low vigor
that could not be rescued by further selfing of plants of the same type. But superior vigor was
obtained routinely by crossing individuals belonging to distinct types, a technique that would
dominate agricultural genetics in years to come and cause a revolution in plant breeding.
The new science of genetics progressed rapidly after the rediscovery of Mendel's principles
of inheritance, with the period of classic genetics and cytology dominating the 1920s and
1930s. Through the efforts of some of the giants of the classic period, including Thomas Hunt
Morgan, Alfred Sturtevant, Calvin Bridges, Herman Muller, and Barbara McClintock (here at
Cold Spring Harbor), the chromosomal theory of inheritance was solidified. Units of inheritance
were mapped to chromosomes, and their recombination was traced to the physical interchange
between chromosomal landmarks. However, it was not until the amazing discovery by Jim
Watson and Francis Crick of the double helix that the secret of inheritance was revealed, set-
ting the stage for the dramatic advances in the last half of the 20th century. Two decades after
the double helix, recombinant DNA set the stage for remarkable advances in cell and molecu-
lar biology, and ushered in the biotechnology era.
It is fitting that just as Mendelism set the stage for the 20th century to become the age of
genetics, so determining the complete DNA sequence of the genome of organisms is setting
the stage for biology in the 21st century. In just the past five years, the genomes of many
microorganisms have been sequenced, as well as those of yeast, the nematode worm
Caenorhabditis elegans, the first two chromosomes of the plant Arabidopsis, and the first
human chromosome. Even as I write this, the next milestone-the sequence of the genome of
the fruit fly Drosophila-will soon be published.
In his 1904 remarks at Cold Spring Harbor, de Vries saw clearly that the new science of
genetics would be useful to mankind since "methods would be discovered which might be
applied to garden plants and vegetables, and perhaps even to agricultural crops, in order to
induce them to yield still more useful novelties." His optimism was fully justified. Manipulation
through classical breeding techniques goes back thousands of years to the founding of agri-
culture itself, but genetics provided a scientific basis for new experimentation leading to such
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advances as Shull's hybrid corn. Our new knowledge of all the genes of important organisms
will have an even greater benefit for all human beings.
Take, for example, what we have learned from the complete sequences of Arabidopsis chro-
mosomes II and IV, determined in part by Dick McCombie and Rob Martienssen at the Cold
Spring Harbor Laboratory Genome Sequencing Center. This new information has uncovered
much about how genomes evolve to create diversity; large regions of duplication of DNA
sequences, exchange between chromosomes, and complicated rearrangement of regions
within chromosomes have created new genes for nature to exploit. From a practical point of
view, what we learn from the Arabidopsis genome will tell us much about genes in other plants.
The complete sequence of the Arabidopsis genome, expected toward the end of 2000, is
eagerly awaited, and insights into the structure of the genome of this plant has propelled efforts,
of which we are apart, to determine the complete sequence of the rice genome. Similar com-
parisons will soon be possible with another international effort to sequence the mouse genome
and, eventually, to compare it with the human genome. The foresight of David Luke, immediate
past chairman of the Laboratory's Board of Trustees, in helping to establish the Genome
Sequencing Center has ensured that Cold Spring Harbor Laboratory remains at the cutting
edge of genetics, just as the Carnegie investment did in the early years of the last century.
De Vries could not have imagined the remarkable discoveries of recombinant DNA and the
ability to manipulate plant genomes with high precision. But we now have available techniques
that enable rational design of desired characteristics that were previously acquired only through
prolonged breeding and selection. Genetically modified plants are the future of agriculture and
the possibilities they offer are both exciting and unlimited. Creation of disease-resistant crops
that do not require the spraying of large amounts of chemicals into the environment makes plain
sense. Production of plants that provide much-needed dietary supplements, particularly in the
third world, is a moral imperative. Production of varieties that reduce the need for vast amounts
of fertilizer also contributes to a better environment and reduces costs to farmers. In the third
world, crops that can better survive under adverse conditions will become a necessity as pop-
ulations expand. The much-touted methods of organic farming are a luxury that only wealthy
individuals in economically privileged societies can indulge in, for they cannot serve the needs
of the masses. Organic farming on a large scale will be nothing short of an environmental dis-
aster. The developments of 20th-century genetics make all of these possibilities a reality.
Unfortunately, this reality has triggered a reaction from some, particularly in Europe, that is
the cause of great concern. The opposition to the use of genetically engineered (GE) food is
most often irrational and not targeted at the science, but at peripheral issues that suit the agen-
das of minority groups. Genetically engineered food has become a sitting duck for groups that
are opposed to such diverse issues as the potential dominance of multinational corporations,
the demise of the local farmer, scientists playing God, the economic dominance of the United
States over technically challenged states, and even international trade. Perhaps more justifiable
concerns are whether the technology is safe and what are the long-term consequences of
modifying crops. There are even rational arguments for the cultivation of genetically modified,
long-lived plants that are designed to be infertile to ensure that they do not mix with native or
wild species. But even these concerns are due to not understanding the technology or are
based on fear of the unknown. If this type of thinking prevails in society, then we are never going
to make any advances, technical or otherwise.
The anti-GE food groups have been quick to jump onto a growing bandwagon that attacks
science indirectly. Often, they use the results of scientific investigation to suit their own pur-
poses and in doing so misrepresent the scientific process. Such was the case following the
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publication in the journal Nature of a study from Cornell University of the forced feeding of pollen
from corn that had been genetically engineered to produce an organic, naturally occurring toxin,
Bt. The study subjected monarch butterflies to a choice of eating milkweed covered with the
pollen or nothing at all and reported that about half of the butterflies died in the experiment. The
experiment confirmed other studies that insects die when they consume Bt. The publication
was heralded by a misguided publicity machine from Cornell and was immediately picked up
by the anti-GE groups as their cause célebre. The paper has since been criticized by colleagues
of the original authors and deemed to be an unlikely event in the field because Bt is rapidly inac-
tivated by sunlight not present in the laboratory studies. Moreover, Bt has been used for many
years, and no adverse effect has been recorded. Despite the fact that further experimentation
and studies have not found any support for the demise of monarch butterflies, the anti-GE
groups continue to flutter around with multicolored wings, pushing their agendas. Such irra-
tional behavior has induced the further inexplicable decisions of a few major corporations to
abandon the use of GE crops, even after they have been using the technology safely for years.
Moreover, such protests gloss over the clear documentation of the adverse effects of the use
of chemical pesticides.
In the early 1970s, the recombinant DNA debate reached the public forum, and misunder-
standing of the science and a fear of the unknown fueled exaggeration of the issues. Now, with
the benefit of hindsight, genetic engineering technology has proved to be one of the safest to
have been used for the benefit of humankind. Perhaps we should learn a lesson from the
recombinant DNA debates about how science, when it receives the attention of the public,
should be discussed. First and foremost is that scientists should make every effort to educate
the public and keep society abreast of the emerging science. Such efforts eventually won the
day in Switzerland, where political events drove the country into referenda about the use of
recombinant DNA technology. Here, improved communication between scientists and the pub-
lic resulted in a slim majority rejecting the excessive claims of the naysayers. Although the issue
has not disappeared in Switzerland, the fact that Swiss scientists did not have to leave the
country to continue to do their research is due to their efforts in public education.
Genetics and genomics have great promise for the future, both for the insight they will pro-
vide into the ways of nature and for the tangible benefits to mankind. For the most part, the sci-
entific community pursues its research and develops technologies in isolation. We are driven by
curiosity to shed light on the unknown, but for biology, times have changed, and we must do
this as members of a broader society. We also have responsibilities as scientists. There are
times when scientists must take a stand against those who seek to manipulate the scientific
harvest for purposes that have nothing to do with the science itself. Otherwise, once encour-
aged by success, science will forever be abused.
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HIGHLIGHTS OF THE YEAR
The research and education programs at the Laboratory remain strong and vibrant. The
recruitment of the first students in the Watson School of Biological Sciences and the com-
pletion of their intensive core courses highlighted progress this year. The DNA Learning
Center introduced new, Web-based educational tools, and the meetings and courses pro-
grams at the main campus and the Banbury Center continued to provide a valuable service
to the scientific community. Significantly, the Laboratory Press saw the continued develop-
ment of its exciting textbook-publishing program as part of the Laboratory's goal to promote
innovative teaching programs for graduate students and senior undergraduate students.
These educational programs occur in the surrounding of a strong research environment, with
research and education braided together in a common enterprise.
Research
Neuroscience
Roberto Malinow and Karel Svoboda have continued to push the limits of
brain imaging by observing the changes that occur in individual neurons as
they respond to electrical stimuli. Combining their expertise in electrophysi-
ology and high-resolution imaging of the brain, they study the cellular events
that underlie "synaptic plasticity"-the ability of brain neurons to reorganize
their connections in response to experience, such as during learning and
consolidation of memories. In particular, Roberto and Karel are exploring the
mechanisms involved in long-term potentiation (LTP), the strengthening of
synaptic connections between nerve cells in response to trained stimuli.
Their studies focus on a region of the brain involved in learning and memory called the hip-
pocampus, a region required for a form of memory called declarative memory, or the con-
scious memory of learned events.
This year, Roberto and Karel studied the distribution of AMPA receptors
within dendrites, a nerve cell property they suspect contributes to LTP.
AMPA and other receptors mediate the effects of glutamate, a key neuro-
transmitter that is one chemical which crosses the synapse or gap between
neurons. They first engineered hippocampal neurons to express a fluores-
cent version of the AMPA receptor so they could track its movement within
the processes called dendrites that branch from the neuronal cell. They used
a high-resolution optical-maging system called two-photon laser-scanning
microscopy, both before and after electrical stimulation.
Before stimulation, AMPA receptors were distributed evenly along the
branch-like shafts of dendrites, but were largely restricted from the dendrit-
ic spines that project from shafts and are where the synapses lie. After stim-
ulation, however, AMPA receptors moved rapidly into the spines. Synapses
are typically located at the tips of spines, but without functional AMPA recep-
Karel Svoboda
tors, such synapses are inactive, or "silent." Therefore, the movement of AMPA receptors
into dendritic spines may contribute to LTP, at least in part, by converting silent synapses to
Roberto Malinow
5
active synapses. Moreover, evidence from Roberto's lab suggests that the constant replen-
ishment of AMPA receptors at synapses may be involved in maintaining synapses in an
active state over long periods of time. It is an intriguing possibility that this form of synaptic
plasticity may underlie the development of the brain's neuronal network and function of neu-
rons in an adult brain.
Roberto and Karel's studies provide some of the first real-time, high-resolution images of
the events that are likely to power the restructuring of vast neural networks within an impor-
tant site for learning and memory in the brain.
Yi Zhong and his colleagues are also studying the neurological basis of
learning and memory, but in the fruit fly Drosophila. They have recently
focused their efforts on explaining the puzzling observation that a human
disease called neurofibromatosis causes both cancer and learning defects.
Neurofibromatosis is one of the most common inherited genetic disor-
ders affecting humans. The disease is characterized by discoloration and
tumors of the skin and is caused by mutations in the NF1 gene. NF1
encodes a protein that inhibits the activity of the Ras protooncogene prod-
uct, another protein that is altered in many human tumors. Thus, when the
NF1 gene is mutated, the resulting uncontrolled activity of Ras can lead to
cancer. But how mutations in NF1 lead to cancer and learning defects was
unknown.
From previous work, Yi knew that an enzyme called adenylyl cyclase was
required for learning in Drosophila. He also knew that adenylyl cyclase activ-
ity was stimulated by the Drosophila NF1 protein (human and Drosophila NF1 are remark-
ably similar, so much so that human NF1 can substitute for its Drosophila counterpart in
transgeneic flies). Yi and his colleagues first established that Drosophila-like humans and
mice-requires NF1 for learning (in this case, learning to avoid a particular odor that was
paired with a small electrical shock).
It was first necessary to determine whether the defects in adult flies lacking NF1 were an
indirect result of developmental abnormalities due to the loss of NF1 activity as the brain devel-
ops. But experiments demonstrated that the learning defect in flies lacking NF1 could be cor-
rected during adulthood by a burst of NF1 from an externally controlled gene. Then, in a series
of elegant experiments, Yi showed that the effects of NF1 on learning are mediated by the
enzyme protein kinase A, an enzyme that lies downstream from NF1 and adenylyl cyclase in
the regulatory pathway controlling learning. Since protein kinase A is a well-characterized
enzyme, the studies suggest that by activating it, the learning deficit could be reversed.
Yi's studies reveal the role of NF1 in a new mechanism that contributes to normal learn-
ing and memory in Drosophila. Because this pathway is conserved from fruit flies to humans,
there is a distinct possibility that pharmacological intervention in the adenylyl cyclase path-
way might reverse the NF1 defect in humans.
Yi Zhong
Virus-induced Pathogenicity: The Case of HIV
The genomes of human and simian immunodeficiency viruses, HIV and SIV, encode several
auxiliary proteins that modulate the function of infected cells and optimize virus propagation
in part by enabling infected cells to evade the host's antiviral immune response. Determining
how these auxiliary proteins work is therefore important for understanding the pathogenesis
of AIDS and how an effective vaccine might be formulated.
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Jacek Skowronski and his colleagues are studying how one of these auxiliary proteins,
Nef, promotes HIV infection. The Nef proteins of HIV and SIV are similar, and each fulfills mul-
tiple roles in the course of viral infection. The goal of the experiments in Jacek's laboratory is
to determine how Nef interacts with protein sorting and signal transduction machinery in T
cells and macrophages, two immune system cell types that are infected by HIV.
Jacek and his colleagues have found that Nef is required for the "down-regulation" or
removal of particular host-cell proteins from the cell surface (CD4 and class I MHC proteins).
Moreover, a collaboration with scientists at Erlangen University (Germany) and Harvard
University has led to the identification of certain mutations in Nef that selectively disrupt its
ability to down-regulate CD4, thereby greatly decreasing viral replication during the acute
phase of viral infection.
One future challenge for the Skowronski group is to determine precisely how down-regu-
lation of CD4 and class I MHC by Nef promotes viral propagation. One possibility is that by
removing CD4 and MHC I from the cell surface, Nef enables HIV-infected cells to evade the
body's immune response. Alternatively, Nef might be required to optimize host-cell survival
so that the virus has a chance to reproduce before it kills the cell.
Cancer Research: Regulation of Cell Death
The genetically programmed death of cells is a normal part of growth and development. In
addition, programmed cell death, or "apoptosis," safeguards organisms from cancer by trig-
gering the self-destruction of precancerous cells. A hallmark of many types of cancer is a
defect in apoptosis that allows precancerous cells to survive and proliferate, and eventually
form a tumor.
Yuri Lazebnik and his colleagues are exploring the possibility that restoring the ability of
cancer cells to self-destruct via apoptosis might be an effective therapeutic strategy. They
study a family of enzymes called caspases that act in a proteolytic cascade to execute pro-
grammed cell death. Among several known caspases, caspases 2, 8, and 9 are thought to
be "initiator" caspases. In response to cellular self-destruct signals, these caspases trigger a
chain reaction in which a series of "effector" caspases are converted from an inactive to an
active form. Once activated, effector caspases cleave key cellular proteins, and cell death fol-
lows due to destruction of DNA, disruption of nuclear structure, and disintegration of cells
into small vesicles.
Previous work from Yuri's lab suggested that a caspase cascade leading to self-destruc-
tion remains functional in cancer cells, but it is uncoupled from the signal that triggers its acti-
vation. To study this critical link between a cell death signal and the caspase-mediated cell
death machinery, Yuri and his colleagues purified a cellular factor that could trigger caspase-
mediated apoptosis. They found that a known protein called APAF-1 (apoptosis activation
factor-/) plus caspase-9 are key components in triggering apoptosis in tumor cells. Another
lab had shown that APAF-1 stimulated the biochemical activity of caspase-9, but precisely
how APAF-1 worked on caspase-9 remained a puzzle.
Effector caspases are synthesized as inactive precursors that are activated upon cleav-
age by other "upstream" caspases. For example, caspase-3 (an effector caspase) is cleaved
and activated by caspase-9 (an initiator caspase), but how the initiator caspase is cleaved
and activated was unclear. The observation that APAF-1 can bind directly to caspase-9 led
some scientists to believe that APAF-1 brings two different caspase-9 molecules together,
which then cleave and activate each other. To the contrary, Yuri and his colleagues have now
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shown that APAF-1 is a regulatory subunit that is in a complex with caspase-9 and causes
a 1000-fold increase in caspase-9 activity, probably by triggering the ability of individual cas-
pase-9 molecules to cleave and activate themselves. Now that the process whereby the
APAF-1/caspase-9 "holoenzyme" activates the cell death machinery has been investigated,
it is possible to investigate ways to recouple this machinery to the self-destruct signals that
are generated in cancer cells, but are normally ignored.
Controlling Cell Shape
During development and throughout adulthood, animal cells within multicellular organisms
proliferate, migrate various distances, and take up residence as parts of tissues and
organs. The regulation of this dynamic process involves the ability of cells to sense and
respond to diffusible growth factors and the extracellular matrix (ECM) that surrounds them.
Metastatic cancer cells become independent of growth factors for their survival and break
free from their extracellular matrix moorings to invade areas of the body outside their nor-
mal domain.
David Helfman studies how growth factors and the interaction of cells with the ECM reg-
ulate oncogene-mediated signal transduction pathways. In particular, he investigates how
growth factors regulate the contractility of the actin/myosin cytoskeleton of cells. All cells
have such a system, but it is particularly effective in muscle cells since actin and myosin are
responsible for muscle cell contractions. David is interested in how increased contractility
stimulates cell-ECM interactions and promotes the growth and survival of cells in part by
blocking programmed cell death.
David has discovered that overexpressing a cytoskeletal protein called caldesmon inhibits
contractility and interferes with the formation of "focal adhesions," the structures that medi-
ate cell-ECM interactions. His results (obtained in collaboration with Alex Bershadsky of the
Weizmann Institute, Rehovot, Israel) identify a new pathway for the regulation of cytoskele-
tal function, and they suggest that caldesmon can counteract some of the stimulatory effects
of the Ras oncogene product on cell growth. Moreover, they provide new information about
how the movement of nonmuscle cells is controlled. David's finding that caldesmon affects
focal adhesion formation is also important for understanding adhesion-dependent signaling,
a process in which the cell's attachment to a substrate triggers changes in cell physiology
that promote cell growth and survival.
Epigenetic Inheritance of Gene Expression
Not all clones are created equal. As genetically identical cells (such as those in an embryo)
multiply, different sets of genes are switched on and others off, giving rise to cells and tis-
sues with distinctive properties (e.g., liver versus muscle).
Such differential gene expression is often established by alterations in the large-scale
architecture, or chromatin structure, of DNA. For example, transcriptionally silent regions of
DNA are packaged into forms of chromatin that may be less accessible to certain transcrip-
tion factors. In contrast, transcriptionally active regions of DNA adopt alternate chromatin
structures that may be more accessible to certain transcription factors. A particular DNA
sequence can be silent or active, depending on its position within the genome or the type of
cell in which it resides. Such states of chromatin are said to be epigenetic because they can
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be inherited in a stable manner. Examples occur in inactivation of one of the X chromosomes
in female mammals, in certain human cancers, and in parental imprinting of genes.
Shiv Grewal and his colleagues use a powerful model system in the fission yeast
Schizosaccharomyces pombe to study how the active and silenced states of gene expres-
sion are established. Working at the National Cancer Institute, Shiv and former CSHL scien-
tist Amar Klar showed that in a particular region of the fission yeast genome, active and silent
states of gene expression can be stably inherited through mitosis (cell division) and, remark-
ably, through meiosis (the division leading to spores or gametes for the next generation).
These findings were striking because scientists had generally believed that different states of
chromatin structure were erased during meiosis to enable unbiased gene expression after
the fusion of gametes.
In essence, Shiv found that the Mendelian inheritance of traits sometimes depends not
only on the faithful replication of DNA sequences, but also on the transmission of higher
orders of chromatin structure. The "gene" in these instances is thus not only DNA, but DNA
plus associated proteins. Shiv has proposed a chromatin replication model in which both the
DNA molecule and higher-order chromatin structure are duplicated.
Since joining the faculty of CSHL in 1998, Shiv has tested several predictions of the chro-
matin replication model. He has found that among several potential candidates, a particular
protein, Swi6, is critical for establishing a silenced state of chromatin structure and that Swi6
is required to maintain silencing through multiple mitotic cell divisions or meiosis.
Histone proteins are major determinants of chromatin structure, and the chemical modifi-
cation of histones (e.g., acetylation) is known to affect chromatin structure. Shiv has observed
that an enzyme that de-acetylates histones, C1r3, is required-in addition to Swi6-for the
silenced state of chromatin structure to be maintained. He also showed that Swi6 binding is
enriched in a silenced region of DNA and that the histones bound to silenced DNA are less
acetylated than are histones bound to the identical region of DNA when it is active.
Because proteins homologous to Swi6 and C1r3 exist in organisms as diverse as fungi,
Drosophila, and humans, mechanisms for the inheritance of chromatin structure akin to that
studied by Shiv are likely to be widespread in nature. In fact, there are proteins in mammalian
cells that function like Swi6, and in my own laboratory, we have found that these mammalian
cell proteins are bound to a chromatin assembly factor (CAF-1) that is itself tethered to one
of the proteins responsible for replicating DNA, called PCNA. Thus, there exists a direct bio-
chemical link between the inheritance of DNA and the inheritance of chromatin. Interestingly,
mutations in CAF-1 in the budding yeast Saccharomyces cerevisiae cause defects in epige-
netic inheritance.
Regulation of Transcription in Cancers
The control of transcription itself is likely a major contributor to progression in human can-
cers and indeed, many oncogene products are errant transcription factors. Bill Tansey and
his colleagues study cell proliferation and how defects in the regulation of transcription can
lead to cancer.
The c-myc gene encodes a transcription factor that plays a critical role in promoting nor-
mal cellular proliferation. Because the Myc transcription factor is a potent cell proliferation
stimulator, the level of Myc within cells is normally tightly controlled. An unfortunate conse-
quence of the power of Myc to stimulate cell proliferation is that unregulated Myc activity can
lead to cancer.
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The amount of Myc protein in cells is determined not only by how much Myc is synthe-
sized in a given time frame, but also by how quickly it is destroyed. Bill is studying how the
destruction of the Myc protein is regulated and how defects in this process lead to abnor-
mally high levels of Myc, and potentially to cancer.
First, Bill showed that Myc is normally destroyed by the proteasome, a large complex of
enzymes that cuts proteins targeted for destruction into small pieces. This process-called
ubiquitin-mediated proteolysis-enables the abundance of many different kinds of proteins,
including Myc, to be adjusted in response to particular cellular conditions.
Next, Bill mapped the regions of the Myc protein necessary to target it for destruction by
the proteasome. He found that a region encompassing the amino-terminal third of the Myc
protein was sufficient to promote the destruction of Myc. Significantly, mutations in this
region of Myc are associated with Burkitt's lymphoma, plasmacytomas, and other kinds of
cancer. Bill and his colleagues tested five such cancer-associated mutations of Myc and
found that four of them blocked Myc degradation. These observations raise the possibility
that the mutations contribute to cancer by blocking Myc degradation, thereby increasing the
levels of Myc in cells and causing them to promote cell division.
Finally, Bill found that the region required for Myc degradation overlaps with the domain
of Myc that mediates its function in activating transcription of certain genes. Thus, he uncov-
ered an intriguing underlying connection between two processes-proteolysis and tran-
scriptional activation-that had not previously been characterized. This connection between
proteolysis and transcriptional activation appears to be common in short-lived regulators of
gene expression.
in the Nucleus
David Spector and his colleagues are studying the dynamic movements of molecular assem-
blages that mediate two essential, intimately connected processes in the cell nucleus: tran-
scription and pre-messenger RNA (pre-mRNA) splicing.
Transcription is the process whereby the enzyme RNA polymerase synthesizes RNA mol-
ecules from DNA templates. During transcription, RNA polymerase proceeds from one end
of a gene to the other, synthesizing a continuously elongating pre-mRNA molecule as it
moves along the DNA.
Pre-mRNA molecules contain sequences that encode protein, called exons, as well as
noncoding pieces of RNA called introns that are removed by the splicing machinery of the
nucleus. Interestingly, splicing often begins before the synthesis of pre-mRNA molecules is
completed, i.e., as pre-mRNA molecules emerge from the transcription apparatus. This year,
David and his colleagues have discovered important new information about the components
of the splicing machinery and how its mode of action is linked to gene transcription.
They showed that truncating the carboxy-terminal domain (CTD) of RNA polymerase pre-
vents the targeting of the splicing machinery to transcription sites and eliminates pre-mRNA
splicing. These results indicate that the splicing machinery is recruited to transcription sites
by binding to the CTD of RNA polymerase. In essence, the splicing machinery gainseasy
access to pre-mRNA transcripts by piggybacking on the enzyme that makes the transcripts.
Abundant evidence indicates that splicing factors are assembled and/or stored in large
multiprotein complexes called interchromatin granule clusters (IGCs). But in the 40 years
since IGCs were described, only a single attempt to purify and characterize them in detail
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has been published. David and his colleagues have now succeeded in purifying IGCs, and
they have used mass spectroscopy protein sequencing, in collaboration with former CSHL
staff member Scott Paterson at Amgen Corporation, to identify over 100 different protein
components of these complexes. In addition to several known splicing factors-whose pres-
ence in IGCs was known or expected-many were known transcription factors whose pres-
ence in IGCs was surprising. In addition, 12 new proteins of unknown function were identi-
fied as IGC components and are the subject of ongoing study in David's lab.
Structural Biology
The phenomenon of splicing of pre-mRNA was discovered at CSHL, and Adrian Krainer's
laboratory continues to investigate the biochemistry of this process and how different genes
are spliced into alternative mRNAs by excising different introns. In collaboration with struc-
tural biologist Rui-Ming Xu, Adrian and his colleagues use X-ray crystallography to study-at
the atomic level-the precise structural basis of the protein-RNA interactions that mediate
pre-mRNA splicing.
Human hnRNP Al is an abundant, versatile protein that both binds to the single-strand-
ed regions of DNA present at the ends of chromosomes (called telomeres) and, as Adrian's
lab discovered, regulates the use of alternative 5' splice sites, probably by binding to pre-
mRNA (although how and where is uncertain).
Rui-Ming and his colleagues, in collaboration with Adrian's lab, have solved the crystal
structure of UP1 (a part of human hnRNP Al) which is complexed with telomeric DNA. The
structure reveals an interesting "railroad tie" mode of DNA binding in which two antiparallel
single-stranded DNA molecules (the rails) bind to the surface of two antiparallel, oblong mol-
ecules of UP1 (the ties) oriented at right angles to the DNA. The structure provides a simple
and elegant model for how hnRNP Al binds to telomeres. Moreover, it suggests how hnRNP
Al might bring two strands of RNA into close proximity during the process of pre-mRNA
splicing.
Rui-Ming's work with Adrian demonstrates the synergy that can result when structural and
molecular biologists collaborate to address a given problem. Two other CSHL scientists,
Xiaodong Cheng (now at Emory University) and Winship Herr, benefited in a similar way from
their collaborative effort this year to determine the crystal structure of the herpes simplex
virus (HSV) transcriptional regulatory protein VP16.
Viruses commandeer the transcriptional machinery of host cells, which they use for the
expression of their own genes. During HSV infection, viral gene expression occurs in three
classically defined phases: immediate early, delayed early, and late. This cascade of viral
gene expression is triggered by VP16, a potent activator of immediate-early gene transcrip-
tion that is released into cells upon infection. Following its release into cells, VP16 binds to a
host cell protein called HCF (host cell factor). Then the VP16/HCF complex binds-in com-
bination with a second host cell protein called Oct-l-to the DNA target present in the pro-
moters of HSV immediate-early genes. The transcription of these genes is thus activated,
and a productive viral infection ensues. VP16 also happens to be one of the most common-
ly utilized transcription factors for activating genes that have been introduced by experi-
menters into cells.
To investigate further the role of VP16 in mediating viral gene expression, Xiaodong,
Winship, and their colleagues determined the structure of the conserved core of the VP16
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molecule using X-ray crystallography. They discovered that VP16 is shaped rather like a
chair. The scientists were able to define what parts of VP16 are involved in a particular func-
tion by determining where mutations that specifically disrupt one VP16 function but not
another map on the surface of the protein. For example, Xiaodong and Winship found that
three mutations known to block the assembly of virus particles all cluster on one side of
VP16. In contrast, a mutation known to block the interaction of VP16 with Oct-1 maps on
the other side of the protein.
Xiaodong and Winship also identified a region of VP16 likely to bind to DNA by examin-
ing the charge distribution on the surface of VP16. DNA is negatively charged. Because like
charges repel, protein surfaces that bind DNA are usually positively charged. The seat of the
VP16 chair-like structure has such a positively charged surface. This region is further impli-
cated in DNA binding by evidence from Winship's lab that mutations in the seat bottom dis-
rupt VP16's DNA-binding activity. In short, DNA sits on the VP16 seat.
Studies of VP16, Oct-1, and HCF by Winship and his colleagues have revealed a great
deal of information about how transcription is regulated. The added dimension of structural
information provides an even clearer view of how the molecules that mediate this complex
and dynamic process interact with each other and with DNA.
X-ray crystallographic data sets for the structures of both hnRNP Al and VP16 were col-
lected at Brookhaven National Laboratory, where we now maintain a dedicated high-energy
beam-line. Our proximity to Brookhaven allows our structural biologists to have immediate
access to this natural resource.
Bioinformatics
Lincoln Stein and his colleagues develop computer software programs that enable biologists
to organize, work with, and make sense of the vast amounts of information that are becom-
ing available from human and other genome sequencing projects.
Bioinformatics (the application of computer science to the analysis of biological informa-
tion) is a relatively young field. Ten years ago, the comparison of a newly discovered DNA
sequence with known sequences usually required several hours on a personal computer and
considerable input by the investigator. Today, the same exercise-which
provides clues about the potential function of an uncharacterized sequence
of DNA-takes a few seconds and is conducted by scientists all over the
world via the Internet. The impact of bioinformatics on the future of basic sci-
ence, medicine, and agriculture is difficult to overestimate.
One of Lincoln's first projects was a user-friendly database that allows
biologists to analyze the nematode worm Caenorhabditis elegans genome
in several ways, such as to determine what genes are expressed in a par-
ticular cell type or what human genes are homologous to a particular C. ele-
gans gene. This database currently receives 25,000 "hits" per week and was
recognized by a computer chamber of commerce, LISTNET, as the "Best
Software of 1999 Developed by a Large Company" on Long Island (and
there are some very large computer companies on Long Island).
Lincoln and his colleagues have recently joined a multi-institutional con-
sortium whose goal is to map single nucleotide polymorphisms, or SNPs,
that are distributed throughout the human genome. SNPs are variations (polymorphisms)
among different individuals that occur in sequences of DNA. Although the majority of SNPs
Lincoln Stein
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have no physiological consequences, a particular SNP might be located near a mutation that
is of great physiological consequence (e.g., disease-causing mutation). SNPs are therefore
extremely useful as markers for genetic disease, for the development of reagents to diag-
nose genetic disease, and for the cloning of disease-related genes. In addition, SNPs are
invaluable to scientists interested in tracing the flow of genetic information through human
populations on global and regional scales.
Lincoln and his colleagues have developed software and hardware systems for storing,
analyzing, and disseminating the large amounts of information currently being generated by
the SNP consortium. A 1.5-ton uninterruptible power supply, a closet-sized 1-terabyte stor-
age array, and a high-performance cluster of 40 individual computers linked together in a
"parallel processing" configuration are now all part of the daily operation in Lincoln's lab.
Symposium LXIV
On June 2-9, our activities centered around the 64th annual CSHL
Symposium, entitled Signaling and Gene Expression in the Immune System.
On Sunday, June 6, meeting attendee Irving Weissman, of Stanford
University School of Medicine, delivered the annual Dorcas Cummings
Lecture to a scientific and public audience. His talk "Repairing the Body: The
Promise of Blood and Tissue Stem Cells" addressed a topic that is much in
the news because of its great potential in repairing human disease tissues.
Judging by the enthusiastic reaction of the audience, the lecture was very
well received and timely.
Watson School of Biological Sciences
Irving Weissman
The Laboratory's graduate school-the Watson School of Biological Sciences-became a
reality this year. Recruitment of the inaugural class was an outstanding success. The six new
students arrived late in the summer, beginning classes on September 7. The two core cours-
es-Scientific Reasoning and Logic and Scientific Exposition and Ethics-were supplement-
ed by specialized minicourses and provided an overview of the current state
of biology in many fields. The lecturing presented a new challenge to most
CSHL scientific faculty and quite happily, everyone involved rose beautifully
to the occasion. The huge success of the program is in large measure due
to the tireless efforts of Winship Herr and Lilian Gann, both of whom have
transformed graduate education at CSHL and we hope beyond.
In our first official celebration of the Watson School, the Laboratory held a
convocation on November 5 at which we bestowed the honorary degree of
Doctor of Science honoris causa on three esteemed scientists: David
Baltimore, president of the California Institute of Technology; Gerald Fink,
director of the Whitehead Institute for Biomedical Research and American
Cancer Society Professor of Genetics at the Massachusetts Institute of
Technology; and Seymour Benzer, the James Griffin Boswell Professor of
Neuroscience at the California Institute of Technology. Each of them played
a significant part in the education programs at the Laboratory, from under- Winship Herr
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graduate research to postgraduate courses. Their citations and acceptance speeches after
receiving the degree are printed in the Watson School of Biological Sciences section of this
Annual Report.
In November, Jim Watson delivered a series of lectures to commemorate the opening of
the graduate school. The lectures were held in Grace Auditorium in anticipation of the siz-
able audience that might be attracted to hear Jim talk, and we were not disappointed. On
each of four evenings, Jim spoke to a full house. The lectures were entitled "Discovering the
Double Helix" (Nov. 2); "George Gamow and His Combinatorial Approach to the Genetic
Code" (Nov. 9); "Finding the Genes of DNA Tumor Viruses Which Unlock Cellular DNA
Synthesis" (Nov. 16); and "Recombinant DNA and the Beginnings of the Human Genome
Project" (Nov. 22). These lectures have been captured on videotape and will be available to
future students.
Watson School Gala
The Laboratory hosted a gala fund-raiser in Grace Auditorium on October 5th to raise money
for the Watson School of Biological Sciences. We were extremely fortunate to have Lola
Grace as the gala chairman. Thanks to the efforts of Laboratory Trustee Mark Ptashne, we
attracted three of the world's greatest classical musicians-pianist Emanuel Ax, violinist
Midori, and cellist Yo-Yo Ma-to perform a joint program of Mendelssohn. Before the excep-
tional ensemble performance, the audience was treated to a tasting dinner featuring cuisine
prepared by chefs from three of New York City's top gourmet restaurants-Charlie Palmer
of Aureole (who was present to serve his culinary creations), Daniel Boulud of Daniel, and
(Top left) Lola Grace, with daughter Lola and Yo-Yo Ma; (bottom left) Chefs of LeBernadin; (right) Midori, Emanuel Ax, Yo-Yo Ma.
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Eric Ripert of Le Bernardin. Exquisite wines, contributed by Iron Horse Vineyard, stunning
displays of flowers by J. Barry Ferguson Flowers Ltd., and gifts from Tiffany, Estee Lauder,
and Sony Classical helped make the evening a spectacular success for the 350 attendees.
The evening was phenomenal, raising more than $750,000 for the Watson School. We must
thank Lola once again for organizing such a unique event in our lives.
URP 40th Anniversary Reunion
In August, the Laboratory held a two-day reunion for alumni
of the Undergraduate Research Program (URP) in celebra-
tion of the program's 40th anniversary. More than 70 people
returned to reminisce about living and working at the
Laboratory. The event included talks by 14 former URPs and
a keynote talk by former URP and Nobel prize winner David
Baltimore. Their stories gave current scientists a glimpse of
days gone by along Bungtown Road, including parties at the
beach, trips to New York City, and, of course, a memorable
science experience.
Banbury Center
First URP Director Arthur Chovnick and
former URP Gerry Rubin
The first Banbury Center Executives' Conference was held 13 years ago in 1986 and the topic
of the meeting was genomics. Although that word had not been invented at the time, the idea
of sequencing the human genome had been discussed at the Cold Spring Harbor Symposium
earlier the same year, and speakers at that first Executive Conference went on to become
leaders of various genome projects. 1999 seemed the right time to review the state of
genomics; it was a milestone year in the history of genome research due to the completion of
the first sequence of a human chromosome. Among the speakers at the 1999 meeting were
Lee Hood of the University of Washington in Seattle and David Botstein of Stanford University,
both of whom spoke at the 1986 Banbury meeting. We heard about advances in sequenc-
ing, potential applications of data, and the controversies over patenting and commercializa-
tion of DNA sequences. Once again, we are indebted to Sandy Warner, chairman of J.P.
Morgan and Co., and David Demming for their enthusiastic support of this unique meeting.
Banbury Center has a long history of meetings on human genetic disorders, beginning
with a 1982 meeting about the application of recombinant DNA techniques to these disor-
ders. These meetings are of immense immediate value for the discussion of data and ideas,
and they also ultimately promote further research. In 1999, we hosted a meeting on ataxia
telangectasia (AT), a progressive degenerative disorder involving DNA repair, characterized
by degeneration of the brain, lack of muscle control, and immunodeficiency. The meeting
was funded by the AT Children's Project. The Children's Project has been a driving force in
promoting research on AT, and research sponsored by the Project has led to remarkable
advances in our understanding of the basic mechanisms of AT, especially through the iden-
tification of the ATM (mutated AT gene) protein. The Banbury AT meeting was designed to
encourage critical analysis of the current body of knowledge concerning the protein's struc-
ture and function, with particular focus placed on its role in nerve cells. In addition, partici-
pants discussed possible applications of current data to the design of new therapies using
genes or stem cells.
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Banbury's J.P. Morgan Conference
In addition to hosting straightforward scientific meetings, Banbury Center also has a long
history of hosting meetings that deal with controversial topics in biology that have important
societal implications. In earlier years, these topics dealt largely with environmental carcino-
genesis and risk assessment. More recently, we have examined and reviewed possible diffi-
culties arising from new developments in human genetics. In 1999, we focused on xeno-
transplantation, the transplantation of tissues or organs between species (e.g., from animals
to humans). Xenotransplantation raised many of the same issues raised by recombinant
DNA technology in the mid 1970s. How, for example, will we deal with what are-for the pre-
sent at least-unquantifiable risks? In the case of xenotransplantation, one such risk is the
transmission of unknown viruses from pig tissues to human transplant recipients. The ambi-
ence of a Banbury Center meeting, with 30-40 participants from diverse backgrounds gath-
ered in an intimate setting, is particularly conducive to discussion of such controversial top-
ics.
DNA Learning Center
Student visits to the DNA Learning Center (DNALC) plateaued at 30,000, as all available lab
space was used at full capacity. Meanwhile, over 380,000 people visited the DNALC Internet
sites, a threefold increase from 1998. The majority visited the animated genetics primer, DNA
from the Beginning, which went online in January 1999 and was funded by the Josiah Macy,
Jr. Foundation. It has proved immensely popular with teachers, students, and casual Web
surfers.
Several other Internet projects neared completion during 1999. The Image Archive of the
American Eugenics Movement is a searchable database of over 1200 photos and docu-
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Creators of the Image Archive of the American
Eugenics Movement. (Back row, left to right)
Chun-hua Yang, Susan Conova, Shirley Chan,
Matthew Christensen; (front row, left to right)
David Mick los, Susan Lauter, Jan Witkowski.
ments from this dark period in the history of science. It is fitting that Cold Spring Harbor
Laboratory be the source of such information, as, indeed, the Eugenics Record Office (ERO)
was founded in 1910 by Charles B. Davenport, then director of the Biological Laboratory
(which later became CSHL). He set up the headquarters for American eugenics research on
land adjacent to the Carnegie Institute's Station for Experimental Evolution (of which he was
also director). The ERO was closed in 1940 when the Carnegie Institute withdrew its sup-
port.
The new eugenics Web site features a unique interface that displays controversial docu-
ments about sterilization, racial stereotyping, and immigration restriction, along with contex-
tual explanations that help users understand how and why the science went so wrong. In a
different vein, Bioservers offer simple bioinformatics tools that allow students to "mine" infor-
mation from DNA-including using their own DNA to reconstruct human evolution.
A mobile bioinformatics teaching lab, Vector Net, is being constructed under a new
$500,000 grant from the Howard Hughes Medical Institute. Ten lap-top computers will con-
nect to a local server running the entire DNALC Web site, bioinformatics software, and gene
databases-providing an Internet experience without an Internet connection! During the aca-
demic year, Vector Net will be deployed in selected New York City schools; during the sum-
mer, it will be used to conduct teacher-training workshops at sites around the United States.
CSHL Press
Financially, the year was satisfactory, with a 6% increase in revenues and an operating sur-
plus gained through publication of new books, improved journal advertising revenue, and
aggressive marketing efforts. More importantly, the Press continued to serve the scientific
community by providing high-quality publications.
The Press published eight new books and a videotape, including the monograph Prion
Biology and Diseases; the manual Imaging Neurons; and the advanced-level textbooks
Essentials of Glycobiology and Transcriptional Regulation in Eukaryotes. Also notable was a
collection of the outstanding research papers published at the Laboratory from 1903 to
1968, Illuminating Life, which should become a valuable teaching tool. Over 240 titles are in
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print, with a strong backlist led by Using Antibodies and At the Bench. A new, targeted sales
program boosted orders through major resellers.
The journal program continued to flourish. Genes & Development (G&D), Genome
Research (GR), and Learning & Memory (L&M) increased or maintained subscription levels.
Advertising revenues were 30% higher. All three journals were offered more manuscripts than
ever before. The impact factors of G&D and GR, as measured by citation analysis, rose sub-
stantially, and G&D maintained its rank among the top ten primary research journals. Online
editions of all three journals were enhanced by new software tools, and GR developed the
capacity to publish papers online well ahead of print.
The Protein Society selected CSHL Press from a list of ten candidates as the next pub-
lisher of its journal Protein Science. The contract is for the period 2001-2005.
A new program to develop and publish textbooks for undergraduates was initiated early in
the year. Five promising projects were identified, including a book on evolution, and approach-
es to potential authors were made. Outlines of prospective books are being developed.
In 1997, the Laboratory purchased the lovely residence of Anne and Wally Meier (daugh-
ter and son-in-law of Charles Robertson) adjacent to the Conference Center on our Banbury
estate. The house has now been altered to serve as a writing center for authors of the new
textbooks. Alex Gann joined our staff as senior editor of textbooks, and his office is located
in Meier House as well. Alex earned a Ph.D. in molecular biology after working on restriction
enzymes in Noreen Murray's lab at Edinburgh University in Scotland. He did postdoctoral
research at Harvard, studying mechanisms of gene regulation with Mark Ptashne, and at
University College London, working on newt limb regeneration with Jeremy Brockes. Most
recently, he was a lecturer in developmental biology at Lancaster University in England.
Gavin Borden Visiting Fellow
Joseph L. Goldstein, M.D., of University of Texas Southwestern Medical Center and a Nobel
laureate for his research on cholesterol metabolism that led to cholesterol-lowering drugs, was
the Gavin Borden Visiting Fellow this year. Dr. Goldstein's lecture, held on March 11, was enti-
tled "A Proteolytic Pathway That Controls Cholesterol Content of Membranes, Cells, and
Blood."
Joseph L. Goldstein
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Titia de Lange, Roel Nusse, Harold Varmus, Steve Hughes, Suzanne Ortiz
Varmus Birthday Celebration
On December 12, 74 scientists gathered at Cold Spring Harbor Laboratory to celebrate the
60th birthday of Harold E. Varmus, M.D., director of the National Institutes of Health. Harold
has since become President of Memorial Sloan-Kettering Cancer Center in New York City.
He has been coming to meetings at CSHL for over a quarter century and is well known for
his research accomplishments-including the discovery of cellular oncogenes with Mike
Bishop that garnered them a Noble prize-as well as for his extraordinary leadership. As
director of the NIH, Harold stressed the importance of biomedical research for the improve-
ment of the human condition, and oversaw a dramatic increase in public support of bio-
medical science.
Harold Varmus's birthday celebration at the Laboratory, which took the form of a two-day
symposium on cancer cell biology, was organized by Steve Hughes of the National Cancer
Institute (NCI); Titia de Lange of Rockefeller University; Roel Nusse, HHMI investigator at
Stanford University Medical Center; all former Varmus laboratory members; and Suzanne
Oritz of Varmus' lab. at the NCI. Prominent speakers included long-time collaborator Mike
Bishop, fellow retrovirologists David Baltimore and Peter Vogt, and former high school mate
Gerry Fink.
Undergraduate Research Program (URPs)
The 1999 summer Undergraduate Research Program consisted of 26 students-12 women,
14 men-from 12 countries. They were chosen from among 520 applicants from around the
world. The objective of the program is to provide a greater understanding of the principles of
biology. It instills in the students an awareness of major topics of investigation, helps devel-
op intellectual tools necessary for modern research, exposes students to the process of
research, and allows them to meet top scientists who visit CSHL.
The program received financial support in 1999 from the C. Bliss Memorial Fund,
Burroughs Wellcome Fund, Jephson Educational Trust, Dorcas Cummings Memorial
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Lecture, Grace Professorship, and the URP Endowment (composed of the Burroughs
Welcome Fund, Emmanuel Ax Fund, Garfield Fund, Libby Fund, Olney Fellowship,
Shakespeare Fellowship, Von Stade Fellowship, Glass Fund, and the Read Fund).
Partners for the Future
The Partners for the Future program was established in 1990 to give outstanding high school
seniors the opportunity to work on original research projects in a laboratory under the super-
vision of a scientist-mentor. The students spend a minimum of ten hours per week at the
Laboratory, beginning in October, and at the conclusion of the program in March, present a
scientific summary to an audience of scientists, teachers, and parents. In the process, the
students gain valuable research experience and are paid a stipend for their efforts. This pro-
gram is supported by the DNA Learning Center Corporate Advisory Board from proceeds of
their annual fund and golf tournament.
The participants for the 1999/2000 school year were David Rubenstein, Bethpage High
School (mentor: Yuri Lazebnik); Michelle Kollmeier, Half Hollow Hills High School West (men-
tor: Marja Timmermans); Jeffrey Winer, Plainview-Old Bethpage J.F.K. High School (mentor:
Masaaki Hamaguchi); Justin Singer, Jericho High School (mentor: Eric Drier); Laura Roche,
Cold Spring Harbor High School (mentor: Michael Hengartner); and Michel John Maloof,
Garden City High School (mentor: Frances Hannan).
Board of Trustees
C. Thomas Caskey concluded his term on the Board of Trustees in 1999. Since 1996, Tom
brought extensive research experience to the Board of Trustees, particularly in the area of
human genetics. Tom first visited the Laboratory in the late 1960s to attend a Phage Course.
We shall miss his always active participation at Board meetings.
Three new members were elected to the Board in 1999: Robert Lindsay is a managing
general partner with Bessemer Partners where he is involved with overseeing the private
equity investment activities of Bessemer Securities Corporation. Robert grew up here in
Laurel Hollow and his family has had a long-running relationship with the Laboratory-his
father, Robert V Lindsey, served as a Trustee on the Laboratory's Board and
treasurer and vice president of LIBA (now CSHLA), and his aunt, Mary D.
Lindsay, served as vice chairman on the Laboratory's Board. Ed Scolnick is
president of Merck Research Laboratories, and executive vice president of
science and technology for Merck and Co., Inc. Before that, he was at the
National Cancer Institute where he discovered the viral RAS oncogene.
Arthur Spiro is president of AMSTEX Enterprises, Inc., a company that deals
in corporate and business marketing, planning, acquisitions, mergers, tex-
tile patents, investments, licenses and leases. He is also adjunct professor
of entrepreneurial studies at the College of Business and Public Affairs at
Clemson University in South Carolina.
On April 23, former Chairman of the Board of Trustees David L. Luke III
was honored at a dinner at the Piping Rock Club in Locust Valley. The din-
ner was held in appreciation of his contributions to the Laboratory during his
12-year tenure on the Board, and for his role in the establishment of theDavid L. Luke III
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Watson School. The keynote speaker was Vartan Gregorian, president of
the Carnegie Corporation of New York and former president of Brown
University. Ed Harlow of Massachusetts General Hospital Cancer Center
and Harvard Medical School offered thoughtful remarks as well. A special
treat during the evening was a performance by Kitty Carlyle Hart, whose
voice and vocal style from a time past were flawless.
Mr. Luke is now an honorary trustee of the Laboratory and chairs the
ongoing $32 million capital campaign to endow the Watson School.
CSHL Association
The CSHL Association (CSHLA) held its annual meeting on February 2. The
membership thanked its retiring directors-W. Dillaway Ayres, David C. Kitty Carlyle Hart
Clark, Carol E. Large, Phillip M. Satow, Jordan Saunders, and Lisa Schiff -and elected
James Spingarn as president of the CSHLA, and Mary Alice Kolodner, Eileen Pulling, and
Larry Remmel as new directors.
The meeting featured a lecture by scientist and author
Edward 0. Wilson of Harvard University. His lecture was entitled
"Consilience: Science Meets the Arts." After the meeting, mem-
bers of Next Generation Initiative (NGI) were invited to the DNA
Learning Center for a special presentation on DNA science by
DNALC Director Dave Mick los and then-Assistant Director John
Kruper. On March 7, the CSHLA sponsored a lecture by John,
introducing the DNA Learning Center's new Web site, DNA from
the Beginning, the Internet's first authoritative genetics primer.
On April 17, the Association held a Jazz Benefit. The perfor-
mance featured Stanley Turrentine and Kenny Blake on saxo-
phone, Harold Betters on trombone, Kevin Moore and Max
Leake on piano, Paul Thompson on bass, and John Uskridge
and Roger Humphries on drums. The evening included an ele-
gant dinner and raised money in support of young scientists'
research at the Laboratory.
The annual major donors cocktail party was held in the Locust Valley home of Carolyn and
011ie Grace. The elegant setting provided an enjoyable opportunity for Laboratory scientists
to mingle with those whose generosity helps support their work.
Fanny Elder, Ann Seifert, E.O. Wilson
DNALC Corporate Advisory Board (CAB)
Each year the DNALC Corporate Advisory Board (CAB), now chaired by Jack Leahy, sup-
ports the DNALC to the extent of 10% of its operating budget by means of a golf tourna-
ment and annual fund.
On October 24, Jim and Liz Watson hosted an evening of cocktails and supper at
Ballybung to thank members of the CAB for their support and to introduce potential new
candidates for the CAB.
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Dedication of the Luke Building
Nancy Marks and Liz Watson at
Marks Laboratory Dedication
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Assembly of the Chihuly glass chandelier
Building Projects
Genome Research Center at Woodbury
Renovations are under way at Cold Spring Harbor Laboratory's new Genome Research
Center at Woodbury. Located on a 12-acre site, 7 miles south of the Laboratory's maincam-
pus, the Genome Research Center will enable the Laboratory to expand its basic research
initiatives in genomics and other gene-based technologies. Upon its completion, the
Genome Research Center at Woodbury will be a 72,000-square-foot facility, outfitted with
state-of-the-art scientific technology.
Research in the center will initially focus on sequencing the Arabidopsis, rice, and mouse
genomes; identifying genes that are mutated in breast and other cancers; bioinformatics;
and establishing a facility funded by the National Science Foundation for identifying mutants
of maize. The administrative offices of the CSHL Press, as well as a 125-seat auditorium and
a full-service dining commons, will round out this first-class, scientific complex.
Other Building Projects
Two other major building projects were completed in 1999. On June 12, the David and
Fanny Luke Building was dedicated. Located on the lower roadway facing the inner har-
bor, the Luke Building consists of two renovated, and now attached, buildings: the old
Carpenter Shop and the Power House. Designed by Jim Childress of Centerbrook
Architects, the Luke Building houses the offices of Development, Human Resources, and
Public Affairs.
The dedication on October 17 of the new Nancy and Edwin Marks Laboratory for
advanced brain imaging was another milestone in the neuroscience program. The state-of-
the-art facility was designed by William H. Grover, FAIA, and Walker Burns, AIA, of
Centerbrook Architects, and constructed by contractor E.W. Howell, Inc. The Marks
Laboratory consists of the Keck Research Laboratories, the Starr Foundation Teaching
Laboratory, the Martha Farish Gerry Seminar Room, and shared space for research and sup-
port staff. Scientists Karel Svoboda, Zach Mainen, and Tony Zador are studying various
aspects of the brain using advanced imaging and electrophysiology techniques in the Marks
Laboratory.
The aesthetic centerpiece of the Marks Laboratory is a magnificent glass chandelier cre-
ated by renowned glass artist Dale Chihuly. Jim and Liz Watson commissioned the piece,
which is fashioned after dendrites, and donated it to the Lab.
We are nearing completion of another research facility-the Samuel Freeman Laboratory.
There, scientists will use and develop sophisticated computer applications for studying the
brain and its function in a relatively new field known as computational neuroscience. The new
building, located just north of Beckman Laboratory and across the courtyard from Marks
Laboratory, was made possible by a gift from the Samuel Freeman Charitable Trust, headed
by CSHL Trustee Bill Murray. We have already recruited one scientist to do research in that
building-Dmitri Chklovskii from the Salk Institute-and are looking forward to a dedication
of this building in late Spring 2000.
Robertson Research Fund
Since 1973, the Robertson Research Fund has been the primary in-house support for sci-
ence at the Laboratory. The fund has grown from approximately $8 million in 1973 to now
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more than $96 million. Last year, Robertson funds supported cancer research in the labs of
David Helfman, Michael Hengarter, Nouria Hernandez, Tatsuya Hirano, Leemor Joshua-Tor,
Scott Lowe, Ryuji Kobayashi, Adrian Krainer, Jacek Skowronski, David Spector, and Rui-
Ming Xu; neuroscience research in the labs of Grisha Enikolopov, Jerry Yin, and Yi Zhong;
and plant research in Rob Martienssen's lab. In addition, Robertson funds supported new
investigators Andy Reiner and Shiv Grewal.
The Marie H. Robertson Memorial Fund, devoted to neuroscience, gave support to Grisha
Enikolopov's lab and start-up support to scientist Zach Mainen.
Major Gifts
1999 was an exceptional year for fund-raising. We conducted two major campaigns-one
to endow the Watson School of Biological Sciences and the other to fund construction of
the Nancy and Edwin Marks Laboratory-and the results for both were on target. We are
most fortunate to have such generous and supportive friends.
The Watson School of Biological Sciences
Former chairman of our Board of Trustees, David L. Luke III, is spearheading the campaign
to endow the Watson School. The progress to date has been very good. The Dean's Chair
was established with a pledge of $1,175,000 from the Lita Annenberg Hazen Charitable
Trust and $500,000 from the Annenberg Foundation, both made possible by Leon and
Cynthia Polsky.
Mr. and Mrs. Leslie C. Quick, Jr., established the Fund for Innovative Graduate Education
with a $1 million gift (bringing their gifts to the graduate school to $2.3 million), and Nicholas
Forstmann pledged $500,000 in support of a core course, Scientific Exposition and Ethics.
Student fellowships were established by Mr. and Mrs. William A. Miller and The William
Stamps Farish Fund, each with a $1 million pledge. Curt Engelhorn established fellowships
for European students, known as Engelhorn Scholars, with a $5 million gift through the
European Foundation for the Advancement of Medicine.
Faculty lectureships were established by Mr. and Mrs. George W. Cutting, Mr. and Mrs.
Norris Darrell, Jr., Mr. and Mrs. Edward H. Gerry, the Esther A. & Joseph Klingenstein Fund,
Mary D. Lindsay, and Quick & Reilly Group, with gifts of $300,000 each.
Visiting lectureships were provided by Mr. and Mrs. John P. Cleary, Mr. and Mrs. Edward
H. Gerry, and The Seraph Foundation, with gifts of $100,000 each.
Gifts to support the School infrastructure were also appreciated. David H. Deming and
Henry U. Harris each gave $50,000 toward the renovation of the students' residence, the
Knight House.
Brain Imaging
Gifts to the neuroscience imaging initiative in 1999 were also significant and most welcome.
The Starr Foundation gave $1,100,000 to establish a state-of-the-art teaching lab, and the
G. Harold and Leila Y. Mathers Charitable Foundation gave $870,419 in start-up funds for
research in Karel Svoboda's laboratory.
Although construction and equipment funds are often the hardest to raise, we were most
pleased with extraordinary support from the following people and foundations. Toward con-
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struction: The Ira W. De Camp Foundation gave $500,000; The Weezie Foundation gave
$100,000; and Mary D. Lindsay gave $50,000. Toward equipment: the Marks Family
Foundation gave $1 million (bringing the Marks' gifts to the brain imaging program to $3.5
million through 1999); the Fannie E. Rippel Foundation gave $355,000; the William E. and
Maude S. Pritchard Charitable Trust gave $255,000; and the Fairchild Martindale Foundation
gave $50,000.
Samuel Freeman Charitable Trust, through William Murray, initiated a $1 million gift toward
the construction of the Samuel Freeman building, which will house our new computational
neuroscience program.
Research Support
We received the following generous gifts in support of research in 1999: the Davenport
Family Foundation gave $325,000 toward cancer research; the American Cancer Society
contributed $360,000 for cancer research; and the Breast Cancer Research Foundation
gave $200,000 toward breast cancer research. The Ellison Medical Foundation and the
Sidney Kimmel Foundation for Cancer Research each gave $200,000 to cancer research.
The Neurofibromatosis Foundation Inc.-through its Illinois, Mass Bay, and Texas chap-
ters-gave $95,000 to neurofibromatosis research at the Laboratory. The Rita Allen
Foundation gave $50,000 to cancer research, and the Seraph Foundation gave $50,000.
In postdoctoral support, we received generous gifts from Mr. and Mrs. Alan Seligson,
$70,000; the Helen Hay Whitney Foundation, $69,000; and the Goldring Family Foundation,
$60,000.
Plant Research
Our plant research program benefitted from the establishment of a Plant Consortium.
Westvaco Corporation, Monsanto, Novartis, and Zenica have pledged $135,000 each per
year for four years (1998-2002).
Education Support
In April 1999, the Howard Hughes Medical Institute (HHMI) made a grant of $1.32 million in
support of the Laboratory's advanced scientific courses in neuroscience, molecular biology,
and structural biology, as well as a new program in advanced imaging techniques. HHMI also
made a grant of $500,000 to the DNA Learning Center in support of the new Vector Net, a
mobile bioinformatics teaching lab that will bring bioinformatics education to students at New
York City schools during the academic year and training workshops to teachers across the
United States during the summer.
HHMI began funding education at the Laboratory back in 1988, with a grant that enabled
the Laboratory to extend its program of summer courses to an intense, nearly year-round
schedule, and funds earmarked for the construction of the Hughes Teaching Laboratories in
the Beckman Neuroscience Laboratory. HHMI's continued support has been the corner-
stone of our excellent educational program, for which we are most grateful.
Mr. and Mrs. David L. Luke Ill gave a generous contribution of $490,234 toward the David
and Fanny Luke Building.
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President's Council
The President's Council was formed six years ago, bringing together leaders from business,
research, and biotechnology who are interested in science and Cold Spring Harbor
Laboratory. Members of the President's Council contribute $25,000 or more annually to sup-
port the CSHL Fellows program for top young scientists fresh from their Ph.D. or M.D. stud-
ies. The program allows promising young researchers to pursue their own high-level, inde-
pendent research, rather than pursuing a more traditional postdoctoral fellowship in the lab-
oratory of an established scientist.
The 1999 meeting of the President's Council, held May 14-15, focused on the Evolution
of Happiness. It began with a luncheon at Ballybung followed by an afternoon lecture by
CSHL scientist Jerry Yin on long-term memory formation. The keynote speaker, Dr. Stanley
Watson, Professor of Psychiatry and Co-Director of the Mental Health Institute at the
University of Michigan, described the role of the molecule POMC in human psychology. The
speakers on Saturday were Dr. Huda Akil also from the University of Michigan, Dr. Jonathan
Rees from the University of Newcastle (UK) Medical School, and Dr. Stephen O'Rahilly from
the Wellcome Trust Clinical Research Facility in Cambridge. The mix of leaders from the busi-
ness world and the scientific community evoked interesting insights, as well as provocative
discussions. The following were members of the 1999 President's Council:
Abraham Appel, Appel Consultants, Inc.
Peter Bloom, General Atlantic Partners, LLC
Michel David-Weill, Lazard Freres & Co., LLC
Jacob Goldfield, Goldman, Sachs & Co.
Leo A. Guthart, ADEMCO
Charles E. Harris, Harris & Harris Group, Inc.
Walter B. Kissinger, WBK Associates
Thomas J. McGrath, Simpson Thacher & Bartlett
Donald A. Pels, Pelsco, Inc.
James H. Simons, Renaissance Technologies Corporation
Ronald P. Stanton, Transammonia, Inc.
Charles L. Stone, Jr., M.D.
Sigi Ziering, Diagnostics Products Corporation
The Harbor Society
The Harbor Society honors those distinguished individuals who have contributed to the
CSHL planned giving program by including the Laboratory in their estate planning. The
Harbor Society gained six new members (or member couples) in 1999: Barbara and Arthur
Crocker, the estate of Lachlan Braden, Lois Learned, Mr. and Mrs. Karl Runkle, Miss Eleanor
Greenan, and Mrs. Lawrence Marks. The annual dinner for the Harbor Society with Jim and
Liz Watson was held at Ballybung on May 2. We are most grateful for the foresight and gen-
erosity of the Harbor Society members.
Breast Cancer Support
In 1999, there was again outstanding support from breast cancer advocacy groups. Through
1 in 9: the Long Island Breast Cancer Action Coalition-our longest-running breast cancer
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donor-we received $100,000 including $10,000 from Rick Shalvoy, proceeds from his Row
For a Cure. This organization's support since 1994 has totaled $411,000.
The Lillian Goldman Charitable Trust and Mrs. Lillian Goldman (through The Breast Cancer
Research Foundation) gave $200,000 to support breast cancer research in Michael Wigler's
lab.
We were also pleased to have the support of several groups for the first time in 1999. The
Manhasset Breast Cancer Coalition gave $25,000. The Long Island Foundation for the
Elimination of Breast Cancer gave $15,750, and the Elizabeth McFarland Foundation
(through the Long Island Foundation for the Elimination of Breast Cancer) gave $20,447. The
Long Beach Breast Cancer Coalition gave $500.
Special Events and Public Outreach
Cancer Lecture Series
The Laboratory hosted a series of four public lectures about
cancer given by four of the country's leading cancer special-
ists. The first, on March 10, featured Richard D. Klausner,
M.D., director of the National Cancer Institute. The title was
"The War Against Cancer: Where Has Science Brought Us
and Where are We Going?" Former Laboratory staff member
Douglas Hanahan, Ph.D., of the University of California at San
Francisco, delivered the second lecture on October 12, enti-
tled "The Conspiracy of Cancer Cells."
The third talk, held on October 19, was given by Neil
Caporaso, M.D., of the National Cancer Institute and was
entitled "Cracking the Causes of Cancer: What We Know;
What We Don't Know." The series concluded on October 26
with Mark Pegram, M.D., Department of Medicine, Division of Hematology/Oncology,
University of California at Los Angeles, speaking about "Targeted Therapy for Breast Cancer."
Richard D. Klausner
School Lecture Series
We held three Great Moments in DNA Science lectures in 1999. On April 27, John Kruper of
the DNA Learning Center spoke about the fruits of the Human Genome Project in a talk titled
"Biology's Gold Rush: Mining Genes from the Human Genome Project." On May 4,
Laboratory scientist Michael Greenberg spoke about HIV research in a talk titled "Molecular
Studies on HIV Nef, an Essential Viral Protein." On May 11, Laboratory scientist Richard
McCombie discussed a critical step in genomic research in "Sequence Analysis of Complex
Genomes." These lectures are designed for a teen-aged audience and attract students and
teachers from many area high schools.
Other Lectures
On September 26, we hosted a public lecture sponsored by the World Wildlife Fund (WVVF)
in Grace Auditorium. The president of WWF, Kathryn S. Fuller, talked about "A Living Planet
for the next Millennium."
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On October 3, the organization Teenspeak, together with the Town of Huntington, held a
"Festival Within-A Marathon Poetry Reading" in Grace Auditorium. That event included the
participation of several Pulitzer-prize-winning poets.
We also continued our Lloyd Harbor Seminars with a lecture by John Coraor of the
Heckscher Museum in nearby Huntington on May 20, entitled "The Lives and Works of
Arthur Dove and Helen Torr."
Concerts
In addition to the benefit concerts described earlier, we hosted 11 free public concerts dur-
ing CSHL meetings, when we have a large captive audience. Many meeting participants
enjoy the cultural respite from their intense scientific sessions. They were as follows:
April 24
May 1
May 8
May 15
May 29
Aug. 21
Aug. 28
Sept. 4
Sept.18
Oct. 2
Oct. 9
Meng-Chieh Liu, pianist
Irina Muresanu, violinist, and Tatiana Goncharova, pianist
Christopher Taylor, pianist
Judith Ingolfsson, violinist, and Ronald Sat, pianist
Jennifer Frautschi, violinist, and Benjamin Loeb, pianist
Ayako Yoshida, violinist, and Andrew Armstrong, pianist
Dmitri Berlinsky, violinist, and Elena Baksht, pianist
Sophie Shao, cellist, and Adrienne Kim, pianist
Michael Shih and Patricia Sunwoo, violinists; Ori Kam, violist; and
Kristian Reiko Cooper, violoncellist
Arcadian Trio: Ara Gregorian, violinist; Andrew Russo, pianist; and
Raphael Bell, cellist
Brentano String Quartet: Mark Steinberg and Serena Canin, violinists;
Misha Amory, violist; and Nina Maria Lee, cellist
Brentano String Quartet
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(Back row) Mary Ellen Goldstein, Michael Ockler,
Dr. James Watson, Robert Gensel,
Dessie Carter, Jim Hope,
Bruce Stillman
(Center two) Daniel Miller, James (Herb) Parsons,
Maureen Berejka
(Front row) Robert Pace, Carmelita Bautista,
Susan Schultz, Katya Davey,
Carlos Mendez
Long-term Service
On June 30, employees celebrating milestone anniversaries with the Laboratory were hon-
ored at a poolside dinner at Robertson House. Lane Smith, veteran plumber, celebrated 25
years at Cold Spring Harbor Laboratory this past year.
Incredibly to me, I celebrated my 20th anniversary with the Laboratory. Although I had vis-
ited the lab in 1978 as a graduate student to speak at the annual CSHL Symposium, I arrived
in 1979 to work as postdoctoral fellow in Mike Mathews' lab. The last 20 years have seen
great progress in biology at CSHL and I would not have missed a minute of it. All of the fol-
lowing people arrived at the Laboratory that same year, and over the course of two decades,
each has had an impact on my life and work at the Laboratory: Maureen Berejka, adminis-
trative assistant to the President; Judith Cuddihy, editor for CSHL Press Acquisitions and
Development; Katya Davey, hostess for Robertson House; Jim Hope, manager of Food
Services; Carlos Mendez, bookkeeper and cash manager; John Meyer, lead painter; Michael
Ockler, supervisor of Scientific Art and Photography; James (Herb) Parsons, director of
Audiovisual; and Susan Schultz, director of grants contracts.
We also had six people celebrating 15-year anniversaries with the Laboratory: Carmelite
Bautista, research associate and facilities manager; Dessie Carter, housekeeper; Robert
Gensel, manager of security; Mary Ellen Goldstein, part-time accounts payable supervisor;
Daniel Miller, grounds foreman; and Robert Pace, business systems manager.
Changes in Administrative Staff
Maureen Bell joined us as administrative director of the Genomic Research Center. Maureen
has a master's degree in biochemistry and an MBA in finance. She was formerly with
American International Group (AIG) in New York City as a senior technical services manager.
Lilian Gann became assistant dean of the Watson School of Biological Sciences.
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Changes in Scientific Staff Titles
Concurrent with the establishment of the Watson School of Biological Sciences, the
Laboratory adopted an academic faculty title structure: assistant professor, associate pro-
fessor, and professor.
Departures
Douglas Conklin went to work at Genetica. Ueli Grossniklaus returned to Switzerland to
become a staff scientist at the Friedrich Miescher Institute in Basel. Thomas Misteli (HHMI)
became principal investigator at the National Cancer Institute (NIH) at Bethesda, Maryland.
Peter Nest ler moved back to Germany to accept a position as research scientist at Hoechst
Marion Roussel Institute in Frankfurt, Germany. Jing (Jenny) Wang left for a career opportu-
nity at Genica.
New Faculty and Staff
Dmitri Chklovskii was recruited from the Salk Institute as an assistant professor, to initiate
studies in computational neuroscience in the newly constructed Samuel Freeman Building.
Tony Zador was recruited from the Salk Institute to an assistant professorship, and Zach
Mainen, upon completion of his postdoctoral studies with Roberto Malinow and Karel
Svoboda at CSHL, was also appointed assistant professor-both as part of the expansion
of our neuroscience program. Sang Yong Kim was recruited from the University of Michigan
to establish a valuable resource for CSHL scientists: a transgenic mouse and gene targeting
facility.
Promotions
Leemor Joshua-Tor and Michael Zhang were both promoted to associate professor. Vivek
Mittel completed postdoctoral studies in Nouria Hernandez's lab and was promoted to
research investigator in Michael Wigler's lab. Michael Myers was promoted from postdoc-
toral researcher to senior fellow in Nick Tonks' lab. Zach Mainen (Malinow and Svoboda labs)
has been appointed assistant professor here at Cold Spring Harbor Laboratory.
Visiting Scientists
Five visiting scientists joined us this year: Eli Hatchwell came from Wessex Human Genetics
Institute at Southampton General Hospital in Southampton, England, to study in Michael
Wigler's lab; Boris Kuzin returned from the Russian Academy of Sciences in Moscow to
study once again in Grisha Enikolopov's lab; Nathalie Pavy came from Gent University,
Belgium in Versailles, France, to study in Lincoln Stein's lab; Hilde Grassmo-Wendler came
from the Max Delbruck Centre for Molecular Medicine in Berlin, Germany, to study in Michael
Wigler's lab; and Fumio Shiobara came from the National Institute of Agrobiological
Resources in Ibaraki, Japan, to study in David Jackson's lab.
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Six visiting scientists wrapped up their stays here: Jiaxin An returned from Yi Zhong's lab
to his position as professor at the China Academy of Space Technology in Beijing, China;
Shern Lin Chew returned from Adrian Krainer's lab to his position as senior lecturer/consul-
tant at St. Bartholomew's Hospital in London; Jyotsna Dhawan returned from David
Helfman's lab to India, where she is staff scientist at the Center for Cellular and Molecular
Biology in Hyderabod; lmran Siddiqi returned from Ueli Grossniklaus' lab to his position as
staff scientist at the Center for Cellular and Molecular Biology in Hyderabod, India; Toshiro
Tsukamoto returned from David Spector's lab to Hyogo, Japan where he is a research asso-
ciate at the Himeji Institute of Technology; and Hannes Buelow, visiting scientist in Linda Van
Aelst's lab, left to begin postdoctoral studies with Oliver Hobert at Columbia University in
New York City.
Postdoctoral Departures
Christine Berthier (Helfman lab) left to become assistant professor at the University Claude
Bernard in Lyon, France.
John Connolly (Tully lab) is continuing his postdoctoral studies at the Foundation Jean
Dausset-CEPH in Paris, France.
Francesca Demarchi (Stillman Lab), a visiting postdoc, returned to her postdoctoral position
at the ICGEB in Trieste, Italy.
Serge Desnoyers (Hengartner lab) accepted a position as adjunct professor at Laval
University in Sainte-Foy, Canada.
Dennis Dong (Wig ler lab) is now a staff scientist with ZymoGenetics in Seattle,
Washington.
Howard Fearnhead (Lazebnik lab) was appointed principal investigator at the National
Cancer Institute Research and Development Center in Frederick, Maryland.
Andrew Fraser (Hengartner lab) is continuing his postdoctoral research in Julie Ahringer's lab
at the Welcome CRC, Cambridge, England.
Anton Gartner (Hengartner lab) accepted an appointment as group leader at the Max Plank
Institute in Munich, Germany.
Ilya loschikhes (M. Zhang lab) is now an Instructor at the Albert Einstein College of Medicine,
Bronx, New York.
Nobuhiro Kashige (Kobayashi lab) accepted an assistant professorship at Fukuoka
University, in Japan.
Balazs Lendvai (Svoboda lab) accepted a position as assistant professor at the Institute for
Experimental Medicine in Budapest, India.
Hong-Xiang Liu (Krainer lab) went to a research scientist appointment at Phylos, Inc., in
Lexington, Massachusetts.
Mireya Marin (Van Aelst lab) is taking some time off to be with her family.
Vivek Mittal (Hernandez lab) moved over to Mike Wig ler's lab here at CSHL as a research
investigator.
Naoki Nakaya (Enikolopov lab) was appointed assistant professor at Okayama University
Medical School in Okayama, Japan. He returned to CSHL shortly thereafter to work as a
visiting scientist back in the Enikolopov lab.
Laurence Parnell (McCombie lab) moved to a job at Cereon Genomics, a subsidiary of
Monsanto located in Cambridge, Massachusetts.
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Jean-Christopher Poncer (Malinow lab) has accepted an assistant professorship at the
Pasteur Institute in Paris, France.
Baskar Ramamurthy (Grossniklaus lab) will continue his postdoctoral studies with Ueli at
Friedrich Miescher Institute in Basel, Switzerland.
Minoru Saito (Tully lab) became an assistant professor at the Tokyo Metropolitan Institute of
Neuroscience in Tokyo, Japan.
Kaetrin Simpson (Stillman lab) moved over to the CSHL Press as a project editor in October
and was to be the managing editor of this volume. Much to the deep sorrow of all of us,
Kate lost her battle with a malignant brain tumor on January 21, 2000.
Charles Spillane (Grossniklaus lab) will continue his postdoctoral studies with Ueli at Friedrich
Miescher Institute in Basel, Switzerland.
Peiqing Sun (Beach lab) accepted an appointment to an assistant professorship at Scripps
Research Institute in San Diego, California.
Jack Tabaska (M. Zhang lab) is now a bioinformatics scientist at Monsanto in St. Louis,
Missouri.
Daan Van Aalten (Joshua-Tor lab) is now a staff scientist at the University of Dundee in
Dundee, Scotland.
Jean-Philippe Vielle-Calzada (Grossniklaus lab) is now a professor at the Center of
Investigation and Studies in Avangados, Mexico.
Tomoki Yokochi (Hirano lab) is continuing his postdoctoral research in Alan Wolffe's lab at the
National Institute of Child Health and Human Development (NICHD) at the NIH in
Bethesda, Maryland.
Shahid Zaman (Malinow lab) is now a staff scientist at the University of Bristol in Bristol,
England.
Shao-Hui Zhang (Tonks lab) is now a scientist with Tanabe Research Laboratories in San
Diego, California.
Dong-Jing Zou (Cline lab) is continuing postdoctoral research in Stuart Firestein's lab at
Columbia University in New York City.
Graduate Students Departures
Robert Babb completed his Ph.D. in Winship Herr's lab and has accepted a postdoctoral
position at Novartis Pharmaceuticals Corp. in Livingston, New Jersey.
Grace Chen completed the Ph.D. portion of her M.D./Ph.D. degree in Arne Stenlund's lab
and moved to the University of Michigan to complete her medical degree.
Jianzhong Jiang completed his Ph.D. with Rui-Ming Xu and is now a postdoctoral researcher
in Rui-Ming's lab at CSHL.
Tracy Kuhlman completed her Ph.D. with Nouria Hernandez and went to work for CSHL
Press as a developmental editor based in her Seattle, Washington home.
Qiong Liu completed her Ph.D. with Michael Hengartner and is now considering new posi-
tions.
Paul Mintz completed his Ph.D. in David Spector's lab and has gone on to do postdoctoral
research in Renata Pasqualini's lab at M.D. Anderson Cancer Center in Houston, Texas.
James Moore went with Ueli Grossniklaus to the Friedrich Miecher Institute in Basel,
Switzerland, where he will continue his graduate studies.
Ahmed Samatar left after receiving his Ph.D.
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Andrew Mark Settles completed his Ph.D. in Rob Martienssen's lab and went on to a post-
doctoral position at theUniversity of Florida, Gainesville.
Tzu-Ling Tseng completed his Ph.D. in Adrian Krainer's lab and has moved on to a post-
doctoral position in the lab of Jeff Struewing and Ken Beutow at the Laboratory of
Population Genetics at the National Cancer Institute in Bethesda, Maryland.
Concluding Remarks
As we rapidly move into the next century and indeed into the next millennium, it is clear that
the opportunities for future discovery in biology and medicine are enormous. The past cen-
tury of biology will be remembered as a golden era that witnessed a renaissance in science
that will have an impact for many years to come. The early years of the new century will be
the age when biology will be only limited by our imagination. There is a distinct sense of
excitement in the air; a feeling that we must endeavor to transmit to the broader communi-
ties that will ultimately benefit from this research.
As the pace of modern science continues to accelerate, the resources of academic insti-
tutions will be considerably strained, particularly when compared to biotechnology and phar-
maceutical companies which have access to technologies that are far beyond the financial
capabilities of academia. This is particularly the case in the genomic era.
Cold Spring Harbor Laboratory and institutions like us will need considerable financial
resources to remain at the forefront of biology, particularly when increases in federal funding
of research abate. But leanness might have a positive benefit in the long run, since acade-
mic researchers will be forced to think carefully about how these precious resources are uti-
lized, performing the type of basic research that the more remunerative institutions will find
increasingly hard to justify. Ideally there will remain a synergism between industry and acad-
emia that will be for the benefit of all.
To me, our mission is as clear as it has ever been. We must continue to pursue basic sci-
ence at the highest possible level, we must make sure that we continue to grow our strong
educational programs, making them even more accessible to scientists and students, and
we must encourage public support and participation in these exciting ventures at all levels.
For together we are entering what will perhaps be the most exciting phase of biology.
March 2000 Bruce Stillman
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ADMINISTRATION
1999 was a remarkable year for Cold Spring Harbor Laboratory. Our institution was founded in
the 19th century, spanned all of the 20th, and now enters the 21st-dynamic, young in spirit,
and at the forefront of the biological sciences.
The year began well, with six of the nine Ph.D. candidates offered admission to our new
Watson School of Biological Sciences choosing to come to Cold Spring Harbor-a 66% accep-
tance rate. Two of them held prestigious fellowships from Howard Hughes Medical Institute. All
had received other offers of admission from top universities here and abroad. The first class,
three men and three women, arrived in late August and in September began the first term of
the intense, highly innovative four-year doctoral program. The students' enthusiasm spread to
the science faculty and others, many of whom were teaching for the first time and finding enjoy-
ment and satisfaction in the process. During the winter, a very large number of high-quality
applications were received for the second class, a good indication that the Laboratory's pro-
gram has become known as unique and likely to make a major impact on graduate education.
Meanwhile, after several years of planning, the Laboratory embarked on its most-ambitious-
ever facilities construction program. Most prominent was the stunning new Nancy and Edwin
Marks Laboratory, where neuroscientists now use state-of-the-art excitation laser microscopy
to image individual neurons and neural networks deep in the brains of living animals as they
experience and react to their environment. The Marks Laboratory was dedicated in November,
and its scientists are alreadying working there in two shifts. The Laboratory functions also as a
national center where visiting scientists can come to learn new imaging techniques in the new
Starr Teaching Laboratory and Gerry Conference Room. A magnificent glass sculpture of a neu-
ron by world-renowned artist Dale Chihuly, a gift from Jim and Liz Watson, graces the main
stairwell.
Across a new courtyard opposite the Marks Laboratory, the Samuel Freeman Building for
bioinformatics was constructed on the hillside next to the Beckman Neuroscience Center. Here
scientists will process the enormous volume of data being generated by the neuroscience and
imaging programs. Also located in the building is Lincoln Stein's program to coordinate and
process data generated by the SNP Consortium and release it on the Internet. The Consortium,
consisting of several pharmaceutical giants-together with five academic partners-aims to
scour the human genome to uncover new heritable DNA sequence variations called single
nucleotide polymorphisms (SNPs). A large SNP library could help researchers pinpoint genetic
origins of diseases and, potentially, the most appropriate drugs to use to treat them. A visual
centerpiece of the Freeman Building is the spacious William E. Murray Room, named for our
Trustee who heads the Samuel Freeman Charitable Trust, which was instrumental in arranging
the funding for this project.
Off campus in Woodbury, construction of the Laboratory's new $25 million Genome
Research Center began in December. All but the shell of the 65,000-square-foot building on the
11-acre site, which the Laboratory purchased from the American Institute of Physics in 1998,
had already been demolished. To be completed by the end of the year 2000, the new Center
will have laboratories for studies of gene sequencing and function and for DNA chip array tech-
nology. There will be a plant technology center and an animal facility for the breeding of mouse
model systems that are extensively used in cancer research and in neuroscience behavior stud-
ies. Cold Spring Harbor Laboratory Press will have new offices in the Center, too.
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On the waterfront of our Laurel Hollow campus, the David and Fanny Luke Building was
completed and dedicated in May. This represents a complete reconstruction of our old Power
House and Carpentry Shop, and it now houses our Human Resources, Development, and
Public Affairs Departments. In the Development offices, the new Vernon Merrill Conference
Room honors the memory of the greatly revered past president of the Cold Spring Harbor
Laboratory Association. In 1997, the Laboratory purchased a seriously deteriorated 18th-cen-
tury residence that used to serve as Cold Spring Harbor's first general store and post office,
directly across the harbor from the Luke Building in the Cold Spring Harbor Historic District.
During 1999, the house was completely renovated as a first-year residence for Watson School
students. Each student has a private room and bath, individual study area, and use of the cen-
trally located "period" common room. The new residence has been renamed the Townsend
Knight House after Townie Knight, an Honorary Trustee of the Laboratory, who grew up and
spent much of his early youth living in the original structure.
Finally, all but invisible from Bungtown Road at the site of the Pond Parking Lot, a new heat-
ing and air-conditioning facility was constructed to serve many of our lower-campus buildings,
such as Freeman, Marks, Sambrook, James, Nichols, Page, and Delbruck, eliminating noisy
outdoor chillers and rooftop cooling towers. The simultaneous management of all these pro-
jects and many other laboratory and office alterations during a single year is an indication of the
capabilities and skill of the Laboratory's Facilities Department, its Director, Art Brings, and the
many contractors with whom they work.
In past reports, I have often stressed the importance to the Laboratory of maintaining strong
finances. 1999 was no exception to the more than 10-year period during which a balanced
budget has been achieved after allowing fully for depreciation. Revenues for the year again
reached a new high, advancing approximately 8% to $57,670,000. After expenses of
$53,840,000, including depreciation of $3,526,000, there was a modest operating surplus of
$304,000. Positive cash flow for the year was $3,830,000. This brings the total funds generat-
ed from operations over the past decade to more than $30 million. These funds are used to
maintain and modernize our capital plant, purchase increasingly expensive scientific equipment,
and pay for the start-up costs of new programs. Financial results were more than $1,000,000
better than projected at the beginning of the year, reflecting our traditional policy of projecting
grant revenues conservatively, given the uncertainty associated with federal grant reviews. It
was not necessary to use any portion of the $1.9 million of reserves set aside in past years for
unanticipated costs of new programs. The good financial results again reflect our scientific
staff's success in obtaining grants, another good year of attendance at our meetings and cours-
es, a strong contribution from the Cold Spring Harbor Laboratory Press, better than break-even
operations at Banbury Center and the DNA Learning Center, higher than expected investment
income, and careful cost control by administrative departments. A modest deficit from the first-
year operation of the Watson School was fully absorbed.
Also remarkable during the year was further rapid growth of the Laboratory's permanent
endowment, which collectively consists of the Robertson and the Cold Spring Harbor Funds.
At year-end, the endowment totaled $220 million, representing an increase of $53 million, or
nearly 32%, from $167 million 12 months earlier. We have outstanding $45 million of tax-
exempt bonds issued by the Nassau and Suffolk County Industrial Development Agencies. The
gain during 1999 was the result of excellent market return and new additions, which included
$4,309,432 of new endowment for the Watson School. The market return on the invested
funds, of which approximately 40% was allocated to fixed income, was truly exceptional, rival-
ing even well-managed pure-equity portfolios. Among the three equity-investment managers
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employed by the Laboratory, Essex Investment Management returned 111%, exceeding 99%
of comparative equity managers; the Vanguard PRIMECAP Fund returned an impressive 42%;
and U.S. Trust Company, selected as a new equity manager in October to replace the Miller
Anderson & Sherrerd Value Fund, comfortably surpassed the Standard and Poor's 500 Index.
Miller Anderson & Sherrerd and U.S. Trust Co. continue to manage the fixed-income invest-
ments. As in past years, the Endowment is invested in a balanced mix of equities, fixed income,
and short-term instruments. The drawdown policy is 4% per annum based on a three-year
moving average of year-end market values. The conservatism of this policy has contributed
greatly to the growth of the endowment over the years.
Two specialized funds included in the endowment are worthy of special mention. The
Science Fund was established by the Board in 1992 and designated as solely for the future
support of science. Since 1992, all equity and royalties received from the Laboratory's technol-
ogy transfer activities have been accumulated in this Fund. In this way, financial gains from
Laboratory research financed by federal and other grants are recycled back into future science.
In the early years, the various equities were carried at nominal valuations, and the Fund grew
slowly to a total of $490,000 at the end of 1996. Thereafter, many of the equities began to be
publicly traded, and under the supervision of a subcommittee led by John Phelan, chairman of
our Commercial Relations Committee, some portions of the Laboratory's holdings were sold
and converted to more conventional investments. By year-end 1997, 1998, and 1999, the
Science Fund was valued at approximately $4.8 million, $6.8 million, and $15.9 million, respec-
tively. By March 31, 2000, it had reached $24.1 million, and $15.2 million of it had been con-
verted to conventional investments managed by the Laboratory's regular managers. The
Science Fund was established with the hope that it might one day represent substantial addi-
tional support for the science program and replace royalty income the Laboratory has been
receiving from a patent expiring June 30th of this year. This goal now seems well within reach.
A second fund, the Quest Fund, was established by the Executive Committee in December
1999 and designated for the support of both the science and the education programs at the
Laboratory. This Fund consists of the equity ownership in SciQuest Corporation-a "B to B
Commerce" Internet company specializing in scientific supplies and equipment-that the
Laboratory received from the sale of the Cold Spring Harbor Laboratory Press "Source Book"
(catalog) and BioSupplyNet (on-line version) to SciQuest in 1998. In late 1999, SciQuest had a
successful IPO, and at March 31, the Quest Fund was valued at approximately $4.7 million,
then including $1.6 million in conventional investments.
The success of the Laboratory's technology-transfer activities, which now include some 14
public and private biotech companies based in whole or in part on CSHL research, is a tribute
to the skill and entrepreneurial spirit of our scientists. It also reflects the impressive ability of our
three-person Technical Transfer Department, headed by John Maroney, assisted by Carol
Dempster and Barry Braunstein, in working with the scientific staff, managing patents, and
structuring agreements and alliances that have served this institution well. Also, the Department
has shouldered responsibility for establishing and managing the Broad Hollow Bioscience Park
located on a 20-acre site at SUNY Farmingdale, about a 20-minute drive from the Laboratory.
The first building of 50,000 square feet was funded by the State of New York and is scheduled
to open in mid-2000 as a home for Laboratory and other young biotech companies.
Another major accomplishment during 1999 was the successful selection, installation, and
on-time start-up of new, Laboratory-wide business-computing software. Such projects have
taken years and cost several millions of dollars at other institutions. Here, it was accomplished
in less than a year and for less than $1 million. The magnitude of this task cannot be overstat-
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ed. All administrative departments were involved. The effort was led and coordinated by Dill
Ayres, associate administrative director, with the strong support of Bill Keen, comptroller. Lari
Russo, assistant comptroller, provided very effective day-to-day direction for the project. Other
major participants who worked long hours in their own departments and in the Wawepex "War
Room," where training and start-up was centered, include Cheryl Sinclair, Human Resources;
Phil Lembo, Purchasing; Susan Schultz, Grants Management; and, very importantly, Jerry
Latter and Robert Pace of Information Services.
The Laboratory's payroll, which includes two different pay schedules for more than 700
employees and all the accompanying federal and state tax-reporting requirements, was
brought in-house from an outside vendor. On the projected start-up date, January 1, 2000, the
whole Laboratory breathed a sigh of relief as newly printed CSHL payroll checks were distrib-
uted Laboratory-wide (with only our President going briefly unpaid due to a bank automatic-
deposit miscue). The otherwise smooth payroll conversion was attributable primarily to Patty
Maroney and to Laura Guterman, who joined the Laboratory in September from Sbarro, Inc.,
where she was payroll manager. The vendors, Lawson Software and Eisner Consultants, pro-
vided the timely guidance and support needed at critical moments. Now, several months into
2000, many administrative personnel continue to put in long hours due to the newness and
complexities of the system. It will be some time before all the vastly increased capabilities are
fully realized. But those working so hard should have the satisfaction of knowing that their
efforts will make it possible to run the Laboratory in this new century on a level consistent with
that of the science for which this Institution is known.
The Library, with the irrepressible leadership of Mila Pollack, was another aspect of the
Laboratory that was greatly upgraded in 1999. Now staffed weekends, and for longer hours
during meetings and courses, the Library has installed the new Web of Science on-line soft-
ware, which provides scientists with past and present journal articles on their desktop com-
puters. There is a much improved new cataloging system, enhanced color-copying capability,
and a staff that is welcoming and anxious to help. The Library can now truly meet the needs of
a first-class research institution and is at a level befitting even the small university to which we
are being transformed by the new Watson School. Mila is also addressing the task of properly
organizing and preserving the extensive archives of the Laboratory and those of Dr. Watson.
These embrace many of the highlights of the history of molecular biology and genetics, and it
is imperative that they be available for scholars and historians in future years. A recent grant
from the Lehrman Institute now makes it possible to hire an experienced archivist and will pro-
vide the impetus for an eventual heritage center at Cold Spring Harbor for making available the
full story of this fascinating era of science and discovery.
There were a number of key personnel changes in administrative departments during 1999.
Deborah Barnes, director of Public Affairs, left the Laboratory at year-end. Among her many
contributions, Deborah did much to professionalize the editorial content and look of Laboratory
publications. She initiated a widely applauded new series of cancer lectures, the first of which
was delivered by Richard Klausner, director of the National Cancer Institute, and another by
Doug Hanahan, professor at the University of California in San Francisco and previously on the
Cold Spring Harbor Laboratory staff. Deborah was also a most effective lecturer on the art of
science writing for the students of the Watson School. She is very talented and a good friend
to many of us. We will miss her and hope she visits often in the future.
The year-end marked the departure of Laura Hundt, events coordinator, also in Public Affairs.
Laura distinguished herself over the years with too many events to mention. She worked very
successfully with the DNA Learning Center Corporate Advisory Board and ran its annual golf
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tournament, which year after year set records in participation and fund-raising. Fortunately, we
have had the good fortune to find a replacement in Charles Prizzi, who joined us just recently
from Long Island University, where he was responsible for all university events on three main-
and a number of satellite-campuses.
In Development, we welcomed Peter Wayne as major gifts officer. Peter is concentrating his
efforts on raising the $25 million needed for the Woodbury Genome Sequencing Center. Vincent
Torti joined the department late in the year as the first development officer specifically for the
DNA Learning Center. Vin has much experience in high-school-level education and in fund-rais-
ing. He will be responsible for DNALC annual funding, including the golf tournament, and for the
capital needed for the planned major building expansion to begin this spring. Cathy Wardell,
who for many years has supported so well the activities of the CSHL Association, left to
become director of Development at the Port ledge School. We will miss Cathy and wish her well
in her new position.
All of us, on March 4 of the current year, were greatly saddened by the death of Jack
Richards, who for so many years was responsible for Buildings and Grounds at the Laboratory.
Dr. Watson wrote extensively about Jack earlier in this report, so suffice it to say that we miss
him greatly and extend our deepest sympathy to Cory, Jean, Lynn, and the rest of the Richards
family.
No report would be complete without recognition of the invaluable support that Roberta
Salant provides for Dill Ayres, John Maroney, and myself and for the members of our Board of
Trustees. She is a constant source of needed information, assistance, and good cheer.
In recent years, we have given much thought to planning for the future of administration at
the Laboratory. This function at a place such as the Laboratory should be run by someone in
their 40s, not in their 60s, as has been my case for several years now. With this in mind, in 1997,
I began to look for a successor as administrative director. Fortunately, it was not necessary to
look very far. Dill Ayres, a resident of our local Laurel Hollow community, was much interested
in science and the Laboratory, and had joined the CSHL Association and become one of its
directors. With the considerable help of John Reese, then our treasurer, I was able to persuade
Dill to join the Laboratory full-time in 1998 as associate administrative director. In the interim, Dill
has had the opportunity to get to know the Laboratory and the staff well. He has taken increas-
ing responsibility for important projects and day-to-day operations. He has vision, good judg-
ment, and a strong business sense. I have much confidence in Dill and, with the strong support
of Jim Watson and Bruce Stillman, intend to recommend that the Board of Trustees name him
as administrative director at the Annual Board Meeting in November. It is my intention to remain
closely associated with the Laboratory, working as needed in areas of future strategic interest.
I have much enjoyed my 15 years as administrative director and look forward to a continuation
of the challenges and personal relationships that I have found so fulfilling. There can be little
doubt that the Laboratory of the 21st century will continue to be a focal point of the biological
sciences and an extraordinarily interesting place.
G. Morgan Browne
April, 2000 Administrative Director
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TUMOR VIRUSES
The investigators in the Tumor Viruses section are unified by the shared use of viruses to probe cell
function and to understand cell transformation. The viruses used include adenovirus, human and
bovine papillomaviruses, simian virus 40, herpes simplex virus, and human and simian immunodefi-
ciency viruses.
Arne Stenlund and Bruce Stillman use papillomavirus and SV40, respectively, to study DNA repli-
cation. The Stillman laboratory also studies cellular DNA replication in human and yeast cells, and
how DNA replication is linked to the establishment of inherited states of gene expression.
Winship Herr and Adrian Krainer study the control of gene expression, particularly the control of
gene transcription and pre-mRNA splicing.
William Tansey studies control of gene expression via modulation of transcription factor stability by
regulated proteolysis, using the Myc oncoprotein as a model.
Yuri Lazebnik and Scott Lowe focus their research on the cellular defenses against cancer includ-
ing programmed cell death or apoptosis and senescence.
Jacek Skowronski studies how the human and simian immunodeficiency viruses disrupt signal
transduction and the expression of cell surface receptors in infected T cells.
See previous page for photos of the following scientific staff.
Row 1: Shannon Pendergrast; Setareh Sepehri; Hunter Maats; Antonella Piccini
Row 2: Jason Gregory, Jenny Wang; Joe Fontana, Catherine Kidner, Juana Marie Arroyo, Andrew
Groover, Amy Dabrowski; Jose A. Esteban
Row 3: Eli Hatchwell; Katherine Braun, Michael Weinreich; Michael Myers, Helena Palka
Row 4: Roberto Malinow, Julius Zhu; Noriko Saitoh, Susan Janicki; Robert Gasparini, Steve Macnick
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TRANSCRIPTIONAL REGULATION
W. Herr E. Julien K. Wu
D. Aufiero S. Lee
R. Babb P. Reilly
A. Bubulya
T. Tubon
J. Wysocka
X. Zhao
We are interested in the mechanisms of transcriptional
regulation in human cells. We use the human herpes
simplex virus (HSV) as a probe to uncover these
mechanisms and to study virus-host cell interactions.
Viruses provide simple regulatory networks in which
the cellular transcriptional machinery is altered to
achieve the goals of virus infection. In a cell infected
by HSV, the virus can grow lytically or remain latent
for many years. In the lytic cycle, HSV gene expres-
sion is initiated by a viral transcription factor called
VP16, which is carried in the infecting virion. Before
activating transcription, VP16 forms a multiprotein-
DNA complex-the VP16-induced complex-on viral
immediate-early promoters with two cellular proteins:
HCF-1, a protein that regulates cell proliferation, and
Oct-1, a POU-homeo domain transcription factor.
Once the VP16-induced complex is assembled, VP16
initiates viral gene transcription through a potent tran-
scriptional activation domain.
Our research continues to focus on three principal
issues: (1) How do transcriptional regulators activate
the basal transcriptional machinery? (2) How do tran-
scription factors, as in the VP16-induced complex,
modify their transcriptional activity through selective
protein-protein and protein-DNA interactions? (3)
What are the natural cellular roles of HCF-1 and Oct-
1, and how do they influence HSV infection?
Enhancer Function
T. Tubon, X. Zhao
Our current studies on how transcriptional regulators
activate the basal transcriptional machinery focus on
two lines of investigation. In the first, we study the
function of basal transcription factors in vivo through
the use of altered-specificity interactions among these
factors, which allows us to circumvent the endogenous
transcriptional machinery and thus study the activity
of mutant basal factors in vivo. We are using this strat-
egy to dissect the role of the basal transcription factor
TFIIB in transcriptional activation by a variety of acti-
vators. TFIIB is a particularly attractive subject for
study because it is not part of a complex of proteins,
making it amenable to genetic and biochemical analy-
ses both in vivo and in vitro.
In the second line of investigation, we study tran-
scription in vitro to dissect how transcriptional activa-
tion domains can distinguish among basal factors
bound to different core promoter elements. For the lat-
ter studies, we use two types of promoters: (1) pro-
moters that direct the synthesis of mRNAs by RNA
polymerase II and contain a TATA box core promoter
element and (2) promoters that direct the synthesis of
small nuclear RNAs (snRNAs) by either RNA poly-
merase II as in the case of the U2 snRNA or RNA
polymerase III as in the case of the U6 snRNA.
snRNAs are involved in RNA processing and their
corresponding promoters contain a dedicated core pro-
moter element called the PSE. The TATA box of the
mRNA-type promoters binds the basal transcription
factor complex TFIID, whereas the PSE element of
snRNA gene promoters binds the basal transcription
factor complex SNAP studied by the Hernandez lab
here at Cold Spring Harbor Laboratory. The transcrip-
tional activation domains we use to study promoter
selectivity of activation domain function discriminate
between the mRNA- and snRNA-type promoters. By
comparing and contrasting the differing activities of
these activators in the variety of promoter contexts, we
continue to dissect how activators communicate with
the basal transcriptional machinery.
Viral Trans-activation
D. Aufiero, R. Babb, A. Bubulya, C. Huang, K. Wu
We study how transcription factors modify their tran-
scriptional activity through selective protein-protein
and protein-DNA interaction by studying the structure
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and function of the VP16-induced complex. This year,
in collaboration with Dr. Xiaodong Cheng (Emory
University School of Medicine, formerly of Cold
Spring Harbor Laboratory), we reported the three-
dimensional crystal structure of the core region of
VP16 that is sufficient for VP16-induced complex
assembly.
VP16 has multiple roles during the HSV infection
cycle. It is synthesized late during infection where it is
incorporated into the tegument of the virion with other
viral proteins. Upon de novo infection, VP16 is
released into the cell where it associates with HCF-1
and Oct-1 on HSV immediate-early promoters. Thus,
VP16 is a multifaceted protein that, at different times
during the HSV infection cycle, interacts with either
viral proteins, as in the virion, or cellular proteins, as
in the VP16-induced complex.
VP16 is a modular protein of 490 amino acids. Its
potent transcriptional activation domain is located
within the carboxy-terminal 80 amino acids, whereas
sequences sufficient for VP16-induced complex
assembly encompass much of the remainder of the
protein. Comparison of the HSV VP16 sequence with
those of the related proteins from other herpesviruses
reveals that the region sufficient for VP16-induced
complex assembly is conserved, whereas the sequence
of the transcriptional activation domain is not con-
served.
The X-ray crystal structure of the free form of the
conserved VP16-induced complex-forming region
was determined at 2.1 A resolution. The results reveal
a novel, seat-like protein structure as illustrated in
Figure 1. Over the years, extensive mutagenesis stud-
ies by a number of different laboratories have identi-
fied residues in VP16 involved in (1) virion formation,
(2) DNA interaction, and (3) association with HCF-1
and Oct-1. Mapping of the residues involved in each of
these three activities on the VP16 structure indicates
that VP16 uses a different surface for each function.
Sequences involved in virion assembly and DNA-
sequence recognition are structured, but sequences
involved in associating with HCF-1 and Oct-1 are dis-
ordered (see the dashed line in the center of the fig-
ure), suggesting that VP16 undergoes conformational
changes during VP16-induced complex assembly. The
surface that interacts with DNA is the concave seat
(see Fig. 1) and represents a novel DNA-binding
domain. Thus, VP16 influences different aspects of the
HSV life cycle through use of different surfaces to
engineer different types of complexes within the viri-
on and on HSV promoters.
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Cellular Functions of HCF-1
E. Julien, S. Lee, P. Reilly, J. Wysocka
HSV must maintain an intimate relationship with the
host cell to remain latent for many years and yet retain
the ability to grow lytically. Because VP16 associates
with the cellular proteins HCF-1 and Oct-1 to initiate
HSV gene expression during lytic infection, we
hypothesize that HCF-1 and Oct-1 are key regulators
of which mode of infection-latent or lytic-HSV
enters. We are therefore interested in the natural cellu-
lar roles of HCF-1 and Oct-1, and how these roles may
influence HSV infection. We focus primarily on the
cellular functions of HCF-1 because HCF-1 has been
highly conserved during evolution and is involved in
cell proliferation.
Human HCF-1 is synthesized as a large approxi-
mately 2000-amino-acid precursor protein, which is
proteolytically cleaved to generate a family of associ-
FIGURE 1 A ribbon diagram of the "side-view" of VP16-core
protein, illustrating the seat-like structure (adapted from Liu et
al. 1999b). The dark-to-light shading is from amino terminus (N)
to carboxyl terminus (C).
ated amino- and carboxy-terminal polypeptides. Only
the amino-terminal 380 residues of HCF-1, however,
are required to associate with VP16 and to stabilize
VP16-induced complex formation. This region of
HCF-1 is not only involved in interaction with VP16:
together with an adjacent basic region, it is also
involved in promoting cell proliferation. During the
past year, A. Wilson and colleagues described an HCF-
1-related protein called HCF-2 (Johnson et al., J. Viral.
73: 3930 [1999]). This protein shares the VP16-inter-
action region with HCF-1 but lacks the basic region of
HCF-1, which is also required for cell proliferation.
Last year, in collaboration with the Hengartner lab
here at the Laboratory, we reported that HCF proteins
have been conserved during metazoan evolution:
Extracts from the worm Caenorhabditis elegans can
stabilize VP16 association with human Oct-1. We
showed that C. elegans expresses a homolog of human
HCF proteins (CeHCF) that can associate with and
activate VP16. The pattern of sequence conservation
between human and worm HCF, however, is uneven.
Like the HCF-2 protein, the amino-terminal sequences
involved in interaction with VP16 and cell prolifera-
tion are conserved, but the basic region is not con-
served in CeHCF. These results suggest that, in its
association with HCF-1, VP16 targets the one of two
elements of HCF-1 known to be involved in cell pro-
liferation that has been conserved in metazoans. We
will continue our studies of CeHCF to uncover the cel-
lular role of this conserved function.
PUBLICATIONS
Liu Y., Hengartner M.O., and Herr W. 1999. Selected elements
of herpes simplex virus accessory factor HCF are highly
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RNA SPLICING
A.R. Krainer L. Cartegni S. Kuusk M. Murray
S. Chew H.-X. Liu T.-L. Tseng
M. Hastings L. Manche J. Zhu
MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE-mRNA SPLICING
RNA splicing is an essential step for the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the spliceo-
some occur with a very high degree of fidelity, which
requires precise interpretation of limited and dispersed
sequence information present throughout introns and
exons. The expression of many cellular and viral genes
occurs via alternative splicing, which involves sub-
stantial flexibility in the choice of splice sites, allow-
ing the expression of multiple protein isoforms from
individual genes. The choice of alternative splice sites
is commonly regulated to alter gene expression, either
tissue specifically or in response to a developmental
program or to extracellular signals. Both constitutive
and alternative splicing mechanisms involve multiple
protein components, as well as RNA components that
are part of small nuclear ribonucleoprotein (snRNP)
particles. Our lab has focused on the identification,
purification, and molecular characterization of protein
factors that are necessary for the catalysis and fidelity
of splicing and/or for the regulation of alternative
splice site selection.
EXONIC SPLICING ENHANCERS
We have continued to study the nature and function of
exonic elements that stimulate the removal of adjacent
introns. These elements are thought to be involved in
exon definition, splicing fidelity, splicing efficiency,
and regulation of alternative exon inclusion. Splicing
enhancers are recognized specifically by individual
members of the SR protein family. H.-X. Liu devel-
oped a powerful method to determine enhancer
sequence motifs recognized by individual SR proteins.
A natural enhancer in the last exon of the IgM gene
was replaced by 20 nucleotides of random sequence,
and the resulting library of transcripts was spliced in
HeLa S100 extract in the presence of one of four dif-
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ferent recombinant SR proteins. Sequences that could
promote splicing were selected by an iterative protocol.
We found that a very large number of sequences could
function as enhancers, suggesting that active enhancers
are very common in nature, with perhaps one or more
being present in all exons. Splicing in the presence of
single SR proteins yielded characteristic short and
degenerate consensus motifs, which were defined with
the help of M. Zhang here at Cold Spring Harbor
Laboratory. These four novel enhancer motifs are more
frequent in exons than in introns, and we are currently
exploring their predictive value in terms of defining
the SR protein requirement for individual transcripts.
Although the motifs we identified may be neces-
sary for enhancer function, they are not sufficient,
apparently because of sequence context effects. Exonic
silencer elements may have a dominant effect over
enhancer elements. For example, A. Mayeda and H.-X.
Liu found that a human immunodeficiency virus
(HIV) substrate that fails to splice when SC35 is the
sole SR protein can do so when a short exonic silencer
element is deleted (in collaboration with X.-D. Fu's lab
at University of California, San Diego); SC35
enhancer motifs are present in the same exon, but the
silencer prevents their recognition or function (Fig. 1).
S. Kuusk and J. Zhu showed that a variety of sequences
can function as silencers in place of the natural HIV
silencer. Although we cannot presently predict what
kinds of sequences have silencer activity, A. Zahler's
lab (University of California, Santa Cruz) showed, in
collaboration with our lab, that a particular silencer in
a different HIV exon was recognized by heterogeneous
nuclear ribonucleoprotein (hnRNP) A1, and that a
high-affinity hnRNP Al- binding site also had silencer
function in this context.
S. Chew pursued mechanistic studies of enhancer
function. Although we and other investigators had pre-
viously determined that enhancers and SR proteins
function in the initial stages of spliceosome assembly,
the fact that SR proteins remain bound to the spliced
exons, and in some cases are exported to the cytoplasm
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FIGURE 1 An exonic splicing silencer (ESS) in HIV-tat pre-mRNA
blocks splicing in the presence of a specific SR protein. (Top) In
vitro splicing of HIV-tat pre-mRNA derivatives with replacement or
internal deletion of segment Tc in the 3' exon. The structures of
the pre-mRNAs are shown schematically at the top. The deleted
ESS element is indicated by a horizontal bar, and the black box
shows the Cc segment of IgM C4 exon replacing the Tc segment.
The positions of the spliced mRNAs are indicated by arrows. (wt)
Wild type. The band between pre-mRNA and mRNA is a cleav-
age product unrelated to splicing. The ESS blocks splicing in the
presence of SC35 but not of SF2/ASF. (Bottom) High-score ESE
motifs in the HIV-tat exon T3. Score matrices derived from func-
tional Selex experiments with SC35 and SF2/ASF were used to
search the exon sequence. The resulting scores (y axis) were
plotted against the nucleotide position along the exon (x axis).
The vertical bars indicate each SF2/ASF heptanucleotide motif
(dark gray) or SC35 octanucleotide motif (light gray). Because dif-
ferent score matrices were used for each protein, the numerical
scores of the two SR proteins cannot be compared. The position
of the SC35-specific ESS is indicated.
bound to mRNA, suggested that both the elements and
the proteins might have additional roles late in the
splicing reaction. Indeed, S. Chew found that both an
enhancer and an SR protein are required for the second
step of splicing, i.e., intron excision and exon ligation.
This requirement was shown by observing a kinetic
effect on both steps of splicing of an enhancer-depen-
dent pre-mRNA and by use of a bimolecular exon lig-
ation assay. In this assay, the first step of splicing is car-
ried out in the absence of a 3' exon, which is later pro-
vided in trans for the second step. We found that the
trans-spliced 3' exon requires an enhancer and a cog-
nate SR protein for efficient bimolecular exon ligation.
STRUCTURE AND FUNCTION OF RRM-CONTAINING
SPLICING FACTORS
Several of the splicing factors we have been character-
izing contain one or two RNA-recognition motifs
(RRMs). The RRM is a particular type of RNA-bind-
ing motif, which is very common and is frequently
present in two or more copies in a single protein.
Among the human proteins we have been investigat-
ing, all the SR and hnRNP A/B proteins contain one or
two RRMs, p54nrb contains two, and RNPS1 contains
one. RNPS 1 was identified by A. Mayeda in the course
of purifying factors that stimulate alternative 3' splice-
site selection by antagonizing SR proteins. Purified or
recombinant RNPS1 has a more general effect on
splicing, behaving as an activator that stimulates usage
of all splice sites in the presence of SR proteins.
The three-dimensional structures of these proteins
are of interest because of the insights they are expected
to provide about their mechanisms of action, and also
because of their implications for how the conserved
RRM fold can be adapted for different functions and
ways of binding nucleic acids. Crystallographic studies
are being pursued in collaboration with R.-M. Xu's lab-
oratory. The structure of the UP1 fragment of hnRNP
Al was determined at high resolution, providing the
first example of how two RRMs are packed within a
single protein. This year, the structure of UP1 bound to
single-stranded telomeric DNA repeats was deter-
mined, revealing an unexpected dimerization of the
protein upon nucleic acid binding. The structure sug-
gests the basis of the high-affinity binding of UP1 or
hnRNP Al to DNA or RNA with the telomeric repeat
sequence. hnRNP Al has been linked to alternative
splicing regulation (through our previous work) and to
telomere length regulation (through B. Chabot's work
at the University of Sherbrooke), and therefore it will
be of interest to explore the importance of different
aspects of the UP 1 structure for each of these process-
es. We are pursuing these functional studies in collabo-
ration with the Xu lab.
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The Xu lab also solved the structure of p32, in col-
laboration with our lab. p32 is a protein that we origi-
nally identified several years ago because of its copu-
rification with the SR protein SF2/ASF. p32 was sub-
sequently tied to a wide variety of cellular processes by
work in many laboratories. Unexpectedly, we and oth-
ers have shown that p32 is predominantly, if not exclu-
sively, a mitochondrial protein, although there is some
evidence that a change in localization can occur under
certain conditions, such as viral infection. The structure
revealed that p32 has a novel fold and forms a
homotrimer in the shape of a donut with an asymmet-
ric charge distribution.
OTHER STUDIES
M. Murray is continuing his analysis of human PP2Cy,
a type-2C Ser/Thr phosphatase that he showed is
required at the onset of spliceosome assembly. He has
shown that PP2Cy is tethered to the spliceosome once
this complex assembles and that the activity of the pro-
tein in spliceosome assembly requires both a charac-
teristic acidic domain and active site residues respon-
sible for dephosphorylation. He is using a variety of
approaches to determine the basis for the physical
association of this phosphatase with the spliceosome
and to understand the mechanistic consequences of the
specific dephosphorylation events it catalyzes in the
context of splicing.
M. Hastings is pursuing the characterization of AT-
AC intron processing, a second splicing pathway for a
small class of introns in higher eukaryotes. She has
found that SR proteins are required for this pathway
and is currently exploring the factors involved in the
interplay between major and minor spliceosomes
assembled on adjacent introns of the two types.
H.-X. Liu and L. Cartegni have been studying the
relationship between inappropriate exon skipping and
the disruption of exonic enhancers by nonsense or
other mutations. J. Zhu is exploring the mechanistic
link between intron recognition and nonsense-mediat-
ed mRNA decay, as well as the functional roles of RS
domains in SR proteins.
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REGULATION OF APOPTOSIS IN CANCER CELLS
Y. Lazebnik D. Duelli X. Opitz-Araya
L. Fa leiro J. Raychaudhuri
H. Fearnhead J. Rodriguez
P. Lassus
Apoptosis is a fundamental biological process critical
for maintaining tissue homeostasis. Consequently,
deregulation of apoptosis contributes to cancer. Our
laboratory is investigating three questions: What is the
apoptotic machinery? How it is regulated? Can it be
used to kill cancer cells?
Central to the apoptotic machinery are caspases, a
family of cysteine proteases. Caspases are activated at
the onset of apoptosis and cause death by cleaving a
number of proteins in a coordinated manner. If caspase
activation is prevented, a cell can become drug-resis-
tant. Caspase activation occurs in two steps. At the
first step, pro-apoptotic signals lead to autocatalytic
activation of caspases that are called initiators.
Activated initiator caspases process effector caspases
which in turn cause cell collapse by cleaving a specif-
ic set of substrates. Each initiator caspase is activated
in response to a subset of signals, indicating that a pre-
requisite for understanding how a specific signal acti-
vates apoptosis is finding the initiator caspase that
mediates it.
We are investigating which caspases are involved
in apoptosis and studying how they are activated, how
this activation leads to cell death, and what prevents
this activation in drug-resistant cells. The ultimate
goal is to understand how caspases can be activated
selectively in cancer cells.
The answer to selective killing of cancer cells may
lie in the observation that expression of oncogenes that
deregulate the cell cycle can sensitize cells to pro-
apoptotic stimuli. An implication of this observation is
that oncogene expression generates a pro-apoptotic sig-
nal that is present in transformed cells but absent in
normal cells. When this signal is uncoupled from the
apoptotic machinery, transformed cells can survive and
become resistant to chemotherapeutic drugs. In princi-
ple, restoring the link between the signal and the apop-
totic machinery should selectively kill transformed
cells because although untransformed cells have the
machinery, they lack the signal. Understanding how the
apoptotic machinery is regulated by oncogenic trans-
formation is the first step in testing this hypothesis.
To investigate how the apoptotic machinery is reg-
ulated by oncogene expression, we previously devel-
oped a cell-free system that mimics apoptosis depen-
dent on expression of E 1 A, an adenoviral oncogene.
Using this system, we found that E1A-dependent apop-
tosis is mediated by caspase-9 and that the expression
of E1A sensitizes cells to apoptosis by facilitating acti-
vation of this caspase. This is achieved in at least two
ways: facilitating the release from mitochondria of
cytochrome c, a cofactor required for caspase-9 activa-
tion, and regulation of an unidentified subsequent step
in caspase-9 processing. Hence, during the last year, we
investigated how E1A regulates cytochrome c release
and caspase-9 processing.
Caspase-9 and APAF-1
Form a Holoenzyme
J. Rodriguez
To understand how E1A can regulate activation of cas-
pase-9, we had to first establish how caspase-9 is acti-
vated. Caspase-9 activation requires binding of the pre-
cursor to a complex of two proteins, Apaf-1 and
cytochrome c, and is dependent on hydrolysis of dATP
or ATP. However, it was not clear how formation of this
complex results in caspase-9 activation and how other
initiator caspases are activated. The induced proximity
model that was widely accepted at the time argued that
the precursor of an initiator caspase has low activity
which is sufficient for autocatalytic processing but only
when two or more precursor molecules are brought into
close proximity by adaptor proteins, such as Apaf-1.
The processed caspase becomes fully active and is free
to cleave its substrates.
We previously postulated an alternative model in
which proteins like Apaf-1 facilitate autocatalysis of
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the caspase precursors by increasing their activity
through a conformational change. During the last year,
we indeed found that the proteolytic activity of cas-
pase-9 in a complex with Apaf-1 is several orders of
magnitude higher than that of the free enzyme. Thus,
this complex functions as a holoenzyme where cas-
pase-9 is the catalytic subunit and Apaf-1 its regulator.
We argue that this regulation is allosteric and suggest
that this mechanism is common for other initiator cas-
pases. The proposed model has several implications.
A practical implication is that in vitro screens for
caspase-9 substrates and inhibitors, which are actively
sought by pharmaceutical companies as potential ther-
apeutics, should use the caspase-9 holoenzyme, rather
than caspase-9 alone. Another implication is that cas-
pase-9 activity may be regulated even after caspase-9
processing, for example, by sequestering caspase-9
from the holoenzyme or by the amount of available
Apaf-1 oligomer. This would explain the otherwise
difficult to explain high efficiency of the caspase-9
dominant-negative mutant and the naturally occurring
caspase-9 "decoys" as inhibitors of apoptosis. This
would also mean that a mutant caspase-9 can inhibit
apoptosis even if expressed by only one allele in a
tumor cell.
We are investigating how expression of El A
affects formation of the caspase-9 holoenzyme, as well
as whether this holoenzyme contains cofactors other
than Apaf-1. We also initiated a collaboration with Dr.
Joshua-Tor's lab here at Cold Spring Harbor to deter-
mine the three-dimensional structure of the holoen-
zyme.
E1A Regulates Cytochrome c
Release from Mitochondria
D. Duelli, J. Raychaudhuri
To investigate how expression of E1A affects
cytochrome c release, we initiated two approaches.
One was to set up a cell-free system in which extracts
from cells expressing E1A induce cytochrome c
release from mitochondria. The results obtained with
this system indicated that extracts from cells express-
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ing E1A contain an activity that is able to release
cytochrome c. This activity is being purified. Another
approach was to establish whether expression of E1A
regulates inhibitors or activators of cytochrome c
release. This was achieved by a complementation
assay in which cells that express E1A are fused with
untransformed cells. We found that expression of ElA
triggers at least two pathways, one of which represses
and one that inhibits cytochrome c release. This
inhibitor is being identified.
Does Caspase-9 Mediate
Oncogene and Drug-induced
Apoptosis in All Cancer Cells?
P. Lassus
Some observations obtained in our and other laborato-
ries suggest that drug-induced apoptosis of cancer
cells can be mediated by caspases other than caspase-
9. During the last year, we identified an experimental
system where apoptosis does not appear to involve
processing of known caspases yet is prevented by a
caspase inhibitor, indicating that a caspase activity is
involved. We have established approaches to identify
this putative caspase and are pursuing them.
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REGULATION OF APOPTOSIS AND SENESCENCE BY
CANCER GENES
S. Lowe E. de Stanchina J. Polyakova
G. Ferbeyre A. Samuelson
A. Lin C. Schmitt
M. McCurrach M. Soengas
Apoptosis is a genetically controlled form of cell death
that is important for normal development and tissue
homeostasis. Senescence produces "genetic death" in
that senescent cells permanently arrest and are inca-
pable of further propagation. Both processes are fre-
quently disrupted in cancer cells, implying that each
can limit tumor development. Moreover, radiation and
many chemotherapeutic agents can induce apoptosis
or senescence, raising the possibility that the integrity
of these programmed responses influences the out-
come of cancer therapy in patients. The goal of our
research is to understand how cancer genes control
apoptosis and senescence in normal cells, and how
mutations that disrupt these processes impact tumor
development and therapy. Our approach emphasizes
genetics, and we typically exploit simple cellular sys-
tems to study cancer gene function. More recently, we
have developed animal models to confirm the rele-
vance of our simple systems for multistep carcinogen-
esis and cancer therapy in vivo.
Much of our research stems from our interest in
the p53 tumor suppressor. p53 functions as a key com-
ponent of several cellular stress responses and as such
acts at a variety of levels to protect against cancer. For
example, p53 can be activated by DNA damage to acti-
vate cell cycle checkpoints or apoptosis, such that cells
lacking p53 are prone to certain forms of mutation and
genomic instability. This implies that p53 can indirect-
ly suppress tumorigenesis by acting as a "Guardian of
the Genome," i.e., to promote the repair or elimination
of cells sustaining potentially deleterious mutations.
Remarkably, since most anticancer agents now in use
damage DNA, the integrity of this p53 response may
contribute to the success or failure of cancer therapy.
In addition to DNA damage, certain mitogenic onco-
genes can activate p53 to promote apoptosis or senes-
cence. Loss of p53 prevents these homeostatic
responses, leading to oncogenic transformation or
tumor progression. These results imply that p53 can
directly suppress tumorigenesis by acting in a fail-safe
mechanism to counter hyperproliferative signals. We
currently study many aspects of p53, including how
oncogenes or DNA damaging agents signal p53, how
p53 executes a biological response, and the factors that
influence whether p53 induces a cell cycle checkpoint,
cellular senescence, or apoptosis.
Oncogene Signaling to p53:
The ARF-p53 Tumor
Suppressor Pathway
C. Schmitt, E. de Stanchina, A. Lin, G. Ferbeyre
[in collaboration with C. Prives, Columbia University,
and C. Sherr and M. Roussel, St. Jude Children's
Research Hospital].
Last year, we and others identified the ARF tumor sup-
pressor as an important intermediate in oncogene sig-
naling to p53 (de Stanchina et al., Genes Dev. 12: 2434
[1998]). These observations raised the possibility that
disruption of ARF, like p53 loss, would accelerate
tumorigenesis initiated by mitogenic oncogenes. To
test this possibility, we examined the impact of
INK4a/ARF and p53 loci on tumor development and
treatment response in Eµ -myc transgenic mice
(Schmitt et al. 1999). These mice constitutively
express the myc oncogene in B cells and, hence, devel-
op B-cell lymphoma. ER-myc transgenic mice were
bred with mice harboring deletions of several tumor
suppressor loci to generate genetically defined tumors
with mutations in the INK4a/ARF; Rb, or p.53 genes.
Like p53 null lymphomas, INK4a/ARF null lym-
phomas formed rapidly and were highly invasive.
Furthermore, INK4a/ARE-1- lymphomas displayed
reduced p53 activity despite the presence of wild-type
p53 genes. These results establish that ARF is impor-
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tant for oncogene-induced apoptosis in developing
tumors and demonstrate that INK4a/ARF and p5.3
mutations lead to aggressive tumors by disrupting
overlapping tumor suppressor functions. We continue
to study ARF action and ARF-independent pathways
involved in oncogene signaling to p53.
p53 Effector Mechanisms
M. Soengas [in collaboration with T. Mak, Amgen
Institute and Ontario Cancer Center]
How p53 promotes apoptosis is controversial (see
Lowe 1999; Wallace-Brodeur and Lowe 1999).
Although many investigators have focused on the tran-
scriptional targets of p53, our recent efforts have
examined how p53 signaling integrates with the cas-
pases. Caspases are a family of cysteine proteases that
are expressed as inactive pro-enzymes that become
activated during apoptosis. "Signaling" caspases link
pro-death signals to the effector caspases, whereas
"effector" caspases disassemble the cell. Importantly,
signaling pro-caspases must associate with specific
adaptor molecules to initiate the caspase cascade.
These complexes include FADD/Casp-8, RAIDD/
Casp-2, and Apaf-1/Casp-9.
Using embryonic fibroblasts derived from various
knockout mice, we examined the requirements for sev-
eral caspases or their adapters on apoptosis in response
to the E1A and c-myc oncogenes. Previously, we
showed that Casp-3 and the FADD/Casp-8 and
RAIDD/Casp-2 complexes were dispensable for p53-
mediated cell death (Woo et al., Genes Dev. 12: 806
[1998]; Yeh et al., Science 279: 1954 [1998]; J.
Polyakova, J. Yuan, and S. Lowe, unpubl.). This year,
we examined the contribution of Casp-9 and its cofac-
tor Apaf-1 to p53 action during Myc-induced apopto-
sis (Soengas et al. 1999). Like p53 null cells, Apaf-1-
and Casp-9-deficient cells expressing c-Myc were
resistant to apoptotic stimuli that mimic conditions in
developing tumors. In contrast, ectopic p53 expression
efficiently induced cell death in p53-deficient cells but
had no pro-apoptotic effect in cells lacking Apaf-1 or
Casp-9. Remarkably, inactivation of Apaf-1 or Casp-9
substituted for p53 loss in promoting the oncogenic
transformation of Myc-expressing cells.
These studies demonstrate that Apaf-1 and Casp-9
can act as essential downstream components of p53 in
Myc-induced apoptosis and identify Apaf-1 and Casp-
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FIGURE 1 Effect of Apaf-1 and Casp-9 on colony formation in
soft agar. The ability of Myc/Ras-expressing MEFs to form
colonies in soft agar is illustrated by Giemsa staining (top) and
phase-contrast microscopy (bottom); 2 x 104 cells of the indi-
cated genotypes were resuspended in 0.3% Noble agar (in
Dulbecco's modified Eagle's medium supplemented with 10%
fetal bovine serum) and plated on 6-cm plates containing a
solidified bottom layer (0.5% Noble agar in growth medium).
Shown is a representative experiment two weeks after plating.
Note that the size and number of colonies derived from Apaf-
1-/- and Gasp-9-i- cells were comparable to those of p53-/-
cells.
9 as candidate tumor suppressors. Although we do not
believe that p53 directly interacts with either Apaf-1 or
Casp-9, it seems likely that the immediate effectors of
p53 converge on the Apaf-1/Casp-9 death effector
complex-or at least require it for their activity. To
extend these observations, we are testing the onco-
genic capacity of Apaf-1/Casp-9 disruption in trans-
genic mice, and screening human tumors for Apaf -1
and Casp-9 mutations.
E1A and Chemosensitivity
A. Samuelson, J. Polyakova in collaboration with
Y. Lazebnik, Cold Spring Harbor Laboratory]
El A has the remarkable property of enhancing cellu-
lar sensitivity to anticancer-agent-induced death. We
have previously shown that this activity involves at
least two separable functions: The first involves inac-
tivation of Rb and the second requires an amino-ter-
minal E1A region. Remarkably, E1A mutants unable
to inactivate Rb but retaining the amino-terminal
function selectively promote chemosensitivity in cells
lacking an intact Rb pathway. As a result, elucidating
the amino-terminal function(s) involved in chemosen-
sitivity may suggest new drug targets. In collabora-
tion with Y. Lazebnik, we have shown that El A
induces several caspases through a posttranscription-
al mechanism that acts independently of p53 and
involves inactivation of the retinoblastoma gene prod-
uct (J. Polyakova, unpubl.). Although pro-caspase
induction by El A cannot solely explain its pro-apop-
totic activity, it seems likely that it contributes to the
p53-independent apoptosis induced by oncogenes.
Although our previous studies associated the amino-
terminal El A function that contributes to apoptosis
with the El A-p300/CBP interaction, we now have
used more refined mutants to separate p300/CBP
binding from E1A-induced apoptosis (A. Samuelson,
unpubl.). We hope that these results will facilitate a
more complete understanding of this E1A action in
chemosensitivity.
Control of Cellular
Senescence
G. Ferbeyre, A. Lin, E. de Stanchina, M. McCurrach
Our previous work demonstrates that expression of
oncogenic ras in primary human or rodent cells results
in a permanent arrest accompanied by accumulation of
p53, p16, and pl9A and has the hallmarks of cellular
senescence. Negation of ras-induced senescence
appears to account for the phenomenon of oncogene
cooperation and may be important for tumor develop-
ment. Currently, we are addressing several questions:
How does ras signaling activate a permanent cell cycle
arrest? How do tumor suppressors such as p53, p16,
and p 1 9ARF initiate and maintain this arrest? What is
the relationship between ras-induced arrest and
replicative senescence? How do epithelial cells
respond to ras? What is the impact of ras-induced
arrest for multistep carcinogenesis in vivo?
This year, we have established an epithelial system
to study ras-induced arrest. We chose to study murine
keratinocytes because (1) protocols have been estab-
lished to culture mouse keratinocytes and (2) the
genetics of chemically induced skin carcinogenesis
involves cooperation between ras and p53 mutations.
Like fibroblasts, keratinocytes respond to oncogenic
ras by inducing p19A", p53, and cell cycle arrest (A.
Lin, unpubl.). Hence, the phenomenon of ras-induced
"senescence" extends to epithelial cells, which give
rise to the majority of human tumors (i.e., carcino-
mas). In addition, with W Funk (Geron Corporation),
we used a 1000-gene eDNA microarray to compare
gene expression profiles in normal diploid human
fibroblasts that were (1) exponentially growing, (2)
quiescent, (3) ras-arrested, or (4) senescent. Although
ras-arrested and senescent cells showed differences,
they were much more similar to each other than to qui-
escent cells (D. Shelton et al., submitted). The com-
mon changes observed in ras-arrested and senescent
cells were reminiscent of an inflammatory response
and raise the possibility that senescent cells are ulti-
mately cleared by signaling to the immune system. In
any case, these data demonstrate that ras arrest and
replicative senescence are highly related processes.
We are now expanding our analysis to survey more
than 18,000 genes and expressed sequence tags, and
hope that this effort will provide additional insights
into the nature of ras-induced arrest.
In Vivo Models of Drug
Sensitivity and Resistance
C. Schmitt, M. McCurrach, E. de Stanchina
Our laboratory has a long-standing interest in the mol-
ecular genetics of drug sensitivity and resistance.
Although we continue to use in vitro models, we have
concluded that some aspects of therapy response must
be studied in vivo. We hypothesized that the Eg-myc
transgenic mouse (described above) would be a
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tractable model for studying factors involved in thera-
py-induced cell death, since (1) tumor burden can be
easily monitored by lymph node palpation or blood
smears, (2) large numbers of pure tumor cells can be
isolated from mice undergoing therapy, (3) therapy is
performed in immunocompetent mice, and (4) lym-
phoma cells readily adapt to culture and can be trans-
planted into syngeneic mice.
E.t -myc lymphomas typically retain p53 function
and are highly responsive to DNA-damaging agents
such as adriamycin and ionizing radiation, which pro-
duce massive p53 induction and apoptosis shortly after
treatment. In contrast, Ep. -myc lymphomas lacking
functional p53 (generated by crossing to the p53
knockout mouse) display reduced apoptosis and are
typically resistant to these same therapies.
Interestingly, tumors lacking the INK4a/ARF locus
were nearly as resistant as p53-deficient lymphomas.
Moreover, these tumors displayed attenuated p53
activity and apoptosis compared to those arising in a
control background. Thus, disruption of the p53 path-
way-through a p53 mutation or by an extragenic
mutation-dramatically reduces the responsiveness of
Eii-myc lymphomas to therapy (Schmitt et al. 1999).
These data have important implications for under-
standing p53 and the clinical behavior of human
tumors. For example, our data demonstrate that tumors
with extragenic mutations in the p53 pathway can dis-
play properties of p53 mutant tumors. This fundamen-
tal point is crucial for interpreting studies relating p53
gene status to clinical parameters in human patients
and may explain why some studies fail to correlate p53
mutations with adverse clinical features. In addition,
we provide the first evidence that INK4a/ARF muta-
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tions can have a negative impact on the outcome of
cancer therapy. Although the extent to which this
impacts human cancer is as yet unknown, it is note-
worthy that p53 mutations are associated with highly
aggressive tumors and drug resistance in hematologi-
cal malignancies (Schmitt and Lowe 1999), indicating
that E.t -myc lymphomas can recapitulate the behavior
of human tumors. We are continuing to use this
tractable system to identify additional determinants of
chemosensitivity in vivo.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski A. Janardhan N. Shohdy
M.E. Greenberg T. Swigut
B. Hill
Our interest is in understanding the molecular mech-
anisms underlying the pathogenesis of AIDS and, in
particular, the functional consequences of the inter-
actions between viral proteins and the cellular regu-
latory machinery. The focus of our research is to
understand the function of Nef, a regulatory protein
of human and simian immunodeficency viruses (HIV
and SIV) that is an important determinant of viral
pathogenicity. Important questions concerning the
normal function of this gene have been raised on the
basis of observations that nef viruses replicate poor-
ly in the host where their presence correlates with
attenuated development of AIDS. In fact, deleting the
nef gene is a promising strategy to generate attenuat-
ed immunodeficiency viruses for use as live vac-
cines.
Natural Nef protein isolates have several con-
served effects on signal transduction and protein sort-
ing machineries that probably enhance viral virulence
in vivo. One effect of Nef is to down-regulate the cell
surface CD4 molecule, an essential component of the
cellular receptor for HIV and SIV virions and a com-
ponent of the antigen receptor on class II major histo-
compatibility complex (MHC)-restricted T lympho-
cytes. Nef also down-regulates expression of class I
MHC complexes at the cell surface, and this effect
may enable infected cells to evade the immune
response in the infected host. We showed previously
that HIV-1 Nef uses two different mechanisms to
down-regulate expression of CD4 and class I MHC
molecules. In previous years, we probed and elucidat-
ed the molecular mechanism(s) that mediate these
effects by the HIV-1-encoded Nef protein, but this
year, we also initiated a similar analysis of Nef encod-
ed by SIV. These experiments identified mutant Nef
proteins that were selectively defective for individual
functions of Nef, which in turn opened the way to ini-
tiate experiments addressing the importance of indi-
vidual functions and molecular interactions of Nef for
viral replication in cell culture and in SIV-infected rhe-
sus macaques.
HIV-1 NEF INDUCES CD4 ENDOCYTOS;S VIA AN
AP-2-CLATHRIN ADAPTOR-DEPENDENT PATHWAY
Evidence from experiments performed in our laborato-
ry suggest a model where Nef accelerates CD4 inter-
nalization from the cell surface by promoting the
recruitment of CD4 molecules expressed at the cell sur-
face to AP-2 clathrin-adaptor complexes (AP-2) at the
plasma membrane. This is supported by observations
that Nef is concentrated at plasma membrane sites con-
taining AP-2 and clathrin heavy chains, two core ele-
ments of clathrin-coated pits that mediate endocytosis
of a number of cell surface receptors (Le Borgne and
Hoflack 1998), that CD4 is redistributed to these sites
in cells expressing Nef or a green fluorescent protein
(GFP)-tagged Nef, and that mutations in Nef that dis-
rupt its ability to colocalize with AP-2 also disrupt its
ability to accelerate CD4 internalization.
During constitutive endocytosis, the CD4 molecule
contacts the endocytic machinery via a dileucine sorting
signal in its cytoplasmic domain, a signaling motif
which, in vitro, has been shown to interact directly with
the I subunits of golgi and plasma-membrane-associated
(AP-1 and AP-2) adaptor complexes. Since we found that
this dileucine sequence is part of a larger hydrophobic
element in the CD4 cytoplasmic domain required for the
ability of Nef to down-regulate CD4 molecules, we
believe that in the presence of Nef, CD4 makes contacts
with elements of the endocytic machinery similar to the
contacts that take place in the absence of Nef during CD4
endocytosis and that Nef likely stabilizes the normal
interaction(s) of the CD4 cytoplasmic domain with the
endocytic machinery, rather than linking CD4 to AP-2.
SIV NEF USES SURFACES AND MOLECULAR
INTERACTIONS DIFFERENT FROM THOSE OF HIV-1
NEF TO DOWN-REGULATE CD4 EXPRESSION
AND TO INTERACT WITH AP-2
We previously found that HIV-1 Nef regions mediating
the interaction of Nef with AP-2 in vivo and in vitro
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map to the disordered loop in the carboxy-terminal
region of the Nef molecule. SIV Nef also uses a simi-
lar mechanism to down-regulate expression of the
CD4 molecule. However, there is little similarity in the
amino acid sequences in the disordered regions of SIV
and HIV-1 Nef proteins. Therefore, to understand how
SIV Nef interacts with AP-2 and down-regulates CD4,
we set out to determine sequences in SIV Nef that are
required for these functions. We found that the amino-
terminal disordered region in SIV Nef is necessary
and sufficient for the ability of Nef to associate with
partially purified AP-2 adaptor complex in vitro, and
for its ability to target heterologous proteins to AP -2-
containing- clathrin coats in vivo. Thus, different
regions in the SIV and HIV-1 Nef proteins mediate
interactions with AP-2 clathrin, which is essential for
the ability of Nef to induce CD4 endocyosis via the
clathrin pathway. Interestingly, we also know of addi-
tional differences in the functional organization of
HIV-1 and SIV Nef in the core domains of the two
molecules. For example, the PPII helix in HIV-1 Nef is
essential for its ability to modulate CD3-initiated sig-
naling in T cells and to induce endocytosis of class I
MHC molecules, but not for the ability of SIV Nef to
perform these functions. The observation that HIV-1
and SIV Nef proteins have evolved different surfaces
to carry out similar functions is striking. That genetic
selection would maintain similar molecular interac-
tions via different surfaces in SIV and HIV-1 Nef pro-
teins is evidence that these interactions have critical
roles for the viral life cycle in vivo.
TWO ELEMENTS TARGET SIV NEF TO AP-2, BUT
ONLY ONE IS REQUIRED FOR THE INDUCTION
OF CD4 ENDOCYTOSIS
The observations that SIV Nef and HIV Nef proteins
use different surfaces to contact AP-2 raised the possi-
bility that the two proteins may use different strategies
to down-regulate CD4 expression. To address this pos-
sibility, we studied in detail the elements in SIV Nef
that are required for its interaction with AP-2 and for
down-regulation of CD4 from the cell surface. We
found that SIV Nef interacts with AP-2 via two ele-
ments located in the amino-terminal region of the Nef
molecule. Interestingly, only the N-distal element is
required to induce CD4 endocytosis. This N-distal AP-
2 targeting element contains no canonical endocytic
signals and therefore probably contacts the AP-2 com-
plex via a novel interaction surface. The data support a
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model where SIV Nef induces CD4 endocytosis by
promoting the normal interactions between the
dileucine sorting signal in the CD4 cytoplasmic
domain and AP-2 but does not substitute for the CD4 -
AP-2 adaptor interaction. Neither element is important
for the induction of class I MHC endocytosis, thus con-
firming our previous conclusion from studies of HIV-1
Nef that different mechanisms underlie the induction of
class I MHC and CD4 endocytosis by Nef.
Interestingly, our data suggest different functional
roles for the N-proximal and N-distal AP-2 interacting
elements in 239-Nef. Why the interaction of 239-Nef
with AP-2 via the N-proximal element is not sufficient
to induce CD4 endocytosis is not known. One possible
explanation of these observations is that the interac-
tion involving the N-distal element, but not the N-
proximal element, reorients the 239-Nef molecule
with respect to the AP-2 complex in a very specific
way that promotes the recruitment of CD4 to AP-2 and
the induction of CD4 endocytosis. Alternatively, the
N-distal element in the amino-terminal loop of SIV
Nef may have an additional function besides linking
Nef to the AP-2 complex, such as a direct or indirect
interaction with CD4 or perhaps with other molecules
that control the recruitment of CD4 and/or morpho-
genesis of the coated pit. Finally, it is possible that the
N-proximal element is important for other sorting
events that involve CD4, perhaps in the context of
other adaptor complexes such as, for example, AP-3 or
that it is involved in another function such as the sort-
ing of membrane proteins other than CD4. Results
from these experiments will now permit us to design
mutant 239-Nef proteins defective in each of the two
AP-2 interacting elements to assess the importance of
these interactions with AP-2 for SIV replication in
SIV-infected rhesus monkeys (in collaboration with
Dr. Frank Kirchhoff, University of Erlangen,
Germany).
THE HIV-1 NEF GENE CAN TO A LARGE EXTENT
REPLACE SIV NEF IN VIVO
We collaborated with Dr. Frank Kirchhoff's group
(University of Erlangen, Germany) to assess whether
HIV-1 Nef can functionally replace SIV Nef in vivo. If
so, it would provide a means by which to study the
function of HIV-1 Nef in vivo. Initially, two rhesus
macaques were infected with the chimeric viruses
(Nef-SHIVs) carrying a large population of HIV-1 nef
genes isolated directly from HIV-1-infected patients. It
was expected that this would permit selection of HIV-
1 nef genes that are most robust in rhesus macaques.
As a result of these initial experiments, a single mole-
cular clone, named SHIV-40K6, was selected. The
SHIV-40K6 nef allele was active in CD4 and class I
MHC down-regulation and enhanced viral infectivity
and replication. Notably, all of the macaques inoculat-
ed with SHIV-40K6 showed high levels of viral repli-
cation early in infection, and approximately half of the
animals maintained high viral loads and developed
immunodeficiency within 1 year from the infection. In
contrast, infection of rhesus macaques with control
SIVs where the nef-coding sequence was inactivated
by deletion does not result in development of AIDS in
a significant fraction of the infected animals. These
data demonstrate that HIV-1 nef can to a large extent
functionally replace SIVmac nef in vivo.
EFFECT OF THE ATTENUATING DELETION
AND OF SEQUENCE ALTERATIONS EVOLVING
IN VIVO ON SIV C8-NEF FUNCTION
The SIVmacC8 variant has been used in a European
Community Concerted Action project to study the
efficacy and safety of live attenuated SIV vaccines in
a large number of macaques. The attenuating deletion
in the SIVmacC8 nef long-terminal-repeat region
encompasses only 12 by and is "repaired" in a subset
of infected animals. It is unknown whether C8-Nef
retains some activity. Since it is important to use only
well-characterized deletion mutants in live attenuated
vaccine studies, we collaborated with Dr. F. Kirchhoff
to analyze the relevance of the deletion and the dupli-
cations and point mutations selected in infected
macaques for Nef function in vitro. The deletion,
affecting amino acids 143-146 (DMYL), resulted in a
dramatic decrease in Nef stability and function. The
initial 12-bp duplication resulted in efficient Nef
expression and an intermediate phenotype in infectiv-
ity assays, but it did not significantly restore the abili-
ty of Nef to stimulate viral replication and to down-
modulate CD4 and class I MHC cell surface expres-
sion. The additional substitutions, however, which sub-
sequently evolved in vivo, gradually restored these
Nef functions. It was noteworthy that coinfection
experiments in the T-lymphoid 221 cell line revealed
that even SIVmac nef variants carrying the original
12-bp deletion readily outgrew an otherwise isogenic
virus containing a 182-bp deletion in the nef gene.
Thus, although C8-Nef is unstable and severely
impaired in in vitro assays, it maintains enough resid-
ual activity to stimulate viral replication. Thus, the nef
mutation in SIVmacC8 does not have the characteris-
tics that would be suitable for use in live attenuated
vaccine studies.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund C. Sanders A. Lee
E. Gillitzer H. Meats
G. Chen
The papillomaviruses infect and transform the basal
epithelium of their hosts, inducing proliferation of the
cells at the site of infection. The resulting tumors are in
most cases benign and will usually regress after some
time, but certain types of human papillomaviruses
(HPVs) give rise to tumors that are prone to progress
toward malignancy, especially frequently cervical car-
cinoma. In total, HPV DNA can now be found in biop-
sies from more than 80% of all cervical carcinomas.
A key impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for human papillomaviruses, largely due
to the fact that these viruses normally require special-
ized differentiating cells that only with difficulty can
be generated in cell culture. Therefore, a bovine papil-
lomavirus (BPV-1) has become the prototype virus for
because a convenient
cell culture system exists for this virus. In this cell cul-
ture system, viral gene expression, oncogenic transfor-
mation, and viral DNA replication can be studied. The
DNA replication properties of papillomaviruses show
some unique and interesting characteristics. As a part
of their normal life cycle, these viruses can exist in a
state of latency that is characterized by maintenance of
the viral DNA as a multicopy plasmid in the infected
cells. The copy number of the viral DNA appears to be
tightly controlled, and the viral DNA is stably inherited
under these conditions. This system therefore provides
a unique opportunity to study plasmid replication in
mammalian cells. In addition, the viral DNA replica-
tion machinery represents the one of the most promis-
ing targets for antiviral therapy.
In previous years, we have reported the characteri-
zation of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. More recently, we have directed
our attention toward detailed biochemical analysis of
initiation of DNA replication. We are studying the bio-
chemical properties of the virus-encoded E 1 and E2
proteins that are required for viral DNA replication. We
are also studying how these two proteins interact with
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the on and with each other to generate initiation com-
plexes. On the basis of these studies, we now have a rel-
atively clear picture of the roles of the El and E2 pro-
teins in replication. El has all of the characteristics of
an initiator protein, including on recognition, DNA-
dependent ATPase activity, and DNA helicase activity.
E 1 can also function to unwind a supercoiled plasmid
that contains the on sequence. The E2 polypeptide,
whose function has remained more elusive, appears to
serve largely as a specificity and loading factor for El.
Through physical interactions with both El and the ori,
E2 can provide sequence specificity in the formation of
the initiation complex.
Our attention has now turned toward elucidation of
the precise biochemical events that precede initiation
of replication at the origin of replication, i.e., binding
of the initiator to the ori, the initial opening of the
DNA duplex, and the assembly and loading of the El
replication helicase at the replication fork. Our studies
indicate that initiation of DNA replication is an
ordered multistep process involving the sequential
assembly of El onto the ori. This sequential assembly
generates different complexes that in turn recognize
the ori, destabilize the double helix at the ori, and
function as a replication helicase.
Binding Sites for the El Initiator
Protein in the ori
G. Chen
The initiator protein E 1 recognizes the papillomavirus
origin of DNA replication and thus determines where
DNA replication initiates. To understand how the El
protein can form oligomeric structures on the ori, we
have analyzed the stoichiometry of binding as well as
defined the sequences that constitute specific recogni-
tion sites for El using a minimal E1 DNA-binding
domain. Because of the variety of forms of El that can
bind to ori, it has been difficult to determine exactly
what constitutes a recognition sequence for El.
However, we have recently demonstrated that El , in
the presence of E2, can bind to the ori in monomeric
form. We have analyzed binding of this specific com-
plex, in combination with mutational analysis of the
ori sequence, to determine what specific sequences are
required for binding of El. These studies have demon-
strated that a monomer of El recognizes the hexanu-
cleotide sequence AACAAT and that binding of a
dimer of El occurs through the recognition of two of
these hexameric sequences, arranged as an inverted
repeat and positioned 3 by apart. Inspection of the ori
sequence demonstrated that in addition to this pair of
El recognition sequences, four additional putative El
recognition sequences are present. Two of these are
arranged in a similar fashion, but overlapping the first
pair by 3 bp. The final two putative sites are present
flanking the four sites in the overlapping array.
Importantly, a similar arrangement of this recognition
sequence is present in the majority of other papillo-
mavirus ori sequences, indicating that both the recog-
nition sequence and the arrangement of binding sites
are conserved features. Through the use of high-reso-
lution footprinting and a combination of interference
and mutational analyses, we have been able to demon-
strate simultaneous binding of four molecules of El to
the four overlapping El -binding sites. This mode of
binding has interesting implications both for how El
recognizes its specific site and for how El induces
structural changes in the ori DNA.
Structural Changes in the
ori Induced by Cooperative
Binding of El and E2
E. Gillitzer
Cooperative binding of the El and E2 proteins to the
ori is essential for viral DNA replication in vivo. We
have previously demonstrated that the interaction
between the El and E2 proteins has two separate com-
ponents. The DNA-binding domains (DBDs) of the
two proteins interact with each other, and the activa-
tion domain of E2 interacts with the helicase domain
of the El protein. The interaction between the activa-
tion domain of E2 and El is the productive interaction,
whereas the interaction between the two DBDs serves
to facilitate this interaction. To determine how the
physical interaction between the two DBDs triggers
the productive interaction, we have analyzed the struc-
ture of the ori in response to binding of the two DBDs.
Both the El and E2 DBDs individually generate mod-
est bends in the DNA upon binding. However, when
the two proteins are bound cooperatively, a much
sharper bend centered between the two binding sites
results. This sharp bend (which approaches 90°) could
result either from the combined intrinsic bends con-
tributed by the individual proteins or from the interac-
tion between the two proteins. To distinguish between
these possibilities, we utilized mutants in the E2 DBD
that fail to interact with the El DBD. Interestingly,
although the intrinsic bend generated by the mutant E2
DBDs was of similar magnitude to that generated by
wild-type E2 DBD, the mutant E2 DBDs failed to gen-
erate a sharp bend in combination with the El DBD.
These results suggested that the physical interaction
between El and E2 DBDs gave rise to the sharp bend
in the sequences between the two sites. To determine
whether bending of the DNA was also a requirement
for cooperative interaction, we wanted to change the
bendability of the DNA sequence between the El- and
E2-binding sites. This sequence includes the sequence
AAT, which is not involved in binding of either El or
E2. It is well established that homopolymeric A and T
stretches are intrinsically stiff. We therefore generated
a double substitution, changing the two A-T base pairs
to T-A base pairs. This creates a T4 sequence that is
predicted to be intrinsically stiff. As a control, we also
generated the two individual mutations. To determine
if the mutations increased the stiffness compared to
the wild-type sequence, we digested the wild-type and
mutant DNAs with with DNase I. Binding of DNase I
to the minor groove requires bending of the DNA. As
a result, stiff DNA is cleaved less efficiently than flex-
ible DNA. When tested by DNase I cleavage, the dou-
ble mutant was cleaved less efficiently than the wild-
type sequence or the individual point mutations, con-
sistent with increased stiffness of the double mutant.
As expected, none of these mutations had a significant
effect on binding of El or E2 alone. Likewise, the indi-
vidual mutations had little or no effect on cooperative
binding of El and E2. Interestingly, however, the dou-
ble mutation which increased stiffness resulted in a
severe reduction of both cooperative binding and bend-
ing. This is consistent with the idea that bendability of
the DNA sequence is important for the interaction
between the two DBDs and that bending of the DNA
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is a prerequisite for cooperative DNA binding.
Furthermore, these results demonstrate that the inter-
action between the El and E2 DBDs serves a predom-
inantly architectural role, analogous to the function of
cellular factors such as HMG proteins, which can
modify the architecture of a protein-DNA complex by
introducing bends in DNA.
Initiator Complex Assembly
C. Sanders
An intriguing aspect of viral initiator proteins is their
ability to perform several different, seemingly unrelat-
ed, biochemical functions. The El protein is known to
be a sequence-specific DNA-binding protein, but it
can also distort the ori, and also serves as a DNA heli-
case. One model to explain how these activities can
reside in one single polypeptide is that different
oligomeric forms of the protein may have different
activities. In agreement with such a model, we have
previously demonstrated that a dimeric form of El
recognizes the ori together with E2 and that the form
of El which has helicase activity is a hexamer. Our
current understanding of the assembly pathway of
these complexes is that a sequence-specific complex
of a dimer of El and a dimer of E2 together bind to the
ori and initially recognize the ori. In an ATP-depen-
dent manner, the E2 dimer is displaced and additional
El molecules are added to the complex. These are
bound sequence-specifically, forming a tetramer on
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the four paired El- binding sites in the core. Additional
El molecules are recruited to this complex, binding to
the DNA sequences on both sides of the core, and
resulting in a protection of approximately 60 by of on
sequence. The binding of El to the flanking sequences
shows little dependence on DNA sequence but is
dependent on protein-protein interactions with the El
molecules bound to the core. This large complex,
which appears to be a precursor of the DNA helicase,
is capable of distortion of the on giving rise to l(Mn04
sensitivity on both sides of the core. Interestingly, the
two halves of this large complex appear to be inde-
pendent of each other, since distortion can be detected
with only one half of the on present. This indicates
that the distortion complex is composed of two func-
tional units, each one of which initiates distortion on
one side of the core, presumably allowing for subse-
quent bidirectional unwinding and initiation of DNA
synthesis. Thus, as predicted, the assembly of initiator
complexes represents a gradual progression from
smaller to larger El complexes. Interestingly, in con-
junction with the assembly of progressively more com-
plex structures, a transition from a high to low degree
of sequence specificity occurs.
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Studies on the mechanism and control of the initiation
of replication of DNA in eukaryotes and the mecha-
nism of chromatin inheritance continued this year with
good progress. During the last 3 years or so, many
aspects of the mechanism of initiation of DNA repli-
cation at each origin have become apparent. The
process begins with the origin recognition complex
(ORC) acting as a landing pad for a series of cell-
cycle-regulated protein-protein interactions that ulti-
mately lead to the initiation of DNA synthesis at each
origin. Cdc6p and the six minichromosome mainte-
nance proteins (Mcm2-7p) form a prereplication com-
plex at each origin before S phase, followed by the for-
mation of a preinitiation complex (pre-IC) containing
additional proteins as each origin fires. We have fur-
ther characterized both complexes and their regulation
by cell-cycle-regulated protein kinases.
Other studies have followed on our observation
that the chromatin assembly factor-1 (CAF-1) protein
interacts with an essential DNA replication protein
called the proliferating cell nuclear antigen (PCNA)
and facilitates the inheritance of epigenetically deter-
mined states of gene expression. This mechanism may
account for how heterochromatin, the bulk of the tran-
scriptionally silent chromatin in higher eukaryotes, is
copied from one generation to the next.
INITIATION OF CHROMOSOMAL DNA REPLICATION
Cdc6p: The mechanism for selection of origins of
DNA replication within eukaryotic chromosomes has
long been of interest. When we found that ORC bound
in a DNA-sequence-specific and ATP-dependent man-
ner to origins of DNA replication, it was logical to
think that ORC was the only protein that defined ori-
gin selection. We had demonstrated previously that
Cdc6p could bind to ORC and that overexpression of
Cdc6p could rescue a defective ORC mutant. In the
last year, we have found that Cdc6p can influence the
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DNA sequences to which ORC binds and that Cdc6p
may alter ORC function on the DNA.
Coprecipitation experiments have shown that ORC
and Cdc6p form a tertiary complex on the DNA and
that Cdc6p ensures that ORC binds only to origin
DNA. When ORC was bound to nonspecific DNAs,
addition of Cdc6p destabilized ORC binding. This
reaction required the functional nucleotide-binding site
within Cdc6p and occurred in the presence of ATP, but
not in the presence of the ATP analog ATP-y-S that is
not easily hydrolyzed. Thus, we have been able to
reconstitute in vitro the first step in origin-dependent
assembly of proteins onto origin-bound ORC. The
reaction occurs very efficiently and with stoichiometric
amounts of ORC, Cdc6p, and origin DNA. We also
have evidence that this complex can attract the MCM
proteins onto the origin in a reaction that requires an
extract from G, -phase cells, but not with an extract
from G2-phase cells. Thus, it will be possible to begin
to reconstitute origin-dependent assembly of the pre-
replication complex (pre-RC) in vitro.
Recent studies on Cdc6p show that the nucleotide-
binding motif in this protein is required for assembly of
the MCM proteins onto the chromatin during the G1
phase of the cell cycle. A mutation of the Walker A
domain of the Cdc6p nucleotide-binding motif prevents
initiation of DNA replication, and the cells arrest with a
G1 content of unreplicated DNA. Interestingly, when the
nonessential amino terminus of Cdc6p was deleted in
the inactive Cdc6p, the cells failed to arrest in late G,
phase and progressed through M phase. Thus, the amino
terminus of Cdc6p contains a regulatory domain that
prevents cells from progressing through the cell cycle
until cells initiate DNA replication. We are mapping the
sites within the Cdc6p amino terminus that perform this
cell-cycle-checkpoint function.
Assembly of the Preinitiation Complex: The pre-RC is
believed to be a precursor for assembly of other pro-
teins onto the origin after activation of the S-phase
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cyclin-dependent protein kinase (CDK) and another
protein kinase called Cdc7p/Dbf4p. We demonstrated
in past years that Cdc45p, an MCM-binding protein
that is essential for the initiation of DNA replication,
binds to the MCM proteins in an S-phase CDK-depen-
dent manner. We have now shown that Cdc45p origin
association also required activation of the S-phase
CDK. In the yeast Saccharomyces cerevisiae, these
kinases are C1b5p and Clb6p cyclins that associate
with the Cdc28p kinase. Interestingly, efficient associ-
ation of Cdc45p with the origin also requires another
protein kinase complex, the Cdc7p/Dbf4p kinase.
Thus, the loading of Cdc45p onto the origin defines a
critical step in the process leading to initiation of DNA
replication.
Consistent with the role of Cdc45p in initiation of
DNA replication, we have shown that the cellular sin-
gle-stranded DNA-binding protein, replication protein
A (RPA), also loads on to the origin at the same time
as Cdc45p. Both Cdc45p and RPA coimmunoprecipi-
tate with each other and with the DNA polymerase E,
a DNA polymerase that functions at the replication
fork. It is possible that other proteins also load onto the
origin at this time, and we are searching for these pro-
teins by direct protein sequencing. The assembly of
Cdc45p and RPA onto the DNA is similar to the events
that involve SV40 T-antigen recruiting RPA to the
SV40 origin of DNA replication.
Cdc7p/Dbf4p Kinase: The requirement for the
Cdc7p/Dbf4p kinase for initiation of DNA replication
has been known for some time, but how it regulates ini-
tiation of DNA replication has only recently begun to
emerge. Other investigators and we demonstrated that
Cdc7p is present in the cells throughout the cell divi-
sion cycle and a large proportion is bound to chro-
matin. On the other hand, the Dbf4p subunit is highly
cell-cycle-regulated. The protein is synthesized at the
G1- to S-phase transition and associates with the Cdc7p
subunit to form an active protein kinase. In vitro,
Cdc7p can phosphorylate five of the six MCM sub-
units, as well as the catalytic subunit of DNA poly-
merase a, another polymerase required for initiation of
DNA replication. The absence of Dbf4p in the G1 phase
of the cell cycle is due in part to the fact that it is a sub-
strate for the anaphase-promoting complex (APC), a
mediator of ubiquitin-dependent degradation of pro-
teins in late mitosis and in G1 phase of the cell cycle.
The activity of Cdc7p kinase is cell-cycle-regulat-
ed by the levels of the Dbf4p subunit. But in the pres-
ence of a block to DNA replication during S phase, we
found that Cdc7p/Dbf4p kinase activity was reduced.
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This would have the consequence of preventing initia-
tion of DNA replication at those origins that have not
yet assembled the pre-IC. The reduction in Cdc7p
kinase activity correlated with hyperphosphorylation
of the Dbf4p subunit, a process that we demonstrated
requires the Rad53p kinase. Rad53p is a cell cycle
checkpoint protein that is required to block cells from
entering mitosis before DNA replication has finished,
or before DNA damage has been repaired. Thus, the
Cdc7p/Dbf4p kinase appears to orchestrate progres-
sion through S phase and monitor events that might
lead to inheritance of DNA damage.
MCM DNA Helicase: There are six sequence-related
MCM proteins in all eukaryotes tested to date, and they
all have some similarity to DNA helicases. Recent
studies from Ishimi's group in Japan have shown a
weak DNA helicase activity using three of the six
MCM proteins from either mouse or human cells. To
date, however, no helicase activity has been found with
the six-subunit complex.
With the sequencing of the genomes of a number of
archaea, in collaboration with Rui-Ming Xu's group
here at Cold Spring Harbor Laboratory, we noticed that
many of these species contained only a single MCM
protein. Thus, the gene encoding a number of archaea
MCM proteins was cloned, and the proteins were
expressed using baculovirus vectors in insect cells. The
Methanobacterium autothermotrophicum MCM
(MtMCM) was purified and shown to contain an intrin-
sic DNA-activated ATPase and DNA helicase. The
helicase migrated in the 3' to 5' direction on the tem-
plate stand, which is the same direction that the SV40
T-antigen helicase migrates on DNA. We also demon-
strated that the MtMCM helicase functions as a double
hexamer, again similar to that of the SV40 T-antigen
helicase. Thus, it is likely that the MCM proteins func-
tion at each origin to help unwind DNA. Whether they
function at the DNA replication fork as the principal
DNA helicase remains to be determined.
EPIGENETIC INHERITANCE OF CHROMOSOME
STATES
PCNA and CAF-1: In addition to investigating the
mechanism and control of initiation of DNA replica-
tion, we are interested in the inheritance of chromatin
and the transcriptional states of gene expression that
are passed on during each cell division. We reported
last year that CAF-1 interacted with the DNA replica-
tion protein PCNA and that PCNA marked replicating
DNA for assembly of chromatin. CAF-1 is required for
the efficient inheritance of silenced states of chromatin
in yeast and for replication-dependent assembly of
nucleosomes during SV40 DNA replication. Thus, the
interaction between CAF-1 and PCNA may be the
mechanism for linking inheritance of chromatin with
inheritance of the DNA itself.
The role of PCNA in epigenetic inheritance was
investigated by first determining the sites in PCNA
that bind CAF-1, with the hypothesis that these inter-
action sites might define a new functional domain in
PCNA. Using existing and new mutations in the yeast
PCNA, we found a number that failed to interact with
CAF-1, yet were able to support cell proliferation. The
mutants were then tested for their ability to inherit the
silent mating-type locus (HMR) or the silenced state
of a gene placed near the telomeres of chromosome
VII in yeast. The PCNA mutants fell into two groups.
One group displayed reduced silencing at both the
telomere and the HMR locus, indicating that PCNA is
required for efficient maintenance of the silenced
state. The other class displayed a variegated pheno-
type, switching from the on state to the off state as
cells divided. We conclude that PCNA is required for
the establishment and stable inheritance of a silenced
transcriptional state of chromatin. These experiments
reinforce the role of this interesting DNA replication
protein in inheritance of gene expression states of
chromatin, providing a possible link between DNA
replication and the determination of states of gene
expression as an organism develops.
CAF-1 and Heterochromatin Proteins: In collabora-
tion with Drs. Natalia Murzina and Ernest Laue at
Cambridge University, we found that human CAF-1
interacted with the mammalian heterochromatin HP1-
like proteins Modl and Mod2 and HP1-a. These pro-
teins are related to the Drosophila HP1 protein that is
found associated with heterochromatin. HP1 mutants
suppress position effect variegation (PEV), a variable
state of expression of genes that happen to be located
near heterochromatin. We found that CAF-1 could
mediate the loading of Modl onto chromatin that was
replicated in vitro. Furthermore, both CAF-1 and
Modl remained associated with heterochomatin in
cells after S phase. Interestingly, the Modl protein was
removed from chromatin as the chromatin condensed
during passage through mitosis but was reloaded in
early G1 phase cells. Thus, we have uncovered a mole-
cular link between a DNA replication protein (PCNA)
and a protein required for inheritance of transcription-
ally repressed chromatin (Modl) that is mediated by
the chromatin assembly factor CAF-1.
KAETRIN SIMPSON (1972-2000)
Kaetrin Simpson came to this laboratory as a
Postdoctoral Fellow in 1997 following a rather bril-
liant career as a student at Cambridge University and
at the Imperial College in London. We were deeply
saddened by her all to soon death in January of the
New Year.
Kate attended secondary school at the Reading
School and entered Cambridge University in 1990
with great promise. In her three years there, she
emerged as one of the top students in biology, gradu-
ating with many honors. During two summer breaks
from her studies at Cambridge, spent near her parents
home in Glasgow, Kate worked in the laboratories of
Professor A. Curtis and Dr. M. Frame where she
excelled in research, publishing two papers as a result
of these summer studies. After graduating with honors
from Cambridge, Kate moved to Imperial College
where she studied for her Ph.D., the replication of
Epstein-Barr virus DNA, with Clare Huxley. There,
Kate achieved a great deal, being able to utilize the
EBV origin of DNA replication to make stable artifi-
cial chromosomes in mouse cells. These studies were
at the cutting edge of that field. Kate first came to
Cold Spring Harbor Laboratory as a teaching assistant
in the Yeast Artificial Chromosome course in 1995. At
the relatively young age of 25, Kate returned to Cold
Spring Harbor to take up postdoctoral studies, working
to understand how the sites of initiation of DNA repli-
cation are determined in human chromosomes. This
was an ambitious project on which she made excellent
progress before succumbing to a brain tumor.
Kate was a very bright, vibrant, and a fun-loving
person who was as charming as she was smart. With a
determination to succeed in life and in academia, the
sky was the limit as she began her career. We will all
miss her always up-beat personality and only wonder
about the contributions that Kate would have made to
science.
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The maintenance of normal cellular growth and differ-
entiation ultimately depends on mechanisms that reg-
ulate cell cycle progression. Two of the most important
of these regulatory mechanisms are transcriptional
activation and proteolytic destruction, which together
control the appropriate appearance and disappearance
of key cell cycle players. Work in our laboratory
explores the intersection between these two processes
to understand how oncogene transcription factors are
regulated at the level of their own destruction.
As a paradigm for transcription factor destruction,
we study Myc. Myc is a basic helix-loop-helix tran-
scription factor that features prominently in the regu-
lation of cell proliferation and in cancer. Myc is also a
highly unstable protein that is destroyed within min-
utes of its synthesis. The rapid destruction of Myc
plays an important part in keeping intracellular levels
of the Myc protein low and responsive to environmen-
tal stimuli. Our laboratory studies how cells control
Myc activity by controlling Myc destruction, and how
this process goes wrong in cancer.
We have previously shown that Myc is an unstable
protein because it is destroyed by a process known as
ubiquitin-mediated proteolysis. In this process, the
covalent attachment of Myc to the protein ubiquitin
(Ub) signals its destruction by the 26S proteasome, a
large complex with several proteolytic activities.
Protein ubiquitylation is a highly specific multistep
process, which begins when an element within the tar-
get protein-termed a degron-is recognized by the
cellular ubiquitylation machinery. After the degron has
been recognized and bound, Ub is then transferred to a
lysine residue within the target protein. This process is
then repeated many times to produce a highly ubiqui-
tylated substrate that is rapidly destroyed by the pro-
teasome. Because proteasomal destruction depends on
prior substrate ubiquitylation, selectivity in degron
recognition by the ubiquitylation machinery-and reg-
ulation of this process-is central to the control of Ub-
mediated proteolysis.
We have mapped the elements in Myc that control
its destruction and have found that the Myc degron
overlaps closely with the transcriptional activation
domain of Myc. We have also shown that cancer-asso-
ciated mutations within the Myc degron-which are
observed in a very high percentage of lymphomas-
subvert the normal destruction of Myc, stabilize the
protein, and allow Myc to accumulate. Importantly,
some of these mutations have also been shown to
enhance the transforming ability of Myc in vitro, sug-
gesting that enhanced protein stability is a mechanism
of Myc activation in cancer.
We continue to study mechanisms of Myc proteol-
ysis. We are exploiting an extraordinary conservation
of Myc destruction in yeast to identify molecules that
participate in this process. Using this approach, we
have identified several components of the Ub-protea-
some pathway that are required for the Ub-mediated
destruction of Myc in yeast; we are currently charac-
terizing their mechanisms of action and asking whether
the human cell homologs of these genes participate in
Myc destruction in human cells. We have also estab-
lished a novel tagging system that allows rapid and sen-
sitive measurement of Myc protein stability. Previous
studies of Myc protein turnover have been hampered by
difficulties in detection of the Myc protein. Using our
tagging system and retroviral gene transfer, however,
we are able to express Myc at physiological levels in
untransformed cells and accurately determine its stabil-
ity. We are currently using this system to complete our
characterization of the elements in Myc that control its
stability and to identify molecules that affect Myc pro-
tein stability.
In addition to our studies of Myc, we are also inter-
ested in more general aspects of how transcriptional
activators are targeted for Ub-mediated destruction.
Like Myc, many of the transcription factors that control
cell growth are unstable proteins that are destroyed by
Ub-mediated proteolysis. We wish to apply what we
have learned about Myc protein destruction to other
unstable transcriptional regulators. Recent studies in
our laboratory have suggested that a common mecha-
nism underlies transcription factor destruction, because
they have revealed that a transcriptional activation
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domain per se can signal Ub-mediated proteolysis. As
mentioned above, we had previously shown that the
Myc degron overlaps closely with the transcriptional
activation domain of Myc. We have found that these
two elements overlap in almost all unstable transcrip-
tion factors. We have also found that acidic activation
domains, but not those classified as glutamine-rich or
proline rich, can signal protein instability. We used a
family of synthetic activation domains to show that
there is an intimate relationship between the transcrip-
tional activation domain and degron function (see Fig.
1), with more potent activation domains always being
more effective at signaling protein instability than
their less active counterparts. We have also shown in
collaboration with Herman Wijnen and Bruce Futcher
that degrons from yeast cyclins, when tethered to a
DNA-binding domain, can activate transcription. The
extensive overlap of activation domains and degrons,
and the close functional relationship between the two
activities, reveals an unexpected convergence of two
FIGURE 1 Intimate functional overlap between acti-
vation domain and degron function in a family of
synthetic activators. To explore the relationship
between transcriptional activation domains and
degrons, we asked whether a family of synthetic
activation domains, derived solely on the basis of
their ability to activate transcription, could function
as degrons. (4) Structure of synthetic activators.
Activators were constructed by fusing 1 x, 2x, 3x, or
6x copies of an 8-amino-acid sequence from the
VP16 activation domain (VN8: DFDLDMLG) or 3x
copies of a mutant sequence (3XM: DADADMLG)
to the DNA-binding domain (DBD) of the yeast tran-
scription factor GAL4. (8) Relative transcriptional
potency of each activator. GAL4 fusion proteins
were assayed for transcriptional activation in human
HeLa cells. Relative transcriptional activity is shown
on a logarithmic scale, setting the transcriptional
activity of the GAL4 DBD alone (A) at 1. (C) Steady-
state levels of the GAL4-VN8 activators. Human
A.
A
1X E:=
2X
3X
6X
3XM =MIMI
very different processes and suggests that many tran-
scription factors are destroyed because of their ability
to activate transcription. We are currently performing
genetic analyses in yeast to understand the true nature
of the split personality of these destruction and activa-
tion domains (DADs).
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GAL4: VN8 modules
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HeLa cells were transiently transfected with expres- a
sion constructs encoding the indicated GAL4 fusion
proteins. Following transfection, cells were either
untreated (-LLnL) or treated with the proteasome
inhibitor LLnL ( +LLnL). Total proteins were prepared
and HA-tagged GAL4 fusion proteins revealed by
SDS-PAGE and immunoblotting analysis. As can be
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tion of the GAL4 DBD, unless the proteasome is
inhibited ( +LLnL). (D) Stability of GAL4-VN8 activators. GAL4-VN8 proteins were transiently expressed in HeLa cells, and their stabilities
were determined by pulse-chase analysis. Potent activation domains destabilize the GAL4 DBD more than weak activators, demon-
strating that the ability of VN8 modules to activate transcription correlates with their ability to signal protein instability.
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MOLECULAR GENETICS
The section on molecular genetics studies problems relating to growth, development, and programmed
cell death in humans and model organisms. The groups in this section share a genetic approach to
these problems.
Dr. Futcher's lab studies the control of cell division in yeast with special emphasis on cyclin-depen-
dent protein kinases and their substrates and also on the regulation of telomeres. Recent studies
have identified critical localization features of the cyclins, identified mutants of telomere mainte-
nance, and identified a cluster of genes under the regulation of "Forkhead" transcription factors.
Dr. Grossniklaus's group studies sexual function in plants (Arabidopsis and maize), in particular the
development of the female gametophyte. They also work on developing methods for the asexual
reproduction of plants.
Dr. Jackson's group also studies Arabidopsis and maize, in particular the development of meris-
terns. They continue to study cell-to-cell communication in plants involving the intercellular traffick-
ing of regulatory proteins and have developed genetic screens for mutations in this pathway.
Dr. Martienssen's lab focuses on the genomic architecture of Arabidopsis and the development of
whole genome approaches, especially enhancer traps, to define genes important in development.
Dr. Hamaguchi's group studies human cancer genes. They have identified two candidate tumor
suppressors from the region of chromosome 8p22-23. They are now screening tumors for point
mutations in these genes in order to validate these candidates.
Dr. Wigler's group also studies tumor suppressors and is developing new genetic tools for the study
of human disease. These tools are increasingly based on microarrays for identifying deletions and
amplifications in cancer, and microarray methods for the functional analysis of candidate cancer
genes. These methods are also being applied to the analysis of spontaneous mutations linked to
sporadic hereditary diseases.
Dr. Hannon's group has developed new technology for the genetic manipulation of mammalian cells,
using highly modified retroviral tools. This technology has been used to identify new candidate
oncogenes that may function in the pathways of programmed cell death and cellular senescence.
Dr. Hengartner's group uses the nematode C. elegans, a simple metazoan, to study highly con-
served but complex biological processes, with an emphasis on apoptosis (programmed cell death)
and developmental neurobiology. They have recently identified a gene, CED-6, required for engulf-
ment of the apoptotic cell and have found that germ line cells have a DNA-damage-induced cell
death pathway. Recently, they have identified mutations that disrupt axonal guidance.
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CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher J. Donovan
N. Edgington
F. Ferrezuelo
S. Honey
T. Volpe
H. Wijnen
J. Zhou
Our main interest is the regulation of Start and mito-
sis in Saccharomyces cerevisiae. We are most inter-
ested in the tethering of division to cell growth and in
the generation of the basic cell cycle oscillation.
Many key cell cycle events are regulated by protein
kinase complexes formed between Cdc28p and one
of nine cyclins. These fall into two broad groups: the
Gi cyclins, which include Clnl, Cln2, and Cln3, that
regulate Start and the mitotic B-type cyclins, which
include Clb 1 , C1b2, C1b3, and C1b4. Two other
cyclins, Clb5 and C1b6, are very important for DNA
replication, but they also have roles at Start and per-
haps also in early mitosis. A second interest is yeast
and human telomerase, and how telomere length
relates to cell senescence.
Dissection of Nuclear
and Cytoplasmic Roles
of Cyclins
N. Edgington
Nine different yeast cyclins bind to and activate the
Cdc28p kinase. Although the enzymatic properties of
the nine different cyclin-Cdc28p complexes are simi-
lar, these nine complexes have very different biologi-
cal roles. We asked how many of these differences
could be accounted for by differences in location. We
have created "forced localization" tags, which, when
appended to a protein, force it to be either cytoplasmic
or nuclear. A previously known mutant allele of Cln3p,
which lacked a few basic amino acids at its carboxyl
terminus, is reverted to wild type by the nuclear tag,
suggesting that these missing amino acids are at least
part of a nuclear localization signal (NLS). Nuclear
forms of Cln3p can complement all CLN3 functions,
whereas cytoplasmic forms of Cln3p cannot comple-
ment any CLN3 function, suggesting that Cln3p is
solely nuclear.
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Cln2p, on the other hand, is both cytoplasmic and
nuclear. Subcellular fractionation and fluorescence
microscopy with Cln2p-GFP (green fluorescent pro-
tein) show mainly cytoplasmic localization, with
some nuclear localization. The cytoplasmic Cln2p is
mostly at the sites of bud growth or polarized growth,
suggesting that the known involvement of Cln2p in
these processes is direct. Neither cytoplasmic nor
nuclear Cln2p can fully complement all functions of
CLN2, showing that Cln2p has important functions in
both locations. In particular, the function of CLN2
that overlaps with the CLB5, CLB6 function is a
nuclear one, whereas the CLN2 functions that overlap
with the functions of PCL1, PCL2, or BUD2 are cyto-
plasmic ones.
Two Yeast Forkhead
Transcription Factors
Regulate a Cluster of
Genes at Mitosis
T. Volpe and B. Futcher [in collaboration with Gefeng
Zhu, University of Washington, Seattle; Tricia
Davis, University of Washington, Seattle; Paul
Spellman, Stanford; and David Botstein, Stanford]
Previously, we used microarrays to identify 800 cell-
cycle-regulated genes in yeast. Among these were a
cluster of 35 genes called the "CLB2" cluster, whose
transcription peaked in mitosis. This cluster included
many genes important for mitosis including the mitot-
ic cyclins CLB1 and CLB2, and the transcription fac-
tors, SWI5 and ACE2. Computer analysis of the pro-
moters of the genes in this cluster revealed that they
contained a binding site for the transcription factor
Mcmlp immediately adjacent to the motif
GTAAAYAA. A variant of the later motif, AACAA,
had previously been identified as important for the
expression of CLB1, CLB2, and SWI5. It was thought
to be the binding site for a hypothetical transcription
factor called "Swi Five Factor" (SFF).
We wished to identify SFF. Because most other
transcription factors for cell-cycle-regulated genes are
themselves cell-cycle-regulated, we searched among
the 800 cell-cycle-regulated genes for putative tran-
scription factors of unknown function. Furthermore,
since previous genetic screens for SFF had been
unsuccessful, we guessed that SFF might be encoded
by redundant genes. Thus, we were especially inter-
ested in pairs of homologs of cell-cycle-regulated
putative transcription factors and found only three
such pairs. One of the pairs was Fkhlp and Fkh2p,
which encode transcription factors of the Forkhead
family. At about this time, Gefeng Zhu and Tricia
Davis determined that the binding site of a GST-
Fkhlp fusion was GTAAACAAA, which is essential-
ly identical to the SFF site. Therefore, we examined
the regulation of the CLB2 cluster of genes in anfkhl
fich2 mutant.
When an flchl fich2 mutant was released from an
a-factor block, the SWI5 transcript (a member of the
CLB2 cluster) failed to oscillate, although control cell
cycle transcripts from other clusters did. mRNAs
from this experiment were then used for microarray
analysis. None of the mRNAs encoded in the CLB2
cluster oscillated, whereas most other cell-cycle-regu-
lated transcripts oscillated normally. However, there
was one additional cluster, the SIC1 cluster, with
aberrant regulation in the fkhl fich2 mutant. The genes
of this cluster are regulated by the transcription fac-
tors Swi5p and Ace2p, which are encoded in the
CLB2 cluster.
We formed the hypothesis that Fkhlp and Fkh2p
regulate the CLB2 cluster directly, by binding to the
SFF sites of the promoters of these genes. On the other
hand, we hypothesized that they regulate the SIC1
cluster indirectly, by altering the transcription of SWI5
and ACE2. To test these hypotheses, we did cross-link-
ing chromatin immunoprecipitations using an Fkh2p
tagged with three tandem copies of the HA epitope.
Immunoprecipitation of this tagged Fkh2p gave spe-
cific coprecipitation of four out of four promoters of
the CLB2 cluster (CLB2, SWI5, HST3, YJL051w).
However, there was no coprecipitation of two out of
two promoters from the SIC1 cluster (EGT2, SIC1).
This suggests that the hypotheses are correct.
The identification of Fkhlp and Fkh2p as critical
components of SFF is significant in two ways. First, it
will allow a detailed understanding of the regulation of
a large cluster of important mitotic genes. Second, it
appears that the FKH1 and FKH2 genes are indirectly
under the control of the G1 cyclin and the G1 phase
transcription factors SBF and MBF. Thus, we will be
able to establish a chain of events linking early G1 to
late mitosis, bringing us almost all the way around the
cycle.
Mechanisms of
Transcriptional Activation
by Cyclin-Cdc28p
Complexes
H. Wijnen
One model for activation is that Cln3p/Cdc28p phos-
phorylates SBF/MBF. This does not seem to be the
case, because mutants lacking all consensus Cdc28p
phosphorylation sites in SBF are wild type for acti-
vation by Cln3p. Another model is that Cln3p joins
the SBF/MBF complex and acts relatively directly on
transcription. This also does not seem to be correct,
because (1) cln3 mutants with an appended VP16
transcriptional activation domain do not hyperinduce
transcription and (2) cln3 mutants with an appended
TUP1 repression domain still induce transcription
normally. Finally, it does not appear that CLN3 acti-
vates an activator of SBF/MBF, because no such acti-
vator could be identified in a saturating high-copy
screen.
A remaining model is that CLN3 inhibits an
inhibitor of SBF/MBF. This would be parallel to the
system in mammalian cells, where cyclin D /CDK4
(analogous to Cln3p/Cdc28p) inhibit RB, an inhibitor
of E2F (analogous to SBF). To look at this model, we
have selected for mutants in which SBF is active even
in the absence of CLN3. Several such mutants have
been found. One is in the CHD1 gene, a chromatin
remodeling protein containing chromodomains. The
CHD1 gene is highly conserved throughout evolu-
tion, with homologs in humans, and it seems to be
involved in repression. Interestingly, RB recruits a
similar chromatin remodeling protein to E2F-regulat-
ed promoters. Other mutations allowing SBF activity
in the absence of CLN3 were in YMR131c (slightly
homologous to an RB-binding protein), YDR295c (a
putative transcription factor), and YGLOO4c (a WD40
repeat protein). We are still characterizing these
mutants.
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New Telomere
Maintenance Mutants
F Ferrezuelo
We have done a screen to identify new yeast telomere
maintenance mutants. Several mutants have been
obtained, and these include two new alleles of est2,
showing that the screen works. Another mutant is
mtr10, a karyopherin 13 involved in nuclear import.
The mtr10 mutant has short telomeres, and although it
is viable, it has a partial senescence phenotype. The
short telomere and senescence phenotype was sup-
pressed by overexpression of the telomerase RNA
Tlclp, but not by other telomerase components.
Furthermore, Northern analysis showed that Tlclp lev-
els were unusually low in the mtr10 mutant, and kinet-
ic experiments showed that the Tlclp RNA has an
unusually short half-life in the mutant. The RNA may
also have an aberrant length. Tlclp is known to be
processed posttranscriptionally, and it may be that
70
transport via MtrlOp is important for this processing.
In the absence of MtrlOp, transport and processing
may be abnormal, preventing accumulation of the sta-
ble, mature form of Tlc 1p.
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DEVELOPMENTAL GENETICS OF PLANT REPRODUCTION
U. Grossniklaus R. Baskar J. Moore
C. Spillane J. Thomas
A. Coluccio J.-P. Vielle-Calzada
We use genetic and molecular approaches to identify
genes controlling plant reproduction and focus on the
complex processes that lead to the formation of the
female gametes. The key events in female gametogen-
esis occur within ovules where a single cell gets com-
mitted to undergo meiosis. Only one of the meiotic
products survives and gives rise to the haploid female
gametophyte, a multicellular structure unique to the
plant life cycle. Two cells in the female gametophyte
differentiate into gametes: the egg and central cell.
Double fertilization of these cells by two sperms deliv-
ered by the pollen tube (male gametophyte) gives rise
to the embryo and endosperm, respectively. We are
particularly interested in unraveling the molecular
mechanisms controlling cell fate decisions that are at
the center of these developmental processes.
In addition to yielding insights into fundamental
concepts of plant development, our research also pro-
vides new tools to manipulate the reproductive system.
We focus on engineering components of apomixis, a
naturally occurring asexual form of reproduction
through seeds. In apomixis, the developmental events
we study in sexual systems are short-circuited or mod-
ified to prevent meiotic reduction and fertilization. As
a result, the progeny of an apomictic plant is geneti-
cally identical to the mother plant. The introduction of
apomixis into sexual crops promises economic and
social benefits exceeding those of the green revolu-
tion. However, the synthesis of apomixis requires
knowledge of the genes controlling all relevant devel-
opmental processes. International collaboration is cru-
cial to harness this complex trait and to provide free
and equal access to apomixis technology (see: http://
billie.harvard.edu/apomixis).
1999 brought major changes for our group. After
spending 7 months in our laboratory, visiting scientist
I. Siddiqi returned to the Center for Cellular and
Molecular Biology in Hyderabad, India. But we wel-
comed new visitors, N. Huck (Friedrich Miescher
Institute, Switzerland) and J.G. Ramike Pimentel (CIN-
VESTAV, Plant Biology Unit, Mexico), who visited the
lab over the summer. In March, J. Moore, R. Baskar,
and C. Spillane relocated to the Friedrich Miescher
Institute in Basel, Switzerland, where I took a position
as Staff Scientist. J.-P. Vielle-Calzada, A. Coluccio, and
J. Thomas stayed at the Laboratory until the end of the
year. We would like to thank everyone who made the
last 5 years at Cold Spring Harbor a stimulating and
enjoyable time for us and our families.
Isolation of Genes Involved
in Megasporogenesis
J.-P. Vielle-Calzada, A. Coluccio, U. Grossniklaus
Sexual and apomictic reproduction are closely related.
The determination of apomictic initial cells usually
occurs during megasporogenesis. Some of the genes
regulating sexual development may also be responsible
for the induction of apomixis. Therefore, we screened
our transposant collection for (1) genes expressed dur-
ing megasporogenesis about which we have reported
previously and (2) mutants resulting in female sterility.
We identified 46 families that segregate sterile plants
among 3700 transposant families tested. The large
majority of these are male sterile mutants or show obvi-
ous floral defects that affect reproduction (33/41 test-
ed). A small class of mutants (3/41) are male and
female-sterile and may affect meiosis. A few mutants
(6/41) are female-specific and most affect ovule mor-
phogenesis. In one mutant, coatlicue (coa), female
sterility is not caused by abnormal ovule morphology
but by a defect in megasporogenesis. In coa ovules, the
functional megaspores arrest at the onset of the game-
tophytic phase, suggesting that COA may be required
for the initiation of the mitotic division cycles during
megagametogenesis.
Cell Specification in the
Megagametophyte: The Egg Cell
R. Baskar, J. Moore, U. Grossniklaus
Although the seven cells of the megagametophyte are
clonally derived, they develop along four alternative
developmental pathways. The small number of cell
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types in the female gametophyte make it an ideal sys-
tem to study cell specification, although the inaccessi-
bility of this tissue has been a major obstacle for mole-
cular investigations. We are particularly interested in
the specification and function of the egg cell. We iden-
tified two transposants with expression in the egg.
Reporter gene constructs containing up to 4.5 kb of 5'
sequences of one of these genes have been introduced
into plants by Agrobacterium- mediated transformation.
The transformants show reporter gene expression in the
female gameotphyte, but expression is not restricted to
the egg cell. This may be due to the presence of a sec-
ond transcription unit on this fragment which we iden-
tified recently. We are analyzing deletion derivatives
that do not contain this second gene with the aim of
identifying egg-cell-specific regulatory elements.
These will be used for genetic cell ablation and misex-
pression of putative regulatory genes to investigate cel-
lular interactions between the cells in the female game-
tophyte and to probe the potential of the egg cell for
autonomous activation, an important component of
apomictic reproduction.
Developmental Genetics of
Megagametogenesis
J. Moore, U. Grossniklaus [in collaboration with N. Huck,
D. Page, and S. Lienhard, Friedrich Miescher Institute,
Switzerland]
Despite the importance of megagametogenesis for
plant breeding, only a small number of mutants affect-
ing this process have been described. In our trans-
posant collection, we identified about 50 mutants
affecting the gametophyte. We characterized 14 of
these at the genetic and morphological level. All
mutants have been mapped and were found to be dis-
tributed across the five Arabidopsis chromosomes.
Some mutants affect distinct steps along the develop-
mental pathway, such as the mitotic divisions, nuclear
migration, cellularization, and nuclear fusion. In con-
trast, others form phenotypically normal female game-
tophytes but are infertile, suggesting that fertilization
is affected. To gain a better understanding of the phe-
notypes, we made use of enhancer detector lines with
GUS expression in specific cell types of the megaga-
metophyte. We crossed these molecular markers into
mutant backgrounds in order to observe how cell-type-
specific gene expression was affected. In a pilot study,
we found expression of an egg-cell-specific marker in
gametophytes that arrested development prior to the
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mitotic divisions. Does the megagametophyte have a
basic egg cell nature even when prevented from form-
ing an egg cell? Is cell type-specific gene expression
directed from the cells surrounding the female game-
tophyte? Does a unicellular gametophyte express char-
acters of all its cell types? We hope to address these
questions by extending this study in the coming year.
Genetic Control of Genomic
Imprinting in Plants
C. Spillane, J. Thomas, J.-P. Vielle-Calzada, U. Grossniklaus
[in collaboration with S. Michele Nunes and D. Page, Friedrich
Miescher Institute, Switzerland]
Imprinted genes are differentially expressed depend-
ing on their parental origin. Gene-specific genomic
imprinting was first described for the maize red color
locus (Kermicle, Genetics 66: 69 [1970]) and was later
found to play a crucial part in mouse embryogenesis
(Surani et al., Nature 308: 548 [1984]). Despite the
importance of genomic imprinting in development,
human disease, and plant breeding, the underlying
genetic mechanisms remain largely unknown. We have
shown that the MEDEA (MEA) gene is regulated by
genomic imprinting. MEA is the first plant gene that
displays characteristics of imprinted genes in mam-
mals: MEA is the only known imprinted plant gene
that affects seed morphogenesis and where imprinting
is not allele-specific.
Our current efforts focus on the elucidation of the
genetic control of imprinting. The mea mutant pro-
vides a unique entry point for identifying genes
involved in the establishment and maintenance of
genomic imprinting. We are using mea to gain insight
into the imprinting process by isolating second-site
modifiers. The genetic and molecular characterization
of such modifiers will yield fundamental insights into
the poorly understood genetic regulation of imprint-
ing. We are currently pursuing three independent
approaches to identify modifiers of mea. (1) We have
screened approximately 2000 chemically mutagenized
plants for second site mutations that alter the seed
abortion characteristics of mea/MEA heterozygous
plants. For instance, a mutation in a gene that is
required for the activation of the maternal MEA allele
will show a higher degree of seed abortion (75%
aborted seeds instead of 50%, if the mutation is fully
penetrant and unlinked). To date, we have identified 15
putative modifiers that are being analyzed in more
detail. (2) We have screened for natural variants in
over 25 Arabidopsis ecotypes and identified two eco-
types where silencing of the paternal MEA copy
appears to be less stable. (3) We are screening through
collections of mutants known to affect methylation or
transgene silencing to identify genes that also affect
genomic imprinting. This approach has led to the iden-
tification of the first trans-acting factor involved in
maintaining a genomic imprint, the DECREASE IN
DNA METHYLATION (DDMI) gene.
Genetic Screens for Mutants
Displaying Apomictic Traits in Maize
U. Grossniklaus, A. Coluccio
Three main steps are relevant to the engineering of
gametophytic apomixis. (1) Avoidance of meiosis, (2)
parthenogenesis, and (3) normal endosperm develop-
ment. During the past few years, we have developed
maize stocks for genetic screens that should allow the
isolation of mutants which are relevant to these
aspects. For instance, no systematic screens for
mutants that produce unreduced gametophytes have
been performed, but some were found fortuitously,
e.g., the elongate] (ell) mutant that produces 30-50%
unreduced megagametophytes (Rhoades and
Dempsey, Genetics 54: 505 [1966]). In maize, normal
kernel development strictly requires a 2m: 1p ratio of
maternal to paternal genomes in the endosperm. If a
unreduced central cell is fertilized by a normal sperm,
the kernel aborts due to an imbalance of imprinted
genes in the endosperm. We developed a tetraploid
stock tetraplex for R-Navajo (R-nj) (allows the identi-
fication of contaminants). Fertilization of an unre-
duced megagametophyte with pollen from this stock
results in a 4m:2p genomic ratio ensuring normal
endosperm development. We screened more than 450
families that were derived from individuals with high
Mutator activity for plants producing plumb kernels
presumably derived from unreduced megagameto-
phytes. Several putative mutants were identified and
are currently being analyzed.
Delayed Activation of the Paternal
Genome during Seed Development
J.-P. Vielle-Calzada, R. Baskar, A. Coluccio,
J. Thomas, U. Grossniklaus
While we were studying imprinting at the mea locus,
we discovered a related phenomenon that apparently
affects most, if not all, of the paternal genome. Because
plant embryos can develop from somatic cells or
microspores, it is generally considered that the mater-
nal contribution is not crucial for embryogenesis. Early
acting embryo lethal mutants in Arabidopsis, including
emb30/gnom that affects the first zygotic division, have
fueled the perception that both the maternal and pater-
nal genomes are active immediately after fertilization.
We identified 19 transposants that show reporter gene
expression in the developing embryo and/or
endosperm after fertilization. To determine if GUS
expression was the result of transcription from one or
both alleles, we performed reciprocal crosses between
the wild type and these transposants. For all 19 lines,
GUS expression was strictly dependent on maternal
transmission (Fig. 1), suggesting that the paternally
inherited allele is not expressed during early embryo
and endosperm development. To determine whether the
absence of paternally derived GUS expression was due
to inactivation of the GUS transgene or if it reflected
silencing of endogenous genes, we analyzed gene
expression using allele-specific reverse transcrip-
tase-polymerase chain reaction (RT-PCR). For PRO-
LIFERA (PRL) (Springer et al., Science 268: 877
[1995]) in which we recovered a new insertion, only
transcripts derived from the maternal allele could be
detected during the first 3-4 days after pollination,
after which the paternal allele was activated.
We isolated and sequenced genomic regions flank-
ing 12 of the Ds elements. Putative functions based on
homology could be assigned to eight of the detected
genes. They encode proteins with a wide variety of
functions and are located throughout the Arabidopsis
genome, suggesting that other genes known to be
expressed at early stages may also be affected by this
regulation. To test this prediction, we examined
EMB30/GNOM expression using allele-specific RT-
PCR. The early phenotype of emb30 (nearly symmet-
rical division of the zygote) has been interpreted as
being caused by a recessive mutation that affects a
gene active during the earliest diploid phase of
embryogenesis. At 24 hours after pollination (HAP),
EMB30 mRNA derived from the paternally inherited
allele cannot be detected. To determine if allele-spe-
cific expression is correlated with genetic activity, we
crossed heterozygous emb30/EMB30 plants to the
wild type and analyzed developing seeds 24-48 HAP.
If the paternally inherited allele is active following fer-
tilization, heterozygous emb30/EMB30 embryos that
inherit a wild-type allele from their father should
undergo normal development. We found no difference
in the frequency of early defects between F1 seeds
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FIGURE 1 Silencing of paternally inherited gene activity during seed development in Arabidopsis. (A) When an
enhancer detector is used as a female parent in crosses to wild type, reporter gene expression can be detect-
ed in the developing embryo and endosperm of Fl seeds 48 hr after pollination (HAP). (8) When the same
enhancer detector is used as the male parent in crosses to wild-type plants, GUS expression is absent from
the embryo and endosperm 48 HAP. The same observation is true for all 19 enhancer detector lines tested.
derived from self-fertilization and an out-cross to the
wild type. However, all F, seeds derived from the out-
cross were normal and viable at maturity, suggesting
that late expression of the paternally derived EMB30
allele is sufficient to rescue the emb30 defects. Thus,
early defects are caused by a maternal effect that can
be rescued by a paternally inherited wild-type allele.
Our results strongly suggest that the first few days of
embryogenesis and endosperm development are large-
ly, if not exclusively, under maternal control, a finding
that should lead to a reinterpretation of the genetic
control of early seed development in flowering plants.
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TUMOR SUPPRESSOR GENES AND BREAST CANCER
M. Hamaguchi R. Jones J. Troge
J. Meth J. Winer
T. Odawara
Breast cancer is by far the most common cancer and
the second leading cause of cancer death in women.
Expanding knowledge of the genetic basis of breast
cancer will be helpful in overcoming this disease in
several ways. Molecular probes can be used to predict
which individuals are at high risk for breast cancer.
Molecular diagnoses may furnish us with useful infor-
mation to determine if treatment should be aggressive
or conservative. A better understanding of the causes
of breast cancer will bring new insights into cancer
development in general and therefore provide new
ideas for prevention and treatment of cancer.
Tumor cells have been studied for this purpose and
have been found to have multiple genetic mutations,
some of which are commonly observed among tumors.
Mutations of certain genes are now believed to play a
critical part in cancer development. A class of these
genes called tumor suppressor genes prevent cells from
growing out of control. Loss of their function drives the
normal cells to act in a malignant manner. As for breast
cancer, some tumor suppressor genes have been cloned
in familial cases, but genes for nonfamilial cancer have
not yet been discovered. Certain chromosomal regions
are suspected of containing tumor suppressors because
they are frequently deleted in breast cancer cells. In
fact, we have identified two homozygous deletions at
8p22 and 8p23. Furthermore, loss of heterozygosity
(LOH) of the short arm of chromosome 8 has report-
edly occurred in more than half of breast cancers. LOH
represents the status that one allele is eliminated and
therefore only one intact gene is left. These facts imply
the presence of tumor suppressor genes in these loci.
Our efforts have been directed at cloning these sup-
pressor genes.
Positional Cloning (Gene Hunting)
M. Hamaguchi, R. Jones, J. Meth, J. Troge [in collaboration with
D. Esposito and M. Wigler, Cold Spring Harbor Laboratory]
The deletion probes in breast cancer have been mapped
by radiation hybrid (RH) mapping. Radiation hybrids
are rodent cells containing human genomic DNA frag-
ments generated by irradiation. If two DNA markers
are close to each other, the retention patterns in these
RHs should be similar. Thousands of known sequence
tagged sites (STSs) have been screened as a frame-
work. Relative distances between a known STS and
the probe in question are obtained by comparison of
their retention pattern. One deletion probe was
mapped to 8p22 and another to 8p23. Thus, RH panels
are useful for obtaining approximate map locations at
a resolution of approximately 500 kbp.
Detail maps of the loci are critical for further
investigation, and thus we have constructed physical
maps of these loci. Library screening and database
searches generated a number of genomic mega clones
(20 YACs, 11 BACs, and 2 Pls). STSs around the orig-
inal deletion probes have been isolated by database
searches, subcloning of genomic clones, and sequenc-
ing of Pls. These STSs have been further mapped by
RH and analyzed by polymerase chain reaction (PCR)
against genomic clones to determine their physical
order. We have utilized 83 STSs to refine the physical
map (see Fig. 1).
Deletion mapping has been carried out by quanti-
tative PCR (Q-PCR) on 200 breast tumors using 18
STSs. The nuclei of tumor and normal cells have been
separated by FACS (fluorescence-activated cell
sorter). A method to immortalize DNA is required
because only a limited amount of nuclei can be
obtained by FACS. We have applied "high complexity
representation" (HCR) developed by Dr. Wigler as a
solution for this problem. Two deletion epicenters have
been demarcated by these analyses, and the size of
each deletion is estimated at 500 kb (see Fig. 1).
A transcript map has subsequently been con-
structed by database searches, rapid isolation of
cDNA by hybridization (RICH), exon trapping, and
sequencing. RICH is a new genetic tool to identify
transcribed sequences developed in our lab. To
improve efficiency, we have also designed a new vec-
tor for exon trapping. Since discovery of genes from
a given genomic region is the rate-limiting step in
positional cloning, we have been devoted to develop-
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ing and employing new technologies for this purpose.
This procedure has provided us with 35 candidate
sequences, including 19 expressed sequence tags
(ESTs), 7 RICH products, 2 trapped exons, and 7
exons predicted by computational analysis. By RT-
PCR analysis, 7 out of 35 fragments have been found
to be expressed in the normal mammary glands and
utilized to isolate full-length cDNAs.
Mutational Analysis of
Candidate Genes
M. Hamaguchi, J. Meth, T. Odawara, J. Winer [in collaboration
with M.C. King, University of Washington, and S. Scherneck,
Max-Delbruck-Centrum for Molecular Medicine[
We have cloned the full-length cDNA of six genes, all
of which are deleted in breast tumors. Our first step
was mutational analyses of these genes in cell lines;
60 cell lines have been screened by the protein trun-
cation test (PTT) as follows: Open reading frames of
the genes are amplified by PCR with specially
designed primers so that the PCR fragments have the
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T7 RNA polymerase promoter at the 5' ends and the
polyadenylation signal at the 3' ends. The amplified
fragments are transcribed in vitro using T7 RNA poly-
merase and then translated into protein with labeling,
and the produced protein is analyzed by electrophore-
sis. If a gene has a deletion/insertion that causes
frame shift or a mutation that generates a stop codon,
the gene product will be shorter than normal, thus, the
term truncation.
We have first examined two genes, Bravo and
Charlie, because they are most frequently deleted
(6/200). They are located in the center of deletion with
their 3' ends overlapping. We have detected a truncat-
ed protein of Bravo in a breast tumor. The causative
mutation was confirmed by sequencing. These facts
support that Bravo as being a strong candidate for the
tumor suppressor gene, although its biological func-
tion is unclear at this moment. Charlie has turned out
to be a TRAIL receptor. TRAIL receptors are related
to programmed cell death, which qualifies them as a
tumor suppressor candidate. We have not detected its
truncating mutation in cell lines. We are screening for
mutations of Bravo and Charlie on surgical specimens
and familial cases. No truncating mutations of the
other four genes have been demonstrated.
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FIGURE 1 Map o chromosome 8p22. (Vertical lines) STSs; (solid lines) SSTs used for both deletion and physical
mapping; (dotted lines) SSTs used only for physical mapping. (Top) Deletion map; the height of each column repre-
sents deletion frequency. (Middle) Transcript map; each solid box represents a candidate gene. B and C represent
Bravo and Charlie, respectively. (Bottom) Physical map; the open boxes represent genomic clones.
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Expression Study of a Tumor
Suppressor Candidate
M. Hamaguchi, J. Meth, T. Odawara [in collaboration
with M. Wig ler, Cold Spring Harbor Laboratory, and
K. Kitamura, National Institute of Health (Japan)]
We have carried out expression studies of Bravo and
Charlie on cell lines, resulting in identification of
several cell lines that do not express these genes. Two
breast cancer cell lines have been demonstrated not
to express either Bravo or Charlie. To clarify their
biological roles, we are performing a forced expres-
sion study on these two cell lines. Bravo and Charlie
have been cloned into a vector with a promoter so
that they can be expressed in the target cells. We will
observe phenotypic changes of the cells caused by
their expression. We will also compare the expression
patterns between the original and transformed cells.
Two inducible gene expression systems have been
developed by Dr. Wigler and Dr. Kitamura. Dr. Wigler
utilizes the retrovirus-mediated ecdysone system, and
Dr. Kitamura uses the vaccinia-virus-mediated RNA
polymerase system. Both systems along with the DNA
microarray will be used to scrutinize the biological
function of the candidate genes. The changes in the
expression pattern by induction of the genes examined
are detected by DNA microarray technology to identi-
fy the genes residing downstream from their signal
transduction pathway.
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GROWTH CONTROL IN MAMMALIAN CELLS
G. Harmon E. Bernstein S. Hammond
S. Boettcher Y. Seger
J. Du
The interests of my laboratory remain the basic mech-
anisms underlying neoplastic transformation. This has
been reflected in the past year by continued efforts to
dissect the transformation process through genetic
approaches in cultured mammalian cells. In addition,
we have also persisted in the development of tools and
technologies that might aid our efforts by improving
our ability to manipulate mammalian cells in vitro.
Finally, our laboratory has delved into an area that is
new for us: homology-dependent gene silencing.
This year, two graduate students, Yvette Seger and
Emily Bernstein, and one postdoc, Jian Du joined our
laboratory. Scott Hammond came as a visiting scien-
tist from Genetica Inc. Sabrina Boettcher left her posi-
tion as media maker in the McClintock lab to become
a technician in our laboratory.
Cancer Genetics
J. Du, Y. Seger
The transformation of a normal cell into a cancer cell
occurs via multiple genetic alterations that release a
cell from the constraints which normally regulate pro-
liferation. These include decreased sensitivity to extra-
cellular signals that control growth and a disruption of
internal controls that ensure that each cell cycle is
completed without error. Ultimately, most normal
cells also have a preprogrammed limitation on the
number of cell divisions that can be executed. During
the past year, we have continued our investigations
into tumor suppression mechanisms, devoting most of
our efforts to seeding new long-term projects that are
designed to reveal basic aspects of the transformation
process. Specifically, we wish to understand the mech-
anisms by which the myc oncogene contributes to
tumor formation (Y. Seger) and to probe genetic alter-
ations that can provoke genomic instability, a hallmark
of cancer cells (J. Du). We have also continued work
on oncogene-induced apoptosis.
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Protection from Oncogene-dependent
Apoptosis
G. Hannon, R. Maestro
Normal cells often respond to pro-oncogenic alter-
ations by activating homeostatic responses that are
likely to act as tumor suppression mechanisms. These
can manifest themselves as growth inhibitory (e.g.,
senescence) or as predisposing to programmed cell
death (apotosis). Since oncogenes such as myc predis-
pose normal cells to apoptosis, additional genetic
alterations must occur during tumorigenesis that coun-
teract these proapoptotic effects. Last year, I described
the results of a screen to identify genes that could pro-
tect normal cells from oncogene-dependent cell death.
One of the genes isolated through this approach is a
developmentally regulated transcription factor, Twist.
This effort has been carried out as a collaboration with
Roberta Maestro, a former visiting scientist here at
Cold Spring Harbor Laboratory and present faculty
member at the CRO in Aviano, Italy. This year has seen
the publication of this work and the emergence of
some hints with respect to the pathways by which
Twist might contribute to tumor formation.
Oncogene-dependent apoptosis proceeds largely
through a mechanism that requires an intact p53 tumor
suppressor protein. Last year, we reported that Twist
could interfere with p53-dependent apoptosis in MEF
(mouse embryonic fibroblast) cells that had been
transformed with E 1 A plus ras, a system originally
characterized by Scott Lowe (CSHL). Twist could also
interfere with p53-dependent growth arrest. The p53
protein is a transcriptional activator that invokes bio-
logical responses through the activation of down-
stream target genes. Twist expression suppressed
induction of p53 targets that are known to contribute to
growth arrest (p21) and cell death (bax).
The p53 tumor suppressor protein is regulated in a
variety of ways. These include control over its abun-
dance and control over its specific activity. In addition,
p53 is regulated through association with proteins that
control activity, stability, and protein trafficking. As a
step toward determining the mechanism by which
Twist interferes with p53, we examined the abundance
of known p53 regulators. We found that Twist expres-
sion reduced the abundance of the ARF (an alternative
reading frame of the INK4a locus) tumor suppressor
mRNA by approximately 5-10-fold.
ARF regulates p53 through its interaction with
MDM2 (mouse double minute, a regulator of p53).
ARF, in turn, is regulated by proapoptotic oncogenes
such as myc and EIA. ARF-null cells are impaired in
the ability to undergo programmed cell death in
response to these proapoptotic oncogenes, thus mim-
icking the phenotype of Twist-expressing cells.
Although Twist could impact the p53 pathway in other
ways as well, suppression of ARF synthesis is suffi-
cient to account for the effects on p53 activity that we
observe. Work during the next year will focus on the
mechanisms that underlie the effect of Twist on ARF
expression.
Homology-dependent
Gene Silencing
E. Bernstein, S. Hammond
In most organisms, the presence of double-stranded
RNA (dsRNA) signals trouble. For example, dsRNAs
could indicate invasion by pathogens or could reflect
the activity of mutagenic and potentially deleterious
mobile genetic elements. Therefore, cells have evolved
mechanisms for detecting and responding to these
threats. In mammals, responses are rather general and
include suppression of translation and nonselective
RNA degradation. However, in a variety of other sys-
tems including Caenorhabditis elegans, Drosophila,
trypanosomes, and plants, the response is specific,
interfering only with the expression of sequences that
are homologous to the dsRNA. The subject of dsRNA-
induced gene silencing (also known as RNA interfer-
ence or RNAi) has recently achieved a more promi-
nent place in the general consciousness because of its
application as a reverse genetic tool. This has high-
lighted the almost complete mystery surrounding the
mechanisms by which dsRNAs can suppress the
expression of specific target genes.
We sought to establish a biochemically tractable
model in which such mechanisms could be investigat-
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FIGURE 1 (Top) Cells were transfected with dsRNAs corre-
sponding to cyclin E or with a control dsRNA (lacZ(, as indicat-
successfully incorporated cotransfected DNA
(lower panels, Gated) were marked using a plasmid that directs
expression of a membrane-inked green fluorescent protein
(GFP). (Bottom) Drosophila S2 cells were transfected with the
indicated dsRNAs. After 3 days, cells were lysed and total RNA
was prepared. This was analyzed by Northern blotting with the
indicated probes. Equal loading was ensured by overprobing
the blot with the RP49 cDNA (encoding a ribosomal protein).
ed. In part because of our familiarity with cell culture
systems, we asked whether dsRNA-induced gene
silencing could be provoked in a Drosophila cell line.
To test this possibility, we introduced into cultured
Drosophila S2 cells a dsRNA corresponding to
Drosophila cyclin E, a gene that is essential for pro-
gression into S phase of the cell cycle. S2 cells nor-
mally reside mostly in G2. However, those transfected
with cyclin E dsRNA arrested in the G1 phase of the
cell cycle (Fig. 1). One hallmark of RNAi is a reduc-
tion in the level of mRNAs that are homologous to the
dsRNA. Cells transfected with the cyclin E dsRNA
showed diminished endogenous cyclin E mRNA as
compared with control cells (Fig. 1). Similarly, trans-
fection of cells with dsRNAs homologous to fizzy, a
component of the anaphase promoting complex (APC)
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or cyclin A, a cyclin that acts in S, G2, and M, also
caused reduction of their cognate mRNAs (Fig. 1).
These results suggest that RNAi may be a generally
applicable method for probing gene function in cul-
tured Drosophila cells.
Mechanistic studies of RNA interference would be
greatly aided by the availability of a cell-free system in
which the process could be attacked biochemically. We
therefore tested cellular extracts for activities that
might contribute to dsRNA-induced gene silencing.
Lysates prepared from cells transfected with cyclin E
dsRNA efficiently degraded a synthetic cyclin E tran-
script; however, a heterologous lacZ transcript was sta-
ble in these lysates. Conversely, lysates from cells
transfected with the lacZ dsRNA degraded the lacZ
transcript but left the cyclin E mRNA intact. These
results suggest that RNA interference ablates target
mRNAs through the generation of a sequence-specific
nuclease activity and provide a context in which the
properties of that enzyme can be studied.
Gene silencing provoked by dsRNA is sequence-
specific. A plausible mechanism for determining
specificity would be incorporation of nucleic acid
guide sequences into the complexes that accomplish
silencing. In accord with this notion, pretreatment of
extracts with a Ca'-dependent nuclease (micrococcal
nuclease) abolished the ability of these extracts to
degrade cognate mRNA. Therefore, our results sup-
port the possibility that the RNAi nuclease is a ribonu-
cleoprotein (RNP), requiring both RNA and protein
components.
In plants, the phenomenon of cosuppression has
been associated with the existence of small (-25
nucleotides) RNAs that correspond to the gene that is
being silenced (Hamilton and Baulcombe, Science
286: 950 [1999]). To address the possibility that a sim-
ilar RNA might exist in Drosophila and guide the
sequence-specific nuclease in the choice of substrate,
we partially purified our activity through several frac-
tionation steps. Active nuclease fractions also con-
tained an RNA species of 25 nucleotides that is
homologous to the cyclin E target. This band is likely
to represent a family of discrete RNAs since it could
be detected with probes specific for both the sense and
antisense cyclin E sequences and with probes derived
from distinct segments of the dsRNA.
RNA interference allows an adaptive defense
against both exogenous and endogenous dsRNAs, pro-
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viding something akin to a dsRNA immune response.
Our results have begun to provide a framework within
which models of dsRNA-induced gene silencing can
be created. According to our data, introduction of
dsRNA into Drosophila cells provokes the assembly of
a sequence-specific nuclease. This occurs through
conversion of the dsRNA, either via processing or
replication, into small RNAs that are homologous to
the substrate. These are incorporated into a nuclease
that is apparently an RNP particle, containing both
essential protein and RNA subunits. Fractionation of
the nuclease and Northern analysis of the 25-
nucleotide RNA indicates that a family of nucleases is
created, with each member having a 25-mer that tar-
gets a specific portion of the substrate.
Our data draw a striking parallel between RNA
interference in Drosophila and posttranscriptional
gene silencing (PTGS) in plants. As stated above,
plants in which PTGS is occurring contain 25-
nucleotide RNA species that are homologous to the
gene that is being suppressed. The identical size of
putative specificity determinants in plants and animals
predicts a conservation of both the mechanisms and
the components of dsRNA-induced, posttranscription-
al gene silencing in diverse organisms. During the next
year, we hope not only to deepen our understanding of
this intriguing gene regulatory mechanism, but also to
extend through that understanding the reach of RNAi
as a tool to study gene function.
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CAENORHABDITIS ELEGANS DEVELOPMENTAL
GENETICS
M. Hengartner J. Bikoff A. Fraser R. Hofmann M. Spector
H. Cosel-Pieper (URP) A. Gartner Q. Liu S. Tharin
S. Desnoyers T. Gumienny S. Milstein J. Ye
L. Englmeier D. Hoeppner B. Schumacher
Our laboratory uses Caenorhabditis elegans to study
two basic biological problems: programmed cell death
(apoptosis) and nervous system development and
function. The value of C. elegans for such studies
derives from its simplicity at the anatomical and devel-
opmental levels, from its powerful genetics and
reverse genetics, and from the ready availability of
genetic and molecular reagents (mutant collections,
genome sequence, and so forth).
Despite its humble dimensions and simple anato-
my, one should not loose sight of the fact that C. ele-
gans is a metazoan-a multicellular animal-and as
such shares with humans many fundamental molecular
and cellular programs. It is this similarity at the level of
genes and biochemical pathways that allows the nema-
tode worm to be used as a useful model system.
PROGRAMMED CELL DEATH
Programmed cell death (PCD), or apoptosis, is a high-
ly regulated program of cell suicide. Apoptosis is ubiq-
uitous in humans. It is used during development to
remove unnecessary cells; in adults, it contributes to
the maintenance of cell populations and to the elimi-
nation of potentially dangerous (e.g., cancer prone)
cells. Defects in cell death have been implicated in the
pathogenesis and/or etiology of many human diseases
including AIDS, various neurodegenerative diseases,
and cancer. A better understanding of the molecular
mechanisms underlying the regulation and execution
of cell death may lead to significant improvements in
how these diseases are treated.
The proximal cause of apoptosis in C. elegans is
the activation of the caspase homolog CED-3 from the
inactive zymogen (proCED-3) into the mature pro-
tease. This activation is mediated by the Apaf-1
homolog CED-4. In cells that should survive, CED-3
and CED-4 are antagonized by the Bcl -2 family mem-
ber CED-9. We previously suggested that CED-9 pre-
vents death by sequestering CED-4, and possibly
proCED-3, in an inactive, mitochondria-associated
complex, the apoptosome. In cells fated to die, CED-9
is in turn inactivated by the proapoptotic BH3 domain-
containing protein EGL-1. All four proteins are struc-
turally and functionally conserved between nematodes
and mammals, strongly suggesting that the apoptotic
program is ancient in origin and that all metazoans
share a common mechanism of apoptotic cell killing.
The C. elegans IAP Homolog BIR-1 Plays a
Conserved Part in Cell Division, Not Apoptosis: IAPs
(inhibitor of apoptosis proteins) have been shown to
suppress apoptotic cell death in a variety of model sys-
tems, including mammals and Drosophila, and have
been suggested to inhibit caspases directly. All IAPs
contain at least one BIR (baculovirus IAP repeat), a
conserved 50-70-amino-acid domain with putative
Zn'tbinding properties. To determine whether this
gene family also controls apoptosis in C. elegans, we
cloned and characterized two worm BIRPs (BIR -con-
taining proteins), BIR-1 and BIR-2; these are probably
the only BIRPs in C. elegans. Expression of either BIR-
1 or BIR-2 is unable to inhibit programmed cell death in
C. elegans. Rather, ablation of BIR-1 expression causes
a complete defect in cytokinesis with resultant embry-
onic lethality. Interestingly, this defect can be partially
rescued by transgenic expression of survivin, the mam-
malian IAP most similar to BIR-1. Our results suggest
that BIRPs not only function in the regulation of apop-
tosis, but rather can also participate in diverse biologi-
cal processes, including cell division.
Physiological Cell Death in the C. elegans Germ
Line: How is the apoptosome regulated? The answer
to this question is likely to be complex, as even a sin-
gle cell might need to integrate multiple signals to
determine whether it should activate the death path-
way or keep on living. To address this question in C.
elegans, we have set out to determine how specific cell
types decide between life and death.
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One of the cell types that we chose to focus on is
the germ cell. PCD is very common in the adult her-
maphrodite germ line: More than half of the germ
cells that differentiate along the oogenic pathway
undergo PCD. We suspect that these deaths serve a
homeostatic function and are needed to regulate the
number of cells that are allowed to differentiate into
oocytes. Indeed, loss of germ cell death results in germ
line hyperplasia, which likely accounts for the lower
fertility of ced-3 and ced-4 mutants.
To understand how germ cells make the decision
between life and death, we have screened for muta-
tions that specifically affect PCD in the germ line. We
have thus far isolated mutations in over half a dozen
genes that result in excessive germ cell death. We are
now in the process of genetically characterizing these
genes and are cloning two representative members of
this group.
DNA Damage-inducedApoptosis in C. elegans: During
our studies of the regulation of germ cell death, we
noticed that genotoxic injury such as exposure to ioniz-
ing radiation or chemical mutagens can induce germ
cell death, as well as germ cell proliferation arrest.
These observations suggested that C. elegans, like
mammals, possesses DNA damage checkpoints that
promote the elimination of damaged cells via apopto-
sis. To better understand how DNA damage activates
the apoptotic machinery, we set out to characterize this
pathway in more detail.
We found that DNA-damage-induced apoptosis
requires the apoptotic core machinery but is genetical-
ly distinct from somatic cell death and physiological
germ cell death. Interestingly, most mutations that
affect physiological cell death did not significantly
affect checkpoint-induced cell death, demonstrating
that multiple death-inducing pathways exist within the
C. elegans germ cell. We have identified mutations in
three checkpoint genes that are required for DNA-
damage-dependent cell proliferation arrest and apop-
tosis. One of these genes, mrt-2, encodes a homolog of
the conserved Schizosaccharomyces pombe rad 1-VS.
cerevisiae RAD17 checkpoint gene. This result for the
first time implicates a radl homolog in DNA-damage-
apoptosis in animals and suggests that induc-
tion (if apoptosis in response to DNA damage might be
an ancient, conserved biological response (Fig. 1). We
hope that further genetic analysis of radiation-induced
cell death in the worm will help us understand the
molecular basis of DNA-damage-induced apoptosis in
general and in particular why and how tumor cells
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FIGURE 1 C. elegans DNA damage checkpoint pathway. The
C. elegans checkpoint proteins MRT-2, RAD-5, and DAM-1 are
required for both cell proliferation arrest and apoptosis following
genotoxic events. Arrows indicate activation events.
eventually become resistant to chemotherapy/radio-
therapy-induced apoptosis.
Genes Involved in Engulfment of Dying Cells: Once
a cell activates the apoptotic machinery, a number of
downstream "subprograms" are activated, with the
goal of rapidly breaking down the cell and removing it
from the body. One important subprogram results in
the generation of signals that promote recognition and
phagocytosis of the dying cell by other cells.
Six genes have previously been shown to function
in this process in C. elegans. Last year, we reported our
cloning and molecular characterization of one of these
six genes, ced-6. CED-6 contains a phosphotyrosine-
binding (PTB) domain and a number of potential SH3-
binding sites, suggesting that CED-6 might act in a sig-
nal transduction cascade activated once a cell recog-
nizes that one of its neighbors is undergoing PCD.
Interestingly, ced-6 possesses a highly conserved
homolog in mammals. We cloned this homolog, which
we named hced-6, and found that it is widely expressed
in humans. Overexpression of hced-6 in worms can
partially rescue the engulfment defect of ced-6
mutants, suggesting that the two genes are functionally
conserved and that the signaling pathway(s) in which
CED-6 participates is conserved from worms to
humans.
NERVOUS SYSTEM FUNCTION AND
DEVELOPMENT
A second area under investigation in the lab is the ner-
vous system in C. elegans. The small size and relative
simplicity of the nematode nervous system allows us
to address readily complex questions at the genetic
and molecular levels.
Cell Death in the Developing Nervous System:
Programmed cell death is very common in the devel-
oping C. elegans nervous system. To better understand
how developing neurons decide between differentia-
tion and death, we have undertaken a detailed study of
cell fate determination in the hermaphrodite-specific
neuron (HSN), a sexually dimorphic motor neuron,
which drives egg laying in hermaphrodites but dies in
males. We have isolated more than a dozen mutations
in at least three genes that specifically rescue the HSN
neuron from death. We expect that a genetic and mol-
ecular analysis of these genes will lead to a better
understanding of how the HSN neuron controls activa-
tion of the apoptotic machinery.
Axonal Guidance and Outgrowth: C. elegans has
proven to be a useful system to identify conserved
genes that function in nervous system development.
We are currently concentrating our attention on unc-
69, which we found to be required for proper guidance
of many axons in the developing worm. The unc-69
gene encodes a small novel protein with a predicted
coiled-coil motif near its carboxyl terminus. Rescuing
unc-69::gfp fusion constructs are expressed through-
out development in the nervous system, predominant-
ly in axons, suggesting that the unc-69 gene acts cell-
autonomously to promote axonal guidance and out-
growth. unc-69 is highly conserved through evolution,
and expression of the human unc-69 homolog (tenta-
tively named hunc-69) completely rescues the loco-
motion defect of unc-69 mutant worms. Our current
data are consistent with a model where unc-69 par-
ticipates in a conserved signal transduction pathway
that relays external guidance cues to the growth cone
cytoskeleton.
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PLANT DEVELOPMENT
D. Jackson G. Birkenmeier G. Sabino
F. Taguchi Shiobara J. Thomas
Z. Yuan D. Bikoff
M. Krishnaswami
The research in our lab aims at elucidating the molec-
ular mechanisms of development, using Arabidopsis
and maize as model systems. Plants are an interesting
system in which to study development because their
mode of development is unique and fundamentally dif-
ferent from that of animal development. In particular,
plants show high developmental plasticity since they
continue to initiate new organs throughout their life
cycle from groups of stem cells called meristems. We
are therefore trying to determine how patterns of
developmental gene expression are established and to
determine the role of cell-to-cell communication in the
shoot meristem. It is clear that the domestication of
crop plants for agricultural use involved the selection
of specific morphological variants, in some cases
affecting the meristems either directly or indirectly,
e.g., in selection for increases in fruit size or of the
number of rows of kernels on an ear of corn.
Therefore, a better understanding of the mechanisms
of plant development will have significant contribu-
tions to agriculture.
Analysis of Mosaic
Sectors of KNOTTED1
in Arabidopsis
G. Birkenmeier
Cell-to-cell communication is an essential step in the
development of any multicellular organism; cells need
to talk to each other in order to coordinate their prop-
er development in space and time. We previously
described a novel pathway of cell-to-cell communica-
tion involving the intercellular trafficking of the plant
homeodomain protein KNOTTED1. KN1 is normally
expressed in the shoot apical meristem, and dominant
mutations show nonautonomous behavior which we
correlated with the movement of KN1 protein between
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leaf cells through specialized channels called plas-
modesmata. KN1 is also required for the development
of the shoot meristem; loss of function mutations of
the Arabidopsis ICN1 ortholog fail to make or to main-
tain the meristem.
As a first step to characterize the range and bio-
logical significance of cell-to-cell transport of KN1,
we designed a system to make marked sectors of KN1
expressing cells in Arabidopsis. This system uses an
organellar targeted green fluorescent protein (GFP) as
a cell autonomous sector marker. This constitutively
expressed marker is flanked by /ox sites and is direct-
ly followed by a promoterless GFP -KN1 fusion.
Stochastic excision of the lox -organellar GFP gene in
a single cell early in development, achieved by induc-
tion of a heat shock CRE transgene, leads to the pro-
duction of clonal sectors where the organellar GFP is
no longer present and the GFP -KN1 fusion protein is
now expressed. By careful observation of sector
boundaries, we can determine the range of movement
of GFP-KN1 at different stages of development. Since
overexpression of GFP -KN1 induces a morphological
phenotype of leaf lobing and aberrant growth, we may
also be able to use this system to determine the bio-
logical consequence of cell-to-cell trafficking, i.e.,
whether movement of KN1 protein into cells where
knl is not being transcribed leads to a discernible phe-
notype.
Using this system, we have produced sectors of
KN1 expression that are easily scored phenotypically;
for example, we observe half-leaf sectors where one
half of the leaf is normal and the other half has the
characteristic overexpression phenotype with severe
lobing. Sector boundaries are visualized by a distinct
boundary of organellar GFP. However, the fluores-
cence from the GFP -KN1 fusion has been difficult to
detect, presumably because the fusion protein level is
regulated and is much lower than that of the organellar
GFP-expressing cells. To solve this problem, we are
using immunohistochemistry to localize the organellar
GFP and the KN1 -GFP fusion to assess the range of
cell-to-cell movement of KN1. This will provide the ear inflorescence meristem, leading to an increase
important information on the range of signaling that in the number of flowers initiated by the ear. The nor-
we can expect for this novel mode of cell-to-cell com- mal function of these genes is therefore important
munication. either to control stem cell proliferation or to promote
lateral organ formation. One of the mutations, fasciat-
ed earl (fae2) arose in a nontargeted Mutator transpo-
Development of a New GFP son tagging screen, and we previously identified and
Enhancer Trap in Arabidopsis cloned a Mu8 element and flanking genomic DNA that
cosegregated with the fae2 mutation. In the past year,
Z. Yuan, D. Bikoff we isolated a putative new allele offae2. The plant car-
rying this new mutation also showed a novel DNA
polymorphism when probed with the Mu8 flanking
GFP has revolutionized cell biology in its ability to
reveal patterns of gene expression in living cells and
organisms. We are using the GFP as a tool to visualize
the cell-to-cell trafficking of a number of plant pro-
teins. An interesting question is to what extent the abil-
ity of proteins like KN1 to traffic through plasmodes-
mata is regulated in different cell and tissue types. To
address this question, we are using a novel enhancer
trap system developed by Dr. Jim Haseloff
(Cambridge University, U.K.). This system relies on
genomic enhancers that activate a GAL4-VP16 fusion
protein, which in turn activates GFP under the control
of the GAL4 UAS. In this system, the GAL4-VP16
and the UAS-GFP are linked on the same transgene,
which is a problem because this can interfere with
visualization of other GFP fusion proteins driven by
the UAS. To overcome this problem, we separated the
two components into separate transgenes with differ-
ent antibiotic selectable markers and are starting to
generate enhancer trap lines with this new system.
Using these lines, we will trans-activate GFP fusions
to different plant proteins in order to assess directly
their ability to traffic through plasmodesmata connect-
ing different cell and tissue types. We therefore hope
to shed light on the regulation of plasmodesmal traf-
ficking, which is proposed to be an important step in
developmental regulation as well as in systemic sig-
naling in viral defense and posttranscriptional gene
silencing.
Isolation of the fae2
Gene of Maize
F. Taguchi Shiobara, G. Sabino, Z. Yuan
We have isolated a series of mutations in maize that
cause aberrant proliferation and growth (fasciation) of
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FIGURE 1 Flower development in normal and fae2 ears.
Scanning electron micrographs of maize flowers which on nor-
mal ears are borne in pairs (A). In fae2 mutants, however, this
pattern is disrupted and flowers arise in irregular groups of three
or more (8). Within the flower, the development of the female
organ, the gynoecium, is often abnormal (C).
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probe, indicating that it is highly likely that we have
cloned the fae2 gene.
We identified an transcript of approximately 2.7
kb, and its sequence reveals significant similarity to a
class of leucine-rich repeat (LRR) proteins that have
been implicated in various aspects of plant signaling,
including resistance to pathogens and response to
plant growth regulators. Expression analysis by north-
ems and in situ hybridization indicates that FAE2 is
expressed in ear primordia, in both inflorescence and
floral meristems. This is consistent with our phenotyp-
ic analysis which indicated that the mutant ears not
only have an enlarged inflorescence meristem, but also
show increased numbers of floral primordia and
increased gynoecium size (see Fig. 1). By analogy to
other known LRR genes, it is likely that FAE2 encodes
a receptor that interacts with an unknown extracellular
ligand to regulate stem cell division or lateral organ
specification.
In the last year, we have also received two further
fasciated ear mutants from maize collaborators and
are testing allelism to the two other mutants in this
class. It is apparent that several loci in maize can
mutate to give a fasciated phenotype, although our
analysis of genetic interactions suggests that at least
some may act in the same pathway to control meris-
tern development.
Progress toward
Transposon Tagging
of the abphyll Gene
M. Krishnaswami, Z. Yuan
The abphyll mutation of maize is the only mutation
described in plants that changes patterns of leaf initia-
86
tion from one regular pattern to another. abphl mutant
plants initiate leaves in opposite pairs rather than indi-
vidually, which is the norm for all grass species. The
abphl mutation arose spontaneously, and we have
therefore carried out directed transposon screens to
isolate additional alleles that will be amenable to
cloning of the abphl locus by transposon tagging.
Specifically, we are using the Mutator transposon sys-
tem, which shows a high forward mutation rate and no
strong target site specificity. We isolated and con-
firmed genetically three new abphl alleles and have
several more that await testing. For one of the alleles,
abphl *-43, we tested for cosegregation of Mu trans-
posons with the new allele using several different Mu
probes specific for different classes of Mu
autonomous and nonautonomous transposons. In one
case, we have found a Mu7 hybridizing fragment of
approximately 4 kb that cosegregates with the abphl *-
43 allele, and we are testing this cosegregation on a
larger number of individuals. If the cosegregation
holds up, we will then clone the transposon band and
isolate the flanking sequence to test whether it corre-
sponds to the abphl gene. The question of what con-
trols the arrangement of leaves, or phyllotaxis, is one
of the oldest problems in plant biology, and the isola-
tion of the abphl gene should provide a unique oppor-
tunity to study this problem from a molecular perspec-
tive.
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PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
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The DNA sequence of the first higher plant genome,
that of the model plant Arabidopsis thaliana, is sched-
uled to be finished by the end of this year (see report
from the McCombie laboratory). Taking advantage of
this landmark in plant genetics, we are systematically
determining the function of genes in Arabidopsis and
maize by using transposable elements to monitor gene
expression and disrupt gene function. We are also con-
tinuing to study genes involved in organogenesis and
the elaboration of the plant body plan: We have char-
acterized the roles of three genes (ramosal, asymmet-
ric, and argonaute), in stem cell determination, differ-
entiation and maintenance, and we have begun to
explore the epigenetic mechanisms that may underlie
these processes. This year, we reported the structural
and functional characterization of the first completely
sequenced heterochromatic region in a higher organ-
ism, a cytogenetically visible structure in Arabidopsis
that resembles the chromosomal "knobs" of maize
described by Barbara McClintock. The genetic conse-
quences of plant genome architecture, which is large-
ly controlled by transposons, remains a focus of the
research in our laboratory.
Functional Genomics:
Maize Targeted Mutagenesis
B. May, E. Vollbrecht, P. Rabinowicz, R. Martienssen
in collaboration with M. Freeling, University of California,
Berkeley; D. Alexander, Novartis Agricultural Biotechnology
Research Institute; and L. Stein, Cold Spring Harbor
Laboratory]
We have established a transposon library in maize for
the purposes of targeted selection of gene knockouts.
Searches are performed by amplifying DNA from these
populations using specific primers from the transposon
and from the gene. We are using Robertson's Mutator
transposons, and in 1998 and 1999, 40,000 plants were
grown at the Novartis nursery in Kauai, individually
T. Singer
E. Vollbrecht
C. Yordan
bar-coded, and sampled. All plants were self-pollinated,
harvested ears were shelled, and the kernels were
bagged and bar-coded. Individual leaf samples were
sorted into row-column grids of 48 x 48 (2304 plants)
in pools.
In the fall of 1998, 23,000 ears from Hawaii were
screened for lethal mutations before they were shelled.
Background mutations in the parental lines were iden-
tified by pedigree analysis and subtracted from the
totals.
New defective kernel mutations (dek):
New viviparous mutations:
New reduced fertility mutations:
3589/14188 (25.3%)
171/22724 (0.8%)
138/15088 (0.9%)
There are 15 known loci that contribute to kernel
vivipary, and we have recovered 171 new mutations.
This is an allele frequency greater than ten alleles per
locus. DNA was extracted from nine grids (864 leaf
pools), and polymerase chain reaction (PCR) amplifi-
cation of the pools was used in a double-blind assay to
identify correctly a new allele of vpl found in the
screen. We are now ready to begin screening for inser-
tions in new genes.
Differential Methylation of Genes and
Retrotransposons Facilitates Shotgun
Sequencing of the Maize Genome
P. Rabinowicz, C. Yordan, R. Martienssen
[in collaboration with W.R. McCombie,
Cold Spring Harbor Laboratory]
The genomes of higher plants and animals are highly
differentiated, comprising a relatively small number of
genes and a large fraction of repetitive DNA. Recently,
it has been shown that the bulk of this repetitive DNA
constitutes transposable, and especially retrotranspos-
able, elements. It has been hypothesized that most of
these elements are heavily methylated relative to
genes, but the evidence for this is anecdotal and con-
troversial. We have shown that repeat sequences in
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maize, because of their sensitivity to bacterial restric-
tion-modification systems, can be largely excluded
from genomic shotgun libraries by the selection of an
appropriate host strain. In contrast, unmethylated
genic regions are preserved in these genetically fil-
tered libraries if the insert size is less than the average
size of genes. This demonstrates that repeats are the
primary targets of methylation in maize. The use of fil-
tered libraries in genome shotgun sequencing in plant
genomes allows significant enrichment of genes,
greatly reducing the number of reactions required for
genome shotgun sequencing analysis.
Chromosome Structure and
Organization in Arabidopsis
C. Yordan, J. Simorowski, B. May, R. Martienssen
[in collaboration with D. Preuss, University of Chicago;
P. Fransz, Gatersleben Institute of Plant Genetics;
R. Wilson, Washington University; E. Chen, PE Biosystems;
and W.R. McCombie, Cold Spring Harbor Laboratory]
Heterochromatin, constitutively condensed chromo-
somal material, is widespread among eukaryotes, but
the complete DNA sequence of such a region had not
been previously determined. The Cold Spring Harbor
Laboratory/Washington University Genome
Sequencing Center/PE Biosystems Arabidopsis
sequencing consortium has sequenced and analyzed
3.0 Mb from A. thaliana chromosome IV, which
includes 0.5-0.7 Mb of isolated heterochromatin
resembling the chromosomal knobs of maize first
described by Barbara McClintock. The knob on chro-
mosome IV is characterized by a low density of
expressed genes, low levels of recombination, and a
low incidence of gene trap insertion. Tandem arrays
of long repeats were found, as well as many individ-
ual transposons. Methylation of repeats and trans-
posons was dependent on chromatin remodeling, as
methylation was lost in ddml (decrease in DNA
methylation) mutant strains. Clustered repeats, com-
prising genes as well as transposons, were associated
with condensed chromosomal domains even when
their heterochromatic nature was not immediately
apparent. The complete sequence of a heterochromat-
ic island provides a unique opportunity to study
sequence determinants of chromosome condensation
in a higher eukaryote.
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Robertson's Mutator Transposons Are
Regulated by DNA Methylation and
Chromatin Remodeling in Arabidopsis
C. Yordan, T. Singer, R. Martienssen
Transposable elements of the Robertson's Mutator
family in maize are very aggressive and widely used
for mutagenesis. Active elements are undermethylated
in maize. We have identified at least 20 intact and
many more defective Mutator transposons in the
Arabidopsis genome. Many of them are located in het-
erochromatic regions and are heavily methylated. In
strains of Columbia carrying the ddml mutation, these
elements become demethylated and transpose at high
frequencies. DDM1 is required for methylation of het-
erochromatic repeats in Arabidopsis (Vongs et al.,
Science 260: 1926 [1993]) and was recently shown to
encode an SNF2 chromatin remodeling enzyme
(Jeddeloh et al., Nat. Genet. 22: 94 [1999]). Thus,
Mutator transposons are indeed regulated by DNA
methylation and chromatin remodeling. Furthermore,
these results indicate a link between heterochromatin,
transposon regulation, and other epigenetic phenome-
na regulated by ddml , such as imprinting and paramu-
tation.
Systematic Functional Genomics in
Arabidopsis Using Gene Traps
B. May, C. Yordan, J. Simorowski, J. Arroyo, R. Shen,
A. Dubrowski, J. Fontana, A. Groover, R. Martienssen
[in collaboration with W.R. McCombie, J. Healy, and
A. Reiner, Cold Spring Harbor Laboratory]
We are developing a database of Arabidopsis gene
function by generating several thousand strains, each
with a unique gene trap or enhancer trap transposon
located somewhere in the genome. DNA is prepared
from each line, and the insertion site is amplified and
sequenced. During the last year, we generated several
thousand new lines and sequenced more than half of
them. Each line is now being routinely screened for
early lethals and then stained for reporter gene expres-
sion. So far, we have mapped more than 2300 inser-
tions and disrupted close to 1000 genes. The
sequences and staining patterns are entered into a rela-
tional database that can be queried for sequence, anno-
tated genes, patterns, and phenotypes. Automated
quality control is used to eliminate sequences from
PCR contaminants, low-quality reads, and selection
artifacts. Annotation is achieved using a tailor-made
Java application that compares each sequence to the
annotated Arabidopsis sequence in Genbank and
updates the gene trap database with gene identifiers,
similarity scores, and insertion orientation. We hope to
disrupt more than half the genes in Arabidopsis in the
next 2-3 years, each indexed by sequence as well as
function.
Gene Trap Screens for
Vascular and Secreted Proteins
A. Groover, R. Martienssen
The plant vascular system is an attractive model for
studying diverse aspects of development, and it is of
prime importance economically (e.g., in the develop-
ment of woody tissues). The development of the vas-
cular system involves patterning of the vascular tissues
within organs (e.g., venation pattern within leaves)
and the differentiation of highly specialized cell types.
We have performed two genetic screens using
Arabidopsis gene traps that identify genes involved in
vascular development. The first screen identified gene
trap insertions into genes encoding secreted and plas-
ma-membrane-spanning proteins. This class of pro-
teins includes key components of cell-to cell-signaling
mechanisms, which are currently poorly understood in
plants. The screen has identified numerous genes of
interest, including membrane-spanning receptors and
novel genes of unknown function. A second screen,
also using Arabidopsis gene traps, has identified genes
expressed at different stages of development and with-
in specific cell types in the vasculature. Together, these
genes give insight into the control of vascular devel-
opment at the molecular level.
Maternal and Zygotic Roles of
PROLIFERA in Arabidopsis
A. Groover, C. Yordan, J. Simorowski, R. Martienssen
[in collaboration with P. Springer, University of California,
Riverside]
PROLIFERA (PRL) encodes a homolog of the DNA
replication licensing factor Mcm7, a highly conserved
protein found in all eukaryotes. Gene trap insertions in
the PRL gene are lethal, resulting in decreased trans-
mission through the female gametophyte and homozy-
gous embryonic lethality. PRL is specifically
expressed in populations of dividing cells in sporo-
phytic tissues of the plant body, such as the palisade
layer of the leaf and founder cells of initiating flower
primordia. Gene fusions with the green fluorescent
protein (GFP) reveal that the PRL protein accumulates
during the G1 phase of the cell cycle and is transiently
localized to the nucleus. During mitosis, the fusion
protein rapidly disappears, returning to daughter cell
nuclei during G1. PRL::GUS fusions are strongly
expressed in the central cell nucleus of mature
megagametophytes, which have a variety of arrest
points reflecting leaky lethality. Expression is also
observed in the endosperm of mutant prl embryo sacs
that arrest following fertilization. Crosses with wild-
type pollen result in occasional embryonic lethals that
also stain for GUS activity. In contrast, embryos
resulting from crosses of wild-type carpels with
PRL::GUS pollen do not stain and are phenotypically
normal. In situ hybridization of GUS fusion RNA indi-
cates that transcription is equivalent from maternally
and paternally derived alleles in these embryos. This
rules out embryonic imprinting and indicates instead
of maternally derived protein and/or
translation of maternal RNA is likely responsible for
the "maternal" effect.
ramosal Controls Meristem Fate
in the Maize Inflorescence
E. Vollbrecht, R. Martienssen
In plants, stem cell fate is perhaps the single most
important determinant of growth and development,
and meristem identity mutants potentially define the
transition from indeterminate to determinate fate.
ramosal is such a mutation in maize. ral mutants have
indeterminate second-order meristems, resulting in a
highly branched inflorescence, both in the ear and in
the tassel. In some respects, ral mutant inflorescences
resemble those of related panicoid grasses. It is there-
fore possible that ral may account for macroevolu-
tionary change in grass inflorescence architecture. We
identified four mutable alleles of ral (Annual Report
1992), and we have now demonstrated that two of
them are caused by the insertion of Suppressor-muta-
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FIGURE 1 PROLIFERA is localized in the nucleus during the G,
phase of the cell cycle. (A) Whole mount of root tip from prl/+
plant stained with X-Gluc, showing GUS localized in the nucle-
us of individual files of cells. (B-D) Accumulation of PRL::GFP
fusion in root tip nuclei. The time between images inB and C is
4 min. The time between the images in C and D is 28 min. The
arrow marks a cell in B that has PRL::GFP localized to the
nucleus. Localization is lost in C and returns in daughter nuclei
(D) following mitosis.
for (Spm) autonomous transposable elements.
Cosegregating elements have been identified by
Southern analysis. We will clone the ral locus and
analyze the expression of the gene in a variety of
mutant backgrounds. We will then study the architec-
ture of mutant inflorescences, and use a combination
of double mutant and mosaic analysis to determine the
function of the gene.
asymmetric leaves] Controls Stem Cell
Function in the Arabidopsis Apex
M. Byrne, J. Arroyo, R. Martienssen [in collaboration with
A. Hudson, Edinburgh University]
Leaves arise as lateral organs from primordia initiated
on the flank of the shoot apical meristem, an indeter-
minate group of stem cells located at the growing
point of the plant. Fundamental to leaf development is
the early establishment of two axes of growth, the
dorsoventral axis and the proximodistal axis. Although
many leaf developmental mutants have been
described, the genetic basis of leaf initiation, determi-
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nation, and patterning is largely unknown. One such
mutant in Arabidopsis is asymmetric leaves] (asl).
Wild-type Arabidopsis adult rosette leaves are spatu-
late in shape. In comparison, as1 leaves are variably
lobed with a drastically altered proximodistal pattern.
We have used positional cloning to isolate the ASI
gene. AS] is a myb transcription factor, closely related
to PHANTASTICA in Antirrhinum and ROUGH
SHEATH2 in maize. These two genes are known to
regulate homeobox genes negatively (Schneeberger et
al., Development 125: 2857 [1998]; Timmermans et
al., Science 284: 151 [1999]). Molecular and genetic
analyses indicate that ASI interacts hierarchically with
homoeobox genes that are principally expressed in the
shoot apical meristem. AS1 itself is expressed in later-
al organ primordia. We have found that as1 mutant
plants misexpress two homeobox genes, KNATI and
KNAT2, which are likely to be contributing factors to
defects in axis specification in as1 leaf development.
Another homeobox gene, STM, is not misexpressed in
as1 mutants. However, as] suppresses the vegetative
shoot meristemless phenotype of strong stm mutants.
This reveals a role of STM as a negative regulator of
AS]. In turn, AS] serves to regulate KNATI and
KNAT2 negatively. This genetic pathway may define
an ancient mechanism for differentiating between the
meristem and lateral organs.
daisy and dandelion Are
Alleles of argonaute and
Regulate Stem Cell
Maintenance in Arabidopsis
C. Kidner, R. Martienssen [in collaboration with S. Grewal,
Cold Spring Harbor Laboratory]
Last year, we reported that dandelion and daisy are
alleles of the argonaute gene, which encodes a mem-
ber of a large gene family required for proper forma-
tion of the dorsoventral axis in plant lateral organs
(Bohmert et al., EMBO J 17: 170 [1998]). We have
now shown that strong alleles have premature stop
codons, whereas weak alleles have changes in con-
served amino acids and splicing defects. Using this
allelic series and the expression patterns revealed by
gene traps and enhancer traps, we have found genes in
the same developmental pathway as DANDELION.
Double mutants indicate that DND interacts with UFO
(an F-box protein required for floral organ identity),
LEAFY (a transcription factor involved in organ and
meristem identity), ERECTA (a receptor kinase
involved in many aspects of plant development), and
STM (a homeobox gene required for stem cell mainte-
nance). Enhancer traps have identified several genes
that are over- or misexpressed in a dnd background,
including a gene with similarity to cycloidea, a tran-
scription factor that controls dorsoventrality in flow-
ers. There is also a representative of the argonaute
gene family in the fission yeast Schizosaccharomyces
pombe. We have made knockouts and GFP fusions of
the fission yeast homolog Pombago. In C. elegans and
Drosophila, related genes are required for stem cell
maintenance and for the inhibition of gene expression
by double-stranded RNA (RNAi), whereas similar
proteins are associated with translational initiation
factors in mammalian cells. We are investigating its
role in stem cell function in plants and yeast.
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MAMMALIAN CELL GENETICS
M. Wig ler J. Alexander
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A. Bug lino
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E. Hatchwell
R. Lucito
V. Mittel
A. Reiner
M. Riggs
L. Rodgers
L. Serina
The pathophysiology of a cancer is mainly determined
by its tissue of origin and the mutations it has accumu-
lated. We do not have specific knowledge of the majori-
ty of genes that cause cancers. There are gaps in our
knowledge of which pathways become deranged, and in
the specific components of the known pathways that go
awry. Without this knowledge, it is likely that our attempts
to control cancer will be incomplete. Therefore, work in
our group is centered upon cancer genomics. We have
developed several methods for detecting genetic alter-
ations in cancers, identifying the genes that are the targets
of these alterations, and exploring the functional analy-
sis of these genes by a variety of means. PTEN, a tumor
suppressor gene isolated by our methods, has been the
subject of our most intensive study. The major change in
our program since last year is the inclusion of microar-
ray analysis for both measuring gene copy number and
profiling gene expression and the development and
application of retrovirus-mediated gene induction sys-
tems for studying gene function. We are also applying
our genomic methods to the analysis of spontaneous
human genetic disease.
Discovery of Loci and Genes
Altered in Cancer
C. Yen, R. Lucito, D. Esposito
The main engine for gene discovery in our lab has
been representational difference analysis (RDA), a
subtractive hybridization technique that allows us to
search for amplified loci and homozygously deleted
regions in cancers (Lisitsyn et al., Science 259: 946
[1993]; Lisitsyn et al., Proc. Natl. Acad. Sci. 92: 151
[1995]). We have applied RDA to the study of breast
cancer, analyzing a total of 18 pairs of tumor/normal
pairs. This has resulted in the discovery of numerous
amplified loci, many of them previously characterized,
such as the loci for ErbB2, c-myc, and cyclin D, but
the majority are uncharacterized. Of these, the 8q11
region has been analyzed by Scott Powers and col-
leagues at Tularik for further analysis. Probes from this
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region detect gene amplification in 6 out of 70 prima-
ry breast tumors, and they have narrowed the candi-
date region to two overlapping BACs (bacterial artifi-
cial chromosomes). We have also discovered with
RDA nine regions of confirmed homozygous deletion.
One of these was the region on 10q23 containing the
PTEN tumor suppressor; one was the region contain-
ing the tumor suppressor p16(INK4) on chromosome
9p (Serrano et al., Nature 366: 704 [1993]; Kamb et
al., Science 264: 436 [1994]); one was the region on
chromosome 3p14 that contains the FHIT candidate
tumor suppressor gene (Ohta et al., Cell 84: 587
[1996]); and one mapped near the p53 tumor suppres-
sor. Five homozygously deleted regions remain that
are not yet fully characterized. Two of these reside on
chromosome 8q22, within 10 Mb of each other, one on
chromosome 4p16, one on 21p11, and one on chro-
mosome 20p11. All but one of these loci have been
observed deleted in a number of clinical specimens
and/or cell lines and have been confined to regions
from a few megabases to a few hundred kilobases.
In collaboration with Dr. Hamaguchi, two main
candidate transcripts have been identified from one of
the 8q22 loci. We are now in the process of obtaining
full-length cDNAs and performing mutational analysis
on these transcripts by a combination of techniques,
including linked transcription-translation premature
truncation and DNA sequencing. For a more compre-
hensive report on this locus, see Dr. Hamaguchi's
research report in this section.
Development of Inducible Gene
Expression Systems
J. Stolarov
In our early studies of the PTEN tumor suppressor, we
used constitutively expressing retroviral vectors and
immediately encountered the problem of great vari-
ability in the phenotypes of the clones that emerged.
Clonal variability, and lingering questions about the
cellular adaption to the chronic expression of PTEN,
prevented us from reaching clear conclusions. Thus,
we sought to develop inducible expression systems in
which, ideally, paired cultures could be compared for
their acute responses to controlled levels of expression
of the tumor suppressor.
In the ideal system, the inducer would be physio-
logically inert but would rapidly induce nearly 100%
of modified cells to express close to endogenous lev-
els of the target gene. Modified cells would not
express this gene in the absence of inducer. Such a sys-
tem would enable the observation of acute effects of
expressing tumor suppressors in cells, both when
growing in cell culture and when growing as a tumor
in an animal. We chose a retroviral delivery system as
it had the additional attraction that the expression sys-
tem could be easily introduced into a variety of cell
backgrounds. We chose the ecdysone system of Evans
and coworkers (No et al., Proc. Natl. Acad. Sci. 93:
3346 [1996]) over the tetracycline system (Saez et al.,
Cure. Opin. Biotechnol. 8: 608 [1997]) because it has no
background in the uninduced state and very swift kinet-
ics of induction. hi brief, we produce both amphotropic
and ecotropic viruses using high-titer packaging lines
that were derived by Beach and Hannon (Hannon et al.,
Science 283: 1129 [1999]) at Cold Spring Harbor
Laboratory. Typically, we infect cells with the receptor
viruses together, and the cells undergo double selection
with puromycin and G418. Single-cell clones are select-
ed, expanded, and tested for their ability to serve as a
good "host," i.e., respond to inducer following infection
and hygromycin selection with a third virus containing
an inducible fl-galactosidase gene.
Our first experiments were performed with
U87MG, a human glioblastoma cell line known to
have no functional PTEN gene. After double infection
with receptor viruses, and double selection, five can-
didate host clones were selected. These were then
infected with a target gene (lacZ) under the control of
ecdysone. For all five hosts, virtually all cells in the
colonies were inducible, and none showed detectable
background expression in the absence of inducer. We
are examining the characteristics of this inducible sys-
tem in other cell hosts and for responsiveness in ani-
mal hosts.
Analysis of PTEN Function
J. Stolarov, K. Chang, D. Dong
In previous years, we collaborated with Nick Tonks
and Mike Myers here at the Laboratory on the study of
PTEN. This work led to the observation that PTEN,
predicted and shown to be a protein phosphatase, was
also a PIP3,4,5 phosphatase (Myers et al., Proc. Natl.
Acad. Sci. 94: 9052 [1997]). Since PIP3,4,5 is an
important second messenger that mediates such fun-
damental cellular processes as response to growth fac-
tors and inhibition of cell death, this lipid phosphatase
activity appeared to be a logical explanation of
PTEN's function as a tumor suppressor. This was sup-
ported by studies for mutant PTEN (Myers et al., Proc.
Natl. Acad. Sci. 94: 9052 [1997]; Myers et al., Proc.
Natl. Acad. Sci. 23: 13513 [1998]).
We have utilized the retroviral system described
above for further studies on PTEN. Expression of
PTEN was clearly controllable in U87 hosts with
muristirone, an ecdysone analog, with induction levels
up to 50-fold above background. Cellular morphology
changed radically, but not in vitro growth characteris-
tics. Expression of several tumor markers were also
affected, including thrombospondin, an inhibitor of
angiogenesis, and TIMP3, an inhibitor of metalo-pro-
teinases. Mutants of PTEN that lost either lipid phos-
phatase or all phosphatase activity were inert.
Significantly, we observed virtually identical changes
in cellular morphology with a small molecular
inhibitor of the p110 PI3-kinase, the enzyme that gen-
erates PIP3,4,5, in keeping with the hypothesis that
PTEN exerts its effects on cells through its lipid phos-
phatase activity. Additional details of the cellular
responses of cells to PTEN are further discussed in the
subsequent section on transcriptional profiling.
We have continued to study the properties of the
PTEN homolog in the yeast Saccharomyces cerevisi-
ae. In particular, we have shown that the yeast enzyme
retains the biochemical activity of its mammalian
homolog, and deletion of PTEN results in an impair-
ment in sporulation.
Microarray Analysis of
Expression
V. Mittal, J. Stolarov, R. Lucito, J. West, A. Reiner
We have begun implementing in our lab the technique
of transcriptional profiling utilizing printed cDNA
microarrays. In this technique, developed at Stanford
in the laboratory of Pat Brown, arrays of cDNA probes
are affixed to a glass surface, and the surface is
hybridized to pairs of cDNA samples, prepared from
the mRNA of two sources, each labeled with a differ-
ent fluorescent dye (Schena et al., Science 270: 467
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[1995]). The ratio of fluorescence detected at each
probe gives a measure of the relative abundance of the
mRNA corresponding to that probe. More than 25,000
expressed sequences, about one quarter of the estimat-
ed transcription units in the human genome, the
IMAGE Consortium clones, are available for printing.
The reasons for implementing this technology in
our lab are many. First, this is a potentially powerful tool
for the functional characterization of new genes, espe-
cially for tumor suppressors and oncogenes, enabling
their association with genes known to control certain
pathways. Second, it is a powerful tool for the analysis
of specific mutations, particularly for genes, such as
RAS and PTEN, that encode proteins with multiple
activities or multiple domains. Third, we can use this
system in combination with our superb inducible
expression system, and we are thus experimentally well
positioned to carry out comparisons of well paired sam-
ples, allowing us to examine both up- and down-regu-
lated genes, with time course and dosage controlled.
We printed moderate density (>6000 probes) cDNA
microarrays within our own facility. We used as our
paired samples U87MG cells induced or not induced to
express PTEN and mutant PTEN genes, and treated or
not with inhibitors of p110 PI3-kinase. The results of
these experiments suggest that there are a very limited
number of large changes in the transcriptional pattern
when PTEN was induced. Of 6218 probes, 0.4% of
transcripts appeared to be suppressed by greater than
threefold upon PTEN induction, and 0.25% of tran-
scripts appeared to be induced by greater than threefold
upon PTEN induction. An overlapping pattern of
change in transcription was observed when U87MG
cells were treated with an inhibitor of PI3-kinase.
These results, although preliminary and requiring
additional controls, strengthen our confidence that our
model for the action of PTEN is at least partly correct
and that our retroviral ecdysone-inducible system cou-
pled with microarray analysis of transcription patterns
is a powerful approach to the functional analysis of
mammalian genes.
Detection of Gene Copy Number
Fluctuations by Microarray
Analysis of Genomic Representations
R. Lucito, J. West, A. Reiner
The search for tumor suppressors and oncogenes by
RDA has been slow. The bottleneck has been the time
and labor spent on "epicenter mapping." Once a locus
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has been identified, we need to demonstrate that the
locus is affected in multiple cancers. Then, because
these loci are large, we then need to find the minimum
region affected so as to facilitate identification of can-
didate genes. This process, which we refer to as epicen-
ter mapping, has required over 6000 individual quanti-
tative polymerase chain reaction (Q-PCR) tests for the
various loci we have identified. We therefore decided to
develop a microarray-based method for gene copy mea-
surements. Our expectation is that once fully estab-
lished, this method will accelerate the rate of gene dis-
covery by a factor of perhaps 1000-fold, as well as pro-
vide a detailed way of categorizing clinical cancers.
Microarrays, while widely utilized for expression
profiling, cannot be effectively used for measuring
gene copy numbers in a straightforward manner. Using
the entire human genome for hybridization is ineffi-
cient due to its nucleotide complexity. To solve this
problem, the microarray system we have developed is
based on representations. A representation is a repro-
ducible amplification of the genome with reduced
complexity. In brief, a representation is produced by
first cleaving the genome with a restriction enzyme,
and then adaptors are ligated and used for a subsequent
PCR amplification. The complexity of a representation
based on BglII cleavage is approximately 3% of the
which is comparable to that of the complexity
of transcripts within a cell. Single fragments from the
representation are then cloned and arrayed on a slide.
Representations from tumor and normal, prepared in
the same manner as that of the array, are then
hybridized to the array, and the results are analyzed to
define regions that have undergone copy number
changes such as deletion and amplification.
To determine the fidelity of our microarray format,
we carried out several experiments. We made multiple
BglII representations of the cell line SKBR-3 on dif-
ferent days. A representation derived from the cell line
was labeled separately with Cy3 and Cy5, two fluores-
cent dyes in common use, and compared. We found
that there was very little deviation from a ratio of one.
These experiments validate the extreme reproducibili-
ty of representations and suggest that making well-
controlled parallel representations introduces no more
noise than is inherent in the measurements made by
the system as we practice it.
We also examined the reproducibility of our
microarray measurements between multiple experi-
ments. Multiple representations of two different human
breast cancer cell lines, SKBR-3 and MDA-MB-415,
were compared by hybridization. The ratios obtained
from one experiment were compared to those obtained
from another parallel experiment. There was excellent
concordance between independent microarray mea-
surements, and excellent agreement with measure-
ments of gene copy number by Southern blot
hybridization. These experiments again attest to the
reproducibility of representations and also to the repro-
ducibility of printing, labeling, and hybridization.
Due to the use of representations, we are able to
use minute amounts of starting material. Thus, we are
able to measure genomic changes in the sorted tumor
and normal nuclei of a cancer biopsy. The results of
the microarray hybridization completely corroborate
the results obtained by other methods. This will allow
us to use primary tumors that have been microdissect-
ed by some means into tumor and normal fractions.
The project is currently in a stage of scaling up. We
are subcloning 30,000 BglII representational frag-
ments and are presently characterizing them. This will
produce a microarray with coverage of 1 probe every
100 kb, on average. This microarray will be used to
scan the genomes of breast cancers to uncover regions
that have undergone copy number changes. Our hope
is that our scan will be done at such precise coverage,
and against such a large number of tumors, that we
will uncover new candidate loci for the location of
tumor suppressors and oncogenes. Furthermore, by
analyzing many tumors, we should also be able to limit
the size of the region needed to look for candidates.
This method also has other potential uses, including
measuring mutational load in cancers, monitoring
DNA methylation patterns, genome-wide genetic typ-
ing, and detection of de novo mutations in humans.
Analysis of De Novo Mutation
in the Human Germ Line
E. Hatchwell, L. Serina
Approximately 1-2% of all children are born with
some degree of learning difficulty. The vast majority
are likely due to genetic factors. In many cases, the
intellectual problems are part of a more global syn-
drome, including various physical abnormalities.
Conventional approaches to diagnosis include bio-
chemical and cytogenetic analysis, and, in specific cir-
cumstances, direct testing of suspect genes. When
exhaustive testing has been performed, however, at
least 50% of cases remain undiagnosed, either because
the syndrome presentation is not specific enough or
because the genetic abnormality is simply not
detectable using conventional methods.
In recent years, a number of syndromes have been
shown to result from submicroscopic genomic alter-
ations (i.e., deletions, duplications, or inversions). In
the vast majority, the knowledge gained depended
heavily on serendipity. It is likely that many of the syn-
dromes that are currently undiagnosed result from a
similar general mechanism.
No general method yet exists for the detection of
submicroscopic genomic alterations. This project aims
to develop such methods, using the techniques of sub-
tractive hybridization and microarray analysis. The
main goal is to modify existing techniques (including
RDA), in order to be able to scan the genome of affect-
ed children for de novo genomic alterations. We have
carefully selected children with sporadic disease (the
majority of those who remain undiagnosed) and
assumed that their mutation is de novo. By direct com-
parison, using RDA and representation-based microar-
rays, we can compare the genome of the child with
genomes of the child's parents. A de novo genomic
alteration will be detected if it creates a novel junction
fragment.
We have successfully conducted experiments on arti-
ficial controls and are currently using families with
known de novo translocations to test out our method. If
successful, we aim to test "unknowns" in the near future.
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CELL BIOLOGY
This section comprises labs studying a diverse set of interests including signal transduction events that
regulate gene expression and ultimately growth and proliferation in normal and cancer cells.
Shiv Grewal's laboratory studies the epigenetic control of gene expression. During the past year,
they have shown that a member of the evolutionarily conserved chromodomain family of proteins
has a crucial role in establishment and inheritance of an epigenetic imprint during mitosis and,
remarkably, even through meiosis. That is, the persistence of macromolecular complexes associat-
ed with DNA contributes to cellular "memory" and maintenance of the gene expression state dur-
ing cell division. Their work suggests that the unit of inheritance, the gene, occasionally comprises
the DNA plus the associated chromatin protein complexes.
David Helfman's group is studying how specific actin assemblies are organized and regulated and how
alterations in actin filament assembly contribute to abnormal cell growth control in cancer. They have
found that the actin cytoskeleton plays an essential part in signal transduction events and that alter-
ations in the components of the cytoskeleton can play an important part in cellular transformation.
Nouria Hernandez and her colleagues work on fundamental mechanisms of transcription using two
model systems, the human snRNA genes and the HIV-1 LTR. Promoters are divided into a core
region, which contains all the information required to assemble a transcription initiation complex and
recruit the correct RNA polymerase, and a regulatory region, which recruits activators or repressors
of transcription that modulate the activity of the core promoter. Their goal is to understand how core
promoters ultimately recruit the correct RNA polymerase and how transcriptional activators perform
their function.
David Spector's laboratory continues to study the protein composition of interchromatin granule
clusters (IGCs), nuclear structures that are thought to be staging grounds for the assembly of com-
plexes of RNA processing factors and transcription factors prior to their recruitment to sites of tran-
scription. Using mass spectrometry, 114 known proteins have been identified thus far, including
splicing and other RNA processing factors. In addition, 12 new IGC protein candidates were iden-
tified and peptides were obtained that correspond to 69 different EST clones. Ongoing studies are
aimed at revealing new aspects of the function of this nuclear structure.
Tatsuya Hirano's laboratory studies higher-order chromosome dynamics with a major focus on the
roles of SMC (structural maintenance of chromosome) proteins in chromosome condensation and
segregation. They have characterized how eukaryotic SMC protein complexes interact with DNA
and nucleosomes, and how their functions are regulated during the cell cycle. A systematic muta-
genesis approach using a bacterial SMC protein is beginning to shed light on the basic mechanisms
of action of this important class of chromosomal ATPases.
Nick Tonks' laboratory is taking a variety of approaches to study the structure, regulation, and func-
tion of the protein tyrosine phosphatase (PTP) family of signal transducing enzymes. They have
developed "substrate-trapping" mutant forms of these enzymes, which form stable complexes with
target substrates in a cellular context, to identify the physiological substrates of members of the PTP
family. This approach has illustrated that the PTPs display exquisite selectivity in a cellular context
and function as specific regulators of cellular signaling events. Ongoing structural analyses are
revealing how such selectivity is achieved.
Linda Van Aelst's laboratory continues to study the function of the Ras and Rho family of small
GTPases in cell growth and development, together with the mechanisms by which they exert their
effects. Using cDNA-RDA strategies in combination with micro-arrays, they have identified targets
of Rac, a Rho family GTPase, that are important for its effects on cell growth. They are also study-
ing the role of Rho family members in neuronal development and metastasis. Their studies of Ras
have focused on the junctional protein, AF-6, which they identified as a novel Ras-binding protein
and which may be an effector of the Ras-related protein Rap1. They are using Drosophila to study
the homolog of AF-6, known as Canoe, which is essential for dorsal closure, a process resembling
wound healing in mammalian cells.
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EPIGENETIC CONTROL OF GENE EXPRESSION
S. G rewa I J. Nakayama
R. Krimper
Our research continues to focus on the fundamental
question of how differentiated cells establish and main-
tain stable patterns of gene expression. Specifically, we
are studying the molecular mechanism of epigenetic
inheritance, whereby nonmutational alterations in chro-
mosomes promote stable transmission of the gene-
expression patterns during mitosis and, sometimes, even
through meiosis. Such changes are known to have pro-
found effects on mammalian development, as they reg-
ulate expression of developmentally important genes.
Moreover, epigenetic changes affect other aspects of
chromosome architecture such as recombination and
chromosome segregation, which in turn have implica-
tions for the maintenance of the genome integrity. In
addition, the abnormal gene expression caused by epi-
genetic changes is believed to play a causal part in can-
cer progression. To understand how epigenetic states are
established and maintained through many rounds of cell
division, we are studying the gene-repression mecha-
nism known as "silencing" at the mating-type region of
fission yeast Schizosaccharomyces pombe. Our earlier
studies have revealed that the inheritance of the epige-
netically maintained silenced state depends on the prop-
er expression of genes that encode either chromatin pro-
teins or factors that modify them. However, the under-
lying mechanism by which cells establish and maintain
an epigenetic imprint affecting the inheritance of the
silenced state has remained elusive. During the past
year, considerable progress has been made toward
understanding the nature of epigenetic imprint. We
found that a member of the evolutionarily conserved
chromodomain protein family plays a crucial part in
imprinting at the mat locus. In addition, we have con-
tinued to investigate the role of putative histone
deacetylase C1r6 in chromatin assembly and are follow-
ing up on our recent finding that a mutation in the gene
encoding DNA polymerase a (pola) affects heritability
of the silenced state.
MECHANISM OF EPIGENETIC INHERITANCE
Our previous studies have revealed that an epigenetic
imprint marking the mating-type region contributes to
maintenance of a heterochromatin-like structure, which
controls both efficiency of mating-type switching and
silencing throughout the approximately 15-kb matt /3
interval. Moreover, expression of the ura4+ marker gene
inserted within the silent domain is variegated. The Ura
efficiently switching (ura4-off) and the inefficiently
switching (ura4-on) states are mitotically metastable
and controlled by an epigenetic mechanism. Mutations
in factors such as histone deacetylase homologs C1r3
and C1r6 and the chromodomain-containing proteins
C1r4 and Swi6 affect propagation of the silenced state.
According to a model, a protein-based imprint marking
the mat locus might contribute to inheritance of the
silenced state during cell division. In the past year, we
have demonstrated that, indeed, chromatin proteins are
important determinants of the imprint, i.e., persistence
of macromolecular protein complexes associated with
the mating-type region presumably contributes to the
propagation of the silenced state. Our analyses suggest
that a chromodomain-containing Swi6 protein is a
dosage-critical component required for establishing and
maintaining the imprint. Interestingly, Swi6 protein is
present throughout the approximately 15-kb silent
domain, and its levels at a particular location correlates
with the stringency of silencing (Fig. 1). More impor-
tantly, the transient presence of three copies of swi6+
altered the chromatin imprint at the mat locus, resulting
in heritable change from the ura4-on state to ura4-off
state. We found that ura4-on cells contain significantly
lower levels of Swi6 at their mat locus than ura4-off
cells. This differential Swi6 localization pattern is main-
tained not only during mitosis, but also remarkably
through meiosis. Furthermore, transition from the ura4-
on to the ura4-off state is tightly coupled to the increase
in Swi6 levels at the mat locus. Once recruited, howev-
er, Swi6 remains associated with the mating-type region
throughout the cell cycle, providing a molecular book-
mark to propagate clonally a specific chromatin config-
uration, hence maintaining the silenced state during cell
division.
In the previous year, we reported that transient
inhibition of histone deacetylase activity by tricho-
statin A (TSA) removes the epigenetic imprint from
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FIGURE 1 Swi6 is present throughout the silent mating-type region. (Top) The map of the mating-type
interval and restriction enzyme positions where prototrophic markers were inserted. For cultures carrying
the ade6* insertion at L(Pvul), L(Sacl), and L(Bglll), cells were grown on adenine-limiting media before
photography. The representative colonies of each strain are shown (middle, left three panels). The gray
or white color of colonies implies Ade- or Ade* phenotypes, respectively. The expression of the ura4,
marker inserted at Kinti, Kint2, and mat3 locations was examined by plating cells onto nonselective
(N/S), AA-URA (URA-), and FOA medium. The URA- medium selects for growth of Ura* cells, whereas
the FOA medium selects for growth of Ura- cells (middle, right three panels). Chromatin immunoprecipi-
tation (CHIP) assay with anti-Swi6 antibodies was employed to determine the presence of Swi6 at each
marker gene location. The DNA recovered from immunoprecipitated (IP) fractions was analyzed quanti-
tatively using a competitive polymerase chain reaction (PCR) strategy. In this approach, strains bearing
ade6* or ura4+ at the mating-type region and a small deletion of their corresponding loci (ade6DN/N and
ura4DS/E, respectively) at the endogenous location were used. By using primers to give different size
products from full-length and mutated alleles, the relative enrichment of the marker gene sequences in
the immunoprecipitated fractions can be accurately determined.
DNA, resulting in heritable change from the ura4-off
state to ura4-on state. We now have shown that TSA
treatment alters the imprint by affecting localization of
Swi6 at the mating-type region. Remarkably, a brief
treatment by TSA for about ten generations induces
heritable decrease in Swi6 levels at the mat locus,
resulting in "erasure" of the imprint. On the basis of
these studies, we suggest that the unit of inheritance,
i.e., the "gene" at the mat locus, comprises DNA plus
the associated Swi6 protein complex.
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Chromodomain-containing proteins, such as poly-
comb group proteins in Drosophila, participate in her-
itable inactivation of gene expression in evolutionarily
unrelated systems. Therefore, it is possible that pro-
tein-based mechanisms of epigenetic inheritance are
responsible for phenotypic variations or increased risk
to diseases within populations. Our recent results
demonstrating the meiotic stability of the Swi6 associ-
ation with the mat locus further supports this possibil-
ity. It can be imagined that certain carcinogens and
environmental factors affect gene expression by alter-
ing epigenetic imprints rather than causing genetic
changes. Since chromatin proteins such as Swi6 also
affect inter- and intrachromosomal recombination as
well as chromosome segregation, it is also possible
that genomic instability observed in certain cancer
cells results from the loss of epigenetic imprints.
Current efforts are directed to study this mode of
inheritance further and to characterize other proteins
that are essential for imprinting.
ROLE OF DNA POLYMERASE a IN SILENCING
A recent observation suggests that the connection
between DNA replication and chromatin machinery
may be more direct than previously assumed; i.e.,
DNA replication machinery may itself be involved in
propagation of the silenced state. In collaboration with
Amar Klar's laboratory (National Cancer Institute), we
have shown that a mutation in polo results in 45-fold
increase in the ura4-off to ura4-on transition and also
causes derepression of the donor mating-type loci.
Even more importantly, the mutant cells are defective
in assembly of repressed chromatin structure at the
silent mating-type interval. Genetic analysis revealed
that Pola acts in the same silencing pathway as previ-
ously identified silencing factors such as Swi6.
Further analysis revealed that mutation in polo affects
silencing by altering the recruitment and maintenance
of Swi6 at the mating-type region; i.e., significantly
lower levels of Swi6 were found at the mat locus of
polo mutant cells, when compared with wild-type
cells. Additionally, we found that mutation in polo
also affects Swi6 localization and transcriptional
silencing at the centromeres. The biochemical basis of
the Pola role in Swi6 localization at the mating-type
and centromeric loci remains to be explored and is the
focus of our current research.
PURIFICATION AND CHARACTERIZATION OF C1r6
In the previous year, we reported the identification of
an essential gene called clr6, which affects silencing at
heterochromatic loci. Interestingly, a mutation in C1r6,
which shares similarity to histone deacetylases, also
causes missegregation of chromosomes and UV light
sensitivity, suggesting general chromatin assembly
defects. Furthermore, Clr6 acts in a partially overlap-
ping manner with another putative histone deacetylase
Clr3, which affects silencing at the mating-type region
and centromeres. We are now characterizing Clr6 to
understand its precise function. In collaboration with
Karl Ekwall's laboratory (Karolinska Institute), we
showed that Clr6 is localized to the nucleus on chro-
matin. We also found that Clr6 levels remain constant
throughout the cell cycle, and a majority of the protein
remains associated with the chromatin. Purification of
Clr6 revealed that it is part of a mutiprotein complex.
Future studies are aimed at determining the identity of
other subunits of the protein complex. In addition, we
are investigating the effect of clr6 mutation on steady-
state levels of histone acetylation and exploring the
possibility of whether lethality observed in mutant cells
is due to defects in de novo nucleosome assembly.
In Press
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THE CYTOSKELETON IN NORMAL AND
TRANSFORMED CELLS
D.M. Helfman E. Araya S. Lee
C. Berthier G. Pawlak
L. Connell A.J. Rai
E. Kim
The actin cytoskeleton is involved in a wide range of
motile activities such as cell movement, cell division,
intracellular transport, phagocytosis, exocytosis, mem-
brane ruffling, formation of microspikes and filopodia,
growth cone formation, cell spreading, adhesion,
changes and maintenance of cell shape, and signal
transduction. In nonmuscle cells, such as fibroblasts,
the formation of actin microfilaments and their assem-
bly into a variety of structures are dynamic processes.
We are studying how specific actin assemblies are
organized and regulated and how alterations in actin
filament assembly contribute to aberrant cell growth.
We are also interested in understanding how the actin
cytoskeleton contributes to signaling cascades that lead
to focal adhesion formation and regulation of adhe-
sion-dependent signal transduction. Below is a descrip-
tion of our studies during the past year.
The Cytoskeleton in
Adhesion-dependent Signaling
G. Pawlak, C. Berthier, S. Lee,
L. Connell, E. Kim
Changes in the organization of actin filaments are
highly correlated with both anchorage-independent
growth and cellular tumorigenicity, suggesting a fun-
damental role for actin filaments in cell growth con-
trol. How the actin cytoskeleton participates in normal
growth control and how changes in microfilament-
associated proteins contribute to transformation are
not understood. The activation of myosin II in non-
muscle cells has been hypothesized to be intimately
associated with adhesion and adhesion-dependent sig-
naling, leading to the formation of focal contacts, tyro-
sine phosphorylation, and signals required for cell
growth and survival. To investigate the role of myosin
II in adhesion-dependent signaling, we have studied
the effects of nonmuscle caldesmon on myosin II,
actin cytoskeleton organization, and focal adhesion
formation in fibroblasts. Caldesmon is an actin-,
myosin-, tropomyosin-, and Ca "-calmodulin-binding
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protein known to inhibit the actin-activated ATPase
activity of phosphorylated myosin II, and it can block
myosin-II-driven motility (see Fig. 1). Transient trans-
fection of nonmuscle caldesmon prevents myosin-II-
dependent cell contractility, induces disruption of
stress fibers, and decreases the number and size of
tyrosine phosphorylated focal adhesions. In addition,
expression of caldesmon interferes with Rho-induced
formation of stress fibers and focal adhesions, as well
as with focal adhesion induction by microtubule dis-
ruption. These results demonstrate a role for nonmus-
cle in the physiological regulation of acto-
myosin contractility and adhesion-dependent signaling
and further demonstrate the involvement of myosin in
focal adhesion formation and signal transduction.
Disruption of adhesion-dependent signaling is a char-
acteristic feature of neoplastic transformation; such
cells often display anchorage-independence, growing
and dividing in suspension without extracellular
matrix contact. On the basis of our results demonstrat-
ing an ability of caldesmon to regulate adhesion-
dependent signaling, we suggest that its interaction
with specific isoforms of tropomyosin could be impor-
tant in maintaining the normal signaling function in
the cell. Studies are in progress to determine how con-
tractility leads to enhanced focal adhesion formation
and what part tropomyosin and caldesmon plays in the
signaling cascades associated with adhesion-mediated
signal transduction events.
Tropomyosins (TMs) are a family of actin-fila-
ment-binding proteins that are essential for the integri-
ty of actin filaments. Normal fibroblasts express three
high-molecular-weight (HMW, 284 amino acids) TM
isoforms, termed TM-1, TM-2, and TM-3, and three
low-molecular-weight (LMW, 248 amino acids) TM
isoforms, termed TM-4, TM-5(NM1), and TM-5a. In
normal cells, TM-1 and TM-2 are the major HMW
TMs and TM-4 is the major LMW TM. Since the first
observations from Hal Weintraub's lab in the early
1980s, alterations in TM synthesis have been reported
in a variety of transformed cells. Changes in TM
expression have also been found in human breast can-
cer and prostate cancer. Although nonmuscle cells
express multiple isoforms of TM, the expression of
only HMW TM isoforms is decreased during onco-
genic transformation. HMW TMs protect actin fila-
ments from severing proteins better than LMW TMs,
consistent with their absence leading to a loss of stable
actin filaments following transformation. We and oth-
ers have found reversal of the transformed phenotype
following forced expression of specific HMW TMs in
cells, including restored formation of microfilament
bundles and contact-inhibited cell growth, inability to
grow on soft agar, and suppression of tumorigenicity
in nude mice. These results show that changes in TM
have a causal role in transformation. We hypothesize
that specific isoforms of TM have a critical role in the
regulation of cell growth by regulating myosin II. This
is based on recent observations from our laboratory
and others that activation of myosin II is essential for
formation of focal adhesions and subsequent adhe-
sion-dependent signaling, by promoting integrin clus-
tering and the associated tyrosine phosphorylation and
signaling events (see Fig. 1).
As diagrammed in the Figure 1, regulation of
myosin is a key event in adhesion-dependent signaling.
TM in association with caldesmon, bound along actin
filaments, functions in regulating actomyosin-based
contractility. Studies in smooth cell systems show that
caldesmon acts cooperatively with TM to regulate
(inhibit) actin-activated ATPase and movement of
myosin. On the basis of our results in nonmuscle cells,
we suggest that the interaction of caldesmon with spe-
cific TMs is important in maintaining the normal signal-
ing in nonmuscle cells. A loss of specific isoforms of
TM might lead to activation of adhesion-dependent sig-
naling pathways as a result of increased actomyosin con-
tractility. Furthermore, caldesmon is a target for various
protein kinases, including MAP kinase, Cdc2 kinase,
and protein kinase C. We propose that TM and
caldesmon function as part of the cellular machinery that
regulates various signal transduction pathways that act
via activation of actomyosin contractility. Studies are in
progress to determine how these actin-filament-associat-
ed proteins function in adhesion-dependent signaling.
Molecular Organization and
Regulation of Actin Filaments
C. Berthier, E. Araya
In nonmuscle cells, the formation of actin filaments
and their assembly into various structures, e.g., stress
Contractility and adhesion-dependent signaling
FIGURE 1 Proposed model for the involvement of actin fila-
ments, myosin II, tropomyosin, and caldesmon in the regulation
of cell contractility and adhesion-dependent signaling.
Actomyosin contractility in nonmuscle cells involves a number
of structural components including actin, myosin II,
tropomyosin, and caldesmon. Tension on integrins at focal
adhesions developed by the actin system affects adhesion-
dependent signaling. This signaling in turn promotes further
assembly of the focal adhesions and also induces downstream
events culminating in cell proliferation. Tension is positively reg-
ulated by myosin light-chain kinase and Rho via Rho-kinase and
negatively regulated by caldesmon. Caldesmon is regulated by
calcium-calmodulin and by a number of kinases. Inhibition of
the actin-activated myosin ATPase activity by caldesmon is
dependent on tropomyosin. For simplicity, isolated copies of
tropomyosin and caldesmon are shown, although in fact they
are localized along the actin filaments. (Pointed arrows)
Stimulation; (blunt arrows) inhibition. (ECM) Extracellular matrix;
(MLCK) myosin light-chain kinase; (MLCP) myosin light-chain
phosphatase.
fibers, contractile ring, filopodia, and lamellipodia,
are dynamic processes. How these different structures
are formed and regulated within a single cell is not
known. It is becoming apparent that in addition to
actin and its associated motor molecules (myosin I and
II), other actin filament-associated proteins, such as
TM, have essential roles in the assembly, function, and
regulation of these structures. To determine if distinct
TMs are associated with distinct actin structures, we
have developed and are using various reagents, includ-
ing green fluorescent protein (GFP)-TM fusions, as
well as hemagglutinin (HA)- and vesicular stomatitis
virus (VSV)-epitope tagged TMs, to localize the dif-
ferent TM isoforms. These studies demonstrate that
specific TM isoforms are involved in different subsets
of actin filaments. Experiments are in progress to
characterize the dynamic localization of the different
TM isoforms during various cellular motility events
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involving reorganization of the actin cytoskeleton,
such as protrusion of filopodia, lamellipodia ruffling,
forward movement, spreading and assembly of stress
fibers, cytokinesis, and following stimulation via the
small GTPases (Cdc42, Rac, and Rho).
Identification and Characterization
of a Novel Phosphoprotein
Involved in Intracellular
Vesicle Transport
A. Rai
We have identified a novel protein from human non-
muscle cells. The protein is well conserved across evo-
lution, as database searches have identified expressed
sequence tags (ESTs) from a wide range of metazoan
organisms that show homology with the human coun-
terpart. These include rodents, zebrafish, flies, worms,
and plants. Analysis of its domain structure indicates a
hydrophobic region at its amino-terminal end, as well as
a coiled-coil region toward the carboxyl terminus.
Antibodies raised against this protein detect the exis-
tence of two isoelectric variants, and phosphatase sensi-
tivity studies have demonstrated that one of these is a
phosphorylated form.
Immunofluorescence studies show that there are two
different populations of this protein. One of these is
associated with free cytoplasmic vesicles, whereas
another lies in a strong juxtanuclear region, similar to the
Golgi compartment. Functional analysis of the protein
reveals specific regions required for the movement
through the Golgi, localization to vesicles, and fusion of
vesicles to tubular membranes. Experiments are cur-
rently in progress to delineate the site of phosphoryla-
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tion. Future experiments using mutational analysis
will allow us to correlate protein modification with a
functional role.
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INITIATION AND TERMINATION OF TRANSCRIPTION IN
HUMAN snRNA GENES AND HIV-1
N. Hernandez F. Emran P.S. Pendergrast
P. Hu L.M. Schramm
T.L. Kuhlman S. Sepehri
B. Ma M. Shanmugam
V Mittal
P. Stavropoulos
Y. Sun
B. Trumbull
X. Zhao
We study fundamental mechanisms of transcription.
Promoters can be divided into two regions, the core
promoter region and the regulatory region. The core
promoter region is sufficient to direct low levels of
transcription in vitro and thus contains all the infor-
mation required to assemble a transcription initiation
complex and recruit the correct RNA polymerase. The
regulatory region recruits activators or repressors of
transcription that modulate the activity of the core pro-
moter. We want to understand how core promoters
ultimately recruit the correct RNA polymerase, and
how transcriptional activators perform their function.
As model systems, we use the human small nuclear
RNA (snRNA) genes and the human immunodeficien-
cy virus type-1 (HIV-1) promoter.
The human snRNA promoters have a number of
features that make them especially suitable to address
the broad questions mentioned above. First, the
snRNA promoters recognized by RNA polymerase II
are very similar in structure to those recognized by
RNA polymerase III, and the RNA polymerase II and
III snRNA promoters recruit several common tran-
scription factors. Thus, any difference we observe in
RNA polymerase II and III transcription initiation
complexes is likely to be relevant to the determination
of polymerase specificity. Second, the structure of
snRNA promoters is relatively simple. The core RNA
polymerase II snRNA promoters consist of just one
element, the proximal sequence element or PSE. The
core RNA polymerase III snRNA promoters consist of
a PSE and a TATA box, and the regulatory region of
snRNA promoters is interchangeable between RNA
polymerase II and III snRNA promoters and virtually
always contains an octamer sequence. Third, the tran-
scription factors binding to the various snRNA pro-
moter elements are well characterized. The TATA box
and the PSE are recognized by TBP (TATA box-bind-
ing protein) and the snRNA activating protein com-
plex (SNAP), respectively, whereas the octamer
sequence is recognized by Oct -l. The crystal struc-
tures of the TBP and Oct-1 DNA-binding domains,
both free and complexed with their respective DNA-
binding sites, have been determined. And recently we
have cloned all of the SNAP subunits and reconstitut-
ed a recombinant complex.
One long-standing interest has been to identify the
remaining factors required for both RNA polymerase II
and III snRNA gene transcription. Another is to use the
tools already in hand to characterize how the RNA poly-
merase II and III snRNA promoters assemble stable
transcription initiation complexes. We find that basal
transcription factors such as TBP and SNAP have built-
in mechanisms that down-regulate their binding to
DNA. These "dampers" of DNA binding are deactivat-
ed by protein-protein interactions with a partner in bind-
ing. Thus, cooperative binding between TBP and SNAP
deactivates a damper of DNA binding in TBP, and coop-
erative binding between SNAP and Oct-1 deactivates a
damper of DNA binding in SNAP, These intricate
mechanisms probably ensure that basal transcription
factors, which are characterized by very slow off-rates,
do not bind to random binding sites in the genome but
rather are targeted specifically to promoters.
The HIV-1 promoter is subject to regulation at the
level of transcription elongation. The promoter con-
tains an element called the inducer of short transcripts
(IST), which activates the synthesis of HIV-1 short
RNA molecules. We have purified a factor that binds
to the IST (FBI-1) and cloned a corresponding cDNA.
One of our interests is to characterize this factor func-
tionally.
Characterization of
Partial SNAPes
V. Mittal, B. Ma, N. Hernandez
Core promoters usually recruit multisubunit complex-
es, and this may be because multisubunit complexes
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confer the flexibility required to perform the very
complicated task of core promoter-binding factors,
namely, to nucleate the assembly of the correct tran-
scription initiation complex in a regulated manner.
This task requires a large number of protein-protein
interactions, imposed in part by a combinatorial mech-
anism of transcription regulation. It is of great interest,
therefore, to understand the functions of individual
subunits that form a core promoter-binding factor. The
PSE recruits the multisubunit complex SNAP,.
Because we can assemble SNAP, from recombinant
subunits, and because SNAP, is involved in the assem-
bly of both an RNA polymerase II and an RNA poly-
merase III initiation complex, it provides us with an
exceptionally interesting case in which to understand
the function of the individual subunits of a core pro-
moter-binding factor.
To study this question, we first determined the net-
work of protein-protein interactions among the five
SNAP, subunits, SNAP190, SNAP50, SNAP45,
SNAP43, and SNAP19. For this purpose, individual
SNAP, subunits, or deleted versions thereof; were
translated in vitro and tested for their ability to associ-
ate with other subunits of the complex in immunopre-
cipitation experiments. These studies indicated that
SNAP43 and SNAP19 associate directly with the
amino-terminal portion of SNAP190, whereas
SNAP45 associates with the carboxy-terminal portion
of SNAP190. SNAP50 joins the complex through
association with SNAP43.
Guided by this map of protein-protein interactions
within SNAP,, we then used the baculovirus expres-
sion system to assemble subcomplexes missing one or
several subunits and characterized the properties of the
resulting partial complexes. The smallest complex we
assembled that was still capable of binding to the PSE
consisted of the amino-terminal third of SNAP190,
SNAP43, and SNAP50 and was named "mini-SNAP,."
SNAP, is capable of binding cooperatively with TBP.
We tested whether mini-SNAP, could do the same and
showed that indeed, mini-SNAP, and TBP bind coop-
eratively to their respective binding sites on an RNA
polymerase III snRNA promoter. Like cooperative
binding of SNAP, and TBP, cooperative binding of
mini-SNAP, and TBP required the nonconserved
amino-terminal domain of TBP. This raised the possi-
bility that mini-SNAP, was still capable of directing
basal snRNA gene transcription. Indeed, mini-SNAP,
could mediate both RNA polymerase II and III snRNA
gene transcription.
SNAP, and the Oct-1 POU domain bind coopera-
tively to their respective targets on the DNA. In previ-
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ous work, we had shown that cooperative binding
required a direct protein-protein contact involving a
glutamic acid at position 7 in the Oct-1 POU domain
and a lysine at position 900 within the largest SNAP,
subunit, SNAP190. Mini-SNAP, is missing the car-
boxy-terminal two thirds of SNAP190, including the
region of SNAP190 required for protein-protein con-
tact with the Oct-1 POU domain. We therefore expect-
ed that the complex would not be able to bind cooper-
atively with the Oct-1 POU domain and would bind
poorly to DNA. To our surprise, however, mini-SNAP,
indeed could not bind cooperatively with the Oct-1
POU domain, but it bound very efficiently to the DNA
on its own, as efficiently, in fact, as the full complex
together with the Oct-1 POU domain. Thus, in a sense,
mini-SNAP, is already activated, and indeed in tran-
scription assays, it behaves like the full complex in the
presence of the Oct-1 POU domain.
These results indicate that SNAP, contains a built-
in inhibitor of DNA binding, which is located some-
where in the carboxy-terminal two thirds of SNAP190
or, perhaps, within the SNAP45 subunit. This region of
the complex is the same region that contains Lys-900
and is required for cooperative binding with the Oct-1
POU domain. Cooperative binding with the Oct-1
POU domain serves to deactivate the inhibitor of
SNAP, binding and to promote
of the two factors. This is very reminiscent of what we
observed previously with SNAP, and TBP. In this case,
cooperative binding of the two factors depends on the
nonconserved amino-terminal domain of TBP. A trun-
cated TBP missing the amino-terminal domain binds
much more efficiently to a TATA box than full-length
TBP, but cannot bind cooperatively with SNAP,. Thus,
in this case also, the domain that down-regulates bind-
ing of the protein is also the target for cooperative
interactions that counteract the inhibition of binding
and promote very efficient binding.
Why devise such complicated mechanisms of
binding, in which a negative regulator must be deacti-
vated before efficient binding can take place? The
answer may have to do with a general property of basal
transcription factors, namely, their very slow off-rates.
It may be important for the cell to ensure that such fac-
tors do not bind to the wrong target, for example, that
TBP not bind to random API -rich sequences in the
genome, since once such factors are bound, they do
not come off the DNA easily. A built-in damper of
DNA binding, which is deactivated by protein-protein
contact with a partner binding to the same promoter,
ensures that the factor does not bind to isolated sites
and also ensures very efficient binding to sites located
within promoters, i.e., close to the partner's binding
site.
Unlike SNAP, and TBP, Oct-1 has a very fast on-
and off-rate. Thus, one can imagine that Oct-1 could
serve as a sensor, constantly probing the DNA for the
presence of octamer sequences. If Oct-1 finds an
octamer sequence, and if the sequence is located with-
in an snRNA promoter, i.e., close to a PSE, then Oct-
1 will recruit SNAP, to the PSE through cooperative
binding, and in RNA polymerase III snRNA promot-
ers, SNAP, will then in turn recruit TBP to the nearby
TATA box. The cooperative interactions thus result in
the assembly of a very stable transcription initiation
complex.
Protein-Protein Interactions
among SNAP,, Subunits
B. Ma, N. Hernandez
To understand the architecture of SNAP,, we are
defining which parts of the various SNAP, subunits
interact with other members of SNAP as determined
by coimmunoprecipitation of in-vitro-, translated pro-
teins. We are introducing point mutations in the vari-
ous partners and testing their effect on complex
assembly. Such information will allow us to build a
"minimal" SNAP, lacking all sequences dispensable
for the integrity of the complex, which will then be
tested for DNA binding and transcription activity. We
are also testing such complexes for cooperative bind-
ing with TBP, with the aim of defining the target with-
in SNAP, for cooperative interactions with the amino-
terminal domain of TBP.
Mechanism of SNAPc
Binding to the PSE
B. Trumbull, N. Hernandez
The largest subunit of SNAP,, SNAP190, is a Myb
domain protein. The SNAP190 Myb domain consists
of four repeats, and we have shown that deletion of the
two most carboxy-terminal repeats strongly reduces
binding of SNAP,, whereas deletion of the two most
amino-terminal repeats has only a slight effect.
SNAP190 is probably not the only SNAP, subunit
involved in DNA binding. Indeed, we can cross-link
SNAP50 to the DNA, suggesting that SNAP50 also
contacts the PSE. To study how SNAP, recognizes the
PSE, we are generating probes with photosensitive
groups at various positions along the PSE and deter-
mining which SNAP, subunit can be cross-linked to
which part of the PSE.
Identification of
SNAP -associated Factors
F. Emran, N. Hernandez
Some of the transcription factors required for RNA
polymerase II and III snRNA gene transcription are
likely to associate with SNAP,. We are developing a
yeast screen to identify such SNAP,-associated fac-
tors.
Characterization of a Human
RNA Polymerase III
Holoenzyme
S. Sepehri, N. Hernandez
A fraction of RNA polymerase II exists in the cell as
part of very large complexes. Some of these complex-
es contain a number of general transcription factors as
well as factors required to mediate response to an acti-
vator. We are purifying an RNA polymerase III com-
plex that, together with TBP and a SNAP, fraction, is
sufficient for U6 transcription. The goal is to deter-
mine the composition of this complex and thus identi-
fy new factors required for U6 transcription.
Factors Required for snRNA
Transcription by RNA
Polymerase III
L. Schramm, N. Hernandez
Basal RNA polymerase III transcription of the human
snRNA genes requires SNAP,, RNA polymerase III,
and the TBP component of TFIIIB. We are determin-
ing which other TFIIIB component is required for U6
transcription.
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Transcription from
Chromatin Templates
X. Zhao, N. Hernandez
Our studies so far have used naked DNA templates.
The goal of this project is to study the transcription of
snRNA genes wrapped into chromatin templates and
to determine the part played by cooperative interac-
tions between the Oct-1 POU domain and SNAP, and
SNAP, and TBP, for transcription from such templates.
Factors Required for snRNA
Transcription by RNA
Polymerase II
P. Hu, N. Hernandez
Previous work has shown that RNA polymerase II
transcription from snRNA promoters requires many of
the general transcription factors required for RNA
polymerase II transcription from mRNA promoters,
namely, TFIIA, TFIIB, TFIIF, and TFIIE. It is not yet
clear whether TFIIH is required, but we know that all
of the general transcription factors together with
SNAP, and TBP are not sufficient to promote RNA
polymerase II transcription from snRNA promoters.
The goal of this project is to determine whether TFIIH
is required for RNA polymerase II snRNA gene tran-
scription and to isolate the missing factors required.
Regulation of snRNA
Gene Transcription
M. Shanmugam, N. Hernandez
snRNA genes are very actively transcribed in prolifer-
ating cells. It is not known, however, whether snRNA
gene transcription is down-regulated in resting cells,
nor is it known when during the cell cycle snRNA
gene transcription is most active. We will address
these questions.
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Localization of FBI-1, SNAP
Oct-1, and Other Factors In Vivo
P.S. Pendergrast, N. Hernandez
FBI-1 binds to the HIV-1 IST, but we have not been
able to demonstrate a role of FBI-1 in short transcript
formation. Instead, FBI-1 synergizes with the HIV-1
trans-activator Tat to produce very high levels of full-
length transcripts. We are now using chromatin
immunoprecipitation experiments to determine
whether FBI-1 can be found bound to the HIV-1 pro-
moter in vivo. We have also used the chromatin
immunoprecipitation method to determine that all five
SNAP, subunits as well as Oct-1 are bound to snRNA
promoters in vivo.
Function of FBI-1
P.S. Pendergrast, P. Stavropoulos, N. Hernandez
Through a combination of transfection and coim-
munoprecipitation experiments, we are deciphering
the function of FBI-1 in HIV-1 transcription. We are
also characterizing how it binds to DNA.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano M. Hirano D. Mac Callum
K. Kimura T. Yokochi
A. Losada
The assembly of mitotic chromosomes is a fundamen-
tal process that ensures the faithful segregation of
genetic information during eukaryotic cell division.
Our laboratory is interested in understanding the mol-
ecular mechanisms underlying this dynamic structural
change of chromosomes. By using a cell-free extract
derived from Xenopus laevis eggs, we previously iden-
tified two protein complexes, 13S condensin and 14S
cohesin, that have central roles in chromosome con-
densation and sister chromatid cohesion, respectively.
Although the two complexes have different cellular
functions and are differently regulated during the cell
cycle, they share a similar subunit organization: Each
of the complexes contains a heterodimeric pair of
SMC (structural maintenance of chromosomes) sub-
units and two or three non-SMC subunits. The goal in
our laboratory is to understand how the two eukaryot-
ic SMC protein complexes work at a mechanistic level
and how they interact with chromatin and other pro-
teins to fulfill their essential functions. We also use a
bacterial SMC homodimer as a model system to dis-
sect the basic mechanisms of SMC action.
condensin-depleted Xenopus egg extracts and separat-
ed them from free proteins by sucrose gradient cen-
trifugation. Removal of histones from the isolated
nucleosomes resulted in negatively supercoiled DNA.
However, if the nucleosomes were preincubated with
13S condensin and topoisomerase I before depro-
teinization, the linking number of DNA shifted to a
less negative (thereby positive) direction. The change
in the linking number was ATP-dependent, and it was
not observed when the nucleosomes were treated with
either 13S condensin or topoisomerase I alone.
Mitosis-specific phosphorylation of condensin sub-
units appeared to be important to support this activity.
One of the most straightforward explanations for these
results is that the mitotic form of 13S condensin intro-
duces positive writhe into nucleosomal DNA as it does
so into naked DNA. We cannot rule out the possibili-
ty, however, that condensin may have an ability to
"remodel" nucleosomes either by altering histone
structure or by dissociating histones from the DNA.
Experiments are now in progress to distinguish
between the two possibilities.
Action of Condensin
on Nucleosomal DNA
K. Kimura, T. Hirano
We found previously that 13S condensin reconfigures
DNA structure in an ATP-dependent manner. In the
presence of a type I topoisomerase and ATP, the com-
plex introduces positive supercoils into a closed circu-
lar DNA. In the presence of a type II topoisomerase
and ATP, 13S condensin promotes the formation of
positive knots into a nicked circular DNA. The two
activities are regulated by mitosis-specific, Cdc2-
dependent phosphorylation of condensin subunits. On
the basis of these results, we proposed that 13S con-
densin actively compacts and organizes DNA by intro-
ducing global positive writhe. Although these findings
provided fundamental insights into the basic mecha-
nism of condensin's action, little was known about
how the complex interacts with its physiological sub-
strate, nucleosomal DNA. To address this question, we
first assembled nucleosomes on a plasmid DNA in
Cell Cycle Regulation of
Condensin-Chromatin
Interactions
D. MacCallum, K. Kimura, T. Hirano
How does 13S condensin initiate chromosome conden-
sation specifically at the onset of mitosis? In the cell-free
extracts of Xenopus eggs, the association of 13S con-
densin with chromatin is mitosis-specific. In contrast,
the mitotic and interphase forms of 13S condensin, once
purified from the extracts, display a comparable level of
DNA-binding activity. Thus, Cdc2-dependent activation
of the supercoiling and knotting activities does not
account for the whole mechanism of mitotic regulation
of condensin. There must be an additional regulatory
mechanism at the level of chromosomal targeting.
To address this issue, we have developed an in vitro
assay to test the interactions between purified con-
densin and isolated chromatin. Sperm chromatin was
incubated with either mitotic or interphase extract that
had been depleted of condensin, and it was then isolat-
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ed by centrifugation through a sucrose cushion. This
structure, termed remodeled sperm chromatin (RSC),
contains cell-cycle-specific chromatin components,
including core histones, and thereby represents the
most physiologically relevant substrate for a con-
densin-binding assay. The mitotic or interphase form of
RSC was incubated with 13S condensin purified from
either mitotic or interphase extracts, and their interac-
tions were assayed by immunofluorescent staining of
chromatin with an anti-condensin antibody. We found
that mitotic condensin was able to bind to mitotic and
interphase RSC in an equal efficiency. Likewise, inter-
phase condensin bound to both mitotic and interphase
RSC. Thus, the cell cycle specificity normally
observed in the cell-free extracts was abolished in this
purified system. However, the addition of an interphase
extract to the reaction prevented condensin from bind-
ing to the RSC. These results suggest that there is a sol-
uble inhibitor in interphase extracts that is necessary to
prevent the interaction between condensin and chro-
matin, thus conferring the cell cycle specificity. This
putative inhibitory factor is currently being purified by
conventional biochemical fractionation.
We have also established an assay to test the inter-
actions between purified condensin and nucleosomes
immobilized on magnetic beads. In this assay, a linear
DNA was coupled to magnetic beads via a biotin-strep-
toavidin linkage, and then incubated with condensin-
depleted extracts. Nucleosomes assembled on the
immobilized DNA were purified in a magnetic field
and tested for their ability to interact with purified con-
densin by quantitative immunoblotting. Consistent with
the results from the RSC-binding assay, we did not
observe any cell-cycle-specific interactions between the
purified nucleosomes and purified condensin. Although
this magnetic bead assay seems to be less physiological
than the RSC assay, the former is technically easier and
more quantitative than the latter. We anticipate that the
two approaches will complement with each other, facil-
itating the identification of factors that determine the
cell-cycle-specific behavior of condensin.
Search for Additional
Condensation Factors
D. MacCallum, T. Hirano [in collaboration with
Ryuji Kobayashi, Cold Spring Harbor Laboratory]
Accumulating lines of evidence from our own and
other laboratories strongly suggest that the condensin
complex has a central role in chromosome condensa-
tion both in vitro and in vivo. Nevertheless, it is possi-
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ble that additional factors cooperate with condensin to
promote full condensation. Recent evidence from our
reconstitution experiments supports this idea. When
isolated mitotic RSC (see above) was incubated with
purified mitotic condensin, some condensation
occurred, but no discrete condensed chromosomes
were observed. When a mitotic extract was added back
into the reaction, full condensation was restored. These
observations, together with other fractionation data,
suggest that an additional soluble factor present in the
extract, other than topoisomerase II, is required for
condensation and resolution of mitotic chromosomes.
As a complementary approach, we have also started a
reevaluation of protein components that are copurified
with chromosomes assembled in Xenopus egg extracts.
Molecular Actions of the Cohesin
Complex
A. Losada, T. Hirano
The cohesion of duplicated chromosomes (sister chro-
matids) is established at the time of DNA replication
and maintained until the metaphase-anaphase transition
in mitosis. We showed previously that eukaryotic cells
contain a second SMC protein complex (termed 14S
cohesin) that plays an essential part in the establishment
of sister chromatid cohesion during interphase. In ver-
tebrates, but not in yeast, most of the cohesin complex
dissociates from the chromatin at the onset of mitosis. It
remains to be determined whether a small amount of
cohesin left on the condensed chromosomes is suffi-
cient to hold sister chromatids together until the
metaphase-anaphase transition, or whether other nonco-
hesin factors are involved in this process. We are cur-
rently trying to determine the mechanisms by which the
chromatin targeting and release of cohesin are regulated
at different stages of the cell cycle.
How does cohesin work at a molecular level? Do
cohesin and condensin share a common mechanism of
action? To address these questions, we have purified the
cohesin complex from both Xenopus egg extracts and
human tissue culture cells and assayed its biochemical
activities in vitro. We found that cohesin possessed a
weak ATPase activity that was stimulated in the pres-
ence of DNA. The complex bound to single-stranded
DNA (ssDNA) but did not support reannealing of com-
plementary DNA strands, an activity displayed by other
SMC complexes such as the bacterial BsSMC dimer.
Cohesin also bound to double-stranded DNA with a
preference for its supercoiled form. When incubated
with a linear DNA template in the presence of DNA lig-
ase, cohesin strongly favored intermolecular end-to-
end joining (concatemer formation) over intramolecu-
lar ligation (recircularization). Furthermore, in the
presence of topoisomerase II, cohesin promoted cate-
nation between nicked circular DNA molecules. In a
striking contrast, condensin directed only intramolecu-
lar knotting, but not intermolecular catenation, in the
same assay. Results from gel-shift experiments also
suggested that cohesin and condensin interact with
DNA in different ways. We hypothesize that cohesin
functions as an intermolecular DNA cross-linker, with
the two putative DNA-binding ends of the complex act-
ing on noncontiguous DNA segments. Condensin,
however, appears to behave as an intramolecular DNA
cross-linker, with both ends of the complex bound to a
contiguous DNA segment. Although this is probably an
oversimplified model, the cross-linker hypothesis pro-
vides a framework for our understanding of how
cohesin, condensin, and other SMC protein complexes
might work in the dynamic organization of chromo-
somes in the cell.
Identification of Additional
Cohesion Factors
A. Losada, T. Yokochi, T. Hirano [in collaboration with
Ryuji Kobayashi, Cold Spring Harbor Laboratory]
The Xenopus cohesin complex consists of two SMC
subunits (SMC1-type and SMC3-type) and at least
three non-SMC subunits. Microsequencing of one of
the previously uncharacterized subunits, p155,
revealed that it is homologous to Scc3p, a gene prod-
uct recently shown to be a component of the yeast
cohesin complex. A cohesin complex purified from
HeLa cell extracts also contained an Scc3p homolog,
providing additional evidence that subunit composi-
tion of the cohesin complex is highly conserved from
yeast to humans. To get more insights into the bio-
chemical mechanisms of sister chromatid cohesion,
we have started characterization ofXenopus homologs
of BimD, a protein that is known to interact with a
cohesin subunit in the fungus Aspergillus nidulans.
Structural and Functional Dissection
of a Bacterial SMC Homodimer
M. Hirano, T. Hirano
Mutations in the single smc gene of the gram-positive
bacterium Bacillus subtilis cause defects in chromo-
some condensation and segregation, suggesting that
the basic function of SMC proteins may be in common
from bacteria to humans. We showed previously that
the B. subtilis gene product (termed BsSMC) is a
DNA-stimulated ATPase and is able to form large
nucleoprotein assemblies with ssDNA in an ATP-
dependent manner. A recent electron microscopy
study from another group showed that BsSMC is
dimerized via antiparallel coiled-coil interactions,
forming a "two-armed" symmetrical structure with a
central flexible hinge. To understand how this unique
structure of BsSMC might contribute to its function at
a mechanistic level, we have started a systematic
mutagenesis approach. We are particularly interested
in constructing two different classes of mutant deriv-
atives. The first class is the so-called "single-armed"
mutant that is composed of an amino-terminal and
carboxy-terminal halves of a BsSMC polypeptide.
The second class is a "stiff-hinge" mutant in which
two functional arms are connected by an inflexible
hinge. To this end, multiple glycine residues highly
conserved in the hinge domain were replaced with
alanines. We found that the hydrodynamic properties
of the expressed proteins were consistent with those
expected for the single-armed and stiff-hinge
mutants. These mutants failed to interact with ssDNA
properly and displayed unusual characteristics of
ATPase activity. Further characterization of these
mutants should provide fundamental insights into
how the ATPase cycle of BsSMC might be coupled
with its mechanical cycle. We also anticipate that this
approach will help us to understand the different
actions of condensin and cohesin in eukaryotic cells
and will shed light on the evolutionary origin of con-
densation and cohesion.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Janicki T. Howard
P. Sacco-Bubulya J. Bizgia
N. Saitoh
Studies in our laboratory are focused on the structur-
al-functional organization of the mammalian cell
nucleus. Our research program evolves around under-
standing the nuclear organization of factors associated
with pre-mRNA splicing and the RNA substrates with
which these factors interact. The microscopy core
facility has been used extensively over the past year,
and numerous collaborations are under way with the
excellent technical expertise of Tamara Howard.
Organization of
Interchromatin
Granule Clusters
P. Sacco-Bubuiya
The majority of RNAs synthesized by RNA poly-
merase II contain introns that must be spliced out prior
to transport of the RNA to the cytoplasm where it
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functions by providing protein-coding information to
the translational apparatus. Interchromatin granule
clusters (IGCs) are regions within mammalian cell
nuclei that are the sites of localization for splicing fac-
tors and other proteins required for pre-mRNA syn-
thesis and processing. Splicing factors are recruited
from these regions to active transcription sites, where
they function in cotranscriptional pre-mRNA process-
ing. Many splicing factors contain an RS domain that,
when hyperphosphorylated, results in the release of
these factors from IGCs. Splicing factors that contain
such a domain are referred to as SR proteins. The
release of splicing factors from IGCs is regulated by
SR protein kinases. When SR protein kinases are over-
expressed in cultured cells, they alter the organization
of nuclear speckles and can ultimately cause complete
redistribution of splicing factors into a diffuse nuclear
localization.
We are using one of these SR protein kinases,
cdc2-like kinase (CLK/STY), as a tool to disrupt IGCs
in vivo. Overexpression of CLKJSTY in A-431 cells
FIGURE 1 Overexpression of FLAG-CLK/STY in A-431 cells. (A-B) Coimmunofluorescence of SR proteins
(panel A, 3C5 antibody) and wild-type FLAG-CLK/STY (panel B, M2 anti-FLAG antibody). Transient overex-
pression of the kinase CLK/STY causes a dramatic redistribution of SR proteins (thick arrow) as compared to
the typical speckled SR protein localization in untransfected neighboring cells that are not overexpressing
CLK/STY (thin arrow).
causes a dramatic reorganization of splicing factors
within the nucleus (Fig. 1). It is not known if IGCs
occupy specific regions of the nucleus or if they con-
tain organizational elements such as filaments or SR
protein receptors. At the ultrastructural level, the IGCs
of normal nuclei appear as clusters of electron-dense
granules each measuring 20-25 nm in diameter. We
are currently evaluating nuclear ultrastructure in cells
that overexpress CLK/STY, as the splicing factors will
be released from IGCs in these cells and the underly-
ing structural elements may be revealed. In addition,
we would like to determine the importance of the
integrity of these clusters for supplying factors
involved in RNA metabolism to active genes. For
example, splicing factors may arrive at transcription
sites in preassembled complexes that are functional
only if they originate from IGCs. This study aims to
reveal the structural organization of the IGCs, and it
will address the significance of the clustered arrange-
ment of RNA synthesis and processing factors for sup-
porting gene expression.
An In Vitro System to
Study Splicing Factor
Dynamics
N. Satoh
Previous studies from our laboratory have shown that
pre-mRNA splicing factors are recruited from IGCs to
sites of transcription. Furthermore, we have shown
that this recruitment is dependent on phosphorylation
of the RS domain of SR splicing factors. To determine
the molecular mechanism of this nuclear dynamics, we
began to establish an in vitro reconstitution system by
using biochemically isolated IGCs. We isolated IGCs
by a modified method so that the morphology of these
structures is maintained in a physiological buffer. The
purified fraction contains large clusters of interchro-
matin granules (Fig. 2). Immunofluorescence microscopy
with an antibody that recognizes a phospho-epitope on the
SR family of splicing factors was used to label the puri-
fied structures. The positive immunolabeling (Fig. 2)
implies that the bulk phosphorylation status of these
proteins is maintained during the purification. One of
the major goals of this project is to recapitulate the
recruitment of splicing factors to the site of active
transcription in a cell-free system. We will place the
fraction in an in vitro transcription system and address
whether splicing factors leave the granule-shaped
structures for a DNA template. Furthermore, we will
fractionate nuclear extract to identify proteins respon-
sible for the recruitment. An additional goal of this
project is to reconstitute the peripheral movement of
the interchromatin granule clusters observed in vivo.
We will record the movement of isolated clusters
mixed with an ATP regenerating system and nuclear
extract by time-lapse microscopy. We will then utilize
the fractionated nuclear extract to identify proteins
responsible for the movement. Other morphological
changes of the isolated IGCs are expected upon treat-
ment with certain reagents such as a-amanitin (round-
ing up), Clk/Sty kinase (disperse), phosphatase 1
FIGURE 2 Fractionated interchromatin granule clusters were adhered to a glass slide and immunolabeled with an antibody that rec-
ognizes the SR family of pre-mRNA splicing factors. Shown are differential interference contrast (A) and fluorescence (8) microscopy
of the same isolated structures.
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inhibitor (enlarged), and mitotic extract (disperse).
These experiments will address the mechanism of
splicing factor recruitment and will bring us closer to
understanding the spatial organization of gene expres-
sion.
Proteome Analysis of a
Nuclear Domain Involved
in Gene Expression
N. Saitoh, P. Sacco-Bubulya, R. Kobayashi [in collaboration
with S. Patterson and C.S. Spahr, Amgen Inc.]
We have continued to use two complementary
approaches toward identification of the protein com-
position of IGCs. In the first approach, we resolved
IGC protein constituents on two-dimensional gels as
performed previously and excised spots enriched in
the IGC fraction for peptide microsequencing. This
method is advantageous because it allows us to direct-
ly identify proteins enriched in the IGCs as well as to
obtain preliminary information about the proteins,
such as their pis and molecular weights. Using this
approach, we have identified 14 known proteins and
one peptide that corresponds to a sequence in the
expressed sequence tag (EST) library. Peptide
sequences obtained from one of the most abundant of
the enriched proteins on the two-dimensional gel were
a precise match to the protein KIAA0111, also called
eukaryotic initiation factor 4A-like protein (eIF-4A-
like). KIAA0111 was fused to yellow fluorescent pro-
tein (YFP) and expressed transiently in He La cells,
where it colocalized with endogenous splicing factor
SC35 in nuclear speckles. The precise role of this IGC
protein is currently being investigated.
In the second approach, we applied the whole IGC
fraction to proteome analysis by mass spectrometry.
This method allows us to identify the entire protein
composition of the isolated IGC fraction by combining
peptide sequence analysis and database searching. The
advantages of this method are that it is rapid, it does
not require separation of each component prior to
mass spectrometry, and it is sensitive enough to iden-
tify less abundant, yet important proteins that other
methods may not detect. On the basis of our previous
studies, we anticipate identifying (1) new splicing fac-
tors, (2) architectural proteins such as molecular chap-
erones that are responsible for assembly and mainte-
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nance of the IGCs or may be responsible for pre-
assembly of splicing factor complexes, (3) proteins
involved in nuclear signal transduction which regulate
movements of splicing factors, (4) receptors for the SR
proteins, (5) a hypothetical molecular motor that may
carry splicing factors to the site of active transcription,
and (6) a series of proteins involved in human disease
such as the two examples related to cancer that have
already been identified (skip, TLS-associated protein
with SR repeats).
We utilized automated micro-column liquid chro-
matography electrospray ionization tandem quadru-
pole mass spectrometry (LC/MS/MS). Using this
method, we identified 114 known proteins that have
previously been localized in the nuclear speckles, or
whose functions have been associated with nuclear
speckles, such as splicing factors and other RNA pro-
cessing factors. We have identified 12 new IGC pro-
tein candidates, and in addition, we obtained peptides
that correspond to 69 different accession codes for
EST clones. We are using information provided by the
primary sequence of the identified proteins, such as
functional analysis for the known proteins and domain
analysis for the less characterized proteins, to screen
for constituents that may be critical for the function of
nuclear speckles. Particular emphasis is being placed
on domain and motif analyses that strongly indicate a
structural component or components that will reveal
an altogether novel function for nuclear speckles.
Identification of the IGC components will lead us to a
better understanding of the function of the IGCs in
coupling transcription and pre-mRNA splicing and to
understanding the functional /structural organization of
the nucleus.
Role of SCAF10 in Coordinating
Recruitment of the
Transcription and Pre-mRNA
Processing Machinery
S. Janicki
Transcription and RNA processing are believed to be
functionally linked in vivo as RNA processing factors
have been found in association with the carboxy-ter-
minal domain of RNA polymerase II. To understand
how these processes are coordinated within the struc-
tural framework of the nucleus, we are studying the
function of SCAF10, a protein that may regulate inter-
actions between factors known to be essential for gene
expression. SCAF 10 localizes to both nuclear speckles
and the nucleoplasm and was identified in yeast two-
hybrid screens for proteins that interact with the CTD
of RNA polymerase II (Bourquin et al., Nucleic Acid
Res. 52: 2055 [1997]) and Clk/Sty kinase (Nestel et
al., Gene 180: 151 [1996]). SCAF10 is a 106-kD pro-
tein with an amino-terminal cyclophilin domain and a
carboxy-terminal serine/arginine-rich RS domain.
Cyclophilins have been reported to act as chaperones
in protein trafficking and macromolecular assembly,
and they contain peptidyl-prolyl cis-trans isomerase
(PPIase) domains that catalyze cis-trans isomeriza-
tions about Xaa-Pro peptide bonds. The peptide fold-
ing activity of this protein may potentially regulate
interactions between RNA processing factors and the
CTD or play a part in the assembly and disassembly of
the macromolecular complexes involved in splicing.
The carboxy-terminal RS domain of SCAF10 is essen-
tial for its association with the RNA polymerase II
CTD. We are currently making antibodies to SCAF10
in order to identify a broader range of proteins with
which SCAF10 is associated. Antisense treatment will
also be used as a means of determining the effects of
knocking out SCAF10 on complex formation, nuclear
structure, and nuclear functions, including transcrip-
tion and splicing. Additionally, we are studying the
dynamics of SCAF10 movement in living cells
through the use of green fluorescent protein fusion
proteins. We are investigating whether SCAF10 is
recruited to active transcription sites and whether
splicing factors move to these sites from the nuclear
speckles in association with SCAF10 and/or RNA
polymerase II.
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PROTEIN TYROSINE PHOSPHATASES AND THE
CONTROL OF CELLULAR SIGNALING RESPONSES
N.K. Tonks H.H. Chen J.P. Liu H.L. Palka
R.L. Del Vecchio T.C. Meng K.A. Pennino
T. Fukada M.P. Myers Y. Shen
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects not only the activity of the
kinases that phosphorylate it, but also the competing
action of protein phosphatases that catalyze the
dephosphorylation reaction. We study the expanding
family of protein tyrosine phosphatases (PTPs) which,
like the kinases, comprise both transmembrane recep-
tor-linked forms and nontransmembrane cytosolic
species and represent a major family of signaling
enzymes. The structures of the PTPs indicate impor-
tant roles in the control of key cellular functions. We
are utilizing a variety of strategies to characterize the
normal physiological function of several members of
the PTP family. Disruption of normal patterns of tyro-
sine phosphorylation has been implicated as a contrib-
utor to several human diseases. Therefore, insights
into the mechanisms involved in modulating PTP
function may ultimately yield important information
to help counter such diseases.
During the last year, Shao-Hui Zhang completed his
postdoctoral studies and accepted a position at Tanabe
Research Laboratories. He and J.P. Liu have now moved
to San Diego. We were joined by Toshiyuki Fukada and
T.C. Meng as postdocs, and Hsu-Hsin (May) Chen has
begun her work as a graduate student in the lab.
IDENTIFICATION OF PTP SUBSTRATES USING
"SUBSTRATE-TRAPPING" MUTANT PTPs
The identification of substrates of PTPs is an essential
step toward a complete understanding of the physiologi-
cal function of members of this enzyme family. We have
developed a method by which we can examine PTP sub-
strate specificity in a cellular context. By mutating the
invariant catalytic acid residue (Asp-181 in PTP1B) to
alanine, we generate a form of the PTP that maintains a
high affinity for substrate but does not catalyze dephos-
phorylation effectively, i.e., we convert an extremely
active enzyme into a "substrate trap." Following expres-
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sion, the mutant PTP binds to its physiological substrates
in the cell, but, because it is unable to dephosphorylate
the target efficiently, the mutant and substrate become
locked in a stable "dead-end" complex. Potential sub-
strates can be identified by immunoblotting lysates of
cells expressing the mutant PTP with antibodies to pTyr
to reveal proteins whose phosphorylation state is altered
as a consequence of expression of the mutant. In addi-
tion, the complex between the mutant PTP and the pTyr
substrate can be isolated by immunoprecipitation and
associated proteins identified by immunoblotting or, on
a larger scale, by primary sequence determination.
Importantly, the residue that is mutated to generate "sub-
strate-trapping" mutants is conserved in all members of
the PTP family. Therefore, the approach should be
applicable to all members of the family. The major take-
home message from this work to date is that members of
the PTP family display exquisite substrate specificity in
a cellular context.
During the past year, our work on characterization
of the cellular substrate specificity of PTP-PEST and
PTPH1 was published. We showed that through specif-
ic dephosphorylation of p130cas, PTP-PEST regulates
the rate of cell migration. In addition, we identified
VCP (valosin-containing protein, also known as p97 or
yeast Cdc48), which is an ATPase involved in cell cycle
regulation, protein degredation, organelle biogenesis,
and vesicle-mediated protein transport, as a major cel-
lular substrate of PTPH1. It appears that PTPH1 may
exert profound inhibitory effects on cell proliferation
through its dephosphorylation of VCP. The exact mech-
anism by which VCP function is regulated by tyrosine
phosphorylation remains to be established.
We have continued our study of the role of TCPTP
in regulating epidermal growth factor (EGF)-induced
signaling events. TCPTP occurs in two forms generat-
ed by alternative mRNA splicing: a 48kD form (TC48)
that is associated with the endoplasmic reticulum (ER)
and a 45 -kD form (TC45) that in the basal state is
nuclear. Both forms share the same catalytic domain.
Previously, we had shown that the TC48-D I 82A sub-
strate-trapping mutant formed a complex in the ER
with the tyrosine-phosphorylated EGF receptor
(EGFR), suggesting that TC48 may regulate the state
of phosphorylation of nascent EGFR that is in transit
through the ER on the way to the plasma membrane. In
contrast, TC45 displayed a distinct substrate specifici-
ty. In response to EGF stimulation, TC45 exits the
nucleus and recognizes the EGFR, one of the isoforms
of the adapter protein Shc, and two, as yet unidentified,
pTyr proteins (p50 and p64) as substrates. Trapping
mutant forms of TC45 displayed preferential recogni-
tion of Shc phosphorylated on Y239, compared to the
protein phosphorylated on Y240 or Y317. These obser-
vations illustrated a remarkable degree of substrate
specificity for TC45 in a cellular context, which
encouraged us to investigate further the effects of this
PTP on EGF-induced signaling events. We noted that
expression of TC45 in COS cells inhibited EGF-depen-
dent activation of the c-Jun amino-terminal kinase
(JNK) but did not effect the activation of extracellular
signal-regulated kinase 2 (ERK), thus illustrating that
TC45 can regulate selectively mitogen-activated pro-
tein kinase (MAPK) signaling pathways emanating
from the EGFR. We observed that wild-type and sub-
strate-trapping mutant forms of TC45 inhibit almost
completely the EGF-dependent activation of PI3-
kinase and PKB/Akt. TC45 and TC45-D182A act
upstream of PI3-kinase, most likely by inhibiting the
recruitment of the p85 regulatory subunit of PI3-kinase
by the EGFR. Recent studies have indicated that the
EGFR can be activated in the absence of EGF follow-
ing integrin ligation. We found that the integrin-medi-
ated activation of PKB/Akt in COS 1 cells is abrogated
by the specific EGFR PTK inhibitor tyrphostin
AG1478 and that TC45 and TC45-D182A inhibit acti-
vation of PKB/Akt following the attachment of COS1
cells to fibronectin. Thus, TC45 may serve as a nega-
tive regulator of growth factor or integrin-induced,
EGF receptor-mediated PI3-kinase signaling. In this
respect, the function of TC45 is reminiscent of that of
Smad7, an inhibitor of transforming frowth factor-13
(TGF-(3) signaling (Itoh et al., J Biol Chem. 273:
29195 [1998]). In the absence of ligand, Smad7 is pre-
dominantly localized in the nucleus. Stimulation of
cells with TGF-13 induces Smad7 to exit the nucleus,
associate with the TGF-I3 receptor at the plasma mem-
brane, and inhibit TGF-13-induced signaling. Whether
or not TC45 (and for that matter Smad7) has a regula-
tory function in the nucleus remains to be established.
STRUCTURAL ANALYSES OF PTP FAMILY MEMBERS
We have also continued our collaboration with David
Barford (now at the Institute of Cancer Research,
Chester Beatty Labs, London, UK) in which we are
undertaking a structural analysis of members of the PTP
family. Our most recent work has focused on the deter-
mination of the structure of complexes between trap-
ping mutant forms of PTP and phosphotyrosyl pep-
tides modeled on physiological sites of tyrosine phos-
phorylation. In 1999, a paper was published [Elchebly
et al., Science 283: 1544 [1999]) which reported that
disruption of the PTP gene yielded apparently nor-
mal mice that displayed enhanced sensitivity to insulin
and resistance to weight gain when fed a high-fat diet.
These observations suggest that PTP is a major reg-
ulator of insulin-induced signaling and fuel metabolism
and may be an important player in type-2 diabetes and
obesity. To understand how PTP may exert specific
effects on insulin-dependent signaling, we solved the
structure of PTP in a complex with a phosphotyrosyl
peptide modeled on two of the autophosphorylation
sites (Y1150, Y1151) from the activation loop of the
insulin receptor. The structure reveals that of the two
adjacent phosphotyrosyl residues, pY1150, which is a
key regulator of the activity of the insulin receptor, is
engaged in the active site of the enzyme, whereas
pY1151 binds to a distinct crevice on the surface of the
protein. At this second site, the phosphate moiety of the
pTyr residue interacts with a basic residue on the sur-
face of PTP that is unique to PTP and its closest
homolog TCPTP. We are currently undertaking further
structural analyses in combination with testing the
effects of mutation of key surface residues of PTP on
substrate recognition. These studies may yield structur-
al insights into the molecular mechanism underlying the
substrate specificity of this important PTP.
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SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner A. Schmitz
E.-E. Govek M. Zhao
M. McDonough R. Packer
Our laboratory continues to study the function of the
Ras and Rho family members of small GTPases and
the mechanisms by which they exert their effects.
These proteins have been implicated in a wide variety
of important cellular activities, including cell growth
control and morphogenesis. Their genes encode low-
molecular-weight guanine nucleotide-binding proteins
that function as binary switches by cycling between an
active GTP-bound state and an inactive GDP-bound
state. It is only in their GTP-bound state that they are
able to interact with downstream effector molecules
which mediate their effects. The ratio of the two forms
is regulated by the opposing effects of guanine
nucleotide exchange factors (GEFs) which promote
the exchange of bound GDP for GTP, and the GTPase-
activating proteins (GAPs) which stimulate hydrolysis
of bound GTP.
Of all the GTPases, the Ras proteins have been
studied most, since activating mutations in ras genes
are commonly found in a wide variety of human
tumors. As outlined below, our research efforts have
been focused mainly on defining the downstream
effector pathways of Ras. In particular, we have con-
tinued the further analysis of a protein, AF-6, which
we had identified as a novel Ras-binding protein. In
addition, we focused on the functional characteriza-
tion of p62d°k, a Ras-GAP-associated protein, which
was found to be constitutively tyrosine-phosphorylat-
ed in chronic myelogenous leukemia (CML) progeni-
tor cells.
Members of the Rho family, namely, RhoA, Rac,
and Cdc42, are best known as regulators of the actin
cytoskeleton. It is believed that alterations in the actin
cytoskeleton triggered by the Rho proteins contribute
to their effects observed on adhesion, invasion, mem-
brane trafficking, and, more recently, neuronal devel-
opment. We previously demonstrated, for example,
that the effect of Rac on T-cell adhesion and spreading
is integrin-dependent and requires an intact actin
cytoskeleton. Currently, we initiated studies examin-
ing the role of the Rho GTPases and their regulators on
neuronal development. In particular, we are assessing
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the physiological role of Oligophrenin, a Rho-GAP
involved in mental retardation. In addition to their role
in controlling the actin cytoskeleton, the Rho GTPases
are also known to regulate gene expression, which
may contribute to their effects on cell growth. To iden-
tify genes whose transcription is regulated by Rac, we
made use of representational difference analysis
(cDNA-RDA).
RAS SIGNALING PATHWAYS
Previous studies have shown that oncogenic Ras pro-
teins signal through the well-established Raf, Ra1GDS,
and PI3-kinase pathways and that all these pathways
participate in the cell-transforming activity of onco-
genic Ras. In addition, we demonstrated that whereas
Ras-mediated tumorigenicity can arise independently
from MAPK activation, experimental metastasis
requires constitutive activation of the Raf /MEK/
MAPK pathway. However, we cannot exclude that
other effectors may contribute to the metastatic pheno-
type, in addition to Raf. Moreover, since an experi-
mental metastasis assay was used, the metastatic phe-
notype relates to later stages of metastasis (e.g.,
extravasation and establishment, and/or secondary
growth) and not to early steps (e.g., intravasation) in
which the Rho-GTPases are likely to have a role. We
initiated studies in collaboration with G. Webb and G.
Vande Woude (Van Andel Research Institute,
Michigan) to assess the contribution of the Rac
GTPase to metastasis.
The importance of cell adhesion and cell shape for
the control of cell cycle progression has been well
established by now. Oncogenic transformation by Ras
is usually accompanied by a loss in cell-cell adhesive
properties and morphological changes. However, the
precise mechanism by which Ras exerts this morpho-
logical phenotype remains elusive. In light of this, we
identified AF-6 as a novel Ras-binding protein and
found that AF-6 accumulates at cell/cell contact sites.
RAS AND RAP1 INTERACTION WITH THE
AF-6 EFFECTOR TARGET
In addition to the ability of the AF-6 protein to bind
Ras, the AF-6 gene was also found to be fused to the
ALL-1 gene in a subset of acute lymphoblastic
leukemias caused by chromosomal (t6;11) transloca-
tion events; hence, the name ALL-1 fused gene on
chromosome 6. Database analysis led to the prediction
of an array of motifs, such as two amino-terminal Ras-
binding domains (RBD), U104 and DIL motifs, that
were initially found in microtubule and actin-based
motor proteins, respectively, and a PDZ domain fol-
lowed by an extended carboxy-terminal tail inter-
spersed with proline-enriched patches. As mentioned
previously, various subcellular localization experi-
ments performed in polarized epithelial cells and tis-
sue sections of intestinal epithelia suggest its distinct
residency in cell-cell junctional complexes. We
observed that in MDCK and MCF7 cells, AF-6 colo-
calizes with zona occludens (ZO-1), an integral com-
ponent of tight junctional complexes. Furthermore, we
isolated profilin as an AF-6-associated protein.
Profilin has a critical role in actin polymerization
events, and hence the AF-6/profilin interaction might
provide another more dynamic link between junction-
al complexes and the actin cytoskeleton. Given AF-6
localization at sites of cell/cell contacts, we investigat-
ed whether oncogenic Ras could perturb AF-6 local-
ization. We observed that the introduction of onco-
genic Ras into MDCK cells causes a dramatic alter-
ation in their morphology: The typical epithelial cell
shape is lost and is transformed into a fibroblastic one.
In these cells, AF-6 does not accumulate at the mem-
brane anymore and ZO-1 also disperses into the cyto-
plasm. A central question in this context, which we are
currently addressing, is whether activation of Ras dis-
sociates AF-6 directly from junctional complexes or if
this may be a secondary effect provoked by events
downstream from other signaling pathways.
In addition to its ability to bind Ras, we recently
found that AF-6 also interacts with the Ras-related
GTPase Rapl, both in vitro and in vivo. The first Rap
GTPase was originally identified in a screen for rever-
tants of the morphology exhibited by Ki-Ras-trans-
formed cells. However, recent studies underline funda-
mental differences between Ras and Rap signaling
pathways. Although Rapl has been implicated in
Drosophila morphogenesis, its function in mammalian
cells remains unclear. RaplA does exhibit some effect
on cell adhesion, though, as yet shown only in inte-
grin-based adhesion complexes that link cells to the
extracellular matrix. We are presently investigating the
role of Rapl and AF-6 in cell/cell adhesion. In addi-
tion, to examine the Ras/Rapl-AF-6 interactions in a
more comprehensive system, we turned to Drosophila
as a model system. A Drosophila homolog of AF-6
known as Canoe was first identified by virtue of its
severe rough eye phenotype, and it has genetically
been placed in the Notch signaling pathway, a pathway
that determines various cell fates in a multitude of
developmental processes. Furthermore, Canoe is
involved in a process called dorsal closure, the dorsal-
ward movement of the lateral and ventral epidermis to
enclose the embryo. We initiated studies to assess
genetic interactions among DrRas, DrRap 1 , and
Canoe. The latter is being done in collaboration with
Ulrike Gaul (Rockefeller University, New York).
FUNCTIONAL CHARACTERIZATION OF P62..
p62°°5 is an adapter protein that is found to be highly
phosphorylated in bone marrow samples of CML
patients and cell lines expressing p210b"-ab", and it was
isolated by virtue of its ability to bind Ras-GAP. It
contains a PH and a PTB domain at its amino termi-
nus, and it harbors 15 tyrosines, 9 proline-rich
domains, and numerous serine/threonine residues at its
carboxy-terminal tail. In addition to bcr-abl, p62°" has
been demonstrated to be a substrate of numerous cyto-
plasmic and receptor tyrosine kinases, including the
platelet-derived growth factor receptor (PDGFR), epi-
dermal growth factor receptor (EGFR), and src family
members. We observed that p6265 becomes phospho-
rylated and recruited to the membrane after PDGF
stimulation or introduction of bcr-abl and that this
event requires an intact PH domain.
To further address the role of p62°", we initiated a
collaboration with P.P. Pandolfi and colleagues
(Memorial-Sloan Kettering Cancer Center, New York),
who generated a null mutation in the dok gene. dok-/ -
mice did not reveal gross aberrant phenotypes.
However, in vitro analysis of p62"k-/- primary cells
from different origins showed growth alterations in
response to several cytokines and growth factors. For
example, p62r"-/- primary bone marrow cells and
mouse embryonic fibroblasts show a higher prolifera-
tion rate compared to wild-type cells when treated
with interleukin-3 (IL-3) and PDGF, respectively, sug-
gesting that p62"" is a negative regulator of cytokine
or growth factor signaling. Since p62° °' associates
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with Ras-GAP upon PDGF treatment, we assessed for
altered levels of Ras and MAPK activation in p62a"-/-
cells in response to growth factors. We observed pro-
longed Ras and MAPK activation after removal of
PDGF in p62""-/- MEF cells when compared to wild-
type cells, suggesting that p62"" is a negative regulator
of the Ras/MAPK pathway. Further experiments assess-
ing the involvement of p62"" in CML are ongoing.
RHO SIGNALING PATHWAYS
Most of the identified Rho GTPases' effector mole-
cules are proteins mediating their effects on actin
cytoskeleton organization. Among them, we identified
POR1 as a Rac 1-interacting protein. Further charac-
terization of these effector proteins is likely to shed
light on the mechanisms by which the Rho GTPases
exert their effects on processes such as adhesion and
neuronal development. Additional roles for the Rho
GTPases, including the regulation of gene expression,
invasion, and proliferation have recently been
revealed. Although large efforts have been taken,
including two-hybrid and biochemical approaches, the
target molecules mediating the effects of Rho GTPases
on cell growth control still remain elusive. Hence, as
alternative approach, we used representational differ-
ence analysis (cDNA-RDA) in combination with a
micro-array technique to identify genes whose expres-
sion is altered as a consequence of activated Rac
expression.
POR1, A RAC-INTERACTING PROTEIN
INVOLVED IN ACTIN REMODELING
We previously identified PORI as a Rac 1 -interacting
protein and demonstrated a role for POR1 in
cytoskeletal organization. Further studies revealed that
POR1 also interacts with ARF6, a GTPase shown to
regulate endocytic traffic at the cell periphery. In addi-
tion to its role in membrane trafficking, ARF6 also
mediates cytoskeletal organization. We recently
obtained data showing that PORI is translocated from
the perinuclear region toward the plasma membrane in
response to various growth factors known to activate
Rac, as well as in the presence of activated Rac. The
above observations hint of a potential role for POR1 in
membrane trafficking. In light of this, in collaboration
with C. D'Souza-Schorey (Notre Dame, Indiana) we
found that the Gq-coupled agonist, bombesin, triggers
the redistribution of vesicle-associated ARF6 and
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Rac 1 to the plasma membrane, resulting in peripheral
actin rearrangements. This bombesin-induced translo-
cation of vesicle-associated ARF6 and Racl to the cell
surface is regulated by ARF6 activation. These find-
ings support a role for vesicle transport in cortical
actin remodeling at the cell periphery.
ROLE OF RHO AND THEIR REGULATORS
IN NEURONAL DEVELOPMENT
The involvement of the Rho GTPases in neuronal
development has become more apparent during the
past year. There is compelling evidence that perturbing
the activity of the Rho GTPases results in alterations
in the formation of neuronal processes. In collabora-
tion with Z. Li and H. Cline here at the Laboratory, we
investigated whether Rho GTPases regulate branch
dynamics and branch extensions in optic tectal neu-
rons in live Xenopus tadpoles. These studies indicated
that the three members of the Rho GTPases have dis-
tinct effects on dendritic arbor development; namely,
Rac and Cdc42 regulate branch additions and retrac-
tions, whereas RhoA regulates the elongation of exist-
ing branches. The importance of the fine-tuned regu-
lation of the neuronal dendritic arbor is emphasized by
the reports suggesting that children with mental retar-
dation have reduced dendritic arbors. We have been
focusing our research on a protein called
Oligophrenin-1, which was originally isolated by posi-
tional cloning methods to identify genes responsible
for MRX (primary or nonspecific X-linked mental
retardation). Oligophrenin contains a domain that is
typical of Rho-GTPase-activating proteins (Rho-
GAP), and this Oligophrenin GAP domain acts as a
GAP for Rac, Rho, and Cdc42 in vitro, thus down-reg-
ulating the activity of these molecules. Oligophrenin
also contains a conserved amino-terminal domain of
unknown function, a PH domain, and a unique car-
boxy-terminal domain. The role that Oligophrenin-1
has in a cellular and in vivo context remains to be
determined, in particular, its role in neuronal develop-
ment and how absence of this GTPase regulatory mol-
ecule may lead to mental retardation on a molecular
and morphological level. Morphological changes as a
result of activation of particular Rho GTPases have
been well-characterized for numerous cell lines,
including Swiss-3T3 cells and neuronal cells. To
determine which GTPase(s) Oligophrenin acts upon in
a cell, we made use of these morphological changes as
a readout. Preliminary studies hint that it may be spe-
cific for RhoA. To assess in a more natural environ-
ment what effect Oligophrenin has on neuronal devel-
opment and ultimately synaptic transmission, we
turned to hippocampal slices. Currently, we are exam-
ining the effect(s) of overexpressing a green fluores-
cent protein (GFP)-tagged Oligophrenin construct in
these slices. Furthermore, we are setting up antisense
versions to mimic a loss of Oligophrenin gene func-
tion and to correlate basic cellular and molecular biol-
ogy with the disease phenotype of mental retardation.
IDENTIFICATION OF RAC TARGET
GENES USING CDNA-RDA
The aforementioned effects of Rac on cell growth,
such as proliferation and invasion, are likely to involve
changes in gene expression patterns. However, specif-
ic genes whose expression is regulated by Rac remain
largely unknown. Toward this end, we have used
cDNA-RDA, which is a modified form of genomic
RDA, a subtractive hybridization technique, which
incorporates kinetic enrichment during PCR. More
specifically, in this technique, one cDNA population
(called the driver) is hybridized in excess against a
second population (the tester) to remove common
hybridizing sequences, thereby enriching target
sequences unique to the tester. We isolated cDNAs
from fibroblasts and epithelial cell lines expressing the
constitutively activated RacV12 mutant under an
inducible promoter. To obtain genes that are either up-
or down-regulated as a result of RacV12 expression,
we used cDNAs from cells induced for RacV12 as
both tester and driver against cDNAs from uninduced
cells. The difference products obtained after two
rounds of cDNA-RDA were subcloned in a bacterial
expression vector for analysis. Approximately 400
colonies from each library were selected at random,
and their individual inserts were PCR-amplified. To
confirm the differential expression of the isolated
clones, we made use of micro-array technology (in
collaboration with R. Lucito and M.Wigler at CSHL).
The PCR-amplified inserts were printed on a glass
slide and then driver and tester cDNAs, each labeled
with a different fluorophore, were hybridized simulta-
neously to this chip. The fluorescence intensities of
each of the two labels were quantified for each clone,
and as such we were able to discern which clones were
up-regulated or down-regulated as a consequence of
RacV12 expression. At present, 300 clones out of a
total of about 3500 were sequenced, resulting in 85
independent gene fragments, of which 23 are novel.
From both cell lines investigated, we found a total of
37 apparently up-regulated and 48 down-regulated
candidate genes. The obtained genes could be catego-
rized in different groups: genes encoding nuclear,
ribosomal, mitochondrial, membrane-associated,
secreted, and cytoskeletal proteins. We are currently
performing Northern blots and other tests for further
validation.
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STRUCTURE AND GENOMICS
Members of the Structure and Genomics group at Cold Spring Harbor continue to interact with a large
number of the Laboratory community. As computational and "wet-lab" methods develop in parallel,
more and more they coalesce in a single research area. In fact, this distinction is largely artificial. The
members of this group combine in vitro, in vivo, and in silico approaches to provide powerful tools to
understand the correlation between structure and function in complex biological processes.
On the computational front, Andy Neuwald has begun applying his computational approaches to
studying protein structure to the study of repeated motifs within a protein. This has allowed him to
detect structural repeats in proteins where they had not yet been detected.
Lincoln Stein's group has developed an Ace Perl program to allow the ACEDB database popular
among biologists to be linked to a Web interface. They have used this to develop a Web-based ver-
sion of the C. e/egans database. The Stein lab has also been chosen as the database developers
for the human Single Nucleotide Polymorphism Consortium (SNP) database.
Michael Zhang's lab has continued their work in predicting gene structure. In the past year, they
have made considerable progress on the difficult problem of predicting the 3' end of genes from
genomic sequence and have a working version of software to do this.
From the more "wet lab" perspective, Ryuji Kobayashi's protein chemistry group has acquired a
new mass spectrometer that will greatly increase their ability to sequence small amounts of protein.
They have been using mass spectrometry to analyze the role of phosphorylation in the Bcr-Abl
pathway.
The McCombie lab, along with their collaborators, completed one of the two first chromosomes to
be sequenced from a higher plant. The region they completed contained a heterochromatic knob,
similar to a structure first described in maize by Barbara McClintock nearly 80 years ago. This was
the first region of heterochromatin sequenced.
The lab of Leemor Joshua-Tor has continued work on bleomycin hydrolase. In the past year, they
have determined the structure of an active site mutant of this enzyme and can now begin studying
that mutant and designing inhibitors of the enzyme.
Rui-Ming Xu has continued his structural studies of the interaction of protein and DNA. His lab has
determined the structure of a fragment of the yeast splicing complex and developed a model for its
interaction with other elements of the complex. They have also begun structural studies on com-
ponents of DNA replication in archaebacteria as a model of eukaryotic DNA replication.
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STRUCTURAL BIOLOGY
L. Joshua-Tor A. Auster
E. Enemark
T. Messick
P.R. Kumar
P O'Farrell
J. Rosenbaum
D. van Aalten
D. Vaughn
H. Zhou
F. St. Pierre (URP)
We study the molecular basis of cell regulatory
processes combining the tools of structural biology
and biochemistry to examine the molecular interac-
tions associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their complexes
with other molecules. We use biochemistry and mole-
cular biology to characterize properties that can be
correlated to protein structure, and we use information
from molecular biology and genetics in collaborative
efforts to study protein function.
Our current efforts center around two distinct
themes. The first is the regulation of proteolysis. Here,
we are studying caspase activation in apoptosis and a
conserved family of oligomeric self-compartmentaliz-
ing intracellular proteases, the bleomycin hydrolases
involved in drug resistance. The second theme in the
lab involves structural studies of protein complexes
involved in DNA regulatory processes.
Caspase Activation
D. Vaughn [in collaboration with Y. Lazebnik,
Cold Spring Harbor Laboratory]
Caspases are cysteine proteases that have a central role
in programmed cell death (apoptosis). They are
expressed as inactive zymogens or precursors which
when activated are part of an irreversible proteolytic
cascade. In response to a variety of pro-apoptotic sig-
nals, initiator caspases, such as caspase-8 and caspase-
9, are activated through an autocatalytic event and then
activate effector caspases by proteolysis. Activation of
caspase-9 occurs through binding of the regulatory
protein Apaf-1 in the presence of cytochrome c and
dATP. Recently, Joe Rodriguez and Yuri Lazebnik here
at Cold Spring Harbor Laboratory showed that the pro-
teolytic activity of caspase-9 is much higher when it is
in complex with Apaf-1. Therefore, it appears that
Apaf-1 not only is required for the activation of cas-
pase-9, but also acts as a regulatory subunit of the pro-
tease. Apaf-1 contains a caspase recruitment domain
(CARD) at its amino terminus, which binds to the
CARD of caspase-9. The CARD is one of several fam-
ilies of small protein interaction domains identified in
proteins involved in programmed cell death and are
grouped into three families: CARDs, death effector
domains (DEDs), and death domains (DDs).
We determined the crystal structure of the Apaf-1
CARD at 1.3 A resolution using a two-element multi-
wavelength anomalous dispersion (MAD) X-ray dif-
fraction experiment. The Apaf-1 CARD adopts a six-
helix bundle fold with Greek key topology (Fig. 1).
The six helices are arranged like a six-pack of bever-
age cans, and when viewed from the top, as in the fig-
ure, they form three stacked pairs of helices. The
helices enclose a tightly packed hydrophobic core and
form a globular shape that provides a structural scaf-
fold for potential binding surfaces which includes both
hydrophobic and electrostatic patches. This fold,
which we call the "death fold," is found in other
domains, other CARDs, DEDs, and DDs that mediate
interactions in apoptotic signaling despite very low
FIGURE 1 Six-helix fold with Greek key topology.
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sequence identity. Indeed, the principal interactions
occur on different surfaces for the different modules.
Even for the interaction between Apaf-1 and caspase-
9, the two molecules use different surfaces.
This utilization of the death fold (a Greek key six-
helix bundle) for protein-protein recognition in apop-
totic signal transduction is analogous to the use of the
immunoglobulin (Ig) fold (a Greek key (3-barrel) in
antigen-protein and cell-cell recognition functions.
Both the death fold and the Ig fold are small (-90
amino acid residues) rigid domains whose secondary
structural elements surround a hydrophobic core. In
each case, there are individual families of domains
(CARD, DED, and DD for death fold and V, I, Cl, and
C2 for the Ig fold) which share additional sequence
and structural characteristics that are common to the
larger superfamily. Both folds occur as specific mod-
ules that are found as components of multidomain pro-
teins with a wide range of functions.
Bleomycin Hydrolases
P. O'Farrell, F St. Pierre [in collaboration with F.
Gonzalez, S.A. Johnston, University of Texas
Southwestern Medical Center, and S.J. Keding
and D.H. Rich, University of Wisconsin, Madison]
Bleomycin hydrolase (BH) is a 300 -kD cysteine pro-
tease with unusual structural and biological features. It
was discovered due to its ability to deactivate the gly-
copeptide antibiotic, bleomycin, which is used as a
therapeutic agent in the treatment of a number of dif-
ferent forms of cancer. The clinical use of bleomycin
is limited due to drug resistance and dose-dependent
production of pulmonary fibrosis. The endogenous
enzyme, BH, is overexpressed in some tumor cells and
is thought to be a major cause of tumor cell resistance
to bleomycin therapy. It was shown that in both yeast
and mammalian cells, BH is the only enzyme with
bleomycin deamidation activity. Interest in its clinical
relevance was heightened by a recent report of the
genetic linkage of an allelic variant to the nonfamilial
form of Alzheimer's disease. BH was also found to
bind amyloid precursor protein (APP).
Since mammals rarely encounter bleomycin,
bleomycin hydrolysis is probably not the normal func-
tion of the enzyme. On the basis of studies with BH
knockout mice, it was shown that BH is important for
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neonatal survival. BH is widely distributed throughout
nature. Homologs exist in bacteria, yeast, birds, and
mammals, with high sequence identity among the dif-
ferent forms. The yeast form negatively regulates the
galactose metabolism system and also binds single-
stranded DNA and RNA with high affinity. Nucleic-
acid-binding activity was also reported for other mem-
bers of the family.
Previously, we determined the crystal structures of
the yeast BH, Ga16, and the human enzyme (hBH).
These structures revealed several unique features of
these proteases. They both have a hexameric ring-bar-
rel structure with the active sites embedded in a cen-
tral cavity. The only access to the active sites is
through the cavity. BH has little substrate specificity
so it is reasonable to assume that this sequestration of
the active sites is necessary to prevent indiscriminate
proteolysis. This places BH in the class of "self-com-
partmentalizing proteases" with, for example, the pro-
teasome and the tricorn protease. The carboxyl termi-
nus of BH lies in the active site, in much the same
position as that taken by inhibitors complexed with
papain. Our previous work on the yeast BH, Ga16, has
shown that it acts as a carboxypeptidase on its car-
boxyl terminus to convert itself to an aminopeptidase
and peptide ligase. The carboxyl terminus anchors the
substrate into the active site and confers "positional"
specificity. This model also serves to explain
BH /Gal6's unique ability to inactivate bleomycin.
In the last year, we designed and solved the struc-
ture of an active-site mutant of the enzyme that would
enable us to study the complex between the enzyme
and the anticancer drug bleomycin. In contrast to pre-
viously designed mutants, the active site remains open
for binding to the drug. In collaboration with Dan
Rich's laboratory at the University of Wisconsin,
Madison, we embarked on an iterative study to design
specific, tight-binding active site inhibitors of BH
activity to increase the efficacy of bleomycin, and per-
haps reduce dosage levels in cancer treatment. The
emerging link between hBH and Alzheimer's disease is
another incentive, since an inhibitor to hBH may be
useful in understanding this connection and may also
be useful in therapy. We are using our crystal structure
to create novel inhibitors by use of computerized struc-
ture-generating programs. Using this approach, we can
create both peptide-like and nonpeptide inhibitors by a
combinatorial process. We identified four compounds
in our initial screens that are good inhibitors, which we
are currently using for structural studies.
The DNA-binding Domain
of the Papillomavirus
Initiator Protein El
E. Enemark, G. Chen, A. Auster [in collabroation with A.
Stenlund, Cold Spring Harbor Laboratory]
Papillomaviruses are a large family of closely related
viruses that give rise to warts in their hosts. Infection
of the genital tract by the human papillomaviruses
(HPVs) from this group represents one of the few firm-
ly established links between viral infection and the
development of cervical cancer, as HPV DNA is found
in practically all cervical carcinomas. Although the
progression to malignancy represents a low-frequency
event, due to the high frequency of infection, this dis-
ease affects a large number of individuals. Bovine pail-
lomavirus (BPV) has served as a prototype for this
group especially regarding viral DNA replication. The
El protein belongs to a family of multifunctional viral
proteins whose main function is related to viral DNA
replication. These proteins bind to the origin of DNA
replication and also have other activities related to
DNA replication, including a DNA distortion and a
DNA helicase activity. Furthermore, these proteins
interact with cellular replication proteins such as DNA
polymerase a and RPA. Thus, this group of proteins is
intimately involved with initiation of DNA replication.
In collaboration with Arne Stenlund's group, we
embarked on structural studies to provide high-resolu-
tion structural information about El and its DNA-bind-
ing activity, which would provide general insight into
the biochemical events that are involved in viral DNA
replication. They can also provide a basis for the devel-
opment of clinical intervention strategies. Second, the
viral DNA replication machinery itself represents an
obvious target for antiviral therapy, and detailed infor-
mation such as high-resolution structures of viral pro-
teins required for replication will greatly facilitate the
development and testing of antiviral agents.
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PROTEIN CHEMISTRY
R. Kobayashi D. Bogenhagen D. Sargent
A. Lin D. Wurtz
S. Lopez
The year 1999 was one of major transition to my lab.
Kimbery Wanat left in January to join a pharmaceu-
tical company. Nobuhiro Kashige returned to
Fukuoka University, Japan, in March, and Nora
Poppitto moved to CSHL Press in August. David
Sargent joined the lab in March, Stacy Lopez in
August, and Andrew Lin and Denise Wurtz in
October, and Dr. Daniel Bogenhagen started his sab-
batical 6-month visit in December. In the summer,
Cold Spring Harbor Laboratory purchased an elec-
trospray ionization ion-trap mass spectrometer with
funds from the Howard Hughes Medical Institute.
FIGURE 1 In vivo tyrosine phosphorylation site
analysis of p62d°k by p210.'-. using MALDI
TOF mass spectrometry. p62'5' purified from
cell lysates expressing p210'5" was digested
by lysylendopeptidase and separated by high-
performance liquid chromatography (HPLC).
One HPLC peptide fraction was found to con-
tain a peptide whose mass was 3114.48, which
matches a combined mass of the peptide
EDPIYDEPEGLAPVPPQGLYDLPREPK
[3035.33] and a phosphate [79.98]. The linear
mode (upper panel) of MALDI TOF mass spec-
trometry showed only intact phosphopeptide,
whereas the reflector mode (lower panel) sepa-
rated metastable ions such as the dephospho-
rylated form and the dehydrated form of the
phosphopeptide, and dehydrated form of the
dephosphorylated peptide. This reflection spec-
tra pattern is typical for a tyrosine-phosphorylat-
ed peptide. Since the MALDI TOF mass spec-
trometry analysis only showed the number of
phosphate molecules in a peptide and the pep-
tide contained two tyrosines, further analysis by
peptide sequencer was used to determine the
phosphorylation site.
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This new mass spectrometer is able to sequence pro-
tein with higher sensitivity than the traditional Edman
sequencer if protein is in the database and it was set up
for the post-genome era.
TYROSINE PHOSPHORYLATION OF P62'"
IN CHRONIC MYELOGENOUS LEUKEMIA
The t(9,22) chromosomal translocation is found in
almost all patients with chromic myelogenous
leukemia (CML). The resultant bcr-abl fusion gene
expresses a chimeric fusion protein p2106 "-°N with
Mau (m/x)
increased tyrosine kinase activity. Hematopoietic
progenitors isolated from CML patients in the chronic
phase contain constitutively tyrosine-phosphorylated
p62" protein. We investigated the role of tyrosine
phosphorylation of p62d" in CML. p62" is directly
tyrosine-phosphorylated by p210h" -"N and is associat-
ed with the Ras GTPase-activating protein (RasGAP),
but only when p62" is tyrosine-phosphorylated. By
using MALDI-TOF mass spectrometry, the truncation
construct, and mutants of p62", we located the sites
of tyrosine phosphorylation in the carboxy-terminal
half of the p62d" molecule. We have found that p62"
is heavily phosphorylated by p2106 "-" and among
them, we identified five tyrosine residues that are
involved in in vivo RasGAP binding. We have investi-
gated the consequences of p62" tyrosine phosphory-
lation on the activity of RasGAP and have found that
tyrosine-phosphorylated p62" inhibits RasGAP
activity. In contrast, we observed no diminution of
RasGAP activity when the assay was conducted in the
presence of nontyrosine-phosphorylated p62" or in
the presence of a five Tyr->Phe point mutation (p62")
unable to bind RasGAP. Since RasGAP is a negative
regulator of Ras, our results suggest that p2101"-°bi
might lead to the activation of the Ras signaling path-
way through tyrosine phosphorylation of p62".
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In 1998, the major changes that we made in our
sequencing operation led to a large increase in our
sequencing capability, and these changes continued in
1999, resulting in another year of major increases in
sequencing throughput. Our application of this capac-
ity to several ongoing projects has continued, and we
have begun two major new genomics initiatives.
In 1999, we nearly doubled the output of finished
sequence submitted to Gen Bank when compared to
1998. This was in addition to redirecting a substantial
part of our sequencing capacity toward the so-called
"rough draft" sequence of the human genome. We
have continued our Arabidopsis and cancer genetics
sequencing projects and have initiated new programs
in both rice and mouse genome sequencing.
ARABIDOPSIS GENOME SEQUENCING
This work was done in collaboration with Rob Martiens-
sen (CSHL), Richard K. Wilson and Marco Marra
(Washington University), European Scientists
Sequencing Arabidopsis (ESSA), and Daphne Pruess
(University of Chicago). In 1999, we reached a major
milestone in our efforts to sequence the Arabidopsis
genome. We and our collaborators have completed the
sequence of Arabidopsis chromosome IV, which was
published in December along with the accompanying
paper describing the sequencing of chromosome II (The
Arabidopsis Consortium, Nature 402: 769 [1999]).
These represent the first ever plant chromosome
sequences to be resolved. The region sequenced by the
CSHL/WU group contained much of the centromeric
regions of chromosome IV and the complete region of
heterochromatin found on the short arm of chromosome
IV
The Arabidopsis Consortium (1999) paper
described a number of interesting findings in the chro-
mosome IV sequence. The sequence of chromosome
IV is composed of 17,380,000 base pairs, and analysis
of this region predicted the presence of 3744 protein-
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coding genes. Interestingly, only about 35% of these
predicted genes are present in the large, public
expressed sequence tag (EST) database. This is due to
huge representation of some common genes in the
public database. For instance, 6% of the predicted
genes from chromosome IV accounted for 75% of the
ESTs that matched chromosome IV (The Arabidopsis
Consortium 1999).
More interesting than the discrepancy between
ESTs and the genomic sequence is the comparison of
the chromosome IV sequence with the rest of the
Arabidopsis genome. Surprisingly, this comparison
showed that large regions of chromosome IV are
duplicated on other parts of chromosome IV or in oth-
ers parts of the Arabidopsis genome (e.g., chromo-
somes II and V). These results indicated that a mini-
mum of 15% of the Arabidopsis genome may be pre-
sent as large duplications in the genome (The
Arabidopsis Consortium 1999).
The centromere of Arabidopsis chromosome IV
was more complex than we expected. Although we
were not able to sequence the entire centromeric
region, we were able to sequence substantial contingu-
ous regions of the centromere. These results showed a
relatively complex structure that has genes containing
unique sequence present between regions of highly
repetitive DNA (The Arabidopsis Consortium 1999;
Copenhaver et al. 1999). This sequence will provide
the tools (probes, information for computational
analysis) to understand further the structure and func-
tion of the centromeres of high eukaryotes.
In addition to the centromeric region, Paul Fransz
(Fransz et al. 2000) observed a region of condensed
chromatin on the short arm of chromosome IV, which
was being sequenced by our group (CSHL/WUGSC/
PEB Arabidopsis Sequencing Consortium 2000). This
region appeared to resemble the heterochromatic knobs
described previously in maize by McClintock (Science
69: 629 [1929]). This region of heterochromatin was
completely sequenced and analyzed. It shows an incred-
ible density of repeat DNA including multiple copies of
a large tandomly arrayed sequence. The availability of
this sequencing will be invaluable in trying to under-
stand the nature of chromosome condensation and its
associated properties.
Following completion of chromosome IV, we will
finish working on our region of chromosome V
including the chromosome V centromere. We are
scheduled to complete the majority of this sequencing
by July 2000. We estimate that all of the euchromatic
region of the Arabidopsis genome will be completed
by the end of 2000.
RICE GENOME SEQUENCING
This work was done in collaboration with Rob
Martienssen (CSHL), Rod Wing (Clemson Univer-
sity), and Elaine Mardis and Richard K. Wilson
(Washington University). The monocot plant rice is
one of the most important crop plants in the world. In
addition, it has the most compact genome among the
cereals (corn, wheat, barley, etc.). Hence, coupled with
the compact dicot genome of Arabidopsis, rice repre-
sents one of the most tractable targets for plant
genome sequencing. The rice genome has recently
been targeted for an international sequencing effort.
Our group, in collaboration with Clemson University,
was funded to begin sequencing chromosome 10 of
rice in late 1999.
Since beginning this project in October 1999, we
have already started sequencing a large number of
BACs. We currently have about 2.5 Mb, one half of
our scheduled sequencing for the period from October
1999 to September 2000, in progress.
CANCER GENETICS
This work was done in collaboration with Mike Wigler,
Masaki Hamaguchi, and Robert Lucito here at the
Laboratory. We have been collaborating with the Wigler
lab to carry out gene discovery by sequencing areas of
the genome deleted in breast cancer. The first three
areas of focus are chromosomes 4, 8, and 20. We have
completed sequence skimming of a 120-kb region on
chromosome 8, and a more complete sequence of
another 120 kb from this region is nearing completion.
We have completed sequencing a 269-kb region on
chromosome 20 and have significant sequence data
from an additional 206-kb-region from chromosome 20
and are completing this sequence. We have completed a
partial sequence of about 360 kb from chromosome 4.
Another roughly 800 kb from different areas of the
genome are being sequenced as part of this project. We
have also begun pilot studies to prepare for the sequence
of probes to be used in microarray studies.
The generation of this much sequence data and its
analysis present considerable challenges to our infor-
matics capabilities. To use this data effectively, we have
begun developing a number of tools both to track the
progress of projects and to analyze the resultant data.
We have set an intranet-based project tracking system
that allows the status of projects to be monitored by staff
in both the Wigler and McCombie labs. This system
also allows appropriate personnel in both labs to enter
data and change the priority of projects. Status informa-
tion such as how many sequence reads have been done
for a project is automatically retrieved from a relational
database and displayed on the web page. We have devel-
oped a data analysis pipeline that relies largely on
BLAST searches at the present time.
For data analysis, the thousands of reads that are
generated are used to search public sequence databas-
es. This is done through a Web-based multiple BLAST
server developed for this project (with partial support
from the Cancer Center Informatics Facility). After
BLAST searches are done, the sequences and the
search results are copied to computer directories
where they can be accessed by the Wigler lab. The data
analysis pipeline will soon have automated searches
that are carried out as sequences are generated. The
results will be parsed for significant matches to the
databases and notifications sent to appropriate person-
nel to check the results of the searches. In addition, the
facility to automatically re-search the databases using
old data to look for new matches will be built into the
process. This is quite important given the rapid pace of
DNA sequence generation worldwide. Importantly,
many of these same tools will be usable by members
of the Cancer Center as a whole and not just those
involved in this specific project.
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SEQUENCE-BASED PREDICTION OF PROTEIN
STRUCTURE AND FUNCTION
Neuwald A. Poleksic
T. Carlson
K. Christie (URP)
Our goal is to derive important clues to the cellular
roles of various proteins by examining conserved pat-
terns present in related sequences. This can be com-
pared to deciphering the meaning of an unknown lan-
guage, where the genome projects perform the role of
the archeologist by unearthing volumes of books writ-
ten in that language. Experimental laboratories serve
as the Rosetta stone by providing insight into the lan-
guage's meaning through direct observation. We per-
form the role of the linguist who attempts to better
understand the language by combining translated
material with observations about the patterns of letters
in the untranslated material; i.e., in the light of the
available experimental evidence, we search for con-
served patterns in protein sequences corresponding to
similarities in structure and function. This year, a
major focus has been the characterization of sequence
motifs corresponding to repetitive structural features.
On a larger scale, we have also studied the types of
domains shared by functionally related proteins.
DETECTION, ALIGNMENT, AND MODELING OF
REPETITIVE PROTEIN STRUCTURES
The repetitive structures we have been studying include
bihelical repeats, 0-stranded repeats, and more com-
plex repeats such as are found, for example, in DNA
polymerase sliding clamp proteins. Bihelical repeats
can be described as molecular curlicues that function as
flexible joints, which wrap around and bind to target
substrates, and as scaffolding, on which other molecu-
lar structures may assemble. Thus, these repeats appear
to function in the recognition of target sequences and in
the assembly of cytoskeleton-like structures. This class
includes HEAT, Armadillo, tetratricopeptide, and
ankyrin repeats. Examples of 13-stranded repeats
include 0-propeller and 0-barrel repeats, which form
repetitive structures resembling the blades of a pro-
peller and the staves of a barrel, respectively.
We have been studying repetitive motifs for sever-
al reasons. First, many repeat-containing proteins are
biologically and medically important, and we aim to
make some key predictions regarding their functions.
Several HEAT repeat proteins described below, for
example, are associated with cohesins and con-
densins-complexes that perform key roles in sister
chromosome cohesion and chromosome condensation
during cell division. HEAT repeats also occur in the
Huntingtin protein, which is associated with a progres-
sive neurodegenerative disorder called Huntington's
disease.
Another motivation for this research is that even
though repetitive structures are quite common, the
corresponding sequence repeats are typically very
subtle, and as a result, the repeats are often only dis-
covered after experimental determination of a protein's
three-dimensional structure. It would be helpful to be
able to predict these repeats based on a protein's
sequence alone, but there has been a lack of adequate
tools for this purpose because repeats add an addition-
al layer of algorithmic and statistical complexity to
fundamental sequence analysis problems. Through the
development and application of several new approach-
es, however, we can now predict the presence of very
subtle repeats in many proteins.
This was achieved by attacking the problem on
three fronts using a combination of computational, sta-
tistical, and biological analyses. First, the use and con-
tinued development of C" libraries containing a large
repertoire of basic sequence analysis routines have
provided us with the necessary computational tools.
Second, improved statistical models were developed
and, within various programs, are now automatically
fitted to the characteristics of a particular repeat fami-
ly. Insertions and deletions within sequences, for
example, can now be detected more readily by using
information about the secondary structure, sequence
conservation, and hydrophobicity associated with a
particular class of repeats. Similarly, repeat alignment
procedures now make use of clusters of closely related
sequences to better locate insertions and deletions.
Finally, rather than developing these methods based on
theory alone, each of these computational and statisti-
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FIGURE 1 Domains present in representative HEAT repeat proteins.
cal improvements stems from extensive testing on actu-
al repeat families, such as the HEAT repeat proteins.
ANALYSIS OF HEAT REPEATS
HEAT repeats correspond to tandemly arranged struc-
tural elements consisting of two conserved a helices
connected by a loop region. The name "HEAT" repeat
is an acronym derived from four characterized proteins
with these repeats, namely the Huntingtin protein,
elongation factor 3, the A subunit of PP2A phos-
phatase, and TOR kinases. In searches of the protein
database for HEAT repeats, we detected matches in
diverse proteins, many of which had not been previ-
ously reported to contain these repeats. These include
several families of condensin- and cohesin-associated
proteins.
In all, we found four families of condensin- and
cohesin-associated proteins with HEAT repeats. These
include members of two proteins families correspond-
ing to the XCAP-D2 and XCAP-G subunits of the
Xenopus laevis 13S condensin complex, which Dr.
Hirano here at the Laboratory has been studying for
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several years now. Because we also detected the HEAT
repeat in vesicle coat proteins that assemble into scaf-
fold structures, an intriguing possibility is that these
XCAP-G, XCAP-D2 condensin subunits perform a
role in nuclear scaffold assembly. HEAT repeats also
occur in another family of proteins that possibly inter-
act with the cohesin complex; this family includes
Sordaria macrospora Spo76p, which is required for
sister chromatid cohesiveness and chromatin conden-
sation in meiosis. A fourth family includes the bud-
ding yeast Scc2p, which is responsible for sister chro-
matid cohesion, and the Drosophila Nipped-B protein,
which participates in transcriptional activation by
remote enhancers. In the same analysis, we discovered
HEAT repeats in other chromosome-associated pro-
teins, including the TBP-associated protein TIP120,
which globally enhances transcription by all three
RNA polymerases, and the budding yeast Mot I p.
Mot 1 p is a member of the SWI2/SNF2 family, which
consists of helicases that perform diverse roles in tran-
scription control, DNA repair, and chromosome segre-
gation and that often form ATP-dependent chromatin
remodeling complexes.
ANALYSIS OF DOMAINS PRESENT IN
FUNCTIONALLY RELATED PROTEINS
We have also examined protein function on a grander
scale by looking at the various domains associated
with groups of functionally related proteins. Figure 1,
for example, shows a number of domains associated
with HEAT repeat proteins. This sort of figure can be
generated automatically using our own and the pub-
licly available protein domain databases, along with
various programs developed in our group. As a result,
we can now very quickly look for domain associations
within a particular protein family and between various
families. There are numerous applications for these
tools. One application, which stems from a collabora-
tion with Dr. Spector's laboratory, is to characterize
proteins associated with internal nuclear domains
called interchromatin granule clusters (IGCs). By ana-
lyzing IGC components identified by Dr. Spector's
laboratory in this way, we aim to better understand the
functions associated with these nuclear domains.
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During 1999, our focus has continued to be on struc-
tural studies aimed at understanding the molecular
mechanisms of pre-mRNA splicing and initiation of
DNA replication. In collaboration with Adrian Krainer
here at the Laboratory, we are continuing our efforts of
crystallizing and solving the crystal structure of vari-
ous complexes of heterogeneous nuclear ribonucleo-
protein (hnRNP) Al and SR proteins. We completed
the crystal structure of the functional domain of
Prpl 8p, a yeast protein involved in the second step of
splicing, in collaboration with David Horowitz at
Uniformed Services University of the Health Sciences.
We are investigating the structure and function of the
origin recognition complex (ORC) and minichromo-
some maintenance complex (MCM) proteins in collab-
oration with the Stillman lab here at the Laboratory.
Two areas of research are highlighted below.
CRYSTAL STRUCTURE OF THE FUNCTIONAL DOMAIN
OF THE SPLICING FACTOR PRP18P
Splicing of mRNA precursors takes place in two
sequential transesterification reactions. The splicing
reactions occur within a large RNP particle called the
spliceosome, which assembles in an ordered pathway
on the pre-mRNA. Once the spliceosome is assembled,
the two splicing reactions appear to require only the
U2, U5, and U6 small nuclear RNP particles
(snRNPs), as well as a large number of proteins. In the
second reaction, nucleophilic attack by the 3'-hydrox-
yl group of the first exon on the phosphate at the 3'
splice site in the lariat intermediate yields the spliced
mRNA and the lariat intron.
In Saccharomyces cerevisiae, Prpl 8p is involved
only in the second step of splicing and is associated
with the U5 snRNP. We have isolated and determined
the crystal structure of a large fragment of the S. cere-
visiae Prpl 8p that lacks the amino-terminal 79 amino
acids. This fragment, called Prp18479, is fully active
in yeast splicing in vitro and includes the sequences of
Prp 1 8p that have been conserved evolutionarily. The
core structure of Prp18479 is compact and globular,
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consisting of five a helices, which adopt a novel fold
that we have designated the five-helix X-bundle. The
structure suggests that the interaction between Prpl 8p
and Slu7p occur on one face of Prpl8p, whereas the
more evolutionarily conserved amino acids in Prpl8p
form the opposite face. The most highly conserved
region of Prpl8p, a nearly invariant stretch of 19
amino acids, forms part of a loop between two a
helices and may interact with the U5 snRNP. The
structure is consistent with a model in which Prp18p
forms a bridge between Slu7p and the U5 snRNP.
PREREPLICATIVE COMPLEX IN EUKARYOTIC DNA
REPLICATION
Eukaryotic initiation of DNA replication requires the
assembly of a multicomponent prereplicative complex
(pre-RC) around the origin of replication. The pre-RC
is composed of the ORC, the MCM complex, and the
CDC6 and CDC45 proteins. Structural information of
any of the pre-RC components will provide important
insights into the mechanism of pre-RC assembly and
function.
FIGURE 1 Scanning transmission electron microscopy (STEM)
showing that mtMCM forms a double hexamer. Bars, 200A.
Complete genome sequencing of a number of
archaea has revealed that the initiation of DNA repli-
cation in archaea may resemble that in eukaryotes.
ORC/CDC6 and MCM-like open reading frames
(ORFs) have been identified in archaea. It is likely that
archaea can serve as a simplified system for studying
eukaryotic DNA replication. In collaboration with
James Chong in Bruce Stillman's lab, we have cloned
several MCM-like genes and have overexpressed and
purified the proteins for structural and functional stud-
ies. The thermophilic methanogen, Methanobacterium
theroautotrophicum, has a single MCM-like gene
(MtMCM), and we have shown that purified protein
forms a complex that is consistent with it being a dou-
ble hexamer (Fig. 1). The protein binds to DNA in an
ATP-independent manner, and it has a DNA-stimulat-
ed ATPase activity and a helicase activity. We are cur-
rently optimizing crystallization conditions for obtain-
ing diffraction quality crystals.
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COMMUNITY ACCESS TO GENOME RESOURCES
D. Stein
During the past year, my lab has developed two soft-
ware tools that are key to the visualization and annota-
tion of the Caenorhabditis elegans genome. Ace Perl
provides a programmatic interface to remote and local
ACEDB databases in the popular Perl programming
language. Ace Browser is layered on top of AcePerl to
provide Web access to the C. elegans data. These soft-
ware tools were released in October of 1998 and are
currently in use at dozens of laboratories around the
world. In addition, the tools have proven to be of use
in nonbiological domains as well. For example, the
tools are in use in the University of Pennsylvania's
library catalog system and at Lawrence Berkeley
National Laboratory to map and manage network
topologies. This general usefulness won the recogni-
tion of the Long Island Software Award organization,
which awarded the software the top prize in the Large
Business category. AcePerl can be found at:
http://stein.cshl.org/AcePerl
AcePerl is now being used as the basis on which to
build a distributed sequence annotation system, which
will allow laboratories around the world to add
sequence annotation information to the reference C.
elegans sequence. This system will work hand-in-
glove with the formal curatorial system installed at
Sanger Centre and Washington University. A proto-
type of this system is available at:
http://stein.cshl.org/wormbase
In the past year, we received a contract from The
SNP Consortium, Ltd., to serve as the bioinformatics
component of a large effort to identify 300,000 new
human single-base-pair polymorphisms (SNPs). We
have designed information workflow systems, analysis
tools, and a database to display and manipulate the
data. Currently, we have mapped and released more
than 7000 SNPs from a total of approximately 40,000.
The first data release occurred on November 11, 1999,
and a subsequent release occurred on December 23.
Regular releases will continue on a bimonthly basis
until the entire set of 300,000 SNPs has been placed in
the public domain.
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FIGURE 1 More than 7000 mapped human single
nucleotide polymorphisms are available at Dr. Stein's
Web site.
COMPUTATIONAL GENOMICS
M.O. Zhang J. Tabaska I. loshikhes J. Zhu
R.V. Davuluri T. Zhang A.G. de Alcantara
Our research interest continues to be identification and
characterization of the genetic elements in nucleic acid
sequences by computational means. As the Human
Genome Project entered its large-scale sequencing
phase, developing efficient computational methods for
identification of genes and their control/regulatory ele-
ments has become extremely important. Knowing the
organization of a gene often becomes the prerequisite
for further functional studies. In the past, we studied
statistical characteristics of exons and introns in pro-
tein-coding regions and developed coding-exon predic-
tion programs by applying multivariate statistical pat-
tern recognition techniques. We then began looking
into more difficult problems of finding regulatory cis
elements in noncoding regions. This year, we continue
to focus on splicing enhancers, promoters, and tran-
scriptional start site and polyadenylation site regions in
order to develop new computational methods for iden-
tification of these functional elements. To facilitate
large-scale gene expression data mining, we have also
developed several computational tools for clustering
and promoter analysis.
Dr. Tabaska has joined Monsanto as a software
engineer, Dr. Ioshikhes went on to an instructor's posi-
tion at Albert Einstein College of Medicine, and Dr.
Zhu started a new staff investigator position at
Koffmann La Roche.
Large-scale Human Promoter
Mapping Using CpG Islands
I. loshikhes, M.Q. Zhang
Approximately 50% of mammalian gene promoters is
known to be associated with CpG islands. We have
devised features that can discriminate the promoter-
associated CpG islands from the nonassociated
islands, which led to an effective algorithm for large-
scale promoter mapping (with 2-kb resolution).
Statistical tests showed that approximately 85% of the
CpG islands within an interval from -500 to +1500
around the TSS (transcriptional start site) were cor-
rectly identified and that about 93% of the CpG-
island-containing promoters were correctly mapped.
3"-Terminal Exon Recognition
J. Tabaska, M.Q. Zhang
Reliable detection of gene termini is critical to the suc-
cess of automated gene discovery in genomic
sequences. To resolve a string of exons into individual
genes, one needs to know the location of the 5'- and
3 "-terminal exons. Terminal exon detection has
remained a weak point for many gene prediction meth-
ods; these programs are frequently criticized for their
propensity to skip terminal exons, thereby fusing sev-
eral genes together. To help fill this gap in gene pre-
diction technology, we have developed a 3 "-terminal
exon recognition module for the MZEF exon finding
program.
The major obstacle to detecting 3' terminal exons
is the signal-to-noise ratio: only about 10% of coding
exons are 3' termini, and since the consensus splice
donor sequence (G1GTRAGT) contains a stop codon,
which is in the best coding frame one third of the time,
roughly this proportion of internal exons will look like
3'-terminal exons. To help overcome this problem, our
terminal exon finder uses a two-pass approach. First,
the program scans input sequences for splice acceptor
sites. Putative splice acceptors are evaluated using a
quadratic discriminant function (QDF) of eight vari-
ables. In addition, for each acceptor site, the best cor-
responding stop codon is determined using a novel
Bayesian scoring function that allows coding frag-
ments of widely disparate lengths to be evaluated and
compared. During this scan, no attempt is made to dif-
ferentiate between internal and terminal exon acceptor
sites; all acceptor stop codon pairs are simply consid-
ered to be terminal exon candidates. An intermediate
filtering step performed after the acceptor site scan
then reduces the candidate list by removing overlap-
ping exons. A second pass through the sequence is
then performed to find splice donors and polyadenyla-
tion signals. This scan makes use of a QDF of six vari-
ables for the donor sites and a QDF of three variables
for poly(A) signals. When a donor site isfound, it is
matched up with an acceptor site to form internal
exons; these candidate exons are then removed from
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consideration. When a poly(A) signal is detected, it is
matched up with an acceptor site and evaluated using
a QDF of four variables. High-scoring terminal exons
are then reported to the user.
In a test using 42 genomic sequences containing 97
known genes, our terminal exon finder correctly iden-
tified 70 3' termini (72.2% sensitivity) with 54 false
positives (56.5% specificity). Including cases where
the program predicted a 3 '-terminal exon that over-
lapped a true terminus, our program achieved 86.6%
sensitivity with 60.9% specificity. On the same test set,
GENSCAN, which is currently regarded as the best
human gene finder, finds 59.8% of the 3 "-terminal
exons with 61.7% specificity. Our exon finder thus has
a higher sensitivity level with comparable specificity.
Significantly, though, in cases where there are two or
more adjacent genes on the same strand, GENSCAN
fuses the genes together more than three fourths of the
time, i.e., it has a sensitivity of less than 25% in such
cases. In contrast, our exon finder's sensitivity remains
approximately the same (75.9%) in these cases as in the
overall test. We are therefore confident that our termi-
nal exon finder will prove to become a valuable addi-
tion to the gene-finding repertoire.
Computational Tools for Large-scale
Gene Expression
J. Zhu, M.Q. Zhang
Coregulated gene clusters could be derived based on
common expression profiles, some function or path-
way information, or sharing promoter regulatory ele-
ments. To obtain a thorough understanding of large-
scale gene expression and global regulation networks,
these three aspects should be combined in an organic
manner. In the process of studying various microarray
gene expression data, we explored possible ways of
analyzing large-scale gene expression data. Three
approaches were used to analyze yeast temporal
expression data: (1) start from clustering on the
expression profiles, followed by function categoriza-
tion and promoter analysis; (2) start from function cat-
egorization, followed by clustering on expression pro-
files and promoter analysis; and (3) start from cluster-
ing on the promoter region, followed by clustering on
expression profiles. For clustering analysis on the
time-series data, we developed a largest-first algo-
rithm, which can provide a mechanism for quality con-
trol on clusters. For promoter analysis, we developed a
core-extension algorithm which can systematically
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detect a motif core and then try to extend it into the
flanking regions by x2 tests. We have also implement-
ed our own version of Kohonen self-organized map
(SOM) clustering algorithm and coupled its result
with a x2-based regulatory motif-finding algorithm
that can detect significant cis elements in the promot-
er region of each cluster of coregulated genes.
Toward Detection of 5' and 3' Ends of
Protein Coding Genes in the Genome
R. Davuluri, M.Q. Zhang
We continue the process of developing a complete
gene prediction system with a current focus on detect-
ing the ends. As one of the steps toward this goal, a 3%
terminal exon recognition module has recently been
added to MZEF (internal exon finding program). Our
next step in achieving this task is the development of a
5 '-terminal exon detection module. Toward this end,
we have prepared a database of human 5'-untranslated
regions (UTR) of mRNA which are complete from the
transcription start site to the translation start site. We
are characterizing the important features of these
5'UTRs by data-mining techniques.
Development of a 5'-terminal exon finder involves
some special challenges, especially with regard to the
detection of transcription start site. Most of the exist-
ing gene-finding programs predict the protein-coding
regions and ignore the untranslated regions of mRNA.
These programs define the 5' end of the gene as the
translation start site. In fact, to our knowledge, no pre-
diction program is available for finding the 5'UTR of
the mRNA. In most of the 5 "-terminal exons, there is
very little or no coding information left, and hence we
are statistically characterizing the 5'UTRs to find
important features present in this part of the gene.
These regions of the gene are known to contain trans-
lational regulatory elements, and the predicted 5'-ter-
minal exon will include this valuable information.
To ensure that we use the best possible data, we
have prepared a nonredundant data set of 2300 full-
length (transcription start site to translation start site)
human 5'UTR sequences. We obtained these
sequences from two different sources: (1) Sugano's
Laboratory, University of Tokyo, Japan and (2)UTRdb
(http://bigarea.area.ba.cnr.it:8000/BioWWW/-
UTRdb). Each of the sequences in the database has
been checked for their completion at both 5' and 3'
ends. We have collected a number of examples on reg-
ulatory elements in the 5 'UTR from published litera-
ture. This information along with computational
approaches allowed us to classify these 5 'UTRs into
two categories (1) genes with low translation efficien-
cy and (2) genes with high translation efficiency. This
will help us to find the feature variables for the gene
modeler. The database of 5 'UTRs is being extended so
that each sequence in the database would contain
flanking regions of 500 nucleotides at both ends.
We currently have a poly(A) signal finder, called
Polyadq, which was developed by Tabaska and Zhang.
We improved this program by adding a new version for
mouse. We call this new version "Polyadq2." Polyadq2
performed substantially better than Polyadq with a
correlation coefficient of 0.601. We are in the process
of adopting this new version for human sequences, and
it will be made available through the World Wide Web.
Computational Characterization
of Liver-specific Promoters
T. Zhang, M.Q. Zhang
Our work focuses on developing computational tools to
detect regulatory regions (i.e., promoters) that confer
tissue-specific gene expression. Our approach uses
liver-specific gene promoters, mainly because of the
recent advances in the studies of the liver-specific tran-
scription factors. First, we collect all liver-specific tran-
scription-factor-binding sites that are experimentally
verified in literature. Second, we construct PWMs
(positional weighted matrices) that summarize the
binding sites in our collection. Third, we apply linear
regression analysis to combine matches to multiple
binding sites into a single model. For various test sets,
our models have achieved the state-of-art performance.
We are currently investigating ways to enhance the
performance of our models. The most promising direc-
tion is to incorporate additional regulatory elements
into our models. Such elements could bind to tran-
scription factors other than the four factors already
examined in building the existing models, or they
could be related to secondary structures. To identify
such elements, we have developed new algorithms to
search for motifs that are significantly over/underrep-
resented in the given promoter sequences. In contrast
to the previous motif-finding methods, we now allow
both mismatches and gaps in our motifs, which reflect
more realistically the actual DNA and protein interac-
tion. Another approach to discover putative motifs is
by comparing promoters from distantly related
species. In general, functional regions are more likely
to be conserved over evolution than nonfunctional
regions. By carefully selecting the organisms under
examination, we can identify conserved regions,
which are the putative functional regions.
Identification of Splicing
Enhancer Motifs and Splicing Factors
M.Q. Zhang in collaboration with A. Krainer and A. Mayeda,
Cold Spring Harbor Laboratory]
We have continued the work of identifying splicing
enhancers by acombination of biochemical and com-
putational means. After charactering SF2/ASF, SRp40,
and SRp55 functional enhancers, we also studied the
SC35 enhancer motif. We have also purified and char-
acterized the human RNPS 1 (a general activator of
pre-mRNA splicing) and found that it is conserved in
metazoans.
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NEUROSCIENCE
As the twentieth century draws to a close, hindsight clearly reveals that we are in the midst of a genet-
ic revolution. Its hstorical roots, of course, reach back in the previous century to the seminal insights of
Darwin and Mendel. The modern revolution, however, began with discovery of the double helix. From
that point on, "molecular biology" has come to encompass all of the natural sciences, including neuro-
biology. The neurogenetic perspective first emerged with simple invertebrate model systems in the
1960s and exploded into mammals in the 1990s. In the next few years, as the Human Genome
Sequence comes on-line, the genetic revolution will sweep full force into human cognition.
Relatively quickly, the DNA sequence will help to identify and categorize various forms of heritable
cognitive dysfunction. To develop useful therapies for cognitive dysfunction, however, we will have to
gain biological insight to how the DNA sequence gives rise to the emergent properties of brain func-
tion. This is the problem of vertical integration of gene function to cognition. In no other organ is the
problem as complex. The brain is unique, evolutionarily designed to sense its internal and external envi-
ronment, to perceive causal relations among stimuli, and to change its response adaptively. To accom-
plish this incredible task, a self-regulating network of 70 thousand genes directs the development of a
cellular network of 1 trillion neurons with 70 trillion connections among them. To add to such stagger-
ing complexity, the computational activity generated by this neural network continually feeds back on
the underlying gene network by regulating the expression of "plasticity" genes, which then alter neural
connectivity.
To accomplish a vertical integration, neurogenetic experiments must be pursued at genetic, cellular,
systems and behavioral levels of analysis. To this end, CSHL was joined by three new faculty this year:
Dmitri Chklovskii, Zach Mainen, and Tony Zador, who focus their research on computational aspects of
brain circuitry. In this manner, the cellular functions (and dysfunctions) of neural genes are translated
into behavioral responses via dynamic properties of the underlying neural circuits. Next stop, human
cognition!
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ACTIVITY-DEPENDENT NEURONAL DEVELOPMENT
H.T. Cline C. Aizenman L. Foa Z. Li
K. Bronson K. Haas E. Ruthazer
I. Cantallops A. Javaherian W.C. Sin
M. Davenne K. Jensen D.-J. Zou
The structure of the dendritic arbor of neurons is a crit-
ical determinant of the neuron's function in terms of the
inputs it receives and the integration of the synaptic
inputs. For instance, a neuron within the visual system
that has a large tangential spread of the dendritic arbor
can receive inputs from more visual afferents, leading
to a larger receptive field over which information is
processed. Similarly, neurons that extend their dendrit-
ic arbor into superficial laminae are capable of receiv-
ing inputs and processing information from afferents in
those laminae. Consequently, the factors that regulate
the development and plasticity of the dendritic arbor
control both the structure and function of the neuron
and likely have an impact on circuit properties.
The molecular mechanisms that underlie the
development of the dendritic arbor are not yet clear. In
my lab, we use in vivo time-lapse imaging to make
direct observations of dendritic arbor development.
We combine this with viral gene transfer to introduce
genes of interest into optic tectal neurons. Time-lapse
images of optic tectal neurons collected at intervals
ranging from minutes to days in living Xenopus tad-
poles show that dendritic branches are very dynamic
during dendritic arbor formation. The dynamic
processes include addition of new branches, retraction
of branches, and selective extension or shortening of
existing branches. These events can be observed and
quantified by collecting repeated images over several
hours. The data suggest that the net growth of dendrit-
ic arbor occurs as a result of several distinct events: the
emergence of a new branch, the selective maintenance
of the new branch, and the extension of the branch
length. It is possible that each of these events is indi-
vidually regulated within the dendrite. One goal of our
research is to determine the mechanisms controlling
dendritic arbor development.
Neuronal dendritic arbors do not develop in a vac-
uum. As part of a circuit controlling brain function,
they develop in a coordinated fashion with presynap-
tic axonal inputs, and these pre- and postsynaptic part-
ners also work together during the development and
plasticity of synaptic connections. Several projects in
the lab examine coordinated development of these
multiple aspects of circuit formation.
Control of Dendritic Structure
In Vivo during Normal
Development and by CaMKII
G.-Y. Wu, D.-J. Zou, K. Bronson, H.T Cline
Developing neurons coordinate their morphological
and functional development. We showed previously
that calcium/calmodulin protein kinase type II
(CaMKII) activity is sufficient to promote both the
maturation of retinotectal glutamatergic synapses in
Xenopus and the morphological maturation of optic
tectal neurons using in vivo time-lapse imaging of sin-
gle neurons over periods up to 5 days. Gang-Yi Wu
carried out a thorough quantitative analysis of the
morphological development of efferent optic tectal
cells. We distinguish the neuronal development into
three stages: Stage-1 neurons are newly differentiated;
they undergo axonogenesis with little elaboration of
the dendritic arbor. Stage-2 neurons are in a phase of
rapid dendritic growth. After 2 days, neurons enter
stage 3, a period of slower dendritic arbor growth.
Short-interval observations indicate that stage-2 neu-
rons have branch additions and retractions twice that
of the more mature stage-3 neurons.
Our previous experiments demonstrated that
CaMKII expression in tectal neurons correlates with
the transition from rapidly growing stage-2 neurons to
more stable stage-3 neurons. D.-J. Zou tested whether
endogenous CaMKII activity in postsynaptic tectal
cells regulates the elaboration of neuronal processes in
the Xenopus tadpole retinotectal projection by selec-
tively infecting postsynaptic tectal cells with recombi-
nant vaccinia viruses that express CaMKII-specific
inhibitory peptides. Using in vivo time-lapse imaging,
he found that CaMKII inhibitor autoinhibitory peptide
(AIP) expression in postsynaptic tectal cells increased
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the elaboration of both tectal cell processes and presy-
naptic retinotectal axon arbors. The results suggest
that endogenous postsynaptic CaMKII activity regu-
lates the coordinated development of pre- and postsy-
naptic arbor structures.
Role of Glutamate Receptor Activity
in Development of Tectal Cell
Dendrites and Retinal Axons In Vivo
I. Rajan, K. Bronson, H.T. Cline
Previous studies by O'Rourke, Cline, and Fraser
(Neuron 12: 921 [1994]) suggested that blocking
retinotectal synaptic activity might increase the elabo-
ration of retinal axon arbors, whereas experiments by
Rajan and Cline (J. Neurosci. 18: 7836 [1998]) indicate
that blocking activity can limit elaboration of the den-
dritic arbor. I. Rajan investigated the role of N-methyl-
o-aspartate (NMDA) receptor activity in the formation
of both the presynaptic axon arbor and postsynaptic
dendritic arbors in vivo by taking time-lapse confocal
images of single DU-labeled Xenopus retinotectal
axons and optic tectal neurons in the presence and
absence of the NMDA receptor antagonist, amino
phosphono valeric acid (APC). Retinotectal axons or
tectal neurons were imaged at 30-minute intervals over
2 hours or twice over a 24-hour period. Retinal axons
in animals exposed to APV in rearing solution show an
increase in rates of branch additions and a decrease in
branch lifetimes compared to untreated axons. Under
the same experimental conditions, tectal neurons show
a decreased rate of branchtip additions and retractions
and a decrease in branch lifetimes. APV treatment over
24 hours had no apparent effect on axon arbor mor-
phology, but it did decrease tectal cell dendritic devel-
opment. These observations indicate that NMDA
receptor activity in postsynaptic neurons promotes the
initial development of the dendritic arbor and stabilizes
presynaptic axon arbor morphology.
Structural Plasticity of
Retinal Axon Arbors
E. Ruthazer, H.T. Cline
The goal of E. Ruthazer's experiments is to analyze the
role of coordinated activity in the structural plasticity
of retinal axon arbors. To do this, he has developed an
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experimental system that allows him to compare the
structural dynamics of retinal axons in an environment
in which their activity is either largely coordinated or
largely not coordinated with the activity of the other
retinal axons in the target area. The experimental sys-
tem that allows this comparison is one in which both
retinal projections are forced to converge on the same
optic tectal neuropil. The activity patterns from the
two eyes differ from each other. Initially, the inputs
from the two eyes overlap in the tectal neuropil, but
they gradually segregate out during a period of 1 week.
E. Ruthazer has collected time-lapse images of single
retinal axons early in the segregation process, when
coactivity levels are relatively low, and later in the seg-
regation process, when coactivity is likely to be high-
er. Comparison of the dynamics of the structure under
these conditions will allow us to test the effects of dif-
ferent degrees of coactivity on axon arbor dynamics.
Imaging Synaptic Activity
in the Intact Brain
K. Haas, H.T. Cline [in collaboration with A.R. Kay,
University of Iowa]
The fluorescent probe FM1-43 has been used exten-
sively for imaging vesicle recycling; however, high
background fluorescent levels have precluded its use
in most experiments using brain slices of intact tis-
sues. We have found that a sulfobutylated derivative of
[3- cyclodextrin has a higher affinity for FM1-43 than
the plasma membrane and can therefore act as a carri-
er to remove FM1-43 nonspecifically bound to the
outer leaflet of the plasma membrane. This has
enabled us to visualize synaptic vesicle recycling in an
isolated brain preparation from Xenopus. We also
found that FM1-43 labeling can work well in the
translucent tadpole brain tissue without the addition of
the cyclodextrin.
Candidate Plasticity Genes
I. Cantallops, M. Davenne, L. Foa, K. Haas, K. Jensen,
A. Javaherian, K. Bronson, H.T. Cline [in collaboration
with K Worley, Johns Hopkins University, and E. Nedivi,
Massachusetts Institute of Technology]
Our experiments have demonstrated the important role
of synaptic activity in promoting the development of
the brain. One potential effect of synaptic activity is to
induce gene transcription. The activity-induced genes
may then promote the further development of the
brain. We have begun to investigate several activity-
induced genes to test their potential function in brain
development.
CPG15 Expression in the Tectal Cell
Increases Presynaptic Retinal
Axon Arbor Growth In Vivo
I. Cantallops, K. Bronson, H.T. Cline
E. Nedivi, G.-Y. Wu, and H.T. Cline had previously
shown that viral expression of CPG15 in optic tectal
neurons selectively increases the dendritic arbor elab-
oration of tectal projection neurons but has no effect
on the elaboration of tectal interneurons. We have also
reported that CPG15 functions in a non-cell
autonomous fashion to promote the growth of neigh-
boring neurons. This suggests that CPG15 may act as
a signaling molecule. I. Cantallops tested the effect of
viral expression of CPG15 in tectal neurons on the
development of presynaptic retinotectal axons. She
collected images of single labeled retinal ganglion cell
axons over a 2-day period in vivo. CPG15 expression
in tectal cells increases the length of retinal axons in
comparison with axons imaged in lacZ vaccinia-virus-
infected controls. Overexpression in tectal cells of a
truncated form of the protein lacking the GPI link
domain blocks the growth-promoting effect seen with
full-length CPG15, indicating that GPI linkage of
CPG15 to the membrane is necessary to mediate this
effect. These results together with those of K. Haas
(below) suggest that CPG15 may coordinate multiple
aspects of circuit formation in the visual system.
CPG15 Promotes Maturation of
Retinotectal Synapses
K. Haas, H.T. Cline
Based on the studies mentioned above, we postulated
that CPG15 affects the synaptic development in the
visual system. K. Haas recorded synaptic responses
from neurons in animals infected with the CPG15 vac-
cinia virus to test whether the enlarged dendritic and
axonal arbors are accompanied by an increase in the
strength of retinotectal synaptic transmission. He
found that expression of CPG15 promotes synapse
maturation, whereas expression of a truncated form of
the protein, lacking the GPI link, deters synaptic mat-
uration. The frequency of spontaneous synaptic cur-
rents also increases with CPG15 expression, as we
have seen with synaptic maturation in control animals.
The strong correlation between the increased matura-
tion of synaptic responses and increased morphologi-
cal complexity in dendritic and axonal arbors suggests
that CPG15 may be a key player in the regulation of
both neuronal growth and synaptic function.
Developmental Regulation of cpg15
Gene and Protein Expression
A. Javaherian, H.T. Cline
To determine how CPG15 expression is regulated in
the developing nervous system, A. Javaherian cloned
cpg15 from Xenopus. The gene from Xenopus is high-
ly homologous to cpg15 from rats, cats, and humans.
The cpg15 message is highly expressed in retinal gan-
glion cells, but no other cells in the retina. Within the
brain, the cpg15 message is widely expressed in dif-
ferentiated neurons. Levels of cpg15 expression can be
decreased by exposure to the NMDA-R antagonist,
APV, supporting the idea that transcription is con-
trolled by glutmate receptor activity.
Analysis of Aberrant Axon
Trajectories in Homer
Expressing Neurons
L. Foa, K. Jensen, H.T. Cline [in collaboration with
P. Worley, Johns Hopkins University]
Axonal growth cone pathfinding during early stages of
central nervous system development is essential to
establish the fundamental connectivity of the brain. The
plethora of molecular mechanisms that guide axons to
their targets operate to minimize axon pathfinding
errors. We have studied axon pathfinding by rostrally
projecting optic tectal neurons in albino Xenopus tad-
poles using time-lapse imaging over periods of several
days. We find that axons do make errors in their pro-
jection pattern, but the errors are typically corrected
over a period of 1 day by retraction of the errant axon.
Furthermore, we find that viral expression of an activ-
ity-regulated gene, homerla, in tectal neurons signifi-
cantly increases the numbers of axons with aberrant
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projection patterns. Time-lapse imaging demonstrates
that the increase in numbers of aberrant projections
results from a failure to correct aberrant axon projec-
tions. The results suggest that normal activity-regulat-
ed expression of Homer in developing tectal neurons
may provide a mechanism that maintains axons within
their target area and thereby limits the ability of the
system to either detect or correct aberrant axons. The
results further suggest that there is a period during ner-
vous system development when axon errors can be cor-
rected, after which such plasticity is limited.
Function of the Rho GTPases
in Regulating Dendritic Arbor
Elaboration and Plasticity
Z. Li, W.C. Sin, K. Bronson, H.T. Cline in collaboration
with L. Van Aelst, Cold Spring Harbor Laboratory]
The Rho family of small GTPases regulates actin
cytoskeletal structure. The signal transduction path-
ways that lead to structural changes in the dendritic
arbor likely include components that regulate the
cytoskeleton. Z. Li tested whether the GTPases, Rac,
Cdc42, and RhoA, regulate dendritic arbor develop-
ment in the intact animal by collecting time-lapse
images over periods of 20 hours of single optic tectal
neurons in albino Xenopus tadpoles expressing domi-
nant negative (DN) or constitutively active (CA) forms
of Rac, Cdc42, or RhoA. Analysis of images collected
at 2-hour intervals over 8 hours indicated that enhanced
Rac activity selectively increased branch additions and
retractions. Cdc42 increased branch dynamics, but to a
lesser extent than Rac. Activation of endogenous RhoA
by LPA dramatically decreased branch extension with-
out affecting branch additions and retractions, whereas
DN RhoA expression increased branch extension.
These data support a model in which Rac and RhoA
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regulate distinct, yet interdependent events in dendritic
arbor development: Enhanced Rac activity increases
new branch additions to the arbor; a decrease in
endogenous RhoA activity promotes the extension of
branches within the arbor. Finally, we provide data sug-
gesting that RhoA activity is involved in mediating the
effect of the NMDA receptor in promoting normal den-
dritic arbor development. W.C. Sin is investigating the
function of the Rho GTPases in short-term dynamics in
optic tectal neurons.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov J. Hemish J. Mignone M. Packer Y. Stasiv
S. John B. Mish N. Peunova A. Vaahtokari
P. Krasnov N. Nakaya V Scheinker M. Verzi
T. Michurina
Stem and progenitor cells receive specific cues to ini-
tiate their differentiation pathways. We are interested
in how cells progress along these differentiation path-
ways and how this is linked to their activity. Our
efforts have been focused mostly on nitric oxide (NO),
a multifunctional second messenger. This signaling
molecule acts in a variety of ways with both short- and
long-term consequences. The former have been well
characterized in the last decade. The latter, including
cessation of proliferation, differentiation, and pro-
grammed cell death, are now beginning to be more
fully appreciated. We have found strong evidence that
NO acts as an essential negative regulator of cell pro-
liferation in several systems. We are now focusing on
the molecular mechanisms of this action of NO during
tissue differentiation and organism development,
using a variety of systems and animal models.
NO and Gene Expression
N. Nakaya, J. Hemish
Much of the action of NO in the organism is mediated
by fast-acting signaling cascades, which rapidly sub-
side after the disappearance of the original stimulus
(e.g., calcium influx). NO can also stimulate signaling
pathways that elicit long-lasting changes in the cell,
such as cessation of cell proliferation, apoptosis, or
acquisition of differentiated phenotype. This action of
NO is presumably due to its ability to affect gene
expression. The molecular mechanisms of gene activa-
tion by NO are poorly understood, and only a few NO-
inducible genes have so far been described.
Identifying an extended set of genes whose expression
is affected by NO will provide an indication of the
direct and indirect targets of NO-related signaling cas-
cades. We have used a eDNA array hybridization
approach to obtain NO-induced transcript profiles and
to identify genes differentially affected by NO. Our
results demonstrate that NO is a potent activator of
gene expression in mammalian cells. More than 7% of
the tested genes are affected by prolonged exposure to
any of three different chemical donors of NO. A sub-
set of genes affected by NO is involved in cell cycle
progression. Another partially overlapping subset of
genes is dependent on p53 for activation by NO, as
revealed by using cells from knockout mice deficient
in p53. Yet other subsets depend on guanylate cyclase,
protein kinase C, and PI3-kinase activity, as revealed
by using selective inhibitors of these enzymes. These
data demonstrate the potential of combining cDNA
array trancript analysis, RNA from normal and trans-
genic animals with defined genetic lesions, and spe-
cific chemical inhibitors to study the long-term effects
of NO action. Our results suggest that NO uses multi-
ple signaling pathways to induce gene activity in
mammalian cells
NO and the p53 Pathway
N. Nakaya in collaboration with S. Lowe,
Cold Spring Harbor Laboratory, and Y. Taya]
NO is an efficient inhibitor of cell proliferation. We
have studied the mechanisms of the antiproliferative
activity of NO and found that it is partially mediated
through the p53 signaling pathway.
We have found that NO strongly induces expres-
sion of genes that are known targets of the transcrip-
tion factor activity of p53. Using cells from transgenic
mice deficient in p53, we have demonstrated that some
of the activated genes depend on p53 for their induc-
tion by NO. We have further found that NO strongly
increases the cellular level of p53 protein. Finally, we
have found that p53-deficient cells are compromised
in their ability to stop dividing in response to NO.
Together, these data strongly implicate p53 and p53-
dependent pathways in NO-induced cell cycle arrest.
Since the activity of p53 often correlates with site-
specific modifications of the p53 molecule, we have
compared the changes in p53 induced by NO and by
other known activators of p53. An extensive overlap
between the telltale signatures of different inducers
may point to commonalties in the signaling pathways
mediating their action. We have studied the temporal
pattern of phosphorylation of certain residues of p53
protein and compared this molecular signature of the
signaling pathway leading from NO to induction of
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p53 with the signatures of other well-characterized
inducers of p53: y-irradiation, UV irradiation, and the
chemotherapeutic agent adriamycin. Our results sug-
gest that NO activates specific signaling pathways that
are unique, but may share some elements in common
with signaling pathways activated by other known
inducers of p53 activity.
Xenopus laevis NOS Gene
V. Scheinker, Y. Stasiv, N. Peunova
We have recently cloned NO synthase (NOS) cDNA
from Xenopus laevis (XN0S1). Its primary structure,
enzymatic properties, and distribution in the tissues of
the tadpole and adult frog suggest that it is an ortholog
of the mammalian neuronal isoform of NOS.
We have now demonstrated that at least five differ-
ent transcripts originate from the XN0S1 gene. They
arise through the use of multiple promoters and alter-
native splicing, and their expression is tissue- and
developmental-stage-specific. For instance, the appear-
ance of some of the transcripts mark the zygotic induc-
tion of the genome and of the others-neurulation and
organogenesis. These findings suggest that the biolog-
ical activity of NO is tightly and specifically regulated
during development by a complex pattern of alternative
transcription initiation and splicing. We are studying
the appearance of new XN0S1 transcripts in the con-
text of the properties of NO as a strong inducer of gene
activity and a potent antiproliferative agent.
NO and Drosophila Development
Y. Stasiv
We have recently identified numerous alternatively
spliced transcripts of the Drosophila NOS gene. One
of them, DNOS4, has an extra exon inserted in the
open reading frame which codes for a truncated pro-
tein with a unique carboxyl terminus. This protein
lacks important domains and does not produce NO;
however, it strongly inhibits DNOS1 activity in
cotransfection experiments, suggesting that it may act
as a negative-dominant inhibitor of NOS activity. To
test the physiological role of DNOS4, we have gener-
ated transgenic flies where this gene is expressed
under the control of an eye-specific GMR promoter.
Transgenic flies have a profound eye phenotype, with
many extra cells per ommatidium, and a decreased
activity of NOS. Furthermore, the DNOS4 transgene
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shows genetic interactions with the components of the
retinoblastoma pathway, thus supporting the hypothe-
sis that DNOS4 codes for an endogenous negative reg-
ulator of the antiproliferative activity of NOS in
Drosophila. We have now raised DNOS4-specific anti-
bodies and are using them to study DNOS4 expression
during fly development and its relation to other pro-
teins arising from the DNOS locus.
NO and Mouse Hematopoiesis
T. Michurina, P. Krasnov
We study the potential of NO to regulate hematopoiesis
in bone marrow. We have found that cells of mouse
bone marrow express various isoforms of NOS.
Moreover, we have found that by regulating the synthe-
sis of NO, we can regulate hematopoietic maturation
along both erythroid and myeloid lineages, change the
proportion of cells with early progenitor markers in
bone marrow, and alter the proportion of stem and early
progenitor cells in retransplantation assays. Our data
suggest that manipulation of NOS activity and NO lev-
els during hematopoiesis may be potentially used for
therapeutic purposes. Indeed, we have begun experi-
ments with human hematopoietic cells and found that
we can change the extent of their proliferation and dif-
ferentiation by manipulating levels of NO.
NO and Xenopus
Brain Development
N. Peunova [in collaboration with H. Cline,
Cold Spring Harbor Laboratory]
The developing brain of Xenopus laevis represents an
excellent system in which to study the role of NO in
organogenesis. Division of neural precursors, their
migration, differentiation, and synaptogenesis occur in
a spatially distinct pattern throughout development of
the tadpole. For instance, in the optic tectum, new cells
are generated in the narrow germinal zone at the cau-
domedial border of the tectum and are displaced later-
ally and rostrally from the germinal zone as they dif-
ferentiate and mature. Consequently, interfering with
the normal course of cell proliferation would be rec-
ognized as a disruption in the spatiotemporal pattern
of development in the optic tectum.
We found that the gene encoding the neuronal iso-
form of Xenopus NO synthase (XN0S1) is strongly
expressed in the developing brain of the Xenopus tad-
poles. We combined in situ hybridization with an
XNOS1- specific RNA probe and detection of prolifer-
ating cells after BrdU labeling to show that a narrow
zone of XNOS/-expressing cells lies adjacent to the
zone of dividing neuronal precursors; however, the
germinal zone itself is free of NOS. This suggests that
NO may act as an antiproliferative agent to suppress
division of neuronal precursors in the tadpole brain.
We have previously shown that by suppressing NOS
activity, we can dramatically increase the number of
proliferating cells in the optic tectum, the total number
of cells, and the overall size of the optic tectum. We
have now found that the converse is also true: We can
decrease the number of proliferating cells, the total
number of cells, and size of the tectum by supplying
exogenous NO to the developing tadpole brain. Our
results strongly implicate NO as an essential negative
regulator of neuronal precursor cell proliferation dur-
ing vertebrate brain development.
NO in Neuronal Differentiation and
Cell Death in the Mouse Brain
M. Packer
We study the potential of NO to change the prolifera-
tion of neuronal precursors in the adult brain. We have
generated transgenic mouse lines where expression of
neuronal NO synthase is placed under the control of
the calcium/calmodulin IM promoter. This promoter
directs strong expression of the transgene in specific
regions of the adult mouse brain. In particular, it
directs the expression of the nNOS transgene in the
subgranule zone of the dentate gyms of the hippocam-
pus, one of the regions of adult neurogenesis in the
rodent brain. These transgenic mice therefore are good
models to test the role of NO in the control of neuronal
precursor proliferation. We are also using this mouse
model to assess the role of NO in death protection
pathways by studying the expression of apoptosis-
related genes in the brains of transgenic animals.
Neural Stem and Progenitor Cells
in the Developing and Adult Brain
J. Mignone
To detect stem and progenitor cells in the developing
and adult brain, we generated transgenic mice which
express green fluorescent protein (GFP) under the
control of nestin gene regulatory sequences. These
sequences, as determined by R. McKay and co-work-
ers, direct highly specific expression of nestin in the
neuroepithelial stem and progenitor cells of the devel-
oping and adult nervous system. We have obtained
several transgenic lines with very strong and region-
specific expression of the GFP transgene, such that
green fluorescence marks neuronal stem and progeni-
tor cells in the developing nervous system of the
embryo and in the brain of adult animals. In the adult
brain, highly selective expression of GFP marks the
limited areas of neurogenesis: subventricular zone,
rostral migratory path, and the dentate gyms. We are
now using these transgenic mice to visualize stem
cells in the developing and adult brain and to study
their proliferation. We are also isolating GFP-express-
ing cells with the help of fluorescence-activated cell
sorting, and using them for transcript and protein
expression profiling of neural stem cells.
Dividing Progenitor Cell Groups
in the Developing and Adult Brain
A. Vaahtokari
We are interested in visualizing clusters and groups of
dividing neural stem and progenitor cells in the devel-
oping and adult brain. We have generated transgenic
mice where expression of GFP marks cells at a specif-
ic phase of the cell cycle. We are now analyzing the
pattern of the marker gene expression in these trans-
genic animals at different stages of development.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow A. Raffia.
N. Dawkins
J. Esteban
Y. Hayashi
F Kamenetz S. Shi
A. Piccini S. Zaman
J.-C. Poncer J. Zhu
We address issues directed toward an understanding of
learning and memory by studying the physiology of
synapses. We study synaptic transmission and plastic-
ity in rodent brain slices, which are complex enough to
show glimpses of emergent properties, as well as sim-
ple enough to allow hard-nosed biophysical scrutiny.
To monitor and perturb the function of synapses, we
use a combination of electrophysiology, microscopic
imaging, and transfection techniques. This allows us to
examine the cell biological basis for changes in elec-
trophysiological function. It is our philosophy that
synapses have key properties whose understanding
will provide insight into phenomena at higher levels of
complexity.
The main result of this year was to determine that
glutamate receptor trafficking is a major contributor to
synaptic plasticity. Our results have led to a model in
which transient (regulated) delivery of receptors is
maintained by a subsequent constitutive receptor
replacement. We have identified a-amino-3-hydroxy-
5-methyl-4-isoxazole receptor (AMPA-R) subunits
that may participate in different aspects of this
process. This model can explain how a transient event
(e.g., induction of long-term potentiation or LTP) may
produce a long-lasting change in transmission despite
protein turnover.
Delivery of Glutamate
Receptors to Synapses
during LTP
Y. Hayashi, S. Shi, J. Esteban, A. Piccini,
J. Poncer
To elucidate mechanisms controlling and executing
activity-dependent synaptic plasticity, AMPA-Rs with
an electrophysiological tag were expressed in hip-
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pocampal neurons. LTP or increased activity of the
calcium/calmodulin-dependent protein kinase II
(CaMKII) induced delivery of tagged AMPA-Rs into
synapses. This effect was not diminished by mutating
the CaMKII phosphorylation site on the G1uR1
AMPA-R subunit, but it was blocked by mutating a
predicted PDZ domain interaction site. These results
show that LTP and CaMKII activity drive AMPA-Rs to
synapses by a mechanism that requires the association
between G1uR1 and a PDZ domain protein.
Dendritic Trafficking,
Clustering, and Synaptic
Delivery of AMPA-R
in Hippocampal Neurons
S. Shi, Y. Hayashi, J. Esteban [in collaboration
with K. Svoboda, Cold Spring Harbor Laboratory;
R. Petra lia and R. Wenthold, National
Institutes of Health]
To monitor optically changes in AMPA-R distribution
in living neurons, the AMPA-R subunit G1uR1 was
tagged with green fluorescent protein (GFP). This pro-
tein (GluRl-GFP) is functional and was transiently
expressed in hippocampal CA1 neurons. In dendrites
visualized with two-photon laser scanning microscopy
or electron microscopy, most of the G1uR1 -GFP is
intracellular, mimicking endogenous G1uR1 distribu-
tion. Tetanic synaptic stimulation induces a rapid
delivery of tagged receptors into dendritic spines as
well as clusters in dendrites. These postsynaptic traf-
ficking events require synaptic N-methyl-o-aspartate
receptor (NMDA-R) activation and may contribute to
the enhanced AMPA-R-mediated transmission
observed during LTP and activity-dependent synaptic
maturation.
Spontaneous Oscillatory
Activity Delivers
GIuR4- containing AMPA-R
into Silent Synapses
during Early Development
J. Zhu, J. Esteban, Y. Hayashi
Spontaneous activity early in postnatal development is
crucial for the formation of functional neuronal cir-
cuits. During this early period, many glutamatergic
synapses contain only NMDA-Rs and are largely
"silent," becoming functional by acquiring AMPA-Rs.
In this series of studies, we show that spontaneous
oscillatory activity in the hippocampus makes silent
synapses functional by selectively delivering G1uR4-
containing AMPA-Rs. This differs from LTP seen in
older animals, which delivers GluR 1 -containing
AMPA-Rs and requires CaMKII activity. Consistent
with this special role, G1uR4 expression in the hip-
pocampus is largely restricted to the first postnatal
week. Once delivered by activity, synaptic G1uR4-
AMPA-Rs are exchanged with G1uR2-containing
AMPA-Rs in a manner that requires little neuronal
activity and maintains the enhanced strength of the
synapse despite protein turnover. This "delivery and
exchange" represents a new form of activity-depen-
dent long-term synaptic plasticity that may be respon-
sible for the initial establishment of functional neu-
ronal circuitry.
Plasticity of NMDA-R-mediated
Synaptic Transmission
A. Barris
Tetanic stimulation of synapses leads to an increase in
AMPA-R function, at least in part due to a rapid deliv-
ery of receptors to synapses. In addition, under cer-
tain conditions, one can also see an increase in
NMDA-R-mediated transmission. We wish to test the
hypothesis that this is due to the formation of new
synapses containing only NMDA-Rs. We are testing
this possibility in a number of ways, using electro-
physiological, imaging, molecular biological, and
pharmacological methods.
Transient Oxygen/Glucose
Deprivation Induces Rapid
Morphological Changes in Rat
Hippocampal Dendrites
A. Piccini
Previous studies on ischemia-induced cell damage
have revealed that pyramidal neurons in the CA1
region of the hippocampus are extremely susceptible
and undergo selective degeneration 2-4 days after the
insult. Nothing is known about early morphological
changes occurring immediately after the insult in neu-
rons in the organotypic hippocampal slice preparation.
Using two-photon laser scanning microscopy, we
monitored dendritic morphology of cells expressing
GFP in response to a transient hypoxic-ischemic
episode. This type of vital imaging provides direct evi-
dence of growth of dendritic filopodia in rat CA1
pyramidal neurons occurring as soon as 20 minutes
after oxygen-glucose deprivation. We propose that
dendritic reorganization may be an early-stage
response to compensate the loss of synapses caused by
ischemia-induced neuronal injury.
(3- amyloid as a Homestatic
Negative Regulator of
Synaptic Transmission
F. Kamenetz [in collaboration with S. Sisodia, University
of Chicago, D. Borchelt, Johns Hopkins Medical School,
T Iwatsubo, University of Tokyo]
We are testing the hypothesis that (3- amyloid acts as a
homestatic negative regulator of synaptic transmis-
sion. In support of this, we find that organotypic slices
secrete less 13-amyloid if transmission is depressed,
and they secrete more 13-amyloid if transmission is
enhanced. Furthermore, we find that acute expression
of amyloid precursor protein (APP) in neurons leads to
a secretion of (3- amyloid and depression of synaptic
transmission onto those neurons. However, if trans-
mission is chronically pharmacologically depressed
onto these APP-expressing neurons, then normal
transmission is preserved. We plan to continue to test
this view by expressing mutant APP molecules that
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perturb the secretion of 13-amyloid in predictable ways.
If this hypothesis is correct, it will have a significant
impact on the proposed therapeutic use of agents that
reduce 13-amyloid secretion for Alzheimer's disease. In
conclusion, we are continuing to elucidate the basic
mechanisms involved in central synaptic transmission
and plasticity.
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PLASTICITY OF CORTICAL NEURONS AND
THEIR CIRCUITS
K. Svoboda B. Burbach
B. Chen
K. Greenwood
I. Koh
B. Lendvai E. Nimchinski B. Sabatini
Z.F. Mainen A. Oberlander E. Stern
M. Maravall P. O'Brien J. Sugrim
The neocortex underlies most cognitive functions in
mammals. Even though these functions are extremely
diverse, the underlying anatomy is relatively well con-
served. Neocortical tissue is dauntingly complex: 1 ill
contains nearly 1 million neurons and more than 1 bil-
lion synapses. A single neuron connects to thousands
of other neurons. It is unclear how electrical and
chemical activity in this awesome network underlies
our perception of the world. To begin to unravel neo-
cortical function, we are studying how the basic units
of this network, namely, neurons and synapses (the
connections between neurons), work within the intact
network, and how they change in response to experi-
ence.
We use sensitive tools to monitor neuronal func-
tion in intact tissue. Two-photon laser scanning
microscopy (TPLSM) allows us to keep track of neu-
ronal excitability at the level of single synapses by
measuring intracellular Ca" levels at high resolution.
Optical stimulation by uncaging of neurotransmitters
allows us to excite subcellular structures with great
spatial and temporal control. Intracellular electrical
recordings using sharp and whole-cell electrodes
allow monitoring of the electrical membrane potential
and synaptic currents of neurons, and intrinsic signal
imaging allows monitoring of the dynamics of a net-
work of neurons in vivo. We have also begun to use
powerful molecular methods to label neurons for
imaging and to introduce transgenes to perturb signal
transduction cascades in very specific ways.
Despite the complexity of the problem, there is
some reason to hope that an understanding might not
be too far off of how neocortical neural networks per-
form computations. This hope is mainly based on the
realization that the neocortex is built up of repeating
elemental functional modules, containing relatively
few types of neurons and synapses. Thus, it could be
that neocortex is decomposable into a simpler prob-
lem, namely, understanding the function of the ele-
mental module. During the last year, we have been
focusing on the function and plasticity of neocotical
neurons and their synapses in isolation. Over the next
several years, we plan to work our way up to the level
of the module.
Quantitative Cellular [Cal
Imaging at the Micrometer
Length Scale
M. Maravall, B. Sabatini, Z.F. Mainen, K. Svoboda
Intracellular Ca" concentration, [Cal, is an impor-
tant state variable encoding neuronal activity. In addi-
tion, [Cal couples electrical excitation to a myriad of
important intracellular biochemical processes. During
the last few years, it has become clear that detailed
features of the spatiotemporal dynamics of [Cal sig-
nals determine their biochemical meanings. To under-
stand [Cal signaling, it is therefore important to
obtain quantitative estimates of [Cal at high spatial
and temporal resolutions. However, traditional
approaches, such as those based on wavelength ratio-
ing, are not useful for rapid imaging in small struc-
tures.
We combined TPLSM fluorescence imaging with
indicators that change their brightness upon binding to
Ca". We developed new calibration procedures that
allow absolute [Cal measurements and do not
depend on wavelength ratioing. These protocols can be
used routinely in situ and are applicable to microme-
ter-sized neuronal compartments. To test the quality of
the estimates delivered by our method, we measured
the sizes of action-potential-evoked [Cal changes in
the apical dendrites of CA1 pyramidal neurons and
determined the dendritic buffer capacity, the ability of
the cytoplasm to bind Ca''. We are now using this
method to explore the intracellular [Cal signaling
underlying synaptic plasticity.
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Optical Studies of Single Synapses Spine Morphogenesis and the
B. Sabatini, Z.F. Mainen
Long-term changes in synaptic efficacy occur when a
postsynaptic neuron consistently fires an action poten-
tial within 10 msec of the arrival of a particular synap-
tic input. It is known that increases in [Cal in the
postsynaptic neuron trigger these changes. We have
used TPLSM and whole-cell patch clamp recordings
to study the [Cal signals that arise in spines and
small dendrites of CAl pyramidal neurons in response
to back-propagating action potentials and synaptic
stimuli. By contrasting the properties of action poten-
tial evoked [Cal transients in the main apical den-
drite with those of distal dendrites and spines, we were
able to define functionally distinct neuronal compart-
ments for Car' signaling. We find that action potential-
evoked [Cal transients in spines reach about 1 tM
and return to baseline in less than 20 msec, much larg-
er and faster than previously thought. These transients
could account for the short integration time that is
observed for the induction of synaptic plasticity. In
addition, we show that spine heads can operate as iso-
lated compartments such that gradients in [Cal can
be maintained between spine head and dendrite. Our
measurements indicate that buffer capacity in the
spine is lower than in the apical dendrite and soma,
facilitating large local increases in [Cal. Finally, we
use a novel analysis of response fluctuations to esti-
mate the number, location, and properties of the volt-
age-sensitive calcium channels and synaptic receptors
contributing to synaptic Car' signals.
a
Cellular Basis of Fragile X Syndrome
E. Nimchinsky, A. Oberlander
The fragile X mental retardation syndrome is the most
common form of inherited mental retardation. The
molecular basis of the syndrome is a large expansion
of a triple repeat (CGG) in the 5 "-untranslated region
(UTR) of the FMR1 gene that renders it transcription-
ally silent. The protein coded by this gene, called
FMRP (fragile X mental retardation protein) is an
RNA-binding protein of unknown function. One sug-
gested function is the transport of mRNA out of the
nucleus and into neuronal dendrites. Interestingly, the
only cellular abnormality in the brains of affected indi-
viduals appears to be restricted to dendritic spines, the
targets of excitatory synapses. These spines have been
described as unusually long, thin, and tortuous, and
more numerous than in normal brains. Since the gene
is functionally knocked out in humans suffering from
fragile X syndrome, a reasonable animal model of this
disease is a mouse lacking FMR1. In these mice, as in
patients, dendritic spines have been described as being
longer and more numerous than in control mice. Long
thin spines are suggestive of immature spines, found
early in development, that are highly motile and pre-
sumably are in search of the correct presynaptic part-
ners.
To understand the nature of this abnormality, we
characterized the developmental aspects of structural
defects. We used in vivo transfection of mouse barrel
cortex neurons with green fluorescent protein (GFP)-
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FIGURE 1 Motility of dendritic protrusions in the developing barrel cortex in vivo. (a) Time-lapse image sequences
showing growth, retraction, and other shape changes of dendritic protrusions (time stamps are in minutes). Colored
arrows point to protrusions that are analyzed further in panel b. (b) Time courses of length changes of selected pro-
trusions.
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expressing virus. Fluorescent neurons were analyzed
postmortem. We find that there is a transient large
abnormality in spine structure and density in the
developing brain (PND 14) that decreases as the brain
matures. To investigate the dynamic aspects of these
spines, we are studying the motility of spines in slice
cultures prepared from mutant mice at a time when
dendritic spines are known normally to be highly
motile. Finally, we are investigating the effects of rein-
troduction of FMRP into knockout mice on both mor-
phology and motility.
Morphological Basis of
Experience-dependent
Plasticity In Vivo
B. Chen, B. Lendvai, B. Burbach, K. Svoboda
The rodent somatosensory cortex contains a map of the
facial whiskers (barrel cortex) where the neuronal
responses in each barrel column are dominated by a
particular principal whisker. Whisker deprivation
changes the responses in the whisker map. It has long
been debated whether changes in neuronal structure
underlie such experience-dependent cortical plasticity.
We used time-lapse TPLSM of layer 2/3 pyramidal
neurons in the developing rat barrel cortex to image the
structural dynamics of dendritic spines and filopodia.
Surprisingly, these protrusions were found to be highly
motile throughout development: Spines and filopodia
appeared, disappeared, or changed shape over tens of
minutes, suggesting that synaptic lifetimes might be
relatively short in vivo (-10-100 hours). To test
whether sensory experience plays a part in driving this
motility, we trimmed whiskers 1-3 days before imag-
ing. Sensory deprivation dramatically (-40%) reduced
protrusive motility in deprived regions of the barrel
cortex during a critical period around PND 11-13, but
had no effect in younger (PND 8-10) or older (PND
14-16) animals. Surprisingly, whisker trimming did
not change the density, lengths, or shapes of spines and
filopodia. These results show that sensory experience
may drive the structural plasticity of dendrites that
underlies the reorganization of neural circuits. More
recently, we developed a technique to image the same
dendritic segment over chronic time scales of several
days. This will allow us to address long-standing ques-
tions regarding the effects of sensory experience on the
large-scale structural plasticity of neural circuits.
Neocortical Experience-dependent
Plasticity In Vivo
E. Stern, K. Greenwood
In parallel with our imaging studies of experience-
dependent morphogenesis, we are exploring the phys-
iological properties of neocortical neurons. In particu-
lar, we are interested in the effects of sensory experi-
ence on the development of topographic maps in the
barrel cortex. In contrast to previous experiments that
have employed extracellular recordings, we are using
intracellular recordings in vivo. Such measurements
inform us not only about neuronal spiking activity, but
also about synaptic potentials. We find that brief
whisker trimming (a couple of days) has a profound
effect on the structure of sensory maps.
Experience-dependent Changes
in the Properties of Neocortical
Pyramidal Neurons
M. Maravall
Some subtle experience-dependent changes in cellular
properties are difficult to study in the intact brain. For
example, the sizes of quantal synaptic currents cannot
be measured in vivo, but they can be measured in brain
slices. We are comparing the properties of neocortical
pyramidal neurons in brain slices derived from animals
that were deprived and from control animals. To discov-
er possibly diverse modes of plasticity, we are using a
barrage of electrophysiological and imaging approach-
es to look for effects of sensory experience on neuronal
Ca:' dynamics, excitability, and synaptic currents.
Algorithms for Automated
Morphometric Analysis
I. Koh, E. Nimchinsky [in collaboration with
Brent Lindquist, State University of New York,
Stony Brook]
Changes in the structure of neurons are intimately
related to neural development and plasticity and its
dysfunctions. It is of interest to find genes that control
aspects of neuronal shape. A conceptually simple
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approach might be to use the gene gun to transfect
neurons with candidate genes together with GFP and
subsequently analyze the structure of transfected cells.
An underappreciated problem with this approach is
that structural data are extremely noisy and difficult to
analyze. Mind-numbing laborious manual analysis
invariably limits the throughput in such studies. For
these reasons, we have invested considerable effort in
developing software that allows essentially automated
analysis of neuronal structure. Our approach consists
of three steps: digital filtering by deconvolution,
image segmentation, and image analysis. A prototype
of a program that reliably detects changes at the level
of spines in time-lapse movies is now running and is
ready to extract useful data.
Instrumentation
K. Svoboda, P. O'Brien, J. Sugrim, Z.F. Mainen
Our instrumentation efforts during the last year have
focused on getting further microscopy/physiology sta-
tions working and others updated. We also set up a sim-
ple intrinsic signal imaging microscope that will in the
future be combined with TPLSM. Finally, we designed
and built an A/D board that allows us to acquire multi-
ple fluorescence wavelengths simultaneously. This
board was implemented in a printed circuit design, sub-
stantially reducing maintenance requirements.
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MOLECULAR NEUROBIOLOGY OF LEARNING AND
MEMORY IN DROSOPHILA
T. Tully C. Alexander R. Gasperini M. Regulski
J. Christensen S. Gossweiler M. Saitoe
J. Connolly L. Grady P. Smith
J. DeZazzo R. Jones M. Sullivan
J. Di Leo H. Li S. Xia
J. Dubnau S. Pinto L. Zhang
Jeff Hall, professor of biology at Brandeis University
once said, "We're all working on the same genes, we just
don't know it yet." Latheo, a gene identified in a behav-
ioral screen for learning mutants, encodes the
Drosophila homolog of ORC3, a protein component of
the origin recognition complex involved in DNA repli-
cation during cell proliferation. In terminally differenti-
ated, nonproliferating motor neurons of the larval ner-
vous system, latheo is expressed in presynaptic termi-
nals. What exactly latheo is doing at the synapse will be
the subject of future research. The fact that this connec-
tion was made between two rather disparate cellular
functions of a gene, however, is the purpose of "forward"
genetics. Classical mutagenesis makes no assumptions
about the molecular mechanism(s) underlying a particu-
lar phenotype. In our context, this approach also allows
the identification of behaviorally relevant mutations in
multifunctional (pleiotropic) genes.
Identification of New Genes
Involved with Associative Learning
T. Tully, S. Pinto, J. Christensen, J. DeZazzo, M. Saitoe,
P. Smith, C. Alexander, H. Li, L. Zhang, L. Grady
[in collaboration with M. Ramaswami, University of
Arizona; K. Broadie, University of Utah]
The Hartford Screen: The behavioral screen (forward
genetics) for new Pavlovian learning/memory mutants
is complete. In all, more than 6700 transposant lines
were generated and assayed for 1-day memory after
spaced training using a 48-array of Robotrainers.
From this screen, we have identified more than 60 can-
didate mutants. From two replicate experiments, one
before and one after outcrossing and egg-bleaching
(for virus; see below), these candidate mutants yielded
average scores less than or equal to 50% of normal.
We now are assessing initial learning, olfactory acuity,
and shock reactivity in these candidate mutants. Some
will show lower-than-normal performance because of
a sensorimotor defect. Most, however, promise to
result from bona fide defects in associative learning or
subsequent memory processing. One such mutant
already has been characterized and named. As shown
in Figure 1, ikar shows normal learning but no 1-day
memory after spaced training. With luck, this screen
will double the number of learning and memory
mutants known in Drosophila.
latheo: latheo encodes the fly homolog of ORC3, an
integral member of the origin recognition complex
(ORC). This molecular identification certainly
explains the cell proliferation defect and pupal lethal-
ity of severe (amorphic) latheo mutants. We wondered,
however, if this cellular function was responsible for
the adult learning defect of less severe (hypomorphic)
mutants. To address this issue, we raised a polyclonal
antibody and a monoclonal antibody against bacterial-
ly expressed LAT antigen and then, in collaboration
with K. Broadie's group, looked at the larval neuro-
muscular junction (NMJ) for LAT expression.
Surprisingly, we detected LAT immunoreactivity at
this peripheral synapse in wild-type larvae but not in
null mutants, thereby demonstrating that LAT is
expressed at the synapse in nonproliferating larval
motor neurons. Moreover, latheo (null and hypomor-
phic) mutants showed defects in basal transmission
and synaptic plasticity at the NMJ. Taken together,
these results suggest an acute role for latheo in synap-
tic plasticity, a cellular function distinct from its role
as a member of ORC. More generally, these are the
first observations to suggest that an ORC subunit may
function outside of the cell nucleus.
linotte: LIO is expressed postsynaptically at the NMJ
and preferentially in both axonal and dendritic process-
es in the adult central nervous system (CNS). We have
discovered defects in synaptic plasticity at the NMJ of
linotte mutants that can be rescued by expression of
153
ll(CL
100
80
60
0
z 40
2
cc 20
LL
cc
-20
Cl 08
wt
mut
24
RETENTION TIME
FIGURE 1 (Left panel) Ikar, one of Pavlov's dogs (from a photo album presented to Pavlov
by his students on his 83rd birthday). (Right panel) Performance indices (Pis) for ikar (strain
C108). Immediately after one training session (0) of an olfactory classical conditioning task,
"learning" is normal, whereas long-lasting memory is defective 24 hr after spaced training
(24).
(two independent) hs-lio+ transgenes. Biochemically,
we have detected reduced levels of cAMP in third-instar
larval CNS. Behaviorally, we have determined that
rut; io double mutants yield no olfactory associative
learning despite the fact that their underlying sensori-
motor responses are normal. Together, these observa-
tions suggest that linotte is a novel molecule involved in
the modulation of cAMP signaling in neurons.
nalyot: In collaboration with M. Ramaswami's group,
we also have shown that nalyot is involved in the mat-
uration of synaptic structure-but not function-at the
NMJ. This observation is in striking contrast to studies
on the cAMP response element-binding protein
(CREB) by G. Davis and colleagues (then at the
University of California, Berkeley), where they showed
that CREB was involved in the development of synap-
tic function but not structure. Thus, ADF 1 and CREB
appear to define two distinct transcription factor cas-
cades involved in activity-dependent synaptic plastici-
ty. Since long-term memory (LTM) formation also
involves synaptic plasticity and CREB, we assessed
LTM in nalyot mutants. As predicted, we have discov-
ered that LTM is abolished, but ARM, an earlier mem-
ory phase, is normal in nalyot mutants. Hence, nalyot
is the first mutation of an endogenous gene known to
disrupt LTM preferentially.
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Characterization of Extant
Mutants
T. Tully, M. Regulski
Although our initial attempts to generate a mutation
by jumping a nearby P element into the NOS (nitric
oxide synthase) transcription unit have failed, we did
identify a small deletion of the NOS region produced
by imprecise excision of the P element. Homozygotes
of this deletion are lethal, but heterozygotes survive.
Using our newly developed enzymatic assay for NOS
activity in Drosophila tissue, we have determined that
NOS activity in deletion heterozygotes is 50% of nor-
mal. Molecular analysis of the genomic region sug-
gests that this deletion eliminates only the NOS and
porin transcripts. Using these deletion heterozygotes,
we have initiated a chemical (EMS) mutagenesis to
identify point mutations in NOS, based on the
assumptions that such mutations will be lethal over
deletion. To date, several mutations have been identi-
fied, and they fall into only two lethal complementa-
tion groups. Hence, we finally may have identified
point mutations in NOS, thereby allowing future
developmental and behavioral analysis of NOS and
synaptic plasticity.
Molecular Search for
CREB-dependent LTM Genes
T. Tully, J. Dubnau, S. Gossweiler [in collaboration
with Helicon Therapeutics, Inc.]
In our attempts to search a portion of the fly genome
for transcriptional responses to LTM formation, we
have discovered a significant signal-to-noise issue
when analyzing data from DNA chips. To validate
such analyses biologically, we have expanded our chip
analyses to include three distinct types of chip com-
parisons: (1) LTM vs. no LTM, (2) drug-enhanced
cAMP signaling vs. no drug, and (3) mutant vs. wild-
type. With the latter comparison (of nalyot vs. wild
type), we already knew that ADF1 transcript levels
were reduced in nalyot mutants. ADF1 was included
on the Affymetrix fly chip and thus constituted an
internal positive control for signal-to-noise analysis.
With this approach, we have determined an appropri-
ate statistical method to identify candidate transcripts
that are differentially regulated. Importantly, not all
statistical approaches returned our positive control as
a statistical candidate. Once the appropriate quantita-
tive method was empirically validated, we analyzed
data from our LTM vs. no LTM comparison. One sta-
tistical candidate that has been confirmed with Q-PCR
(polymerase chain reaction) is C/EBP-an immediate
early gene that is transcriptionally regulated by CREB
during LTM formation in Aplysia.
The Virus Hypothesis
T. Tully, R. Gasperini [in collaboration with
B. Stillman and T. Howard, Cold Spring
Harbor Laboratory]
The viral pathogen that has infected our fly colony is
under control. We identified the virus to be Drosophila
C virus (DCV) and have developed a sensitive reverse
transcriptase (RT)-PCR method to detect its presence.
Using RT-PCR, we then developed a stringent egg-
bleaching protocol, which can significantly reduce the
virus titer carried by a fly strain. With this decontami-
nation method, combined with sterile culturing of fly
stocks, we now can maintain stocks for several gener-
ations before virus titers again become problematic.
We currently are studying a curative method to elimi-
nate DCV infections altogether.
Behavioral Analyses
T. Tully, S. Xia
Recently, T. Preat's group published a claim that most
of the learning and memory mutants are not defective
for associative learning but rather perform poorly in
the Pavlovian assay because of a nonassociative effect
on the perception of odors. We do not agree with this
interpretation of these experiments. To address this
issue, we have (1) replicated the published results, (2)
produced data suggesting that this "Preat effect" actu-
ally reflects an associative process, and (3) shown that
the Preat effect does not influence the calculation of an
associative Performance Index.
From these behavioral experiments, we suggest
that the Preat effect can influence Pavlovian perfor-
mance only if it changes the flies' ability to discrimi-
nate between two odors simultaneously delivered. To
this end, we have developed three behavioral assays of
discriminability, each of which appears normal in the
learning and memory mutants. Thus, we find no
defects in sensorimotor responses of learning and
memory mutants that are sufficient to explain the
mutants' performance in the olfactory associative task.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin M. Cowan
E. Drier
R. Filipkowski
E. Friedman
J.. Horiuchi
W. Jiang M. Stebbins
K. La Vine M. Tello
Z. Lin P. Wu
C. Margulies H. Zhou
K. Seidenman
Regulation of dCREB2
DNA-binding Activity
J. Horiuchi, W. Jiang, P. Wu, H. Zhou
Endogenous and transgenic dCREB2 protein is totally
inhibited from binding DNA in crude, cell-free
extracts. Inhibition is seen in extracts made from
embryonic, pupal, and adult stage tissue, as well as
from Schneider (tissue culture) cells. Phosphatase
treatment of extracts unmasks the DNA-binding activ-
ity. Four apparent casein kinase phosphorylation sites,
amino-terminal to the well-characterized 5133 residue,
are partially responsible for inhibition of binding.
In vitro, incubation of bacterially expressed
dCREB2 protein with casein kinase I or II, or
Schneider cell extracts, but not PKA, calcium-calmod-
ulin kinase II (CaMKII), or GSK-3, inhibits DNA bind-
ing. Subsequent phosphatase treatment partially revers-
es this inhibition of DNA binding. In vitro phosphory-
lation with PKA, CaMKII or IV, or GSK-3, does not
reverse the inhibition produced by casein kinase I,
demonstrating that this inhibition is "dominant" to
other phosphorylation events. Bacterially expressed
mutant protein (containing alanine substitutions in all
four conserved serine sites) is partially immune to
Schneider extract-mediated inhibition of binding.
Tryptic analysis of bacterially expressed protein treated
in vitro with casein kinase I, or Schneider cell extracts,
and y-ATP, have identical phosphopeptide patterns.
Cell-free extracts made from mouse tissue (brain,
heart, kidney) show that, unlike flies, there are two
approximately equal pools of protein: one is binding-
competent and one is inhibited from binding unless
treated with phosphatase. Preliminary transfection
experiments show that a mutant rat cAMP response
element-binding protein (CREB) gene (containing
five serine to alanine substitutions) has greater tran-
scriptional activity than the wild-type gene. This sug-
gests that phosphorylation of the conserved casein
kinase sites can inhibit DNA binding and transcrip-
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tional activity of a CREB activator isoform. Since
most, if not all, of the fly dCREB2 protein seems to
exist in a phosphorylated form, one of the major regu-
latory steps in the activation of dCREB2 must be
dephosphorylation. It is hypothesized that one of the
signaling pathways activated during learning and
memory formation must target the relevant phos-
phatase(s).
Regulation of dCREB2
Subcellular Localization
C. Margulies, W. Jiang, P. Wu, H. Zhou
We have previously reported that much of the
dCREB2-b (blocker) protein, whether endogenous or
transgenic, is localized to the cytoplasmic compart-
ment. Deletion of the amino-terminal portion of the
protein or mutation of all four conserved casein kinase
sites results in more protein localization to the nucle-
us. We are using the yeast two-hybrid system to search
for proteins that interact with the Drosophila protein.
S162, a Lethal Mutation
in the dCREB2 Gene
M. Tello, E. Drier, H. Zhou
We have identified the DNA alteration in the S162
mutation. A stop codon is present in exon 7 of the
dCREB2 gene, resulting in premature truncation of the
protein. Western blot analysis supports this finding,
since dCREB2 protein from escaper flies shows a pair
of truncated proteins, about 5-8 kD shorter than the
wild-type doublet. The larval/pupal lethality of this
mutation can be rescued using a 9-kb genomic trans-
gene that codes for the wild-type proteins. Lethality
cannot be rescued using a 9-kb fragment containing a
premature stop codon engineered into the dCREB2
open reading frame.
Role of Sleep in Memory
Formation
M. Cowan, P. Wu, H. Zhou
[in collaboration with Joan Hendricks,
University of Pennsylvania]
We have previously shown that there is periodic, cir-
cadian-regulated, CRE-mediated transcription in the
living fly and that one peak occurs during the dark
period of a 12-hour light:12-hour dark cycle. In flies,
proteins from the dCREB2 gene show highest binding
affinity to CRE sites in vitro and are one of two pro-
tein families that bind to these sites. Flies show many
of the characteristics of "sleep" during the nighttime
period, including long periods of locomotor inactivity
and rebound (the tendency to rest more) if part of this
period is disrupted. Because there is a lot of specula-
tion about the possible role of sleep in mammalian
memory consolidation, we are trying to demonstrate
that this nightly peak in CRE-mediated transcription is
important for memory formation. Experiments using
light as the experimental variable to disrupt the circa-
dian system and cycling transcription yield inconsis-
tent results. We believe the inconsistencies are due to
the pleiotropic effects of light itself. Therefore, we are
currently using molecular approaches to disrupt the
circadian system, and periodic CRE-mediated tran-
scription, to ask if the persistence of this cycling tran-
scription is needed for consolidation or maintenance
of previously formed memories.
In a related experiment, flies that are entrained to
a 12-hour light:12-hour dark period show a striking
"time of day" effect on memory formation. Flies
trained at six different time points during the 24-hour
cycle show significant differences in their ability to
form memories. Flies trained shortly after lights-out
perform the best, whereas flies trained late in the dark
cycle do the worst. The nighttime peak in CRE-medi-
ated transcription occurs shortly after lights out.
PKMc-mediated Enhancement
of Memory Formation
E. Drier, M. Cowan, P. Wu, H. Zhou
[in collaboration with Todd Sacktor,
State University of New York, Brooklyn]
Experiments in hippocampal slices and honeybees
suggest the critical involvement of nonconventional
PKC family members in the maintenance of long-term
potentiation (LTP) and long-lasting memory.
Induction of a mouse PKM1 (the truncated version of
PKC) transgene enhances memory formation after a
single training trial, resulting in significant memory
retention 24 hours after training. There is no 24-hour
memory in wild-type flies, whether or not heat-
shocked, or transgenic flies that are not induced.
Induction of the PKA4 transgene also enhances mem-
ory after 10x massed trials, producing robust retention
4 days after training. Wild-type flies, or transgenic
flies that were not induced, do not have any memory 4
days after 10x massed training. To produce enhance-
ment, the transgene must be induced after behavioral
training, and there is a short "window" when induction
is effective. Induction of PKCc, the full-length gene,
does not enhance memory after a single training trial.
We are investigating which phases of memory
PKM1 enhances as well as its molecular mechanism(s).
Identification of a Drosophila
Atypical PKC Gene
M. Tel lo
In mammals, there are 11 members of the PKC fami-
ly, which are divided into three subgroups: conven-
tional, novel, and atypical. The conventional PKC
genes require Ca'' and DAG, the novel genes require
DAG, and the atypical genes require neither.
Despite these biochemical distinctions, little is
known about the physiological functions of each sub-
group, nor the relationship between them. In
Drosophila, one novel and two conventional genes
have been described. Scanning the sequence database,
we have identified a Drosophila atypical family mem-
ber and are beginning the basic molecular characteri-
zation of this gene.
Technologies for Disrupting
Gene Function in Animals
M. Stebbins, Z. Lin, W. Jiang, H. Zhou, P. Wu,
K. La Vine, E. Drier, K. Seidenman [in collaboration
with Wolfgang Hillen, University of Erlangen; Gerry Byrne,
Nextran; Matt During, Thomas Jefferson]
Tetracycline-inducible System: We have improved the
tetracycline-inducible system for use in Drosophila. By
using insulator elements, we can achieve about 100x
repression of target gene expression, measured in the
living fly. This change in gene expression can be spa-
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tially and temporally regulated by combining the tetra-
cycline and Ga14-UAS systems. Spatially and tempo-
rally regulated repression can be achieved in the adult
or embryonic stages. In the "tet on" version of this sys-
tem, the addition of doxycycline causes DNA binding
and transcriptional activation. If insulators and gene
expression parameters (removal of a cryptic splicing
site, use of mammalian codon usage) are optimized,
doxycycline feeding results in about a 10-20x induc-
tion (which can be spatially delimited) in adult flies.
We are currently testing a new "tet on" trans-acti-
vator in flies, which has a whole new set of mutations
that changed the binding properties of the protein. In
primary neurons, this new trans-activator is 3-4x more
active than the original one.
When implemented in mice, the old "tet on" trans-
activator does not perform well. Molecular analysis
shows that although the trans-activator protein is
detectably expressed, it has more degradation than
when expressed in flies. In addition, both mouse and
fly extracts show endogenous protein(s) that can bind
to the expanded tetracycline operator sequences,
which are commonly used. However, the affinity or
levels of the endogenous protein in flies are lower than
that in mice.
Alternative Strategies in Mice: We are investigating
the possibility of using adenovirus-associated virus
(AAV) infection as a means to introduce genes into
cells and tissue. The advantage of this virus is that it is
relatively harmless, shows a long period of expression
in infected tissue, and shows a strong preference for
infecting neurons. In addition, TAT-protein-mediated
transduction has been shown to be a viable method for
introducing proteins into cells and tissue. We are
investigating this technology, envisioning its usage in
a combinatorial manner with regular transgenic tech-
nology and viral infection.
Single-chain Antibodies: Single-chain antibodies are
proteins made from the variable region of hybridoma
heavy and light chains fused onto one contiguous
polypeptide. This peptide retains the binding specificity
and most of the affinity of the original monoclonal anti-
body. We are creating these molecules and testing their
feasibility as inactivating molecules in transgenic flies.
The ultimate goal is to have spatial (anatomically
delimited), temporal, and subcellular control over their
presence and location. It is anticipated that such tools
will facilitate the analysis of proteins that participate
in the process of memory formation, especially those
who change their intracellular location in response to
training-induced signaling events.
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Development of Mouse Behaviors
E. Friedman, R. Filipkowski
To develop behavioral assays that are useful for evaluat-
ing molecules involved in memory formation, we have
focused on two different "spatial" tasks: contextual dis-
crimination and a modified Morris water maze. In con-
textual discrimination, mice are serially exposed to two
similar, but discernibly different, conditioning boxes and
are shocked in one of the two. Multiple training trials are
required for the formation of stable, consolidated mem-
ory of the pairing-specific box. If the multiple trials are
separated by short intervals, 4-day memory, but not 7-
day memory, is formed. If the trials are separated by
longer intervals, 7-day memory forms. Preliminary evi-
dence shows that the memory generated after long-inter-
val training is susceptible to protein synthesis inhibition,
whereas the memory produced following shorter-inter-
val training is not. These behavioral properties are rem-
iniscent of the spaced/massed distinction in fly behavior,
although some details are not identical.
We have modified the training protocal for the
Morris water maze, allowing mice to form 7-day mem-
ory with only a single day of training. The multiple
training trials occur all in one day and have specific
requirements in terms of the total number of trials, the
grouping of individual trials into blocks of trials, and
the interblock intervals. We are investigating the pro-
tein synthesis requirements of the different consolidat-
ed memories that form after distinct training protocals.
The Search for Memory Genes
R. Filipkowski, K. Seidenman [in collaboration with Tim Tully,
Cold Spring Harbor Laboratory]
We are using array-based methods to search for genes
whose expression changes during long-term memory
formation. Our strategy is to compare different models
of neuronal plasticity, cellular plasticity and behavior
for genes that change in more than one situation, or for
genes whose pattern of response is similar. We are
focusing on hippocampal-dependent behavioral tasks,
such as contextual discrimination, fear conditioning,
and the Morris water maze.
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NEURAL BASIS OF LEARNING AND MEMORY IN
DROSOPHILA
Y. Zhong E Hannan J. Tong
H.-F. Guo I. Hakker
Y. Wang J. An
J. Pathenveettil
We are interested in the neural basis of learning and
memory, and our research is currently following two
paths. First, we are establishing Drosophila models for
studying genes involved in human neurodisorders that
impair learning and memory. In particular, we are
interested in genes known to contribute to neurofibro-
matosis 1 (Nfl) and Alzheimer's disease. Nfl patients
are identified by neurofibromas and other symptoms
including learning defects. We are investigating a
hypothesis that the tumor suppressor gene Nfl not only
acts as a Ras-specific GTPase activating protein
(GAP), but also is involved in mediating G-protein-
stimulated activation of adenylyl cyclase (AC), and
this NF1-dependent AC pathway is required for learn-
ing. In the case of Alzheimer's disease, our study has
been limited to examining how presenilin and accu-
mulation of A13 affect the age-dependent decline of
learning ability. This approach, on the one hand, serves
as a new way to identify biochemical cascades under-
lying learning and memory in Drosophila. On the
other hand, it may also provide insights into pathogen-
esis of the diseases. Second, we have developed the
first preparation that enables optical recordings of
neural activity from the living Drosophila brain, which
has allowed us to investigate problems related to sen-
sory representation, perception, and learning. The spe-
cific projects are described below.
NF1-regulated cAMP
Pathway in Learning
H.-E Guo, J. Tong, F Hannan
The tumor suppressor gene Nfl encodes a large pro-
tein containing a fragment homologous to Ras-GAPs,
which inhibit Ras activity. Drosophila NF1 is highly
conserved since 60% of its 2803 amino acids are iden-
tical to those of human NFL Our previous electro-
physiological, biochemical, and behavioral analyses of
Drosophila Nfl mutants have indicated that in addition
to functioning as a Ras-GAP, NF1 regulates activation
of adenylyl cyclase. This NF1-dependent cAMP path-
way is crucial for learning and memory. Our recent
effort in biochemical assays of AC activity has
revealed that G-protein-stimulated AC activity con-
sists of an NF1- dependent component and an NF1-
independent component. The NF1-dependent activity
is largely mediated via the rutabaga (rut)-encoded AC.
The NF1-dependent component is largely mediated
via the rutabaga (rut)-encoded AC, which is required
for learning in Drosophila.
Site-directed Mutagenesis
in Human NF1
F. Hannan, I, Hakker
To understand how NF1 regulates AC activity, we have
conducted yeast two-hybrid screening in an attempt to
determine whether NF1 interacts directly with Rut-AC
or to identify intermediates that mediate interactions
between NF1 and Rut-AC. The effort has failed to gain
positive evidence. We are now taking another
approach by utilizing point mutations found in NFl
patients to investigate problems related to how NFl
regulates AC activity. Our collaborator Dr. Nurnberg
(Institut far Medizinische Genetik) has compiled a list
of 17 missense mutations after analyzing approxi-
mately 400 patients for mutations in the whole coding
region. Some of these mutations fall into the region
critical for Ras binding, and one of them has been
shown to disrupt the binding of Ras to NF1 drastical-
ly. A large number of mutations fall into domains
without defined functions. All of these mutations will
allow us to investigate the following issues. First,
mutations falling in the Ras-related-domain will
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enable us to test whether Ras activity or binding of Ras
is required for NF1- regulated AC activity. If expres-
sion of human NF1 with such mutations can still res-
cue Drosophila Nfl phenotypes related to the cAMP
pathway, Ras activity or binding of Ras is not required
for NF1-dependent regulation of AC activity. Second,
studies of mutations outside the Ras-related-domain
will help to determine regions of NF1 important for
regulating AC activity. It is expected that expression of
human NF1 with some mutations will be unable to res-
cue the phenotypes, and the regions in which the muta-
tions are located must be important for regulation of
AC activity. We have shown that induced expression of
human NF1 was capable of rescuing Drosophila NF1
phenotypes, including the small body size, defective
neuropeptide response, and reduction in G-protein-
stimulated AC activity. We are now conducting site-
directed mutagenesis and making constructs that con-
tain mutated human NFl. We will then generate trans-
genic flies carrying these constructs for testing effects
of these mutations as outlined above.
NR-regulated cAMP
Pathway in Vertebrates
J. Tong
All of the above studies have been confined in
Drosophila. Yet, studies of NF1 function in vertebrates
have largely been limited to GAP activity. It remains to
be determined whether NF1 also regulates AC activity
in vertebrates. The observation that expression of
human NF1 rescues fly NF1 phenotypes resulting
from impaired NF1- regulated AC activity suggests
that a similar NF1-regulated AC pathway is also
expected in vertebrates. We want to study this issue by
assaying AC activity in Nfl knockout mouse. Since
these Nfl mutant mice are embryonically lethal at
stage E13.5, our assay has used brain tissue from
embryos at E12.5 to E13.5. Preliminary data indicated
that GTP'yS- stimulated AC activity was reduced in
NF1 homozygous mice as compared to heterozygous
or wild type, supporting the idea that NF1 is both
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structurally and functionally conserved between verte-
brates and invertebrates.
Ensemble Coding and Odor
Perception: Ca" Imaging of
Odor-evoked Neural Activity
in the Mushroom Body
of the Living Drosophila
Y. Wang, J. An, H.-F. Guo
Drosophila has been a powerful genetic model for dis-
secting the molecular basis of learning and memory.
Yet, it has fallen short for studying the physiology of
learning and memory because of the small size of its
brain and central nervous system neurons. We have
now developed an imaging method that will allow us
to monitor fly brain activity by neural activity-depen-
dent changes in intracellular Ca" concentrations.
Odor-induced neural activity was recorded by Ca'
imaging in the cell body region of the Drosophila
mushroom body, the second relay of the olfactory cen-
tral nervous system. Its simple organization and super-
ficial position have allowed visualization of odor-
induced widely distributed spatial activity patterns.
The activity pattern, but not amplitude, of an odor
response is specific for the odor chemical identity and
concentration. This specific activity pattern can be
altered by genetic manipulation of an odor-binding
protein; the alteration of the spatial representation of
an odor is closely associated with a behavioral defect
of odor preference. These results strongly support the
idea that olfactory information is internally represent-
ed or encoded by spatially distributed activity patterns
at the second relay of the olfactory system.
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COMPUTATION IN THE AUDITORY CORTEX
A. Zador M. DeWeese
E. Verdee
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our goal
is to understand this computation at the synaptic, cel-
lular, behavior, and algorithmic levels. One example of
such a hard computation is the "cocktail party prob-
lem": our ability to attend selectively to a single voice,
effortlessly filtering it out from the others that make
up the banter that surrounds us. The model system in
which we study this computation is the rat auditory
cortex. Since arriving here at Cold Spring Harbor
Laboratory this year, we have begun to pursue two
related projects.
SYNAPTIC MECHANISMS UNDERLYING AUDITORY
STIMULUS-EVOKED RESPONSES
A first step toward understanding complex processing
in the auditory cortex involves understanding how neu-
rons represent auditory stimuli, and how these repre-
sentations are computed from the cochlear input five
synapses away. We hypothesize that the precise relative
timing of excitatory and inhibitory input determines
whether a cortical neuron responds to a stimulus with-
in its receptive field. To test this hypothesis, we are
using whole-cell patch clamp recording in vivo to mea-
sure the synaptic currents elicited by simple and com-
plex auditory stimuli. Patch clamp recordings provide a
much richer source of information than do convention-
al single-unit extracellular recordings because they
allow us to monitor not just the output of the neuron-
the spike train-but the inputs as well. Preliminary
data using pure tone-pip stimuli support our hypothe-
sis. These data suggest how we can design new stimuli
to probe the representations with which the cortex
solves hard problems in auditory processing.
NEURAL CORRELATES OF SELECTIVE AUDITORY
ATTENTION
When we tune in to one voice at a cocktail party, and
tune out the others, we are engaging in a form of selec-
tive auditory attention. Our ability to attend selective-
ly is not limited to the auditory domain: Analogous
tasks demand selective attention in the visual and even
somatosensory domains. In monkeys, visual attention
selectively enhances neural activity even in the most
peripheral areas of the visual cortex. This enhance-
ment is surprising because early sensory areas have
traditionally been thought of as representing the sen-
sory world faithfully, in a way that depends only on the
properties of the sensory input itself. The discovery of
attentional modulation overturns the notion that the
early sensory cortex is a passive "TV screen" available
for viewing by a "homunculus" buried deep in the cor-
tex, and instead raises the possibility that the
"homunculus" is distributed throughout the cortex.
More than a decade has passed since the first
reports of a neural correlate of selective attention in
monkeys, but the mechanism underlying the enhance-
ment of neural activity remains largely a mystery. We
are therefore developing a simpler preparation for
studying selective attention. rodents to
perform a simple selective auditory attention task. This
simple rodent preparation will have many advantages
over the existing primate preparation, as it will permit
us to bring to bear the full cellular and molecular arma-
mentarium. A better understanding of the mechanism
underlying selective attention may eventually allow us
to resolve basic questions about brain function.
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NEURAL ORGANIZATION OF OLFACTORY PERCEPTION
AND BEHAVIOR
Z.F. Mainen R. Gasperini K. Greenwood
M. Glander S. Macknik
Our laboratory is working toward understanding the
general principles of neural organization that allow
organisms to perceive, remember, anticipate, and act
on complex sensory information. The goal is an inte-
grative understanding that relates information process-
ing at the microscopic level (individual synapses and
neurons) to its macroscopic function. Our research is
currently centered on the olfactory system. The princi-
ples of chemical sensation are still poorly understood,
but the olfactory system offers numerous experimental
advantages including known receptor genes linked
directly to the initial encoding of stimuli, accessibility
by optical imaging techniques, a simpler neuronal
architecture compared to the neocortex, and a very
direct connection between sensory periphery and cen-
tral processing. My laboratory opened this fall in the
Marks Building, and we are now beginning to use a
variety of physiological and advanced optical tech-
niques such as two-photon microscopy and intrinsic
imaging to explore perception, learning, and behavior
in the olfactory system. The three main areas of
research are described below. We are also continuing
our investigation of the biophysics of synaptic trans-
mission and Ca" dynamics in collaboration with K.
Svoboda here at the Laboratory.
Neural Correlates of
Olfactory Perception
S. Macknik, R. Gasperini, Z.F. Mainen
Why do flowers smell more similar to one another than
to trees? What is the neural basis for the perceived
qualities, similarities, and differences between odors?
To address these questions, we are combining optical
imaging techniques to probe neural representations
with human and rat psychophysical techniques to
quantify perceptual characteristics of odors. Because
each glomerulus in the olfactory bulb is targeted by
neurons expressing a single olfactory receptor type, it
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is thought that the olfactory glomeruli form a map of
chemical structure. Any odor, either a single molecule
or a mixture of a many different molecules, activates a
specific subset of odor receptors and hence a particu-
lar pattern in the olfactory bulb. Because the location
of particular receptors within the glomerular map is
preserved from individual to individual, the receptor
map could provide the basis for the invariant perceptu-
al qualities of odors. Our main hypothesis is that per-
ceptual qualities of odors are direct correlates of the
spatial patterns of activity produced across the
glomerular input layer to the olfactory bulb.
Alternative hypotheses include the possibility that
such perceptual maps are only formed later in the
olfactory pathway, such as in the olfactory cortex, and
the possibility that perceptual qualities are not directly
related to any kind of spatial map, but instead rely on
nonspatial factors such as synchronization of neural
activity. We are testing the main hypothesis by com-
paring the perceptual discriminability of pairs of
odors, measured by errors made by mice in a behav-
ioral task, with the similarity of their glomerular activ-
ity patterns, measured by intrinsic imaging of odor-
evoked responses in anesthetized mice. We will also
test the first alternative hypothesis by carrying out
similar imaging in the pyriform cortex.
Neural Mechanisms
of Mouse Neonatal
Olfactory Learning
K. Greenwood, R. Gasperini, Z.F. Mainen
Why do mice get stuck in peanut-butter-baited traps?
Most rodent behavior is based on olfactory sensory
cues. As a basis for understanding how particular
behaviors are guided by specific sensory stimuli in a
mammalian nervous system, we are investigating the
neural bases of olfactory behavior in the neonatal
mouse. In the developing rodent brain, the basic archi-
tecture is in place, but the most complex central
processes are still not on line, leaving the animal with
a functional but substantially less complicated nervous
system and behavioral repertoire. We view this as a
particularly advantageous system in which to pursue a
neuroethological understanding of the basic organiza-
tion of information processing in the brain. Our start-
ing point is the use of behavioral paradigms in which
neonatal rodents learn long-lasting preferences and
aversions to particular odors they encounter in their
environment. We are using classical conditioning tech-
niques to isolate specific learning events. Previous
work has implicated structures within the olfactory
bulb in the formation and access of olfactory memo-
ries in this system. We are pursuing two broad ques-
tions. First, what are the cellular and circuit mecha-
nisms involved in the formation of a specific odor
preference? Second, what are the changes in cellular
and circuit properties responsible for changes in
behavior that follow learning?
Imaging Olfactory Structure and
Function in Xenopus Tadpoles
M. Glander, Z.F. Mainen [in collaboration with H. Cline,
Cold Spring Harbor Laboratory]
In collaboration with H. Cline, we are examining the
structure and function of the olfactory system in the
albino frog Xenopus. The developing nervous system
of the tadpole is particularly amenable to high-resolu-
tion imaging. We are using fluorescent dyes to label
olfactory receptors neurons and two-photon imaging
to resolve the structure of their axonal arbors. Ca "-
sensitive versions of these dyes are being used to
obtain functional maps of activity in the olfactory bulb
and epithelium. We are also examining the effect of
odor experience on the behavior of tadpoles, which,
there is reason to believe, may mirror the effects seen
in the developing mammalian system.
Biophysical Mechanisms of
Synaptic Transmission
Z.F. Mainen [in collaboration with R. Malinow and
K. Svoboda, Cold Spring Harbor Laboratory]
We have been using two-photon microscopy to image
transient increases in Ca' concentration mediated by
NMDA (N-methyl-D-aspartate) receptors in single
dendritic spines of CA1 pyramidal neurons in hip-
pocampal slices. This optical approach has allowed us
to study single synapses at a resolution impossible
with traditional electrical recordings and to thereby
address outstanding problems in the biophysics of
synaptic transmission.
At excitatory synapses in the central nervous sys-
tem, the number of glutamate molecules released from
a vesicle is much larger than the number of postsy-
naptic receptors. But does release of a single vesicle
normally saturate these receptors? Answering this
question is critical to understanding how the amplitude
and variability of synaptic transmission are set and
regulated. To test for NMDA receptor saturation, we
compared responses to stimulation with single and
double pulses. We found that a single release event
does not saturate spine NMDA receptors; a second
release occurring 10 msec later produces -80% more
NMDA receptor activation. Our results imply that the
amplitude of spine NMDA-receptor-mediated [Cam]
transients (and the synaptic plasticity which depends
on this) may thus be sensitive to the number of quanta
released by a burst of action potentials and to changes
in the concentration profile of glutamate in the synap-
tic cleft.
PUBLICATIONS
Mainen Z.F. 1999. Functional plasticity at dendritic synapses. In
Dendrites (ed. G. Stuart et al.), pp. 310-338. Oxford
University Press.
Mainen Z.F., Malinow R., and Svoboda K. 1999. Synaptic [Ca++]
transients in single spines indicate that NMDA receptors
are not saturated. Nature 399: 151-155.
Mainen Z.F., Maletic-Savatic M., Shi S.H., Hayashi Y., Malinow
R., and Svoboda K. 1999. Two-photon imaging in brain
slices. Methods 18: 231-239.
Svoboda K. and Mainen Z.F. 1999. Synaptic calcium:
Intracellular stores spill their guts. Neuron 22: 427-
430.
In Press
Malinow R., Mainen Z.F., and Hayashi Y. 2000. LTP mecha-
nisms: from silence to two-lane traffic. Curr. Opin.
Neurobiol. (in press).
Maravall M., Mainen Z.F., Sabatini B.L., and Svoboda K.
2000. Estimating intracellular calcium concentrations and
buffering without wavelength ratioing. Biophys J. (in
press).
163
STRUCTURE AND FUNCTION OF BRAIN CIRCUITS
D.B. Chklovskii
I am interested in discovering key organizing princi-
ples of the brain and applying these principles to
understand brain function. One such principle, that of
wiring economy, proved to be particularly useful for
understanding the organization of the brain. This prin-
ciple, which goes back to Cajal, asserts that the brain
has evolved under pressure to keep its volume to a
minimum. Thus, for a given circuit, the layout of brain
components, such as neuronal bodies and synapses,
should minimize the length of wiring, i.e., that is
axons and dendrites.
WIRING CATASTROPHE IN THE BRAIN
This work was carried out in collaboration with C.F.
Stevens (Salk Institute). The mammalian neocortex
has an astronomical number of connections: A micro-
liter of gray matter contains approximately 10' neu-
rons, 109 synapses, and 4 km of axons. In a mouse cor-
tex, 60% of the gray matter is taken up with "wire,"
half of this by axons and the other half by dendrites.
Because of such high volume occupied by wire, any
layout inefficiencies resulting in additional wiring
would be very costly: Wire would encroach upon the
space that could be devoted to "non-wire" such as neu-
rons and synapses. In view of this, evolution must have
optimized wiring the brain. This suggests solving a
wiring optimization problem to understand organizing
principles of the cortex.
Suppose we are given the wiring diagram of the
brain that lists all of the neurons and their intercon-
nections. Our task is to design a brain that implements
this wiring diagram. This task can be broken into two
stages. First, we need to find an optimal placement of
non-wire components: neurons and synapses. Second,
we need to determine the optimal parameters of the
wire components: axons and dendrites. Here, we focus
on the second stage and derive the optimal volume
fraction taken up by axons and dendrites for fixed rel-
ative positions of neurons and synapses. Anatomical
data suggest that the observed volume fraction is close
to the prediction.
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On this basis, we argue that settling on a subopti-
mal layout in the first stage cannot be offset by an
increase in volume but degrades performance by
reducing processing speed or simplifying wiring dia-
gram. This happens because of the sequence of events
which we call the wiring catastrophe. Layout ineffi-
ciencies lead to longer wiring. To maintain the same
time delays in axons and attenuation in dendrites, they
must be thicker, thus occupying greater volume. This
pushes neurons and synapses farther apart. Thus, the
wiring length must increase, and so on, resulting in a
runaway volume growth.
THEORY FOR THE GLOBAL STRUCTURE
OF THE OCULAR DOMINANCE PATTERN
Ocular dominance patterns in the primary visual cor-
tex have been actively studied ever since their discov-
ery about 30 years ago. However, several crucial ques-
tions about the appearance of the patterns remained
unanswered. One of the questions is what determines
the global structure of ocular dominance stripes on the
cortical surface. Because the structure is reproducible
between different animals, there is likely to be a func-
tional reason.
I predict the orientation of ocular dominance
stripes on cortical surface by analyzing the role of VI
in binocular stereopsis. If one calculates the predomi-
nant direction of stereo disparity in different regions of
the visual field and then maps this direction back onto
the cortex, the ocular dominance stripes should run in
the same direction. This relationship minimizes the
length of wiring required to make the appropriate
binocular connections between neurons representing
the disparities. My theory agrees with the observations
made in macaque and Cebus monkeys. By relating the
appearance of the maps to the cortical circuitry, my
results provide a tool for analyzing the function of the
brain circuits. These are timely results because fMRI is
about to achieve resolution sufficient to image ocular
dominance patterns in humans.
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DERIVATION OF A RULE RELATING DENDRITIC
AND AXONAL ARBOR SIZES TO CONVERGENCE
AND DIVERGENCE IN NEURONAL CIRCUITS
Understanding brain function requires knowing con-
nections between neurons. However, experimental
studies of interneuronal connectivity are difficult, and
the connectivity data are scarce. At the same time,
neuroanatomists possess much data on cellular mor-
phology and have powerful techniques to image neu-
ronal shapes. In this situation, I propose to use mor-
phological data to infer intemeuronal connections.
Such inference must rely on rules that relate shapes of
neurons to their connectivity.
I use the principle of wiring economy to derive a
rule that relates axonal and dendritic arbor sizes to the
convergence/divergence of neuronal connections.
Qualitatively, the rule states that in a projection
between two neuronal layers, neurons in the sparser
layer should have wider arbors. I derive a quantitative
FIGURE 1 The wiring diagram (a) for a projection between the layers
of input (circles) and output (squares) neurons can be implemented
in two ways; (b) wide dendritic arbors and no axonal arbors; (c) wide
axonal arbors and no dendritic arbors. The neuronal circuit in b is
preferred because it has shorter wire length than c. Convergence of
a neuronal circuit favors wide dendrites and no axons.
version of this rule and test it against experimental
data. The existing anatomical data from different brain
areas such as retina, cerebellum, olfactory bulb, and
cerebral cortex support the rule. Because cellular mor-
phology is much better known than neuronal connec-
tivity, this rule provides a useful tool in unraveling
brain circuitry.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to 3 years on projects
of their own choice. Fellows are provided with a salary, research support, and technical assistance so
that they can accomplish their goals free from other distractions. The interaction among research groups
at the Laboratory and the program of courses and meetings on diverse topics in molecular biology con-
tribute to a research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Fellows Adrian Krainer (1987) and Scott W. Lowe (1995) are current-
ly members of the faculty at the Laboratory. After nine years at the Laboratory, Carol Greider (1988) left
to join the Department of Molecular Biology and Genetics at Johns Hopkins University School of
Medicine. Eric Richards (1989) is currently in the Department of Biology at Washington University. After
finishing his fellowship, David Barford (1991) returned to the Laboratory of Molecular Biophysics at
Oxford University. Ueli Grossniklaus (1994) was a member of our faculty before leaving last year to join
the Friedrich Miescher Institut in Basel, Switzerland. Marja Timmermans, the current Cold Spring
Harbor Laboratory Fellow, joined us from Yale University in 1998.
PLANT DEVELOPMENTAL GENETICS
M. Timmermans P. Vahab
C. Merrick (URP)
Research in our laboratory is aimed at understanding
the molecular basis of axis specification and pattern
formation during lateral organ development in plants.
Organogenesis in higher plants continues beyond the
period of embryogenesis, and lateral organs of the
shoot develop progressively from small groups of
stem cells named meristems. During or soon after ini-
tiation, developmental axes are specified in the new
primordium, which ultimately results in the differen-
tiation of specific cell types in the appropriate posi-
tions. Early surgical experiments on shoot apices of
potato (Sussex, Nature 167: 651 [1951]) suggested
that the establishment of dorsoventral asymmetry in
leaves requires a signal(s) from the shoot apex.
Incisions that isolated the incipient leaf primordium
from the meristem resulted in the development of
radially symmetric organs. However, the genes
involved in the initiation and patterning of lateral
organs in plants are still largely unknown.
We are using transposable elements to generate
mutants that affect the initiation and patterning of lat-
eral organs in maize. In particular, we are analyzing
the roles of two genes: Leafbladelessl and Rough
sheath2. A better understanding of the function of
these and other genes involved pattern formation will
provide new insights into fundamental concepts of
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plant development. Variations in the expression pat-
terns of such genes are likely to contribute to the diver-
sity of leaf shapes among many plant species. More
importantly, however, the isolation and characterization
of genes involved in the patterning of leaves may facil-
itate the manipulation of plant architecture, which has
become increasingly more important for aspects of
crop yield such as shade tolerance.
ROUGH SHEATH2 IS REQUIRED FOR THE
TRANSITION FROM STEM CELL-LIKE GROWTH
OF THE MERISTEM TO DETERMINATE
GROWTH OF LATERAL ORGANS
A family of homeobox genes, the Knox genes, is
expressed in the shoot apical meristem and is required
for the indeterminate growth of the tissue. Deter-
minate lateral organs such as leaves are initiated by the
recruitment of founder cells, which is facilitated by the
down-regulation of Knox gene expression in a subset
of cells within the meristem. The recessive leaf mutant
rough sheath2 (rs2) affects cell differentiation along
the proximodistal axis, resulting in the distal displace-
ment of sheath and auricle tissues into the distal blade
region of the leaf. The number of founder cells recruit-
ed into rs2 mutant leaves is also reduced. We showed
that both phenotypes result from the misexpression of
KNOX proteins in rs2 mutant leaf primordia. rs2 thus
functions as a negative regulator of Knox gene expres-
sion, and plays an important part in the transition
from the indeterminate growth of the meristem to the
determinate growth of lateral organs.
We cloned the Rs2 gene, which is the ortholog of
the Antirrhinum Phantastica gene and encodes a
Myb-domain protein. In wild-type apices, Rs2 is
expressed in young leaf primordia in a pattern that is
consistent with the rs2 mutant phenotype. However,
the down-regulation of Knox gene expression, during
leaf initiation preceded the onset of Rs2 expression,
suggesting that Rs2 may not act to down-regulate
Knox gene expression, but rather to maintain the Knox
genes in an "off" state. The pattern of ectopic KNOX
protein accumulation in rs2 mutants is consistent with
this interpretation. Ectopic KNOX protein accumula-
tion in rs2 mutant leaves occurs in a subset of the nor-
mal Rs2 expressing cells. Furthermore, KNOX pro-
teins accumulated in patches with sharp lateral
boundaries, suggesting that rs2 leaves are clonal
mosaics of Knox' and Knox- sectors. The numbers and
sizes of such sectors varied among leaves and did not
correlate with normal developmental domains. This
variegated accumulation of KNOX proteins in rs2
mutants suggests that Rs2 represses Knox expression
through epigenetic means.
We are currently studying the mechanism by
which Rs2 regulates Knox gene expression. We are
taking several approaches to identify genes that act
together with Rs2 in this process. As a first step, we
have generated Rs2-specific monoclonal and poly-
clonal antibodies. These will also be used to determine
the precise expression pattern of Rs2 throughout
development and to analyze potential changes in Rs2
accumulation in other maize mutants affecting leaf ini-
tiation and patterning.
LEAFBLADELESSI IS REQUIRED FOR
DORSOVENTRALITY OF LATERAL ORGANS
Normal maize leaves develop as flattened dorsoventral
organs with distinct cell types on the adaxial/dorsal
and abaxial/ventral sides. We have previously shown
that the recessive leafbladelessl (1b11) mutation caus-
es a loss of adaxial cell types. The most extreme lbll
mutant phenotype is the formation of radially sym-
metric, abaxialized leaves. Less severe phenotypes
include the formation of ectopic blade tissue at the
boundaries of abaxialized sectors on the adaxial leaf
surface. In addition, we have shown that the number of
founder cells incorporated into lbll leaf primordia is
FIGURE 1 A maize plant that carries a mutation in the leaf -
blade/ess (1b11) gene shows threadlike leaves and stunted
growth. These and other defects result from the failure to
establish the adaxial domain of the leaf. This dorsoventral pat-
terning defect also affects lateral expansion of the leaf, which
normally occurs at the adaxial/abaxial boundary. As a result,
Ibll mutant leaves develop as radially symmetric rather than as
flattened organs.
strongly reduced. These observations suggest (1) that
Lbll plays a direct or indirect part in the down-regula-
tion of Knox genes during organ initiation, (2) that
adaxiaUabaxial patterning of the maize leaf primordia
occurs within the meristem during initiation, and (3)
that lateral growth of the organ occurs at the boundary
between adaxial and abaxial domains. This latter point
is particular intriguing because lateral growth of insect
wings occurs similarly at the dorsal/ventral boundary.
Several new alleles of lbll were obtained from
EMS and transposon-mutagenized populations. The
most severe allele of lbll results in embryo lethality.
Even though the root system develops normally in the
mutant, the shoot arrests early in development after the
formation of a variable number of short filamentous
organs. In addition, two new mutations with defects in
dorsoventral patterning of the leaf have been identi-
fied. To characterize these and the different lbll
mutants in more detail, we have cloned the maize
homologs of several Arabidopsis genes that are
expressed specifically in either the adaxial or abaxial
domains of the leaf. These maize homologs will be
used in in-situ hybridization experiments. We have
also begun to analyze the double mutant phenotypes of
lbll and the other dorsoventral patterning mutants.
Preliminary results suggest that all mutations affecting
dorsoventral patterning that have been identified so
far, act in the same pathway.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
On September 7, 1999, Cold Spring Harbor Laboratory opened its doors to the first class of the
Watson School of Biological Sciences. What had been a vision for the new millennium only four years
before had become a reality-a reality that was certain to have a significant change on the life of the
Laboratory. The immediate reality was a major, year-long effort, involving all the elements of the
Laboratory, to prepare for the students' arrival and the Laboratory's first academic term.
Recruitment of the Founding Class
The most important task at the beginning of the year was to recruit an outstanding founding class of
five to six students. The school was aided by extensive news media coverage in the fall of 1998 engi-
neered by the Public Affairs Department and its director, Deborah Barnes. Articles or news pieces
appeared in Science, Nature, and the Chronicle of Higher Education, as well as local news media.
Furthermore, we placed advertisements in the major scientific journals, the Watson School Web site
was launched, and posters, brochures, and letters were mailed to biology departments and colleagues
at academic institutions around the world. In return, the Laboratory received approximately 1000
requests for application forms. By the deadline of February 1, 1999, 130 students had submitted com-
pleted applications.
The Watson School's Admissions Committee had the daunting, albeit exciting, task of reviewing all
the applications and narrowing them down to a group of candidates that it felt had the ability to excel
in our new and intensive doctoral program. Twenty applicants were thus selected and invited to the
Laboratory for interviews. Nineteen students accepted our invitation, and each enjoyed a two-to-three-
day visit to the campus and discussions with 10 to 15 members of the research and nonresearch fac-
ulty. The candidates were all excellent. We found ourselves in the enviable position, as had been hoped,
of choosing from among the world's most promising students. Nine students were offered places in the
Watson School-six of them accepted. Each student has an outstanding academic record comple-
mented by many enriching experiences, and two have been awarded the prestigious Howard Hughes
Medical Institute predoctoral fellowship.
Cold Spring Harbor Laboratory has a long tradition of shared graduate programs with the State
University of New York (SUNY) at Stony Brook. Before the Watson School was established, there was
the concern that the new school might inadvertently discourage students from applying to the shared
SUNY Stony Brook programs and, thus, possibly, lose them from the pool of students who come to
Long Island for their doctoral studies. As a result of this concern, the Watson School and SUNY Stony
Brook graduate programs in the life sciences established a co-application mechanism, whereby appli-
cants to the Watson School could also automatically apply to the SUNY Stony Brook programs in
Genetics, Molecular and Cellular Biology, Molecular Genetics and Microbiology, and Neurobiology and
Behavior. We are pleased that as a result of this shared application mechanism, five students joined
either the Genetics or the Molecular and Cellular Biology programs at SUNY Stony Brook this fall. This
success was due in large part to the extraordinary efforts of Peter Gergen, chair of the joint Genetics
and Molecular and Cellular Biology admissions committee. We have Lawrence Martin, dean of the
Graduate School at SUNY Stony Brook, to thank for suggesting the successful co-application mech-
anism.
In establishing the Watson School, the Laboratory was, from the outset, hopeful that it would be
able to recruit students who had participated in the Laboratory's summer Undergraduate Research
Program. This program, which celebrated its 40th anniversary this year, has year after year recruited
some of the best undergraduate talent in the world to spend 10 weeks in the summer at the Laboratory
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to get a flavor for scientific research. Our hopes of attracting such students were not dashed. One of
the entering Watson School students, Elizabeth Thomas, heralds from the undergraduate class of
1997, when she spent the summer studying pre-mRNA processing with Adrian Krainer-and estab-
lished our Undergraduate Research Program Web site.
The successful recruitment of our founding class depended heavily on the efforts of all the Watson
School faculty, including the Laboratory's president and director. Jim Watson and Bruce Stillman met
extensively with nearly all the candidates. And Jim Watson was even known to follow up with some
candidates by finding them at the Blackford dining hall during breakfast for a few additional words!
Preparing for the First Class
Our success in recruiting outstanding students invigorated us to prepare for the fall, which was fortu-
nate because there was no time for pause. Over the spring and summer months, much effort was
spent preparing for the Fall Course curriculum. A Core Course Coordination Working Group consisting
of Lilian Gann, David Helfman, Michael Hengartner, Winship Herr, and William Tansey met regularly over
the summer months to discuss the development of the Scientific Reasoning and Logic (SRL) and
Scientific Exposition and Ethics (SEE) core courses and coordinate them with each other and the
Specialized Disciplines courses. They met with instructors of the Specialized Disciplines courses to dis-
cuss the development of those courses (in bioinformatics, transcription, and neurobiology) and how
they might best be integrated into a coordinated Fall Course curriculum. During this period, the SEE
course instructors, Deborah Barnes, Adrian Krainer, and William Tansey, met regularly to discuss how
to teach communication and ethics as one coherent course. The SRL instructors, Grigori Enikolopov,
David Helfman, Michael Hengartner, Winship Herr, David Jackson, Scott Lowe, and W. Richard
McCombie, divided the weekly segments among themselves and, together with other Watson School
faculty, developed the individual problem sets and selected readings to be assigned for discussion with
the students. To integrate and refine the course segments, the SRL course instructors took advantage
of the Banbury Conference Center for a two-day retreat in August. Lastly, our assistant dean, Lilian
Gann, put her organizational skills to the test by establishing a School calendar, so that all of the stu-
dents and faculty would end up in an available classroom at the right time. All of these efforts proved
essential to the success of the first Fall Course curriculum.
But not only courses had to be prepared. We also had to arrange to offer foreign students Fl visas,
get facilities ready, and obtain equipment.
The task of obtaining Fl visa status for the School fell to Merilyn Simkins and Cheryl Sinclair from
our Human Resources department. As spring became summer, so the possibility of obtaining our visa
status in time appeared to diminish. In mid-June, it came to light that there was some confusion over
our accreditation status. Barbara Meinert and Madeleine Ries of the State Education Department, who
had helped us so much with getting our accreditation, came to our rescue, providing us with the nec-
essary letters for the Immigration and Naturalization Service. Our Fl visa status came through at the
end of June.
The school's permanent home, Urey Cottage, would not be ready for occupancy during the
1999-2000 academic year, so temporary accommodation was required. Art Brings, director of
Facilities, and his team worked fast and furious to identify and prepare a study area for the students in
the lower floor of the Wawepex building. They also had to prepare a suitable classroom for the Scientific
Reasoning and Logic core course. The new Marks Imaging Building was in the final stages of comple-
tion and, again, Art and his team came through and were able to accelerate the work on the Gerry sem-
inar room in Marks so that it would be available for our first class. We are extremely grateful for all their
efforts.
The final hurdle in getting ready to deliver courses was getting the appropriate computer facilities in
place. We had worked extensively with the director of Information Services, Gerald Latter, over the
summer months, and things seemed to be going smoothly, or so we thought. We had received notifi-
cation on August 27 that the students' laptop computers had been shipped and were all confident that
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they would be up and running by matriculation on September 7. On September 7, however, we
received the following e-mail message from Jerry: "I just got off the phone with the shipper of the lap-
tops. The bad news is they got screwed up in shipment and ended up in Baltimore. The other bad
news is that they do not at this moment know where they are." The only thing left to do was laugh!
Thankfully, Jerry and his team received the computers the following day and had them operational for
our first week of the SRL course on macromolecular structure.
In addition to readying the facilities and equipment, we had to establish a handbook of School reg-
ulations! To help prepare this and learn about how graduate schools are run, Lilian Gann and I drove
to Portland, Maine, in July to attend the Council of Graduate Schools' Deans' Workshop. There we
learned from people who have been doing this much longer than we have. In addition to hearing how
things can go awry-and be righted-we met many graduate school administrators, who gave us
invaluable insights into what it is to be a graduate school, albeit the smallest one around!
With the help of what we learned in Maine, much of what we had already done to become accred-
ited by the State Education Department, and a Rockefeller University handbook given to me 2 years
earlier, Lilian Gann, with modest help from me, prepared a handbook for the entering Watson School
students. And in the nick of time! It was well past midnight on September 7 when we finished it-
matriculation took place just seven hours later.
The Founding Class Arrives
The students arrived during August and the beginning of September, and on September 7, 1999, the
first class of the Watson School of Biological Sciences matriculated. It was truly a historic occasion for
the Laboratory. The first class consists of six students (see previous page), each sponsored by a
Watson School fellowship. They came from across the United States-Massachusetts, Missouri, and
Washington-and abroad-London, Ankara, and Buenos Aires-and are interested in a wide range of
fields, including bioinformatics, cancer, gene expression, neurobiology, plant biology, and structural
biology. The students have adapted well to being pioneers in the Watson School. The permanent res-
idence for the students-the Knight House-was not ready until the end of December; those students
requiring Laboratory housing were placed in temporary housing on the grounds-some in a cabin in
the woods in keeping with the pioneering spirit!
An Intensive Fall Course Curriculum
The goal of the Fall Course curriculum is to teach students how to think independently and critically so
that in the future they can acquire, on their own, new knowledge in areas they have chosen to explore.
The Fall Course curriculum provided intense instruction in a series of integrated interdependent cours-
es. We were able to do this, in part, because we had maintained a small class size. Students could
receive individual attention and participate actively in class activities.
One of the great unknowns before this fall was how faculty of an institution with a rich tradition of
research, but not teaching, would respond to the demands of teaching. I am pleased to report that the
response of the faculty was nothing less than exceptional. Essentially without exception, faculty devot-
ed much effort to lectures and came out of the experience excited. The commitment of faculty was well
beyond expectations-over 70% of faculty participated in teaching either as full course instructors or
as guest lecturers. This success grew in large part out of the excellence and commitment of the six
students. I often heard remarks from faculty about how they had enjoyed the interactions with the stu-
dents during the lectures.
The three core courses in which the students participated during the fall were SRL, SEE, and
Research Topics (a research seminar series by all research faculty), which spanned the length of the fall
term. In parallel, students participated in three tandem, four-week lecture courses in the specialized dis-
ciplines. Students were also introduced to the Laboratory through the annual Laboratory-wide
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Symposium, and graduate student and Laboratory-wide seminars. The schedule was demanding, to
say the least-but we all made it! Because the courses had been so carefully integrated, we were able
to gauge when we had overloaded the students and take corrective action. The students were also
quick to bring concerns to our attention at the weekly "Dean's Tea," where each Monday afternoon
Lilian Gann and I met for discussions with the students over tea and cookies. In addition to feedback
via the teas, the SRL and SEE core course instructors met separately each week to review not only
student progress, but also their own progress. These and other experiences have taught a new teach-
ing faculty how to improve the course didactics.
The Fall Course term also saw the beginning of the academic mentoring program headed by William
Tansey. To achieve a high level of mentoring and guidance, the Watson School instituted a "two-tier
mentoring" program, through which each student has an academic mentor and a research mentor.
Shortly after matriculation, each student was assigned a faculty member as an academic mentor.
To make the mentor assignments, self-selected faculty put their names forward as eligible mentors and
students interviewed the ones they were most interested in. After the interviews, knowing the prefer-
ences of students and faculty, I matched them up for the mentoring program. Through regular meet-
ings, the academic mentors are able to follow student progress and guide them through their acade-
mic development.
Special Events
The establishment of the Watson School of Biological Sciences has also generated great excitement
within the institution generally. Last fall, there were two events that were centered around the School:
a gala concert with Emanuel Ax, Yo-Yo Ma, and Midori, which helped raise valuable funds for the
School, and an inaugural convocation of the Watson School.
Watson School Convocation
On November 5, the Watson School held its inaugural convocation. The purpose of the convocation
was to celebrate the opening of the Watson School and to recognize the contributions of Cold Spring
Harbor Laboratory to education in the biological sciences in its 109-year history. The Watson School
awarded three scientists who best illustrate the Laboratory's contributions to education in the biological
sciences-David Baltimore, Seymour Benzer, and Gerald Fink-the Honorary Degree of Doctor of
Science. David Baltimore illustrates the importance of the Laboratory's Undergraduate Research
Program, Seymour Benzer exemplifies how the Laboratory's postgraduate courses have influenced the
careers of scientists, and Gerald Fink is a model of the influence and dedication of the Laboratory's post-
graduate course instructors. Their contributions are described in greater detail below.
At the convocation, we were also honored to have Susan Hockfield, dean of the Graduate School
of Arts and Sciences at Yale University and an alum of Cold Spring Harbor Laboratory, present the
keynote address. In her address, she spoke of graduate education and the role Cold Spring Harbor
Laboratory may play in this enterprise. She paid particular attention to the Watson School's goal of
training doctoral students in a four-year program and pointed out how, through our programs in exten-
sive mentoring, teaching students to think critically and logically, and emphasizing that learning is a life-
long endeavor, the School may succeed. For me, it was a very special speech because it laid out so
clearly the goals of the Watson School.
The convocation also gave the Watson School an opportunity to put the achievements of one of its
first-year students on display. Michelle Cilia, who hails from New Hyde Park on Long Island and is a
former middle and high school student of the DNA Learning Center, is an accomplished singer. She
gave a virtuoso performance of excerpts from "House of Comedy", an opera composed by Christian
H. Mc Leer. Michelle and Christian have been friends since childhood, and he accompanied her singing
on the piano. All in all, it was a wonderful occasion.
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James D. Watson, "How Science Happens"
In recognition of Jim Watson's contribution to Cold Spring Harbor Laboratory and to research and edu-
cation in the biological sciences, the Board of Regents of the University of the State of New York, on
behalf of the State Education Department, on February 3, 1999, granted the Laboratory permission to
name the School in Jim Watson's honor-we became the Watson School of Biological Sciences. In the
fall, the School was further honored when Jim gave a series of scientific lectures to the Cold Spring
Harbor Laboratory community to commemorate the opening of the School. These lectures, entitled
"How Science Happens" and open to the public, gave the audience insights into scientific processes
and covered four stages in Jim's career:
discovering the double helix,
George Gamow and his combinatorial approach to the genetic code,
finding the genes of DNA tumor viruses that unlock cellular DNA synthesis, and
recombinant DNA and the beginnings of the Human Genome Project.
Gavin Borden Lecture
The fifth Gavin Borden Visiting Fellow Lecture (so named after the energetic and charismatic publisher
of The Molecular Biology of the Cell, who died in 1991 of cancer) was given by Joseph L. Goldstein,
M.D., of the University of Texas Southwestern Medical Center. The lecture, entitled "A Proteolytic
Pathway That Controls Cholesterol Content of Membranes, Cells, and Blood," was followed by a
reception and dinner for the speaker with the graduate students. The next day, Dr. Goldstein met with
Laboratory faculty and, after lunch with the faculty, with all the graduate students again for an informal
discussion.
Career Pathways for the Biology Ph.D.
In the Career Pathways for the Biology Ph.D. seminar series, students and postdoctoral fellows are
exposed to the many different career opportunities for Ph.D. graduates in biology. Biology Ph.D.s who
have taken a variety of different career paths are invited to discuss their career choices and to describe
how they use their Ph.D. training in their jobs. The guest speakers for this year's seminars were two
former SUNY Stony Brook graduate students who studied at the Laboratory. George Tokiwa was a
graduate student with Bruce Futcher and studied regulation of yeast cell growth. Carmel la Stephens
was a graduate student with Ed Harlow and studied the adenovirus El A transforming protein.
George Tokiwa, Ph.D., Orchid Biocomputer Inc.
"From CSHL to Life in a Start-up Biotech Company ... a Personal Experience"
Carmel la Stephens, Ph.D., Baker and Botts, L.L.P.
"Patenting in Biotechnology: Challenges for the Patent Attorney"
Shared Programs with SUNY Stony Brook
The six Watson School students were not the only students to arrive at the Laboratory in 1999.
Although the Laboratory only became a degree-granting institution in 1998, it has been involved in
graduate education leading to the Ph.D. degree in the biological sciences for over 25 years. Many grad-
uate students from institutions with Ph.D.-degreegranting authority, most notably SUNY Stony Brook,
have performed their doctoral research at Cold Spring Harbor Laboratory. The Laboratory remains
committed to these shared programs with SUNY Stony Brook, which continue to be a source of excel-
lent young scientists. Indeed, many of the Watson School faculty members have enjoyed the opportu-
nity to design and teach graduate courses at SUNY Stony Brook and have found this invaluable in the
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When I was named dean of the Watson School of Biological Sciences in the fall of 1998, I knew that
one of my most important challenges was to establish an administration that would have the desire and
vision to create a new school. In meeting this challenge, I have been most fortunate.
First, I was able to depend on the energy and experience of Jane Reader to help in the first critical
phase, that of recruiting the founding class. Jane has worked for many years as administrator of the
Undergraduate Research Program, Hengartner since he took over
the program in 1995. She had also helped me in earlier efforts to recruit students to our shared grad-
uate programs with SUNY Stony Brook. In those roles, she gained much experience in how to man-
age a recruitment effort, a complex and intense enterprise, and she brought this expertise to the very
successful recruitment of the founding class of the Watson School. The School is deeply indebted to
Jane for that effort at such a critical time.
Just as the students began coming for interviews in early March, Lilian Gann arrived from England
to assume the position of assistant dean. Good fortune played a role in this development, as the
Laboratory simultaneously recruited her husband, Alexander Gann, to join the Laboratory Press as
senior editor, textbooks. In Lilian Gann, the Watson School found the perfect candidate for assistant
dean. Lilian received her Ph.D. in the biological sciences from the University of St. Andrews in Fife,
Scotland, for her studies of adenovirus transcriptional regulation. After postdoctoral studies at Memorial
Sloan-Kettering Cancer Center, Harvard Medical School, and the Imperial Cancer Research Fund
(ICRF) in London, she became administration manager at ICRF and also earned a master's degree in
business administration (MBA) from the University of Westminster in London. In her role as administra-
tion manager, she was involved in both the graduate student and postdoctoral programs. Most recent-
ly, Lilian was director of cancer support services at CancerBACUP, a U.K. cancer charity focused on
helping people live with cancer. Lilian's contributions to the Watson School so soon after her arrival
have been striking. I regard recruiting Lilian to the Watson School as my single most important accom-
plishment in establishing the School.
In October 1999, the School's administration was further enhanced when Janet Duffy joined us as
admissions and academic records administrator. Janet is a graduate of Hofstra University, where she
majored in English literature, with a minor in secondary education. After a brief spell as a high school
teacher, she switched to real estate administration and now, to our benefit, academic administration.
The Watson School may not have a large administration, but it is blessed with a very effective one!
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Graduate Program Development and Oversight
Throughout the development of the graduate program, the School has relied on the support and com-
mitment of the Laboratory's scientific and support staff, especially the School's Executive Committee.
The Executive Committee meets monthly to address the wide range of issues involved in creating a
new program and to oversee the program in general. Issues the committee addresses are numerous
and include
determining the roles of faculty in the program,
overseeing the committees for admissions and qualifying examinations,
monitoring graduate student progress, and
developing and monitoring the curriculum.
The faculty and students on the committee have been instrumental to the process and have devot-
ed considerable time and intellectual resources to the program's development.
External Advisory Committee
Evaluating and implementing changes for improvement are critical to establishing and maintaining an
exceptional graduate program. In this, we are assisted by an External Advisory Committee comprising
senior figures in science and graduate training. The External Advisory Committee evaluates the quality
and effectiveness of our academic programs and provides advice and guidance. The committee visit-
ed the Laboratory in April 1999, primarily to review the planned Fall Course curriculum. At that time,
they also interviewed the Laboratory and School administration, faculty, students, and postdoctoral fel-
lows. After this visit, the External Advisory Committee prepared a report of its findings, together with
recommendations for improving the graduate program. These findings and recommendations were
instrumental in highlighting areas of change to improve the Fall Course curriculum that could be imple-
mented over the spring and summer months. We were exceptionally pleased with the enthusiasm the
External Advisory Committee expressed for the Watson School graduate program.
A Dedicated Endowment
One of the very special features of the Watson School is the commitment the Laboratory has made to
ensuring its success by raising an endowment dedicated to the support of the School. By covering the
costs of the four-year training of the graduate students, including tuition, stipend, and research expens-
es, the School can guarantee that the education of each student remains focused on his or her acad-
emic development. The Watson School's capital campaign has been immensely successful in large part
because of the dedicated efforts of its chairman, David Luke, and the generous contributions of our
many benefactors. I am especially thankful to Marjorie and William Matheson for endowing the George
A. and Marjorie H. Anderson Founder's Endowment. Without that early and generous support the
Watson School could not possibly have begun in such a splendid manner.
In Conclusion
And so it has been an exciting year indeed! This adventure of establishing a new school has been a
resounding success because of the support and contributions of the entire Laboratory community and
its friends. I have had a most marvelous experience working with so many outstanding and generous
colleagues. If such dedication continues, the School is guaranteed success as it grows and flourishes.
April 2000 Winship Herr
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FALL COURSE CURRICULUM
CORE COURSES
Scientific Reasoning and Logic
FUNDED IN PART BY George A. and Marjorie H. Anderson Founder's Endowment
INSTRUCTORS Grigori Enikolopov David Jackson
David Helfman Scott Lowe
Michael Hengartner W. Richard McCombie
Winship Herr
GUEST LECTURERS Alexander A.F. Gann Robert Martienssen Bruce Stillman
Gregory Hannon Jacek Skowronski Linda Van Aelst
Leemor Joshua-Tor David L. Spector Michael Wigler
Adrian R. Krainer Lincoln Stein Jan Witkowski
Yuri Lazebnik Arne Stenlund Rui-Ming Xu
VISITING LECTURER James Konopka, SUNY Stony Brook
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the Fall Course curriculum, faculty covered (1) a broad base of knowledge in
the biological sciences, (2) the scientific method, and (3) how to think critically. This course consisted of
13 weekly segments, each of which had a different theme. Each week, students read an assigned set
of research articles (generally five articles) and provided written answers to a problem set that guided
them through two (or, on occasion, one) of the articles. Twice weekly, students attended lectures relat-
ed to the week's topic, which included concepts and experimental methods. During the week, the stu-
dents met to discuss among themselves the assigned papers not covered by the problem set. At the
end of each weekly segment, the students submitted their problem sets and spent the evening dis-
cussing with faculty the assigned articles not covered by the problem set. The weekly topics were
Week 1 Macromolecular Structure
Week 2 RNA Processing
Week 3 DNA Replication and Chromosome Dynamics
Week 4 Protein Synthesis, Protein Kinesis, and the Cytoskeleton
Week 5 Signal Transduction
Week 6 Cell-cycle Regulation
Week 7 Cancer Genes
Week 8 Apoptosis
Week 9 Virus-Host Cell Interactions
Week 10 Mobile Genetic Elements
Week 11 Genome Structure and Evolution
Week 12 Cell-Cell Communication
Week 13 Development
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Research Topics
ARRANGED BY Lilian Gann
David Helfman
This course spanned the fall term. It provided students with an in-depth introduction to the fields of
research that Laboratory scientists investigate. Students and faculty attended a weekly evening
Research Topics seminar, at which faculty members presented seminars on their current research top-
ics and methods of investigation. The students learned how to approach important problems in biolo-
gy. These seminars, together with the annual fall in-house symposium, provide students with a basis
for selecting laboratories in which to do rotations. The weekly speakers were as follows.
Week 1 Andrew Neuwald, Leemor Joshua-Tor, Rui-Ming Xu
Week 2 David Helfman, Adrian Krainer, Michael Wig ler
Week 3 Nouria Hernandez, Tatsuya Hirano
Week 4 David Jackson, David Spector
Week 5 Grigori Enikolopov, Linda Van Aelst
Week 6 Shiv Grewal, Ryuji Kobayashi, Bruce Stillman
Week 7 Masaaki Hamaguchi, Arne Stenlund, William Tansey
Week 8 Gregory Hannon, Michael Hengartner, Yuri Lazebnik
Week 9 Winship Herr, Scott Lowe, Jacek Skowronski
Week 10 Robert Martienssen, Tim Tully, Jerry Yin
Week 11 W. Richard McCombie, Lincoln Stein, Michael Zhang
Week 12 Dmitri Chklovskii, Roberto Malinow, Karel Svoboda, Yi Zhong
Week 13 Hollis Cline, Zachary Mainen, Anthony Zador
Scientific Exposition and Ethics
FUNDED IN PART BY Nicholas C. Forstmann and the Edward H. Gerry Visiting Lectureship
INSTRUCTORS Deborah M. Barnes
Adrian Krainer
William Tansey
GUEST LECTURERS Alexander A.F. Gann
Terri Grodzicker
Noun's Hernandez
VISITING LECTURERS Robert P. Charrow, Esq., Crowell & Moring LLP
Robert Day, University of Delaware
Ellie Ehrenfeld, National Institutes of Health
Boyce Rensberger, Massachusetts Institute of Technology
This core course offered instruction about the fundamental elements of scientific exposition-writing
skills and public speaking-and ethics. The abilities to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; communications and ethics were taught in
a series of example-based lectures and discussion groups. Writing skills included the fundamentals of
modern scientific English and the organization and preparation of papers, research abstracts, and grant
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applications. Oral presentation skills were taught by scientists with excellent, albeit different, modes of
presentation. Together with instructors, students also critiqued formal seminar presentations at the
Laboratory. Instruction and discussions about ethics included the ethical implications of biological dis-
covery for society, as well as the nature and boundaries of ethical behavior of individual scientists and
their rights and responsibilities. A primary objective of the course was that students understand that
exposition and ethics should be an integral part of scientific research. An added benefit of this course
was that two of the guest lecturers, Robert Day and Ellie Ehrenfeld, were also able to give additional
lectures to the Cold Spring Harbor Laboratory community.
SPECIALIZED DISCIPLINES COURSES
Fundamentals of Bioinformatics
FUNDED IN PART BY Edward H. and Martha F. Gerry Lectureship
INSTRUCTORS Andrew Neuwald
Lincoln Stein
Michael Zhang
In biology today, the computer is as essential a tool for research as the microcentrifuge and elec-
trophoresis unit. With computer software, scientists can digest the enormous amount of information
produced by the human genome project, answer questions about evolution,
es such as signal transduction and gene regulation, and manage and organize experiments. This
course provided a practical introduction to bioinformatics, including computational biology, biological
data modeling, and laboratory workflow management. Topics covered included database basics, Web-
based resources for genome maps and sequence data, elementary probability and statistics, protein-
and DNA-sequence analysis, phylogenetic analysis, and molecular evolution.
Mechanisms of Transcriptional Regulation:
From E. coli to Elephants
FUNDED IN PART BY Martha Farrish Gerry Visiting Lectureship
INSTRUCTORS Winship Herr
William Tansey
GUEST LECTURERS Alexander A.F. Gann
Nouria Hernandez
VISITING LECTURER Walter Gilbert, Harvard University
This course covered both prokaryotic and eukaryotic transcriptional regulation. The discussion of prokary-
otic transcription was centered on a historical perspective of the discovery of key mechanisms of tran-
scriptional regulation in the Escherichia coli lac operon. Discussions about eukaryotic transcription built on
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the information shared from studies of prokaryotes and emphasized fundamental similarities-and impor-
tant differences-between eukaryotic and prokaryotic transcriptional regulatory mechanisms. Two recur-
ring themes in this course were the complementary nature of studies of diverse organisms and the impor-
tance of diverse approaches to scientific discovery.
Mechanisms of Synaptic Plasticity and Learning
FUNDED IN PART BY John Klingenstein Lectureship
INSTRUCTORS Hollis Cline
Roberto Malinow
Karel Svoboda
This course explored the cellular plasticity that underlies changes in brain function associated with
development and with learning and memory. The study of the development of the visual system shows
how organized topographic sensory projections develop in the central nervous system. Discussions of
research on the mammalian hippocampus using behavioral, cellular, and molecular approaches were
analyzed to describe the cellular basis of learning and memory in the adult brain. Ultimately, students
gained an understanding of neural plasticity in development and in learning and memory.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
INAUGURAL CONVOCATION
On November 5, 1999, Cold Spring Harbor Laboratory celebrated the opening of the Watson School
of Biological Sciences with an inaugural convocation. The event included a celebration of the 109-year
history of science education at the Laboratory and the awarding of the Honorary Degree of Doctor of
Science to three outstanding scientists-David Baltimore, Seymour Benzer, and Gerald Fink. Following
are the citations that describe each recipient's association with educational activities at the Laboratory,
and the respective acceptance speeches.
David Baltimore
Citation
David Baltimore is president of the California
Institute of Technology. Born in New York
City on March 7, 1938, Dr. Baltimore
received his B.A. degree from Swarthmore
College in 1960 and his Ph.D. degree in biol-
ogy from Rockefeller University in 1964 for
studies on RNA viruses, including poliovirus.
After postdoctoral studies at the Massa-
chusetts Institute of Technology and Albert
Einstein College of Medicine with James
Darnell and three years at the Salk Institute
as a research associate, Dr. Baltimore joined
the MIT faculty in 1968. There, in 1970, Dr.
Baltimore isolated, contemporaneously with
Howard Temin, the reverse transcriptase
enzyme, which copies RNA into DNA. In
1975, he shared the Nobel prize in Physiol-
ogy or Medicine with Howard Temin for this
extraordinary discovery. He has since been
the founding director of the Whitehead
Institute, president of Rockefeller University,
and chairman of the National Institutes of Health AIDS Vaccine Research Committee.
In 1959, while an undergraduate at Swarthmore College, Dr. Baltimore spent the summer at Cold
Spring Harbor Laboratory as a member of the first class of the Undergraduate Research Program. He
studied the genetics of bacteriophage viruses with George Streisinger. Dr. Baltimore best illustrates the
influence the Laboratory's Undergraduate Research Program has had in preparing outstanding scien-
tists in the biological sciences.
Acceptance Speech
"The Cold Spring Harbor Laboratory has always embodied for me the deepest values of science. The
emphasis on basic advances, the commitment of the staff to a full-time life in science, makes the Lab
an ideal to emulate. So, I can't think of any higher honor than to receive this honorary degree from the
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Watson School, especially because it comes for the work I have done in the field that I chose here so
many years ago.
"In 1959, I was in the first URP class, and I had no idea how lucky I was. I came here because I had
heard about bacteriophages and I wanted to see what the plaques they made looked like. That odd
impetus-and my own knowledge that Cold Spring Harbor was just down Route 25A from my home-
town of Great Neck-changed my life. It is a remarkable symmetry of my career that I was in the first
URP class here and am now the recipient of the first honorary degree from the Watson School.
"The Watson School is sure to do great things. Many people say that the world doesn't need-that
America doesn't need-more Ph.D.s. But I think there are never too many people of excellence who
have been trained by the kind of faculty that is here. This faculty is able to impart to young students an
understanding of what they have gotten into and where they can go with it. I'm not positive that four
years is enough for a Ph.D. today. It is a complicated world that the students are entering. But it is an
experiment worth trying-in a sense, going back to. This school is new, but there is no question that
the faculty has the right stuff to make it a school of great excellence.
"I am relatively new to Caltech. I've only been there for two years, and I still see Caltech from the
outside. Caltech, to me, has redefined excellence because what it means there-and what it should
mean anywhere-is only doing things when you can do them exactly the way you feel is right. It means
having the best people and very deep resources-then you can insist that only the best students are
good enough to come and work with the people at your institution.
"As I walk around here, I've been comparing Cold Spring Harbor in 1959 and Cold Spring Harbor
now. I think of it then as a few, sort of quaint shacks on the harbor-and now they have metamorphosed
into palaces. It's like a sort of skinny, ugly caterpillar that emerges as an elegant butterfly. There is no
secret who is the magician: Jim Watson, a great builder of institutions. And now his institution is to meta-
morphose again, this time into a school. Congratulations Jim, Bruce, and Dean Winship. Thank you."
Seymour Benzer
Citation
Seymour Benzer is James Griffin Boswell
professor of neuroscience at the California
Institute of Technology. Born in New York
City on October 15, 1921, Dr. Benzer
received his B.A. degree from Brooklyn
College in 1942 and his Ph.D. degree in
physics from Purdue University in 1947 for
studies on germanium crystal rectifiers, a
predecessor to the transistor. After reading
What Is Life? by Erwin Schrodinger and
learning of Max Delbruck's studies of muta-
tions in phage, Dr. Benzer was convinced by
Salvador Luria to attend the Cold Spring
Harbor Laboratory Phage Course in the
summer of 1948-the same summer that
James Watson first came to the Laboratory
as Luria's graduate student. While attending
the Phage Course, Dr. Benzer decided to
change fields and subsequently became a
preeminent biologist. His early studies
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focused on the structure of the gene through an exquisitely detailed genetic analysis of the ril region of
phage T4. During the 1960s, Dr. Benzer switched his interests to the study of animal behavior, using
Drosophila genetics to uncover genes that control behavior. Dr. Benzer has been widely recognized for
his outstanding contributions to the biological sciences. He was awarded the Lasker award in 1971
and the National Medal of Science in 1983. As a preeminent biologist who was in part directed to the
biological sciences by his attendance at a Cold Spring Harbor Laboratory course, he exemplifies the
impact Laboratory courses have had on scientists in the field of biology.
Acceptance Speech
"This morning, I gave a lecture on the current work of my group at Caltech in seeking the genetic basis
of longevity. Afterward, Gerald Fink brought up a quotation from Mark Twain saying
that a better design would be to be born at 80 and age backwards, ending up around
16. That kind of time travel has not yet been achieved. We are working on it.
"The best means I can offer for going backwards is to show some photographs of
Cold Spring Harbor, taken when I was a student in the Phage Course in the summer
of 1948. There, I underwent a quantum change from physics to biology, simply as a
result of 3 weeks of exposure to bacteriophage. The first slide shows a picture of
myself in the course, when I had more hair. In the background, you can see Gunther
Stent, another later-to-become distinguished member of that class. The third person
is Bernie Davis, to whom I have always been grateful because he was the first person
to explain to me what an antibody was.
"At that time, little enough was known about bacteriophages that it was possible
to know almost everything that had been done. Once you mastered the one-step growth experiment,
you could begin. The biggest hurdle in getting started was learning how, while holding a test tube in
one hand, to hold both a cotton plug and a pipette in the other. The rest was easy. I am forever indebt-
ed to my lab partner, Peggy Lieb, for having taught me that.
"One of the traditions was, at the end of the Phage Course, to
conduct a costume party graduation. The main activity was worship-
ping a portrait of Max Delbruck, who had initiated the course,
although, by then, it was given by Mark Adams. In the picture, you can
also see Salvador Luria, just below the string at the left, and others
who have since had distinguished careers.
"I must say that I am taken aback by the aus-
terity of today's occasion, which is in utter contrast to
all the earlier experiences I have had at Cold Spring
Harbor. Informality then extended to everything. As
proof, I offer this picture of Andre Lwoff. I know how
he behaved in Paris because I spent a year at the Pasteur Institute in his laboratory,
where he was very much the patron-distinguished, polite, and formal. And here he
was at Cold Spring Harbor shooting a water pistol. I
believe he was aiming at me, because I was holding
the camera, in an attempt to destroy the evidence.
"Jim Watson, at that time, was making his living by waiting tables
in Blackford. That is Jim on the right side of the picture, unfortunately
in a fringe area. Although he has risen from that lowly status to where
he is now, it is ironic that he is still very much preoccupied with getting
food onto the table. In the next picture, we see how he was attired in
those days. Jim made a practice of keeping his sneaker strings untied.
If some kind person, out of pity, tied them up, Jim would immediately
untie them again. You can see some of the changes that occur with
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age in morphology, behavior, and attire, by comparing with the contemporary version sitting here on the
stage.
"Finally, on one occasion, when Jim sampled the food at Cold Spring Harbor, he decided that some-
thing simply had to be done about it, as you can see in the picture. I recall a group reaction, on one
occasion, to dehydrated eggs, which may have helped to turn the tide.
"So, I must say thank you to Cold Spring Harbor, Jim Watson, Salvador Luria, Max Delbruck, and
the unusually competent and dedicated people who keep this great place running, and who will surely
make this already world-class school into one having the name as well as the game."
Gerald R. Fink
Citation
Gerald R. Fink is director of the Whitehead
Institute for Biomedical Research and
American Cancer Society Professor of
Genetics at the Massachusetts Institute of
Technology. Born in Brooklyn, New York, on
July 1, 1940, Dr. Fink received his B.A.
degree from Amherst College in 1962 and
his Ph.D. degree in genetics from Yale
University in 1965. After performing his post-
doctoral studies with Bruce Ames at the
National Institutes of Health, Dr. Fink joined
the faculty at Cornell University in 1967,
where he became professor of biochemistry
in 1979. In 1982, he moved to the
Massachusetts Institute of Technology as
professor of molecular genetics. Dr. Fink is
known for his pioneering work in genetics.
He has developed yeast as a model system
for studying the basic molecular biology of
eukaryotic organisms. He was the first to
show that DNA could be taken up by yeast,
leading to its stable transformation, and he has elucidated mechanisms for the control of amino acid
synthesis and sexual reproduction in yeast. More recently, he has been a leader in the development of
the small flowering plant Arabidopsis thaliana as a model for the study of plant development. He was
elected to the National Academy of Sciences in 1981 and received the Genetics Society of America
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Medal in 1982. In 1970, encouraged by James Watson who had recently assumed the Laboratory
directorship, Dr. Fink initiated the well-known Cold Spring Harbor Laboratory Yeast Course with Fred
Sherman. Four years later, Dr. Fink additionally joined David Botstein and John Roth on sabbatical leave
at the Laboratory. Drs. Fink and Sherman continued to teach the Yeast Course for 17 years -It played,
and continues to play, a seminal role in the development of yeast as a model organism for the study of
eukaryotes. Many of the leaders in the field of yeast biology were introduced to yeast through this
course. Dr. Fink best illustrates the extraordinary intellectual leadership, teaching ability, and dedication
of the Cold Spring Harbor Laboratory course instructors who are responsible for the Laboratory's pre-
eminent role in postgraduate education in the biological sciences.
Acceptance Speech
"You have heard that I taught here for 17 years, and as I reflect on my years of teaching here at Cold
Spring Harbor, it's very easy for me to understand why every summer I was magnetically drawn back
here. Personally, the Lab was enormously hospitable to my family and me. For a month in the summer,
my wife, Rosalie, and my two daughters, Julie and Jennifer, were guests of the Cold Spring Harbor
community and shared this lovely scenery, and perhaps as interesting, the spicy gossip that had been
stored up over the winter.
"Scientifically, a Cold Spring Harbor course offered me the opportunity to seed a new field, because
a course at Cold Spring Harbor was really a different challenge, different from anything that a universi-
ty course offered. I think university courses are often captured by Peter Druckers' comment, "When a
subject becomes totally obsolete, we make it a required course."
"A Cold Spring Harbor course is built on the presumption of novelty, and for me, teaching here had
the allure of starting something different with the prospect of making remarkable discoveries. The tech-
niques and concepts that we taught were really not in a single book, and you couldn't learn them at
any university. This pioneering spirit gave us, both teachers and students, the shared sense that we
were standing at the threshold of a golden lode. We knew there was great potential and we were eager
to set about mining it.
"I must say that the isolated environment of Cold Spring Harbor contributed a kind of mystical qual-
ity that seems simultaneously to expect and portend great discoveries, and as a consequence, I asa
teacher had the best of all possible situations: Curious students, desperate to learn, and smart enough
to force me to learn. And furthermore, we had nothing else to do for three weeks. Actually, the longevi-
ty of the course required considerable political skill on my part because every year Jim Watson would
call me into his office and declare, "This is the last year of the course!" and, "There can't be anymore
interest in this subject!" This pronouncement was Jim's method of quality control. In the ritual psy-
chodrama that followed, I would plead the case for just one more year to an ever more skeptical grand
inquisitor. Inevitably, these sessions ended with Jim's comment, "Well, I guess we'll try it for one more
year."
"Jim would not allow for obsolescence. And I detect this both in Winship and all of the staff, and I
can see that Bruce is looking for the same kind of novelty. By 1989, Jim and I agreed that it was time
for me to stop teaching the course. Our former students were professors that now populated every
major university in this country and in Europe. Cold Spring Harbor has created, I think, the most unique
postgraduate program in the world and it has built on the presumption of novelty. Today, we are cele-
brating the nativity of this Graduate Program. I am delighted to be honored at the birth of the Watson
Graduate School, which I think is the child of a remarkable postgraduate program. Science will not be
the same."
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ACADEMIC AFFAIRS
With courses ranging from bioinformatics to the cloning of genes expressed in single neurons and with
our meetings schedule highlighted by the Laboratory's world famous Symposium, the 1999 academ-
ic program was designed to serve the broader scientific community. This year, more than 6000 scien-
tists, ranging from graduate students to senior faculty, participated in laboratory and lecture courses,
workshops, and large conferences. These scientists represent an international group who come from
universities, medical schools, research institutes, and industry.
The academic program includes a series of 3-week laboratory courses that are held in the summer,
as well as 1- and 2-week laboratory courses that are given in the spring and fall. They are held in the
Howard Hughes Medical Institute (HHMI) teaching laboratories in the Beckman Neuroscience Center
and in Delbruck Laboratory. The Informatics courses take place in the Bush Auditorium, which is
adapted for them, and the Neurobiology lecture courses are held at the Laboratory's Banbury Center.
The new Marks Imaging Laboratory, which opened in the fall, contains a teaching laboratory and was
inaugurated with a course on DNA Microarrays.
Courses cover areas including molecular biology, structural biology, neurobiology, genomics, and
informatics. A new course on Genome Informatics was added this year, joining the course on
Computational Genomics. Both were heavily oversubscribed, highlighting both the quality of the cours-
es and the need for training in this area. In fact, all of the courses had more applicants than could be
accommodated, which is a reflection of their timeliness as well as the expertise of the instructors. The
instructors include a few Cold Spring Harbor faculty, but most come from universities and research
institutes from around the world. Their energy, enthusiasm, and very hard work are the key to the suc-
cess of the program. Many of them return for several years to teach at the Laboratory for which we
continue to be very grateful. Course instructors, assistants, lecturers, and students are listed in the fol-
lowing pages.
The courses were supported this year by grants from NIH, NSF, HHMI, the Esther and Joseph A.
Klingenstein Fund, the Grass Foundation, the Merck Genome Research Institute, and the Burroughs
Wellcome Fund. We were extremely pleased that our 4-year grant from HHMI was renewed this year
and will continue to support neurobiology courses as well as a range of new courses. We also receive
valuable loaned equipment and donated supplies from a variety of companies, which are listed below.
Nineteen meetings were held at the Laboratory this year, including our annual Symposium.
Signaling and Expression in the Immune System was the title of the 1999 Symposium. The meeting
brought together 445 scientists to discuss their latest research and was organized by Bruce Stillman.
The other meetings covered a broad range of topics, extending from Telomeres and Telomerase to
Microbial Pathogenesis and Host Response. Many of the meetings filled the Grace Auditorium to
capacity, including Programmed Cell Death, Genome Sequencing and Biology, Retroviruses, and
Mechanisms of Eukaryotic Transcription. An important feature of these meetings is that most talks are
selected by the organizers from submitted abstracts. This not only results in presentation of the most
recent and innovative work, but also allows more junior scientists to speak about their research. In fact,
at many meetings and lectures, senior scientists announce that they had their first opportunity to pre-
sent a talk at a Cold Spring Harbor meeting. The organizers, session topics, and session chairs for the
1999 meetings are listed below.
The success of the very large program of courses and meetings is also due to the skilled efforts of
many people at the Laboratory. Two of these, who are very well known to the scientific community, are
retiring this year. They are Micki McBride, the Course Registrar, and Herb Parsons, the Director of
Audiovisual Services. Both Micki and Herb have worked with enormous professionalism, tact, and
good humor to contribute in a very significant way to the excellence of the program. While Micki is
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moving and will no longer be a neighbor, we are pleased that Herb will continue to do special projects
for the laboratory. They will be replaced by their very able colleagues, Andrea Stephenson as the new
Course Registrar, and Ed Campodonico as the new Manager of Audiovisual Services. The staff of the
Meetings and Courses office handle all aspects of the day-to-day management of the programs of
meetings and courses at the Laboratory. This ever-growing job is carried out with skill and efficiency by
a group that includes Michael Glaessgen, Drew Mendelson, Kathy Ruffo lo, Mary Smith, Marge
Stellabotte, Andrea Stephenson, Diane Tighe, Jenna Williams, and Barbara Zane. Housing and front
desk operations are skillfully handled by Nancy Weeks, Donna Dykeman, and Andrea Newell, and
audiovisual services are ably provided by Ed Campodonico, William Dickerson, John Parsons, and the
part-time audiovisual staff. Staff from several other departments are crucial to the success of the cours-
es: Wendy Crowley manages the educational grants; Cliff Sutkevich and his staff set up and maintain
the courses equipment; the Information services group under Gerry Latter provide computer support
for all courses; and Leigh Johnson in the Library handles the book and journal needs of the course pro-
gram.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Director of Meetings and Courses
Symposium 64 barbecue.
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64th COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Signaling and Gene Expression in the Immune System
June 2-7 445 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
The concept of this Symposium emerged from two separate sources. During the past decade, our
understanding of the signal transduction pathways that lie downstream from cytokine action at the cell
surface has advanced rapidly. As a consequence, I had imagined that a symposium on cytokines
would be of considerable interest on its own, especially given the medical importance of the topic. At
the same time, discussions with Stephen Smale and Rudi Grosschedl one summer during the Cold
Spring Harbor Laboratory Gene Expression Course led to the suggestion of a symposium dealing with
gene expression in the immune system, events that lie at the other end of immune cell signaling path-
ways. The obvious solution was to merge these two interesting topics.
Although not meant to be a Symposium covering all aspects of modern immunology, the time was
certainly right to hold another meeting on some aspect of immunology in this series, now in its 64th
year. The Antibodies Symposium in 1967 followed immediately after the cracking of the genetic code,
itself celebrated at the 1966 Symposium, and naturally focused on immunoglobulin production and
amino acid sequence diversity. The Origins of Lymphocyte Diversity Symposium in 1976 saw the begin-
nings of a molecular understanding of this diversity when Susumu Tonegawa presented his exciting dis-
covery of immunoglobulin gene rearrangements that explained, in large measure, the mechanism of
generating B-cell diversity. This meeting, held in the aftermath of the discovery by Doherty and
Zinkernagel of MHC restriction, was also in the heyday of T-cell immunology.
It was nearly a decade and a half before the 1989 Symposium on Immunological Recognition her-
alded the understanding at the structural level of antigen presentation and host cell restriction. It was
about this time that cytokine research was starting to take off and the concept of Th1 and Th2 T cells
appeared. What has emerged since is a complicated, yet fascinating, story about how the immune cell
network is controlled, both during development and in the adult. Cytokine signaling and differential
gene expression underlie much of modern immunology research. The bringing together of these two
apparently separate areas was an experiment that was worth trying. This field has been greatly aided
by technologies such as gene deletions and gene replacements in mice, as well as by rapid develop-
ments in our general understanding about signal transduction and gene expression. If we really grasp
how these complex signaling pathways interact and how they can be manipulated, by both extracellu-
lar and intracellular means, then medical problems such as inflammation, autoimmunity, and immune
system disorders may lead to rational therapy. Manipulating the immune system by such means has
long been a goal, but at the moment, unexpected results are more common than not.
The final program contained 72 oral presentations and 210 poster presentations, making it a busy
five days for the 445 participants who packed Grace Auditorium.
The Symposium started with a fascinating first night of introductory talks from David Goeddel, Tak
Mak, James Darnell, and Martin Gellert. I thank Richard Flavell for agreeing to summarize the meeting
and for writing such a marvelous and thoughtful summary, matching the great summaries of previous
symposia.
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Essential funds to run this meeting were obtained from the National Cancer Institute, a branch of
the National Institutes of Health. In addition, financial help from the corporate sponsors, affiliates, and
contributors of our meetings program is essential for these symposia to remain a success, and we are
most grateful for their continued support. Corporate Sponsors include Alafi Capital Company; Amgen
Inc.; BASF Bioresearch Corporation; Bayer Corporation; Bristol-Myers Squibb Company; Chiron
Corporation; Chugai Research Institute for Molecular Medicine, Inc.; Diagnostic Products Corporation;
Du Pont Pharmaceuticals Company; Eli Lilly and Company; Forest Laboratories; Genentech, Inc.;
Genetics Institute; Glaxo Wellcome Inc.; Hoechst Marion Roussel; Hoffmann-La Roche Inc.; Johnson
& Johnson; Merck Research Laboratories; New England BioLabs, Inc.; Novartis Pharma Research;
OSI Pharmaceuticals, Inc.; Pall Corporation; Parke-Davis Pharmaceutical Research; PE Biosystems;
Pfizer Inc.; Pharmacia & Upjohn, Inc.; Research Genetics, Inc.; Schering-Plough Corporation;
SmithKline Beecham Pharmaceuticals; Wyeth-Ayerst Research; and Zeneca Group plc. Plant
Corporate Associates include Monsanto Company; Novartis Agricultural Discovery; Kyowa Hakko
Kogyo Co., Ltd.; Pioneer Hi-Bred International, Inc.; and Westvaco Corporation. We also thank our
Foundation Associate, Albert B. Sabin Vaccine Institute, Inc., at Georgetown University; our Corporate
Affiliates, Affymetrix, ICOS Corporation, and Sugen; and our Corporate Contributors, Alexis
Corporation, Biogen, Inc., Genome Systems, CuraGen, Pharmingen, Qiagen, Stress Gen
Biotechnologies Corp., Trevigen, Inc., and Zymogenetics, Inc.
T. Honjo, M. Davis, C. Goodnow Y. Linderson
M. Nussenzweig, U. Weiss
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PROGRAM
Introduction
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
Gene Regulation and Chromatin
Chairperson: R. Grosschedl, University of California, San
Francisco
T-cell Differentiation and Receptor Signaling
Chairperson: A. Weiss, University of California, San Francisco
Transcription Factors in the Immune System
Chairperson: T. Maniatis, Harvard University, Cambridge,
Massachusetts
Cytokine Signaling
Chairperson: L. Glimcher, Harvard School of Public Health,
Boston, Massachusetts
Recombination, Mutation, and Allelic Exclusion
Chairperson: K. Rajewsky, University of Cologne, Germany
Development
Chairperson: U. Storb, University of Chicago, Illinois
Cell Death and Survival
Chairperson: J . Allison, University of California, Berkeley
B Cells
Chairperson: F. Alt, HHMI, Children's Hospital, Boston,
Activation, Selection, and Commitment
Chairperson: M. Davis, Stanford University School of
Medicine, California
Dorcas Cummings Lecture: Repairing the Body: The
Promise of Blood and Tissue Stem Cells
Speaker: Irving Weissman, Stanford University School of
Medicine
T-cell Receptor Signaling
Chairperson: K. Jones, The Salk Institute, La Jolla, California
Nf -xB and NFAT
Chairperson: S. Smale, University of Califomia, Los Angeles
Summary: R. Flavell, Yale University
R. Flavell, J.D. Watson
C. Janeway
J. Biro, M. Reth
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BIOTECHNOLOGY CONFERENCE
Vector Targeting Strategies for Therapeutic Gene Delivery
March 11-14 151 participants
ARRANGED BY David Curiel, University of Alabama, Birmingham
Wayne Marasco, Dana Farber Cancer Institute
The paramount requirement for advancement of gene therapy is the development of vector systems
with the capacity for efficient and cell-specific gene delivery. The achievement of this goal requires that
the vector system recognizes specific cell signatures. For efficiency, both nonviral and viral vectors have
been engineered. For identification of cell-specific markers, a variety of high-throughput methods have
been advanced. This special conference provided an update of key technologies relevant to develop-
ing vectors with efficient, cell-specific gene delivery. Since the last biotechnology conference on this
topic, held in 1997, significant progress had been made in this field. Especially noteworthy was the
progress in viral vector tropism modifications. This progress has predicted the translation of novel,
advanced secretion vectors into human clinical applications. Future work will be required to define the
range of cell-specific signatures of relevance in the clinical context. Nevertheless, the linkage of the two
technologies-target definition and vector targeting-is already yielding important advancements in the
outcomes achievable via gene therapy methods.
This meeting was funded in part by Transgene, S.A.; Selective Genetics, Inc.; Lilly Research
Laboratories, A Division of Eli Lilly and Company; Gene Medicine, Inc.; Glaxo Wellcome, Inc.; Zeneca
Pharmaceuticals; Genzyme Corporation; Berlex Laboratories, Inc.; Gen Vec, Inc.; SyStemix, Inc., A
Novartis Company; Johnson & Johnson; and Megabios Corporation.
W. Marasco
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PROGRAM
Introductory Comments
Chairpersons: D. Curiel, University of Alabama, Birmingham;
W. Marasco, Dana-Farber Cancer Institute, Boston,
Massachusetts
Target Definition
Chairperson: W. Stemmer, Maxygen, Inc., Santa Clara,
California
Retargeted Adenovirus
Chairperson: R. Hawkins, Christie CRC Research Center;
Manchester, United Kingdom
Genetically Retargeted Adenovirus
Chairperson: D. Curiel, University of Alabama, Birmingham
Retargeted Retroviruses
Chairperson: W. Marasco, Dana-Farber Cancer Institute,
Boston, Massachusetts
Nonviral Vectors
Chairperson: R Feigner, Gene Therapy Systems Inc., San
Diego, California
Transcriptional Targeting
Chairperson: N. Lemoine, Imperial Cancer Research Fund,
London, United Kingdom
Targeted MV
Chairperson: J. Robbins, Immusol, Inc., San Diego, California
Emerging Technology
Chairperson: P. O'Hare, Marie Curie Research Institute, Surrey,
United Kingdom
Poster session
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SPRING MEETINGS
Telomeres and Telomerase
March 25-28 266 participants
ARRANGED BY Elizabeth Blackburn, University of California, San Francisco
Titia de Lange, Rockefeller University
Carol Greider, Johns Hopkins University School of Medicine
The conference consisted of six sessions of talks and two poster sessions. Each session consisted of
two chairs; the chairpersons were established scientists in the field who not only chaired the session
(one chair for each half session), but also gave a scientific presentation. This format was chosen to pro-
vide a high profile for this new Cold Spring Harbor conference. The rest of the presentations were cho-
sen to represent as many younger scientists as possible, including graduate students and postdoctoral
fellows. Attendance exceeded 260 participants, a large fraction of whom presented a total of about
100 posters and 55 talks.
The topics covered all aspects of telomere and telomerase biology, grouped by talk session as fol-
lows: telomere structure and function; telomere length regulation; telomeric chromatin and silencing;
telomeres and recombination in mitosis and meiosis; regulation of telomerase and telomeres, and
telomerase in proliferation, senescence, and cancer.
The scientific content was very high throughout the conference in both the talks and the posters,
with significant amounts and quality of new, unpublished data being presented and extensively dis-
cussed. Discussion after each talk during the sessions was lively and informative. The conference was
verbally judged to be highly successful by all who attended. Participants were very enthusiastic about
having another meeting on the same topic in 2001.
This meeting was funded in part by the National Institute on Aging and the National Cancer Institute,
branches of the National Institutes of Health.
C. Greider, A. Kass-Eisler
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PROGRAM
Telomerase Structure and Function
Chairpersons: E. Blackburn, University of California, San
Francisco; C. Price, University of Nebraska, Lincoln
Telomere Length Regulation
Chairpersons: T. de Lange, Rockefeller University New York,
New York; V Zakian, Princeton University New Jersey
Telomere Chromatin and Silencing
Chairpersons: D. Gottschling, Fred Hutchinson Cancer
Research Center, Seattle, Washington; D. Shore, University
of Geneva, Switzerland
Telomeres and Recombination in Meiosis and Mitosis
Chairpersons: R. Allahire, MRC Human Genetics Unit,
Edinburgh, United Kingdom; S. Roeder, Howard Hughes
Medical Institute, Yale University New Haven, Connecticut
Regulation of Telomerase
Chairperson: S. Bacchetti, Mcmaster University Hamilton,
Ontario
Telomeres and Telomerase in Proliferation, Senescence, and
Cancer
Chairpersons: C. Greider, Johns Hopkins University School of
Medicine; H. Cooke, MRC Human Genetics Unit, Edinburgh,
United Kingdom
C. Harley, S. Primmer
V Zakian, S. Roeder
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Human Evolution
April 21-25 101 participants
ARRANGED BY Luigi L. Cavalli-Sforza, Stanford University
Douglas C. Wallace, Emory University School of Medicine
The Human Evolution conference brought together fossil, linguistic, and substantial amounts of mole-
cular genetic information in an attempt to achieve a new synthesis in our understanding of human ori-
gins. New paleontological evidence was presented that supports a recent "out-of-Africa" origin for
modern Homo sapiens, implying that modern humans arose once in Africa between 100,000 and
150,000 years before present (YBP), migrated out of Africa in perhaps two migrations, and replaced
contemporaneous Homo erectus and Neanderthal individuals. This view is further supported by the
recent comparison of Neanderthal and modern mitochondrial (mt) DNA sequences that reveals a strik-
ing molecular discontinuity between archaic and modern humans.
Molecular anthropological studies of maternally inherited mtDNA and paternally inherited Y chro-
mosomes were presented which indicate that Africa harbors both the greatest genetic diversity and the
oldest lineages, with the two complementary approaches yielding a remarkable consensus that mod-
ern humans arose in Africa about 143,000-144,000 YBP. Molecular analysis of variation in autosomal
and X-chromosome loci has proved more cumbersome, but work presented at the meeting clearly indi-
cates that the African populations are the oldest and the Native American populations are the youngest.
This suggestion is remarkably consistent with the data from mtDNA and Y chromosomes. In contrast,
early studies of primate automosomal and X-linked gene trees have given much older coalescence
times. Additional analytical tools will be necessary to resolve these discrepancies. One promising
approach discussed at this meeting is the analysis of recently arising transposable elements: SINES
and LINES. Analysis of recent Alu repeats in Africans and Europeans indicates that these two popula-
tions diverged about 135,000 YBP.
Besides being used to address global questions of human origins, molecular anthropology has per-
mitted novel approaches to the study of local population issues. Among a number of interesting
D. Nelson, K. Kidd
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reports, particularly noteworthy was a Y-chromosome study of Jewish individuals with the family name
of Cohen, purportedly direct descendants of the Jewish priesthood, which showed that a specific Y-
chromosome haplotype is indeed markedly enriched in this population. Intriguingly, this same haplo-
type is also enriched in the South African Lemba, a black Bantu-speaking population whose members
practice Jewish religious rituals and have an oral tradition of Jewish ancestry.
This type of study confirms that considerable historical information can be deduced from our genes.
New sources of data and new analytical tools are needed now. A great deal of data remains to be
extracted from the autosomal DNA. Moreover, more reliable mathematical methods will be required to
accurately extract the information. Not only will such studies tell us much about human history, they
will provide vital data on continent- and population-specific variation that will be important for localiz-
ing and cloning common disease genes.
This meeting was funded in part by the Oliver Grace Professorship Fund.
PROGRAM
Paleoanthropology and Paleodemography
Chairperson: C. Stringer, Natural History Museum, London,
United Kingdom
Y Chromosome
Chairperson: P. Underhill, Stanford University California
Roundtable: Language Evolution in Africa, Eurasia, America
Moderator: M. Ruh len, Stanford University California
mtDNA
Chairperson: D. Wallace, Emory University School of Medicine,
Atlanta, Georgia
mtDNA, Y Chromosome, Autosomes Compared
Chairperson: L. Cavalli-Sforza, Stanford University California
Primates
Chairperson: M. Weiss, Wayne University Detroit, Michigan
Roundtable: Ethical Issues in Research in Human Evolution
Moderator: H. Greely, Stanford University California
Linkage Disequilibrium
Chairperson: K. Kidd, Yale University School of Medicine,
New Haven, Connecticut
Technology
Chairperson: P. Oefner, Stanford University California
X Chromosomes
Chairperson: L. Jorde, University of Utah, Salt Lake City
Autosomes I
Chairperson: M. Stoneking, Max-Planck Institute for
Evolutionary Anthropology Leipzig, Germany
Roundtable: HGDP Organization
Chairperson: L. Cavalli-Storza, Stanford University California
Autosomes II
Chairperson: J. Bertranpetit, Universitat Pompeu Fabra,
Barcelona, Spain
M. Stoneking, M. Kayser, S. White
0. Smino, P. Underhill
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Learning and Memory
April 28-May 2 161 participants
ARRANGED BY Thomas Carew, University of California, Irvine
Joseph LeDoux, New York University
Leslie Ungerleider, National Institute of Mental Health
The fourth biennial Learning and Memory meeting consisted of platform and poster presentations and
discussions of current research and concepts in the biological basis of memory. Studing the biological
bases of learning and memory is a most exciting field in neuroscience. Progress is currently very rapid,
particularly at molecular, cellular, neural systems, and computational levels. Commonalties of mecha-
nisms appear to be emerging from studies of gene expression, synaptic plasticity (LTP and LTD), and
processes of memory storage in invertebrate systems. In particular, similar changes in the properties of
membrane channels and intracellular messenger systems were identified in a number of different neur-
al systems in both vertebrate and invertebrate preparations. Discussion topics ranged from brain sys-
tems of memory in humans through brain circuits and systems of memory, to brain plasticity and devel-
opment, basic processes of learning and memory, mechanisms of synaptic plasticity-for example,
long-term potentiation (LTP) and long-erm depression (LTD)-and biophysical and molecular substrates
of synaptic plasticity, to genetic approaches to mechanisms of memory.
There were two special foci of the meeting. The first was a strong representation of studies of human
memory. World leaders reported on their recent findings which show that rapid advances have been
made in using imaging techniques such as PET and fMRI to probe the formation and retrieval of human
memories in real time.
The second focus of the meeting was on the use of mutant and transgenic mice to identity the roles
of gene expression of particular enzyme systems in synaptic plasticity and memory. The "gene knock-
out" approach is new and very promising. There was much discussion about the possibility of devel-
oping localized, inducible, reverse knockout preparations.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke and
the National Institute on Aging, branches of the National Institutes of Health, and the National Science
Foundation.
J. Byrne, T. Carew
204
PROGRAM
Cellular Analysis of Learning and Memory I
Chairperson: T. Carew, Yale University New Haven,
Connecticut
Cellular Analysis of Learning and Memory II
Chairperson: J. Ledoux, New York University New York
Cellular Analysis of Learning and Memory III
Chairperson: H. Eichenbaum, Boston University
Massachusetts
Cognitive Analysis of Learning and Memory: Human Studies
Chairperson: L. Ungerleider, NIMH, National Institutes of
Health, Bethesda, Maryland
Cognitive Analysis of Learning and Memory: Animal Studies
Chairperson: C. Barnes, University of Arizona, Tucson
Molecular Analysis of Learning and Memory I
Chairperson: T. Tully, Cold Spring Harbor Laboratory
Molecular Analysis of Learning and Memory II
Chairperson: E. Schuman, California Institute of Technology
Pasadena
Quantitative Analysis of Plasticity in Neurons and Networks
Chairperson: E. Marder, Brandeis University Waltham,
Massachusetts
K. Maubach, M. Bear
K. Rankin, S. Vollman
R. Malinow, C. Jennings
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Biology of Proteolysis
May 5-9 203 participants
ARRANGED BY Charles S. Craik, University of California, San Francisco
Mark Hochstrasser, University of Chicago
Susan Gottesman, National Cancer Institute
Yuri Lazebnik, Cold Spring Harbor Laboratory
Proteases are key regulators in a wide range of biological processes, from cell cycle and development
to cell death. This biennial meeting provides a forum that fertilizes cross-talk between experts on these
processes and experts on the proteases as enzymes.
This second meeting attracted more than 200 scientists, who discussed the role of proteolysis in
signal transduction, gene regulation, development, cell cycle, control of protein expression, neoplasia
and cell transformation, immune control, and cell death. The reported experimental systems ranged
from prokaryotes to animals and plants, whereas the interests of speakers varied from the dissection of
protease structure to regulation of cell cycle. Despite such a diversity, the participants commented that
the meeting was focused, informative, and very exciting. The cross-talk was made possible in large part
by the chairs, who presented extensive overviews at the beginning of each session. In summary, the
Biology of Proteolysis meeting was a unifying forum that will increase the understanding of how pro-
teases control life and death.
This meeting was funded in part by the National Cancer Institute; the National Institute of Child
Health and Human Development; and the National Institute on Aging, branches of the National
Institutes of Health; and the National Science Foundation.
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PROGRAM
Signal Transduction
Chairpersons: J. Goldstein, University of Texas Southwestern
Medical Center, Dallas; C. Gross, University of California, San
Francisco
Complexes and Cascades
Chairpersons: W. Baumeister, Max-Planck Institute for
Biochemistry, Martinsried, Germany; J. Degen, Children's
Hospital Research Foundation, Cincinnati, Ohio
Chaperones, Quality Control
Chairpersons: A. Norwich, Yale University School of Medicine,
New Haven, Connecticut; S. Wickner, National Cancer
Institute, Bethesda, Maryland
Development
Chairpersons: L. Shapiro, Stanford University California; T
Kornberg, University of California, San Francisco
Cell Cycle
Chairpersons: M. Kirschner, Harvard Medical School, Boston,
Massachusetts; J. Diffley, Imperial Cancer Research Fund,
South Mimms, United Kingdom
Infectious Disease/Host-Pathogen Interaction
Chairpersons: H. Ploegh, Harvard Medical School, Boston,
Massachusetts; J. McKerrow, University of California, San
Francisco
Neoplasia
Chairpersons: Z. Werb, University of California, San Francisco;
P. Howley, National Cancer Institute, Bethesda, Maryland
Cell Death
Chairpersons: N. Thornberry, Merck Research Laboratories,
Rahway New Jersey; S. Nagata, Osaka Bioscience Institute,
Japan
C. Chu, D. Keopp
E. Lam, Y. Lazebnik
M. Holder, S. Gottesman
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Tyrosine Phosphorylation and Cell Signaling
May 12-16 193 participants
ARRANGED BY Nick Tonks, Cold Spring Harbor Laboratory
Sara Courtneidge, SUGEN, Inc.
Ben Neel, Beth Israel Hospital, Harvard Medical School
This third meeting on Tyrosine Phosphorylation and Cell Signaling at Cold Spring Harbor opened with
keynote addresses by Lew Cant ley and Ernst Hafen. Dr. Cant ley discussed various biochemical
approaches to the study of signal transduction and illustrated how tyrosine phosphorylation and phos-
pholipid-dependent signaling mechanisms may be integrated. Dr. Hafen reviewed some important con-
tributions of genetic approaches to the study of cell signaling. The format of the meeting provided a
combined emphasis on the physiological roles of protein tyrosine kinases and phosphatases and how
their actions are integrated to modulate signaling events in vivo. The sessions were based largely
around physiological processes and cellular functions to try to provide the biological context for the
data. The program included scientists from the United States, Europe, the Far East, and the South
Pacific. Fourty-three speakers were selected to present their data in sessions that dealt with protein
kinases and adaptor molecules, hematopoietic cell signaling, adhesion-mediated signaling, kinases and
phosphatases, signaling in the immune system, signaling in development, and signaling abnormalities
in disease. A variety of systems were described, with great progress reported in genetic and biochem-
ical approaches to the characterization of physiological functions for tyrosine phosphorylation. In par-
ticular, exciting insights were provided into how signaling pathways may be abrogated in a variety of
human disease states. The meeting continues to be successful and alternates with a conference with
the same format held every other year at The Salk Institute so there is an annual Tyrosine
Phosphorylation meeting.
This meeting was funded in part by the National Cancer Institute, a branch of the National Institutes
of Health; and the National Science Foundation.
P. Simoncic, A. Cheng, M. lbarra-Sanchez, A. Davy
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PROGRAM
Keynote Lectures
Chairperson: B. Neel, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, Massachusetts
Lew Cant ley, Beth Israel Deaconess Medical Center, Harvard
Medical School
Ernst Hafen, University of Zurich
Kinases and Adaptors
Chairperson: J. Cooper, Fred Hutchinson Cancer Research
Center, Seattle, Washington
Hematopoietic Cell Signaling
Chairperson: M. Roussel, St. Jude Children's Research
Hospital, Memphis, Tennessee
Adhesion-mediated Signaling
Chairperson: L. Van Aelst, Cold Spring Harbor Laboratory
Kinases and Phosphatases
Chairperson: J. Dixon, University of Michigan, Ann Arbor
Signaling in the Immune System
Chairperson: B. Sefton, The Salk Institute, La Jolla, California
Signaling in Development
Chairperson: D. Morrison, NCI-Frederick Cancer Research and
Development Center, Maryland
Signaling Abnormalities in Disease
Chairperson: J. Brugge, Harvard Medical School, Boston,
Massachusetts
L. Rohrschneider, B. Sefton
J. Cooper, R. Geahlen
209
Genome Sequencing and Biology
May 19-23 475 participants
ARRANGED BY Mark Boguski, National Center for Biotechnology Information
Richard Gibbs, Baylor College of Medicine
Stephen Brown, MRC Mouse Genome Centre, United Kingdom
This meeting marked the 12th annual gathering of genome scientists in this setting. The past 10 years
have seen remarkable progress in the mapping and sequencing of the genomes of many "model organ-
isms," and there is now strong confidence that the human genome sequence is an attainable goal.
Phrases such as "functional genomics" and "postgenome biology" have become common terms. In the
light of this emerging shift of emphasis, the new organizers chose to modify the name of the annual
meeting to reflect these changes, by the inclusion of the term "biology." Just over 450 people from
around the world attended the meeting, and 242 abstracts were presented describing a broad array of
topics relating to the analysis of genomes from a number of different organisms.
The session topics included areas such as biological insights from phylogenomics, mapping meth-
ods and technologies, functional genomics, computational genomics, and 21st century genetics. This
year's poster symposium featured progress on sequencing the human genome. Once again, projection-
style, interactive computer demonstrations in Grace Auditorium effectively highlighted the critical new
bioinformatics tools being developed for storing, organizing, and analyzing genomic maps and
sequences. There was also a panel discussion on the genome ELSI (Ethical, Legal, and Social
Implications) program, chaired by Francis Collins, director of the National Human Genome Research
Institute, which included a timely presentation on the ethical and scientific issues relating to the appli-
cation of single-nucleotide polymorphisms (SNPs).
The major themes of the meeting related to the gathering pace of human genomic sequencing and
the increasing number of approaches being developed for using sequence data to perform important
biologic studies. Specific presentations continued to report major achievements in the sequencing of
microbial genomes, the development of new sequencing technologies, and the use of microarrays for
M. Boguski, K. Pruitt
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performing genome analysis. The now traditional Saturday afternoon keynote talk was delivered by
Harold Varmus, Nobel laureate and director of the National Institutes of Health.
With the anticipated achievements in the next decade, future genome meetings at Cold Spring
Harbor should continue to serve as the premiere showcase for the human genome project and genome
research.
This meeting was funded in part by the National Human Genome Research Institute, a branch of the
National Institutes of Health.
PROGRAM
Polymorphisms I: Discovery and Mapping
Chairpersons: D. Nickerson, University of Washington, Seattle;
L. Kruglyak, Fred Hutchinson Cancer Research Center,
Seattle
Polymorphisms II: Detection and Scoring
Chairpersons: P.-Y. Kwok, Washington University St. Louis,
Missouri; M. Dean, National Cancer Institute-Frederick
Cancer Research and Development Center, Maryland
Bioinformatics I: Database Resources
Chairperson: B.F. Francis Ouellette, University of British
Columbia, Vancouver
Comparative Genomics I
Chairpersons: M. Ashburner, European Bioinformatics
Institute, Hinxton, United Kingdom; J. Nadeau, Case
Western Reserve University, Cleveland, Ohio
Human Sequencing Poster Symposium
Chairpersons: E. Green, NHGRI, National Institutes of Health,
Bethesda, Maryland; G. Schuler, NCBI, National Institutes of
Health, Bethesda, Maryland
Bioinformatics Software and Algorithms
Chairperson: T. Matise, Rockefeller University New York, New
York
ELSI Panel Discussion
Moderator: F. Collins, NHGRI, National Institutes of Health,
Bethesda, Maryland
Functional Genomics I: Technologies and Infrastructure
Chairpersons: M. Mann, University of Southern Denmark,
Odense; M. Lovett, Washington University School of
Medicine, St. Louis, Missouri
Comparative Genomics II
Chairpersons: R. Martienssen, Cold Spring Harbor Laboratory;
S. Rounsley, Cereon Genomics, Cambridge, Massachusetts
Bioinformatics III: Expression Technologies
Chairperson: A. Baxevanis, NHGRI, National Institutes of
Health, Bethesda, Maryland
Keynote Speakers
Chairpersons: Richard Wilson, Washington University Genome
Sequencing Center; Ira Herskowitz, University of California,
San Francisco
Functional Genomics II: Applications
Chairpersons: S. Gullans, Harvard Institutes of Medicine,
Boston, Massachusetts; S. Nelson, University of California,
Los Angeles
E. Lander, J. Hudson M. Ashburner, R. Martienssen
211
Retroviruses
May 25-30 453 participants
ARRANGED BY Paul Bates, University of Pennsylvania
Michael H. Malim, University of Pennsylvania
As always, many exciting new findings in diverse areas of retrovirology were presented. The traditional-
ly strong sessions on viral entry, reverse transcription, integration, and accessory proteins were typical-
ly impressive. Increased interest in two general areas was also evident: host factors and their possible
roles in intracellular aspects of replication, and structural biology. For instance, several groups working
on virus assembly and early postentry events presented results indicative of crucial roles played by cel-
lular proteins. We can expect these areas to provide future insight into virus replication and host cell
biology. Several new structures were presented in a session devoted specifically to this topic.
Particularly impressive were the cryo-electron microscopy analyses of RSV and HIV virion cores. In
summary, retroviruses continue to be excellent systems for drawing together groups working in diverse
areas using a variety of approaches.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates,
Corporate Contributors, and Foundations provided core support for this meeting.
P. Bieniasz, M. Malim
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S. Hughes
PROGRAM
Entry
Chairpersons: M. Roth, UMDNJ-Robert Wood Johnson
Medical School, Piscataway; E. Hunter, University of
Alabama, Birmingham
Reverse Transcription
Chairpersons: B. Berkhout, Academic Medical Center
Amsterdam, The Netherlands; A.M. Skalka, Fox Chase
Cancer Center Philadelphia, Pennsylvania
Host Factors and Early Events
Chairpersons: D. Trono, University of Geneva, Switzerland; J.
Luban, Columbia University New York
Integration
Chairpersons: R. Katz, Fox Chase Cancer Center
Philadelphia, Pennsylvania; A. Engelman, Dana-Farber
Cancer Institute, Boston, Massachusetts
Transcription and RNA Processing
Chairpersons: B. Cullen, Howard Hughes Medical Institute,
Duke University Durham, North Carolina; T. Hope, Salk
Institute for Biological Studies, La Jolla, California
Assembly
Chairpersons: E. Freed, NIAID, National Institutes of Health,
Bethesda, Maryland; M. Resh, Memorial Sloan-Kettering
Cancer Center New York
Accessory Factors
Chairpersons: 0. Schwartz, Institut Pasteur Paris, France; D.
Rekosh, University of Virginia, Charlottesville
Pathogenesis
Chairpersons: H. Fan, University of California, Irvine; J. Dudley,
University of Texas, Austin
Antivirals/PackagingNectors/Evolution
Chairpersons: A. Lever, University of Cambridge, United
Kingdom; P. Cannon, University of Southern California, Los
Angeles
Structures
Chairperson: W. Sundquist, University of Utah, Salt Lake City
Emerging Topics
Chairperson: J. Stoye, National Institute for Medical Research,
London, United Kingdom
R. Tun, C. Ngian
A. Engelman, L. Mansky, E. Freed
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SPECIAL CONFERENCE
New York Structural Biology Group
July 14 220 participants
ARRANGED BY Barry Honig, Columbia University, New York
Leemor Joshua-Tor, Cold Spring Harbor Laboratory
John Kuriyan, Rockefeller University
The summer meeting of the New York Structural Biology Discussion Group was the second in day-long
meetings allowing structural biologists from all over the region to meet and discuss their latest results.
The meeting was open to structural biologists from different disciplines, including crystallographers,
spectroscopists, computational biologists, and biochemists, with 220 participants from academia and
industry from the tristate area. The program featured 10 talks, a poster session, and a beach barbecue,
which allowed a wonderful opportunity for informal interactions. This meeting complements the
bimonthly evening meetings of the group held at Rockefeller University. No registration was required,
and participants were encouraged to set up posters.
Financial support was provided by Hampton Research Inc., Molecular Structure Corporation, Bruker
AXS Inc., Nonius, Inc., Protein Solutions Inc., Pfizer Inc., Hoffmann-La Roche Inc., and Cold Spring
Harbor Laboratory.
PROGRAM
SESSION I
Chairperson: Ann McDermott, Columbia University
Wayne Hendrickson, Columbia University
Jannette Carey, Princeton University
Benoit Roux, University of Montreal
SESSION II
Chairperson: Andy Neuwald, Cold Spring Harbor Laboratory
Dan Raleigh, State University of New York, Stony Brook
Yuh-Min Chook, Rockefeller University
Jay Pandit, Pfizer Inc.
POSTER SESSION
SESSION III
Chairperson: Steve Roderick, Albert Einstein College of
Medicine
Steve Burley, Rockefeller University
David Cowburn, Rockefeller University
Paula Fitzgerald, Merck
Barry Honig, Columbia University
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FALL MEETINGS
Yeast Cell Biology
August 17-22 424 participants
ARRANGED BY Brenda Andrews, University of Toronto, Canada
Chris Kaiser, Massachusetts Institute of Technology
Mark Winey, University of Colorado, Boulder
The Yeast Cell Biology conference was the seventh biannual international meeting devoted to major
aspects of cell biology in yeast. This conference is unique in having all major areas of cell biology rep-
resented at a single meeting organized around a simple eukaryotic organism, the budding yeast
Saccharomyces cerevisiae.
A common interest in one organism, instead of one topic in cell biology, encourages extensive cross-
fertilization of ideas, insights, and methodologies. Important insights were further gained by studies in
the fission yeast Schizosaccharomyces pombe, as well as other yeasts. The meeting included a ses-
sion on genome-wide expression analysis in yeast during critical cellular processes and at different parts
of the life cycle. Major areas of interest included the functions of the actin and microtubule cytoskele-
ton with collaborating proteins, and the targeting and sorting of proteins in the secretory, endocytotic,
and nuclear localization pathways. The coordination of several cellular processes was discussed in the
context of the response to mating pheromone, meiosis, and the cell cycle, with the exit from mitosis
being particularly important. All told, it was a very rich and exciting meeting, with 424 scientists in atten-
dance presenting some 317 abstracts in the form of 111 talks and 206 posters.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates,
Corporate Contributors, and Foundations provided core support for this meeting.
C. Kaiser, D. Pellrnan
0. Cohen-Fix, Y. Guacci, M. Winey
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PROGRAM
Chromosome Structure and Mating Pathway
Chairperson: J. Thorner, University of California, Berkeley
Actin and Polarized Growth
Chairperson: D. Botstein, Stanford University School of
Medicine, California
Signaling
Chairperson.: E. Elion, Harvard Medical School, Boston,
Massachusetts
Early Secretion and Organelles
Chairperson: T. Fox, Cornell University Ithaca, New York
Mitotic Exit/Cytokinesis and Meiosis
Chairperson: J. Pringle, University of North Carolina, Chapel
Hill
Microtubule Cytoskeleton
Chairperson: M. Rose, Princeton University New Jersey
Cell Cycle
Chairperson: G. Fink, Whitehead Institute/MIT, Cambridge,
Massachusetts
Late Secretion
Chairperson: R. Fuller, University of Michigan, Ann Arbor
Functional Genomics
Chairperson: J. Berman, University of Minnesota, St. Paul
Nuclear Transport
Chairperson: M. Cyert, Stanford University California
G. Fink
M. Solomon, C. Slayman
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Resting up during poster session.
Eukaryotic mRNA Processing
August 25-29 273 participants
ARRANGED BY Adrian KraMer, Cold Spring Harbor Laboratory
James Manley, Columbia University
Timothy Nilsen, Case Western Reserve University
The second Eukaryotic mRNA Processing meeting was held this year and focused on the mechanisms
and regulation of pre-mRNA splicing, 3--end formation, editing, and turnover in yeast and multicellular
eukaryotes.
The structural characterization of spliceosomal snRNP particles has progressed significantly from the
identification and characterization of constituent polypeptides to the visualization of the three-dimen-
sional structure of the U1 snRNP at 25-A resolution by electron cryomicroscopy. Continued interest in
understanding the integration of mRNA processing with transcription revealed new aspects of this link,
such as the dependence of alternative splicing patterns on the particular promoter from which a pre-
mRNA is transcribed in vivo. Links between RNA splicing, RNA export to the cytoplasm, and turnover
were further studied by analyzing specific splicing-dependent complexes assembled on the mature
mRNA, as well as proteins present at the exon-exon junctions.
Components responsible for recognition of the 3' splice site AG dinucleotide in both mammalian cis-
splicing and nematode trans-splicing were identified, one of which was shown to be required for dis-
crimination between correct and incorrect 3' splice sites and is conserved from yeast to humans. cis-
spliced introns were reported for the first time in trypanosomes. Exonic splicing enhancers and silencers
and the proteins that recognize them have been extensively characterized in several systems. The func-
tions of several nematode SR proteins and of some of the kinases that phosphorylate them were
probed in vivo using gene inactivation by RNAi. Mechanistic studies of the phenomenon of RNAi itself
in Drosophila and trypanosomes were reported, including the development of the first in vitro system,
which should allow biochemical dissection of this remarkable phenomenon. Novel RNA-RNA interac-
M. O'Connell, W. Keller
B. Bass, M. Moore
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tions between the spliceosomal snRNAs and between snRNAs and specific sites on the substrate con-
tinue to be found.
Other presentations at the meeting described genetic, biochemical, and cell biological approaches
applied to the study of diverse aspects of mRNA metabolism, including 3"-end processing mechanisms
and regulation, splicing, editing, turnover, and transport in yeast, metazoans, plants, and viruses.
This meeting was funded in part by the National Cancer Institute and the National Institute of Child
Health and Human Development branches of the National Institutes of Health, and by the National
Science Foundation. The Laboratory thanks the RNA Society for its support of this meeting.
PROGRAM
snRNPs and SR Protein Kinases
Chairperson: C. Guthrie, University of California, San Francisco
Integration of Processing Pathways
Chairperson: J. Dahlberg, University of Wisconsin, Madison
Splicing Factors and Mechanisms of Enhancement
Chairperson: R. Reed, Harvard Medical School, Boston,
Massachusetts
3' End Formation
Chairperson: W. Keller, Biozentrum, University of Basel,
Switzerland
Splicing Mechanisms and Signals
Chairperson: M. Rosbash, Brandeis University/HHMI,
Waltham, Massachusetts
Splicing Regulation
Chairperson: D. Rio, University of California, Berkeley
RNA Stability and Editing
Chairpersons: R. Parker, University of Arizona/HHMI, Tucson;
B. Bass, University of Utah School of Medicine/HHMI, Salt
Lake City
M. Rosbash, A. Krainer, J. Manley, T. Nilsen
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R. Sperling, J. Sperling, J. Dahlberg
Mechanisms of Eukaryotic Transcription
September 1-5 439 participants
ARRANGED BY Nouria Hernandez, Cold Spring Harbor Laboratory
Robert Kingston, Massachusetts General Hospital
Richard Treisman, Imperial Cancer Research Fund, London
Mechanisms of Eukaryotic Transcription was the sixth biennial Cold Spring Harbor meeting devoted to
mechanisms of transcriptional regulation in eukaryotes. The conference focused on the structure and
function of RNA polymerase, mechanisms of epigenetic regulation and chromatin remodeling, structure
and function of regulatory complexes, mechanisms of activation, regulatory pathways, and mechanisms
of promoter clearance and elongation. The conference was attended by an international audience of
scientists who study transcription in widely different organisms. Significant advances in our under-
standing of transcription mechanisms were presented, perhaps most notably the first high-resolution
crystal structure of a multisubunit RNA polymerase. A number of presentations also addressed the role
of various multisubunit complexes in chromatin remodeling, the role of TFIID, in particular the TBP-asso-
dated factors in TFIID, and the role of other regulatory complexes in regulation of gene expression, and
the mechanisms that govern promoter opening and transcription elongation.
N. Hernandez, Q. Zhou
D. Allis, R. Tjian, S. Triezenberg
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This meeting was funded in part by the National Cancer Institute and the National Institute of Child
Health & Human Development, branches of the National Institutes of Health; and the National Science
Foundation.
PROGRAM
RNA Polymerase
Chairperson: K. Yamamoto, University of California, San
Francisco
Epigenetic Regulation
Chairperson: B. Emerson, The Salk Institute, La Jolla,
California
Chromatin Remodeling
Chairperson: I. Grummt, German Cancer Research Center
Heidelberg
Regulatory Complexes I
Chairperson: P. Verrijzer, Leiden University Medical Centre, The
Netherlands
Regulatory Complexes II
Chairperson: L. Freedman, Memorial Sloan-Kettering Cancer
Center New York
Activation Mechanisms
Chairperson: J. Lis, Comet University Ithaca, New York
Regulatory Pathways
Chairperson: B. Dynlacht, Harvard University Cambridge,
Massachusetts
Promoter Clearance and Elongation
Chairperson: R. Roeder, Rockefeller University New York
R. Young, R. Kingston
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A. Rao, S. Tilghman, A. Chepelinsky
Workshop on Computational Biology:
Bridging the Gap between Sequence and Function
September 7-9 127 participants
ARRANGED BY Michael Q. Zhang, Cold Spring Harbor Laboratory
Eugene V. Koonin, National Center For Biotechnology Center
Edward Uberbacher, Oak Ridge National Laboratory
The first Cold Spring Harbor Workshop on Computational Biology was held over two days in
September. The primary focus of the meeting was "to bridge the gap between sequence and function."
As the human genome project picks up speed to deliver a "rough draft" of the human genetic code by
the dawn of the new century, deciphering and making use of massive amounts of information coming
from genome sequencing and functional genomics/proteomics are becoming ever more challenging to
all biologists. In an effort to foster greater collaboration between computational and experimental biol-
ogists, this workshop asked people to address the following questions: (1) What have we already
learned from computational analysis of "genomic" information? (2) What do we hope to learn in the
future for which we do not yet have enough data? (3) What concepts, methods, and infrastructure are
missing that keep us from exploiting the genome information to the fullest?
The workshop concentrated primarily on biological rather than algorithmic aspects of computation-
al biology. The topics covered a wide range of structural and functional issues in genomics and pro-
teomics. Despite its brevity, the workshop attracted substantial international participation from labora-
tories in Russia, Japan, China, and South Africa, as well as from Europe and Canada. Among many
distinguished session chairs (of whom half were female) and speakers, two special guest lectures were
given by Lee Hood, University of Washington, and Terry Sejnowski, The Salk Institute. Many attendees
praised this workshop for its quality and unique setting and expressed strong interest in this format
being continued in the future.
This meeting was funded in part by the Alfred P. Sloan Foundation.
PROGRAM
Gene Finding/Polymorphisms and Evolution
Chairpersons: E. Uberbacher, Oak Ridge National Laboratory,
Tennessee; J. Eppig, Jackson Laboratory, Bar Harbor, Maine
Promoters and Gene Regulation/Databases
Chairpersons: M. Kanehisa, Kyoto University, Japan; L.
Landweber, Princeton University New Jersey
General Interest
Chairpersons: M. Zhang, Cold Spring Harbor Laboratory; R.
Durbin, Sanger Centre, Cambridge, United Kingdom
Protein Families/Structure Genomics
Chairpersons: E. Koonin, NCBI, National Institutes of Health,
Bethesda, Maryland; L. Holm,EMBL-EBI, Cambridge, United
Kingdom
Closing Remarks
Chairperson: E. Uberbacher, Oak Ridge National Laboratory
Tennessee
M. Zhang, B. Stillman
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Eukaryotic DNA Replication
September 15-19 375 participants
ARRANGED BY Thomas Kelly, Johns Hopkins University School of Medicine
Bruce Stillman, Cold Spring Harbor Laboratory
This was the seventh biannual meeting on eukaryotic DNA replication held at Cold Spring Harbor.
Studies of eukaryotic DNA replication are advancing rapidly on many fronts, and this meeting is now
established as the most important in the field. A total of 375 investigators participated in the 10 scien-
tific sessions, and there were nearly 275 platform and poster presentations. Thus, interest in the mech-
anisms and regulation of DNA replication in eukaryotic cells remains extremely high, and the meeting is
playing a key role in fostering the exchange of new ideas and experimental approaches.
A major goal of work in the field is to define the mechanisms of initiation of eukaryotic DNA replica-
tion at replication origins. The kinases that signal the triggering of initiation were further characterized.
In addition, many labs have begun to consider the role of chromatin structure in defining origins of repli-
cation. Detailed biochemical characterization of a number of previously identified replication proteins
was reported, and this work will undoubtedly have a bearing on the ultimate elucidation of the initiation
process. Results from a number of novel model systems were described and added further clarity to
the eukaryotic paradigm.
Essential funding for the meeting was provided by the National Cancer Institute and the National
Institute of Environmental Health Sciences, branches of National Institutes of Health, and the National
Science Foundation.
A. Matsukage, T. Kelly
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J. Hurwitz, B. Stillman
PROGRAM
Early Events in Initiation and Unwinding
Chairperson: M. Wold, University of Iowa College of Medicine,
Iowa City
Origin Recognition
Chairperson: J. Campbell, California Institute of Technology
Pasadena
Triggering Initiation
Chairperson: H. Araki, National Institute of Genetics, Shizuoka,
Japan
Defining Origins
Chairperson: S. Bell, Massachusetts Institute of Technology
Cambridge
Polymerases and Accessory Proteins
Chairperson: A. Stenlund, Cold Spring Harbor Laboratory
RPA, Helicases, and Telomeres
Chairperson: C. Newlon, University of Medicine and Dentistry
of New Jersey Newark
Repair and Checkpoint Control
Chairperson: U. Hubscher, University of Zurich, Switzerland
Virus Replication and Polymerase
Chairperson: S. Forsburg, The Salk Institute, La Jolla, California
J. Diffley, C. Hardy
C. Newlon, C. Price, J. Hamlin
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Microbial Pathogenesis and Host Response
September 22-26 268 participants
ARRANGED BY P.T. Magee, University of Minnesota
Stanley Maloy, University of Illinois, Urbana
Ronald Taylor, Dartmouth Medical School
Understanding microbial pathogenesis demands a detailed knowledge of the host response as well as
of the pathogen itself and requires an interdisciplinary approach, integrating the fields of microbiology,
eukaryotic cell biology, and immunology. The second Cold Spring Harbor Microbial Pathogenesis and
Host Response meeting was planned to facilitate such integrations. The meeting attracted 268 inter-
national scientists who approach the study of bacterial and fungal pathogens from a broad range of
perspectives and included 57 talks and 140 posters.
The first session dealt with adhesion of microbial pathogens to the eukaryotic host. Several sessions
focused on how microbial pathogens sense different microenvironments in the host and regulate gene
expression in response to these environments. Additional sessions focused on host defenses to micro-
bial pathogens. One session focused on what we have learned about microbial virulence and the evo-
lution of virulence from genome analysis. This session conveyed a variety of exciting new insights into
the understanding of how microbial-virulence mechanisms evolve and suggested that with appropriate
perspicacity, genomic analysis can provide clues to virulence determinants and their acquisition. The
final oral session focused on emerging pathogens and novel environmental niches.
In addition to the oral sessions, the poster sessions presented a variety of new insights into bacte-
rial and fungal pathogens and host defenses to microbial pathogens. Finally, Stanley Falkow (Stanford
University) gave an inspiring, introspective keynote address on future challenges facing the field of
microbial pathogenesis. He discussed the importance of the numerous pathogens that have not yet
been adequately studied due to the lack of suitable molecular tools and argued that the application of
new tools may make these organisms more pliable.
This meeting was funded in part by the National Institute of Allergy and Infectious Diseases, the U.S.
Army, AstraZeneca R&D Boston, Infection; Burroughs Wellcome; Intrabiotics Pharmaceuticals, Inc.; and
Pharmacia & Upjohn Inc. Contributions from the Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations also provided core support for this meeting.
J. Inglis, J. Witkowski, S. Maloy
224
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PROGRAM
Introduction
Chairperson: S. Maloy, University of Illinois, Urbana
Adhesion to the Host
Chairperson: P. Orlean, University of Illinois, Urbana-
Champaign
Regulatory Responses to Environmental Cues
Chairperson: C. Lee, Harvard Medical School, Boston,
Massachusetts
Virulence Determinants That Manipulate the Host Reponse
Chairperson: R. Taylor, Dartmouth Medical School, Hanover,
New Hampshire
Survival in the Host
Chairperson: S. Libby, North Carolina State University Raleigh
Host Defenses
Chairperson: B. Cookson, University of Washington, Seattle
Evolution of Pathogens
Chairperson: S. Maloy, University of Illinois, Urbana
Toxins and Superantigens
Chairperson: J. Scott, Emory University, Atlanta, Georgia
Future Perspectives
Chairperson: S. Falkow, Stanford University California
Emerging Pathogens, Environmental Niches, and Model
Systems
Chairperson.: P. Fields, Centers for Disease Control and
Prevention, Atlanta, Georgia
P.T. Magee, B. Magee, A. Casadevall A.-M. Verheyden, T. Hag
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Programmed Cell Death
September 29-October 3 430 participants
ARRANGED BY Hermann Steller, HHMI/Massachusetts Institute of Technology
Craig Thompson, HHMI/University of Chicago
Eileen White, HHMI/Rutgers University
The third Cold Spring Harbor meeting on Programmed Cell Death again attracted a standing-room only
crowd to hear the latest news in a fast-paced field. There were numerous seminal discoveries present-
ed. Data from C. elegans demonstrated that Egl-1 functions by binding to Ced-9 and Ced-4 which
causes Ced-4 to be released, whereupon it can activate Ced-3 and induce cell death. Genetic studies
of Drosophila revealed that the IAP homologs function in the reaper pathway to regulate cell death.
Furthermore, Bcl -2 and Apaf-1 homologs were also identified, and their role in fly development and cell
death regulation was demonstrated. Regulation of mitochondrial function by mammalian Bcl -2 family
members also resulted in heated discussions related to the different theories and data generated by
competing groups. The precise role of mammalian ICAD/DFF45 and a new nuclease in apoptosis were
reported. Data from numerous mice with mutations in apoptotic regulators were also presented, which
enhance our understanding of apoptotic-signaling pathways. These and numerous other discoveries
led to heated discussions at poster sessions and during question periods.
This meeting was funded in part by the National Cancer Institute, the National Institute on Aging, and
the National Institute of Child Health and Human Development, branches of the National Institutes of
Health; and the National Science Foundation.
K. Fladmark, M. Zigmond
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D. Hockenbery, D. Faustman
PROGRAM
Invertebrate Development
Chairpersons: J. Abrams, University of Texas Southwestern
Medical Center, Dallas; K. White, Massachusetts General
Hospital, Harvard Medical School, Charlestown
Special Lecture
Speaker: H. Robert Horvitz, Howard Hughes Medical Institute,
Massachusetts Institute of Technology Cambridge
BCL-2 Family
Chairpersons: S. Cory, Walter and Eliza Hall Institute of
Medical Research, Parkville, Australia; D. Green, La Jolla
Institute for Allergy and Immunology California
Special Lecture
Speaker: Stanley Korsmeyer, Dana-Farber Cancer Institute,
Harvard University Medical School, Boston, Massachusetts
Caspase Regulation
Chairpersons: X. Wang, University of Texas Southwestern
Medical Center, Dallas; J. Tschopp, University of Lausanne,
Switzerland
P. Branton, S. Lowe
Receptor Signaling
Chairpersons: D. Wallach, Weizmann Institute, Rehovot, Israel;
S. Nagata, Osaka Bioscience Institute, Japan
Transcription
Chairpersons: A. Wyllie, University of Cambridge, United
Kingdom; B. Osborne, University of Massachusetts, Amherst
Signal Transduction
Chairpersons: G. Nunez, University of Michigan, Ann Arbor; G.
Evan, Imperial Cancer Research Fund, London, United Kingdom
Viral Regulators
Chairpersons: W. Wold, St. Louis University School of Medicine,
Missouri; R Friesen, University of Wisconsin, Madison
Caspase Action
Chairpersons: J. Yuan, Harvard Medical School, Boston,
Massachusetts; E. Alnemri, Thomas Jefferson University,
Philadelphia, Pennsylvania
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Neurobiology of Drosophila
October 6-10 314 Participants
ARRANGED BY Ulrike Heberlein, University of California, San Francisco
Haig Keshishian, Yale University
As it is now traditional, the primary goal of this year's meeting on Neurobiology of Drosophila was to
provide a forum for exchange of ideas, techniques, and new discoveries within the field of Drosophila
neurobiology. The meeting consisted of platform and poster presentations by a mixture of junior and
established investigators. The platform sessions were arranged to reflect the exciting advances that
have been made in understanding the molecular mechanisms underlying neurophysiology, sensory sys-
tems, adult nervous system development and structure, behavior, cellular determination and differenti-
ation, axon guidance, and synaptic plasticity and target recognition. The work presented included
results of genetic, cell biological, molecular, neurophysiological and behavioral investigations of topics
from nervous system development to nervous system function. The highlights of the meeting included
presentations of such exciting new developments as the identification of a mechanosensory transduc-
tion channel, a gene encoding a taste receptor, new genes controlling circadian rhythms, and genes
that control dendritic development and synaptic homeostasis. The Elkins plenary lecture, given by a
recent Ph.D. graduate, focused on mechanisms of olfaction. The setting of the meeting provided ample
opportunities for informal discussions. The high quality of presentations and the novel findings in many
areas made it amply clear that this format, which is inclusive of all aspects of neurobiology, is extreme-
ly useful to both young and seasoned scientists because it provides an ideal opportunity to cover all the
different aspects of Drosophila neuroscience.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, and
the National Institute of Child Health and Human Development, branches of the National Institutes of
Health; and the National Science Foundation.
U. Heberlein, J. Hirsh, M. Rosbash
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P. Taghert, M. Landgraf
PROGRAM
Neurophysiology
Chairperson: C.-F. Wu, University of Iowa, Iowa City
Sensory Systems
Chairperson: M. Mlodzik, European Molecular Biology
Laboratory Heidelberg, Germany
Adult NS Development and Structure
Chairperson: L. Restifo, University of Arizona, Tucson
Behavior
Chairperson: M. Rosbash, Howard Hughes Medical Institute,
Brandeis University Waltham, Massachusetts
Cellular Determination and Differentiation
Chairperson: A. Brand, University of Cambridge, United
Kingdom
Axon Guidance and Target Recognition
Chairperson: R. Murphey, University of Massachusetts,
Amherst
Elkins Memorial Lecture
Speaker: Peter J. Clyne, Department of Molecular, Cellular,
and Developmental Biology Yale University New Haven,
Connecticut
Synaptic Plasticity and Target Recognition
Chairperson: G. Davis, University of California, San Francisco
J. Witkowski, H. Keshishian
J. Ewer, A. Chiba
P. Harin, J. Yin
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WINTER BIOTECHNOLOGY CONFERENCES
Molecular Approaches to Vaccine Design
December 2-5 196 Participants
ARRANGED BY Rahi Ahmed, Emory University School of Medicine
Dennis Burton, Scripps Research Institute
Margaret Liu, Chiron Corporation
Molecular Approaches to Vaccine Design was a new meeting organized by Rafi Ahmed, Dennis Burton,
and Margaret Liu. This meeting grew out of the previous Cold Spring Harbor Laboratory vaccine meet-
ings initiated in 1983 by Bob Chanock and Richard Lerner. The emphasis of the meeting was on under-
standing the basic concepts underlying immune responses to infectious agents and how this knowl-
edge could be applied to design new and more effective vaccines.
The meeting began with a session on HIV and an overview of progress to date and future prospects
for an AIDS vaccine from Neal Nathanson, Director of the Office of AIDS Research at the National
Institutes of Health. This was followed by a talk by Joe Sodroski from Harvard on strategies for pro-
ducing stable HIV envelope trimers that might serve to elicit better antibody responses than the enve-
lope molecule used to date. In the next session on mechanisms of protective immunity, Frank Chisari
J. Jin, K. Schuman
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D. Burton, J. Monroe, J. Bin ley
from the Scripps Research Institute described how inflammatory cytokines can cure hepatitis B infect-
ed cells and Kim Hasenkrug from the Rocky Mountain Laboratories showed how all three immune cell
types (CD4, CD8, and B cells) were required to fully protect against a retroviral challenge. After a lively
and well attended poster session, the meeting then moved on to the controversial area of mucosal
immunity. John Robbins from the National Institutes of Health argued the case for the importance of
serum IgG in mucosal protection, and Jerry McGhee from the University of Birmingham argued for the
significance of mucosally stimulated immune responses.
The mechanisms and requirements for T-cell memory were described by Rafi Ahmed from Emory
University, and Dennis Burton from the Scripps Research Institute discussed the limitations of the mol-
ecules of natural infection in eliciting useful antibody responses and how vaccine design should per-
haps look beyond these molecules. In a session on costimulation and dendritic cells, Antonio
Lanzavecchia from the Basel Institute for Immunology described mechanisms of costimulation and T-
cell activation and Jim Allison from the University of California at Berkeley discussed the role of CTLA-
4 in T-cell responses. The meeting concluded with a session on vaccine delivery systems in which
Margaret Liu from Chiron discussed DNA and alphavirus vectors, Bernie Moss from the National
Institutes of Health described poxvirus vectors particularly in relation to SIV and James Galen from the
University of Maryland presented a series of studies on molecules expressed in attenuated Salmonella
typhi.
The meeting proved to be a unique forum in which to discuss how modern molecular and structur-
al biology and immunology are beginning to contribute to an understanding of how vaccines work and
how new vaccines can be designed.
This meeting was funded in part by Chiron Corporation.
PROGRAM
HIV
Chairperson: J. Moore, Aaron Diamond AIDS Research
Center New York
Mechanisms of Protective Immunity
Chairperson: D. Burton, Scripps Research Institute, La Jolla,
California
Mucosal vs. Systemic Immunity
Chairperson: F. Brown, USDA, Plum Island Animal Disease
Center, New York
Immune Memory
Chairperson: R. Ahmed, Emory University School of Medicine,
Atlanta, Georgia
Costimulation and Dendritic Cells
Chairperson: J. Allison, University of Califomia, Berkeley
Delivery Systems
Chairperson: M. Liu, Chiron Corporation, Emeryville, California
R. Ahmed, A. Catazaro, J. Luhan
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Physiological Genomics and Rat Models
December 9-12 151 participants
ARRANGED BY Douglas Vollrath, Stanford University School of Medicine
Howard Jacob, Medical College of Wisconsin
This first meeting on Physiological Genomics and Rat Models was a landmark for two reasons. First,
there had not been a rat-specific meeting at the Laboratory in many decades (earlier in the 20th cen-
tury, the Laboratory had a rich history of rat research). Second, it brought together and cemented a
growing field. Nearly 150 scientists from around the world met and discussed research in the areas
related to cloning in the rat and the use of genetics, genomics, and physiology to unravel the genetic
basis of autoimmunity, cancer, cardiovascular diseases, diabetes, neuroscience, and technology plat-
forms (from databases to microarrays), to name but a few topics. The significance of this meeting was
that it was the first time a "rat" meeting had been held that brought together researchers from such a
broad range of fields. Traditionally, investigators using rats have clustered by disease, not by organism
of interest.
The laboratory rat, Rattus norvegicus, was the first mammalian species domesticated for scientific
research, with work dating back to before 1850. From this auspicious beginning, the rat has become
the most widely studied experimental animal model for biomedical research. Since 1966, nearly
900,000 research articles about rats have been published, most focused on evaluating the biology
and/or the pathobiology of the rat. In contrast to its central role in the study of behavior, biochemistry,
neurobiology, physiology, and pharmacology, the rat has lagged far behind the mouse as a genetic
"model" organism, until recently. A major goal of this meeting was to bring together the disparate
groups and link them via genetics and genomics. The meeting appears to have had a catalytic effect
on the field. Not only were the meeting attendees extremely pleased with the meeting, but they voted
to hold it annually, with the Laboratory hosting every other year. We expect this field of research to play
a major role in the era of functional genomics.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates,
Corporate Contributors, and Foundations provided core support for this meeting.
L. Blankenhorn, H. Hedrich, A. Mac Murray
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PROGRAM
Genomics
Chairpersons: D. Vollrath, Stanford University School of
Medicine, California; J. Nadeau, Case Western Reserve
University Cleveland, Ohio
Model I
Chairpersons: J. Rapp, Medical College of Ohio, Toledo; M.
Printz, University of California, San Diego
Transgenic
Chairpersons: J. Mullins, University of Edinburgh, United
Kingdom; M. Paul, Institute of Clinical Pharmacology and
Toxicology, Berlin, Germany
Expression
Chairpersons: T. Altman, MRC Clinical Sciences Centre,
London, United Kingdom; G. Cicila, Medical College of Ohio,
Toledo
Bioinformatics
Chairpersons: J. Eppig, Jackson Laboratory, Bar Harbor,
Maine; G. Levan, Goteborg University Sweden
Forum on the Future of Rat Research
Transgenic Mini-course
Chairperson: J. Mullins, University of Edinburgh, United
Kingdom
Model II
Chairpersons: M. LaVail, UCSF School of Medicine, California;
C. Walker, University of Texas M.D. Anderson Cancer Center,
Smithville
Model Ill
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; A. Lernmark, University of Washington, Seattle
A. Cowley, Jr., M. Michalkiewicz
J. Eppig, A. Reiner
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Cycling through the Cancer Cell, Fishing for Oncogenes:
A Symposium in Celebration of the 60th Birthday of Harold E. Varmus
December 17-19 75 participants
ARRANGED BY Titia de Lange Steve Hughes
Roel Nusse Suzanne Ortiz
The Cycling through the Cancer Cell, Fishing for Oncogenes symposium was a private celebration of
Harold Varmus' 60th birthday. A significant portion of the symposium was dedicated to scientific pre-
sentations, as science has been the major focus of Harold's career, reflecting his wide range of inter-
ests. Apart from the science, Harold Varmus' career has had many other aspects: scholar of medieval
literature, physician, researcher, teacher, and, most recently, NIH director, where he managed the
largest and most complex scientific enterprise in the world.
Harold's training as a physician directed him toward basic science, but basic science with the under-
lying idea that there are important diseases that cannot yet be effectively treated. This led to a long and
fruitful collaboration with Mike Bishop, resulting in the discovery of cellular oncogenes and the Nobel prize.
This was a period of great intellectual ferment, with dozens of exciting discoveries, some of which involved
the discovery of new oncogenes, others elucidating the rules that govern the replication of retroviruses.
Winning the Nobel prize could have been the capstone on what was already a remarkable career.
However, a few years after receiving the prize, Harold took on the directorship of the NIH, during a diffi-
cult time for American science. Funding, in particular funding for extramural research, was exceptionally
tight. The relationship between Congress and the NIH leadership was at a low ebb, and the future looked
anything but bright. Harold has effected a remarkable transformation in the institution and in its relation-
ship to Congress and the public. The best leadership creates respect for the institution from the outside
and respect for the leader within the organization. Few expected that someone who had never managed
an organization larger than a research laboratory could revitalize NIH. Harold's leadership has set a new
standard and, we hope, points the way for other eminent scientists to follow in his footsteps as NIH direc-
tor. It is, furthermore, a measure of Harold's love of basic science that, as director of NIH, he maintained
an active laboratory whose research program involves both oncogenes and retroviruses.
Harold Varmus has now left NIH to become the head of Memorial Sloan-Kettering Cancer Center in
New York. This will allow him to continue to work to bring the discoveries of basic research into the
clinic.
PROGRAM
Development
Chairperson: M. Bishop
Retroviruses
Chairperson: D. Baltimore
Cell Biology
Chairperson: A. Huang
Cancer Biology I
Chairperson: P. Vogt
Cancer Biology II
Chairperson: B. Alberts
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POSTGRADUATE COURSES
The program of Postgraduate Courses at Cold Spring Harbor Laboratory is aimed at meeting the spe-
cial need for training in interdisciplinary subjects that are either so new or so specialized that they are
not adequately treated by universities. Our aim is to provide intensive study in the most recent devel-
opments and techniques in these subjects and to prepare students to enter directly into research in a
particular area. To ensure up-to-date coverage of current research work, we bring together course fac-
ulty from many laboratories around the world and supplement this staff with a series of seminar speak-
ers.
Advanced Molecular Cytogenetics
MARCH 9-15
INSTRUCTORS Ried, T., Ph.D., National Cancer Institute, NIH, Bethesda, Maryland
Schrock, E., Ph.D., National Cancer Institute, NIH, Bethesda, Maryland
ASSISTANTS Janish, C., Applied Spectral Imaging, Carlsbad, California
Veldman, T., Georgetown University, Washington, D.C.
This course focused on advanced molecular cytogenetic methods for the visualization of chromosome
aberrations. Emphasis was placed on applications of spectral karyotyping (SKY) for the refinement of
clinical and tumor cytogenetic diagnostics. In addition, the course covered comparative genomic
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hybridization (CGH) and novel, sensitive methods for visualization of FISH-experiments (tyramides).
Methodologies, technologies, and scientific expertise for the microscopic visualization of chromosomal
alterations were provided. The course was designed for cytogeneticists who use chromosome analyt-
ical methods in diagnostics and basic research and for molecular biologists who intend to use
advanced molecular cytogenetic methods in mammalian chromosome analysis. Among the methods
presented were the preparation of tagged DNA probes, fluorescence in situ hybridization and multicol-
or detection methods, quantitative digital image analysis, spectral imaging, and data interpretation.
Students were encouraged to bring their own samples of human or mouse origin for SKY and CGH
analysis. State of the art microscopic and imaging equipment was available for hands-on experience.
The laboratory portion of the course was supplemented by invited lectures by Drs. 011ie-P. Kallioniemi,
Cynthia Morton, Janet D. Rowley, Robert L. Strausberg, and David C. Ward, who presented updates
in the field of molecular cytogenetic research and diagnostics and genomics. The course was sup-
ported by the National Cancer Institute, Applied Spectral Imaging, Chroma Technology, Leica Imaging
Systems, and Vysis.
PARTICIPANTS
Andersen, C., M.S., Danish Cancer Society, Aarhus, Denmark
Cabal-Manzano, R., M.D., Georgetown University Medical
Center, Washington, D.C.
Cote, G.B., Ph.D., Sudbury General Hospital, Ontario,
Canada
Crolla, J.A., Ph.D., Salisbury District Hospital, United
Kingdom
Hsu, B., M.S., Tsan Yuk Hospital, Hong Kong, China
Kerr, J., Ph.D., The DuPont Merck Pharmaceutical Company,
Wilmington, Delaware
Lindemann, G.W., Ph.D., Roche Diagnostics, Berkeley,
California
Myska, A.E., Ph.D., Armed Forces Radiobiology Research
SEMINARS
Garini, Y., Applied Spectral Imaging, Carlsbad, California.
Spectral imaging.
Kallioniemi, 0.-P., National Institutes of Health, Bethesda,
Maryland. Genome screening.
Morton, C., Brighams & Women's Hospital, Boston, Mass-
achusetts. FISH tales from the clinical cytogenetics laboratory.
Rowley, J., University of Chicago Medical Center, Illinois.
Chromosome translocationsi Dangerous liasions.
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Institute, Rockville, Maryland
Neal, D.R., B.S., Children's Hospital Medical Center of Akron,
Ohio
O'Connor, S.J., M.Sc., The General Infirmary at Leeds,
United Kingdom
Ohmido, N., Ph.D., Hokuriku National Agricultural
Experimental Station, Joetsu, Japan
Parada, L.A., M.Ph., Lund University Hospital, Sweden
Reddy, V. Ph.D., Osmania University, Hyderabad, India
Schumacher, V., B.S., University of Duesseldorf, Germany
Wan, T.S.K., Ph.D., University of Hong Kong, China
Watson, M.L., Ph.D., University of Texas Southwestern
Medical Center, Dallas
Schrock, E., National Institutes of Health, Bethesda,
Maryland. Cancer cytogenetics revisited: Comparative
genomic hybridization and spectral karyotyping.
Strausberg, R.L., National Institutes of Health, Bethesda,
Maryland. Genes, genomes, and the molecular profiling of
cancer.
Ward, D., Yale University School of Medicine, New Haven,
Connecticut: Mutation analysis using rolling circle amplification.
Advanced Genome Sequence Analysis
MARCH 17-30
INSTRUCTORS Chen, E., Ph.D., PE-Applied Biosystems, Foster City, California
Gibbs, R., Ph.D., Baylor College of Medicine. Houston, Texas
Mardis, E., Ph.D., Washington University School of Medicine, St. Louis, Missouri
McCombie, W.R., Ph.D., Cold Spring Harbor Laboratory
McPherson, J., Ph.D., Washington University School of Medicine, St. Louis, Missouri
Muzny, D., Ph.D., Baylor College of Medicine, Houston, Texas
Wilson, R., Ph.D., Washington University School of Medicine, St. Louis, Missouri
Zuo, L., Ph.D., AxyS Pharmaceuticals, Inc., La Jolla, California
ASSISTANTS Dedhia, N., Cold Spring Harbor Laboratory
De la Bastide, M., Cold Spring Harbor Laboratory
Fitzgerald, M., Genome Therapeutics Corporation, Waltham, Massachusetts
Habermann, K., Cold Spring Harbor Laboratory
Huang, E., Cold Spring Harbor Laboratory
Hutchison, D., AxyS Pharmaceuticals, Inc., La Jolla, California
Johnson, D., Washington University School of Medicine, St. Louis, Missouri
Dugan, S., Baylor College of Medicine, Houston, Texas
Ma, P., PE-Applied Biosystems, Foster City, California
Miner, T., Washington University School of Medicine, St. Louis, Missouri
Nhan, M., Washington University School of Medicine, St. Louis, Missouri
Preston, R., Cold Spring Harbor Laboratory
Schutz, K., Cold Spring Harbor Laboratory
See, L.H., Cold Spring Harbor Laboratory
Shah, R., Cold Spring Harbor Laboratory
Spiegel, L., Cold Spring Harbor Laboratory
VII, D., Cold Spring Harbor Laboratory
This course focused on obtaining and analyzing genomic DNA sequence data and on large-scale
sequencing, presenting students with important information on the technical and project management
aspects of genomic DNA sequencing projects as well as the computational analysis of the sequence.
This was achieved by carrying out a large-scale sequencing project during the class, with a special
emphasis on the technical nuances of large-scale sequencing. Increases in sequencing efficiency now
permit us to carry out the production phase of the student's sequencing project in less time. Asa result,
the course increased its emphasis on two areas: the finishing process and the analysis of DNA
sequence (both computational and experimental). Last year's course included a module on sequence-
based polymorphism analysis. This year, the course expanded the polymorphism analysis to include
sequencing of regions from multiple individuals and additional SNP analysis. This curriculum allowed
students to learn advanced techniques and principles of genomic DNA sequence analysis, from data
generation to analysis of sequence variations in populations.
PARTICIPANTS
Blomstergren, A., M.S., Royal Institute of Technology,
Stockholm, Sweden
Bonds, W.D., Ph.D., Yale University, New Haven, Connecticut
Chen, Z., M.D., Baylor College of Medicine, Houston, Texas
Dharakul, T., M.D., Mahidol University, Bangkok, Thailand
Gan, W., Ph.D., National Human Genome Research Institute,
Gaithersburg, Maryland
Hadd, AG., Ph.D., Molecular Dynamics Research and
Development, Sunnyvale, California
Lin, L., B.S., Stanford University, California
Liu, K., Ph.D., Huazhong Agricultural University, Wuhan, China
Mullen, L.M., B.S., SmithKline Beecham Clinical Laboratories,
Van Nuys, Califorinia
Peters, S.O., Ph.D., United Kingdom Human Genome
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Mapping Resource Center, Cambridge
Rajagopal, R., B.S., Biomaterials Technology Center, St. Paul,
Minnesota
Scarcez, T., Eng., M.S., Eurogentec, Herstal, Belgium
Skopicki, H., Ph.D., Columbia University College of
Physicians & Surgeons, New York
SEMINARS
Bashkin, J., Molecular Dynamics, Sunnyvale, California. DNA
sequencing by capillary array electrophoresis.
Eisen, J., Stanford University, Stanford, California. How evolu-
tionary methods can benefit genome analysis and vice
versa: The uses of a composite phylogenomic approach.
Eisen, M., Stanford University School of Medicine,
California. Making biological sense of genome-wide
expression data.
Galperin, M., National Institutes of Health, Bethesda,
Maryland. Functional annotation of microbial genomes:
Evolutionary approaches (PSI-BLAST, COGS, and metabolic
reconstructions).
Gordon, D., University of Washington, Seattle. Semi-automat-
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Snoeyenbos-West, 0.L., M.S., Ph.D., University of
Massachusetts, Amherst
Stinnett, S.W., M.S., Glaxo Wellcome, Research Triangle
Park, North Carolina
Vanavichit, A., Ph.D., Kasetsart University, Nakorn Pathom,
Thailand
ed finishing with the phred/phrap/consed system.
Green, E., National Institutes of Health, Bethesda, Maryland.
Mapping and sequencing a human chromosome: How and
why.
Halushka, M., Case Western Reserve University, Cleveland,
Ohio. SNPs and genetic analysis.
Kwok, P., Washington University School of Medicine, St.
Louis, Missouri. SNP discovery and scoring.
Marra, M., Washington University Genome Sequencing
Center, St. Louis, Missouri. High throughput fingerprinting of
large insert bacterial clones.
Ross-MacDonald, P., Bristol-Myers Squibb, Princeton, New
Jersey. Beyond the yeast genome sequence.
Protein Purification and Characterization
April 7-20
INSTRUCTORS Burgess, R., Ph.D., University of Wisconsin, Madison
Courey, A., Ph.D., University of California, Los Angeles
Lin, S.-H., Ph.D., University of Texas/M.D. Anderson Cancer Center, Houston
Mische, S., Ph.D, Boehringer Inge Iheim Pharmaceuticals, Inc., Ridgefield, Connecticut
ASSISTANTS Bhaskar, V., University of California, Los Angeles
Chen, G., University of California, Los Angeles
Gharandaghi, F., Rockefeller University, New York
Phan, D., University of Texas/M.D. Anderson Cancer Center, Houston
Pietz, B., University of Wisconsin, Madison
Thompson, N., University of Wisconsin, Madison
Weinberg, C., Rockefeller University, New York
This course was intended for scientists who are not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with a
discussion session every evening. Each student became familiar with each of the major techniques in
protein purification by performing four separate isolations of (1) a regulatory protein from muscle tissue,
(2) a sequence-specific DNA-binding protein, (3) recombinant protein overexpressed in Escherichia
coli, and (4) a membrane-bound receptor. Students used a variety of bulk fractionation, electrophoret-
ic, and chromatographic techniques, including precipitation by salts, pH, and ionic polymers; ion-
exchange, gel-filtration, hydrophobic-interaction, and reverse-phase chromatography; lectin affinity, lig-
and affinity, oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel elec-
trophoresis and electroblotting; and high-performance liquid chromatography. Procedures were pre-
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sented for solubilizing proteins from inclusion bodies and refolding them into active monomeric forms.
The methods of protein characterization used included immunological and biochemical assays, pro-
tein-protein interaction studies by far-Western analysis, peptide mapping, amino acid analysis, protein
sequencing, and mass spectrometry. Emphasis was placed on strategies of protein purification and
characterization rather than on automated instrumental analysis. Guest lecturers discussed protein
structure, modification of proteins, methodologies for protein purification and characterization, and
applications of protein biochemistry to cell and molecular biology.
PARTICIPANTS
Brix, J., B.S., Ph.D., University of Freiburg, Germany
Brock, H., B.S., Ph.D., University of British Columbia,
Canada
Canhoto, A., B.S., Ph.D., Dana-Farber Cancer Institute,
Boston, Massachusetts
Chadwick, B., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Cimprich, K., B.S., Ph.D., Stanford Univeristy Medical
School, California
De Wulf, P., B.S., M.S., Ph.D., Harvard University, Boston,
Massachusetts
Gordon, C., B.S., Ph.D., Medical Research Council,
Edinburgh, United Kingdom
SEMINARS
Alber, T., University of California, Berkeley. Origins of specifici-
ty in protein structure/structural polymorphisms in regulatory
proteins.
Baker, T., Massachusetts Institute of Technology, Cambridge.
Protein machines in DNA transposition.
Burgess, R., University of Wisconsin, Madison. Overview of
protein purification, immunoaffinity purification. Biochemical
studies of RNA polymerase-sigma factor interactions.
Courey, A., University of California, Los Angeles. Protein-pro-
tein interactions in dorsal-ventral pattern formation in
Drosophila.
Guidotti, G., Harvard University, Cambridge, Massachusetts.
Membrane proteins and extracellular ATP.
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Haggarty, S., B.S., Harvard University, Cambridge,
Massachusetts
Iftner, T., B.S., Ph.D., University of Tubingen, Germany
Karpova, A., B.S., M.S., Harvard University, Boston,
Massachusetts
Lydall, D., B.S., Ph.D., University of Manchester, United Kingdom
Schild, D., B.A., Ph.D., Lawrence Berkeley National
Laboratory, Berkeley, California
Sharon, M., B.S., Ph.D., Weizmann Institute of Science,
Rehovot, Israel
Sepehri, S., B.S., Cold Spring Harbor Laboratory
Skene, K., B.S., Ph.D., University of Dundee, United Kingdom
Voytas, D., A.B., Ph.D., Iowa State University, Ames
Joshua-Tor, L., Cold Spring Harbor Laboratory. Protein struc-
ture using a three-dimensional visualization system.
Lin, S.-H., University of Texas/MD Anderson Cancer Center,
Houston. C-CAM: A novel tumor suppressor with anti-
angiogenesis activity.
Mische, S., Boehringer Inge 'helm Pharmaceuticals, Inc.
Ridgefield, Connecticut. Microanalytical protein preparation
and characterization.
Neuwald, A., Cold Spring Harbor Laboratory. Protein
sequence alignment to find protein superfamilies.
Stillman, B., Cold Spring Harbor Laboratory. Biochemical
approaches to understanding replication of the eukaryotic
cell.
Cell and Developmental Biology of Xenopus
APRIL 10-20
INSTRUCTORS Krieg, P., Ph.D., University of Texas, Austin
Moody, S., Ph.D, George Washington University Medical Center, Washington, D.C.
ASSISTANTS Cleaver, 0., University of Texas, Austin
Kenyon, K., George Washington University Medical Center, Washington, D.C.
Kroll, K., Harvard University, Boston, Massachusetts
Zorn, A., Welcome/CRC Institute, Cambridge, United Kingdom
The frog Xenopus is an important vertebrate model for studies of maternal factors, molecular mecha-
nisms of tissue inductions, and regulation of cell fate decisions. In addition, Xenopus oocytes and
embryos provide a powerful system in which to conduct a number of cell biological and gene regula-
tion assays. This course provided extensive laboratory exposure to the biology, manipulation, and use
of oocytes and embryos of Xenopus. Intensive laboratory sessions were supplemented by daily lec-
tures and demonstrations from experts in cellular, experimental, and molecular development. Areas
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covered included (1) care of adults; (2) oocyte isolation and embryo production; (3) stages of embry-
onic development and anatomy; (4) whole-mount in situ hybridization and immunocytochemistry; (5)
microinjection of eggs and oocytes with lineage tracers, DNA constructs, mRNA, and antisense
oligonucleotides; (6) micromanipulation of embryos, including explant and transplantation assays; (7)
preparation of transgenic embryos; and (8) use of Xenopus tropicalis for genetic analyses. This course
was suited both for investigators who had no previous experience with Xenopus and for those who had
worked with Xenopus and wished to learn new and cutting-edge techniques. All participants had cur-
rent training in molecular biology and some knowledge of developmental biology.
PARTICIPANTS
Cutler, R., B.S., Ph.D., Sugen, Inc., South San Francisco,
California
Greenwood, J., B.S., Columbia University College of
Physicians & Surgeons, New York
Krishnan, R, BA., Ph.D., Eli Lilly & Co., Indianapolis, Indiana
Lansbery, K., BA., Washington University, St. Louis, Missouri
Mullegger, J., M.S., Austrian Academy of Sciences, Salzburg
Mueller, P., B.S., Ph.D., University of Chicago, Illinois
Nagai, T., B.S., Ph.D., Riken, Ibaraki, Japan
Olmedo, E., B.S., Ph.D., University of Barcelona, Spain
Od, M., B.S., University of Pisa, Italy
Ossipova, 0., B.S., M.S., University of Goettingen, Germany
SEMINARS
Christian, J., Oregon Health Sciences University, Portland.
The role of CaM kinases in cardiovascular development.
Grainger, R., University of Virginia, Charlottesville. Xenopus
tropical's: A new model for vertebrate developmental genet-
ics.
Krieg, P., University of Texas, Austin. Development of the
heart and blood vessels.
Keller, R., University of Virginia, Charlottesville. Early embry-
onic anatomy and morphogenesis of Xenopus.
King, M.L., University of Miami, Florida. Localized maternal
RNAsi Understanding the how and why.
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Park, C.Y., B.S., Ph.D., State University of New York, Stony
Brook
Pierreux, C., B.S., Ph.D., Imperial Cancer Research Fund,
London, United Kingdom
Pignoni, F., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Roesijadi, G., B.S., M.S., Ph.D., University of Maryland,
Solomons
Tietge, J., B.S., M.S., U.S. Environmental Protection Agency,
Duluth, Minnesota
Wayman, G., B.S., Ph.D., Oregon Health Sciences University,
Portland
Kroll, K., Harvard Medical School, Boston, Massachusetts.
Neural cell fate determination in the early embryo.
Moody, S.A., George Washington University, Washington,
D.C. Maternal control of dorsal cell fates in the blastula.
Smith, J., National Institute for Medical Research, London,
United Kingdom: T targets.
Thomsen, G., State University of New York, Stony Brook.
Ubiquitination in TGFI3 signaling and Xenopus pattern for-
mation.
Zorn, A., Wellcome Trust, Cambridge, United Kingdom. Sox
proteins are negative regulators of Wnt signaling.
Developmental Neurobiology
June 9-22
INSTRUCTORS Bargmann, C., Ph.D., University of California, San Francisco
Burden, S., Ph.D., New York University Medical Center, New York
Cline, H., Ph.D., Cold Spring Harbor Laboratory
The aim of this lecture course was to discuss principles and recent advances in developmental neuro-
biology. Prospective students had a background in neurobiology or molecular biology. Major topics
considered included determination, proliferation, and differentiation of neural cells; trophic interactions
in neural development; gradients and compartments; guidance of axons to targets; and the formation
of synapses. The topics were considered within the context of the development of both invertebrate
and vertebrate neural systems.
PARTICIPANTS
Abrell, S., B.S., MS., Max Planck Institute, Gottingen, Germany Fraidakis, M., M.D., Karolinska Institute, Stockholm, Sweden
Akerman, C., M.A., University of Oxford, United Kingdom Furutani-Seiki, M., M.D., Ph.D., University of Freiburg,
Austin, C., B.S., Ph.D., University of Newcastle, United Germany
Kingdom Holmberg, J., B.S., M.S., Karolinska Institute, Stockholm,
Bingham, S., B.S., University of Missouri, Columbia Sweden
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Lu, Q., B.S., Ph.D., Dana Farber Cancer Institute, Boston,
Massachusetts
Noveroske, J., B.S., M.S., Baylor College of Medicine,
Houston, Texas
Nutt, C., B.S., Ph.D., Yale University, New Haven,
Connecticut
Ong, M.T., B.S., M.S., University of Geneva, Switzerland
Peters, M., B.A., Harvard Medical School, Boston,
Massachusetts
Rusten, T.E., M.S., European Molecular Biology Laboratory,
Heidelberg, Germany
SEMINARS
Ben-AU, Y., Maternite de Port-Royal, Paris, France.
Sequential expression of GABA and glutamate synapses in
the developing hippocampal network.
Barde, Y., Max Planck Institute, Martinsried, Germany.
Neurotrophins.
Bargman, C., University of California, San Francisco.
Pathfinding in C. elegans-Olfaction.
Barres, B., Stanford Medical School, California. Glial differenti-
ation.
Burden, S., New York University Medical Center, New York.
Neuromuscular synapse formation.
Cepko, C., Harvard Medical School, Boston, Massachusetts.
Retinal differentiation.
Cline, H., Cold Spring Harbor Laboratory. Synaptic plasticity.
Davis, G., University of California, Berkeley. Modulation of
synapses in Drosophila.
Fox, K., University of Wales, Cardiff, United Kingdom.
Somatosensory system.
Jan, Y.-N., University of California, San Francisco. Neuro-
genesis and asymmetric cell divisions.
Jessell, T, Columbia University, New York. Neurogenesis in
the spinal cord.
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Saura, C., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Singer, J., B.S., Ph.D., National Institutes of Health,
Bethesda, Maryland
Solecki, D., B.S., State University of New York, Stony
Brook
Talamillo, A., B.S., Ph.D., Medical Research Council,
Edinburgh, United Kingdom
Toresson, H., M.S., Lund University, Sweden
Wallen, A., M.S., Karolinska Institute, Stockholm, Sweden
Yeomans, H., B.S., University of Sheffield, United Kingdom
Lemke, G., Salk Institute, La Jolla, California. Regulation of
Schwann cell differentiation.
Lichtman, J., Washington University, St. Louis, Missouri.
Editing of synaptic connections.
Mombaerts, P., Rockefeller University, New York.
Olfaction.
O'Leary, D., Salk Institute, La Jolla, California. Pathfinding in
the visual system.
Poo, M.-M., University of California, San Diego. Growth cone
guidance.
Raft M., University College London, United Kingdom.
Gliogenesis/apoptosis.
Serafini, T, University of California, Berkeley. Synapse forma-
tion in the CNS.
Shatz, C., University of California, Berkeley. Visual system
development.
Stern, C., Columbia University, New York. Neural introduc-
tion.
Van Vactor, D., Harvard Medical School, Boston, Massachu-
setts. Pathfinding.
Walsh, C., Harvard Institute of Medicine, Boston, Massachu-
setts. Neuronal migration.
Advanced Bacterial Genetics
June 9-29
INSTRUCTORS Bass ler, B., Ph.D., Princeton University, New Jersey
Manoil, C., Ph.D., University of Washington, Seattle
Slauch, J., Ph.D., University of Illinois, Urbana
ASSISTANTS Gallagher, L., University of Washington, Seattle
Jankiraman, A., University of Illinios, Urbana
Schauder, S., Princeton University, New Jersey
The laboratory course presented logic and methods used in the genetic dissection of complex biolog-
ical processes in bacteria. The methods presented included mutagenesis using transposons, mutator
strains, and chemical and physical mutagens; mapping mutations using genetic and physical tech-
niques; generation and analysis of gene fusions; molecular cloning; polymerase chain reaction;
Southern blot analysis; epitope insertion mutagenesis; and site-directed mutagenesis. A key compo-
nent of the course was the use of sophisticated genetic methods in the analysis of pathogenic and
"undomesticated" bacteria. Invited lecturers described the use of genetic approaches to study bio-
logical processes in a variety of bacteria.
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PARTICIPANTS
Camacho, C., Margarita, M.S., Leiden University, The
Netherlands
Eng len, M., B.A. Ph.D., U.S. Department of Agriculture,
Athens, Georgia
Judd, E., B.A., Stanford University, California
Kishony, R., B.S., Nuclear Research Center Negev, Beer-
Sheva, Israel
Kostelidou, K., B.S., Ph.D., University of Birmingham, United
Kingdom
Knivt, K., B.S., M.S., Gothenburg University, Goteborg, Sweden
Lenz, L., B.A., Ph.D., University of California, Berkeley
Morin, P., B.S., Ph.D., Albert Einstein College of Medicine,
Bronx, New York
Navarro, F., B.S., Ph.D., Hospital de Sant Pau, Barcelona,
SEMINARS
Craig, N., Johns Hopkins Medical School, Baltimore,
Maryland. Tn7: A smarter transposon.
De Boer, P., Case Western Reserve University, Cleveland,
Ohio. Formation and positioning of the division apparatus in
E. coll.
Ehrmann, M., University of Konstanz, Germany. Site-specific
proteolysis in vivo: A genetic method to study protein struc-
ture and function.
Kolter, R., Harvard Medical School, Boston, Massachusetts.
Genetic dissection of biofilm development.
Losick, R., Harvard University, Cambridge, Massachusetts.
Asymmetric division and cell fate in a bacterium.
Parkinson, J., University of Utah, Salt Lake City. Dissecting
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Spain
Philp, J., B.S., Ph.D., Napier Polytechnic University, United
Kingdom
Prince, H., B.A., Dartmouth College, Hanover, New
Hampshire
Ramos, A., B.S., Ph.D., Institute de Tecnologia Quimica e
Biologica, Oeiras, Portugal
Rudnick, P., B.S., University of Arizona, Tucson
Songsivilai, S., B.S., M.D., Ph.D., Mahidol University,
Bangkok, Thailand
Stroppolo, M.E., B.S., Ph.D., University of Roma 'Tor
Vergata," Italy
Xavier, K., B.S., Instituto de Tecnologia Quimica e Biologica,
Oeiras, Portugal
the three-protein brain of E. coll.
Phillips, G., Iowa State University, Ames. Genetic analysis of
the bacterial signal recognition particle.
Pogliano, K., University of California, San Diego. Moving and
fusing membranes during Bacillus subtilis sporulation.
Reznikoff, W., University of Wisconsin, Madison. Molecular
analysis of the Tn5 transposition machine. Using Tn5 in vitro
transposition as a genome analysis tool.
Segall, A., San Diego State University, California. Using
recombination to probe the folded structure of the bacterial
chromosome.
Silhavy, T., Princeton University, New Jersey. Parallel path-
ways perceive periplasmic problems.
Molecular Embryology of the Mouse
June 9-29
INSTRUCTORS
CO-INSTRUCTORS
ASSISTANTS
Nagy, A., Ph.D., Samuel Lunenfeld Research Institute/Mount Sinai Hospital,
Ontario, Canada
Tam, P., Ph.D., Children's Medical Research Institute, Sydney, Australia
Goss ler, A., Ph.D., The Jackson Laboratory, Bar Harbor, Maine
Ang, S.-L., Ph.D., Institute of Genetics, Molecular and Cellular Biology, Strasbourg,
France
Gad, J., Children's Medical Research Institute, Sydney, Australia
Hadjantonakis, A.K., Samuel Lunenfeld Research Institute/Mount Sinai Hospital,
Ontario, Canada
This intensive laboratory-lecture course was designed for biologists interested in applying their exper-
tise to the study of mouse embryonic development. Laboratory components provided an introduction
into the technical aspects of working with and analyzing mouse embryos, and lectures provided the
conceptual basis for contemporary research in mouse development. Experimental techniques includ-
ed in vitro culture and manipulation of pre- and postimplantation embryos; transgenesis by DNA
microinjection; embryo transfer; the establishment, culture, and genetic manipulation of embryonic
stem cells; production of chimeras by aggregation with and injection of embryonic stem cells; and the
analysis of development by whole-mount in situ hybridization, skeletal preparation, and transgene
expression.
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PARTICIPANTS
Agate, R., B.S., University of California, Los Angeles
Chan, A., B.S., Ph.D., University of Texas/M.D. Anderson
Cancer Center, Houston
Cunningham, D., B.A., Ph.D., Children's Hospital Research
Foundation, Columbus, Ohio
Duate, A., D.V.M., Ph.D., University of Lisbon, Portugal
Feng, G.-S., B.S., Ph.D., Indiana University School of
Medicine, Indianapolis
Gong, S.-G., M.S., M.A., Ph.D., University of Michigan
School of Dentistry, Ann Arbor
Hyatt, B., B.S., B.A., Ph.D., Children's Hospital Medical
Center, Cincinnati, Ohio
SEMINARS
Ang, S.-L., Institute of Genetics, Molecular and Cellular
Biology, Strasbourg, France. Establishment of anterior-pos-
terior polarity in the mouse embryo.
Behringer, R., University of Texas/M.D. Anderson Cancer
Center, Houston. Gene targeting 101 and conditional
genetic manipulation. Genetic regulation of mouse axis for-
mation and transgenic mouse methods in biomedical
research.
De Crombrugghe, B., University of Texas/M.D. Anderson
Cancer Center, Houston. Skeletal development.
Goss ler, A., The Jackson Laboratory, Bar Harbor, Maine.
Genetic analysis of somitogenesis in the mouse.
Harvey, R., Victor Chang Cardiac Research Institute,
Darlinghurst, Australia. Heart development.
Hogan, B., Vanderbilt University Medical School, Nashville,
Tennessee. BMPs: Germ cells, lungs, eyes, and kidneys.
How to cope with a pleiotypic phenotype.
Jenkins, N., National Cancer Institute, NIH, Frederick,
Maryland. Mouse genetics.
Joyner, A., New York University Medical Center, New York.
Genetic approaches in mouse to study CNS patterning.
Koopman, R, University of Queensland, Brisbane, Australia.
In situ hybridization. Eye of newt, hair of mouse, sox fac-
tors, and the control of organogenesis.
Lovell-Badge, R., National Institute for Medical Research,
London, United Kingdom. Introduction to embryo manipula-
tion and animal experiments. Mammalian sex determination.
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Lindemann, L., B.S., Max Planck Institute, Munich,
Germany
Luetteke, N., B.A., Ph.D., University of North Carolina, Chapel
Hill
Pabon-Pena, L., B.S., Vanderbilt University, Nashville,
Tennessee
Robson, P., B.S., Ph.D., Children's Hospital of Philadelphia,
Pennsylvania
Wilhelm, M., B.S., Karolinska Institute, Stockholm, Sweden
Wright, T, B.S., Ph.D., University of Utah, Salt Lake City
Xavier-Neto, J., M.D., Ph.D., Massachusetts General
Hospital, Charlestown
Maeda, N., University of North Carolina, Chapel Hill. Modeling
artherosclerosis in mice.
Magnuson, T, Case Western Reserve University, Cleveland,
Ohio. Genetic approaches to development.
Martin G., University of California, San Francisco: Use of site-
specific DNA recombinases to study FGF functions in devel-
opment.
McLaren, A., Wellcome/CRC Institute, Cambridge, Massa-
chusetts. Germ cells.
McMahon, A., Harvard University, Cambridge, Massa-
chusetts. SHH signaling.
Nagy, A., Mt. Sinai Hospital/ Samuel Lunenfeld Research
Institute, Ontario, Canada. ES cells and chimeras. Gene tar-
geting 101 and conditional genetic manipulation.
Papaioannou, V., Columbia University, New York. The T-box
gene family in vertebrate development.
Rossant, J., Samnuel Lunenfeld Research Institute, Ontario,
Canada. Regulation of extraembryonic development.
Smithies, 0., University of North Carolina, Chapel Hill. HOM
recombination and disease models.
Solter, D., Max Planck Institute, Freiburg, Germany. From egg
to blastocyst-A hard road to follow. Hows and whys of
imprinting and cloning.
Tam, P., Children's Medical Research Institute, Wentworthville,
Australia. Postimplantation development: Organogenesis to
early fetus. Embryological tools. Gastrulation and morpho-
genesis: Building the body plan.
Physiological Approaches to Ion Channel Biology
June 9-29
INSTRUCTORS Otis, T., Ph.D., University of California, Los Angeles
Ribera, A., Ph.D., University of Colorado Health Sciences Center, Denver
Trussell, L., Ph.D., Oregon Health Sciences University, Portland
ASSISTANTS Brenowitz, S., Oregon Health Sciences University, Portland
Lim, I., University of Wisconsin, Madison
This intensive laboratory-lecture course introduced students to electrophysiological approaches for the
study of ion channels in their native environments. Hands-on exercises included patch-clamp record-
ing of ion channel activity in acutely isolated or cultured cells or neurons in brain slice preparations. The
advantages and disadvantages of different methods and preparations were considered in order to
match experimental approaches to scientific questions. Similarly, various methods for ligand-drug
application were demonstrated. A primary goal was to identify properties of ion channels that allow
neurons and nonneuronal cells to carry out their unique physiological or systems-level roles. These
properties were related to information previously gained from molecular cloning and heterologous
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expression of ion channel genes. Areas of particular interest included channels that (1) are activated by
neurotransmitter at central and peripheral synapses, (2) interact with other channels to shape the
response properties of neurons, (3) respond to neuromodulators with changes in functional properties,
or (4) are developmentally required and regulated. The research interests of guest lecturers comple-
mented and expanded this list. This course was intended for students with specific plans to apply these
techniques to a defined problem, and students were encouraged to bring their preparation to the
course for preliminary studies. Guest lecturers included Meyer Jackson, Wade Regehr, Paul Fuchs,
Vince Dionne, Gerard Borst, Irwin Levitan, Robert Manilow, Bruce Bean, and John Huguenard.
PARTICIPANTS
Johnson, J., B.S., Ph.D., University of California, Los
Angles
Kiel land, A., B.S. M.S., University of Oslo, Norway
Kuehl-Kovarik, C., B.S., Ph.D., Colorado State University, Ft.
Collin
Kurschner, C., M.S., Ph.D., St. Jude's Children Research
Hospital, Memphis, Tennessee
Parameshwaran, S., B.S., M.S., University of Maryland,
College Park
SEMINARS
Bean, B., Harvard Medical School, Boston, Massachusetts.
Ionic mechanisms of spontaneous activity of central neu-
rons.
Borst, G., Max Planck Institute, Heidelberg, Germany.
Physiology of a presynaptic terminal in the CNS, I.
Physiology of a presynaptic terminal in the CNS, II.
Dionne, V., Boston University, Woods Hole, Massachusetts.
Odor modulated conductances in olfactory receptor neu-
rons.
Fuchs, P., Johns Hopkins University Medical School,
Baltimore, Maryland. Hair cell physiology-A molecular
mechanism for electrical tuning. Efferent control of the
cochlea-Cholinergic inhibition of the cells.
Huguenard, J., Stanford University Medical Center, California.
Differential ion channel expression in neuronal subclasses:
Cellular and circuit consequences.
Jackson, M., University of Wisconsin, Madison. Roles for ion
channels in regulating neurosecretion from peptidergic
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Perruccio, L., B.A., New York Medical College, Valhalla
Soong, T.-W., B.S., Ph.D., National Neuroscience Institute,
Singapore
Storjohann, L., B.S., M.S., University of Utah, Salt Lake City
Tombola, F., M.S., Ph.D., University of Padua, Italy
Wu, F.-F., B.S., University of Pittsburgh, Pennsylvania
Yamada, E., M.D., M.S., Ph.D., University of Texas, Houston
Yang, H., B.S., M.S., Johns Hopkins University, Baltimore,
Maryland
nerve terminals. Cable properties of neurons.
Levitan, I., Brandies University, Waltham, Massachusetts. Ion
channel modulation-A role for regulatory protein complex-
es.
Malinow, R., Cold Spring Harbor Laboratory. Probing synaptic
transmission and plasticity in hippocampal slices using .
acute recombinant expression techniques.
Otis, T., University of California, Los Angeles. Glutamate
transporters: Ion channels that actually do some useful
work.
Regehr, W., Harvard Medical School, Boston, Massachusetts.
Calcium control of synaptic transmission I.
Calcium control of synaptic transmission II.
Ribera, A., University of Colorado, Denver. Regulation of ion
channels in embryonic neurons: Using forward and reverse
genetics to identify physiological mechanisms.
Trussell, L., University of Wisconsin, Madison. Gating kinetics
of glutamate receptor channels and synaptic function.
Molecular Mechanisms of Human Neurodegenerative Diseases
June 24-30
INSTRUCTORS: Aguzzi, A., Ph.D., University Hospital of Zurich, Switzerland
Gandy, S., M.D., Ph.D., New York University, Orangeburg
How and why do neurons die in specific acute or chronic human neurological disorders? What are the
molecular and biochemical manifestations of specific genetic lesions in specific neurodegenerative dis-
orders? Do different pathological deaths share common mechanisms? What practical treatments can
be contemplated? This lecture course explored possible answers to these important questions, and it
focused principally on the specific hypotheses and approaches driving current research. Recent
advances in neurogenetics and in molecular and cell biology have begun to shed light on the mecha-
nisms that underlie nervous system injury in disease states such as Alzheimer's disease, amyotrophic
lateral sclerosis, neurofibrillary tangle diseases (tauopathies), Lewy body diseases (cortical Lewy body
disease, Parkinson disease synucleinopathies), prion diseases, and polyglutamine repeat disorders.
Taking advantage of small class size and extensive discussion, invited faculty lecturers examined criti-
cal issues in their areas of expertise. Overviews were provided, and course participants did not need
to be familiar with neurological diseases. Emphasis was placed on the highly dynamic interface
between basic and clinical investigation, including the interdependence of clinical research and disease
model development, and the value of disease research in understanding the function of the normal ner-
vous system.
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PARTICIPANTS
Amet, L., B.S., Ph.D., Edinburgh University, United Kingdom
Barnes, N., B.S., Wake Forest University School of Medicine,
Winston-Salem, North Carolina
Cabelli, D., B.A., Ph.D., Brookhaven National Laboratory,
Upton, New York
Carnicero, A., B.S., M.S., University of Murcia, Spain
Cotman, S., B.S., Ohio State University, Columbus
DeFeo, A., B.A., Ph.D., Mercy College, Dobbs Ferry, New
York
Gearhart, D., B.S., Ph.D., Medical College of Georgia,
Augusta
Glatzel, M., B.S., M.D., University Hospital Zurich,
Switzerland
Grant, E., B.S., Ph.D., Organon Laboratories, Lanarkshire,
Scotland, United Kingdom
Gupta, A., M.D., Harvard Medical School, Boston,
Massachusetts
Heikki la, H., B.S., M.S., University of Helsinki, Finland
Hughes, R., B.S., Ph.D., University of Washington, Seattle
SEMINARS
Aguzzi, A., University of Zurich Hospital, Switzerland.
Transgenic models of piton diseases.
Borchelt, D., Johns Hopkins University, Bethesda, Maryland.
Transgenic models of Alzheimer's disease.
Cleveland, D., University of California, San Diego. Mechanisms
of motor neuron growth and death: Neurofilaments, SOD1,
Gandy, S., New York University, Orangeburg. Vesicle biology
of AR generation.
Ghiso, J., New York University Medical Center, New York.
Cerebrovascular amyloidosis.
Glockshuber, R., Institut ffir Molekularbiologie and Biophysik,
Zurich, Switzerland. Prion disease.
Hardy, J., Mayo Clinic, Jacksonville, Florida. Genetic dissec-
tion of neurodegeneration.
Holtzman, D., Washington University School of Medicine, St.
Louis, Missouri. Potential roles of apoE in the normal and
diseased nervous system. Astrocyte-secreted apoE/lipopro-
teins: Characterization and role in amyloid 13 metabolism.
Koo, E., University of California, San Diego. Trafficking and
endosomal processing of APP and Al3. Modulation of 13-
catenin by presenilins.
Lee, V., University of Pennsylvania, Philadelphia. Tauopathies.
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Indyk, J., B.S., State University of New York, Stony Brook
Jankowsky, J., BA., California Institute of Technology,
Pasadena
Ka lender, A., B.S., M.S., SmithKline Beecham
Pharmaceuticals, Essex, United Kingdom
Kornuc, M., BA., M.S., AMGEN, Thousand Oaks, California
Kuan, C.-Y., M.D., Ph.D., Yale University, New Haven,
Connecticut
Oluwatosin, Y., B.S., Ph.D., ASTRA Arcus USA, Inc.,
Worcester, Massachusetts
Sohur, U., B.S., Ph.D., Vanderbilt University School of
Medicine, Nashville, Tennessee
Van Deer lin, V., B.S., M.S., M.D., Ph.D, University of
Pennsylvania, Philadelphia
Van Sweiten, J., Ph.D., AZR Dijkzigt, Rotterdam, The
Netherlands
White, J., B.S., Scripps Research Institute, La Jolla, California
Yvert, G., B.S., University Louis Pasteur, Illkirch Strasbourg,
France
Macdonald, M., Massachusetts General Hospital,
Charlestown. Genetics and models of Huntington's dis-
ease.
Morris, J., Jewish Hospital of St. Louis, Missouri. Are
Alzheimer's disease and aging dichotomous or continuous?
Age-associated memory impairment, mild cognitive impair-
ment, and incipient Alzheimer's disease: Clinicopathologic
studies.
Orr, H., University of Minnesota, Minneapolis. Pathogenesis of
a polyglutamine neurodegenerative disease, SCA1.
Selkoe, D., Harvard Medical School, Boston, Massachusetts.
Clinical, pathological, and biochemical underpinnings of
Alzheimer's disease. Genotype-to-phenotype relationships
in Alzheimer's disease.
Tag le, D., National Institutes of Health, Bethesda, Maryland.
Approaches to understanding the pathogenesis of
Huntington's disease.
Trojanowski, J., University of Pennsylvania, Philadelphia.
Molecular and cellular mechanisms of brain degeneration in
synucleinopathies.
Tanzi, R., Harvard Medical School, Charlestown, Masssa-
chusetts. Using genetics to develop molecular models for
Alzheimer's disease.
Arabidopsis Molecular Genetics
July 2-22
INSTRUCTORS Barton, K., Ph.D., University of Wisconsin, Madison
Deng, X.W., Ph.D., Yale University, New Haven, Connecticut
Grossniklaus, U., Ph.D., Friedrich Miescher Institute, Basel, Switzerland
ASSISTANTS Fernandez, A., University of Wisconsin, Madison
Huck, N., Friedrich Miescher Institute, Basel, Switzerland
Shiu, S., University of Wisconsin, Madison
This course provided an intensive overview of topics in plant growth, genetics, physiology, and devel-
opment, focusing on molecular genetic approaches to understanding plant biology. It emphasized
recent results from research using Arabidopsis thaliana and other model plants and provided an intro-
duction to current methods used in Arabidopsis research. It was designed for scientists with experi-
ence in molecular techniques or in plant biology who wished to work with Arabidopsis. The course con-
sisted of a vigorous lecture series, a hands-on laboratory, and informal discussions. Discussions of
important topics in plant research were presented by the instructors and by invited speakers. Seminar
topics included plant morphology and anatomy, plant development, including development of flowers,
roots, meristems, and leaves, male and female gametophytes, and embryos; perception of light and
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photomorphogenesis; and synthesis, function, and perception of hormones. Lectures describing bioin-
formatics tools available to the Arabidopsis community and the potential of the Arabidopsis genome
project for accelerating Arabidopsis research were also included. Speakers provided overviews of their
fields, followed by in-depth discussions of their own work. The laboratory sessions provided an intro-
duction to important techniques currently used in Arabidopsis research and included studies of
Arabidopsis development, mutant analysis, in situ detection of RNA, histochemical staining, transient
gene expression, applications of green fluorescent protein fusions, protein interaction and detection,
techniques commonly used in genetic and physical mapping, map-based cloning, and mutant isola-
tion by mouse genetics. Important topics in genetics were discussed in a series of four workshops.
PARTICIPANTS
Boudonck, K., M.S., Ph.D., John lanes Centre, Norwich,
United Kingdom
Brembu, T., B.S., M.S., Norwegian University of Science and
Technology, Trondheim, Norway
Costa Nunes, J., B.S., University of Oxford, United Kingdom
Date, S., B.S., M.S., University of Texas, Austin
Edwards-Stuart, A., BA., University of Oxford, United
Kingdom
Giuli, P, B.A., M.S., University "La Sapienza" of Rome, Italy
Huntley, R., B.S., Ph.D., University of Cambridge, United
Kingdom
Kalbina, I., M.S., Goteborg University, Sweden
SEMINARS
Barton, K., University of Wisconsin, Madison. Embryogenesis.
Benfey, P., New York University, New York. Root development.
Briggs, W., Carnegie Institute, Stanford, California. Blue light
signal transduction.
Cande, Z., University of California, Berkeley. Meiosis.
Chory, J., Salk Institute, La Jolla, California. Brassinosteroids.
Cohen, J., U.S. Department of Agriculture, Beltsville,
Maryland. Biochemistry of Arabidopsis.
Deng, X.-W., Yale University, New Haven, Connecticut. Light
regulation and transcriptional control.
Deng ler, N University of Toronto, Ontario, Canada. Anatomy
of Arabidopsis. Vascular anatomy and its development.
Grossniklaus, U., Friedrich Miescher Institute, Basel,
Switzerland, The female gametophyte. Pollen development
and fertilization.
Jack, T, Dartmouth College, Hanover, New Hampshire.
Flower development.
Jackson, D., Cold Spring Harbor Laboratory. Leaf and meris-
tem development.
Kerk, N., Yale University, New Haven, Connecticut. Auxin and
the quiescent center.
Martienssen, R., Cold Spring Harbor Laboratory. Use of
254
Kmieciak, M., B.S., M.S., Adam Mickiewicz University, Poland
Lorkovic, Z., B.S., Ph.D., Friedrich Miescher Institut, Basel,
Switzerland
Matzke, A., B.S., M.S., Ph.D., Austrian Academy of Sciences,
Salzburg
Naested, H., B.A., M.S., Copenhagen University, Denmark
Racicot, V., BA., M.S., NEN Life Science Products, Boston,
Massachusetts
Sohlenkamp, C., B.S., M.S., Max Planck Gesellschaft, Golm,
Germany
Sponsel, V., B.S., Ph.D., University of Texas, San Antonio
Van Wijk, K., M.S., Ph.D., University of Stockholm, Sweden
enhancer traps.
McCourt, P., University of Toronto, Ontario, Canada. Abscisic
acid and giberellins.
Palmenberg, A., University of Wisconsin, Madison.
Bioinformatics.
Poething, S., University of Pennsylvania, Philadelphia. Time
and plant development.
Richards, E., Washington University, St. Louis, Missouri.
Epigenetics.
Spector, D., Cold Spring Harbor Laboratory. Imaging theory
and practice.
Sussex, I., Yale University, New Haven, Connecticut.
Introduction to plant development.
Sussman, M., University of Wisconsin, Madison. Reverse
genetics.
Theologis, A., University of California, Berkeley. The
Arabidopsis genome. Molecular biology of auxin.
Von Arnim, A., University of Tennessee, Knoxville. Subcellular
targeting.
Wessler, S., University of Georgia, Athens. Transposable ele-
ments.
Weigel, D., Salk Institute, La Jolla, California. Flowering.
Molecular Cloning of Neural Genes
July 2-22
INSTRUCTORS
CO-INSTRUCTORS
ASSISTANTS
Boulter, J., Ph.D., University of California, Los Angeles
Darnell, R., M.D., Ph.D., Rockefeller University, New York
Du lac, C., Ph.D., Harvard University, Cambridge, Massachusetts
Lai, C., Ph.D., The Scripps Research Institute, La Jolla, California
Lavery, D., Ph.D., Glaxo Wellcome Research Development, Lausanne, Switzerland
Rupp, F., Ph.D., Johns Hopkins University, Baltimore, Maryland
Amrein, H., Duke University, Durham, North Caroline
Schwab, M., The Scripps Research Institute, La Jolla, California
Chang, E., Harvard University, Boston, Massachusetts
Fung, E., The Scripps Research Institute, La Jolla, California
Gu, C., Johns Hopkins University, Bethesda, Maryland
Kong, H., Skirball Institute/New York University, New York
Samson, M., Harvard University, Boston, Massachusetts
This intensive laboratory-lecture course was intended to teach neuroscientists current approaches to
molecular neurobiology. The course consisted of daily lectures and laboratory exercises on the prac-
tice of molecular neurobiology, with an emphasis on modern approaches to cloning and analyzing the
expression of neural genes. A series of evening research seminars by invited speakers focused on the
ways these molecular techniques have been successfully applied. In the past, evening seminar topics
have included expression cloning; single cell cloning; subtractive cDNA cloning strategies; and genet-
ic and mechanistic studies of neurologic disease, aquisition of cell identity, and axon guidance in the
developing nervous system. The laboratory portion of the course began with instruction in a series of
basic molecular biological techniques and rapidly advanced to more sophisticated methodologies.
Students learned to prepare genomic, phage, and plasmid DNAs and total and poly(A)' RNAs, and to
generate and screen cDNA libraries. Additional topics and methods covered included restriction map-
ping, agarose and polyacrylamide gel electrophoresis, Northern and Southern blotting, subcloning,
oligonucleotide primer design, a selection of PCR-based techniques, and the use of nucleotide and
protein sequence databases. Gene expression studies included the production of fusion proteins in
bacteria and mammalian cell transfection. Advanced techniques included the construction of cDNA
libraries from single cells and the use of subtractive cDNA methods to clone genes expressed in limit-
ed populations of cells.
PARTICIPANTS
Bhattacharyya, S., B.S., California Institute of Technology,
Pasadena
Butler, A., B.A., Ph.D., The Salk Institute, La Jolla, California
Chow, R., B.A. M.D., Ph.D., University of Edinburgh, United
Kingdom
Corwin, J., B.S., Ph.D., University of Virginia, Charlottesville
Dutt, A., M.S., Columbia University, New York
Gray, P., B.S., University of California, Los Angeles
Irving, C., B.S., Ph.D., King's College London, United
Kingdom
Jakeman, L., BA., Ph.D., Ohio State University, Columbus
Johansson, C., B.A. D.D.S., Karolinska Institute,
Stockholm, Sweden
McGinty, J., B.A., Ph.D., East Carolina University School of
Medicine, Greenville, North Carolina
Molnar, Z., M.D., Ph.D., University of Lausanne,
Switzerland
Momma, S., M.S., Karolinska Institute, Stockholm, Sweden
Owens, D., B.A., Columbia University, New York
Tuttle, R., B.S., Ph.D., The Salk Institute, La Jolla, California
Udolph, G., B.S., Ph.D., National University of Singapore
Xiong, Z., M.D., Ph.D., University of Toronto, Canada
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SEMINARS
Barres, B., Stanford University, California. Neuron-glial inter-
actions in the developing rat optic nerve.
Bettler, B., Novartis, AG, Basel, Switzerland. Molecular
insights into GABA-B receptor physiology.
Chao, M., Skirball Institute/New York University, New York.
Cell death and survival receptors in the nervous system.
Darnell, R., Rockefeller University, New York. Functional stud-
ies of neuron-specific proteins cloned as paraneoplastic
neurologic disease antigens.
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Du lac, C., Harvard University, Cambridge, Massachusetts.
Molecular analysis of pheromone sensory coding in the
mammalian brain.
Lemke, G., The Salk Institute, La Jolla, California. Mutation of
the Tyro 3 family of receptors.
Stein, L., Cold Spring Harbor Laboratory. Sequence analysis
resources on the World Wide Web.
Weinmaster, G., University of California, Los Angeles. Notch
signal transduction in mammalian cells.
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Neurobiology of Drosophila
July 2-22
INSTRUCTORS Broadie, K., Ph.D., University of Utah, Salt Lake City
De Belle, S., Ph.D., University of Nevada, Las Vegas
Taylor, B., Ph.D., Oregon State University, Corvallis
Tear, G., Ph.D., King's College, London, United Kingdom
ASSISTANTS Alldredge, A., University of Nevada, Las Vegas
Feathersone, D., University of Utah, Salt Lake City
Myat, A., King's College, London, United Kingdom
This laboratory-lecture course was intended for researchers at all levels who want to use Drosophila
as an experimental system for studying behavior, physiology, and development. Daily seminars intro-
duced students to a variety of research topics and developed those topics by addressing recent exper-
imental contributions and outstanding questions in the field. Guest lecturers brought original prepara-
tions for viewing and discussion and/or direct laboratory exercises and experiments in their area of
interest. Students had hands-on experience with a variety of experimental preparations that are used
in the investigation of current neurobiological questions. The lectures and laboratories focused on both
the development of the nervous system and its role in controlling larval and adult behaviors. In addition
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to an exposure to the molecular genetic approaches available in Drosophila, students learned a variety
of techniques, including embryo in situ hybridization, labeling of identified neurons, electrophysiological
recording from nerves and muscles, and the analysis of larval and adult behavior. Collectively, the
course provided a comprehensive and practical introduction to modern experimental methods for
studying the Drosophila nervous system.
PARTICIPANTS
Babu, K., B.S., National University of Singapore
Lee, R., B.S., University of California, Los Angeles
Lloyd, T., B.S., Baylor College of Medicine, Houston, Texas
Lohr, R., M.S., Johannes Gutenberg-University Mainz,
Germany
McGuire, S., BA., Baylor College of Medicine, Houston,
Texas
Oh, P., BA., Stanford University, California
SEMINARS
Blau, J., Rockefeller University, New York. Neurobiology of
rhythmicity in Drosophila.
Brand, A., The Wellcome/CRC Institute, Cambridge, United
Kingdom. The role of asymmetric determinants in the speci-
fication of neural cell fate.
Broadie, K., University of Utah, Salt Lake City. Overview of
Drosophila physiology. The neuromuscular junction:
Synaptogenesis, neurotransmission, and synaptic plasticity.
De Belle, S., University of Nevada, Las Vegas. Behavior-
genetic analysis in Drosophila. Neuroanatomy of odor learn-
ing and memory in Drosophila.
Hartenstein, V., University of California, Los Angeles. An intro-
duction to Drosophila development.
Ito, K., National Institute for Basic Biology, Aichi, Japan. Iden-
tification and lineage tracing of postembryonic neuroblasts.
Kernan, M., State University of New York, Stony Brook.
Hearing and touch reception in Drosophila,
Murphey, R., University of Massachusetts, Amherst.
Drosophila neural circuits.
O'Dell, K., University of Glasgow, United Kingdom. Courtship
and its neurobiological basis in Drosophila.
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Ren, X., B.S., University of California, Berkeley
Speese, S., B.S., University of Utah, Salt Lake City
Tavosanis, G., M.D., European Molecular Biology Laboratory,
Heidelberg, Germany
Wildonger, J., BA., University of California, San Francisco
Wolf, F., B.S., Ph.D., University of California, San Francisco
Wucherpfennig, T., B.S., M.S., MPI for Biophysical Chemistry,
Goettingen, Germany
Prokop, A., Johannes Gutenberg-University Mainz, Germany.
Determination and analysis of embryonic neuroblast lineage.
An ultrastructural investigation of synaptogenesis.
Restifo, L., University of Arizona, Tucson. Development of the
pupal central nervous system in Drosophila.
Sokolowski, M., University of Toronto, Canada. Neurobiology
of foraging behavior in Drosophila.
Stark, W., St. Louis University, Missouri. Phototransduction:
Light reception and processing in Drosophila.
Strauss, R., Max Planck Institute, TObingen, Germany. Central
processing of motor behavior in Drosophila.
Tear, G., King's College London School of Medicine, London,
United Kingdom. Axon pathfinding in the embryo.
Treisman, J., New York Medical Center/Skirball Institute, New
York. Development of the adult visual system.
Tully, T., Cold Spring Harbor Laboratory. Learning and memo-
ry in Drosophila: Psychology meets biology.
Zhong, Y., Cold Spring Harbor Laboratory. Plasticity in central
and peripheral synapses.
Zinsmaier, K., University of Pennsylvania, Philadelphia.
Genetic control of the synaptic vesicle cycle.
The Biology of Memory: From Molecules to Behavior
July 7-20
INSTRUCTORS Byrne, J., Ph.D., University of Texas, Houston
Eichenbaum, H., Ph.D., Boston University, Massachusetts
Pearson, K., Ph.D., University of Alberta, Edmonton, Canada
Squire, L., Ph.D., University of California, San Diego
This lecture course provided an introduction to cell, molecular, and systems approaches to learning
and memory. It was suited for graduate students in molecular biology, neurobiology, and psychology
as well as research workers interested in an introduction to this field. Topics ranged from behavioral
considerations of learning and memory to gene regulation in the nervous system. The lectures provid-
ed an intensive coverage of six selected areas: (1) an introduction to modern behavioral studies of
learning and memory, (2) an overview of the cell biology of neuronal plasticity and second messenger
systems, (3) the regulation of gene expression, (4) cellular and molecular mechanisms of simple forms
of learning and memory in invertebrates and vertebrates, (5) cellular and molecular mechanisms of
long-term potentiation and depression in various regions of the mammalian brain, and (6) systems
approaches to learning in vertebrates and humans.
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PARTICIPANTS
Chin, J., B.A., B.S., University of Texas, Houston
Dragoi, G., M.S., M.D., Rutgers University, Newark, New
Jersey
Fortin, N., B.S., Ph.D., Boston University, Massachusetts
Fullgrabe, C., BA., MA., Fondation des Etats-Unis, Paris,
France
Gray, N., B.S., Mayo Graduate School, Rochester, Minnesota
Hristov, K., M.S., University of Oxford, United Kingdom
Kim, D.G., M.D., Ph.D., Yonsei University, Seoul, South Korea
Libbey, M., BA., Boston University, Massachusetts
Lucic, V., B.S., Ph.D., California Institute of Technology,
SEMINARS
Ball, G., Johns Hopkins University, Baltimore, Maryland.
Ethological approaches to learning.
Byrne, J., University of Texas, Houston. Introduction to the
cellular study of learning. Overview of membranes and
synaptic transmission. Nonassociative learning in Aplysia I.
Nonassociative learning in Aplysia II.
Davis, M., Emory University, Atlanta, Georgia. Fear condition-
ing.
Eichenbaum, H., Boston University, Massachusetts. Role of
LTP and LTD in learning. Memory systems in rodents.
Gilbert, C., Rockefeller University, New York. Dynamics of
adult visual cortex.
Greenough, W., University of Illinois, Urbana. Morphological
correlates of learning and experience.
Griffith, L., Brandies University, Waltham, Massachusetts.
Genetic approaches to study learning in Drosophila.
Holland, P., Duke University, Durham, North Carolina.
Introduction to learning-Theory I.
Introduction to learning-Theory II.
Kaczmarek, L., Yale University, New Haven, Connecticut.
Structure, function, and modulation of ion channels.
Kennedy, M., California Institute of Technology, Pasadena.
Overview of second-messenger systems and their role in
learning and memory I. Overview of second-messenger
systems and their role in learning and memory II.
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Pasadena
Mehren, J., B.S., Brandeis University, Waltham, Massachusetts
Petersson, P., M.S., Lund University, Sweden
Petkov, C., B.S., University of California, Davis
Petrulis, A., B.S., Ph.D., Boston University, Massachusetts
Stark, C., BA., Ph.D., University of California, San Diego
Stewart, D., B.S., Imperial College, London, United Kingdom
Tapechum, S., M.D., University of Edinburgh, United Kingdom
Tautpenfeld, S., B.A., Brown University, Providence, Rhode
Island
Volkar, V., M.D., University of Helsinki, Finland
Linden, D., Johns Hopkins University, Baltimore, Maryland.
Long-term depression.
Lisberger, S., University of California, San Francisco. Adaptive
modifications of the VOR.
Lu, B., National Institutes of Health, Betheda, Maryland.
Long-term potentiation II.
Malinow, R., Cold Spring Harbor Laboratory. Long-term
potentiation I.
Mayford, M., University of California, San Diego. Gene-knock-
ing/transgenic approaches to study learning.
McGaugh, J., University of California, Irvine. Modulation of
memory.
Menzel, R., Freie University, Berlin, Germany. Memory phases
in honeybees.
Posner, M., Cornell University, New York. Neuropsychology of
cognition.
Sahley, C., Purdue University, West Lafayette, Indiana.
Nonassociative and associative learning in the leach.
Sweatt, D., Baylor College of Medicine, Houston, Texas.
Long-term potentiation III.
Thompson, R., University of Southern California, Los Angeles.
Classical conditioning of the nictitating membrane response.
Squire, L., University of California, San Diego. Memory sys-
tems in nonhuman primates. Human memory and disorders
of memory.
Structure, Function, and Development of the Visual System
July 22-August 4
INSTRUCTORS Bonhoeffer, T., Ph.D., Max Planck Institute, Munchen, Germany
Fitzpatrick, D., Ph.D., Duke University Medical Center, Durham, North Carolina
McAllister, K., Ph.D., The Salk Institute, La Jolla, California
Usrey, M., Ph.D., Harvard Medical School, Boston, Massachusetts
This lecture-discussion course explored the functional organization and development of the visualsys-
tem as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It was
designed for graduate students and more advanced researchers who wished to gain a basic under-
standing of the biological basis of vision and to share in the excitement of the latest developments in
this field. Topics included phototransduction and neural processing in the retina; functional architecture
of striate cortex; cellular basis of cortical receptive field properties; the anatomy, physiology, and per-
ceptual significance of parallel pathways; functional parcellation of extrastriate cortex; the role of pat-
terned neuronal activity in the development of central visual pathways; and molecular mechanisms of
development and plasticity in the visual system.
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PARTICIPANTS
Alliston, E., B.S., New York University, New York
Barbarosie, M., B.S., Ph.D., Brown University, Providence,
Rhode Island
Boudreau, E., B.A., Baylor College of Medicine, Houston,
Texas
Briggs, F., B.A., The Salk Institute, La Jolla, California
Burkitt, G., B.S., Ph.D., Rockefeller University, New York
Chisum, H., B.S., Duke University, Durham, North Carolina
Cueva, J., B.S., University of California, Los Angeles
Duffy, K., B.A., McMaster University, Ontario, Canada
Fiser, J., M.S., Ph.D., University of Rochester, New York
Florer, F., M.S., Ph.D., Marymount College and New York
University, Tarrytown
Furtado, D., B.S., M.S., University of Rio de Janeiro, Brazil
Godinho, L., B.S., Howard Florey Institute, Victoria, Australia
SEMINARS
Adelson, T., Massachusetts Institute of Technology,
Cambridge. Psychophysics and human imaging.
Assad, J., Harvard Medical School, Boston, Massachsuetts.
Extrastriate cortex.
Bear, M., Brown University, Providence, Rhode Island.
Development.
Bonhoeffer, T., Max Planck Institute, Munich, Germany. Striate
cortex.
Chapman, B., University of California, Davis. Development.
Dacey, D., University of Washington, Seattle. Retina.
De Yoe, T., Medical College of Wisconsin, Milwaukee.
Psychophysics and human imaging.
Feller, M., National Institutes of Health, Bethesda, Maryland.
Development.
Ferster, D., Northwestern University, Evanston, Illinois. Striate
cortex.
Fitzpatrick, D., Duke University, Durham, North Carolina.
Striate cortex.
Gross, C., Princeton University, New Jersey. The history of
the visual system.
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Kara, P., B.S., M.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Koh ly, R., B.S., M.A., York University, Toronto, Canada
Macknik, S., B.A., Ph.D., Harvard Medical School, Boston,
Massachusetts
Martinez, L., B.A., Ph.D., Rockefeller University, New York
Martinez-Conde, S., B.A., Ph.D., Harvard Medical School,
Boston, Massachusetts
Oberdorfer, M., B.A., Ph.D., National Institutes of Health,
Bethesda, Maryland
Sermasi, E., M.A., Ph.D., International School for Advanced
Studies, Trieste, Italy
Tropea, D., B.S., International School for Advanced Studies,
Trieste, Italy
Vaz, A.M., M.D., Max Planck Institute, Munich, Germany
Hubei, D., Harvard Medical School, Boston, Massachusetts.
Striate cortex.
Maunsell, J., Baylor College of Medicine, Houston, Texas.
Extrastriate cortex.
McAllister, K., Salk Institute, La Jolla, California. Development.
Miller, K., University of California, San Francisco. Develop-
ment.
Movshon, T, New York University, New York. Extrastriate cor-
tex.
Reid, C., Harvard Medical School, Boston, Massachusetts.
Striate cortex.
Rieke, F., University of Washington, Seattle. Retina.
Shad len, M., University of Washington, Seattle. Extrastriate
cortex.
Singer, W., Max Planck Institute, Frankfurt, Germany. Striate
cortex.
Usrey, M., Harvard Medical School, Boston, Massachusetts.
Striate cortex.
Eukaryotic Gene Expression
July 27-August 16
INSTRUCTORS Gill, G., Ph.D., Harvard Medical School, Boston, Massachusetts
Gilmour, D., Ph.D., Pennsylvania State University, University Park
Goodrich, J., Ph.D., University of Colorado, Boulder
Lees, J., Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANTS Benjamin, L., Pennsylvania State University, University Park
Kotovsky, I., Harvard Medical School, Boston, Massachusetts
Kugel, J., University of Colorado, Boulder
Verona, R., Massachusetts Institute of Technology, Cambridge
This course was designed for students, postdocs, and principal investigators who had recently ven-
tured into the dynamic area of gene regulation. The course focused on state-of-the-art strategies and
techniques employed in the field. Cell-free extracts for in vitro transcription were prepared and RNA lev-
els were measured by primer extension analysis. An emphasis was placed on biochemical studies of
protein-DNA and protein-protein interactions. A detailed characterization of the DNA-binding proper-
ties of a site-specific transcription factor was carried out using electrophoretic mobility shift and DNase
I footprinting assays. These assays were used to study protein-DNA interactions in crude extracts and
using recombinant proteins purified in class. Chromatography and coimmunoprecipitation methods
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were used to investigate protein-protein interactions. Over the past few years, the gene regulation field
has begun to emphasize the importance of in vivo approaches to studying protein-DNA and protein-
protein interactions. Students were therefore exposed to in vivo footprinting, mapping of DNase I
hypersensitive sites, and yeast two-hybrid methodologies. Experience with basic recombinant DNA
techniques was a prerequisite for admission to this course. Lectures by the instructors covered the cur-
rent status of the gene-expression field, theoretical aspects of the methodology, and broader issues
regarding strategies for investigating the regulation of gene expression in eukaryotes. Guest lecturers
discussed contemporary problems in eukaryotic gene regulation and technical approaches to their
solution.
PARTICIPANTS
Beere, H., B.S., Ph.D., La Jolla Institute for Allergy and
Immunology, San Diego, California
Cuff, M., B.S., Ph.D., University of Liverpool, United Kingdom
Damberg, M., M.S., Ph.D., Uppsala University, Sweden
Esumi, N., M.D., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Ford, J., B.A., M.D., Stanford University, California
Hamilton, N., B.S., Meharry Medical College, Nashville,
Tennessee
Hollowell, G., B.S., Ph.D., National Institutes of Health,
Bethesda, Maryland
Huot, T., B.S., M.S., Imperial Cancer Research Fund,
London, United Kingdom.
SEMINARS
Archer, T, National Institutes of Health, Bethesda, Maryland.
Posttranslational modification of histones, chromatin remod-
eling, and activated transcription.
Bentley, D., University of Colorado, Denver. The role of the pol
II CTD in transcription and RNA processing.
Blackwell, K., Harvard Medical School, Boston,
Massachusetts. Activation and repression of zygotic tran-
scription in the early C. elegans embryo.
Burley, S., Rockefeller University, New York. X-ray crystallo-
graphic studies of eukaryotic transcription factors.
Carey, M., University of California, Los Angeles.
Enhanceosome-mediated transcription complex assembly.
Gill, G., Harvard Medical School, Boston, Massachusetts.
Transcription factors that function in the Drosophila nervous
system.
Gilmour, D., Pennsylvania State University, University Park.
Transcription regulation of the hsp70 heat shock gene of
Drosophila.
Goodrich, J., University of Colorado, Bolder. Mechanisms of
human RNA polymerase II transcription.
Freedman, L., Memorial Sloan-Kettering Cancer Center, New
264
Jonsson, C., B.S., Karolinska Institute, Stockholm,
Sweden
Kimura, A., B.S., M.S., University of Tokyo, Japan
Koentges, G., B.A., Ph.D., Harvard University, Cambridge,
Massachusetts
Lepique, A., B.S., M.S., University of San Paolo, Brazil
Luce, M., B.S., Ph.D., Yale University, New Haven,
Connecticut
Mc Tiernan, C., B.A., Ph.D., University of Pittsburgh,
Pennsylvania
Reddi, R, B.S., Ph.D., University of Virginia, Charlottesville
Zhang, J., B.M., M.D., Beth Israel Deaconess Medical Center,
Boston, Massachusetts
York. DRIPS: A multiprotein coactivator complex for nuclear
receptors and beyond.
Hernandez, N., Cold Spring Harbor Laboratory. Structure and
function of SNAP, a core promoter binding factor involved
in RNA polymerase II and III snRNA gene transcription.
Lees, J., Massachusetts Institute of Technology, Cambridge.
E2F in proliferation and development.
Price, D., University of Iowa, Iowa City. Factors controlling the
elongation phase of transcription by RNA polymerase II.
Reese, J., Pennsylvania State University, University Park.
Molecular and genetic analysis of yeast TATA-binding pro-
tein associated factors (TAFs).
Smale, S., University of California/Howard Hughes Medical
Institute, Los Angeles. Nuclear architecture and nucleosome
remodeling in the immune system.
Workman, J., Pennsylvania State University, University Park.
Transcription regulation by SWI/SNF and HAT complexes.
Young, R., Massachusetts Institute of Technology,
Cambridge. The new genetics of gene expression.
Zaret, K., Brown University, Providence, Rhode Island.
Opening up specific chromatin domains in development.
Imaging Structure and Function in the Nervous System
July 27-August 16
INSTRUCTORS Denk, W., Ph.D., Lucent Technologies Bell Laboratory, Murray Hill, New Jersey
Halpain, S., Ph.D., Scripps Research Institute, La Jolla, California
Kay, S., Ph.D., Scripps Research Institute, La Jolla, California
ASSISTANTS Arnth-Jensen, N., University of Zurich, Switzerland
Littlefield, R., Scripps Research Institute, La Jolla, California
Oheim, M., Ecole Superieure de Physique et Chimie Industrielles, Paris, France
Ozer, R., Scripps Research Institute, La Jolla, California
Advances in light microscopy and digital image processing and the development of a variety of power-
ful fluorescent probes present expanding opportunities for investigating the nervous system, from
synaptic spines to networks in the brain. This intensive laboratory and lecture course provided partici-
pants with the theoretical and practical knowledge they need to use emerging imaging technologies.
The primary emphasis of the course was on vital light microscopy. Students learned the principles of
light microscopy, as well as the use of different types of electronic cameras, laser scanning systems,
functional fluorophores, delivery techniques, and digital image-processing software. In addition to trans-
mitted light microscopy for viewing cellular motility, the course examined a variety of molecular probes
of cell function, including calcium-sensitive dyes, voltage-sensitive dyes, photoactivated ("caged") com-
pounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological
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methods were covered. Particular weight was given to multiphoton laser scanning microscopy and to
newly available biological fluorophores, especially green fluorescent protein (GFP) and its variants. A
spectrum of neural and cell biological systems, including living animals, brain slices, and cultured cells,
was used. Participants had a strong background in the neurosciences or in cell biology.
PARTICIPANTS
Bringuier, V, M.S., Ph.D., Medical Research Council Laboratory
of Molecular Biology, Cambridge, United Kingdom
Diamond, J., B.S., Ph.D., Oregon Health Sciences University,
Portland
Harris, R., B.S., Ph.D., National Institutes of Health,
Bethesdsa, Maryland
Kuperman, R., B.S., University of California, San Francisco
Luscher, C., M.D., University of California, San Francisco
Mikko, I., B.A., New York University, New York
Orger, M., B.A., University of California, San Francisco
Roesch, H., B.S., Max Planck Institute, Munich, Germany
SEMINARS
Aoki, C., New York University, New York. EM: Imaging macro-
molecular organization.
Betz, W., University of Colorado, Denver. Imaging neurotrans-
mitter release.
Bonhoeffer, T, Max Planck Institute, Munich, Germany.
Intrinsic imaging.
Brand, A., Wellcome/CRC Institute, Cambridge, United
Kingdom. Imaging neuronal development in flies.
Connor, J., University of New Mexico, Albuquerque. Calcium
imaging in brain slices.
Day, R., University of Virginia, Charlottesville. Studies of pro-
tein-protein interaction using FRET in vivo.
Denk, W., Lucent Technologies Bell Labs, Murray Hill, New
Jersey. Optical physics. Lasers. Reviews of optical princi-
ples. Introduction to multiphoton imaging.
Fetcho, J., State University of New York, Stony Brook.
Calcium imaging in zebrafish.
Forscher, R, Yale University, New Haven, Connecticut.
Principles of DIC-DIC imaging of growth cones.
Halpain, S., Scripps Research Institute, La Jolla, California.
Fixation and staining: Immunocytochemistry. Gene, protein,
and probe delivery into neurons.
Helmchen, F., Lucent Technologies Bell Labs, Murray Hill,
New Jersey. Introduction to calcium imaging.
Jay, D., Tufts University, Boston, Massachusetts.
Chromophore-assisted laser inactivation.
Keller, E., Zeiss Microscopes, Thornwood, New York.
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Scolnick, E., M.D., Merck Research Laboratories, West Point,
Pennsylvania
Sharma, G., M.S., Ph.D., University of Colorado Health
Sciences Center, Denver
Uchida, N., B.S., Ph.D., RIKEN Brain Science Institute,
Saitama, Japan
Usdin, M., B.S., Stanford University, California
Van Roessel, P., B.S., M.S., University of Cambridge, United
Kingdom
Zeng, H., B.S., Ph.D., Massachusetts Institute of Technology,
Cambridge
Introduction to the light microscope.
Kleinfeld, D., University of California, San Diego. Imaging
blood flow in the living brain.
Lichtman, J., Washington University, St. Louis, Missouri.
Introduction to confocal microscopy. Imaging long-term
changes in synapses using confocal microscopy.
Loew, L., University of Connecticut Health Sciences Center,
Farmington. Voltage-sensitive dyes.
Matus, A., Friedrich Miescher Institute, Basel, Switzerland.
Imaging dendritic spine motility in living neurons.
Moomaw, L., Hamamatsu Photonics, Bridgewater, New
Jersey. Cameras and detectors.
Schafer, W., University of California, San Diego. Imaging neu-
ronal development in frog.
Svoboda, K., Cold Spring Harbor Laboratory. Application of
multiphoton imaging.
Taylor, L., Cellomics, Inc., Pittsburgh, Pennsylvania.
Fluorescence and the genomic revolution.
Tsien, R., University of California, San Diego. Imaging
cameleons in C. elegans and other new applications of fluo-
rescent probes.
Waterman-Storer, C., Scripps Research Institute, La Jolla,
California. Combining DIC and fluorescence microscopy for
live cell imaging. Fluorescent speckle microscopy.
Weiss, S., Lawrence Berkeley National Lab, Berkeley,
California. Q-Dots.
Yeast Genetics
July 27-August 16
INSTRUCTORS Burke, D., Ph.D., University of Virginia, Charlottesville
Dawson, D., Ph.D., Tufts University, Boston, Massachusetts
Stearns, T., Ph.D., Stanford University, California
ASSISTANTS Frank, J., University of Virginia, Charlottesville
Preble, A., University of Colorado, Boulder
Shanks, R., Tufts University, Boston, Massachusetts
The major laboratory techniques used in the genetic analysis of yeast were studied in this course,
including the isolation and characterization of mutants, tetrad analysis, complementation, and mitotic
recombination. All students carried out the micromanipulation used in tetrad analysis. They studied
molecular genetic techniques, including yeast transformation, gene replacement, analysis of gene
fusions, and generation of mutations in cloned genes. Indirect immunofluorescence experiments were
done to identify the nucleus, microtubules, and other cellular components. Lectures on fundamental
aspects of yeast genetics were presented along with seminars given by outside speakers on topics of
current interest.
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PARTICIPANTS
Boddy, C., B.S., Ph.D., Scripps Research Institute, La Jolla,
California
Chan, D., M.A., M.D., Ph.D., Massachusetts Institute of
Technology/Whitehead Institute, Cambridge
Fabrizio, P., B.S., Ph.D., University of Southern California, Los
Angeles
Galindo-Castro, I., B.S., Ph.D., Polar Technology Center,
Venezuela
Gendron, C., B.S., Ph.D., Max Planck Institute, Rostock,
Germany
Ideker, T, B.S., M.S., University of Washington, Seattle
SEMINARS
Amon, A., Massachusetts Institute of Technology, Cambridge.
Regulation of mitotic exit in yeast.
Boeke, J., Johns Hopkins University, Baltimore, Maryland.
The Tyl elements of yeast.
Fink, G., Whitehead Institute, Cambridge, Massachusetts.
Invasive growth.
Hopper, A., Pennsylvania State University, Hershey. Evidence
for nuclear tRNA charging and its role in nuclear export of
endogenous tRNAs in budding yeast.
Konopka, J., State University of New York, Stony Brook.
Activation and regulation of the a-factor mating pheromone
receptor.
Lichten, M., National Cancer Institute, NIH, Bethesda,
Maryland. Meiotic recombination.
Lundblad, V. Baylor College of Medicine, Houston, Texas. Tethering
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Jonson, L., M.S., Copenhagen University Hospital, Denmark
March, T., B.S., University of Idaho, Moscow
Monje Casas, F., B.S., University of Cordoba, Spain
Newman, J., B.S., Massachusetts Institute of
Technology/Whitehead Institute, Cambridge
Otterstedt, K., M.S., Goteborg University, Sweden
Pannunzio, A., B.S., McGill University, Montreal, Canada
Perlstein, D., B.S., Massachusetts Institute of Technology,
Cambridge
Schuller, D., M.S., University of Minho, Braga, Portugal
Yao, G., B.S., University of Wisconsin, Madison
telomerase to the telomere: Analysis of in vivo regulators.
Meluh, P., Memorial Sloan-Kettering Cancer Institute, New
York. Centromere assembly and function.
Pellman, D., Dana Farber Cancer Institute, Boston,
Massachusetts. Neoclassicism in yeast cell biology.
Roof, D., University of Pennsylvania, Philadelphia. Molecular
motors.
Smith, M., University of Virginia, Charlottesville. Histone struc-
ture and function.
Snyder, M., Yale University, New Haven, Connecticut. Yeast
genomics.
Weiner( T, University of Arizona, Tucson. DNA damage
checkpoint.
Winey, M., University of Colorado, Boulder. Budding yeast
spindle pole body duplication.
Brain Mapping
August 6-12
INSTRUCTORS Mazziotta, J., M.D., Ph.D., University of California, Los Angeles
Toga, A., Ph.D., University of California, Los Angeles
The aim of this lecture course was to describe the rapidly evolving developments in methods used for
mapping the structure and function of the brain, both to understand its normal function and to evalu-
ate neurological, neurosurgical, and psychiatric disease states. This course described new and tradi-
tional methods, including magnetic resonance imaging (including functional, spectroscopic, and angio-
graphic approaches), positron emission tomography, electrophysiological techniques, optical intrinsic
signal imaging, digital approaches to conventional postmortem neuroanatomical investigations, and
experimental design, data analysis, statistical approaches, visualization, and stereotaxy. The course
was not designed to simply describe methods, but rather to discuss how brain-mapping strategies can
be used in combination with biological models for understanding the structure and function of the
brain. Findings relevant to the function of the visual, motor, language, memory, and cognitive brain sys-
tems, as well as diseases that adversely affect them, were discussed. Students developed specific
hypotheses and experimental designs for mock execution, and they went on a field trip to an imaging
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laboratory. They toured an active PET laboratory and a 4-tesla MRI center, both at Brookhaven National
Laboratory. Invited speakers included world leaders in each of the respective brain mapping subspe-
cialties.
PARTICIPANTS
Bussey, T., Ph.D., National Institutes of Health, Bethesda,
Maryland
Capaday, C., Ph.D., Universite Laval Robert Giffard, Quebec,
Canada
Cash, D., B.S., University of London, Kings College, United
Kingdom
Giedd, J., M.D., National Institutes of Health, Bethesda,
Maryland
Holm, L., Ph.D., European Molecular Biology Laboratory,
SEMINARS
Bandettini, P., National Institutes of Health, Bethesda,
Maryland. MRI.
Belliveau, J., Massachusetts General Hospital, Charleston.
Vision.
Grafton, S., Emory University, Atlanta, Georgia. Motor sys-
tems.
Fletcher, P., Heinrich Hein Universitat, Dussseldorf, Germany.
Language and memory.
Mayberg, H., University of Toronto, Ontario, Canada.
Emotions and mood disorders.
Mazziotta, J., University of California, Los Angeles. PET.
ATLASES.
Petersen, S., Washington University, St. Louis, Missouri.
Experimental design.
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Cambridge, United Kingdom
Jacobs, M., B.A., National Institutes of Health, Bethesda,
Maryland
Margolis, D., B.S., Brown University, Providence, Rhode
Island
Pinsk, M., B.S., National Institutes of Health, Bethesda,
Maryland
Speer, A., M.D., National Institutes of Health, Bethesda,
Maryland
Petrides, M., McGill University, Quebec, Canada. Cortex:
Structure and function.
Pons, T., Wake Forest University, Winston-Salem, North
Carolina. Plasticity.
Simpson, G., Albert Einstein College of Medicine, Bronx, New
York. EEG-MEG-ERP.
Toga, A., University of California, Los Angeles. Microtech-
niques: 01S, histology, cryomacrotome.
Woods, R., University of California, Los Angeles. Spatial
issues, statistical issues.
Woolsey, T., Washington University, St. Louis, Missouri.
Hemodynamics.
Zeffiro, T., Sensor Systems, Inc., Sterling, Virginia. Data analy-
sis.
Advanced In Situ Hybridization and Immunocytochemistry
October 13-26
INSTRUCTORS Ochs, R., Ph.D., Precision Therapeutics, Pittsburgh, Pennsylvania
Murray, J., M.D., Ph.D., University of Pennsylvania, Philadelphia
Spector, D., Ph.D., Cold Spring Harbor Laboratory
Ried, T., Ph.D., National Institutes of Health, Bethesda, Maryland
Schrock, E., Ph.D., Institut fur Molekulare Biotechnologie, Jena, Germany
ASSISTANTS Binnie, A., Sir William Dunn School of Pathology, Oxford, United Kingdom
Howard, T., Cold Spring Harbor Laboratory
This course focused on specialized techniques in microscopy related to localizing DNA and RNA
sequences and proteins in cells for microscopic examination. It emphasized the use of the latest equip-
ment and techniques in epifluorescence microscopy, confocal laser scanning microscopy, electron
microscopy, and digital image processing. The aims of the course were to provide state-of-the-art
technology and scientific expertise in the use of microscopic applications to address basic questions
in genome organization and cellular and molecular biology. The course was designed for the molecu-
lar biologist who was in need of microscopic approaches and for the cell biologist who was not famil-
iar with the practical application of the advanced techniques presented. Among the methods present-
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ed were the preparation of tagged nucleic acid probes, fixation methods, detection of multiple DNA
sequences in single nuclei or chromosome spreads, comparative genomic hybridization, spectral kary-
otyping, cellular localization of RNA, use of a variety of reporter molecules and nonantibody fluorescent
tags, indirect antibody labeling, detection of multiple proteins in a single cell, and immunoelectron
microscopy. Several experimental protocols were presented in each method, allowing the students to
assess the relative merits of each and to relate them to their own research. Students were encouraged
to bring nucleic acid or antibody probes to the course, which were used in addition to those provided
by the instructors. The laboratory portion of the course was supplemented by invited lecturers, who
presented up-to-the-minute reports on current methods and research using the techniques being pre-
sented in the course.
PARTICIPANTS
Abramsson, A., M.S, Ph.D., Goteborg University, Sweden
Craig, E., B.S., Albert Einstein College of Medicine, Bronx,
New York
Di Daniel, E., B.A., International School for Advanced
Studies, Trieste, Italy
Hemken, P., B.S., M.A., Ph.D., Abbott Laboratories, Abbott
Park, Illinois
Holmberg, S., M.S., Uppsala University, Sweden
Jones, G., B.S, Ph.D., University of Kentucky, Lexington
Karpova, A., B.S., M.S., Harvard Medical School, Boston,
Massachusetts
Kisielow, J., B.S., M.S., Basel Institute for Immunology,
SEMINARS
Day, R.N., University of Virginia Health Sciences Center,
Charlottesville. Visualizing protein interactions in living cells
using digitized GFP imaging and FRET microscopy.
Dernburg, A., Stanford University School of Medicine,
California. In situ hybridization in embryos.
Ernst, L., Carnegie Mellon University, Pittsburgh,
Pennsylvania. Filters and fluorochromes for fluorescence
microscopy.
Martone, M., University of California at San Diego, La Jolla.
Electron microscopy as a tool in cell and molecular biolo-
gy.
Matera, G., Case Western Reserve University, Cleveland,
Ohio. Fluorescence in situ hybridization.
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Switzerland
Margotti, E., B.S., Ph.D., International School for Advanced
Studies, Trieste, Italy
O'Doherty, U., B.A., M.D., Ph.D., University of Pennsylvania,
Philadelphia
Ozcan, T., B.S., M.D., Yale University, New Haven, Connecticut
Raghib, A., B.S., University College London, United Kingdom
Roethy, W., M.S., Columbia University, New York
Soultanakis, R., B.A., University of Vermont, Burlington
Tuttle, J., B.S., Ph.D., Indiana University, Indianapolis
Wegel, E., B.S., M.S., John Innes Centre, Norwich, United
Kingdom
Murray, J., University of Pennsylvania, Philadelphia. Basic
introduction to light and fluorescence microscopy. Principles
of confocal microscopy and deconvolution.
Pederson, T., University of Massachusetts Medical School,
Worcester. RNA dynamics in living cells.
Ried, T., National Institutes of Health/NCI, Bethesda,
Maryland. CGH and SKY.
Singer, R.H., Albert Einstein College of Medicine, Bronx, New
York. Cytoplasmic organization of mRNA.
Spector, D.L., Cold Spring Harbor Laboratory.
Immunocytochemistry.
White, J., University of Wisconsin, Madison. Multi-photon
microscopy.
Genome Informatics
October 13-26
INSTRUCTORS Rozen, S., Ph.D., Massachusetts Institute of Technology/Whitehead Institute, Cambridge
Stein, L., Ph.D., Cold Spring Harbor Laboratory
ASSISTANT Sachidanandam, R., Cold Spring Harbor Laboratory
The desktop computer is rapidly becoming an indispensable tool in the biologists' toolchest. The suc-
cess of the human genome project has created an explosion of information: billions of bits of biologi-
cal information stashed electronically in databases around the globe just waiting for the right key to
unlock them. New technologies such as DNA microarrays and high-throughput genotyping are creat-
ing an information overload that the traditional laboratory notebook cannot handle. To exploit the infor-
mation revolution in biology, biologists must move beyond canned Web interfaces and Excel spread-
sheets. They must take charge of the data by creating their own software to fetch, manage, and inte-
grate them. The goal of this course was to provide biologists with the tools needed to deal with this
changing landscape. Designed for students and researchers with little prior knowledge of program-
ming, this two-week course taught the fundamentals of the UNIX operating system, Perl scripting,
dynamic Web page development with the CGI protocol, and database design. The course combined
formal lectures with hands-on experience in which students worked to solve a series of problem sets
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drawn from common scenarios in biological data acquisition, integration, and laboratory workflow
management. Students were also encouraged to pose problems using their own data and to work
together with faculty to solve them.
PARTICIPANTS
Brown, J., B.S., Ph.D., SmithKline Beecham
Pharmaceuticals, Collegeville, Pennsylvania
Caffrey, J., B.A., Ph.D., National Institutes of Health,
Research Triangle Park, North Carolina
Caporale, L., B.S., Ph.D., Independent Research, New York
Chen, T., B.S., B.A., Ph.D., Forsyth Institute, Boston,
Massachusetts
Davis, B., B.A., Ph.D., Proteome, Inc., Beverly,
Massachusetts
Glass, J., B.S., M.A., Eli Lilly & Company, Indianapolis,
Indiana
Gomez, M., B.S., Ph.D., Public Health Research Institute,
New York
Halgren, R., B.S., Ph.D., Michigan State University, East
Lansing
Harris, T., B.A., Ph.D., University of Utah, Salt Lake City
Huang, L., B.S., Ph.D., University of California, San
Francisco
SEMINARS
Bader, J., CuraGen Corporation, New Haven, Connecticut.
Access to gene expression data.
Birney, E., EMBL-European Bioinformatics Institute,
Cambridge, United Kingdom. Peri Scripting 5: Installing and
creating Perl modules. Perl Scripting 6: Objects. Sequence
alignment. Web-based protein analysis resources.
Chervitz, S., Neomorphics, Inc., Berkeley, California.
Introduction to BioPerl. Similarity searching with BioPerl.
Introduction to neomorphics tools.
Eddy, S., Washington University School of Medicine, St.
Louis, Missouri. RNA sequence/structure analysis.
Gish, W., Washington University School of Medicine, St.
Louis, Missouri. The BLAST/FAST family of sequence-simi-
larity tools I. The BLAST/FAST family of sequence-similarity
tools II.
Jamison, C., National Institutes of Health, Bethesda,
Maryland. Web-based nucleotide analysis resources.
Leach, M., CuraGen Corporation, New Haven, Connecticut.
CGI Scripting 1: Basic. CGI Scripting 2: Advanced.
Marth, G., Washington University School of Medicine, St.
Louis, Missouri. Basic sequence manipulation: Primer pick-
ing, repeat masking, vector finding.
Peitzsch, R., Pfizer, Inc., Groton, Connecticut. SQL data-
bases.
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Kissinger, J., A.B., Ph.D., University of Pennsylvania,
Philadelphia
McCombie, W.R., B.A., Ph.D., Cold Spring Harbor
Laboratory
Rabinowicz, P., B.S., M.S., Ph.D., Cold Spring Harbor
Laboratory
Sana, T., B.S., Ph.D., DNAX Research Institute, Palo Alto,
California
Stein, J., B.S., Ph.D., Cereon Genomics, Cambridge,
Massachusetts
Stoddard, S., B.S., Ph.D., Archer Daniels Midland
Company, Decatur, Illinois
Udar, N., B.S., Ph.D., Jules Stein Eye Institute, Los Angeles,
California
Viriyakosol, S., B.S., Ph.D., University of California, San
Diego
Walhout, A., M.D., Ph.D., Massachusetts General Hospital,
Charlestown
Rehban, M., AstraZeneca, Inc., Cambridge, Massachusetts.
Web design and usability.
Rozen, S., Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts. Using the UNIX operating sys-
tem 2: Command pipes, redirection, periodic tasks.
Review of Perl essentials: Arrays, hashes, etc.
Review of database essentials.
Review of Perl essentials: Control constructs.
Perl scripting 4: Perl references.
Providing Web information services 1.
Introduction to databases. The UNIX DBM family.
Sachidanandam, R., Cold Spring Harbor Laboratory. Pert
scripting 3: Perl basics: Arrays and hashes.
Snoody, J., Oak Ridge National Laboratory, Oak Ridge,
Tennessee. Gene prediction software.
Stein, Lincoln, Cold Spring Harbor Laboratory.
Using the UNIX Operating System 1: Files, directories, com-
mands, text editor.
Perl Scripting 1: Perl basics: Operators, functions.
Perl Scripting 2: Perl basics: Loops, input/output, regular
expressions.
Introduction to the Web: HTML, HTTP, FTP.
Extracting information from Web pages: Client-side FTP and
HTTP techniques.
Macromolecular Crystallography
October 13-26
INSTRUCTORS Furey, W., Ph.D., Veteran's Administration Medical Center, Pittsburgh, Pennsylvania
Gilliland, G., Ph.D., National Institute of Standards and Technologies, Rockville, Maryland
McPherson, A., Ph.D., University of California, Irvine
Pflugrath, J., Ph.D., Molecular Structure Corporation, The Woodlands, Texas
ASSISTANT Chu, S., National Institute of Standards and Technology, Rockville, Maryland
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensive laboratory-computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function but who were new to macromolecular crystallog-
raphy. Topics covered included crystallization (proteins, nucleic acids, and complexes), crystal charac-
terization, X-ray sources and optics, crystal freezing, synchrotron data collection, data reduction, mul-
tiple isomorphous replacement, multiwavelength anomalous diffraction phase determination, solvent
flattening, molecular replacement, electron density interpretation, structure refinement, molecular
graphics, noncrystallographic symmetry averaging, simulated annealing, and coordinate desposition.
Participants learned through extensive hands-on experiments. They crystallized and determined a pro-
tein structure, heard lectures on the theory, and had informal discussions about what is behind the
techniques.
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PARTICIPANTS
Caffrey, M., B.S., Ph.D., Ohio State University, Columbus
Domaille, P., B.S., Ph.D., DuPont Pharmaceuticals Company,
Wilmington, Delaware
Dottorini, T., B.S., Institute of Research and Molecular
Biology, Pomezia, Italy
Harvey, S., B.S., Ph.D., University of Alabama, Birmingham
Manning, N., B.S., M.S., Brookhaven National Laboratory,
Upton, New York
Mapelli, M., B.S., Ph.D., European Molecular Biology
Laboratory, Heidelberg, Germany
Mark, B., B.S., University of Alberta, Edmonton, Canada
Mesecar, A., B.S., Ph.D., University of Illinois, Chicago
SEMINARS
Adam, P., Yale University/Howard Hughes Medical Institute,
New Haven, Connecticut. Simulated annealing refine-
ment.
Gilliland, G., National Institute of Standards and Technology,
Rockville, Maryland. Deposition and querying the protein
data bank.
Hung, L.-W., Lawrence Berkeley National Laboratory,
Berkeley, California. Practical aspects of MAD methods.
Joshua-Tor, L., Cold Spring Harbor Laboratory. Bleomycin
hydrolase: Intriguing structure, enigmatic activities, and links
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Rife, C., BA., Vanderbilt University, Nashville, Tennessee
Rosen, M., B.S., Ph.D., Cornell Medical College, New York
Sorensen, T., M.S., University of Aarhus, Denmark
Spicer, E., B.S., Ph.D., Medical University of South Carolina,
Charleston
Stevens, A., B.S., M.S., Monsanto Company, St. Louis,
Missouri
Tang, W.-J., B.S., Ph.D., University of Chicago, Illinois
Tsai, S.-C., B.S., Ph.D., University of California, San
Francisco
Zarembinski, T., B.A., Ph.D., Argonne National Laboratory,
Illinois
to diseases.
Richardson, David and Jane, Duke University, Durham, North
Carolina. The importance of packing hydrogens when mak-
ing a rotamer library.
Vaughn, D., Cold Spring Harbor Laboratory. In the Apaf-1
CARD game, two pair is more than good enough.
Weeks, C., Hauptman-Woodward Medical Research Institute,
Inc. Buffalo, New York. Finding seleniums with SnB.
Xu, R., Cold Spring Harbor Laboratory. A novel structure of
human mitochondrial protein p32.
Positional Cloning: Contig to Candidate Gene
October 13-26
INSTRUCTORS Jacob, H., Ph.D., Medical College of Wisconsin, Milwaukee
Silverman, G., M.D., Ph.D., Harvard Medical School, Boston, Massachusetts
Spencer, F., Ph.D., Johns Hopkins University, Baltimore, Maryland
CO-INSTRUCTORS Baxevanis, A., National Human Genome Research Institute, Bethesda, Maryland
Parimoo, S., Johnson & Johnson, Skillman, New Jersey
ASSISTANTS Kwitek-Black, A., Medical College of Wisconsin, Milwaukee
Mills, D., Brown University, Providence, Rhode Island
This laboratory-based course was designed for investigators to use genetic and physical mapping
tools or functional assays to isolate genes of interest, with emphasis on procedures for isolating and
evaluating a candidate gene after it has been localized genetically. Principal procedures included phys-
ical mapping by contig construction using YACs and BACs/PACs, STS-content mapping, DNA finger-
printing, pulsed-field gel electrophoresis, and end-sequence rescue. Additional procedures illustrating
the use of yeast as a host organism for YAC analysis and manipulation were covered, including YAC
transfer between yeast strains to facilitate isolation of pure clone DNA, the generation of high-density
physical maps using a YAC fragmentation strategy, and the introduction of mammalian selectable
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markers or specific mutations into YACs. Techniques for preparing large-insert DNA for transfer into
embryonic stem cells or other cell lines via lipofection, spheroplast fusion, or pronuclear injection were
included. Gene identification from large cloned DNA segments was accomplished by laboratory exer-
cises in cDNA selection and/or exon trapping. Candidate gene evaluation through computer-based
sessions designed to access data and applications available on the World Wide Web was emphasized,
including map, similarity, and expression profile information. Studies in mutational analysis for identify-
ing the gene of interest were discussed in depth. The laboratory-based component of the course was
supplemented by lectures by prominent investigators who use many of the procedures taught in the
course. All participants gave presentations about their own research topics, which were used as the
basis for structured discussions of how to apply current technologies to specific research projects.
PARTICIPANTS
Amaral, E., B.S., Ph.D., Universdade Estadual Pau lista, Sao
Jose Rio Preto, Brazil
Arieff, Z., B.S., M.S., University of Western Cape, Bellville,
South Africa
Beebe, A., B.A., Ph.D., DNAX Research Institute, Palo Alto,
California
Gallego Sanchez, G., B.S., International Center for Tropical
Agriculture, Palmira, Colombia
Ikea, J., B.S., M.S., Ph.D., International Institute for Tropical
Agriculture, lbadan, Nigeria
Krusell, L., MS., University of Aarhus, Denmark
Nunes, I., B.S. 0.D., Ph.D., Columbia University, New
York
Phaneuf, D., B.S., Ph.D., Laval University, Ste-Foy, Quebec,
Canada
SEMINARS
Birren, B., Whitehead Institute/Massachusetts Institute of
Technology, Cambridge, Massachusetts. From genome
to clones and BAC again.
Eddy, R., Lawrence Berkeley and Women's Hospital, Boston,
Massachusetts. Sifting sequence for function: Exploiting the
mouse.
deJong, P, Children's Hospital of Oakland Research Institute,
Oakland, California. Construction of YAC/BAC shuttle
libraries by recombination.
Green, E., National Institutes of Health, Bethesda, Maryland.
Mapping and sequencing mammalian chromosomes: How
and why.
Hengartner, M., Cold Spring Harbor Laboratory. Positional
cloning in C. elegans.
Kwiatkowski, D., Brigham and Women's Hospital, Boston,
Massachusetts. Methods for mutation/SNP detection: HD
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Pogue-Geille, BA., Ph.D., University of Pittsburgh,
Pennsylvania
Raman, C.S., B.S., Ph.D., University of California, Irvine
Rattink, A., M.S., Wageningen Agricultural University, The
Netherlands
Rithidech, K., B.S., Ph.D., State University of New York,
Stony Brook
Roden, L., B.S., Ph.D., University of Warwick, Coventry,
United Kingdom
Ron, M., B.S., Ph.D., Volcani Research Center, Bet-Dagan,
Israel
Sobrido, M., B.S., M.D., Ph.D., University of California, Los
Angeles
Velickovic, M., B.S., Wellington School of Medicine,
Wellington, New Zealand
gels, SSCP, DGGE, DHPLC.
Meltzer, R, National Institutes of Health, Bethesda, Maryland.
Gene expression profiling with cDNA microarrays.
Parimoo, S., Johnson & Johnson CPVVVV, Skillman, New
Jersey. Identification of gene defect in asebia mouse.
Reeves, R., Johns Hopkins University School of Medicine,
Baltimore, Maryland. The face of Down syndrome: Meeting
complex genetic traits head-on.
Roe, B., University of Oklahoma, Norman. The Human
Genome Project: So many bases, so little time-A view
from the trenches.
Schuler, G., National Institutes of Health, Bethesda, Maryland.
EST mapping.
Trask, B., University of Washington School of Medicine,
Seattle. Fluorescence in situ hybridization (FISH) and
genome analysis.
Making and Using DNA Microarrays
October 20-November 2
INSTRUCTORS Brown, P., Ph.D., Stanford University, California
Eisen, M., Ph.D., Stanford University, California
DeRisi, J., Ph.D., University of California, San Francisco
ASSISTANTS Alizadeh, A., Stanford University, California
Diehn, M., Stanford University, California
Spellman, P., Stanford University, California
A DNA microarray is a simple, inexpensive, and versatile tool for experimental explorations of genome
structure, gene expression programs, gene function, and cell and organismal biology. In this hands-on
course, students were guided through the processes of building a robot for printing DNA microarrays,
preparing DNA samples and slides to be used for printing microarrays, printing DNA microarrays,
designing and conducting experiments for analysis by DNA microarray hybridization, and analyzing,
displaying, and interpreting data. Experimental applications covered in the course included systemat-
ic studies of global gene expression programs, inferring gene function by using microarrays, genotyp-
ing, and measuring changes in gene copy number. Students who completed this course were able to
set up their own independent facility for printing and experimental use of DNA microarrays. Guest
instructors presented state-of-the-art technology, experimental applications, and interpretation of large
genomic data sets.
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PARTICIPANTS
Bah ler, J., B.S., Ph.D., Imperial Cancer Research Fund,
London, United Kingdom
Chinnaiyan, A., B.S., M.D., Ph.D., University of Michigan, Ann
Arbor
Collingwood, D., B.S., Ph.D., University of Washington,
Seattle
Futcher, B., B.S., Ph.D., Cold Spring Harbor Laboratory
Hager, J., B.S., Ph.D., Yale University, New Haven,
Connecticut
Hinton, J., B.S., Ph.D., University of Oxford, United Kingdom
Kaltschmidt, C., B.S., Ph.D., University of Frieburg, Germany
Kocarek, T., B.S., Ph.D., Wayne State University, Detroit,
Michigan
SEMINARS
Pollack, J., Stanford Medical Center, Stanford, California.
CGH using cDNA microarrays.
Botstein, D., Stanford University School of Medicine,
California. Designing experiments using micro-
arrays.
Blalock, B., Affymetrix Technology, Santa Clara, California.
Gene expression and SNP analysis utilizing Affymetrix
Gene Chip technology.
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Lagerstrom-Fermer, M., B.S., Ph.D., University of Uppsala,
Sweden
Lorenz, M., B.A., B.S., M.S., Ph.D., National Cancer Institute,
NIH, Gaithersburg, Maryland
Love, D., B.S., Ph.D., University of Auckland, New Zealand
Marron, M., B.S., B.A., Ph.D., University of Florida, Gainsville
Mittal, V., B.S., Ph.D., Cold Spring Harbor Laboratory
Notterman, D., A.B., M.D., Princeton University, Princeton,
New Jersey
Ryan, M., B.S., Ph.D., New York State Department of Health,
Albany
Veeraraghavan, S., B.S., Ph.D., Scripps Research Institute,
La Jolla, California
Miller, L., National Cancer Institute, NIH, Gaithersburg,
Maryland. Experiences with using microarrays and micro-
arrayers.
Kallioniemi, 0.-P., National Human Genome Research
Institute/NIH, Bethesda, Maryland. cDNA and tissue
microarrays.
Young, R., Massachusetts Institute of Technology,
Cambridge. The new genetics of gene expression.
Caenorhabditis elegans
November 2-15
INSTRUCTORS Hengartner, M., Ph.D., Cold Spring Harbor Laboratory
Jorgensen, E., Ph.D., University of Utah, Salt Lake City
Plasterk, R., Ph.D., Netherlands Cancer Institute, Amsterdam
ASSISTANTS Harris, T., University of Utah, Salt Lake City
Korswagen, H.C., University Hospital Utrecht, The Netherlands
Tharin, S., B.S., M.S., Cold Spring Harbor Laboratory
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome pro-
ject. The course was suited for those who had current training in molecular biology and some knowl-
edge of genetics but had no experience with C. elegans, as well as students with some prior worm
experience who wished to expand their repertoire of expertise. The following topics were covered both
in the laboratory and by lectures from experts in the field: worm pushing, C. elegans databases and
worm bioinformatics, anatomy and development, forward genetics, chemical and transposon mutage-
nesis, generation of transgenic animals, expression pattern analysis, reverse genetics, construction
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and screening of deletion libraries, and RNA inactivation. The course was designed so that students
would know enough about the most important attributes of the C. eleganssystem to embark on their
own research projects after returning to their home institutions.
PARTICIPANTS
Bobinnec, Y., B.S., Ph.D., Kyoto University, Japan
Dreier, L., B.S., Ph.D., Harvard University, Boston,
Massachusetts
Fuellekrug, J., B.S., Ph.D., European Molecular Biology
Laboratory, Heidelberg, Germany
Gomez, M., B.S., Ph.D., Hoffman-LaRoche, Basel,
Switzerland
Grill, S., B.S., European Molecular Biology Laboratory,
Heidelberg, Germany
Haycraft, C., B.S., M.S., University of Alabama, Birmingham
Manoil, C., A.B., Ph.D., University of Washington, Seattle
More ly, J., B.S., Northwestern University, Evanston, Illinois
SEMINARS
Anderson, P., University of Wisconsin, Madison. mRNA sur-
veillance worm biochemistry.
Bargmann, C., University of California, San Francisco.
Nervous system function-Use of GFP for reporters.
Hengartner, M., Cold Spring Harbor Laboratory. Programmed
cell death suppression genetics.
Johnson, C., Axys Pharmaceuticals, South San Francisco,
California. C. elegans as a model system for the human.
Jorgensen, E., University of Utah, Salt Lake City. Synaptic
transmission-Nomenclature, forward genetics.
Kimble, J., University of Wisconsin, Madison. Germ line
development.
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Payvar, F., M.S., Vanderbilt University, Nashville, Tennessee
Petersen, C., B.S., Ph.D., Vanderbilt University, Nashville,
Tennessee
Rocha, J., B.S., Babraham Institute, Cambridge, United Kingdom
Samuel, A., B.A., Ph.D., Harvard University, Cambridge,
Massachusetts
Sonnichsen, B., B.S., Ph.D., European Molecular Biology
Laboratory, Heidelberg, Germany
Steele, R., B.S., Ph.D., University of California, Irvine
Sun, Y., M.D., Ph.D., Parke-Davis Pharmaceutical Research,
Ann Arbor, Michigan
Wong, G., B.S., Ph.D., University of Kuopio, Finland
Mello, C., University of Massachusetts Medical Center,
Worcester. Early embryonic development RNA inhibi-
tion.
Montgomery, M., Macalester College, St. Paul, Minnesota.
Gene expression-Reporter gene constructs, ectopic
expression.
Plasterk, R., Netherlands Cancer Center, Amsterdam.
Reverse genetics, genome analysis.
Stein, L., Cold Spring Harbor Laboratory. The C. elegans
genome.
White, J., University of Wisconsin, Madison. Worm cell biolo-
gy microscopy.
Phage Display of Combinatorial Antibody Libraries
November 2-15
INSTRUCTORS Barbas, C., Ph.D., Scripps Research Institute, La Jolla, California
Siegel, D., M.D., Ph.D., University of Pennsylvania, Philadelphia
Silverman, G., M.D., University of California, La Jolla
ASSISTANTS Fuller, R., Scripps Research Institute, La Jolla, California
Goodyear, C., Glasgow Caledonian University, United Kingdom
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory-lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and on the selection of desired antibodies from the library. Students learned theoretical and
practical aspects of constructing combinatorial libraries from immune and nonimmune sources as well
as the construction of synthetic antibody libraries. Antibodies were selected from the library by pan-
ning. Production, purification, and characterization of Fab fragments expressed in E. coil were also cov-
ered. The lecture series was presented by a number of invited speakers and emphasized PCR of
immunoglobulin genes, the biology of filamentous phage and the utility of surface expression libraries,
expression of antibodies in E. coli and mammalian cells, antibody structure and function, catalytic anti-
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bodies, directed protein evolution, the immunobiology of antibody activity, and recent results on the use
of antibodies in therapy. The theory behind and practical implications of selecting from phage displayed
libraries of random peptides, cDNA products, and semisynthetic proteins were also explored.
PARTICIPANTS
Anderson, M., M.A., Ph.D., University of Alabama, Birming-
ham
Bull, P., B.S., Ph.D., University of Oxford, United King-
dom
Deno lf, P., B.S., Ph.D., Plant Genetic Systems (AgrEvo),
Gent, Belgium
Fernandez, P-A., B.S., M.D., Ph.D., University College
London, United Kingdom
Concalves, J., B.S., Ph.D., University of Lisbon, Portugal
Gould, M., B.A., Ph.D., Universidad Autonoma de Baja
California, Ensenada, Mexico
Graslund, S., M.S., Royal Institute of Technology, Stockholm,
Sweden
Gross, G., B.A., M.S., Ph.D., MIGAL-Galilee Technology
Center, Rosh-Pina, Israel
SEMINARS
Barbas, C., The Scripps Research Institute, La Jolla,
California. Phage display of antibodies and zinc finger pro-
teins.
Lowman, H., Genentech, Inc., South San Francisco,
California. SAR of peptides using phage.
Pasqualini, R., La Jolla Cancer Research Institute, California.
In vivo panning.
Sanz, I., University of Rochester Medical Center, New York.
Generation and features of antibody diversity.
Scott, J., Simon Fraser University, Burnaby, British Columbia,
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Olee, T, B.S., Ph.D., Scripps Research Institute, La Jolla,
California
Schober, M., B.S., Wayne State University, Detroit, Michigan
Stephano, J., B.S., M.S., Ph.D., Universidad Autonoma de
Baja California, Ensenada, Mexico
Thisted, T., B.S., Ph.D., University of Pennsylvania,
Philadelphia
Von Buedingen, H.C., M.D., University of California, San
Francisco
Weiss, K., B.A., Elan Pharmaceuticals, South San Francisco,
California
Werner, D., M.S., University of Potsdam, Luckenwalde,
Germany
Yu, J., B.S., Ph.D., Korean Institute of Science and
Technology, Seoul
Canada. Phage display of peptides.
Siegel, D.L., University of Pennsylvania Medical Center,
Philadelphia. Cell surface selection of combinatorial Fab
libraries.
Silverman, G.J., University of California, San Diego, La Jolla.
Repertoire cloning of SLE autoantibodies.
Webster, R., Duke University Durham, North Carolina. The
biology of filamentous phage.
Wilson, I., The Scripps Research Institute, La Jolla, California.
Structural biology of the immune system.
Computational Genomics
November 4-9
INSTRUCTORS Pearson, W., Ph.D., University of Virginia, Charlottesville
Smith, R., Ph.D., SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania
Beyond BLAST and FASTA-This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches to extracting the maximum amount of information from protein and
DNA sequence similarity through sequence-database searches, statistical analysis, and multiple-
sequence alignment. Additional topics included gene recognition (exon/intron prediction), identifying
signals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. This year, the course made extensive
use of local World Wide Web pages to present problem sets and computing tools to solve those sets.
Students used Windows and Mac workstations attached to a UNIX server; participants were comfort-
able using the UNIX operating system, the GCG sequence-analysis package, and a UNIX text editor.
The course was designed for biologists seeking advanced training in biological sequence analysis,
computer core directors and staff for molecular biology or genetics resources, and scientists in other
disciplines, such as computer science, who wished to survey current research problems in biological
sequence analysis.
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PARTICIPANTS
Andrews, B., B.S., Astra Research Center Boston, Cam-
bridge, Massachusetts
Crawford, M., B.A., Ph.D., Proteome, Inc., Beverly, Massa-
chusetts
Cutler, G., B.A., Ph.D., Tularik, Inc., South San Francisco,
California
Dauner, M., B.S., Swiss Federal Institute of Technology,
Zurich, Switzerland
Edwards, S., B.S., Ph.D., National Library of Medicine, NIH,
Bethesda, Maryland
Elsik, C., B.S., M.S., Texas A&M University, College Station
Fassler, J., B.S., Ph.D., University of Iowa, Iowa City
Fischer Lindahl, K., M.S., Ph.D., University of Texas
Southwestern Medical Center, Dallas
Gosink, M., Parke Davis Pharmaceuticals, Ann Arbor, Michigan
Grigor, M., B.S., Ph.D., AgResearch, Hamilton, New Zealand
Hong-geller, E., B.A., Ph.D., Cornell University, Ithaca, New York
Howard, K., B.A., Ph.D., MRC Laboratory, London, United
SEMINARS
Atschul, S., National Library of Medicine, Bethesda,
Maryland. Statistics of patterns and profiles.
Eddy, S., Washington University School of Medicine, St.
Louis, Missouri. Blocks, motifs, domains, and other protein
databases. Multiple sequence comparison with hidden
Markov models.
Lawrence, C., Wadsworth Center, Albany, New York.
Bayesian approaches to sequence alignment/motif identifi-
cation.
Overton, C.G., University of Pennsylvania, Philadelphia.
Genome databases.
The Laboratory would like to acknowledge the generosity
reagents to the various courses:
5 Prime-3 Prime
ALA Scientific Instruments, Inc.
Ambion
Amersham Life Science Incorpor-
ated
Amersham Pharmacia Biotech,
Inc.
A.M.P.I.
Applied Precision
Applied Scientific Instrumentation,
Inc.
Applied Spectral Imaging
Axon Instruments
Becton Dickinson Labware
Bio-Red Laboratories
Boehringer Mannheim Corp.
Brinkmann Instruments
Burleigh Instruments, Inc.
Calbiochem-Novabiochem
Carl Zeiss
CBS Scientific
Chrome Technology Corpo-
ration
Clontech Laboratories, Inc.
Codonics Inc.
Coherent Laser
Corning Costar Corporation
Corning Inc.
Cygnus Technology, Inc.
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Dagan Corporation
Delaware Diamond Knoves
Diagnostic Instruments, Inc.
Diruscio & Associates
Drummond Scientific Company
DuPont NEN
Dynal
Dynes
E. Licht
Eastman Kodak Company
Empire Imaging Systems
Epicentre Technologies
Eppendorf Scientific
Fisher Scientific
FMC Corporation
Fostec Inc.
Fotodyne
General Valve
Genetic Microsystems, Inc.
GIBCO/Ufe Technologies
Hamamatsu Photonic Systems
Hampton Research
Havard Apparatus Inc.
Hewlett Packard
Hitatchi Denski America LTD.
ICN Biomedicals
Improvision-Image Processing and
Vision Co. LTD.
Instrutech
Kingdom
Jang, W., B.S., Ph.D., National Institutes of Health, Rockville,
Maryland
Kelly, M., B.S., M.S., SmithKline Beecham Pharmaceuticals,
King of Prussia, Pennsylvania
Lyster, P., B.S, Ph.D., University of Maryland, College Park
McCutcheon, J., B.S., University of Utah, Salt Lake City
Mount, S., B.A., Ph.D., University of Maryland, College Park
Peng, H.-M., B.S., Ph.D., Texas A&M University, College
Station
Prades, C., DEA, Ph.D., Rhone Poulenc Rorer, Evry, France
Roof, D., BA., Ph.D., University of Pennsylvania, Phildelphia
Rubin, G., B.S., Ph.D, University of California, Berkeley
Se linger, D., B.S., Ph.D., University of Arizona, Tucson
Semple, C., B.S., Ph.D., MRC Laboratory, London, United
Kingdom
Vanavichit, A., B.S, Ph.D., Kasetsart University, Nakom
Pathom, Thailand
Pearson, W., University of Virginia, Charlotteville. Protein evo-
lution-Biology. Algorithms for pairwise sequence compari-
son.
Smith, R., SmithKline Beecham, King of Prussia,
Pennsylvania. Introduction to multiple sequence compari-
son.
Stormo, G., Washington University Medical School, St. Louis,
Missouri. Identifying sites in unaligned sequences.
Eukaryotic gene finding.
Zhang, M., Cold Spring Harbor Laboratory. Competing on
yeast promoters.
of the following companies who loaned equipment and
Invitrogen Corporation
Jackson lmmunoresearch Labs
Jouan, Inc.
Kopf Instruments
Leica, Inc.
McMaster Carr
Micro Video Instruments
Millipore
MJ Research, Inc.
Modulation Optics, Inc.
Molecular Devices Corporation
Molecular Dynamics
Molecular Probes
Nalge Nunc International
Narishige International USA, Inc.
NEN Life Science Products
Newark Electronics
New England Biolabs
Newport Corporation
Nikon
Novagen
Novex
Olympus America, Inc.
Operon Technologies Inc.
Optronics Engineering
Pel-Freez Biologicals
Perkin-Elmer Applied Biosystems
PerSeptive Biosystems
Pfanstiehl Laboratories, Inc.
Pharmacia Biotech
Polysciences
Promega Corporation
Qiagen Inc.
Robbins Scientific Corporation
SD Instruments
Savant Instruments
Scanalytics Inc.
Schleicher & Schuell
Sigma-Aldrich
Sony Medical Systems
Specialty Media
Spectra-Physics Lasers, Inc.
Stratagene
Sutter Instruments
Tamargo Associates
Techne, Inc.
Technical Manufacturing Corp.
Technical Products International
USB Corporation
Universal Imaging Corporation
Upstate Biotechnology Inc.
Vector Laboratories
VWR Scientific Products
Vysis Inc.
Wal lac, Inc.
Warner Instrument, Corp.
Western Technology Marketing,
Inc.
SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
latest findings on a weekly basis. These seminars keep the CSHL staff current on the latest develop-
ments and broaden their perspectives. Graduate students and postdoctoral fellows meet with the
seminar speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of
ideas in an informal setting.
January
Dr. Joseph Fetcho, Department of Neurobiology and
Behavior, SUNY, Stony Brook. Imaging, ablations, and
behavior: Optical studies of neuronal circuits in zebrafish.
(Host: Hollis Cline)
Dr. Charles Sherr, HHMNI/St. Jude Children's Research
Hospital. The ARF-p53 pathway. (Host: Scott Lowe)
Dr. Dafna Bar-Sagi, Department of Molecular Genetics and
Microbiology, SUNY, Stony Brook. Ras signaling and
growth control. (Host: Winship Herr)
Dr. Stuart Kim, Stanford University. MAP kinase signaling in
C. elegans. (Host: Tern Grodzicker)
February
Dr. Pat Brown, HHMI/Stanford University, Department of
Biochemistry. Watching a genome in action. (Host: Michael
Zhang)
Dr. James Manley, Columbia University. A genetic approach
to gene expression in vertebrate cells. (Host: Terri
Grodzicker)
Dr. Eric Davison, California Institute of Technology. Gene reg-
ulatory circuity in the embryogenesis of sea urchin. (Host:
Andy Neuwald)
Dr. Charles Craik, University of California, San Francisco.
Reverse biochemistry: Using macromolecular protease
inhibitors to dissect complex biological processes. (Host:
Leemor Joshua-Tor)
March
Dr. Julian Downward, Imperial Cancer Research Fund.
Mechanisms by which Ras oncogenes control cell prolifera-
tion and survival. (Host: Linda Van Aelst)
Dr. Sue McConnell, Stanford University. The determination of
axonal connectivity in the developing brain. (Host: Hollis Cline)
Dr. Ron Desrosiers, Harvard Medical School. Mutations that
allow immunologic control of simian immunodeficiency
virus. (Host: Jacek Skowronski)
Dr. Pamela Bjorkman, HHMI/California Institute of Technology.
MHC homologs in immune recognition. (Host: Leemor
Joshua-Tor)
Dr. George Tokiwa, Orchid Biocomputer, Inc. From CSHL to
life in a start-up biotech company ... A personal experience.
Career pathways for the biology Ph.D. seminar.
April
Dr. Thomas Stossel, American Cancer Society Professor of
Medicine. Machinery of cell crawling. (Host: Linda Van
Aelst)
Dr. David Tank, Bell Laboratories, Lucent Technologies.
Cellular and circuit mechanisms of persistent neural activity.
(Host: Karel Svoboda)
October
Dr. Jeffrey Rothstein, Johns Hopkins University. Glutamate
transporters: Regulation and dysregulation-associated neu-
rodegeneration. (Host: Adrian Krainer)
Dr. Susan McConnell, Stanford University, Department of
Biological Science. The Determination of neuronal connec-
tivity in the developing brain. (Host: Holly Cline)
Dr. Rolf Sternglanz, SUNY, Stony Brook. Studies on transcrip-
tional silencing in yeast. (Host: Adrian Krainer)
November
Dr. Richard Flavell, Yale University School of Medicine. The
role of caspases in cell death in vivo. (Host: Yuri
Lazebnik)
Dr. Luc Montagnier, Queens College. Apoptosis and AIDS.
(Host: Michael Hengartnen
Dr. Richard A. Young, Whitehead Institute for Biomedical
Research. Genome-wide expression analysis: Mindless data
collection? (Host: Michael Zhang)
December
Dr. Todd Sacktor, Associate Professor of Physiology,
Pharmacology, and Neurology, SUNY Downstate. Protein
kinase 14 and the maintenance of late-LTP. (Host: Jerry
Yin)
Dr. Mark Ginsberg, The Scripps Research Institute. Integrins:
The inside story. (Host: Linda Van Aelst)
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In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. They are particularly useful for research
personnel who have recently joined the Laboratory. The seminars also afford a necessary opportunity
for the graduate students and postgraduate staff to develop their skills in organizing, presenting, and
defending their research.
January
Bruce Futcher: The cell-cycle-regulated genes of yeast, in
shades of green and red.
Ilya loshikhes (Zhang Lab); Periodical distribution of transcrip-
tion factor sites in promoter regions and connection with
chromatin structure.
Keiichi Shibahara (Stillman Lab): Mechanisms of replication-
coupled chromatin assembly by CAF-1.
Hong-Xiang Liu (Krainer Lab): Finding exons in a sea of
introns: The nature and function of exonic splicing
enhancers.
February
Ueli Grossniklaus: Sex, parental conflicts, and infanticide
(developmental genetics of plant reproduction).
Athena Lin (Lowe Lab): Premature senescence induced by
oncogenic ras.
Lincoln Stein: Browsing the C. elegans genome.
Robert Lucito (Wigler Lab): Genetic analysis using genomic
representations.
March
Rob Babb (Herr Lab): Mechanisms of combinatorial transcrip-
tional regulation: It takes two for three) to tango.
Grace Chen (Stenlund Lab): Unraveling the mechanics of
origin recognition by the papillomavirus El DNA heli-
case.
Daan Van Aalten (Joshua-Tor Lab): Bent, flipped, and straight:
A dancing dynamic DNA duplex duo.
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April
Paul Mintz (Spector Lab): Everything you ever wanted to
know about nuclear speckles.
Christine Berthier (Helfman Lab). Choreographing actin
cytoskeleton dynamics in nonmuscle cells.
David Jackson: Two ways of talking: Channels and receptors
for cell-to-cell communication in plants.
October
Josh Dubnau (Tully Lab): Functional genomics of memory for-
mation.
Shiv Grewal: Genetics of epigenetics: Where Mendel's gene
is more than a DNA moeity.
Herman Wijnen (Futcher Lab): Transcriptional control at the
start of the cell cycle.
November
Catherine Kidner (Martienssen Lab): The role of ARGONAUTE
in leaf development"
December
Joe Rodriguez (Lazebnik Lab): APAF1 and caspase-9 form an
active holoenzyme.
Suzanne Tharin (Hengartner Lab): HUNCS, DrUNCS, and
axon guidance in C. elegans.
Benjamin Boettner (Van Aelst Lab): AF-6, A component of cell-
cell adhesion complexes: An investigation in man and flies.
UNDERGRADUATE RESEARCH
Co-Program Directors: Michael Hengartner, Ph.D./Leemor Joshua-Tor, Ph.D.
Program Administrator: Jane Reader
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time laboratory staff mem-
bers. The program was initiated in 1959. Since that year, 534 students have participated in the course,
and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, and molecular and cellular biology;
and (4) a personal acquaintance with research, research workers, and centers for study. The following
students, selected from 520 applicants, took part in the program:
Kelly Brown, Harding University
Sponsor: National Science Foundation
Advisor: Dr. Bruce Stillman
Human CDC6: An essential gene for DNA replication.
Kevin Christie, College of William and Mary
Sponsor: National Science Foundation
Advisor: Dr. Andrew Neuwald
A computational system for comprehensive sequence analys
for protein domains.
Heather Cosel-Pieper, New York University
Sponsor: Jephson Educational Trust
Advisor: Dr. Michael Hengartner
Toward an understanding of apoptosis in C. elegans.
Adriano Costa de Alcantara, Universidad Federal da Bahia
Sponsor: Frederica Von Stade
Advisor: Dr. Michael Zhang
s First steps in building up a C. elegans promoter database.
Top Row: Fazila Pinar Erciyas; Keith Wu; Catherine Merrick; Marco Mangone, Francois St-Pierre; Heather Cosel-Pieper; Daniellla
Dumitriu; Rebecca Ewald; Satoshi Kawashima; Andrew Cotton; Kevin Christie; Trevor Yeung; Ben Lehner; Maithreyi Krishnaswami;
Michael Verzi; Kelly Brown; Benjamin de Bivort
Bottom Row: Adriano Costa de Alcantara; Fernando Ontiveros-Llamas; Justin Cross; Jamil Scott; Silja Kuusk; Megan Sullivan;
Natashe Thorne; Sashay Franklyn; Bryce Portier
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Andrew Cotton, Harvard University
Sponsor: James D. Watson Fund
Advisor: Dr. Richard McCombie
An ASN.1 to XML converter.
Justin Cross, University of Cambridge
Sponsor: The Olney Fund
Advisor: Dr. Linda Van Aelst
The role of Rap and AF-6/canoe in the control of cell morphol-
ogy and adhesion.
Benjamin de Bivort, Duke University
Sponsor: Jephson Educational Trust
Advisor: Dr. Yi Zhong
Proteins in learning and memory: Morphology of the
Drosophila neuromuscular junction.
Daniel la Dumitriu, University of California, Santa Barbara
Sponsor: Burroughs Wellcome
Advisor: Dr. Hollis Cline
Behavioral assessment of visual acuity development in
Xenopus tadpoles.
Fazila Pinar Erciyas, Bogazici University
Sponsor: Emanuel Ax Fund
Advisor: Dr. Rui-Ming Xu
Purification and crystallization of S. cerevisiae ORC1-BAH
domain.
Rebecca Ewald, King's College London
Sponsor: Burroughs Wellcome
Advisor: Dr. Scott Lowe
Comparison of gene expression profiles of p53-mediated
growth arrest and p53-mediated senescence.
Sashay Franklyn, Harvard University
Sponsor: National Science Foundation
Advisor: Dr. Shiv Grewal
Characterization of C1r6 histone deacetylase.
Satoshi Kawashima, University of Kobe School of Medicine
Sponsor: Shakespeare Fund
Advisor: Dr. Yuri Lazebnik
Epitope mapping by protein fragmentation.
Maithreyi Krishnaswami, Hobart and William Smith Colleges
Sponsor: The Bliss Memorial Fund
Advisor: Dr. David Jackson
Regulation of shoot morphogenesis in plants: Studying an
altered phyllotaxy in maize.
Si lja Kuusk, Tartu University
Sponsor: Burroughs Wellcome
Advisor: Dr. Adrian R. Krainer
In vitro selection for exonic splicing silencers.
Ben Lehner, University of Cambridge
Sponsor: Burroughs Wellcome
Advisor: Dr. Rob Martienssen
Molecular characterization of the gene Argonaute in A. thaliana
and S. pombe.
290
Marco Mangone, University of Rome
Sponsor: The Read Fund
Advisor: Dr. Lincoln Stein
In silico mapping of human single nucleotide polymorphisms.
Catherine Merrick, Cambridge University
Sponsor: Burroughs Wellcome
Advisor: Dr. Marja Timmermans
Analysis of the leafbladelessl mutant of maize.
Fernando Ontiveros-Llamas, National Autonomous
University of Mexico.
Sponsors: Glass Fund/Libby Fund
Advisor: Dr. David L. Spector
Ultrastructural visualization of a genetic locus and the pathway
followed by its RNA.
Bryce P. Fortier, Texas A&M University
Sponsor: National Science Foundation
Advisor: Dr. Bruce Futcher
Exploring the active site of a cyclin-dependent kinase.
Jamil B. Scott, Tennessee State University
Sponsor: National Science Foundation
Advisor: Dr. William Tansey
Characterization of the transcriptional repressor region in Myc.
Francois St-Pierre, University of Cambridge (Trinity College)
Sponsor: Burroughs Wellcome
Advisor: Dr. Leemor Joshua-Tor
Investigating the active site of human bleomycin hydrolase.
Megan R. Sullivan, Indiana University
Sponsor: National Science Foundation
Advisor: Dr. Tim Tully
Testing two approaches of concurrent spatial and temporal
control of gene expression in Drosophila.
Natasha Thorne, University of Massachusetts
Sponsor: National Science Foundation
Advisor: Dr. Gregory Hannon
Construction of a cDNA library of secreted and cell surface pro-
teins: A strategy to identify diagnostic markers for breast cancer.
Michael Verzi, The College of New Jersey
Sponsor: National Science Foundation
Advisor: Dr. Grigori Enikolopov
Alternative splicing of the Drosophila nitric oxide synthase gene.
Keith Wu, Cambridge University
Sponsor: Garfield Fund
Advisor: Dr. Winship Herr
Role of the VP16 core and transcriptional activating regions in
HSV virion formation.
Trevor Ming-Yee Yeung, Clare College, University of
Cambridge
Sponsor: James D. Watson Fund
Advisor: Dr. David Helfman
An investigation into one postulated mechanism regulating the
distribution of tropomyosin in human SV80 fibroblasts.
NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to acquire
a greater knowledge and understanding of their environment. Through a series of specialized field
courses, younger students can engage in introductory programs, such as Nature Bugs, Nature
Detectives, and Nature Discovery. Older students can enroll in more advanced programs, such as
Marine Biology and Nature Photography.
During the summer of 1999, a total of 350 students participated in 26 courses within the program.
The classes were held outdoors, weather permitting, at the West Side School. The Laboratory has
equipped and maintains classroom and laboratory facilities as well as a darkroom at West Side School.
This facility is used as a base for the students' exploration of the local environment. Field classes are
held on Laboratory grounds, St. John's Preserve, Fire Island National Seashore, Caumsett State Park,
the Cold Spring Harbor Fish Hatchery and Aquarium, as well as other local preserves and sanctuaries.
In addition to the three 2-week sessions, the Adventure Education course meets on two Fridays for
trips. The students go on a three-masted schooner to navigate and explore the waters of Long Island
Sound and on a 12-mile canoe trip on the Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR
Amy Stiso, Cold Spring Harbor Laboratory
INSTRUCTORS
Alison Forte, B.S. in Marine Science, University of Rhode Island
Donna Pandaliano, M.S., Science Teacher, Valley Stream School District
Linda Payoski, M.S., Science Teacher, Uniondale School District
Marjorie Pizza, M.S., Science Teacher, Locust Valley School District
Brian Withers, Fine Arts Teacher, New York City School System
COURSES
Nature Bugs
Nature Detectives
Nature Discovery
Ecology Explorers
Frogs, Flippers, and Fins
Pebble Pups
Freshwater Life
Seashore Life
Flora, Fauna, and Fun with Watercolors
Marine Biology
Nature Photography
Adventure Education
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BANBURY CENTER
DIRECTOR'S REPORT
The Banbury Center program continues to be as eclectic and exciting as ever. The year was filled with
more meetings than ever before-a record 23 of them! Laboratory scientists used the Center for seven
in-house meetings, and local community groups came here on eight occasions. Together with the five
neurobiology courses, there was hardly a week when the Center was not in use.
Not surprisingly, 1999 was also a record year for the number of visitors to Banbury Center: 667 par-
ticipants attended the 23 meetings. The demographics of our participants remain much the same: 25%
of visitors to Banbury Center came from abroad, with the United Kingdom, Germany, and Canada lead-
ing the way. Of the American scientists, those from New York, Massachusetts, and California together
accounted for more than 32% of the total. However, participants were drawn from no fewer than 42
states.
This is the first year that we have been able to use the Meier House to accommodate participants,
which proved to be wonderful. Now the number of participants that we can house on the Banbury
estate matches the number we can have in the Conference Room-we do not have to transport peo-
ple between the Center and the main campus.
Biological and biomedical research is becoming ever more interdisciplinary, and as it does so, it also
becomes ever more difficult to categorize the topics of Banbury Center meetings. A meeting may deal
with the same phenomenon in a range of organisms, or many different strategies may be used to study
one phenomenon in a single species. Nevertheless, the meetings followed the general themes for
Banbury Center meetings-molecular biology, genetics, neurobiology, science policy, and education-
and, as always, the topics were important and, on occasion, controversial.
Meier House provides accommodations for meeting participants at Banbury Center.
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Human Genetic Disorders
Banbury Center has a long-standing interest in human genetics, and our meetings have helped pro-
mote research on many disorders. We have developed close relationships with a number of the foun-
dations supporting such research, and scientists from three of these came to the Center in 1999.
The first meeting on neurofibromatosis was held at Banbury in 1990, and we have followed the sig-
nificant advances in the field as researchers supported by the National Neurofibromatosis Foundation
have returned for other meetings. This year, the Foundation turned to the painful and disfiguring nerve
sheath tumors-plexiform neurofibromas-that grow along the length of nerves. They are an important
target for trials of potential therapeutic agents, but first, a reliable scheme must be developed for
assessing the size and growth rate of these tumors. A project is just beginning to do this, and the meet-
ing Natural History of Plexiform Neurofibromas in NF1 , organized by Bruce R. Korf (Children's Hospital,
Boston) and funded by the U.S. Army Medical Research, was held to advance planning. It brought
together all the principal investigators for each section of the project as well as representatives from
each center that is recruiting patients for the study. The main goal of the meeting was to work out the
final arrangements for recruitment of study subjects, to make any necessary modifications of the pro-
tocol, and to present some of the pilot data already being collected.
The Ehlers-Danlos syndrome (EDS) is a genetically heterogeneous group of disorders affecting con-
nective tissue. Although the molecular basis of some forms of EDS is known, the pathogenesis of the
disorders is largely unknown. This makes diagnosis and differentiating among the forms of EDS diffi-
cult, and it delays the search for treatments. Our meeting, The Clinical and Biological Basis of the
Ehlers-Danlos Syndrome, organized by Peter Byers (University of Washington) and Petros Tsipouras
(University of Connecticut) was funded by the Ehlers-Danlos Foundation. It addressed the diagnostic
difficulties by reviewing what is known of the natural history of the various forms of EDS and discussing
molecular mechanisms. In addition, participants presented data on the molecules that make up the
extracellular matrix and that might be candidate molecules for the differing types of EDS.
The DNA-repair disorder ataxia telangectasia has reached a stage that is both a great advance and
a great challenge. It is known now that the protein involved is a protein kinase called ATM, and the chal-
lenge is to discover precisely what this protein does and capitalize on this to develop treatments. The
Molecular Neurobiology of ATM meeting, organized by Stephen Elledge (Baylor College of Medicine),
Nathaniel Heintz (Rockefeller University), and Eugene Johnson (Washington University Medical School)
and funded by the A-T Children's Project, was designed to tackle this challenge. Participants reviewed
data on the structure of the ATM protein and the proteins with which it interacts, as well as its local-
ization and possible function in neurons. One session was devoted to discussing gene therapy and
stem cell therapy in ATM.
Strategies for Inactivation of Mutant Genes was also devoted to moving from knowledge of the fun-
damental molecular pathogenesis of a disorder to therapies. The meeting resulted from a collaboration
between the two foundations that funded it: the Amyotrophic Lateral Sclerosis Association and the
Hereditary Diseases Foundation. Organized by Robert Brown (Massachusetts General Hospital), Robert
Nussbaum (National Human Genome Research Institute), Ethan Signer (Massachusetts Institute of
Technology), and Nancy Wexler (Columbia University), the meeting was devoted to examining whether
interventions might be possible at the nucleic acid level rather than at the protein level. This far-sighted
approach involved participants using a variety of tools that modify gene expression, including antisense,
ribozymes, RNA interference, DNA excision, and peptide nucleic acids.
It has been extraordinarily difficult to determine the factors, genetic and otherwise, that contribute
to the pathogenesis of schizophrenia. The first Banbury Center meeting on the genetics of schizo-
phrenia was held in 1988, and 11 years later, Arthur Pardee (Dana-Farber Cancer Institute) and Ann
Goodman (The Nathan S. Kline Institute for Psychiatric Research) organized the meeting Molecular
Neurobiological Mechanisms in Schizophrenia-Seeking a Synthesis. It was an ambitious program
seeking to bring together studies ranging from diagnosis, through genetics and cell biology, to poten-
tial leads for therapies.
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Genomics
In 1999, there were only two meetings concerned with the technical aspects of genomics, which is
unusual for Banbury Center. Sequence data are being generated at an extraordinary rate and sequenc-
ing itself is no longer the bottleneck in genomics. Rather, making sense of all the sequences-finding
genes and understanding what they do-has become the limiting step in using the data. Finley Austin
(Merck Genome Research Institute) and Robert Strausberg (National Cancer Institute) organized the
meeting Functional Genomics: Technology Development and Research Applications to examine this
problem. Funded by the Merck Genome Research Institute and the National Cancer Institute, partici-
pants, drawn from technological as well as biological fields, assessed the current state-of-the-art strate-
gies in functional genomics both in their own and other areas. We hoped that the meeting would pro-
mote interactions among investigators who use different approaches in different research fields.
The second genomics meeting, Comparative Plant Genomics, was organized by Ben Burr
(Brookhaven National Laboratory), John Doebley (University of Minnesota), and Rob Martienssen (Cold
Spring Harbor Laboratory). "Model" plant species are being sequenced in the hope and expectation
that gene discovery and functional analysis in these species will speed the application of genomics to
economically important plants. The first complete sequence of a plant-Arabidopsis thaliana-will be
finished in late 2000, and it seemed the right time to think more carefully about the assumptions implic-
it in the "model" genome approach. This meeting reviewed critically the question of the usefulness of
plant model genomes; e.g., the extent to which syntenic relationships will be useful in identifying genes
and quantitative trait loci, and whether comparative analysis of the genes involved in common path-
ways will reveal functional relationships.
Using Biological Knowledge
The common theme to this set of otherwise disparate topics was the use of biological knowledge to
help solve biomedical problems.
The conference What Are Stem Cells? From Embryo to Adult Tissues brought together scientists
studying multipotent cells of the embryo and adult tissues, including hematopoietic, mesenchymal,
neural, pancreatic, endothelial, hepatic, and germline systems. The organizers were Dan Marshak
(Osiris Pharmaceuticals Inc.), Roland Scollay (Systemix Inc.), and Iry Weissman (Stanford University).
The meeting was funded by Osiris Pharmaceuticals and Systemix. Participants were chosen so that a
whole range of interesting questions relating to stem cell biology could be explored, including the bio-
logical definition of a stem cell, what constitutes clonality, how stem cells retain lineage commitment
and proliferative capacity, and how differentiation is initiated.
Xenotransplantation: A Scientific Basis for Risk Assessment dealt with some fascinating biology and
a topic of medical importance that is also highly controversial. There are great hopes that transplants of
organs from animals might help overcome the acute shortage of human organs for transplantation.
However, these hopes are tempered by fear that such transplants might lead to the transmission of virus-
es from animals to human beings. This workshop, organized by John Coffin (Tufts University), Mark
Hanson (Hastings Center), Frederick Murphy (University of California, Davis), and Robin Weiss (Institute
of Cancer Research), brought virologists from the academic and biotechnology worlds together with
individuals concerned about public health issues of xenotransplantation. They reviewed what is known
of the biological basis of the transmission of viruses from one species to another and of the conse-
quences of such cross-species infections. These reviews formed the basis for a discussion of the pub-
lic policy and ethical issues raised by uncertainties in understanding the risks in the application of xeno-
transplantation. The meeting was funded by the William Stamps Farish Fund and by the Hastings Center,
which is dedicated to considering the societal and ethical issues relating to modern biomedical research.
The involvement of the Hastings Center added a particularly valuable element to the meeting.
Viruses featured largely in the meeting on Microbial Targets for Small Molecules, organized by Peter
Howley (Harvard Medical School), Arnold Levine (Rockefeller University), and Gregory Verdine (Harvard
University) and funded by the Laboratory's Corporate Sponsor Program. Participants came from
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diverse backgrounds and included chemists, structural biologists, cell biologists, and microbiologists.
The meeting provided an opportunity for the participants to meet for an informal exchange of ideas and
information relevant to potential novel drug targets for bacteria, viruses, or fungi, with a specific empha-
sis on the development of new strategies for identifying novel small-molecule inhibitors.
Infectious agents of quite a different kind were the focus of the meeting Physical and Structural
Chemistry of Prion Protein and Prion-like Phenomena. Organized by Byron Caughey (NIAID, NIH) and
Kurt Wuthrich (Institut fOr Molekularbiologie and Biophysik, Zurich), participants discussed the self-
propagating protein-protein interactions that result in the accumulation of abnormal conformers and/or
polymers of a host protein. These produce pathogenic conditions such as scrapie in sheep, bovine
spongiform encephalopathy (BSE) in cows, and Creutzfeld-Jacob disease in human beings. However,
there is considerable controversy over the mechanisms by which a protein conformational change can
be imposed by an abnormal form of a protein on a normal form. The aim of the meeting was to con-
sider the latest insights into the structural basis of prion-like phenomena and other disease states that
involve the insidious spread of aberrant protein.
When thinking about infectious diseases, our tendency is to concentrate on the infectious agent,
but it is clear that the host plays an important part in determining whether an infection is established.
Host Pathogens Interactions, organized by Barry R. Bloom (Harvard University), Sally Blower (University
of California, San Francisco), and Nelson B. Freimer (University of California, San Francisco), was fund-
ed by the Corporate Sponsor Program. It tried to redress the concentration on infectious agents by
reviewing what is known about the role of host genetic variation in relation to susceptibility to infection.
The goal of the meeting was to examine interactions between host and pathogen that are influenced
by genetics from the perspective of evolutionary biology-in particular, from population genetics and
infectious-disease-modeling approaches.
Biological Studies
This group of meetings dealt with what might be called basic research, although even here the research
is not far from application.
Robertson House also provides housing accommodations at Banbury Center.
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Much research on the regulation of gene expression has concentrated on the sets of proteins-tran-
scription factors-that bind to transcription start sites. Less attention has been paid to the role played
by structural changes in the DNA molecule. The Role of DNA Topology, Conformation and Associated
Factors in Gene Expression, organized by David Levens (National Cancer Institute) and Lucia Rothman-
Denes (University of Chicago) and funded by the Corporate Sponsor Program, explored the extent to
which topological changes in a DNA molecule act directly on the transcription machinery. Participants
reported research on the physics of strained DNA, the topology of DNA molecules-single-stranded
regions, hairpins, bends, super coils-and how these changes are brought about by topoisomerases
and the transcription apparatus.
Pigmentation is a fascinating biological phenomenon and one that has been the subject of recent
advances. The meeting on the Biology of Pigmentation organized by Greg Barsh (Stanford University
School of Medicine) and Dorothy C. Bennett (St. George's Hospital Medical School, United Kingdom)
reviewed a number of longstanding questions in pigmentary cell biology, development, genetics, and
evolution in relation to these advances. Participants discussed research on model organisms and sys-
tems that may lead to a deeper understanding of human eye, hair, and skin color and of the genetic and
evolutionary forces that have contributed to the tremendous variation in human pigmentary phenotypes.
Studies of cell death in plants have been somewhat overshadowed by research on apoptosis in ani-
mal cells, especially in relation to cancer. But cell death occurs during many processes of normal plant
growth and development, and its regulation is especially important for organisms where dead cells can-
not be removed-their cell walls remain. Cell death occurs in response, for example, to pathogens as
well as through the developmental regulation of genes whose activities lead to death. Jeffrey Dangl and
Alan Jones (University of North Carolina) and Christopher J. Lamb (The University of Edinburgh) invit-
ed cell biologists, genetics, and plant pathologists to Banbury for a meeting on Cell Death in Plants:
Functions and Mechanisms. Participants discussed recent progress toward understanding why cell
death occurs in plants and whether common mechanisms lead to cell death.
Neuroscience
Neuroscience plays an increasingly large part in the research of the Laboratory, and this interest is
reflected in the increasing number of Banbury Center meetings in this area. The Functional Organization
of the Thalamus and the Cortex and Their Interactions organized by Paul R. Adams (State University of
New York, Stony Brook), Christof Koch (California Institute of Technology), Karel Svoboda (Cold Spring
Harbor Laboratory), and S. Murray Sherman (State University of New York, Stony Brook) was one such
meeting. Many new advances have occurred in this area, and this meeting, funded by The Swartz
Foundation, provided a forum for bringing together experts to discuss issues of emerging importance.
Participants included an interesting mixture of experimentalists and theoreticians whose research
spanned different levels of description (synaptic, cellular, network, and system).
One of the seemingly inescapable consequences of growing older is the loss of memory, a natural
process but one that may be deeply worrisome, especially if it is thought to be the onset of Alzheimer's
disease. Old Memories, organized by John D. Gabrieli (Stanford University), Michela Gallagher (Johns
Hopkins University), and Tim Tully (Cold Spring Harbor Laboratory), was funded by the John Hartford
Foundation to review the effects of aging on working memory, long-term memory storage, and recall. In
particular, participants examined the question of what constitutes normal versus abnormal age-related
memory loss, and how the former is distinguished from the onset of Alzheimer's disease and other dis-
orders that affect memory. Participants also reviewed whether there is any evidence that age-related
memory loss is heritable and what therapies exist or might be developed to restore memory in old age.
Science and Public Health Policy
Banbury Center has a long history of meetings that examine issues of public health policy in relation to
biomedical research. Examples include the series of early meetings on risk assessment and environ-
mental carcinogenesis. But none has the potential impact of the meeting on Vaccines for Developing
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Economies, Who Will Pay?, organized by Philip Russell (Albert B. Sabin Vaccine Institute) and Stanley
Lemon (University of Texas Medical Branch, Galveston), with Jeffrey Sachs (Center for International
Development, Harvard University) and Peter Hotez (Yale University) as co-chairs. The meeting was
funded by the Albert B. Sabin Vaccine Institute, Inc., which was established to promote the develop-
ment and use of vaccines. Participants included scientists, economists, vaccine producers, represen-
tatives of international bodies such as the World Health Organization and the World Bank, and individ-
uals from foundations. They came to Banbury to deliberate on how to provide vaccines to those most
in need of them.
The Executives' Meeting
We are extremely grateful to Sandy Warner and David Deming of J.P. Morgan, who each year make
possible a wonderful meeting. This year, we returned to genomics, the topic of the 1986 meeting, the
first in this series. Then, the usefulness of embarking on a human genome project was still being hotly
debated, in marked contrast to the 1999 meeting, Genes and Genomes: Sequences to Proteins. Now
Leroy Hood, who spoke at the first meeting in 1986, was able to review the extraordinary advances
that have led to the sequencing of the complete genomes of bacteria, yeast, and the nematode worm
Caenorhabditis elegans. Richard Gibbs described what it is like to do large-scale sequencing, and
David Botstein (who also spoke at the 1986 meeting), Gerald Rubin, John Todd, and Michael Bevan
described how genome sequences are being used. The meeting closed with a fascinating and illumi-
nating presentation by Maria Freiere on the patenting of DNA sequences.
Basic Issues of Science
For the third year, the Federal Judicial Center and Cold Spring Harbor Laboratory combined to provide
federal and state judges with some insights into the way scientific research is carried out and into the ways
that scientists think. The presentations at the meeting ranged from the history of eugenics and experi-
mental biology, through human genetics and its societal implications, to environmental hazards and risk
assessment. It was a pleasure to have Rich Roberts come back to Cold Spring Harbor Laboratory to
recount his experiences as a scientific expert witness taking part in criminal and patent cases.
Eugenics on the Web
This project, funded by the National Human Genome Research Institute, is progressing very well. On
two occasions during 1999, our Editorial Advisory Board came to Banbury Center to review what we
had done, offer suggestions, and work at improving the site by writing essays and captions. We are
well on target for completing the project on time, and the final meeting of this funding period will take
place in January of 2000.
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MEETINGS
Natural History of Plexiform Neurofibromas in NF-1
February 6-9
FUNDED BY U.S. Army Medical Research, with additional support from the National
Neurofibromatosis Foundation
ARRANGED BY B.R. Korf, Children's Hospital, Boston, Massachusetts
SESSION 1: Overview
B.R. Korf, Children's Hospital, Boston, Massachusetts:
Overview of project.
W. Slattery, House Ear Institute, Los Angeles, California:
Overview of NF2 project.
S. Huson, The Churchill Hospital, Oxford, United Kingdom:
Patterns of plexiform neurofibromas in different anatomical
locations.
B.R. Korf, Children's Hospital, Boston, Massachusetts:
Subject acquisition protocols.
B.R. Korf, Children's Hospital, Boston, Massachusetts:
Reimbursement and administration.
SESSION 2: MRI Protocol
D. Jaramillo, Children's Hospital, Boston, Massachusetts:
MRI of peripheral plexiform neurofibromas (including proto-
col).
T. Young Poussaint, Children's Hospital, Boston,
Massachusetts: MRI of cranial and spinal plexiform neurofi-
bromas (including protocol).
J. Tsuruda, University of Utah, Salt Lake City: MR neurography
and advanced image processing.
J.B. Zimmerman, World Care, Inc., Cambridge,
Massachusetts: World Care MRI protocol.
J. DiCanzio, Children's Hospital, Boston, Massachusetts:
Statistical analysis of radiological data.
SESSION 3: Clinical and Pathological Data
J.M. Friedman, University of British Columbia, Vancouver,
Canada: Clinical database.
B.R. Korf, Children's Hospital, Boston, Massachusetts: Patient
questionnaire.
D. Wolfe, Mt. Sinai Medical Center, New York: Histopathologic
correlates of growth in plexiform neurofibroma.
D. Wolfe, Mt. Sinai Medical Center, New York, and B.R. Korf,
Children's Hospital, Boston, Massachusetts: Pathology review
facility.
SESSION 4: Tissue Bank and Cell Biology: Studies of Cell Biology
L. Rutkowski, Abramson Center, Philadelphia, Pennsylvania:
Understanding biological defects in neurofibroma-derived
Schwann cells. Part 1: Resolving obstacles.
N. Ratner, University of Cincinnati College of Medicine, Ohio:
Neurofibroma-derived Schwann cells are invasive and show
high Ras-GTP.
D. Viskochil, University of Utah, Salt Lake City: Somatic DNA
alterations in peripheral nerve sheath tumors.
D.H. Gutmann, Washington University School of Medicine, St.
Louis, Missouri: Administration of tissue bank and mechanisms.
SESSION 5: Logistical Issues
B.R. Korf: Children's Hospital, Boston, Massachusetts: Time
Line; Publication of Policy; Finance; Consent.
J. Tsuruda, T Poussaint, D. Jaramillo, J. Zimmerman
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What Are Stem Cells? From Embryo to Adult Tissues
February 21-24
FUNDED BY Osiris Therapeutics, Inc., and SyStemix, Inc.
ARRANGED BY D.R. Marshak, Osiris Therapeutics, Inc., Baltimore, Maryland
R.G. Scollay, SyStemix, Inc., Palo Alto, California
I.L. Weissman, Stanford University School of Medicine, California
SESSION 1
Chairperson: I.L. Weissman, Stanford University School of Medicine, California
R.L. Gardner, University of Oxford, United Kingdom: Stem
cells in the preimplantation mouse conceptus.
A.L. Spradling, Howard Hughes Medical Institute, Carnegie
Institution of Washington, Baltimore, Maryland: Regulation of
Drosophila germ line stem cells by short-range extracellular
signals.
M.T. Fuller, Stanford University School of Medicine, California:
Genetic control of stem cell self-renewal, proliferation, and dif-
ferentiation in the male germ line.
B.L.M. Hogan, Howard Hughes Medical Institute, Vanderbilt
University Medical Center, Nashville, Tennessee: Primordial
germ cells.
J.A. Thomson, University of Wisconsin, Madison: Human
embryonic stem cells.
General Discussion-Nomenclature
Moderator: I.L. Weissman, Stanford University School of Medicine, California:
SESSION 2
Chairperson: R.G. Scollay, SyStemix, Inc., Palo Alto, California
I.L. Weissman, Stanford University School of Medicine, Califor-
nia: Hematopoietic stem cells.
I.R. Lemischka, Princeton University, New Jersey: The molecu-
lar biology of hematopoietic stem cells and their microenvi-
ronment; Do unique gene expression patterns reflect unique
biological properties?
P.J. Quesenberry, University of Massachusetts Medical School,
Worcester: Phenotype of hematopoietic stem cells.
R. Gardner, D. Anderson, M. Fuller
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L.I. Zon, Howard Hughes Medical Institute, Children's
Hospital, Boston, Massachusetts: Genes that specify
hemangioblasts during vertebrate development.
J.M. Isner, St. Elizabeth's Medical Center of Boston,
SESSION 3
Chairperson: R.L. Gardner, University of Oxford, United
Kingdom
P.G. Robey, National Institute of Dental and Craniofacial
Research, NIH, Bethesda, Maryland: The biological signifi-
cance of marrow stromal in health and disease.
D.R. Marshak, Osiris Therapeutics, Inc., Baltimore, Maryland:
Mesenchymal stem cells.
R. Cancedda, Istituto Nazionale per la Ricerca sul Cancro,
Genoa, Italy: Bone marrow stromal cells from healthy donors
SESSION 4
Chairperson: D.R. Marshak, Osiris Therapeutics, Inc., Baltimore,
D.J. Anderson, Howard Hughes Medical Institute, California
Institute of Technology, Pasadena: Neural stem cells in the
peripheral nervous system.
F.H. Gage, The Salk Institute, La Jolla, California: Multipotent
stem cells from the adult central nervous system.
R. McKay, National Institute of Neurological Disorders and
Massachusetts: Mobilization of bone-marrow derived progen-
itor cells and incorporation into neovascular foci.
H.M. Blau, Stanford University School of Medicine, California:
Stem cells-Angioblasts.
and from bone-marrow-transplant recipients.
A.B. Moseley, Osiris Therapeutics, Inc., Baltimore, Mary-
land: Therapeutic implications for MSCs in transplanta-
tion.
D.J. Prockop, MCP Hahnemann University, Philadelphia,
Pennsylvania: Marrow stromal cells as vectors for diseases of
the central nervous system.
Maryland
Stroke, NIH, Bethesda, Maryland: A CNS stem cell is as
good as the neurons it makes.
C.O. Doe, University of Oregon, Eugene: Neural stem cell divi-
sion in Drosophila.
Y.-N. Jan, Howard Hughes Medical Institute, University of California,
San Francisco: The control of neuronal progenitor cell fate.
SESSION 5
Chairperson: B.L.M. Hogan, Howard Hughes Medical Institute, Vanderbilt
University Medical Center, Nashville, Tennessee
F.M. Watt, Imperial Cancer Research Fund, London, United
Kingdom: Role of cell adhesion in regulating stem cell rate in
human epidermis.
M. Grompe, Oregon Health Sciences University,
Portland: Therapeutic liver repopulation: Are stem cells
needed?
N. Sarvetnick, The Scripps Research Institute, La Jolla,
California: Pancreas growth and regeneration.
D.E. Harrison, Jackson Laboratory, Bar Harbor, Maine: Genetic
regulation of hemopoietic stem cell aging.
H.R. Bode, University of California, Irvine: Evolution of stem
cells.
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Comparative Plant Genomics
February 28-March 3
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY B. Burr, Brookhaven National Laboratory, Upton, New York
J. Doebley, University of Minnesota, St. Paul
R. Martienssen, Cold Spring Harbor Laboratory
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
B. Burr, Brookhaven National Laboratory, Upton, New York
J. Doebley, University of Minnesota, St. Paul
R. Martienssen, Cold Spring Harbor Laboratory
SESSION 1: Sequence Polymorphism and Evolutionary Change
Chairperson: J. Messing, Rutgers University, Piscataway, New
M.T. Clegg, University of California, Riverside: Dynamics of
plant gene family evolution: Duplication and divergence in
flavonoid biosynthesis genes.
J. Doebley, University of Minnesota, St. Paul: Insights into
maize evolution from the analysis of nucleotide diversity in
teosinte branched 1.
SESSION 2: Syntenic Relationships I
Chairperson: J. Doebley, University of Minnesota, St. Paul
R. Schmidt, Max-Delbruck-Laboratorium, Kei In, Germany:
Comparative genome analysis in cruciferous plants.
G. Moore, John Innes Centre, Norwich, United Kingdom: To
pair or not to pair: The Phi locus 40 years on.
Jersey
S. Tingey, DuPont Company, Wilmington, Delaware: EST pro-
grams for gene discovery in maize, soybean, wheat, and
rice.
0. Savolainen, University of California, Davis: From
Arabidopsis to pine trees: Genetics of natural popula-
tions.
W.R. McCombie, Cold Spring Harbor Laboratory: Sequence
analysis of the rice and Arabidopsis genomes.
R. Martienssen, Cold Spring Harbor Laboratory: Stripping
repeated DNA from the maize genomic sequence.
S. Tingey, D. Zamir, J. Messing, X. Wong
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SESSION 3: Syntenic Relationships II
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
L.D. Stein, Cold Spring Harbor Laboratory: Comparative
genomics of animals, mapping, and sequencing.
J. Messing, Rutgers University, Piscataway, New Jersey:
Cereal genomics to study chromosome expansion.
P. San Miguel, Purdue University, West Lafayette, Indiana:
SESSION 4: Common Pathways
Chairperson: M.T. Clegg, University of California, Riverside
R.J. Schmidt, University of California, San Diego: Arabidopsis
to maize.
J.B. Nasrallah, Cornell University, Ithaca, New York: Evolution
of mating systems in the Brassicaceae.
T.C. Osborn, University of Wisconsin, Madison:
SESSION 5: Useful Genes From Wild Relatives
Chairperson: S. Tingey, DuPont Company, Wilmington, Delaware
T. Mitchell-Olds, Max-Planck Institute for Chemical Ecology,
Jena, Germany: Wild relatives of Arabidopsis: Phylogenetic
relationships and comparative genomics.
S.J. Knapp, Oregon State University, Corvallis: Genomics in
newly domesticated, neglected, and underutilized oilseed
crops.
L.M. Pollak, U.S. Department of Agriculture-Agricultural
Plant genome colinearity as modeled by Adhl and sh2/al
regions in maize, sorghum, rice, and Arabidopsis.
R. Tarchini, DuPont Genomics Group, Newark, Delaware:
Genome structure and organization around the Adhl/Adh2
region of rice and rice-maize microsynteny.
Comparison of Brassica and Arabidopsis flowering time
genes.
B. Burr, Brookhaven National Laboratory, Upton, New York:
Genes controlling leaf trichome development may be involved
in cotton fiber formation.
Research Service, Iowa State University, Ames: Improving
corn germplasm for yield and value-added traits by introgres-
sion of genes from exotic varieties and Tripsacum dacty-
bides.
D. Zamir, Hebrew University of Jerusalem, Rehovot, Israel:
Tomato introgression lines: Applications for synteny, evolution,
and Otl mapping.
Meeting participants take a coffee break
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Role of DNA Topology, Conformation, and Associated
Factors in Gene Expression
March 14-17
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY D.L. Levens, National Cancer Institute, NIH, Bethesda, Maryland
L.B. Rothman-Denes, University of Chicago, Illinois
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D.L. Levens, National Cancer Institute, NIH, Bethesda, Maryland
SESSION 1: Conformational/Topological Changes at Transcription Sites
Chairperson: N. Hernandez, Cold Spring Harbor Laboratory
M. Timmers, Utrecht University, The Netherlands: Promoter
opening and transcription initiation by RNA polymerase II.
J.A. Goodrich, University of Colorado, Boulder: Promoter
escape by DNA polymerase II on negatively supercoiled
DNA.
M. Meisterernst, Ludwig-Maximilians-Universitat MOnchen,
Germany: Structure-function analysis of PCY-A transcrip-
tion cofactor with unique DNA-binding properties.
L.F. Liu, UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Suppression of R-loops by DNA
topoisomerases.
S. Adhya, National Cancer Institute, NIH, Bethesda, Maryland:
DNA strand separation during isomerization: Rate limiting
steps.
SESSION 2: Propagation of Stress to Remote Sites
Chairperson: S. Adhya, National Cancer Institute, Bethesda, Maryland
J.F. Marko, University of Illinois at Chicago: Altered states of
DNA.
P. Droge, University of Cologne, Germany: The role of DNA
topology, conformation, and associated factors in gene
expression.
G.W. Hatfield, University of California, Irvine, College of
Medicine: DNA supercoiling-dependent, protein-mediated
activation of transcription from the ilypG promoter of
Escherichia coli.
H.-Y. Wu, Wayne State University School of Medicine, Detroit,
Michigan: LeuO, a new transcription regulator.
R.R. Sinden, Texas A&M University, Houston: Transcriptional
state of the mouse mammary tumor virus promoter can
affect topological domain size in vivo.
M. Dunaway, University of California, Berkeley: Insulators,
enhancers, and the DNA path.
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S. Adhya
SESSION 3: Stress-induced Conformational Changes
Chairperson: A. Rich, Massachusetts Institute of Technology,
P. Nelson, University of Pennsylvania, Philadelphia:
Torsional directed walks, entropic elasticity, and DNA
twist stiffness.
S.M. Mirkin, University of Illinois at Chicago: DNA structures
generated by transcription.
L.B. Rothman-Denes, University of Chicago, Illinois: DNA
structural transitions and single-stranded DNA binding pro-
Cambridge
teins in transcription activation.
C.T. McMurray, Mayo Clinic, Rochester, Minnesota: Duplex to
cruciform switching in the enkephalin enhancer controls
expression of the human pronekephalin gene.
P. Sassone-Corsi, CNRS, Illkirch-Strasbourg, France:
Transcriptional repression by DAX-1 via binding to hairpin
structures.
SESSION 4: Role of Single-stranded DNA-binding Transcription Factors
Chairperson: D. Reinberg, Howard Hughes Medical Institute, UMDNJ-
Robert Wood Johnson Medical School, Piscataway, New Jersey
D.L. Levens, National Cancer Institute, NIH, Bethesda, Maryland:
Regulating c-myc expression with the FUSE binding protein.
P.D. Gardner, University of Texas Health Science Center, San
Antonio: Transcriptional regulation of neuronal nicotinic
acetylcholine receptors by single-stranded DNA-binding pro-
teins.
J. Ting, University of North Carolina, Chapel Hill: Regulation of
a topologically constrained promoter (class II MHC) by gene-
specific coactivator, double-stranded, and single-stranded
DNA-binding proteins.
L.D. Kohn, National Institutes of Health, Bethesda, Maryland:
Regulation of TSH receptor and MHC gene expression by
single-stranded binding proteins and Sox-4: Relevance to
autoimmunity.
SESSION 5: Diverse Roles for Stressed-DNA and Associated Factors
Chairperson: L.F. Liu, UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey
C.J. Benham, Mt. Sinai School of Medicine, New York:
Structural transitions in superhelical DNA.
A. Rich and T. Schwartz, Massachusetts Institute of
Technology, Cambridge: Structural basis of the interaction
between Z-DNA and the mRNA editing enzyme dsRNA
adenosine deaminase.
E.M. Johnson, Mt. Sinai School of Medicine, New York:
Activation of initiation of DNA replication at the JC viral origin
by the HIV-1 protein TAT, dependent on cellular sequence-
specific single-stranded DNA-binding protein, pura.
A.R. Wolffe, National Institute of Child Health and Human
Development, NIH, Bethesda, Maryland: Chromatin, DNA
topology, and transcription.
T. Kohwi-Shigematsu, Lawrence Berkeley Laboratory,
California: Base-unpairing regions (BURS): Their roles in high-
er-order chromatin structure, gene regulation, and apoptosis.
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Biology of Pigmentation
March 21-23
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY G. Barsh, Stanford University School of Medicine, California
D.C. Bennett, St. George's Hospital Medical School, London, United Kingdom
Introduction and Goals of the Conference:
G. Barsh, Stanford University School of Medicine, California
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Biochemistry of Melanins and Melanogenesis
Chairperson: V.J. Hearing, National Institutes of Health, Bethesda, Maryland
S.J. Or low, New York University School of Medicine: Melanins,
cells, and tissues: From molecules to phenotypes.
P.A. Riley, Windeyer Institute of Medical Science, London,
United Kingdom: The biochemistry of melanogenesis: The
SESSION 2: Cell Biology of Pigmentation
Chairperson: S.J. Or low, New York University School of Medicine,
New York
R.A. Spritz, University of Colorado Health Sciences Center,
Denver: Genetics and functional analysis of Hermansky-
Pudlak syndrome.
M.H. Brilliant, University of Arizona Health Sciences Center,
Tucson: Aberrant pH of melanosomes in pink-eyed dilution
(p) mutant melanocytes.
M. Robinson, University of Cambridge, United Kingdom: The
role of the AP-3 complex in the trafficking of proteins to
melanosomes.
S. Hoening, University of Gottingen, Germany: Sorting of
melanosomal and lysosomal membrane proteins:
Implications for the biogenesis of melanosomes.
J. Hammer, National Heart, Lung, and Blood Institute, NIH,
Bethesda, Maryland: Myosin V, microtubular motors, and
melanosome dynamics in murine melanocytes.
R. Yip, National Cancer Institute-Frederick Cancer Research
Center, Maryland: Positional cloning of the mouse coat color
mutation ashen.
General Discussion
Moderator: Seth J. Or low, New York University School of
Medicine, New York
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generation and significance of DOPA (3,4-dihydroxypheny-
lalamine) in phase I melanogenesis.
T.P. Dooley, Altruis, LLC & IntegriDerm, Vestavia Hills,
Alabama: Pharmacologic inhibitors of pigmentation.
P. Riley, V. Hearing
SESSION 3: Extrapigmentary Functions of the Melanocortin System
Chairperson: M.E. Hadley, University of Arizona, Tucson
S. MacNeil, Northern General Hospital, Sheffield, United
Kingdom: MSH, oxidative stress, immunomodulation, and
(only when all else fails) pigmentation.
J. Tatro, New England Medical Center, Boston, Massa-
chusetts: The CNS melanocortin system in the coordinated
General Discussion:
Moderator: M.E. Hadley, University of Arizona, Tucson
response to microbial toxins.
R.A. Adan, Utrecht University, The Netherlands: Roles of the
melanocortin system in nerve regeneration, stress, and
grooming behavior.
SESSION 4: Development
Chairperson: C.R. Goding, Marie Curie Research Institute, Surrey, United
Kingdom
H. Arnheiter, National Institute of Neurological Disorders and (Ednrb) by a tetracycline-inducible system.
Stroke, NIH, Bethesda, Maryland: The role of microphthalmia I.J. Jackson,Western General Hospital, Edinburgh, United
in eye and neural crest development. Kingdom: Survival, proliferation, and migration of melano-
D.C. Bennett, St. George's Hospital Medical School, London, blasts in vivo and in organ culture.
United Kingdom: Immortalization and molecular characteri- H. Yoshida, Kyoto University, Japan: Role of Steel factor in sur-
zation of melanoblasts and pluripotent neural crest-like vival of melanocytes in different environments.
cells. D.M. Parichy, Washington University School of Medicine, St.
M.K. Shin, Princeton University, New Jersey: Determining the Louis, Missouri: Evolutionary genetics of Danio pigment pat-
spatial/temporal requirement for endothelin receptor B tern development.
SESSION 5: Cell Signaling
Chairperson: D.C. Bennett, St. George's Hospital Medical School, London,
United Kingdom
G. Barsh, Howard Hughes Medical Institute, Stanford Massachusetts: Microphthalmia: Central regulator in
University School of Medicine, California: Identification and melanocyte development.
characterization of the mahogany gene. R. Ballotti, Institut National de la Sante et de la Recherche
V. Hearing, National Institutes of Health, Bethesda, Maryland: Medicale, Nice, France: Role of microphthalmia-associated
Biochemical and molecular regulation of melanin biosynthe- transcription factor (MITF) in the regulation of melanogenic
sis. enzyme expression.
G. Imokawa, Tokyo Women's Medical University, Japan: E.E. Medrano, Baylor College of Medicine, Houston, Texas:
Intracellular signaling mechanisms leading to the synergistic Regulation of MITF protein levels by association with the ubiq-
effect on melanocyte proliferation of cultured human uitin-conjugating enzyme hUBC9.
melanocytes between endothelin-1 and stem cell factor. C.R. Goding, Marie Curie Research Institute, Surrey, United
E.R. Price, Dana-Farber Cancer Institute, Boston, Kingdom: Transcription regulation in melanocytes.
General Discussion:
Moderator: D.C. Bennett, St. George's Hospital Medical School, London,
United Kingdom
SESSION 6: Genetics
Chairperson: G. Barsh, Howard Hughes Medical Institute, Stanford University
School of Medicine, California
A.H. Robins, University of Cape Town, South Africa: The evo-
lution of human skin color.
A. Chakravarti, Case Western Reserve University, Cleveland,
Ohio: Human genetic variation in pigmentation genes.
R.N. Kelsh, University of Bath, United Kingdom: Zebrafish pig-
mentation mutations, colorless embryos, and a model for
human Waardenburg-Shah syndrome.
J. L. Rees, University of Newcastle Medical School,
Newcastle-upon-Tyne, United Kingdom: Genetics of the
human MC1-R: Genotype and phenotype.
R.A. Sturm, University of Queensland, Australia: Genetic analysis
of human pigmentation gene polymorphisms in twins.
W.J. Pavan, National Human Genome Research Institute, NIH,
Bethesda, Maryland: A combined informatic expression array
approach to dissect the transcriptional regulation of
melanocyte development/function.
General Discussion:
Moderator: G. Barsh, Howard Hughes Medical Institute, Stanford University
School of Medicine, California
309
Functional Organization of Thalamus and Cortex and
Their Interactions
April 5-9
FUNDED BY The Swartz Fund for Computational Neuroscience
ARRANGED BY P.R. Adams, State University of New York, Stony Brook
K. Svoboda, Cold Spring Harbor Laboratory
S.M. Sherman, State University of New York, Stony Brook
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
P.R. Adams, State University of New York, Stony Brook
K. Svoboda, Cold Spring Harbor Laboratory
S.M. Sherman, State University of New York, Stony Brook
SESSION 1: Neurons and Synapses
Chairperson and Discussion Leader: D.L. Ferster, Northwestern University,
Evanston, Illinois
B.W. Connors, Brown University, Providence, Rhode Island:
An electrically coupled network of interneurons mediates
feed-forward inhibition from thalamus to cortex.
A. Destexhe, Laval University, Quebec, Canada: Modeling
dendritic integration in thalamic and neocortical neurons in
vivo.
Y. Amitai, Ben Gurion University, Beer-Sheva, Israel: Thalamo-
cortical and intracortical pathways in the barrel cortex:
Distinctive synaptic properties and functional organization.
A.M. Thomson, Royal Free Hospital School of Medicine,
London, United Kingdom: Synaptic specialization and fre-
quency filtering (in cortical circuits).
11
K. Cox, K.-P. Hoffmann
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SESSION 2: Thalamocortical I
Chairperson and Discussion Leader: R.M. Shapley, New York University,
New York
R C. Reid, Harvard Medical School, Boston, Massachusetts:
Thalamocortical relations in the visual system: The role of
synchronous input.
E.G. Jones, University of California, Davis: The core and matrix
of thalamic organization.
M.J. Berry, Harvard University, Cambridge, Massachusetts:
Anticipation of moving stimuli by the retina.
P R. Adams, State University of New York, Stony Brook:
Correlation measurement and plasticity control by layer 6 cells.
T. Sejnowski, The Salk Institute for Biological Studies, San
Diego, California: Predictive learning of temporal sequences
in recurrent neocortical circuits.
SESSION 3: Thalamocortical II
Chairperson and Discussion Leader: T. Sejnowski, The Salk Institute for
Biological Studies, San Diego, California
D.L. Ferster, Northwestern University, Evanston, Illinois: The
role of neuronal conductance and threshold in orientation
selectivity.
K.D. Miller, University of California, San Francisco: Circuitry
underlying orientation and temporal frequency selecting in
cat visual cortex.
D.A. McCormick, Yale University School of Medicine, New
Haven, Connecticut: Dynamic properties of thalamocortical
interactions in normal and abnormal (epileptic) function.
T Elliott, University of Nottingham, United Kingdom: A neu-
rotrophic model of synaptic competition in the developing
visual cortex.
SESSION 4: Cortical Circuitry
Chairperson and Discussion Leader: K.D. Miller, University of California,
San Francisco
L Borg-Graham, IAF CNRS, Gif-Sur-Yvette, France: Silent shunt-
ing-It's not nothing: Synaptic dynamics in visual cortex.
E.M. Callaway, The Salk Institute for Biological Studies, La
Jolla, California: Local circuits in visual cortex.
R.M. Shapley, New York University, New York: The dynamics
of visual responses in macaque striate cortex.
M. Nicolelis, Duke University Medical Center, Durham, North
Carolina: Thalamocortical interactions in the somatosensory
system.
A. Pouget, University of Rochester, New York: Information
transfer in population codes: Implications for theories of corti-
cal computation.
SESSION 5: Cortico-cortico and Cortico-thalamo-cortical
Chairpersons and Discussion Leaders: P.R. Adams and S.M. Sherman,
State University of New York, Stony Brook
J. Bullier, Faculte de Medecine de Rangueil, Toulouse, France: nization.
Role of feedback connections in the visual cortex-Spatial H.S. Seung, Massachusetts Institute of Technology, Cambridge:
and temporal aspects. Cellular and circuit mechanisms of short-term memory.
R.W. Guillery, University of Wisconsin School of Medicine, D.H. Ballard, University of Rochester, New York: Synchronous
Madison: Corticothalamic pathways: Classification and orga- models in predictive coding.
SESSION 6: Cognitive
Chairperson and Discussion Leader: H.S. Seung, Massachusetts Institute
of Technology, Cambridge
J.L. McClelland, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Complementary learning systems, Hebbian
learning, and human amnesia.
J.L. Gallant, University of California, Berkeley: The function of
the nonclassical receptive field in natural vision.
K. -P. Hoffmann, Ruhr-University, Bochum, Germany:
Synchronization of neuronal activity in extrastriate cortical
areas during movement perception.
S. Treue, University of Tubingen, Germany: The role of attention
in visual information processing.
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Molecular Neurobiological Mechanisms in Schizophrenia:
Seeking a Synthesis
April 11-14
FUNDED BY The Charles A. Dana Foundation, with additional support from The Nathan S. Kline
Institute for Psychiatric Research and Merck KGaA
ARRANGED BY A.B. Pardee, Dana-Farber Cancer Institute, Boston, Massachusetts
A.B. Goodman, The Nathan S. Kline Institute for Psychiatric Research,
Orangeburg, New York
Introduction and Goals of Conference:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
A.B. Pardee, Dana-Farber Cancer Institute, Boston, Massachusetts
SESSION 1: Fundamental Questions
Chairperson: A.B. Pardee, Dana-Farber Cancer Institute, Boston,
Massachusetts
N.C. Andreasen, University of Iowa Hospitals and Clinics, Iowa
City: Schizophrenia: Fundamental questions.
J.F. Nash, Princeton University, New Jersey: Case
history.
SESSION 2: Characteristics, Genetics, Animal Models
Chairperson: R. Cancro, The Nathan S. Kline Institute for Psychiatric
Research, Orangeburg, New York: Opening remarks
L.J. Ingraham, George Washington University, Washington,
D.C.: Clinical and subclinical correlates of schizophrenia.
P.S. Holzman, Harvard University, Belmont, Massachusetts:
Schizophrenia and area MT.
P. McGuffin, The Maudsley Institute of Psychiatry, London,
United Kingdom: Gene mapping and positional cloning.
J.L. Kennedy, Clarke Institute for Psychiatry, Toronto, Canada:
L. Ingraham, J. Nash
Neurodevelopment genes and unstable DNA in schizophrenia.
R.E. Straub, Virginia Commonwealth University, Richmond:
Linkage results in schizophrenia-Disappointing only to those
with unjustified expectations?
D.R. Weinberger, NIMH Neurosciences Center at St.
Elizabeth's Hospital, Washington, D.C.: Schizophrenia, candi-
date genes, and candidate phenotypes.
A. Pardee, J. Kennedy, M. Tsuang
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SESSION 3: Brain Structure, General Brain Models
Chairperson: F.M. Benes, McLean Hospital, Belmont, Massachusetts:
Opening Remarks
F.M. Benes, McLean Hospital, Belmont, Massachusetts: The
role of stress and dopamine-GABA interactions in the devel-
opment of schizophrenia.
P.S. Goldman-Rakic, Yale University School of Medicine,
New Haven, Connecticut: The prefrontal model of
schizophrenia.
S. Akbarian, Whitehead Institute, Massachusetts Institute of
Technology, Cambridge: Altered gene expression in pre-
frontal cortex of schizophrenics-A perspective from post-
mortem studies.
A.B. Goodman, The Nathan S. Kline Institute for Psychiatric
Research, Orangeburg, New York: Chromosomal colocaliza-
tion (CC) at genetic loci linked to schizophrenia.
A.-S. La Mantia, University of North Carolina at Chapel Hill:
Induction, retinoids, and the initial development of the fore-
brain.
B.T. Woods, Central Texas Veterans Health Care System,
Temple: Discord in the developmental symphony: Can persis-
tently active genetically determined abnormalities of apopto-
sis or neuritic pruning explain schizophrenia?
SESSION 4: Neuromolecular Biology
Chairperson: J.E. Dowling, Harvard University, Cambridge, Massachusetts:
Opening remarks
J.W. Olney, Washington University School of Medicine, St.
Louis, Missouri: NMDA receptor hypofunction model of
schizophrenia.
J.T. Coyle, Massachusetts General Hospital, Boston: NMDA
receptor hypofunction and the pathophysiology of schizo-
phrenia-Clinical evidence.
B.S. Mc Ewen, Rockefeller University, New York: Stress, sex,
and the hippocampus: From animal models to clinical appli-
cation.
U.C. Drager, E. Kennedy Shriver Center, Waltham,
Massachusetts: Retinaldehyde dehydrogenases create pat-
terns of retinoic acid in the central nervous system.
G. Eichele, Baylor College of Medicine, Houston, Texas: Gene
expression analysis in the brain: A meaningful approach to
mental disorders?
P Greengard, Rockefeller Institute, New York: Beyond the
dopamine receptor: The DARPP-32/protein phosphatase 1
cascade.
SESSION 5: Molecular Signaling and Transcription
Chairperson: J. Maddox, London, United Kingdom: Opening remarks
E.J. Nest ler, Yale University, New Haven, Connecticut:
Regulation of gene expression in striatum: 6,FosB: A molecu-
lar mediator of long-term neural plasticity.
L.L. Iversen, University of Oxford, United Kingdom:
Neuropharmacology- Dopamine and 5-hydroxytryptomine.
K.S. Kristensson, Karolinska Institut, Stockholm, Sweden:
Targeting of viruses and African trypanosomes in the nervous
system.
SESSION 6: Treatment Strategies
Chairperson: A.B. Pardee, Dana-Farber Cancer Institute, Boston,
Massachusetts: Opening remarks
M.T. Tsuang, Harvard Institute of Psychiatric Epidemiology and
Genetics, Boston, Massachusetts: "Schizotaxia": Prevention
strategies for schizophrenia.
T.H. McGlashan, Yale University School of Medicine, New
Haven, Connecticut: Can current treatments prevent the
dementing process of dementia praecox?
R.A. Heyman, Ligand Pharmaceuticals, Inc., San Diego,
California: A pharmacological dissection of RXR signaling
General Discussion
Chairperson: J.D. Watson, Cold Spring Harbor Laboratory
E. Borrelli, CNRS-INSERM, Strasbourg, France: Role of
dopa-mine receptors in schizophrenia and other neuro-
pathologies.
T Perlmann, Karolinska Institut, Stockholm, Sweden: Role of
NURR1 in developing and mature dopamine cells.
B.M. Spiegelman, Dana-Farber Cancer Institute, Boston,
Massachusetts: Control of oxidative metabolism and thermo-
genesis through a regulated transcriptional coactivator.
pathways with rexinoids.
G. Bartoszyk, Merck KGaA, Darmstadt, Germany: Classification
of atypical neuroleptics: Catalepsy versus anticatalepsy.
Y. Ohno, Sumitomo Pharmaceuticals Research Center, Osaka,
Japan: Recent advances in antipsychotic development: The
role of 5-HT2 receptor antagonism in schizophrenia treatment.
C. Mondadori, Hoechst Marion Roussel, Bridgewater, New
Jersey: The difficulty of selecting the right target.
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Image Archive on the American Eugenics Movement Editorial
Advisory Panel Workshop
April 15-17
FUNDED BY National Human Genome Research Institute, NIH
ARRANGED BY D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Introduction.
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: New panel members, workshop objectives, site
narrative structure.
S. Lauter, DNA Learning Center, Cold Spring Harbor
Laboratory: Introduction to site interface.
Computer Work I: Site Interface.
Computer Critique I: Site Interface.
Discussion of Theme Essays I
G.E. Allen, Washington University, St. Louis, Missouri: Social
origins of the movement.
E.A. Carlson, State University of New York, Stony Brook:
Scientific origins of the movement.
S. Selden, University of Maryland, College Park: Eugenics
popularization.
SESSION 2
Introduction to Site Editing Shell
M. Christensen, DNA Learning Center, Cold Spring Harbor
Laboratory: Caption writing/editing, series, emerging
style.
Computer Work II: Captioning.
Computer Critique II: Captioning.
Discussion of Theme Essays II
R Lombardo, University of Virginia, Charlottesville:
Eugenics and social policy I: Anti-miscegenation;
Eugenics and social policy II: Reproductive restriction and
sterilization;
Eugenics and social policy III: Immigration restriction.
E.A. Carlson, State University of New York, Stony Brook: The
end of transformation of eugenics.
SESSION 3
Discussion of Theme Essays III: Review.
Computer Work III: Revisit Site Interface and Editing Shell.
Computer Critique III: Additional Problems and Challenges.
Wrap-up, Future Tasks, and Meetings.
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T. Shearer, S. Selden
Clinical and Biological Basis of the Ehlers-Danlos Syndrome
April 18-21
FUNDED BY Ehlers-Danlos National Foundation and the March of Dimes
ARRANGED BY P.H. Byers, University of Washington School of Medicine, Seattle
P. Tsipouras, University of Connecticut Health Center, Farmington
Introduction and Goals of Conference:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
P. Tsipouras, University of Connecticut Health Center, Farmington
SESSION 1: Molecular Basis of the Ehlers-Danlos Syndrome
Chairperson: P.H. Byers, University of Washington School of
A. De Paepe, University Hospital Ghent, Belgium: Collagen
gene mutations in the classical type.
U. Schwarze, University of Washington, Seattle: Collagen V
gene mutations in the classical type.
R. Wenstrup, Children's Hospital Research Foundation,
Cincinnati, Ohio: Collagen V gene mutations in the classical
type.
Discussion: Collagen V gene mutations.
U. Schwarze, University of Washington, Seattle: Collagen Ill
Medicine, Seattle
gene mutations in the vascular type.
B. Steinmann, University Children's Hospital, Zurich, Switzer-
land: Collagen I gene mutations in the arthochalasia type.
A. Nicholls, University of Cambridge, United Kingdom: Collagen
I gene mutations in the classical type.
Discussion: Collagen I gene mutations.
A. Co lige, Tour de Pathologie, Liege, Belgium: Procollagen
N-peptidase gene mutations in the derematosparaxis
type.
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SESSION 2: Molecular Basis/Pathogenesis
Chairperson: R. Wenstrup, Children's Hospital Research Foundation,
Cincinnati, Ohio
L. Ala-Kokko, University of Oulu, Finland: PLOD gene.
H.N. Yeowell, Duke University Medical Center, Durham, North
Carolina: PLOD gene mutations in the kyphoscoliosis type.
I. Hausser, Universitats-Hautklinik, Heidelberg, Germany:
SESSION 3: Matrix Biology
Chairperson: D.R. Eyre, University of Washington, Seattle
L.Y. Sakai, Shriners Hospitals for Children, Portland, Oregon:
Extracellular matrix molecules I.
R.E. Burgeson, Massachusetts General Hospital/Harvard,
Charlestown, Massachusetts: Extracellular matrix molecules
D.R. Eyre, University of Washington, Seattle: Collagen
Histopathological observations.
P.H. Byers, University of Washington School of Medicine,
Seattle: Abnormalities in the intracellular processing of colla-
gen.
interactions.
J. Rosenbloom, University of Pennsylvania, Philadelphia: Elastin
and microfibrils.
K. Kadler, University of Manchester School of Biological
Sciences, United Kingdom: Effects of mutations on collagen
fibrillogenesis.
SESSION 4: Natural History
Chairperson: C.A. Francomano, National Human Genome Research
Institute, NIH, Bethesda, Maryland
F.M. Pope, University of Wales College of Medicine, Cardiff,
United Kingdom: Overview of the natural history of the
Ehlers-Danlos syndrome.
M. Pepin, University of Washington, Seattle: Natural history of
B. Steinmann, University Children's Hospital, Zurich,
Switzerland: Natural history of the kyphoscoliosis and
arthrochalasia types.
N. Schechter, Saint Francis Hospital and Medical Center,
Hartford, Connecticut: Musculoskeletal pain.
R.K. Portenoy, Beth Israel Medical Center, New York: Pain and
Ehlers-Danlos syndrome.
M. Geraghty, Johns Hopkins Hospital, Baltimore, Maryland:
Physiological and psychological management of individuals
C.A. Francomano, National Human Genome Research
Institute, NIH, Bethesda, Maryland: Longitudinal
studies.
S. Rodeo, Hospital for Special Surgery, New York: Orthopedic
treatment of patients with joint laxity.
SESSION 5: Management and Future Directions
Chairperson: P. Tsipouras, University of Connecticut Health Center,
Farmington
P.G. Danias, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Noninvasive assessment of the elastic prop-
erties of modicum size arteries.
B.T. Baxter, University of Nebraska Medical Center, Omaha:
Panel Discussion: Future directions.
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Management of arterial aneurysms/rupture in the vascular
type.
G.F. Whalen, University of Connecticut Health Center,
Farmington: Management of bowel rupture.
Functional Genomics: Technology Development and Research
Applications
April 25-28
FUNDED BY Merck Genome Research Institute and National Cancer Institute
ARRANGED BY M.J.F. Austin, Brigham and Women's Hospital, Boston, Massachusetts
R.L. Strausberg, National Cancer Institute, NIH, Bethesda, Maryland
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M.J.F. Austin, Brigham and Women's Hospital, Boston Massachusetts
R.L. Strausberg, National Cancer Institute, NIH, Bethesda, Maryland
SESSION 1
Chairperson: M. Boguski, National Library of Medicine, NIH,
J. Pollack, Howard Hughes Medical Institute, Stanford
University Medical School, California: Microarray analysis of
gene expression and DNA copy number in breast cancer.
V.G. Cheung, Children's Hospital of Philadelphia, Pennsylvania:
Whole-genome microarray- A tool for gene mapping.
D. Pinkel, University of California, San Francisco: Issues in
DNA copy number analysis by array CGH.
Bethesda, Maryland
SESSION 2
Chairperson: G.M. Church, Harvard Medical School, Cambridge,
Massachusetts
K. Gunsalus, Rutgers University, Piscataway, New Jersey:
Structure-based functional genomics.
J. Skolnick, The Scripps Clinic Research Institute, La Jolla,
California: Structure-based approaches to the prediction of
protein function.
M. Yaffe, Harvard Institute of Medicine, Boston, Massachusetts:
Placing proteins into pathways: An interactive World Wide Web
protein signature motif database using peptide library information.
P. Andrews, University of Michigan, Ann Arbor: Approaches to
high-throughput proteome analysis and visualization.
R. Aebersold, University of Washington, Seattle: The pro-
teome: Analysis and utility.
P.H. Uetz, University of Washington, Seattle: Large-scale two-
hybrid analysis of the yeast proteome.
D. Nickerson, University of Washington, Seattle: Genome
sequence variation.
D.C. Muddiman, Virginia Commonwealth University, Richmond:
Rapid and accurate characterization of VNTRs, SNPs, and
DNA-drug interactions through development of electrospray
lionization Fourier transform ion cyclotron resonance mass
spectrometry.
G. Church
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SESSION 3
Chairperson: D. Nickerson, University of Washington, Seattle
E.A. Golemis, Fox Chase Cancer Center, Philadelphia,
Pennsylvania: Interaction technology interactions with organ-
ismal biology.
M. Vidal, Massachusetts General Hospital Cancer Center,
Charlestown: The C. elegans protein interaction map project.
G.M. Church, Harvard Medical School, Cambridge,
Massachusetts: Integrating measurements, motifs, and mod-
els for comprehensive molecular quantitations of cell popula-
tions.
J. Green, National Cancer Institute, NIH, Bethesda, Maryland:
Insights from the C3(1)/Tag transgenic models of prostate
and mammary cancer.
SESSION 4
Chairperson: L.M. Staudt, National Cancer Institute, NIH, Bethesda, Maryland
G.A. Churchill, The Jackson Laboratory, Bar Harbor, Maine:
Sources of variation in large-scale gene-expression experi-
ments.
G. Eichele, Baylor College of Medicine, Houston, Texas:
Methods and instrumentation for gene-expression analysis
by in situ hybridization.
X. Gao, University of Houston, Texas: A novel method for on-
chip parallel syntheses of molecular microarrays using pho-
togenerated reagents.
H.R. Garner, University of Texas Southwestern Medical Center,
Dallas: Hardware and software for array-based expression
profiling and re-sequencing.
U. Alon, Princeton University, New Jersey: Analysis of gene
expression patterns.
S.R. Gullans, Brigham and Women's Hospital, Boston, Massa-
chusetts: Profiling gene expression using DNA microarrays.
SESSION 5
Chairpersons: R.L. Strausberg, National Cancer Institute, NIH, Bethesda,
Maryland and M.J. F. Austin, Brigham and Women's Hospital, Boston,
Massachusetts
L.M. Staudt, National Cancer Institute, NIH, Bethesda,
Maryland: Genomic-scale analysis of gene expression in
human lymphomas and leukemias using the Lymphochip
cDNA microarray.
M.R. Emmert-Buck, National Cancer Institute, NIH, Bethesda,
Maryland: An integrated approach to the analysis of human
prostate cancer.
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G.J. Biggins, Duke University Medical Center, Durham, North
Carolina: The Public CGAP/SAGE database as one model for
collaborative expression genomics.
R Spellman, Stanford University School of Medicine, California:
Analysis of genome expression data.
M. Boguski, National Library of Medicine, NIH, Bethesda,
Maryland: Reflections.
Strategies for Inactivation of Mutant Genes
May 2-5
FUNDED BY Amyotrophic Lateral Sclerosis Association and
Hereditary Disease Foundation
ARRANGED BY R.H. Brown, Massachusetts General Hospital, Charlestown
E.R. Signer, Massachusetts Institute of Technology, Cambridge
N.S. Wexler, Columbia University, New York
Introduction and Goals of Conference:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R.H. Brown, Massachusetts General Hospital, Charlestown
E.R. Signer, Massachusetts Institute of Technology, Cambridge
N.S. Wexler, Columbia University, New York
SESSION 1
Chairperson: N.S. Wexler, Columbia University, New York
A. Lieberman, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland: Androgen effects on
motor neuron gene expression.
R.H. Brown, Massachusetts General Hospital, Charlestown:
Mechanisms of neuronal cell death in SOD1-associated
motor neuron disease.
SESSION 2
Chairperson: E.R. Signer, Massachusetts Institute of Technology,
E.B. Kmiec, Jefferson Center for Biomedical Research,
Doylestown, Pennsylvania: Targeted mutagenesis using
chimeric oligonucleotides: Mechanism of action and applica-
tions to functional genomics and gene therapeutics.
C.J. Steer, University of Minnesota Medical School,
S.O. Zeit lin, College of Physicians & Surgeons, Columbia
University, New York: Conditional inactivation of the mouse
HD gene.
H.J. Federoff, University of Rochester, New York: Somatic
gene transfer of cre recombinase to alter brain
function.
Cambridge
Minneapolis: The use of RNA/DNA oligonucleotides to rewrite
genome sequence.
D.M. Turnbull, University of Newcastle-upon-Tyne, United
Kingdom: Inhibition of mitochondrial DNA replication by peptide
nucleic acids: Potential in the treatment of human disease.
E. Signer, N. Wexler, J. Witkowski
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SESSION 3
Chairperson: A. Tobin, University of California, Los Angeles
P.S. Fishman, University of Maryland School of Medicine, Baltimore:
Protein delivery to neurons using bacterial toxin-based vectors.
J.W. Engels, Johann Wolfgang Goethe-Universitat, Frankfurt
am Main, Germany: Hammerhead ribozymes: Chemotherapy
SESSION 4:
Chairperson: R.N. Brown, Massachusetts General Hospital, Cha
J.J. Rossi, City of Hope National Medical Center, Duarte,
California: Ribozymes: Intracellular strategies for genomic
studies and therapeutics.
B. Sullenger, Duke University Medical Center, Durham, North
contra gene therapy.
W.W. Hauswirth, University of Florida College of Medicine,
Gainesville: Ribozyme approaches to therapy and gene dis-
covery in the retina.
rlestown
SESSION 5
Chairpersons: E.R. Signer, Massachusetts Institute of Technology,
Cambridge, and A. Tobin, University of California, Los Angeles
N. Muzyczka, University of Florida, Gainesville: Use of viral vec-
tors to study gene function in the central nervous system.
S. Kochanek, University of Cologne, Germany: Gene transfer
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Carolina: Ribozyme-mediated repair of mutant RNAs.
L.-H. Yen, Yale University School of Medicine, New Haven,
Connecticut: Sequence-specific cleavage of Huntington
mRNA by catalytic nucleotides.
with "gutless" adenoviral vectors.
D.J. Fink, University of Pittsburgh School of Medicine,
Pennsylvania: Novel applications of genomic herpes vectors.
Coffee break between meeting sessions.
Xenotransplantation: A Scientific Basis for Risk Assessment
May 9-12
FUNDED BY The Hastings Center and William Stamps Farish Fund
ARRANGED BY J.M. Coffin, Tufts University School of Medicine, Boston, Massachusetts
M. Hanson, The Hastings Center, Garrison, New York
F. Murphy, University of California, Davis
R.A. Weiss, University of London, United Kingdom
Welcome and Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J.M. Coffin, Tufts University School of Medicine, Boston, Massachusetts
M. Hanson, The Hastings Center, Garrison, New York
R.A. Weiss, Institute of Cancer Research, London, United Kingdom
SESSION 1
Chairperson: R.A. Weiss, Institute of Cancer Research, London,
J.L. Platt, Mayo Clinic, Rochester, Minnesota: Potential appli-
cations and challenges of xenotransplantation.
H.Y. Vanderpool, University of Texas Medical Branch,
Galveston: Risk assessments in the 1996 reports of the
Institute of Medicine (USA) and the Nuffield Council on
Bioethics (UK).
C.R. McCarthy, Georgetown University, Richmond, Virginia:
United Kingdom
Risk benefit from the perspective of the IRB, the IACUC, and
the subject.
D.R. Salomon, The Scripps Research Institute, La Jolla,
California: Clinical trials in xenotransplantation- Why a mora-
torium based on risk concerns is bad medicine, bad science.
N. Daniels, Tufts University, Medford, Massachusetts: Public
accountability for risks and the rationale for a moratorium.
S. Donnelley, F Bach, N. Daniels
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SESSION 2
Chairperson: N. Daniels, Tufts University, Medford, Massachusetts
D.K.C. Cooper, Massachusetts General Hospital, Charlestown: D.E. Onions, Q-One Biotech Ltd., Glasgow, United Kingdom:
Efforts to induce tolerance in the pig-to-baboon Control of virological risks associated with porcine xenotrans-
model. plantation.
M.A. Michaels, Children's Hospital of Pittsburgh, Pennsylvania: C. Patience, BioTransplant Inc., Charlestown, Massachusetts:
Cytomegalovirus infections after xenotransplantation. The biology of PERV in an inbred herd of miniature swine.
SESSION 3
Chairperson: M.A. Martin, National Institute of Allergy and Infectious
Diseases, NIH, Bethesda, Maryland
S.S. Morse, Joseph L. Mailman School of Health, Columbia
University, New York: Strategies for assessing and reducing
the infectious disease risk.
M.J. Buchmeier, The Scripps Research Institute, La Jolla,
California: Biology and pathogenesis of rodent-borne emerg-
ing viruses.
S.J. O'Brien, National Cancer Institute-Frederick Cancer
Research Center, Maryland: Endogenous retroviral genomes:
Relics of ancient plaques.
J.S. Allan, Southwest Foundation for Biomedical Research,
San Antonio, Texas: Simian viruses in baboons: Risks to
humans in the transplant setting.
C.R. Parrish, Cornell University, Ithaca, New York: Host range
adaptation and evolution.
SESSION 4
Chairperson: J. Stoye, National Institute for Medical Research, London,
United Kingdom
E. Fleissner, Columbia University, New York: Retrovirus-host
interactions: Why are germ line viruses xenotropic, except in
the laboratory?
W. Heneine, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta, Georgia:
Surveillance of xenogeneic retroviral infections in xenograft
recipients.
SESSION 5
Chairperson: M. Hanson, The Hastings Center, Garrison, New
J.A. Bradbury, Pacific Northwest National Laboratory,
Washington, D.C.: Addressing public concerns about risk:
Some insights from U.S. Department of Energy and Army
programs concerning the disposal of radioactive waste and
chemical weapons.
F.H. Bach, Beth Israel-Deaconess, Boston, Massachusetts:
Xenotransplantation: Where are we and what needs to be
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C. Wilson, Food and Drug Administration, Bethesda, Maryland:
Studies in cross-species infectivity of porcine endogenous
retrovirus: Implications for pig-to-human xenotransplantation.
G. Langford, Imutran Ltd., Cambridge, United Kingdom:
Analysis of samples from primates transplanted with hDAF
transgenic organs for evidence of cross species transmission
of PoERVs.
York
done?
S. Donnelley, The Hastings Center, Garrison, New York: The
moral landscape of xenotransplantations.
L. Chapman, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta, Georgia:
Development of U.S. PHS policy on infectious disease issues
in xenotransplantation.
Image Archive on the American Eugenics Movement Editorial
Advisory Panel Workshop
October 1-3
FUNDED BY National Human Genome Research Institute
ARRANGED BY D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Welcome, general instructions and hospitality.
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: Workshop objectives and summary of April
meeting transcripts.
S. Lauter, DNA Learning Center, Cold Spring Harbor
Laboratory: Features of the modified user interface.
Computer Work I: Site Interface.
SESSION 2
Caption Style
M. Christensen, DNA Learning Center, Cold Spring Harbor
Laboratory: Features of the modified editor interface.
Computer Work II: Captioning and essay illustration
Computer Critique I: Site Interface.
Discussion of New Theme Essays.
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: Eugenics research methods.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Traits and conditions studied.
G.E. Allen, Washington University, St. Louis, Missouri: Flaws in
eugenics research.
SESSION 3
Computer Work III: Revisit Site Interface and Editing Shell.
Presentation of Revised Work.
Future Tasks and Meetings.
P. Ryan, P. Colbert-Cormier
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Physical and Structural Chemistry of Prion Protein and
Prion-like Phenomena
October 3-6
FUNDED BY Cold Spring Harbor Corporate Sponsor Program
ARRANGED BY B. Caughey, Rocky Mountain Laboratories, National Institute of Allergy
and Infectious Diseases, NIH, Hamilton, Montana
K. Wuthrich, Institut fur Molekularbiologie und Biophysik, Zurich,
Switzerland
Welcome and Opening Remarks:
J. A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
B. Caughey, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana
K. Wuthrich, Institut kir Molekularbiologie und Biophysik, Zurich, Switzerland
SESSION 1: PrP: NMR Structure and Folding
Chairperson: B. Caughey, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana
K. Wuthrich, Institut fur Molekularbiologie und Biophysik,
Zurich, Switzerland: Outlook to the molecular structure of
PrP in PrP..
H.J. Dyson, The Scripps Research Institute, La Jolla,
California: Copper binding to the prion protein.
R. Glockshuber, InstitOt fur Molekularbiologie und
Biophysik, Zurich, Switzerland: Folding of the cellular
prion protein.
W.K. Surewicz, Case Western Reserve University, Cleve-
land, Ohio: Folding intermediates and in vitro
aggregation/fibrillization of the recombinant human
prior protein.
Roundtable Discussion: Immune responses to PrP and 3-D
structures of PrP in vivo and in vitro
Moderator: A. Norwich, Howard Hughes Medical Institute,
Yale University School of Medicine, New Haven, Connecticut
Participants:
C. Weissmann, Imperial College School of Medicine at St.
Mary's, London, United Kingdom
K. Wuthrich, InstitOt fur Molekularbiologie und Biophysik,
Zurich, Switzerland
J. Collinge, Imperial College School of Medicine at St. Mary's,
London, United Kingdom
J. Hope, Institute for Animal Health, Berkshire, United Kingdom
R. Rubenstein, New York State Office of Mental Retardation
and Development, Staten Island
W. Surewicz, D. Eisenberg
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SESSION 2: Prion Propagating Proteins in Yeast
Chairperson: K. Wuthrich, Institut fur Molekularbiologie und Biophysik,
Zurich, Switzerland
R.B. Wickner, National Institutes of Health, Bethesda,
Maryland: Generation and propagation of the (URE3) prion of
S. cerevisiae: Ure2p domains, curing and involvement of
new factors.
S.L. Lindquist, Howard Hughes Medical Institute, University of
Chicago, Illinois: The yeast (PSI.) factor.
M.D. Ter-Avanesyan, Institute of Experimental Cardiology,
Moscow, Russia: Artificial yeast prions.
Y.O. Chernoff, Georgia Institute of Technology, Atlanta: Host
proteins influencing formation, propagation, and toxicity of
the yeast prion (PSI).
J.S. Weissman, University of California, San Francisco:
Mechanism of amyloid formation and propagation: Lessons
from a yeast prion.
C.-Y. King, Florida State University, Tallahassee: Nonsense sup-
pression, antisuppression, and strains of the yeast prion (PSI).
K.L. Taylor, National Institute of Diabetes and Digestive and
Kidney Diseases, NIH, Bethesda, Maryland: Amyloid-based
inheritance of (URE3): Initiation of amyloid formation in vitro
by the Ure2p prion domain.
SESSION 3: PrP and Disease I
Chairperson: J. Hope, Institute for Animal Health, Berkshire, United Kingdom
S.B. Prusiner, University of California, San Francisco:
Therapeutic approaches to prion diseases.
C. Weissmann, Imperial College School of Medicine at St.
Mary's, London, United Kingdom: The role of the lym-
phoreticular system in experimental mouse scrapie.
J. Collinge, Imperial College School of Medicine at St. Mary's,
London, United Kingdom: Molecular studies of prion propa-
gation and strain diversity.
B. Caughey, Rocky Mountain Laboratories, NIAID, NIH,
Hamilton, Montana: Interactions between normal and abnor-
mal forms of PrP.
D.A. Harris, Washington University School of Medicine, St.
Louis, Missouri: Transgenic models of familial prion disease
membrane topology of PrP. Interactions of PrP and copper
at the cellular level.
Roundtable Discussion: Infectivity from recombinant PrP and
molecular basis of TSE strains
Moderator: D.S. Eisenberg, University of California, Los
Angeles
Participants:
S.B. Prusiner, University of California, San Francisco
R. Glockshuber, Institut fur Molekularbiologie und Biophysik,
Zurich, Switzerland
J.G. Safar, University of California, San Francisco
B. Caughey, Rocky Mountain Laboratories, NIAID, NIH,
Hamilton, Montana
D.A. Harris, Washington University School of Medicine, St.
Louis, Missouri
SESSION 4: PrP and Disease II
Chairperson: R.B. Wickner, National Institutes of Health, Bethesda, Maryland
J. Hope, Institute for Animal Health, Berkshire, United
Kingdom: Bridging the gap between the chemistry and biol-
ogy of prion protein.
P.T. Lansbury, Brigham and Women's Hospital, Boston,
Massachusetts: Alpha-synuclein fibrillization, Lewy bodies,
and Parkinson's disease? What is the connection?
J.G. Safar, University of California, San Francisco: Quantitative
traits of prion strains are enciphered in the conformation of
the prion protein.
D. Dormont, Commisariat a L'Energie Atomique, Fontenary-
aux-Roses, France: Neuronal death induced by PrP pep-
tides.
D.S. Eisenberg, University of California, Los Angeles: A 7-
residue fragment of Sup35 that forms on amyloid.
T Wisniewski, New York University School of Medicine, New
York: The conformation of Pr Pse as a determinant of strain
properties and as a therapeutic target.
D. Riesner, Instittit fur Physikalische Biologie, Dusseldorf,
Germany: Intermediates in PrP-refolding: A soluble 5-sheeted
structure.
SESSION 5: Other Models of Protein Misfolding
Chairperson: C. Weissmann, Imperial College School of Medicine at St.
Mary's, London, United Kingdom
J.W. Kelly, The Scripps Research Institute, La Jolla, California:
Understanding amyloid disease and developing small-mole-
cule inhibitors of misfolding.
D. Westaway, University of Toronto, Canada: The Doppel
gene encodes a novel mammalian prion-like protein.
General Discussion
P. Fraser, University of Toronto, Canada: Assembly and struc-
ture of a p amyloid.
R. Wetzel, University of Tennessee Medical Center, Knoxville:
Polyglutamine aggregation.
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J.P. Morgan & Co., Incorporated/Cold Spring Harbor Laboratory
Executive Conference on Genes and Genomes: Sequences to
Patents
October 15-17
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Genes and Genomes
J.D. Watson, Cold Spring Harbor Laboratory: Welcoming
remarks.
L. Hood, University of Washington, Seattle: The human
genome project: From start to finish.
SESSION 2: Sequencing and Genome Biology
R. Gibbs, Baylor College of Medicine, Houston, Texas: DNA
sequencing and the future.
D. Botstein, Stanford University School of Medicine, California:
Seeing when genes act: Genome-wide patterns for gene
expression.
G. Rubin, Howard Hughes Medical Institute, University of
California, Berkeley: Biological annotation of Drosophila
genome sequence.
SESSION 3: Cold Spring Harbor Laboratory Research
B. Stillman, Cold Spring Harbor Laboratory: Introduction-
Genomics at Cold Spring Harbor Laboratory.
L. Stein, Cold Spring Harbor Laboratory: Managing sequence
data.
M. Wig ler, Cold Spring Harbor Laboratory: Using DNA arrays.
SESSION 4: Applications and Patents
M. Bevan, John Innes Centre, Colney, Norwich, United
Kingdom: Sequencing a weed genome.
J. Todd, Cambridge Institute for Medical Research, United
Kingdom: The evolution, causes, prevention, and economics
of inflammation.
M. Freire, Office of Technology Transfer, NIH, Bethesda,
Maryland: Commercial exploitation of genomic sequences.
J.D. Watson, Cold Spring Harbor Laboratory: Discussion and
closing remarks.
B. Stillman, J. Todd, C. Harley, J. Watson
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Cell Death in Plants: Functions and Mechanisms
October 17-20
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Dangl, University of North Carolina, Chapel Hill
A. Jones, University of North Carolina, Chapel Hill
C.J. Lamb, John Innes Centre, Norwich, United Kingdom
SESSION 1: Is Developmental PCD in Plants a Cell Recycling Program?
Chairperson: J. Dangl, University of North Carolina, Chapel Hill
M. Hengartner, Cold Spring Harbor Laboratory: Programmed R. Amasino, University of Wisconsin, Madison: Regulation of
cell death in C. elegans. gene expression during developmental senescence.
A. Bleecker, University of Wisconsin, Madison: The role of eth- V. Buchanan-Wollaston, Horticulture Research International,
ylene in senescence and abscission. Warwick, United Kingdom: Links between pathogen respons-
H. Thomas, Institute of Grasslands and Environmental es and leaf senescence in Arabidopsis.
Research, Aberystwyth, Wales, United Kingdom: Creating, R.L. Jones, University of California, Berkeley: Blue light, reactive
mapping, cloning stay-greens (mutants with defective meso- oxygen, and hormonal control of plant (cereal aleurone) cell
phyll cell senescence). death.
SESSION 2: What Is the Role of PCD in Cellular Proliferation
and Differentiation?
Chairperson: R. Amasino, University of Wisconsin, Madison
A. Jones, University of North Carolina, Chapel Hill: Regulation
of programmed cell death by a secreted protease during ter-
minal differentiation of tracheary elements.
K. Roberts, John Innes Centre, Norwich, United Kingdom: Cell
death as a consequence of cell differentiation.
R. Whetten, North Carolina State University, Raleigh: Programmed
cell death in pine xylem formation-Signals and mechanisms.
M.G. Drew, Texas A&M University, College Station: Ethylene-
dependent programmed cell death in aerenchyma formation
in roots.
J. Greenberg, J. Dangl, B. Staskawicz
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SESSION 3: How Do R Gene Products Initiate HR?
Chairperson: R. Amasino, University of Wisconsin, Madison
D.C. Baulcombe, John Innes Centre, Norwich, United B. Staskawicz, University of California, Berkeley: Bacterial effec-
Kingdom: Autoactivation of cell death based on mutant for proteins specifying plant cell death and disease resis-
forms of the Rx gene from potato. tance.
SESSION 4: Are ROls Signals, Executioners or Both?
Chairperson: R. Whetten, North Carolina State University, Raleigh
C.J. Lamb, John Innes Centre, Norwich, United Kingdom:
Hypersensitive cell-death cues and mechanisms.
D.F. Klessig, Waksman Institute, Rutgers University,
Piscataway, New Jersey: NO- and SA-mediated signaling in
plant disease resistance.
K. Shimamoto, Nara Institute of Science and Technology,
Ikoma, Japan: Rac signaling in cell death and disease resis-
tance of rice.
G. Johal, Pioneer Hi-Bred International, Inc., Johnston, Iowa:
Cell death in maize disease lesion mimic mutants.
K.R. Davis, Ohio State University, Columbus: Ozone as a tool
for probing programmed cell death in plants.
SESSION 5: How Does Negative Regulation Effect HR?
Chairperson: M. Grant, University of London, Ashford, United Kingdom
J. Dangl, University of North Carolina, Chapel Hill: Negative
regulation in disease resistance.
R Schulze-Lefert, John Innes Centre, Norwich, United
Kingdom: A possible role for SCF complexes in the signaling
of R-gene-triggered hypersensitive cell death.
SESSION 6: Where Do the Early Branchpoints of Pathogen Recognition Lead?
Chairperson: P. Schulze-Lefert, John Innes Centre, Norwich, United
Kingdom
J.D.G. Jones, John Innes Centre, Norwich, United Kingdom:
Possible roles for CDPKs and NADPH oxidase homologs in
plant defense.
D. Scheel, Institute of Plant Biochemistry, Halle, Germany:
Calcium and reactive oxygen species in plant defense signaling.
M. Grant, University of London, Ashford, United Kingdom: The
role of intracellular calcium increase in hypersensitive cell
death.
SESSION 7: What Are The Cellular Rearrangements That Follow Infection?
Chairperson: J.D.G. Jones, John Innes Centre, Norwich, United Kingdom
M.G. Heath, University of Toronto, Canada: Commonality of Korn, Germany: Hypersensitive cell death upon fungae infec-
cell-death induction and executive in different forms of the tion.
hypersensitive response. E. Lam, Rutgers University, New Brunswick, New Jersey:
E. Schmelzer, Max-Planck Institute fur Zuchtungsforschtung, Caspase involvement in HR cell death.
SESSION 8: How Do Pathogens Usurp Cell Death Pathways?
Chairperson: J.D.G. Jones, John Innes Centre, Norwich, United Kingdom
F.M. Ausubel, Massachusetts General Hospital, Boston: Use
of fumonisin B1 to study PCD in Arabidopsis thaliana.
A. Levine, The Hebrew University of Jerusalem, Israel: Cell
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death in plant interaction with necrotrophs.
J.T. Greenberg, University of Chicago, Illinois: Are cell death
and cell growth coupled in plants?
The Art of Judging: Perspectives of Science
October 26-29
FUNDED BY The Federal Judicial Center, Judiciary Leadership Development
Council, and Cold Spring Harbor Laboratory
ARRANGED BY J.G. Apple, The Federal Judicial Center, Washington, D.C.
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1 SESSION 6
G.E. Allen, Washington University, St. Louis, Missouri:
Eugenics: Past, present, and future.
SESSION 2
J. Maienschein, Arizona State University, Tempe: From Darwin
to Dolly: Developments in the biological sciences in the 20th
century.
L.M. Silver, Princeton University, New Jersey: Cloning: The
biological and social implications of a new science.
SESSION 3
J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory: Human genetics.
J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory: Human Genome Project.
SESSION 4
R.G. Crystal, Cornell University Medical College,
New York, New York: Gene therapy.
SESSION 5
P. Reilly, Eunice Kennedy Shriver Center, Waltham,
Massachusetts: Social implications of genetic
research.
M.-E. Ruvolo, Harvard University, Cambridge,
Massachusetts: Human origins.
Banbury Conference Center
R. Shapiro, New York University, New York: Origins of life.
M.A. Gallo, UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Toxicology, the environment, and
risk assessment.
SESSION 7
R.J. Roberts, New England BioLabs, Inc., Beverly,
Massachusetts: The process of science vs. science in the
courtroom.
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The Molecular Neurobiology of ATM
November 7-10
FUNDED BY A-T Children's Project
ARRANGED BY S.J. El ledge, Baylor College of Medicine, Houston, Texas
N. Heintz, Rockefeller University, New York
E.M. Johnson, Washington University Medical School, St. Louis, Missouri
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
B. Margus, A-T Children's Project, Deerfield Beach, Florida
SESSION 1: Can We Identify Key Issues That Should Be
Covered In This Meeting?
B. Margus, A-T Children's Project, Deerfield Beach,
Florida
S.J. El ledge, Baylor College of Medicine, Houston, Texas
SESSION 2: Review of A-T the Disease
Chairperson and Discussion Leader: H.M. Lederman,
Johns Hopkins Hospital, Baltimore, Maryland
Overview: T. Crawford, Johns Hopkins Hospital, Baltimore,
Maryland
Discussion Point(s): What can the clinical picture tell us
about missing areas of research?
SESSION 3: The A-T Protein and Interacting
Proteins/Complexes
Chairperson and Discussion Leader: S.J. El ledge, Baylor
College of Medicine, Houston, Texas
Overview: Y. Shiloh, Tel Aviv University Sack ler School of Medicine, Israel
Discussion Point(s): Resolving controversies-Identifying key experiments.
Brief Presentations by Participants:
C.J. Bakkenist, St. Jude Children's Research Hospital, Memphis, Tennessee:
Activation of neuronal ATM by growth factors.
M.H.L. Green, University of Brighton, United Kingdom: Ataxia
telangiectasia and endogenous mutagens.
S. Harris, University of Connecticut Health Center, Farmington:
Suppression of ATM kinase defects by mutational inactiva-
tion of a RecQ helicase.
B. Hempstead, New York Hospital-Cornell Medical College,
New York: Novel signaling pathways regulating neuronal sur-
vival.
D.S. Lawrence, The Albert Einstein College of Medicine,
Bronx, New York: Gene expression patterns in A-T cell lines.
E.Y.-H. Lee, University of Texas Health Science Center at San
Antonio: Multiple signal transduction pathways mediated by ATM.
J. Qin, Baylor College of Medicine, Houston, Texas: Purification
and identification of ATM complexes.
Y. Shiloh, Tel Aviv University Sack ler School of Medicine, Israel:
ATM-mediated signaling pathways.
R. Vibhakar, University of Iowa, Iowa City: Regulation of the
AKT(PKB) kinase by ATM.
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SESSION 4: New Insights or Plans Involving Mouse Models
of A-T
Chairperson and Discussion Leader: M. Segal, The
Weizmann Institute, Rehovot, Israel
Overview: C. Barlow, The Salk Institute for Biological
Studies, La Jolla, California
Discussion Point(s): How "authentic" are mouse models?
Brief Presentations by Participants:
P.J. McKinnon, St. Jude Children's Research Hospital,
Memphis, Tennessee: ATM-dependent apoptosis in the ner-
vous system.
R. Eilam, The Weizmann Institute of Science, Rehovot, Israel:
Nigro-striatal deficits in the ATM mice.
G.S. Rotman, Tel Aviv University, Sackler School of Medicine,
Israel: SAT mice-An animal model for increased oxidative
stress on the background of ATM deficiency.
M. Segal, The Weizmann Institute, Rehovot, Israel:
Dopaminergic deficits in ATM knockout mice.
SESSION 5: Electrophysiology and Ion Channel Defects
Discussion Point(s)
SESSION 6: Progress toward Gene Therapy
Overview: S. Wang, Human Gene Therapy Research
Institute, Des Moines, Iowa
Discussion Point(s)
Brief Presentation by Participant:
S. Wang, Human Gene Therapy Research Institute, Des
Moines, Iowa: ATM gene delivery and expression by a
Heerper amplicon vector.
SESSION 7: Cytokines and A-T
Overview: L.C. Gahring, University of Utah School of
Medicine, Salt Lake City
Discussion Point(s)
Brief Presentation by Participant:
L.C. Gahring, University of Utah School of Medicine, Salt Lake
City: Exploring the role(s) of cytokines in the brain.
SESSION 8: Primate Models of A-T
Overview: R.L. Sidman, New England Regional Primate
Research Center, Southborough, Massachusetts, and R.
Norgren, University of Nebraska Medical Center, Omaha
Discussion Points(s): Potential and Problems of Using
Primate Models
Brief Presentations by Participants:
R. Norgren, University of Nebraska Medical Center, Omaha:
Development of a rhesus macaque of ataxia-telangiectasia.
R.L. Sidman, New England Regional Primate Research Center,
Southborough, Massachusetts: Initial steps toward a cere-
bellar Purkinje neuron degeneration model in monkeys by
injection of onconase.
SESSION 9: Stem Cells, Neural Implantation, and A-T
Overview: E.Y. Snyder, Children's Hospital, Boston,
Massachusetts
Discussion Point(s)
Brief Presentation by Participant:
D.A. Steindler, University of Tennessee Center Health Science,
Memphis: Adult neural stem cells: Molecular cell biology and
clinical applications.
SESSION 10: Oxidative Stress and A-T
Chairperson and Discussion Leader: E.M. Johnson,
Washington University Medical School, St. Louis, Missouri
Overview: G.S. Rotman, Tel Aviv University, Sackler School of
Medicine, Israel
Discussion Point(s)
Brief Presentations by Participants:
C. Barlow, The Salk Institute for Biological Studies, La Jolla,
California: Oxidative stress and lysosomal accumulation in
ATM-deficient mouse brain.
A. Barzilai, Tel Aviv University, Israel: Oxidative stress as a pos-
sible cause for neurodegeneration in A -T.
L.L. Dugan, Washington University School of Medicine, St.
Louis, Missouri: Developmental mechanisms underlying
increased free radical load in brain relevant to A -T.
H.M. Geller, UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Molecular mechanisms of neuronal
apoptosis.
M.F. Lavin, Queensland Institute of Medical Research,
Brisbane, Australia: Peroxisomal ATM and oxidative stress.
SESSION 11: Closing Discussion-Identifying Key Issues and
Critical Experiments
Brief Comments:
S.J. Elledge, Baylor College of Medicine, Houston, Texas
E.M. Johnson, Washington University Medical School, St.
Louis, Missouri
Y. Shiloh, Tel Aviv University Sackler School of Medicine, Israel
C. Barlow, The Salk Institute for Biological Studies, San Diego,
California
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Old Memories
November 14-17
FUNDED BY The John A. Hartford Foundation, Inc.
ARRANGED BY J.D. Gabrieli, Stanford University, California
M. Gallagher, Johns Hopkins University, Baltimore, Maryland
T. Tully, Cold Spring Harbor Laboratory
SESSION 1
T. Tully, Cold Spring Harbor Laboratory: CREB, Hartford, and
old age.
J.R. Burke, Duke University Medical Center, Durham, North
Carolina: The natural history of mild cognitive impairment in
the elderly.
B. Johansson, University College of Health Sciences, Jonko-
SESSION 2
P.R. Rapp, Mt. Sinai School of Medicine, New York: Strategies
for exploring cognitive and neurobiological aging in the mon-
key.
D.C. Park, University of Michigan, Ann Arbor: Visuo-spatial
and verbal working memory across the lifespan: Integrating
brain data with behavioral data.
K.F. Berman, National Institute of Mental Health, NIH,
Bethesda, Maryland: Context-dependent, neural
system-specific neurophysiological concomitants
SESSION 3
J.D. Gabrieli, Stanford University, California: Age-associated
changes in brain activation during memory performance.
F.I.M. Craik, University of Toronto, Canada: Age-related
changes in encoding and retrieval processes in human
memory.
N. Raz, Weizmann Institute of Science, Rehovot, Israel:
Differential age-related changes in the brain and their role in
SESSION 4
M. D'Esposito, Hospital of the University of Pennsylvania,
Philadelphia: Isolating the neural mechanisms of age-related
changes in human working memory using event-related
functional MRI.
H. Tani la, University of Kuopio, Finland: Memory encoding in
old and young rat hippocampus.
C. Mondadori, Hoechst Marion Roussel, Bridgewater, New
SESSION 5
A.J. Silva, University of California, Los Angeles: Age-depen-
dent cognitive decline: A tale of unwelcome channels, lazy
synapses, and blasé neurons.
P. Chapman, University of Wales, Cardiff, United Kingdom:
Animal models of Alzheimer's disease: The role of aging in
behavioral and physiological pathology.
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ping, Sweden: Individual differences in episodic memory.
D. Carmel li, SRI International, Menlo Park, California: Brain
structure and cognitive function in men remain heritable in
the seventh and eighth decades of life.
R.E. Cabeza, University of Alberta, Canada: Functional neu-
roimaging of cognitive aging.
of aging: Mapping PET correlates during cognitive
activation.
C.L. Grady, Rotman Research Institute, Baycrest Centre for
Geriatric Care, Toronto, Canada: Neuroimaging studies of
aging and memory.
L.L. Light, Pitzer College, Claremont, California: Some aspects
of episodic priming in young and older adults.
R. West, University of Notre Dame, Indiana: Is working memory
more variable in older than younger adults?
age-related changes in memory and executive function.
C.M. Hulette, Duke University Medical Center, Durham, North
Carolina: Neuropathological changes associated with normal
aging.
S.A. Small, Columbia University, New York: Regional analyses
of the hippocampal formation in aging and Alzheimer's dis-
ease.
Jersey: The dynamics of long-term memory and drug-
induced memory.
Y. Stern, Columbia University, The Sergievsky Center, New
York: Cognitive and imaging studies of memory in aging.
M. Gallagher, Johns Hopkins University, Baltimore, Maryland:
New data in old models: Effects of aging on hippocampus in
rats with cognitive impairment.
R.N. Rosenberg, University of Texas Southwestern Medical
Center at Dallas: How is Alzheimer's disease first detected?
A. Wingfield, Brandeis University, Waltham, Massachusetts:
Age-related speech-speed preferences.
C.R. Green, Mt. Sinai School of Medicine, New York: Memory
training for healthy adults: Where do we go from here?
Microbial Targets for Small Molecules
November 28-December 1
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY P. Howley, Harvard Medical School, Boston Massachusetts
A.J. Levine, Rockefeller University, New York
G.L. Verdine, Harvard University, Cambridge, Massachusetts
Introductory Remarks and Welcome:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Viral Structure Targets
Chairperson: A.J. Levine, Rockefeller University, New York
D.C. Wiley, Howard Hughes Medical Institute, Harvard
University, Cambridge, Massachusetts: The structure of an
HIV-1-specific cell entry inhibitor in complex with the HIV-1
gp41 trimeric core.
P.S. Kim, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: HIV entry and its
inhibition.
SESSION 2: Bacterial Targets
Chairperson: J.E. Davies, Terra Gen Discovery Inc., Vancouver, C
W.R. Jacobs, Howard Hughes Medical Institute, Albert
Einstein College of Medicine, Bronx, New York: Lipid metab-
olism: A life and death struggle for tubercle bacillus.
C.T. Walsh, Harvard Medical School, Boston, Massachusetts:
Enzymes conferring resistance to vancomycin.
T. Muir, Rockefeller University, New York: Peptide inhibitors of
virulence in Staphylococcus aureus.
J.J. Skehel, National Institute for Medical Research, London,
United Kingdom: Influenza HA in virus entry.
J.J. Hog le, Harvard Medical School, Boston, Massachusetts:
Structurally biased combinatorial design of antivirals.
R.A. Lamb, Howard Hughes Medical Institute, Northwestern
University, Evanston, Illinois: Influenza virus M2 ion channel
and paramyxoviral fusion-protein structure.
anada
A. Tomasz, Rockefeller University, New York: New targets
against multiresistant clones of Staphylococcus aureus and
Enterococcus faecium: Clues from molecular epidemiology
and from mechanisms of resistance.
D. Williams, University of Cambridge, United Kingdom:
Restoring the affinity of vancomycin-group antibiotics against
resistant bacteria without modification of the binding site.
J. Davies, P. Howley, A. Tomasz
SESSION 3: Molecular Targets I
Chairperson: P.M. Howley, Harvard Medical School, Boston, Massachusetts
A.J. Levine, Rockefeller University, New York: Oligonucleotide
array analysis.
H.L. Ploegh, Harvard Medical School, Boston, Massachusetts:
New tools to study proteolytic pathways.
G.L. Verdine, Harvard University, Cambridge, Massachusetts:
Chemical biology approaches to macromolecular targeting
and functional analysis.
SESSION 4: Fungal and Bacterial Targets
Chairperson: C.T. Walsh, Harvard Medical School, Cambridge,
Massachusetts
J.E. Davies, Terra Gen Discovery, Inc., Vancouver, Canada:
Mining molecular diversity from microbes.
J.C. Clardy, Cornell University, Ithaca, New York: Dihydro-
orotate dehydrogenase as a bacterial target.
E. Elion, Harvard Medical School, Boston, Massachusetts: A
signal transduction rescue system for cell wall damage in
D. Cane, Universite Louis Pasteur, Strasbourg, France:
Enzymatic and molecular strategies for the biosynthesis of
unnatural natural products.
E. Kieff, Brigham and Women's Hospital, Brookline,
Massachusetts: Molecular targets for preventing or treating
herpesvirus-related cancers.
Saccharomyces cerevisiae.
E.K. O'Shea, University of California, San Francisco: Regula-
tion of nuclear transport.
T.J. Silhavy, Princeton University, New Jersey: Two
component regulatory systems: The sensory organs of
bacteria.
SESSION 5: Molecular Targets II
Chairperson: G.L. Verdine, Harvard University, Cambridge, Massachusetts
D.E. Kahne, Princeton University, New Jersey: New targets for
glycopeptide antibiotics: How to overcome resistance.
J.M. Berger, University of California, Berkeley: Mechanisms of
drug activity in type II topoisomerases.
C.R. Raetz, Duke University Medical Center, Durham, North
Carolina: Enzymes of lipid A biosynthesis: Targets for the
design of new antibiotics.
P.M. Howley, Harvard Medical School, Boston,
Massachusetts: Harnessing the ubiquitination machinery to
degrade specific cellular proteins.
S. Hecht, University of Virginia, Charlottesville: RNA as a thera-
peutic target.
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Participants continue discussing the meeting outdoors.
Vaccines for Developing Economies: Who Will Pay?
December 5-7
FUNDED BY Albert B. Sabin Vaccine Institute, Inc.
ARRANGED BY P. Russell, Albert B.Sabin Vaccine Institute, Inc., Potomac, Maryland
S. Lemon, University of Texas Medical Branch, Galveston
CO-CHAIRPERSONS J. Sachs, Harvard University, Cambridge Massachusetts
P. Hotez, Yale University, New Haven, Connecticut
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
H.R. Shepherd, Albert B. Sabin Vaccine Institute, Inc., New Canaan, Connecticut
SESSION 1: Setting the Stage: The Imbalance of Global
Science
Chairperson: D.T. Jamison, University of California, Los
Angles
D.T. Jamison, University of California Los Angeles: What
harms and kills the world's children: Implications for science
and technology.
M. Miller, World Health Organization, Geneva, Switzerland:
Economic and epidemiological factors encouraging adoption
of vaccines into national vaccine programs.
A. Mahmoud, Merck and Company, Inc., Whitehouse Station,
New Jersey: Market pressures on academic biotechnological
advances.
W. Vandersmissen, SmithKline Beecham BioServices,
Rixensart, Belgium: Market pressures on industry.
G.W. Perkin, Global Health Program, Bill and Melinda Gates
Foundation, Seattle, Washington: The new role of founda-
tions.
T Godal, UNICEF, Geneva, Switzerland: The GAVI perspective.
K.W. Bernard, National Security Council, Washington, D.C.:
International Public Health-The evolving U.S. government
policy on vaccines.
SESSION 2: Case Studies In Orphan Vaccines
Chairperson: P.K. Russell, Albert B.Sabin Vaccine
Institute, Inc., Potomac, Maryland
B. Schwartz, Centers for Disease Control and Prevention,
Atlanta, Georgia: Case studies in orphan vaccines.
P.K. Russell, Albert B. Sabin Vaccine Institute, Inc.,
Potomac, Maryland: Malaria vaccines.
P. Hotez, Yale University School of Medicine, New
Haven, Connecticut: Helminth vaccines.
R.E. Shope, University of Texas Medical Branch,
Galveston: Dengue vaccines.
S. Berkley, International AIDS Vaccine Initiative,
New York: HIV vaccines.
SESSION 3: Mobilization of Science and Technology for
Developing Countries
A. Attaran, The Malaria Project, Vancouver, Canada:
Globalizing intellectual property.
SESSION 4: The Millennium Vaccine Fund: Impact of a
"Promised Market"
Chairperson: G.T. Keusch, Fogarty International Center,
National Institutes of Health, Bethesda, Maryland
M. Kremer, Harvard University, Cambridge, Massachusetts:
Overview of incentive issues.
A. Batson, The World Bank, Washington, D.C.: Results of
World Bank study.
J.D. Sachs, Harvard University, Cambridge, Massachusetts:
Millennium Fund proposal.
L Eros, R. Skolnik, A. Mahmoud
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Host-Pathogen Interactions
December 12-15
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor
Program, with additional support from Glaxo Wellcome Inc.
ARRANGED BY B.R. Bloom, Harvard University, Boston, Massachusetts
S. Blower, University of California, San Francisco
N.B. Freimer, University of California, San Francisco
SESSION 1: Approaches for Studying Host-Pathogen Interactions
Chairperson: N.B. Freimer, University of California, San Francisco
J.M. McNicholl, Centers for Disease Control and Prevention,
Atlanta, Georgia: Host genes and infectious disease: A pub-
lic health perspective.
N.B. Freimer, University of California, San Francisco: An
overview of genetic-mapping approaches.
C.M. Fraser, The Institute for Genomic Research, Rockville,
SESSION 2: Pathogen Evolution
Chairperson: S. Blower, University of California, San Francisco
J.L. Gerberding, Centers for Disease Control and Prevention,
Atlanta, Georgia: Antibiotic resistant bacteria: A public health
perspective.
M. Achtman, Max-Planck Institute for Molecular Genetics,
Berlin, Germany: Population genetics of N. meningitidis, H.
pylon, and N pestis.
Maryland: Genomics of microorganisms.
B. Rannala, State University of New York, Stony Brook:
Phylogenetic methods to reconstruct the evolutionary history
of a virulent pathogen.
D. Kirschner, University of Michigan Medical School, Ann Arbor:
Understanding host-pathogen interactions using modeling.
G. Myers, Los Alamos National Laboratory, New Mexico:
Sexually transmitted disease pathogens: A database
approach.
J.W. Kazura, Case Western Reserve University, Cleveland,
Ohio: Polymorphisms for Plasmodium vivax malaria:
Simplicity and complexity.
D. Kirschner, C. Fraser
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SESSION 3: Host Evolution
Chairperson and Introduction: N.B. Freimer, University of California, San
Francisco
M. Carrington, National Cancer Institute-Frederick Cancer
Research and Development Center, Maryland: Host suscep-
tibility to HIV.
P. Demant, The Netherlands Cancer Institute, Amsterdam:
Genetic dissection of disease susceptibility in the mouse.
P. Gros, McGill University, Montreal, Canada: Role of
NRAMP genes in macrophage function and divalent
cation transport.
SESSION 4: Tuberculosis as a Model for Host-Pathogen Interactions
Chairperson: B.R. Bloom, Harvard University, Boston, Massachusetts
B.R. Bloom, Harvard University, Boston, Massachusetts:
Introduction to TB.
J.M. Musser, Rocky Mountain Laboratories, National Institute
of Allergy and Infectious Diseases, NIH, Hamilton, Montana:
Molecular population genetic analysis of antibiotic resistance
and antigen genes in M. tuberculosis.
D.B. Young, Imperial College School of Medicine, London,
United Kingdom: Trafficking of mycobacteria and mycobac-
terial antigens in infected macrophages.
SESSION 5: Co-Evolution and Future Directions
Chairperson: S. Blower, University of California, San Francisco
J.T. Williams, Southwest Foundation for Biomedical Research,
San Antonio, Texas: Statistical genetic analysis of host-
pathogen interaction.
M.J. Wade, Indiana University, Bloomington: Evolution of host
maternal effects in response to pathogens affecting off-
spring.
D.R. Taylor, University of Virginia, Charlottesville: The evolution
of infectious mitochondrial mutants in plants.
I. Kramnik, Harvard School of Public Health, Boston, Massa-
chusetts: Genes regulating host resistance to virulent
mycobacteria.
A.V.S. Hill, University of Oxford, United Kingdom: Genome-
wide screening for TB susceptibility genes.
R.D. Fleischmann, The Institute for Genomic Research,
Rockville, Maryland: The genome of M. tuberculosis.
S. Blower, University of California, San Francisco: Epidemic
models of TB.
S. Gupta, University of Oxford, United Kingdom: The
effects of immune selection on pathogen population
structure.
M.J. Roossinck, The Noble Foundation, Ardmore, Oklahoma:
The role of the host in the evolution of RNA viruses.
T. Lenormand, University of British Columbia, Vancouver,
Canada: Long-term resistance management in vectors: The
mosquito case.
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Nancy Daidola
Vin Torti
INSTRUCTION MULTIMEDIA
Scott Bronson Susan Lauter
Patricia Maskiell Shirley Chan
Amanda Mc Brien Chun-hua Yang
Martha Mul lally Susan Conova
Danielle Sixsmith
To many, 1999 will be remembered as the year of the Internet. As Internet stocks and initial public offer-
ings soared, so did the number of visitors to our World Wide Web (VNW) site, Gene Almanac. Like other
established MAN sites-and people who bought technology stocks early on-we were able to ride the
crest of Internet interest in 1999. More than 380,000 people visited Gene Almanac, requesting 14.5 mil-
lion documents from our Web server-a threefold increase over 1998. Visitation peaked in October, when
our server logged 68,221 visitors, 177,863 page views, and 2.5 million document requests. This growth
was fueled primarily by the release of our animated online genetics primer, DNA from the Beginning
(DNAFTB), which by year's end accounted for the majority of pages viewed at our site.
Unlike conventional textbooks, which are organized around chapters, DNAFTB is organized around
key concepts. To date, we have released sections on 24 concepts in classical and molecular genet-
ics. Each contains an animation that presents key experiments as done by the scientists, a gallery with
seldom-seen archival photos, video interviews, biographies, and links to other Web sites of interest.
The site received positive reviews in the Net Watch column of Science (http://www.science.com), HMS
Beagle (http://www.biomednet.com/hmsbeagle), and Oncology Times.
Late in the year, we passed another milestone when Carolina Biological Supply Company (CBS)
became the first sponsor of Gene Almanac. CBS is one of the nation's oldest and most respected sup-
pliers of science products for the education market. Since 1987, the DNA Learning Center (DNALC)
has collaborated with CBS to develop the DNA Science laboratory text and more than ten molecular
genetics experimental kits. We were surprised to find that other major science centers have yet to seek
sponsorships for their WWW sites.
We continued to expand our server infrastructure to accommodate the exponential increase in vis-
itation. Frequent crashes showed that our Microsoft NT server and database system could not effi-
ciently handle some of our complex scripts and bioinformatics routines. At the same time, experiments
revealed that this system could not be scaled up to the heavy loads we predict over the next year. To
remedy this situation, in November, we switched over to a Linux server running an open-source oper-
ating system, Web server, and database server. This combination has proved remarkably stable and
has not experienced a single crash yet. Using open-source software has the added bonus of reducing
our license costs to near zero, making future system expansions more affordable.
At year's end we had a portfolio of $2.66 million in the following projects involving Internet science
education, making the DNALC one of the largest providers of multimedia learning materials for biolo-
gy education:
DNAFTB, funded by an $820,000 grant from the Josiah Macy, Jr., Foundation, is the worlds first
online, animated genetics text. An encyclopedia of genetic disorders will be added soon.
Vector Net, funded by a $500,000 grant from the Howard Hughes Medical Institute (HHMI), is a
mobile computer laboratory designed to provide state-of-the-art bioinformatics to New York City
students and teachers across the nation.
Oreit Van
This logo first
appeared on the
DNALC Web site
in November.
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Cold Spring liadmr Laboratory
announces the release of the second
section of Its genetics printer.
Word was spread about DNA from the Beginning with two postcard mailings to 12,000 biology educators around
the nation. The mailings were timed to coincide with the release of the first section of concepts in March, and the
second section in September.
Digital Image Archive on the American Eugenics Movement, funded by a $405,000 grant from the
National Human Genome Research Center, will allow students to explore materials from several
archives that have never before been released for public use.
A Partnership to Develop Advanced Technology Units on Genomic Biology, funded by a $600,000
grant from the National Science Foundation (NSF), is a nationwide program for high school and col-
lege faculty, which includes extensive use of Internet tools for analyzing genes.
The Science and Issues of Human DNA Polymorphisms, funded by a $335,000 grant from the
Department of Energy (DOE) Human Genome Project, is a nationwide training program for high
school biology teachers, which includes custom, online databases of student "DNA fingerprints."
We Anxiously Await Construction of an Expanded Facility
As our virtual visitation continued its exponential growth, our real-world visitation has plateaued at
about 30,000. Although we increased student lab instruction by nearly one third during the last 2 years,
our teaching lab facilities are now completely saturated. Labs are fully booked year-round, and our staff
teaches as many elementary students in schools as at the DNALC.
To make matters worse, the doubling of our staff during the past 2 years has made the basement
offices cramped as well as dreary. At one point in 1999, 12 staff members shared 1000 square feet of
office space. This situation was eased slightly at the expense of converting the Barbara McClintock
exhibit into an administrative office. As the year progressed, we realized that we had "hit the wall" of
growth and creativity in our current facility. At times it seemed that the deterioration of our work envi-
ronment even threatened our high level of innovation. Therefore, news that the Town of Huntington
approved our building permit for a 9000-square-foot Biomedia addition ended the year on a hopeful
note. It now seems certain that several years of dreaming and planning will come to fruition.
Construction will begin in spring 2000, with completion of the new facility scheduled for summer 2001.
The prospect of upstairs offices, an additional teaching lab, and state-of-the-art facilities for multime-
dia production tempered the news that ten staff members will be relocated during construction. In the
upcoming year, the instructional group will make its home in the small exhibit gallery on the main floor,
and the multimedia group will move to a temporary office (a.k.a. a trailer) on the main CSHL campus.
Centerbrook Architects and Planners of Essex, Connecticut, have designed the new facility. This
firm has been responsible for the eclectic mix of beautiful buildings and additions constructed at CSHL
in the past 30 years. Their handiwork is also seen in the initial renovation of the DNALC, including the
striking multimedia auditorium, or "multitorium." In 1998, the American Institute of Architects honored
Centerbrook as architectural firm of the year.
True to form, principal architect Jim Childress has crafted a two-story brick addition that merges eas-
ily with the existing Georgian revival structure. Cunningly, the main level extends into the hill to the rear
of the current building, allowing the second story to "emerge" on grade at the crest of the hill. Thus,
seen from the back, the addition appears to be a single-story structure-in keeping with the residential
feel of our neighborhood. The centerpiece of the addition, a hexagonal computer laboratory, is a 21st
century reprise of the classical architecture that inspired the original building. A new exhibit on the
Human Genome Project-including a Visible Sequencing Lab in which DNALC staff will produce DNA
sequences from samples submitted by biology classes from around the country-will occupy expand-
ed galleries. We cannot wait to inhabit our new spaces.
Developing the Vector Net Mobile Bioinformatics Laboratory
In the summer, we received a 4-year grant from the HHMI Precollege Science Education Initiative for
Medical Research Institutes, effectively renewing a previous 5-year award. The new program will intro-
duce high school students and teachers to the use of modern networked computing in genomic biol-
ogy. Of 150 applicants and 35 awardees, the DNALC was one of only two institutions to receive the
maximum award of $500,000.
The focal point of the program is Vector Net, a stand-alone, portable computer laboratory that
demonstrates state-of-the-art server and networking technology. Ten laptop computers are linked to a
central server via a wireless network. The central server mirrors the entire DNALC Web site, including
bioinformatics tools and Gen Bank data sets. A presenter laptop with video projector allows the instruc-
tor to demonstrate use of the programs. This "bioinformatics laboratory in a box" can be shipped and
set up anywhere, providing full bioinformatic resources without the need for an Internet connection.
Vector Net incorporates insight from 3 years' experience conducting bioinformatics training at sites in
Great Britain and around the United States. We have found that even in the best of dedicated computer
laboratories, any number of problems can halt work, including Internet and local network unreliability, local
security provisions, nonuniform hardware setups, and software misconfigurations. By the same token, we
have found that even the best of students and teachers have difficulty staying on task when they have the
ability to check E-mail or sports scores. Therefore, we concluded that the best bioinformatics training
experience is ensured by providing one's own network and all needed resources offline. This offers all the
power of distributed computing without the distractions of an open Internet connection.
During the academic year, Vector Net will be placed in one public high school in each of the five bor-
oughs of New York City. This local component of the program, New York City Genes, will allow large
numbers of minority students in metropolitan New York to participate in an authentic analog of the
Human Genome Project. The five schools are culturally and economically diverse: Stuyvesant High
School, Manhattan; Jamaica High School, Queens; J.F. Kennedy High School, Bronx; Port Richmond
High School, Staten Island; and Brooklyn Technical High School, Brooklyn. Each has a working DNA
laboratory where students can generate DNA-polymorphism data, which can be used as a starting
point in bioinformatics explorations. During a several-week loan period, Vector Net will be set up in the
science wing of each high school, allowing students to move seamlessly among classroom theory and
discussion, wet labs on DNA polymorphisms, and online computer analyses. New York City Genes is
supported by an extensive collaboration with the Gateway to Higher Education Program of the Mount
Sinai School of Medicine and New York City Public Schools. The Gateway Program prepares minority
and low-income students to graduate from high school and go on to high achievements in college pro-
grams in medicine, science, and technology.
During the summer, Vector Net will be used in teacher-training workshops at locations around the
country. The Vector Bioinformatics Workshop will target lead biology teachers, most of whom already
incorporate hands-on DNA laboratories into their classes. Our goal is for teacher participants to gain an
intuitive command of key principles of genomic biology and bioinformatics, accelerate the development
of technology environments in their own schools, incorporate case studies and workshop units into their
teaching, and help catalyze instructional change at the local and regional levels. Workshops will be
hosted by members of the Association of Independent Research Institutions (AIRI), of which Cold
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Spring Harbor Laboratory is a member. Hosts for the summers of 2000 and 2001 will include the
Foundation for Blood Research, Fred Hutchinson Cancer Research Institute, Oklahoma Medical
Research Institute, Salk Institute, and Trudeau Institute.
Eugenics Archive Readied for Release
By year's end, we had substantially finished our 2-year project to develop an online Digital Image
Archive on the American Eugenics Movement. Eugenics was an effort to apply Mendel's laws to breed
"better" human beings. Eugenicists encouraged people with "good" genetic stock to reproduce and
discouraged people with "bad" stock. They wrongly assumed that single genes explained complex
behaviors and mental illnesses that we now know involve many genes. Eugenicists sought an exclu-
sively genetic explanation of human development, neglecting the important contributions of the envi-
ronment. The American movement began in about 1910 and reached its peak in the 1920s, when
eugenics permeated many facets of public and private life. Flawed eugenics data were the basis for
social legislation to separate racial and ethnic groups, restrict immigration from southern and eastern
Europe, and sterilize people considered "genetically unfit." After enduring years of criticism, the
American movement collapsed in 1940, as the horrid results of the Nazi eugenics program were
revealed.
Digital Image Archive on the American Eugenics Movement, which will open to the public early in
2000, gives students, teachers, scholars, and the interested public an extraordinary window into a
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The Eugenics Archive home
page (left) includes links to "vir-
tual exhibits" that provide con-
text for the 1200 images in the
Archive. The image window
(above) provides basic informa-
tion about the image, a link to a
higher resolution "detail" image,
access to source archives to
use permissions, and a printer-
formatted page.
"hidden" chapter of history. We hope that the opportunity to revisit this period will stimulate people to
think critically about our current involvement in human genetics. The site contains more than 1200
images drawn from four major scholarly archives: the American Philosophical Society Library, the
Rockefeller University Archive Center, the Truman State University Archives, and the Cold Spring
Harbor Laboratory Research Archives. By providing access to the eugenicists' own words and "data,"
we hope to challenge visitors to assume the role of historian-researcher. By focusing primarily on visu-
al documents, we hope to engage young people and others who would not normally access a schol-
arly collection.
The Eugenics Archive makes no attempt to lead users to a "correct" interpretation of the materials.
However, the site assists users in understanding the historical, social, political, and ethical context in
which the American eugenics movement developed, flourished, and finally collapsed. Context is built
into the Archive on two levels. First, users are encouraged to enter the site through a series of 11 vir-
tual exhibits that introduce the key events, people, and social conditions that contributed to the devel-
opment of eugenics. Second, all images are sorted into more than 20 topic areas. Browsing by topic
or searching by keyword returns a set of related images with extended captions. The topic captions
are designed to help the user understand relationships among images and the relationship of the
image to the eugenics movement and society. Both levels were developed in collaboration with sev-
eral leading historians of eugenics. At each level, users are reminded that the vast majority of what is
presented as scientific "fact" by eugenicists was fundamentally flawed and has been discredited by
modern research standards. In November, the Archive was the subject of a feature article in the pop-
ular online magazine Salon (http://www.salon.com/tech/feature/1999/11/17/eugenics/index.html).
We believe that the Eugenics Archive can serve as a model for other online projects on the histo-
ry and social interpretation of modern science. At the start of the project, none of the participating
archives had policies governing the release of their materials over the Internet, and this project marks
the first large-scale release of items via the Internet by a second party. We developed guidelines for
online publication, educational "fair use" of documents, and privacy protections that can guide other
projects dealing with the release of sensitive documents via the Internet. These policies were devel-
oped by consensus during 6 days of workshop sessions with our 15-member advisory panel:
Garland E. Allen, Washington University, St. Louis,
Missouri
Elof Carlson, State University of New York, Stony
Brook
Patricia Colbert-Cormier, Lafayette High School,
Louisiana
Nancy L. Fisher, Regence Blue Cross, Seattle,
Washington
Henry Friedlander, City University of New York
Daniel J. Kev les, California Institute of Technology,
Pasadena
Philip Kitcher, University of California, San Diego
Martin L. Levitt, American Philosophical Society,
Philadephia, Pennsylvania
Instructional Program Continues to Grow
Paul Lombardo, University of Virginia, Charlottesville
Nancy Press, Oregon Health Sciences University,
Portland
Philip R. Reilly, Shriver Center for Mental Retardation,
Inc., Waltham, Massachusetts
Pat Ryan, Carolina Biological Supply Company,
Burlington, North Carolina
Marsha Saxton, World Institute on Disability, San
Francisco, California
Steven Selden, University of Maryland, College
Park
G. Terry Shaffer, National Museum of American
History, Washington, D.C.
A record 10,150 students, 30% of them minorities, conducted experiments during field trips to the
DNALC facility. Middle school labs-typically DNA extraction, microscope observation, or "green gene"
engineering-take 1 hour. High-school labs-DNA restriction analysis, bacterial transformation, and
human DNA polymorphisms-take between 2 1/2 and 3 1/2 hours. We also had a busy summer,
instructing 444 students at 17 workshops at the DNALC and at sites in the New York metropolitan area.
Five workshops for minority students, supported by the HHMI, were conducted at Central Islip High
School (Suffolk County), Intermediate School #59 (Queens), Brooklyn Technical High School (Queens),
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and J.F. Kennedy High School (Bronx). In addition, 400 students attended the 15th annual Great
Moments in DNA Science honors seminars:
Sequence analysis of complex genomes, Dick McCombie, CSHL
Molecular studies on HIV Nef, an essential viral protein, Michael Greenburg, CSHL
Biology's gold rush: Mining genes from the Human Genome Project, John Kruper, DNALC
Programs funded by the DOE, NSF, and Gateway to Higher Education reached 227 teachers at
sites around the nation. During the academic year, the DOE workshop, The Science and Issues of
Human DNA Polymorphisms, was conducted at California Lutheran University (Thousand Oaks), Fred
Hutchinson Cancer Research Center (Seattle, Washington), and Laney Community College (Oakland,
California). The NSF workshop, Genomic Biology, was conducted at New Hampshire Technical
Community College (Portsmouth), Madison Area Technical College (Wisconsin), University of Maryland
School of Medicine (Baltimore), and University of Texas (Austin). Gateway Summer Institutes for middle
and high school faculty were conducted at Stuyvesant High School (Manhattan).
The middle school program, Genetics as a Model for Whole Learning (GMWL), continued to
expand, reaching 10,500 students from 60 elementary and middle schools. Participants include 19 dis-
tricts and five private schools in Nassau, Suffolk, and Queens Counties. Under the GMWL program,
fifth and sixth grade students typically perform labs in school, such as constructing cell models, observ-
ing examples of cells under compound microscopes, constructing DNA models, and observing mutat-
ed fruit flies with stereomicroscopes. In addition, students perform DNA extractions and bacterial trans-
formations during a field trip to the DNALC. A chemistry lab sequence for advanced students includes
experiments on molecular modeling, enzyme structure and function, practical enzymology, and biore-
actors. These efforts were aided by a complete redesign of our instructional materials to make them
more children friendly.
Two labs usually reserved for high school students-genetically engineering bacteria to glow green
and making a personal DNA fingerprint-were successfully piloted with advanced middle school chil-
dren. In collaboration with Mike Hengartner's lab, we also piloted Caenorhabditis elegans as a model
for observing mutations in living organisms.
The GMWL program received a significant endorsement when we signed a 3-year, $100,000 con-
tract with the New York City Board of Education to provide genetics instruction for Community School
District 29 in southeast Queens. Located near Kennedy Airport, School District 29 serves 25,000 stu-
dents in grades K through 8-of whom 95% are minorities, 67% are eligible for lunch assistance, and
31% have limited English proficiency. The new contract is the culmination of a collaboration begun in
1996, which has involved a total of 5100 fifth through seventh grade students. In addition to teacher
training, the GMWL also includes parent workshops and a recognition dinner to familiarize district
administrators and school board members with the program. We hope that the District 29 agreement
becomes a model for other large-scale projects in New York City.
Middle-school students looked at
Caenorhabditis elegans mutations as part of a
pilot program. The C. elegans worm is the dark
squiggle in the center of the image, and the
longer lines are C. elegans tracks. This image
was provided by Daniel Hoeppner of Cold
Spring Harbor Laboratory.
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Genomic Laboratory Development
During the year, we continued to develop new educational experiments and improve existing ones. As in
the past, our objective is to identify research methods that can be modified for use in educational settings.
We strive to identify "icon" labs, which illustrate key techniques and integrate key biological concepts.
Recently, we have concentrated on labs that have a strong bioinformatics component and allow students
to share data via the Internet. Typically, we test and popularize new labs through grant-funded workshops,
and then develop a ready-to-use kit to be distributed by the Carolina Biological Supply Company.
Through grants from the HHMI, NSF, and DOE, we developed educational polymerase chain reac-
tion (PCR) kits that use a 20-minute sample prep and three-part chemistry based on freeze-dried core
reagents. These highly reproducible experiments allow students to analyze two types of chromosomal
DNA polymorphisms-an A/u insertion and a VNTR repeat. These DNA variations offer an excellent
starting point for discussions of disease diagnosis, forensic biology, identity testing, and the ethical
implications of this technology.
In parallel with human-based labs, we developed a new lab for introducing plant genomics. Here,
we have focused on Arabidopsis thaliana, a member of the mustard family that is considered the sim-
plest model system for flowering plants. The lab allows students to visually compare wild-type and
mutant plants, and then to relate the mutant phenotype to a PCR genotype showing an insertion poly-
morphism. In this case, a dwarf, curly-leaf phenotype is due to the insertion of the Ds transposon at
the C /f -2 locus. This system aptly illustrates how the first transposon system, discovered in the 1950s
by CSHL scientist Barbara McClintock, has now been transformed into a research reagent that pro-
vides a relatively straightforward method for cloning genes of interest. As a defective transposon, Ds is
similar to A/u -these ubiquitous "junk" DNA sequences can also stimulate students to consider the
possible role of transposons as evolutionary agents. In developing this system for education, we relied
heavily on research collaborators at the main Laboratory campus. Jean-Philipe Vielle-Calzada provid-
ed us with an amazingly rapid and efficient DNA prep from leaf material that does not require organic
extraction, Rob Martienssen provided us with Clf-2 stocks, and farm manager Tim Mulligan provided
greenhouse space and taught us how to culture Arabidopsis.
Especially exciting has been the success of our new Sequencing Service, which allows students and
teachers to analyze differences in their own DNA sequences. First, a highly variable region of the mito-
chondrial genome, the control region, is amplified via PCR. The amplified samples are mailed to the
DNALC, where a high school intern performs the final DNA sequencing reaction. The mitochondrial
sequences are then sent to the CSHL Genome Sequencing Center, where they are loaded onto a gel
for analysis. Finally, the sequence data are posted at the Sequence Server facility at our VWVVV site
(http://vectorcshl.org/sequences/). An easy to use interface allows users to launch database search-
es, sequence alignments, and phylogenetic analyses from a centralized workspace. With these tools,
students can use their own DNA data to explore human population genetics and test theories of human
evolution. Using this protocol, we have processed and posted more than 1300 sequence samples. We
also piloted a mitochondrial sequencing field trip, in which students amplified and electrophoretically
visualized their mitochondrial DNA during a 3-hour visit to the DNALC. Several days after being
processed, their sequence data were posted on the Internet. We hope to introduce this as a standard
lab field trip in academic year 2000-2001.
While we will continue to focus effort on the human mitochondrial control region, we intend to devel-
op other educational sequencing projects that allow students to collect, analyze, and share new data. A
pilot project on mitochondrial typing of trout, initiated by several of our high school interns, embodies
several features that may make it attractive to students and teachers in many parts of the country: (1)
Trout and other members of the salmon family are widely distributed in freshwater and saltwater through-
out the United States. (2) Commercial and sport fisheries are of considerable economic importance in
most regions of the country. (3) Conservation of wild populations and hybridization between species are
important biological problems. (4) Tissue samples are readily available from fishermen, conservation
departments, and supermarkets. (5) Primer sequences are conserved in most, if not all, species.
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Corporate Advisory Board
During the past several years, we have benefited greatly from the help of our Corporate Advisory Board
(CAB), a group of business leaders from large and small companies around Long Island. Each year, this
group takes on the challenge of raising 15% of the DNALC's annual operating expenses from local busi-
ness sources. As has become its fashion, the CAB again exceeded its goal in 1999, raising a total of
$256,000. Most of this went to support the activities of the DNALC, but some also supported the
Partners for the Future Program at the main Laboratory campus. The CAB contribution has been a major
factor in achieving a balanced budget for the past 2 years, including full payment of depreciation.
The 1999 board was ably led by Jack Leahy, of Citibank, who has been Chairman of the Board for
the past 4 years. Key to the year's success was the 6th annual golf tournament, chaired by Eddie
Chernoff and cochaired by John Kean. The tournament, which was hosted by special guest Deborah
Norville, drew approximately 200 players and netted $145,000. The year was topped off by an addi-
tional $111,000 from the winter Annual Fund Drive.
Operating behind the scenes-organizing meetings, making calls, and nudging board members to
follow up on leads-was Julie Sutherland, Development Officer of Corporate and Foundation Relations.
We owe her special thanks for a job done so well. Julie succeeded brilliantly, despite having a very
tough act to follow when she assumed this liaison position from Laura Hundt 2 years ago. During
Laura's tenure, the CAB had also exceeded its yearly goals.
Staff and Interns
During the past 2 years, the management of the DNALC has become increasingly decentralized, allow-
ing for greater collaboration among staff members. Under this arrangement, we have created a tier of
senior "coordinators," who share responsibility for key management functions. This is in line with the
educational movement to site-based management, where teacher teams are more directly responsible
for institutional policy and change.
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The first element of this decentralization occurred in 1998, when the DNALC high school and mid-
dle school education groups were merged into a single group. Since then, this team of five people has
been co-led by Educational Coordinators Patricia Maskiell, who is the primary liaison with school
clients, and Scott Bronson, who is primarily responsible for laboratory development. The education
group was strengthened in 1999 with the recruitment of lab instructor Danielle Sixsmith. Before she
joined the DNALC, she made use of her degrees in biology and science education as a biology teacher
at Martin Van Buren High School in Queens. In addition to her strong instructional background, Danielle
has completed an internship at Im Clone, a Manhattan-based biotechnology company.
The departure of BioMedia group leader John Kruper to the Internet startup company unext.com
provided an opportunity to apply the same strategy of shared responsibility within the multimedia
group. Thus, Shirley Chan was promoted to multimedia coordinator, and Matt Christensen was pro-
moted to technology coordinator. Shirley is responsible for the content and day-to-day operation of the
WWW sites. Her earlier work as science writer set the style and tone for DNA from the Beginning. Matt
is responsible for the DNALC's computer backbone and functionality of the WWW sites. With exper-
tise in Perl programming, he has developed many unique features at our WWW sites, including online
editing interfaces that can be reached from any computer.
When part-time animator Gisella Walter left for a position in Manhattan's "silicon alley," we were for-
tunate to hire Chun-hua Yang as a full-time replacement. After completing undergraduate work in her
native Taiwan, Chun-hua received two master's degrees-one in computer graphics from C.W. Post
and one in design technology from Parsons School of Design. She brings a new world view and a fresh
look to our WWW site. The resynthesized Biomedia group was rounded out with the recruitment of sci-
ence writer Susan Conova. While doing doctoral research in marine zoology, Susan began writing
about research topics for the newsletter of the Duke University Marine Laboratory. Just before she
joined the DNALC, she completed an American Association for the Advancement of Science writing
fellowship at ABCNEWS.com. The Biomedia group was further assisted by two summer interns, fund-
ed through a grant from the Josiah Macy, Jr., Foundation. Writing intern Ryan Luce recently complet-
ed his doctorate in chemistry at the University of Washington, and media design intern Maria Gililova,
of Syracuse University, returned for a winter internship. Maria was primarily responsible for the fun car-
icatures of each staff member found in the "About" section of our WWW site.
The core administrative group, headed by Program Coordinator Judy Cumella-Korabik, was round-
ed out with the addition of secretary Nancy Daidola. Nancy obtained excellent administrative experi-
ence in several departments at Grumman Aerospace and most recently was a real estate agent with
Coldwell Banker Sammis.
New employees in 1999:
From the left, Nancy Daidola, Secretary;
Chun-hua Yang, Multimedia Designer;
Danielle Sixsmith, Laboratory Instructor;
and Susan Conova, Science Writer.
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As the year ended, we received news that the Laboratory had recruited Vin Torti as a full-time devel-
opment officer dedicated to the DNALC. In addition to managing the CAB, Vin will raise funds for the
construction of the Biomedia addition, as well as the substantial operating increase it will engender. Vin
joined the Laboratory at the beginning of the new year, after having spent 3 years as development offi-
cer for Xaverian High School in Brooklyn. We were thrilled to find that Vin's background includes 15
years of teaching, so he has a true appreciation for our work. Vin will report to Development Director
Rick Cosnotti, with whom he shares a background in theology.
Several researchers from the main CSHL campus provided part-time instruction for high school lab
field trips: Joan Alexander (Wig ler lab), Thomas Volpe (Futcher lab), Michelle McDonough (Van Aelst
lab), and James Tong (Zhong lab). We bid farewell to Joel Stern, who left for graduate studies at
Columbia University, and to Vivek Mittal, who assumed responsibility for the microarray program in
Michael Wigler's lab.
College students and interns from high schools in Nassau and Suffolk Counties provided key sup-
port for the instructional and multimedia staff. Jermel Watkins, of the New York Institute of Technology,
extended his record service to 5 years by providing regular help during the academic year while Mera
Goldman returned from Barnard College to help with summer workshops. Veteran high school interns
Ken Mizuno (Cold Spring Harbor) and Yan Haung (Harborfields) assumed leadership roles as three of
their colleagues left for their first year of college: Rebecca Yee (Huntington) to Wellesley, Karin Glaizer
(Port ledge) to Vassar, Hana Mizuno (Cold Spring Harbor) to the Massachusetts Institute of Technology,
and Gerry DeGregoris (Chaminade) to Notre Dame. In the fall, we welcomed newcomers Daniel
Goldberg (Half Hollow Hills East), Janice Lee (Oyster Bay), Adam Frange (Wantagh), Greg Bautista
(Chaminade), Caroline Lau (Syosset), and Rebecca Shoer (Syosset). The Biomedia group was assist-
ed by a brother-sister team from Syosset High School-Tracy Mak who came to work when brother
Stephen began his freshman year at Cornell.
In addition to prepping for labs and editing multimedia files, many interns conduct independent
research projects. In many cases, these projects contribute to the development of new student field
trips, student and teacher workshops, and kits distributed by Carolina Biological Supply Company. Ken
Mizuno was awarded high honors in the Long Island Science Congress for his work on mitochondrial
DNA sequence analysis of Long Island brown trout (Salmo trutta), and Yan Huang performed a similar
study of local rainbow trout (Onchorhynchus mykiss). This work laid the foundation for a collaboration
with students from Curtis High School in Tacoma, Washington, who used our protocols and bioinfor-
matics tools to study wild populations of coho and chinook salmon. Laura Roche (Cold Spring Harbor)
was one of only six Long Island students selected for the Laboratory's Partners for the Future Program.
Under this program, Laura joins Michael Hengartner's lab, which is investigating the developmental
genetics of the nematode worm C. elegans.
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1999 WORKSHOPS
January 9-11
January 12-16
January 21-22
January 26
January 28-29
March 8-10
March 26-28
March 30
April 3
April 5
April 13
April 15-17
April 20
April 26
April 27
April 28
May 4
May 5
May 6
May 7
May 11
May 24-27
June 1
June 2
June 3
June 4
June 7
June 9
June 14-19
June 17
June 21-26
June 28-July 2
June 28-July 9
July 6-9
July 12-16
July 19-23
, MEETINGS, AND COLLABORATIONS
Department of Energy ELSI Workshop, The Science and Issues of Human DNA Polymorphisms,
California Lutheran University, Thousand Oaks
Department of Energy Contractor-Grantee Meeting, Oakland, California
National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collection
visit to American Philosophical Society Library, Philadelphia, Pennsylvania
National Human Genome Research Institute ELSI Project, Eugenics Image Archive,
DNAFTB collection visit to Rockefeller University Archive Center, Tarrytown, New York
Site visits to DNA Lab Schools, New York, New York
National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collection
visit to the Harry Laughlin Archives, Truman State University, Kirksville, Missouri
Department of Energy ELSI Workshop, The Science and Issues of Human DNA Polymorphisms,
Fred Hutchinson Cancer Research Center, Seattle, Washington
DNA from the Beginning interview, Frank Stahl, University of Oregon, Eugene
Laboratory for Rampart and Sierra High Schools, Colorado Springs, Colorado
Site visit by Marie-Luce Vignais, Institut de Genetique Moleculaire, Montpellier, France
DNA from the Beginning interview, Joshua Lederberg, Rockefeller University, New York, New
York
National Human Genome Research Institute ELSI Project, Eugenics Image Archive, Editorial
Advisory Panel Meeting, Banbury Center
Site visit by Donna DeSoto, Cablevision
DNA from the Beginning interview, Marshall Nirenberg, National Institutes of Health, Bethesda,
Maryland
Great Moments in DNA Science Honors Students Seminar, CSHL
DNA from the Beginning interview, Paul Zamecnik, Harvard University, Boston, Massachusetts
DNA from the Beginning interview, Phillip Sharp, Massachusetts Institute of Technology, Boston
Great Moments in DNA Science Honors Students Seminar, CSHL
interview, Richard Roberts, New England Biolabs, Beverly,
and
DNA from the Beginning
Massachusetts
DNA from the Beginning interview, Matthew Meselson, Harvard University, Boston,
Massachusetts
DNA from the Beginning interview, Mahlon Hoagland, Thetford, Vermont
Great Moments in DNA Science Honors Students Seminar, CSHL
National Science Foundation ATE Project, Genomic Biology, Editorial Advisory Board Meeting,
DNALC
Site visit to Long Island Children's Museum, Garden City, New York
Site visit by Victor Albert, New York Botanical Garden, Bronx
Site visit by June Osborn, Josiah Macy, Jr., Foundation, New York, New York
Site visit by Mark Hertle, Howard Hughes Medical Institute, Chevy Chase, Maryland
National Institutes of Health ELSI Review Panel, Bethesda, Maryland
National Science Foundation ATE Biotechnology Fellows Workshop, San Francisco, California
National Science Foundation Workshop, Genomic Biology, Madison Area Technical College,
Wisconsin
Site visit by Seyed Hasnain, Centre for DNA Fingerprinting and Diagnosis, Hyderbad, India
National Science Foundation Workshop, Genomic Biology, University of Texas, Austin
Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
Genomic Biology and PCR Minority Workshop, Central Islip High School, New York
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
Fun With DNA Workshop, DNALC
Fun With DNA Minority Workshop, Intermediate School 59, Springfield Gardens, New York
DNA Science Workshop, DNALC
DNA Science Minority Workshop, John F. Kennedy High School, Bronx, New York
Fun With DNA Workshop, DNALC
Fun With DNA Minority Workshop, Intermediate School 59, Springfield Gardens, New York
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July 26-30
July 29
August 2-6
August 2-7
August 9-13
August 9-14
August 16-20
August 23-27
August 30-
September 3
October 1-3
October 7-8
October 11-13
October 20
October 22-23
October 25
October 28
October 28-31
November 4-7
November 15
December 8-5
December 11
December 15
December 30
DNA Science Minority Workshop, Brooklyn Technical High School, New York
Fun With DNA Workshop, DNALC
Genomic Biology and PCR, DNALC
Site visit by Shozo Enokita, The Institute of Physical and Chemical Research, Saitama, Japan
World of Enzymes Workshop, DNALC
National Science Foundation Workshop, Genomic Biology, University of Maryland, School of
Medicine, Baltimore
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC
National Science Foundation Workshop, Genomic Biology, New Hampshire Community
Technical College, Portsmouth
Fun With DNA Workshop, Section I and II, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
Genomic Biology and PCR Workshop, DNALC
National Human Genome Research Institute ELSI Project, Eugenics Image Archive, Editorial
Advisory Panel Meeting, Banbury Center
Site visit to Carolina Biological Supply Company, Burlington, North Carolina
Howard Hughes Medical Institute Director's Meeting, Chevy Chase, Maryland
Tour of DNALC and luncheon for educators from Queens District 29
National Science Foundation ATE Principal Investigator Meeting, Alexandria, Virginia
Site visit by Fiona Cunningham, Murdoch Institute, Melbourne, Australia
Site visit and laboratory for participants in Federal Judicial Center workshop, Basic Issues of
Science
National Association of Biology Teachers Annual Meeting, Fort Worth, Texas
Science Education Website Developers Meeting, Eccles Institute of Human Genetics, Salt Lake
City, Utah
Site visit by Robert Vizza, The Dolan Foundation
Department of Energy Workshop, The Science and Issues of Human DNA Polymorphisms;
Laney College, Oakland, California
Biology Education Workshop at the Annual American Society for Cell Biology Meeting,
Washington, D.C.
Site visit and seminar by Dr. Carey Phillips, Bowdoin College, Brunswick, Maine
Site visit by John Watson, European Initiative for Biotechnology Education, Luxembourg
Sites of Major Faculty Workshops 1985-1999
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA Foothill College, Los Altos Hills 1997
University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
Canada College, Redwood City 1997
Pierce College, Los Angeles 1998
California Lutheran University, Thousand Oaks 1999
Laney College, Oakland 1999
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
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University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992, 1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Beverly High School 1986
City Lab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994, 1996
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math and Science, Columbus 1990, 1991
MISSOURI Washington University, St. Louis 1989
Washington University, St. Louis 1997
NEW HAMPSHIRE St. Paul's School, Concord 1986, 1987
New Hampshire Community Technical College, Portsmouth 1999
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Columbia University, New York 1993
Cold Spring Harbor High School 1985, 1987
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988-1995
DNA Learning Center 1990, 1992, 1995
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
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Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991,1993
Wheatley School, Old Westbury 1985
U.S. Military Academy, West Point 1996
Stuyvesant High School, New York 1998, 1999
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON University of Washington, Seattle 1993, 1998
Fred Hutchinson Cancer Research Center, Seattle 1999
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
Madison Area Technical College 1999
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SWEDEN Kristineberg Marine Research Station, Fiskebackakil 1995
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1999 PUBLICATIONS
Laboratory Manuals Cancer Surveys Series
Imaging Neurons: A Laboratory Manual Vol. 33: Infections and Cancer
Rafael Yuste, Fredrick Lanni, and Arthur Konnerth (eds.) Robert Newton, Valerie Beral, Robin A. Weiss
Early Development of Xenopus laevis: A Laboratory Manual
Hazel L. Sive, Robert M. Grainger, and Richard M. Harland
CSHL Monograph Series
Prion Biology and Diseases
Stanley B. Prusiner (ed.)
General Books
Journals
Genes & Development (Volume 13, 24 issues)
T. Grodzicker and D. Solter (eds.)
Genome Research (Volume 9, 12 issues)
A. Chakravarti, R. Gibbs, E. Green, R. Myers, M. Boguski, and
L. Goodman (eds.)
Learning & Memory (Volume 6, 6 issues)
J.H. Byrne (ed.)
Mechanisms of Transcription Other
Cold Spring Harbor Symposia on Quantitative Biology LXIII
CSHL Annual Report 1998
Essentials of Glycobiology
Ajit Varki, Richard Cummings, Jeffrey Esko, Hudson Freeze, Banbury Center Annual Report 1998
Gerald Hart, and Jamey Marth
Administration and Financial Annual Report 1998
Illuminating Life: Selected Papers from Cold Spring Harbor
(1903-1969)
Jan Witkowski
Transcriptional Regulation of Eukaryotes
Michael Carey and Stephen Smale
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Video
Manipulating the Early Embryo of Xenopus laevis: A Video
Guide
Robert M. Grainger and Hazel Sive
COLD SPRING HARBOR LABORATORY PRESS
In 1999, the Laboratory's publishing program completed a decade of operation under the banner of Cold
Spring Harbor Laboratory Press. Its evolution from an administrative department of the Laboratory into
a fully developed operating unit with its own balance sheet and day-to-day financial management has
produced a substantial and gratifying growth in size, scope, ambition, and professionalism. And if judged
by the quality of the program's output, its financial performance, and the creation of opportunities for
future growth, the past year was one of the most successful yet.
Books for Scientists
Eight new books and a videotape were published for use by scientists at postgraduate level. Laboratory
manuals are the core of our program, and our growing list was enhanced by two titles with roots in
courses taught at the Laboratory. The scope of Imaging Neurons goes far beyond what could be taught
during students' two-week stay, encompassing a wide range of technologies that offer a look at living
cells in action. The publication of the manual coincided with the completion of the Laboratory's new
Marks Building, in which many of the approaches described in the book are being put to use. The sec-
ond manual, Early Development of Xenopus laevis, and its companion videotape are the product of sev-
eral years' evolution of an important course taught by the authors at the Laboratory. They are invaluable
assets for the community of investigators for whom amphibian eggs are the most useful system for
studying events in embryogenesis.
Two of the 1999 books provided a structured introduction to subjects with growing cross-discipli-
nary importance. Nature makes use of carbohydrates in many and varied ways, and glycoproteins have
roles as diverse as receptors for pathogens, antifreeze agents for cells, and structural support for tis-
sues. Studying these compounds is technically demanding but there is growing appreciation of their
importance in cell biology, structural biology, molecular genetics, and even clinical medicine, as defects
in carbohydrate function are linked with disease states. Essentials of Glycobiology is therefore a timely
book, assembled by a committed group of editors intent on providing the scientific community with an
excellent introduction to carbohydrate biology. The book's enthusiastic reviews suggest that they have
succeeded. Transcriptional Regulation in Eukaryotes is also a crusading work, by experienced teachers
of a course at the Laboratory who believe that the regulation of gene expression must be understood
by anyone investigating a biological or medical problem in which DNA is implicated. Their book, a com-
bined textbook and laboratory manual, has been very warmly received.
Special mention must also be made of a handsome book initially conceived by James Watson as
a gift to all future incoming graduate students at the Laboratory. A collection of outstanding research
papers published by scientists at Cold Spring Harbor from 1903 to 1969, Illuminating Life is an account
of the Laboratory's scientific heritage, made attractive and accessible through a series of masterly com-
mentaries on the papers and their authors by Jan Witkowski, director of the Banbury Center.
The celebrated series of Cold Spring Harbor Laboratory monographs was expanded by the addi-
tion of a new title, Prion Biology and Diseases. This book is the most comprehensive and authoritative
yet published on these fascinating and mysterious infectious proteins and was made possible by the
unrelenting energy of the Nobel-prize-winning discoverer of prions, Stanley Prusiner, who not only edit-
ed the book but wrote or co-wrote a substantial part of it.
Amid the noisy debate about the value of the Internet as an alternative distribution medium for
books, the staff of our Editorial Development Department quietly laid the foundation for its use in a less
glamorous but nevertheless fundamental task. FTP sites were used extensively for communication
between authors and our far-flung network of talented developmental editors. Transcriptional Regulation
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in Eukaryotes was the first title to be handled entirely in this manner, with no resort to expensive couri-
ers for manuscript delivery. In addition, we incorporated the use of End Note. reference management
into the development of our books and created databases for information such as cautions and trade-
marks that recur in many different titles.
Books for Students
In March, Alex Gann joined us as senior editor for textbooks and quickly took the lead in identifying
interesting publishing projects and likely authors. To this task, he brings postdoctoral research and writ-
ing experience with Laboratory Trustee Mark Ptashne, a stint as an editor at Nature magazine, teach-
ing experience at the University of Lancaster, broad scientific interests, and a flair for language. The
beginnings of this new and ambitious program are promising, and by year's end several books were
under way. The use of the Meier House at the Banbury Center is an invaluable asset to this program,
allowing authors of complex publishing projects to get together in comfort without distraction.
Books Online
Although high-quality books remain popular and economically viable, the use of the Internet as a pub-
lishing medium is very alluring and can only grow in importance as screen and printing technologies
advance. A number of initiatives were taken this year that will bear fruit in 2000 and beyond. Among
them was an agreement to partner with the National Center for Biotechnology Information in their
Books@NCBI program. This is an experiment in the integration of book content with the invaluable
Pub Med database of journal bibliographic information. A user doing a keyword search in Pub Med will
be able to go beyond the journal abstracts to sections from selected books that provide background or
reference information on the topic being explored.
The Cold Spring Harbor books to be included are the authoritative monograph Retroviruses and
the new advanced textbook Essentials of Glycobiology. Neither will be available electronically in its
entirety, but the usage data available from the NCB! Web site will tell us much about how readers might
use such information if whole texts were to be posted online. And although these projects are very early
stage, we are already reflecting on how this means of distribution would affect the editorial organization
of scholarly books and the mechanics of bookmaking.
Journal Publishing
All three Cold Spring Harbor journals, Genes & Development, Genome Research, and Learning &
Memory, had a satisfactory year. Subscription levels were either maintained or actually increased, no
small achievement under current market conditions. Although keenly interested in the many experi-
ments with online-only subscriptions being conducted by scientific societies, we elected to continue
offering both the print and online editions in a combined subscription package to both individual and
institutional subscribers. All three journals were offered substantially more manuscripts than ever
before. Advertising sales in the two larger journals jumped by a remarkable 30%. The utility of the online
editions continued to be enhanced by the software tools developed by our excellent electronic pub-
lishing partner High Wire Press at Stanford University. In the case of Genome Research, this included
the ability to publish papers online much ahead of their appearance in print.
The impact factor of all three journals, measured by citation analysis, continued to rise. Genes &
Development's score, 19.07, maintained the journal's rank among the top ten primary research jour-
nals in biology.
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After 12 years' experience in the creation of successful, high-quality publications, journal publish-
ing is decidedly a core competence of CSHL Press. In that time, we have declined a number of offers
of journal-publishing partnerships. However, this year we competed for, and won, a contract to publish
the journal Protein Science for its owner, the Protein Society. This journal is well established, has a large
and productive constituency, and is well positioned for the deluge of new scientific information to come
from the era variously called "postsequence biology" or "proteomics." It also has much unfulfilled poten-
tial for subscription and advertising sales and the application of electronic publishing techniques. The
first issue of the journal published from Cold Spring Harbor will be dated January 2001, and by year's
end, we were already working with the Society's editors and officers on the myriad details required to
ensure a seamless transition from the journal's previous publisher.
Sales, Marketing, and Distribution
Promotional activities in 1999 encompassed direct mail, meeting exhibits, and advertising in print pub-
lications and online. We attended ten professional meetings, displaying our newest books as well as
popular backlist titles. The Press's Web site was enhanced to include the covers of all new books as
well as excerpts from reviews. Sales from the site continued to rise significantly.
A complete database of information on our titles was created to supply appropriately formatted
data to online booksellers such as Amazon.com and Barnesandnoble.com, an increasingly important
marketing channel.
A new, more aggressive sales program aimed at major resellers resulted in a substantial increase
in orders. New agreements were signed with partners who could provide effective book promotion and
distribution in Canada and in China, Taiwan, and Hong Kong. A long-standing agreement for distribu-
tion of our books in Japan was renewed. Agreement was reached for the creation of low-cost editions
of several titles for exclusive sale in Korea, a first step toward the routine publication of affordable inter-
national editions for scientists in less wealthy countries. We have long had difficulty ensuring reliable and
effective distribution of Cold Spring Harbor books through bookstores in Europe, and after an intense
round of meetings at the Frankfurt Book Fair in October, we closed the year poised to launch an ambi-
tious plan to address the European challenge.
Staff
The staff members of the Press (as of December 1999) are listed elsewhere in this volume. Their hard
work, commitment, cordial dealings with the scientific community, and dedication to high standards
were essential to the year's achievements. Many of the new initiatives in sales and marketing were the
responsibility of Guy Keyes, who added the new role of sales manager to his duties as fulfillment and
distribution manager. We also welcomed several new members of staff: Alex Gann as senior textbook
editor; Emily Huang as assistant editor for Genome Research and Learning & Memory; Jennifer Bloch
as financial assistant; Ma la Mazzullo as production assistant; and Nora Mclnerny as development assis-
tant. In October, Kaetrin Simpson joined us as developmental editor for the annual Symposium volume
and Annual Report. After her outstanding research career had been cut short by illness, her abundant
talent in this new role was quickly evident. Her death in February was a tragedy for her brave and ded-
icated family and robbed us of a much valued colleague.
After the past decade's growth, we now have a staff of 40 in five locations throughout the United
States engaged in a publishing program of increasing size, diversity, and technical complexity. I am
more grateful than ever for the leadership and drive for excellence that characterize the senior staff of
our organization: Jan Argentine, editorial development manager; Ingrid Benirschke, marketing manag-
er; Marcie Ebenstein, advertising manager; Nancy Hodson, business manager; Guy Keyes, sales and
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fulfillment manager; Denise Weiss, production manager; and the editors of our journals, Terri
Grodzicker at Genes & Development and Laurie Goodman at Genome Research. New media tech-
nologies are fascinating in their power to create and transform communities and change the way infor-
mation is distributed and used. But effective publishing relies primarily on the efforts of talented peo-
ple at every level and the success with which they work together. At Cold Spring Harbor, we are for-
tunate to have both an outstanding staff and access to remarkable authors and editors, to whose ser-
vice in the next decade we will continue to bend the best of the new technologies.
John R. Inglis
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FINANCIAL STATEMENTS
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
December 31, 1999 and 1998
Assets: 1999 1998
Cash and cash equivalents $ 34,830,286 16,258,527
Investments 203,853,845 158,108,972
Accounts receivable:
Publications 837,564 782,598
Other 333,310 172,405
Grants receivable 2,759,349 2,384,707
Contributions receivable 4,878,895 2,657,748
Publications inventory 2,138,874 1,923,784
Prepaid expenses and other assets 1,321,313 1,482,543
Investment in employee residences 2,751,580 2,464,260
Land, buildings, and equipment:
Land and land improvements 12,614,303 12,557,726
Buildings 80,460,206 69,897,882
Furniture, fixtures, and equipment 5,427,259 5,037,823
Laboratory equipment 12,405,968 12,626,629
Library books and periodicals 365,630 365,630
Construction in progress 4,514,827 4,256,539
115,788,193 104,742,229
Less accumulated depreciation and amortization (34,481,784) (32,455,453)
Land, buildings, and equipment, net 81,306,409 72,286,776
Total assets $ 335,011,425 258,522,320
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 4,840,651 2,809,788
Notes payable 251,918 276,163
Bonds payable 45,200,000 30,000,000
Deferred revenue 2,878,365 3,358,722
Total liabilities 53,170,934 36,444,673
Net assets:
Unrestricted
General operating 14,690,474 10,598,288
Designated by board for:
Research programs 1,900,000 1,900,000
Capital expenditures 812,186 1,207,889
Endowment 110,214,894 71,296,987
Net investment in plant 33,760,513 42,010,613
Total unrestricted 161,378,067 127,013,777
Temporarily restricted 8,587,520 4,185,424
Permanently restricted 111,874,904 90,878,446
Total net assets 281,840,491 222,077,647
Total liabilities and net assets $ 335,011,425 258,522,320
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 1999
With comparative totals for the year ended December 31, 1998
Unrestricted
Temporarily
Restricted
Permanently
Restricted
1999
Total
1998
Total
Revenue, gains, and other support:
Public support (contributions and
nongovernment grant awards) $ 8,998,897 8,587,520 6,291,765 23,878,182 22,568,032
Government grant awards 17,658,439 - 17,658,439 15,929,141
Indirect cost allowances 11,377,795 - - 11,377,795 11,230,797
Other revenue:
Program fees 2,385,687 2,385,687 2,388,531
Rental income 358,934 358,934 333,196
Publications sales 6,400,303 - - 6,400,303 6,341,142
Dining services 2,445,184 - 2,445,184 2,444,384
Rooms and apartments 1,865,047 - 1,865,047 1,877,794
Royalty and licensing fees 606,691 606,691 754,705
Gain on sale of investments (net) 3,192,266 - 3,327,199 6,519,465 10,426,775
Investment income
(interest and dividends) 6,967,857 - 6,967,857 6,053,220
Miscellaneous 146,841 146,841 124,984
Total other revenue 24,368,810 - 3,327,199 27,696,009 30,744,731
Net assets released from restrictions 4,185,424 (4,185,424)
Total revenue, gains, and other support 66,589,365 4,402,096 9,618,964 80,610,425 80,472,701
Expenses:
Research 31,454,215 - - 31,454,215 28,718,081
Meetings and courses 9,153,276 9,153,276 7,834,447
Publications 6,159,371 - 6,159,371 6,219,895
Banbury Center conferences 1,111,921 1,111,921 877,834
DNA Learning Center programs 1,059,168 - 1,059,168 1,034,538
General and administrative 7,767,286 7,767,286 6,663,226
Dining services 3,117,043 3,117,043 2,850,714
Total expenses 59,822,280 59,822,280 54,198,735
Increase (decrease) in net assets 6,767,085 4,402,096 9,618,964 20,788,145 26,273,966
Other changes in net assets:
Net unrealized gain on fair value
of investments 28,195,266 11,377,494 39,572,760 1,517,302
Extraordinary item-loss on
refinancing of debt (598,061) (598,061)
Change in net assets 34,364,290 4,402,096 20,996,458 59,762,844 27,791,268
Net assets at beginning of year 127 013 777 4,185,424 90,878,446 222,077 647 194,286,379
Net assets at end of year $ 161,378,067 8,587,520 111,874,904 281,840,491 222,077,647
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended December 31, 1999 and 1998
1999 1998
Cash flows from operating activities:
Increase in net assets $ 59,762,844 27,791,268
Adjustments to reconcile increase in net assets to net
cash provided by operating activities:
Depreciation and amortization 3,526,229 3,443,290
Write off deferred bond costs 598,061
Net appreciation in fair value of investments (46,092,225) (11,944,077)
Contributions restricted for long-term investment (10,043,571) (10,762,186)
Changes in assets and liabilities:
(Increase) decrease in accounts receivable (215,871) 32,885
(Increase) decrease in grants receivable (374,642) 654,186
Increase in contributions receivable (2,221,147) (950,143)
(Increase) decrease in publications inventory (215,090) 67,923
Increase in prepaid expenses and other assets (436,831) (105,279)
Increase in accounts payable and accrued expenses 2,030,863 210,027
Decrease in deferred revenue (480,357) (2,195,315)
Net cash provided by operating activities 5,838,263 6,242,579
Cash flows from investing activities:
Capital expenditures (12,545,862) (11,132,700)
Proceeds from sales and maturities of investments 70,618,250 25,341,828
Purchases of investments (70,270,898) (30,933,170)
Net change in investments in employee residences (287,320) (194,915)
Net cash used in investing activities (12,485,830) (16,918,957)
Cash flows from financing activities:
Permanently restricted contributions 6,291,765 9,342,949
Contributions restricted for investment in land, buildings, and equipment 3,751,806 1,419,237
Repayment of bonds payable (27,000,000) -
Issuance of bonds payable 42,200,000
Repayment of notes payable (24,245) (369,676)
Net cash provided by financing activities 25,219,326 10,392,510
Net (decrease) increase in cash and cash equivalents 18,571,759 (283,868)
Cash and cash equivalents at beginning of year 16,258,527 16,542,395
Cash and cash equivalents at end of year $ 34,830,286 16,258,527
Supplemental disclosures:
Interest paid $ 1,494,414 1,254,036
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COMPARATIVE OPERATING HISTORY 1995-1999
(Dollars in Thousands)
1995 1996 1997 1998 1999
Revenue:
Main Lab:
Grants and contracts $ 19,653 20,879 22,743 24,025 27,397
Indirect cost reimbursement 8,881 9,704 9,910 11,054 11,207
Other 7,461 7,859 8,472 9,441 9,426
CSHL Press 5,119 4,805 5,238 6,341 6,400
Banbury Center 1,732 1,214 1,495 1,444 1,848
DNA Learning Center 954 754 875 1,334 1,392
Total income 43,800 45,215 48,733 53,639 57,670
Expenses:
Main Lab:
Research and training 19,653 20,879 22,743 24,025 27,397
Operation and maintenance of plant 5,266 5,446 5,274 5,549 5,765
General and administrative 3,329 3,438 3,625 3,378 3,844
Other 4,959 5,367 5,759 7,328 7,863
CSHL Press 5,079 5,032 5,320 6,141 6,077
Banbury Center 1,643 1,225 1,437 1,321 1,614
DNA Learning Center 958 781 887 1,228 1,280
Total expenses, excluding depreciation 40,887 42,168 45,045 48,970 53,840
Excess before depreciation, amortization,
and release of designated funds 2,913 3,047 3,688 4,669 3,830
Depreciation and amortization (2,821) (2,988) (3,371) (3,443) (3,526)
Release (designation) of funds (1) - (750)
Net operating excess $ 92 59 317 476 304
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the imaging, computational neuroscience, and other research programs.
COLD SPRING HARBOR LABORATORY Endowments and Board
SOURCES OF REVENUE
Designated Funds
7.7
YEAR ENDED DECEMBER 31, 1999
Foundation and Private
Contributions and Grants
28.1%
Royalty and Licensing
Fees
3.1%
Royalty and Licensing
Fees
17.2%
Interest and Miscellaneous
1.4%
Corporate Contributions
and Grants
4.8%
Federal Grants
37.7%
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substantial
portion of their funding through grants from the Federal Government and through grants, capital gifts,
and annual contributions from private foundations, corporations, and individuals. The following section
summarizes funding that occurred during 1999.
GRANTS January 1, 1999-December 31, 1999
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 1999 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Dr. Herr 1/92-12/01 $ 4,115,617
Dr. Stillman 8/90-7/00 2,867,555
Research Support Dr. Cline 12/95-11/04 459,969
Dr. Cline 3/98-2/01 274,338
Dr. Enikolopov 8/99-5/04 315,957*
Dr. Enikolopov 9/94-11/03 346,363
Dr. Futcher 4/93-3/01 275,448
Dr. Futcher 1/91-6/00 57,273
Dr. Hannon 8/95-5/00 286,286
Dr. Helfman 9/99-8/04 316,950
Dr. Hengartner 5/95-4/00 252,086
Dr. Herr 8/96-7/00 219,725
Dr. Hirano 5/96-4/00 223,376
Dr. Joshua-Tor 8/96-7/00 239,659
Dr. Krainer 7/89-6/02 425,968
Dr. Lowe 7/99-6/04 308,741
Dr. Malinow 5/92-4/00 260,426
Dr. Malinow 4/95-2/03 368,051
Dr. McCombie 1/99-12/03 432,555
Dr. McCombie 9/99-9/02 1,306,667
Dr. Neuwald 10/98-8/01 334,876
Dr. Skowronski 4/98-3/03 459,736
Dr. Stillman 7/91-5/00 535,861
Dr. Svoboda 12/98-11/03 68,943
Dr. Tonks 8/91-3/01 515,571
Dr. Tonks 5/97-4/01 290,564
Dr. Tully 4/94-3/02 342,191
Dr. Tully 8/96-6/00 299,938
Dr. Van Aelst 12/97-11/01 370,787
Dr. Wig ler 9/95-8/00 256,486
Dr. Wig ler 7/98-4/02 887,709
Dr. Wig ler 5/99-4/00 168,000
Dr. Xu 1/98-12/02 294,209
Dr. Yin 9/96-4/02 345,586
Dr. M. Zhang 9/97-8/00 364,376
Dr. Zhong 2/96-1/00 260,402
*New Grants Awarded in 1999
*Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1999 Funding*
Fellowships Dr. Groover 5/99-4/01 31,720 *
Dr. Haas 7/98-6/01 36,700
Dr. Horiuchi 10/98-9/00 36,700 *
Dr. Nimchinsky 9/98-8/01 38,368
Dr. Ruthazer 3/99-2/02 36,700 *
Training Support Training in Cancer Cell Biology and 7/94-12/03 279,686
Tumor Virology
Course Support Cancer Research Center Workshops 4/92-3/00 276,440
Neurobiology Short-term Training 5/82-4/01 149,803
Analysis of Large DNA Molecules 4/91-3/01 56,288
Computational Genomics 9/91-8/01 42,461
In Situ Hybridization and Immunocytochemistry 7/98-6/03 67,757
Automated Genome Sequencing 4/95-3/01 80,299
Molecular Biology and Development
of Xenopus laevis
4/96-3/00 10,000
C. elegans 8/98-6/01 36,1010
Meeting Support Genome Mapping and Sequencing 4/90-3/02 34,900 "
Telomeres and Telomerase 3/99-4/00 19,320 *
Learning and Memory 3/99-2/00 15,525 *
Tyrosine Phosphorylation and 4/99-4/00 8,000 *
Cell Signaling
Biology of Proteolysis 4/99-4/00 11,000 *
Neurobiology of Drosophila 6/99-5/00 13,000 *
64th Symposium: Signaling and Gene 6/98 5/01 10,000
Expression in the Immune System
Microbial Pathogenesis and Host Defense 6/99-5/00 2,000 "
Mechanisms of Eukaryotic Transcription 7/99-6/00 7,000 "
Eukaryotic mRNA Processing 7/99-7/00 6,000 *
Programmed Cell Death 8/99-7/00 10,000 *
Eukaryotic DNA Replication 8/99-8/00 11,000 *
Making/Using DNA Microarrays 9/99-9/01 49,034 *
NATIONAL SCIENCE FOUNDATION
Cooperative Agreement Dr. McCombie 2/99-1/02 2,831,574 *
Research Support Dr. Cline 5/99-8/03 120,000 *
Dr. Grossniklaus 8/97-7/00 120,000
Dr. Helfman 2/99-1/03 105,426 *
Dr. Jackson 1/98-12/00 100,000
Dr. Martienssen 11/98-10/99 545.691
Drs. NestlerANigler 4/98-3/00 100,000
Training Support Undergraduate Research Program 6/91-5/00 50,000
Course Support Advanced Bacterial Genetics 5/99-4/02 62,879 *
Arabidopsis Molecular Genetics 6/94-5/00 60,000
Early Development of Xenopus laevis 9/98-8/02 19,311 *
Meeting Support Biology of Proteolsis 4/99-3/00 6,000 *
Tyrosine Phosphorylation and Cell Signaling 4/99-3/00 8,000 *
Learning and Memory 4/99-3/00 9,488 *
Mechanisms of Eukaryotic mRNA Processing 7/99-6/00 5,000 *
*New Grants Awarded in 1999
*Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1999 Funding*
Mechanisms of Eukaryotic Transcription 7/99-6/00 5,000 *
Eukaryotic DNA Replication 8/99-7/00 6,000
Programmed Cell Death 9/99-8/01 4,000
Neurobiology of Drosophila 10/99-9/00 15,010 "
Equipment A Scanning Electron Microscope for 3/99-2/01 129,654 *
Studies in Developmental Biology
DEPARTMENT OF ENERGY
Research Support Dr. Martienssen 8/91-2/01 100,000
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Drs. McCombie/Martienssen 9/97-8/00 124,042
Dr. Martienssen 9/97-8/00 67,097
Drs. McCombie/Martienssen 7/98-8/01 90,444
Dr. Jackson 9/99-8/01 105,000 *
Dr. Grossniklaus 9/98-8/00 60,000
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Futcher 7/97-6/00 102,628
Dr. Hannon 9/96-8/00 149,998
Dr. Helfman 7/99-6/02 117,600
Dr. Hengartner 7/97-6/00 103,120
Dr. Van Aelst 7/99-6/02 117,600 *
Dr. Zhong 9/99-8/02 238,901 *
Fellowship Support Dr. Donovan 7/97-6/00 41,053
J. Polyakova 7/97-6/00 20,000
Dr. Samuelson 6/98-5/01 41,053
Dr. De Stanchina 5/99-6/02 40,920 *
Dr. Simpson 7/99-6/02 42,000 *
Meeting Support Microbial Pathogenesis and Host Response 3/99-2/00 10,000 *
MISCELLANEOUS GRANTS
Research Support
Alzheimer's Association Dr. Barris 8/99-7/00 40,000 *
Dr. Esteban 8/99-7/00 40,000 *
Dr. Malinow 8/99-7/00 60,000 *
American Cancer Society Dr. Wig ler, Professorship 1986-2012 50,000
Dr. Wig ler, Supply Allowance 1999 10,000
Dr. Lowe 7/00-6/02 150,000 *
Dr. Joshua-Tor 7/00-6/02 120,000 *
R. Badge ley Trust Dr. Hengartner 6/99-5/00 25,000 *
Calbiochem-Novabiochem Dr. Krainer 2/96-1/00 60,000
Corporation
Council for Tobacco Research Dr. Futcher 1/97-12/99 70,3040
Dr. Skowronski 7/97-6/00 83,000
Devgen N.V. Dr. Hengartner 4/98-3/01 200,000
*New Grants Awarded in 1999
*Includes Direct & Indirect Cost
Grantor Program/Principal Investigator Duration of Grant 1999 Funding'
Fairchild Martindale Foundation Advanced Neuroscience Imaging Center 1999-2000 50,000 *
Equipment
The Freya Foundation Dr. Svoboda 6/99-6/00 30,000 *
The Lillian Goldman Charitable Dr. Wig ler 1999 200,000
Trust through The Breast
Cancer Research Foundation
Lita Annenberg Hazen Neurobiology Support 12/98-11/00 200,000
Foundation
The John A. Hartford Dr. Tully 1/97-12/99 317,706
Foundation, Inc.
Human Frontier Science Dr. Hirano 7/98-6/01 55,000
Program Dr. Svoboda 9/98-8/01 68,690
Dr. Tully 8/99-8/00 46,670 *
The Hyde and Watson Foundation Advanced Neuroscience Imaging Center 1999-2000 10,000 *
Equipment
L.I.F.E. Dr. Wig ler 10/98-9/99 48,822 *
Manhassett Women's Coalition Dr. Wig ler 1999 25,000 *
Against Breast Cancer
March of Dimes Dr. Enikolopov 6/98-5/00 66,048
Dr. Hengartner 6/99-5/00 54,402 *
Edwin and Nancy Marks Advanced Neuroscience Imaging Center 1999-2000 1,000,000 *
Program and Equipment Costs
G. Harold & Leila Y. Mathers Dr. Svoboda 3/99-2/02 290,138 *
Charitable Foundation
Maxfield Foundation Dr. Lazabnik 1/98-12/99 10,000
The McKnight Endowment Dr. Yin 7/96-6/99 50,000
Fund for Neuroscience
Mellam Family Foundation Dr. Tonks 12/96-11/00 50,000
Merck Genome Research Dr. M. Zhang 11/97-10/99 90,000
Institute
Monsanto, Inc.-Plant Dr. Martienssen 1/98-12/02 135,000
Consortium Program
Neurofibromatosis Foundation Dr. Van Aelst 1999 40,000 *
Dr. Zhong 1999 50,000 *
NIH/Sloan Kettering Dr. Wig ler 9/95-8/00 589,819
Consortium Agreement
NIH/Sloan Kettering Drs. TonksNan Aelst 8/97-5/01 457,484
Consortium Agreement
NIH/Nanoprobes, Inc. Dr. Spector 9/96-8/00 31,100
Consortium Agreement Dr. Spector 9/99-2/00 12,180 *
NIH/University of Pennsylvania Dr. Yin 10/97-9/01 100,000
Consortium Agreement
NIH/Washington University Dr. Stein 1/98-6/99 182,762 *
Consortium Agreement Dr. Stein 3/99-2/00 35,576 *
Dr. Stein 9/99-8/00 134,118 *
N.A.T.O. Dr. Hannon 1/98-4/99 5,080
Novartis-Plant Consortium Dr. Martienssen 1/98-12/02 135,000
Program
N.S.F./Clemson Dr. McCombie 10/99-9/02 365,500 *
Offin Charitable Trust Dr. Hengartner 8/98-7/99 25,000
Perkin Fund Dr. Zhong 6/97-5/99 25,000
Pioneer Hi-Bred International Dr. Grossniklaus 10/97-9/99 35,000
Michael Rankowitz and Shelia Dr. Zhong 1999 25,000
Heffron
Seraph Foundation Dr. Enikolopov 12/98-11/99 27,000 *
Dr. Lazebnik 12/98-11/99 23,000 *
*New Grants Awarded in 1999
Includes Direct & Indirect Cost
369
Grantor Program/Principal Investigator Duration of Grant 1999 Funding*
Schwarz Foundation Dr. Svoboda 2/99-1/00 33,440 *
SNP Consortium Dr. McCombie 11/99-11/00 89,057 *
Dr. Stein 4/99-9/01 1,176,916 *
Lauri Strauss Leukemia Dr. Tonks 1999 15,000*
Foundation, Felix Schnyder
Memorial Fund
St. Giles Foundation Dr. Wig ler 4/98-3/00 257,400
Tularik, Inc. Dr. Wig ler 10/97-10/03 660,000
U.S.D.A./Clemson Dr. McCombie 10/99-9/02 365,500 *
Westvaco-Plant Consortium Program Dr. Martienssen 1/98-12/02 135,000
The Whitaker Foundation Dr. Svoboda 6/98-7/01 52,940
Zeneca, Ltd-Plant Consortium Dr, Martienssen 7/99-12/02 135,000 *
Fellowships
Rita Allen Foundation Dr. Hengartner 9/94-8/99 30,000
Dr. Lowe 9/99-8/00 50,000 *
American Cancer Society Dr. Drier 7/99-6/02 30,000 *
Burroughs Wellcome Fund Dr. Mainen 9/97-8/00 121,000
Cancer Research Fund of the Damon Dr. Z. Zhang 6/99/5/02 37,000 *
Runyan-Walter Winchell Foundation
CSHL Association 1999 193,280 *
Joyce Green Foundation Dr. Zhong 1/99-12/99 10,000 *
Joseph G. Goldring Foundation Dr. Stillman 7/99-6/00 60,000 *
Helen Hoffritz Foundation Dr. Cline 12/97-12/99 30,000
The Ellison Medical Foundation Dr. Grewal 9/99-8/00 50,000 *
Sidney Kimmel Foundation Dr. Tansey 7/99-6/01 100,000 *
Esther A. and Joseph Dr. Svoboda 7/98-6/01 40,000
Klingenstein Fund, Inc.
Charles Henry Leach II Dr. Enikolopov 1/97-12/99 25,000
Foundation
Leukemia Society of America Dr. Julien 7/99-6/02 33,250 *
Inc. Dr. Kimura 7/97-6/00 36,700
Dr. Pendergrast 7/98-6/01 39,700
Dr. Soengas 7/99-6/02 39,700 *
Dr. Weinreich 7/97-6/00 36,700
NARSAD Dr. Esteban 7/99-6/00 30,000 *
Life Science Research Dr. Vollbrecht 6/99-5/02 40,000 *
Foundation
Pew Charitable Trust Dr. Hannon 7/97-6/01 60,000
Dr. Hirano 7/96-6/00 60,000
Dr. Svoboda 7/98-6/02 60,000
Searle Scholars Program Dr. Grossniklaus 7/98-6/01 60,000
Andrew Seligson Memorial Dr. Herbst 1999 35,000
Fellowship Dr. Mac Cullum 1999 35,000
Tularik, Inc. Fellowships 1/98-12/03 150,000
The V Foundation Dr. Myers 1999 50,000
Helen Hay Whitney Dr. Sabatini 4/99-3/02 32,000 *
Foundation Dr. Sun 1/97-12/99 36,000
Course Support
Burroughs Wellcome Fund Genome Informatics 1999 25,000*
Chroma Technology Advanced Molecular Cytogenics 1998-1999 2,500
Corporation
Grass Foundation Scholarships 1999 15,000
*New Grants Awarded in 1999
*Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1999 Funding*
Howard Hughes Medical Advanced Neurobiology Courses 1991-1999 275,000
Institute
Institute for Biological Crystallography Workshop 1999 1,000 "
Recognition & Catalysis, Inc.
Esther A. and Joseph Advanced Neurobiology Courses 3/98-2/01 60,000
Klingenstein Fund, Inc.
Merck Genome Research Institute Genome Informatics 1999 20,000 "
Meeting Support
Alexis Biochemical Corp. Corporate Contribution Program 1999 1,500 *
Asi/Applied Spectral Imaging Advanced Molecular Cytogenics 1999 7,000 *
AstraZeneca Pathogenesis 1999 2,000 *
Biogen, Inc. Corporate Contribution Program 1999 6,000 *
Bruker Axs, Inc. Crystallography Workshop 1999 1,000
Burroughs Wellcome Fund Pathogenesis 1999 5,000 *
Chiron Corporation Molecular Approaches to Vaccine Design 1999 10,000 *
Chroma Technology Corp. Advanced Molecular Cytogenics 1999 2,500 *
CuraGen Corporation Corporate Contribution Program 1999 6,000 *
Genome Systems, Inc. Corporate Contribution Program 1999 6,000 *
Hoffmann-LaRoche, Inc. Crystallography Workshop 1999 500
Intrabiotics Pharmaceuticals Pathogenesis 1999 1,500 *
NCI-Frederick Cancer Advanced Molecular Cytogenics 1999 25,000 "
Research and Development
Center
Nonius Crystallography Workshop 1999 300 *
Pfizer Crystallography Workshop 1999 750 *
Pharmacia and Upjohn Pathogenesis 1999 2,000 *
Company
PharMingen Corporate Contribution Program 1999 6,000 *
Protein Solutions, Inc. Crystallography Workshop 1999 500 *
Qiagen GMBH Corporate Contribution Program 1999 3,000 *
Alfred P. Sloan Foundation Computational Biology Workshop 1999 9,650 *
"New Grants Awarded in 1999
*Includes Direct & Indirect Cost
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BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant 1999 Funding'
FEDERAL SUPPORT
The Federal Judicial Center,
Judiciary Leadership
Development Council
NIH-NCI-Frederick Cancer
Research and Development
Center
NIH-National Human Genome
Research Institute
U.S. Army Medical Research
(through a grant to Children's
Hospital)
NONFEDERAL SUPPORT
Meeting Support
ALS Association
A-T Children's Project
The Charles A. Dana Foundation
Ehlers-Danlos National
Foundation
The William Stamps Farish
Fund
Glaxo Wellcome Inc.
The John A. Hartford
Foundation, Inc.
The Hastings Center
Hereditary Disease Foundation
The Esther A. and Joseph
Klingenstein Fund, Inc.
Merck & Co., Inc.
Merck KGaA
The National Neurofibromatosis
Foundation, Inc.
Osiris Therapeutics, Inc.
Albert B. Sabin Vaccine
Institute, Inc.
SyStemix, Inc.
The Swartz Fund for
Computational Neuroscience
*New Grants Awarded in 1999
'Includes Direct & Indirect Cost
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The Basic Issues of Science for
Federal and State Judges
Functional Genomics: Technology
Development and Research
Applications
Digital Image Archive on the American
Eugenic Movement Editorial Advisory
Panel Workshops
Natural History of Plexiform Neurofibromas
in NF-1
Strategies for Inactivation of Mutant Genes
The Molecular Neurobiology of ATM
Molecular Neurobiological Mechanisms
in Schizophrenia: Seeking a Synthesis
The Clinical and Biological Basis of
the Ehlers-Danlos Syndrome
Xenotransplantation: A Scientific
Basis for Risk Assessment
Host Pathogens Interactions
Old Memories
Xenotransplantation: A Scientific
Basis for Risk Assessment
Strategies for Inactivation of Mutant Genes
Klingenstein Neuroscience Fellows
Conference
Functional Genomics: Technology
Development and Research Applications
Molecular Neurobiological Mechanisms
in Schizophrenia: Seeking a Synthesis
Natural History of Plexiform
Neurofibromas in NF-1
What are Stem Cells? From Embryo
to Adult Tissues
Vaccines for Developing Economies:
Who Will Pay?
What are Stem Cells? From Embryo
to Adult Tissues
The Functional Organization of Thalamus
and Cortex and Their Interactions
1999
1999
1999
1999
1999
1999
' 1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
$ 18,325 *
20,000 *
17,025
13,567 *
13,919 *
30,624 *
45,000 *
25,009 *
21,950
7,200 *
31,639
9,249 *
13,919 *
44,187 *
10,778 *
5,000 *
11,406 *
23,032 *
30,983 *
15,000 *
44,187 *
DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant 1999 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH Creation of a Digital Image Archive on the 3/98-2/00
ELSI Research Program American Eugenics Movement
NATIONAL SCIENCE FOUNDATION A Partnership to Develop Advanced 8/97-7/00
Technology Units on Genomic Biology
DEPARTMENT OF ENERGY The Science and Issues of Human DNA 1/97-1/00
Polymorphisms: An ELSI Training Program
for High School Biology Teachers
NONFEDERAL GRANTS
Hearst Foundation
Howard Hughes Medical Institute
Josiah Macy, Jr. Foundation
Genetics as a Model for Whole Learning
Precollege Science Education Initiative
for Biomedical Research Institutions
DNA from the Beginning
7/98-6/99
7/94-8/99
10/97-9/00
The following schools each awarded a grant for Genetics as a Model for Whole Learning Program:
East Meadow Union Free School District
East Woods School
Elwood Union Free School District
Garden City Public School
Great Neck Union Free School District
Green Vale School
Harborfields Central School District
Half Hollow Hills Central School District
Intermediate School 59
Jericho Union Free School District
LaSalle Regional
$4,025
730
2,850
6,535
4,860
3,550
8,800
2,875
350
6,950
125
$181,948
178,915
85,732
27,766
82,730
264,775
Lawrence Union Free School District $ 6,650
Locust Valley Central School District 13,650
Northport-East Northport Union Free School District 1,650
NYC Community School District 17
Plainedge Union Free School District
Port Jefferson Union Free School District
Port Washington Union Free School District
Old Westbury School of the Holy Child
South Huntington Union Free School District
St. Dominic Elementary School
Syosset Central School District
The following schools each awarded a grant for the Curriculum Study Program:
Commack Union Free School District
East Meadow Union Free School District
East Woods School
Friends Academy
Garden City Union Free School District
Great Neck Union Free School District
Half Hollow Hills Central School District
Harborfields Central School District
Herricks Union Free School District
Island Trees Union Free School District
Jericho Union Free School District
Lawrence Union Free School District
Levittown Union Free School District
$1,100
1,100
1,500
1,500
1,100
1,100
2,200
2,100
1,100
1,100
1,100
2,200
1,100
Locust Valley Central School District
Long Beach City School District
North Shore Central School District
Oceanside Union Free School District
Plainedge Union Free School District
Plainview-Old Bethpage Central School District
Portledge School
Port Washington Union Free School District
Ramaz School
Roslyn Union Free School District
Syosset Central School District
West Hempstead Union Free School District
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1,075
250
3,600
1,775
16,970
3,175
23,625
$1,100
1,100
1,100
1,500
1,100
1,100
1,100
1,100
1,100
1,100
1,100
1,100
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We wish to express the genuine gratitude of the trustees, administration, and most especial-
ly the scientists of Cold Spring Harbor Laboratory for the generous financial support of those
persons, corporations, and foundations whose names appear on the following pages of the
Annual Report.
Richard L. Cosnotti, Chief Development Officer
Cold Spring Harbor Laboratory is a nonprofit research and educational institution chartered
by the University of the State of New York. Less than half (35.8%) of our annual revenues are
derived from Federal grants and contracts, and thus, we rely heavily on support from the pri-
vate sector: foundations, corporations, and individuals. Contributions from the private sector
are tax exempt under the provisions of Section 501(c)(3) of the Internal Revenue Code. In
addition, the Laboratory is designated a "public charity" and, therefore, is enabled to receive
funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker.
Appreciated securities should be given outright, which will avoid capital gains taxes on the
appreciated value. Securities that have decreased in value should be sold, and the proceeds
donated. In this way, a donor will receive a deduction for both the loss and the charitable
contribution.
Life Insurance: You may designate the Laboratory as the beneficiary of an existing or new
policy, or irrevocably assign ownership of the policy. There are estate tax benefits in either
case. If ownership is assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive
investment and tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to
extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be
done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets
of the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a sup-
porting organization of Cold Spring Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or
the Watson School of Biological Sciences. Please check with your employer to augment
your gift.
For additional information, please contact the Chief Development Officer, Cold Spring Harbor Laboratory,
One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, 516-367-8840.
374
CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 1999-December 31, 1999
Contributions of $5,000 and above, exclusive of Annual Fund
In 1999, the Laboratory received significant support in the form of capital and program contributions
from individuals, foundations, and corporations.
Rita Allen Foundation, Inc.
Arrow Electronics
Rose M. Badge ley Residuary Charitable Trust
Banbury Fund, Inc.
The Breast Cancer Research Foundation
Davenport Family Foundation
Ellison Medical Foundation
Fraxa Research Foundation
Samuel Freeman Charitable Trust
Bernard E and Alva B. Gimbel Foundation
Goldring Family Foundation
The Grass Foundation
Mr. Henry U. Harris, Jr.
The John A. Hartford Foundation
Mr. Jeffrey C. Hawkins
Lita Annenberg Hazen Foundation
The Helen Hoffritz Foundation
Illinois Neurofibromatosis, Inc.
Sidney Kimmel Foundation for Cancer Research
The Esther A. and Joseph Klingenstein Fund, Inc.
Charles Henry Leach II Foundation
Long Island Foundation for the Elimination of Breast
Cancer
Mr. and Mrs. David L. Luke III
Manhasset Women's Coalition Against Breast Cancer
G. Harold & Leila Y. Mathers Charitable Foundation
Total $5,470,387
Marjorie A. and William L. Matheson Charitable Trust
The Maxfield Foundation
Elizabeth McFarland Foundation through the Long Island
Foundation for the Elimination of Breast Cancer
Mellam Family Foundation
Neurofibromatosis, Inc., Mass Bay Area
1 in 9: The Long Island Breast Cancer Action Coalition
Oxnard Foundation
Pew Charitable Trust
Michael L. Rankowitz and Sheila Heffron
John R. Reese
Row for a Cure
Schering-Plough Foundation
Mr. and Mrs. Alan Seligson
Robin and Enrique Senior Philanthropic Fund
The Seraph Foundation
Alfred P. Sloan Foundation
St. Giles Foundation
Laurie Strauss Leukemia Foundation
Swartz Foundation
Texas Neurofibromatosis Foundation
Mary G. Turner
Dr. and Mrs. James D. Watson
Westvaco
The Whitaker Foundation
Helen Hay Whitney Foundation
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NANCY AND EDWIN MARKS LABORATORY
CAPITAL CAMPAIGN
January 1, 1999-December 31, 1999
Contributions of $10,000 and above, exclusive of Annual Fund
The Nancy and Edwin Marks Laboratory, which was dedicated and officially opened in October 1999,
employs a revolutionary, new imaging technique called two-photon laser optical scanning that uses
tremendous pulses of light to image individual brain cells and networks of such cells in the intact brains
of living animals. In 1999, the Laboratory received significant support from individuals, trusts, and foun-
dations.
The Ira W. De Camp Foundation
Estate of Lachlan P. Braden
Fairchild Martindale Foundation
Irving A. Hansen Memorial Foundation
The Hyde and Watson Foundation
Mary D. Lindsay
Marks Family Foundation
Charitable Foundation
William E. and Maude S. Pritchard Charitable Trust
Fannie E. Rippel Foundation
The Starr Foundation
Dr. and Mrs. James D. Watson
The Weezie Foundation
Total $4,355,419
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
CAPITAL CAMPAIGN
January 1, 1999-December 31, 1999
Contributions of $10,000 and above, exclusive of Annual Fund
The Watson School of Biological Sciences at Cold Spring Harbor Laboratory was established for the
purpose of granting the Ph.D. degree. In its first year, the Watson School received 130 applications for
the five available student positions. Six students accepted over other high-caliber schools, and class-
es started in September 1999. In 1999, the laboratory received significant support from individuals,
Core Course in Scientific Mr. Nicholas C. Forstmann
Exposition and Ethics
Dean's Chair
Faculty Lectureships
Pall Fund
Fellowships
Fund for Innovative
Graduate Education
Knight House
Lita Annenberg Hazen Charitable Trust
Annenberg Foundation
Mr. and Mrs. George W. Cutting
Mr. and Mrs. Norris Darrell, Jr.
Mr. and Mrs. Edward H. Gerry
The Glickenhaus Foundation
Mr. and Mrs. Abraham Krasnoff
Leydig, Voit & Mayer, LTD.
The Esther A. and Joseph Klingenstein
Fund, Inc.
Quick & Reilly Group, Inc.
European Foundation for the Advancement of Medicine
The William Stamps Farish Fund
Mr. and Mrs. William R. Miller
Mr. and Mrs. Leslie C. Quick, Jr.
Arnone, Lowth, & Mullady Administrative
Services, LLC
Mr. David H. Deming
Mr. Edward Giles
Mr. James Goodwin
Visiting Lectureships Mr. and Mrs. John P. Cleary
Mr. and Mrs. Edward H. Gerry
Watson Fund Nancy H. Hopkins, Ph.D.
Total $11,320,219
Mr. Henry U. Harris, Jr.
Dr. Robert V Lewis
Mr. Thomas S. Murphy
W.P. Carey and Co. Inc.
The Seraph Foundation
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The Watson School of Biological Sciences Gala Benefit Concert ($10,000 and above)
Platinum Helix Benefactor
Cablevision Systems Corp.
Mr. Roderick H. Cushman
Mrs. Oliver R. Grace
J.P. Morgan and Co. Inc.
Mrs. Mary D. Lindsay
Mr. and Mrs. Edwin Marks
Mr. and Mrs. William R. Miller
Dr. and Mrs. Norton Zinder
Total $252,812
Gold Helix Benefactor
Centerbrook Architects
Mr. and Mrs. Harry G. Charleston
Clarkson Family Foundation
Fisher Scientific International, Inc.
Fleet Bank
Mr. and Mrs. Edward H. Gerry
Mr. and Mrs. John S. Grace
Mr. and Mrs. Oliver R. Grace, Jr.
Mr. and Mrs. Robert M. Grace
Mr. Richard A. Grasso
*41,17.41:
Mrs. Robin T. Hadley
Mr. and Mrs. Charles E. Harris
Mr. Lindsay C. Herkness, Ill
Mr. and Mrs. James Large
Mr. and Mrs. Robert D. Lindsay
Mr. and Mrs. David L. Luke, III
Mr. and Mrs. Thomas J. McGrath
Dr. and Mrs. Walter C. Meier
New York Stock Exchange
OBX, Inc.
Total Watson School Funds
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293,745
Dr. David B. Pall
Mr. and Mrs. Edward L. Palmer
Honorable and Mrs. Leon B. Polsky
Quick & Reilly Group, Inc.
Mr. and Mrs. William Robertson
Mr. and Mrs. Anthony Sbarro
Mr. and Mrs. Alan Seligson
Mr. Howard Solomon
Mrs. Helene P. Victor
$11,981,776
ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program continues to be an essential factor in the overall success of the
Laboratory's meetings programs, for meetings held in Grace Auditorium on the main Laboratory cam-
pus and at Banbury Center. The funding provided by the Program enables us to plan ahead for the fol-
lowing year's meetings, and we are able to use it to select new and unusual topics. However, the wave
of mergers in the pharmaceutical and biotechnology industries is severely reducing the pool of com-
panies that we can approach, and we are therefore ever more grateful to the 40 corporate sponsors
and affiliates who joined us in 1999 and are listed below.
The Corporate Affiliates Program began in 1999 with the expectation that smaller biotechnology
companies that of necessity must devote their resources to research might nevertheless find it useful
to have some of the benefits of the Corporate Sponsor Program. We are very grateful to the founding
members of this program.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for eight representatives of each company at our meetings. The number of
meetings has increased, so that in 1999, no fewer than 17 meetings took place in Grace Auditorium.
Three scientists from member corporations may attend meetings at Banbury Center, where attendance
is otherwise only by invitation of the organizers. Corporate Sponsors receive gratis copies of Cold
Spring Harbor Laboratory Press publications, including the journals Genes and Development, Learning
and Memory, and Genome Research. We acknowledge our Sponsors in all relevant publications,
including the books of abstracts given to each of the 7000 participants who come to the meetings each
year. The names of the sponsoring companies are listed on the poster describing the meetings; this is
mailed to approximately 17,000 scientists throughout the world. In addition, the companies are listed
on the Cold Spring Harbor Laboratory Web site, on the Meetings and Banbury Center pages.
COLD SPRING HARBOR LABORATORY CORPORATE SPONSORS
Alafi Capital Company
Amgen Inc.
BASF Bioresearch Corporation
Bayer Corporation
Bristol-Myers Squibb Company
Chiron Corporation
Chugai Research Institute for
Molecular Medicine, Inc.
Diagnostic Products Corporation
DuPont Pharmaceuticals Company
Forest Laboratories, Inc.
Genentech, Inc.
PLANT CORPORATE ASSOCIATES
Monsanto Company
Novartis Agricultural Discovery Institute
Pioneer Hi-Bred International, Inc.
Westvaco Corporation
Genetics Institute
Glaxo Wellcome Inc.
Hoechst Marion Roussel
Hoffmann-La Roche Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
Eli Lilly and Company
Merck Research Laboratories
New England BioLabs, Inc.
Novartis Pharma Research
OSI Pharmaceuticals, Inc.
Pall Corporation
CORPORATE AFFILIATES
Affymetrix, Inc.
ICOS Corporation
SUGEN, Inc.
Total $925,000
Parke-Davis Pharmaceutical
Research
PE Biosystems
Pfizer Inc.
Pharmacia & Upjohn, Inc.
Research Genetics, Inc.
Schering-Plough Corporation
SmithKline Beecham
Pharmaceuticals
Wyeth-Ayerst Research
Zeneca Group PLC
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
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DNALC Corporate Advisory Board Annual Fund
An important objective of the Corporate Advisory Board is to provide a sustainable level of annual fund-
ing for the DNA Learning Center's programs and to increase visibility in the local business community. As
a means of reaching this objective, the Board conducts an Annual Fund and an Annual Golf Tournament
with the proceeds benefiting the DNA Learning Center and the Partners for the Future program. This pro-
gram teaches the principles and methods of basic scientific research to six Long Island high school
seniors, who work with a scientist 10 hours per week after school, from October through March.
Chairman: John J. Leahy, Citibank
Michael Aboff, Aboff's Inc.
Andrew D. Ackerman, Chase
Manhattan Bank
Rocco S. Barrese, Esq., Dilworth &
Barrese
Howard M. Blankman, The Blankman
Group
Jane S. Block, Pall Corporation
Thomas J. Calabrese, Daniel Gale
Agency
Richard Catalano, KPMG, LLP
Edward Chernoff, Motors & Armatures,
Inc.
Paul Czeladnicki, Rivkin, Radler & Kremer
Robert Diller, Brinkmann Instruments
ANNUAL FUND CONTRIBUTORS
CORPORATE BENEFACTORS
Contributions of $10,000 or more
Luitpold Pharmaceuticals, Inc.
Edward A. Chernoff, Motors & Armatures, Inc.
The Pfizer Foundation
CORPORATE PATRONS
Contributions of $5,000 or more
EAB
Laurie J. Landeau, V.M.D.
Marsh, Inc.
Newsday
Pall Corporation
CORPORATE ASSOCIATES
Contributions of $2,500 or more
Citibank
Louis and Virginia Clemente Foundation, Inc.
Dilworth & Barrese
KPMG, LLP
Meenan Oil Co., LP
Pittway Corporation Charitable Foundation
OSI Pharmaceuticals, Inc.
Rivkin, Radler & Kremer
The Schiff Foundation
CORPORATE MEMBERS
Contributions of $1,000 or more
Aboff's Inc.
Adchem Corporation
Atlantic Bank of New York
The Blankman Group
Brinkmann Instruments, Inc.
Daniel Gale Agency
Marilyn DeLalio
Herman Development Corp.
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Gary E. Frashier, OSI Pharmaceuticals,
Inc.
Candido E. Fuentes, M.D.
Arthur D. Herman, Herman
Development Corp.
Richard Kalenka,
PricewaterhouseCoopers
John Kean III, Kean Development
Company
Laurie J. Landeau, V.M.D.
Ralf Lange, Luitpold Pharmaceuticals, Inc.
Lilo Leeds, The Institute for Community
Development
James Mattutat, BDO Seidman, LLP
Patricia Petersen, Daniel Gale Agency
Gerard and Lilo Leeds
George and Nancy Roche
Mr. and Mrs. William D. Roche
Donald J. Sutherland
Mr. and Mrs. Thomas Tucker
Windmere Development Corp.
FRIENDS OF THE DNALC
Contributions of $50 or more
John V. Aksak
Anonymous
Aon Risk Services, Inc. of Long Island
Thomas and Nancy Arcati
Arthur Andersen, LLP
Astrorep Incorporated
Bergers Wholesale Meats
Martin and Pam Bernard
Jonathan R. Blau
Rosemary Bourne
William J. and Cathleen M. Callahan
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President's Report
The last year of the century was a very busy one
for Cold Spring Harbor Laboratory, with its ever-
expanding research and educational programs,
not to mention new and planned facilities. Just
trying to grasp all this growth and accomplish-
ment tends to energize those of us involved with
the "public" arm of the Lab, the Cold Spring
Harbor Laboratory Association. J.L. Spingarn, D. Ayres, C. Large, L. Schiff
The year 1999 was momentous in many ways, and the membership of the CSHLA responded with
a resonant determination to add our own success to the fabulous achievements of the Lab itself.
First, in honor of our late esteemed past president, Vernon L. Merrill, the Association board mem-
bers funded a special contribution to the Laboratory to be used specifically for breast cancer research.
Our annual meeting, held February 6, commenced with the election of officers and new directors. I
am honored to have been elected president and am delighted to have very capable fellow officers:
Trudy H. Calabrese, first vice president; John Grace, second vice president; Cathy Cyphers Soref, sec-
retary; and Antoine C. Kemper, Jr., treasurer. Mary Alice Kolodner, Eileen K.S. Pulling, and Lawrence
Remmel were elected new directors. Our retiring directors, Dill Ayres, Carol Large, David Clark, Phillip
Satow, and Lisa Schiff, gave unstintingly of their expert, devoted service and made substantial contri-
butions to the Association. Even now we miss their sage counsel and leadership, for which we again
thank them. Our new directors have already been most worthy successors, and we are delighted they
have joined us.
The lecture that followed our annual meeting was given by Edward 0. Wilson, the world-famous
expert on biodiversity and professor from Harvard University. Professor Wilson's topic was
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"Consilience: Science Meets the Arts" and his delightful and easy-to-follow interpretation of the very
significant interfacing of science, particularly biology, with the creative accomplishments of mankind
(and how to make this work and succeed) was very well received. His audience rightfully thought they
had experienced a unique opportunity to understand an important subject from a master. A dinner fol-
lowed in Blackford Hall, while our young leadership group, the Next Generation Initiative, was treated
to a short presentation and dinner at the DNA Learning Center.
On March 7, John Kruper of the DNA Learning Center made a presentation on the virtual-textbook
project at an Association-sponsored lecture. It was resoundingly applauded.
A fabulous jazz concert, much of it arranged by the Lab's own Director of Development, Rick
Cosnotti, with a group of top jazz musicians from Pittsburgh, was held in Grace Auditorium on April 17.
It was a wonderful evening-and the group is coming back on April 15, 2000.
On February 4, Pam and David Banker hosted a lovely and well-attended reception in Manhattan.
Both Dr. Watson and Dr. Stillman addressed the attendees.
Our great annual event, the Dorcas Cummings Memorial Lecture, was held on June 6. Irving L.
Weissman, Ph.D., gave a fascinating talk on "Repairing the Body: The Promise of Blood and Tissue
Stem Cells." Learning more about this fascinating area of research and medical treatment was both
very illuminating and encouraging. Its dividends, if successful, could be life-enhancing, and Dr.
Weissman made the research very interesting. The lecture was followed by 19 fabulous dinner parties
which were enjoyed greatly by all (including visiting scientists and our own scientists and friends). The
parties were organized by Cynthia Stebbins and Eileen Pulling-many kudos for a great job. Our thanks
to all of you who so generously hosted these dinners:
Mr. and Mrs. W. Dillaway Ayres, Jr.
Ms. Mary Lenore Blair
Mr. and Mrs. G. Morgan Browne
Mr. and Mrs. Thomas J. Calabrese, Jr.
Mr. Richard L. Cosnotti and The
Rev. Shari Bledsoe
Mr. and Mrs. Joseph T. Donohue
Mr. and Mrs. John S. Grace
Mr. Huy ler C. Held
Mr. and Mrs. E. Coe Kerr
Mr. and Mrs. Michael L. Kolodner
Mrs. George N. Lindsay
Mr. and Mrs. David L. Luke Ill
Mrs. Theresa Mullarkey
Mr. and Mrs. Robert O'Connor
Mr. and Mrs. Gilbert R. Ott, Jr.
Mr. and Mrs. John J. Phelan
Mr. and Mrs. Thomas L Pulling
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. James F. Stebbins
Mr. and Mrs. John Stevenson
Mr. and Mrs. Thomas Vandeventer
Mr. and Mrs. Paul Vermylen
Mr. and Mrs. Robert P. Walton
On October 12, with the generous sponsorship of U.S. Trust Company, we held the First Annual
Biotech Enterprise Luncheon, in New York City. Many distinguished invitees had an opportunity to learn
much directly from Dr. Stillman and hedge fund manager Dr. Stuart Weisbrod. Thank you, Larry
Remmel, Linda Franciscovich, and U.S. Trust!
Carolyn and 011ie Grace were the perfect couple to host a most enjoyable tribute on October 22 to
our most significant supporters at the annual Major Donor Cocktail Party. Carolyn and 011ie, a most sin-
cere thank you!
In addition to the extraordinary success of the marvelous Gala Concert and Dinner on October 5,
chiefly orchestrated by Lola Grace, Trustee and Treasurer of the Laboratory, we raised $739,453.35, a
new record. We are especially grateful to those individuals who supported both the new Watson School
for the Biological Sciences and the Association and made our 1999 Annual Fund Campaign a won-
derful success. We thank each and every one of you for your generous interest, time, and support and
wish you all a very happy, healthy new year.
January 2000 James L. Spingarn
Members of the Cold Spring Harbor Laboratory Association
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CSHLA Annual Fund
Green Point Financial
The Henry Luce Foundation, Inc.
IBM Corporation-Matching Gifts
Program
J. P. Morgan
The Lubrizol Foundation
Matthew Bender
Merrill Lynch & Company, Inc.
CSHLA Membership and Other Support
Angels, Benefactors, Patrons, Associates $641,340.52
Friends and Basic Members $95,047.83
Other $3,065.00
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MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Mr. Jerry Armstrong
Mrs. Robert F. August
Ms. Flora Bernstein
Mr. and Mrs. Robert E. Cooper
The Davidson Family Foundation
Arline and Irwin Frish
Lola and Allen A. Goldring
Mrs. George Hussey, Jr.
IN MEMORY OF
Dennis Vincent Begley
Arthur Berger
Joe Bernstein
Bernice Bevins
Irving Cos loy
Catherine Feeney
Mr. George N. Lindsay, Jr. and Ms. Nancy Metz
Mary D. Lindsay
The Lynchpin Foundation, Inc.
Mr. and Mrs. William E. Mahoney
Dr. and Mrs. William P. McBride
Ms. Lilia L. Mu la
Mr. and Mrs. Howard A. Patterson
Mr. and Mrs. Paul G. Pennoyer, Jr.
David R. Grace
Mary Jeanne Harris
C. Margaret Lapnow
Vernon L. Merrill
Jane and Walter H. Page
Jeb Satow
Memorials and In Honor Totals
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Dr. and Mrs. Albert Sherwyn
Cathy Cyphers Soref
Mr. and Mrs. James L. Spingarn
Mr. and Mrs. Alfred H. Von Klemperer
Mr. and Mrs. Colton P. Wagner
Cathie B. Wardell
Charles W. B. Wardell, Jr.
Mrs. Joan F Williams
IN HONOR OF
Rita Frey
Shirley Gartlir
George J. Joseph
$3295.00
Joan Somyak
James Spingarn
Harry Stern
President's Council
The President's Council was formed six years ago in an effort to bring together a small group of lead-
ers from business, research, and biotechnology who are interested in science and the work at Cold
Spring Harbor Laboratory. Members of the President's Council contribute $25,000 or more to support
research and educational programs at the Laboratory. The funding helps the Laboratory attract top
young scientists fresh from their Ph.D. or M.D. studies. The fellowships allow promising young
researchers to pursue their own high-level, independent research, rather than assisting in the labora-
tory of an established scientist. The following are members of the 1999 President's Council:
Abraham Appel, Appel Consultants, Inc.
Peter L. Bloom, General Atlantic Partners, LLC
Michel David-Weill, Lazard Freres & Co., LLC
Jacob Goldfield, Goldman, Sachs & Co.
Leo A. Guthart, ADEMCO
Charles E. Harris, Harris & Harris Group, Inc.
Walter B. Kissinger, WBK Associates
Thomas J. McGrath, Simpson Thacher & Bartlett
Donald A. Pels, Pelsco, Inc.
James H. Simons, Renaissance Technologies Corporation
Ronald P. Stanton, Transammonia, Inc.
Charles L. Stone, Jr., M.D.
Sigi Ziering, Diagnostics Products Corporation
Total $248,588
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The Harbor Society
One of the most personal and meaningful ways of saying, "I believe in what Cold Spring Harbor
Laboratory does" is to make a planned gift. A planned gift takes many forms such as a bequest in your
will, a charitable remainder trust, a gift of real estate, securities, life insurance, retirement plan, or other
assets.
The Harbor Society is a distinguished group of individuals, currently numbering 49, who have made
planned gifts to the Laboratory and have given us permission to list their names. In 1999, several indi-
viduals pledged to support Cold Spring Harbor Laboratory.
CONTRIBUTORS
Arthur and Barbara Crocker
Estate of Lachlan P. Braden
Miss. Eleanor Greenan
Mrs. Lawrence Marks
Mr. and Mrs. Karl Runkle
Undergraduate Research Program
The Undergraduate Research Program introduces college students to the skills they need to become
research scientists. Approximately 20 participants work under the guidance of staff scientists for 10
weeks each summer on projects of mutual interest.
CONTRIBUTORS ENDOWMENTS
Cornelius N. Bliss Memorial Fund
Dorcas Cummings Memorial Lecture
Grace Professorship
Reverend Linda P. Hancock
Dr. Ira Herskowitz
Jephson Educational Trust
JM Foundation
National Science Foundation
Joan P. Tilney
Burroughs Wellcome Fund
Garfield Fellowship Emanuel Ax Fund
H. Bentley Glass Fellowship
Libby Fellowship
Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
Total $208,143
Total All Annual Funds $24,114,377
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LABORATORY STAFF
James D. Watson, President
Bruce W. Stillman, Director
Winship Herr, Asst. Director/Dean, Watson School of
Biological Sciences
G. Morgan Browne, Administrative Director
W. Dil laway Ayres, Jr., Assoc. Administrative Director
John P. Maroney, Asst. Administrative Director
William D. Keen, Comptroller
Terri I. Grodzicker, Asst. Director for Academic
Affairs
Jan A. Witkowski, Director of Banbury Center
David A. Mick los, Director of DNA Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Director of Meetings and Courses
FACULTY
Professors
Hollis Cline
David Helfman
Noun's Hernandez*
Adrian Krainer
Roberto Malinow
Robert Martienssen
David Spector
Nicholas Tonks
Timothy Tully
Michael Wig ler
Associate Professors
Grigori Enikolopov
Bruce Futcher
Michael Hengartner
Tatsuya Hirano
Leemor Joshua-Tor
Ryuji Kobayashi
Yuri Lazebnik
Scott Lowe
W. Richard McCombie
Jacek Skowronski
Arne Stenlund
Linda Van Aelst
Michael Zhang
Yi Zhong
Assistant Professors
Dmitri Chklovskii
Shivinder Grewal
Masaaki Hamaguchi
Gregory Hannon
David Jackson
Zachary Mainen
Andrew Neuwald
Lincoln Stein
Karel Svoboda
William Tansey
Rui Ming Xu
Chi-Ping (Jerry) Yin
Anthony Zador
Cold Spring Harbor
Laboratory Fellow
Marja Timmermans
Research Investigators
Nei lay Dedhia
Robert Lucito
Vivek Mittal
Natalia Peunova
Andrew Reiner
Clifford Yen
Adjunct Professor
David Beach
Adjunct Associate
Professor
Scott Powers
Adjunct Assistant
Professor
Craig Ogata*
Visiting Scientists
Jiaxin An
Eli Hatchwell
Tatyana Michurina
Nathalie Pavy
Jyoti Raychaudhuri
Vladimir Scheinker
Fumio Shiobara
Imran Siddiqi
Toshiro Tsukamoto
Senior Fellows
Michael Myers
Edward Stern
Postdoctoral Fellows
Carlos Aizenman
Andres Barria-Roman
Guy Birkenmeier
Benjamin Bottner
Katherine Braun
Athanasios Bubulya
Paula Bubulya
Mary Byrne
Isabel Cantallops
Luca Cartegni
James Chong
Marc Davenne
Ramana Davuluri
Robert Del Vecchio
Elisa De Stanchina
Michael Deweese
James Dezazzo
Joseph Donovan
Eric Drier
Jian Du
Joshua Dubnau
Dominik Due lli
Nicholas Edgington
Viola Ellison
Eric Enemark
Ludwig Englmeier
Jose Esteban
Gerardo Ferbeyre
Francisco Ferrezuelo
Robert Filipkowski
Lisa Foa
Toshiyuki Fukada
Michael Greenberg
Andrew Groover
Hui-Fu Guo
Kurt Haas
Frances Hannan
Michelle Hastings
Mariko Hayashi
Yasunori Hayashi
Andreas Herbst
Edward (Randy) Hofmann
Sangeet Honey
Junjiro Horiuchi
Susan Janicki
Jianzhong Jiang
Eric Julien
Alyson Kass-Eisler
Catherine Kidner
Keiji Kimura
Peter Krasnov
Prakash Rajesh Kumar
Patrice Lassus
Wen-Chuan (Athena) Lin
Zhixin Lin
Ana Losada
David Mac Callum
Miguel Maravall
Carla Margulies
Bruce May
Shanmugam Mayilvahanan*
Juan Mendez
Tzu-Chen Meng
Tohru Mizushima
Michael Murray
Jun-ichi Nakayama
Esther Nimchinsky
Paul O'Farrell
Takashi Odawara
Michael Packer
Helena Palka
Geraldine Pawlak
Shannon Pendergrast
yee of Howard Hughes Medical Institute.
389
Antonella Piccini
Jairaj Puthenveetil
Pablo Rabinowicz
Michael Regulski
Edward Ruthazer
Bernardo Sabatini
Noriko Saitoh
Cyril Sanders
Clemens Schmitt
Arndt Schmitz
Kenneth Seidenman
Lidia Serina
Yu Shen
Keiichi Shibahara
Wun Chey Sin
Tatjana Singer
Maria Soengas
Mona Spector
Yuri Stasiv
Yu lin Sun
Anne Vaahtokari
Daniel Vaughn
Erik Vollbrecht
Michael Weinreich
Shouzhen Xia
Lifang Zhang
Tongtong (Theresa) Zhang
Zhiguo Zhang
Xinyang Zhao*
Xuemei Zhao
Jianlong (Jim) Zhou
Jian Zhu
Jun Julius Zhu
Graduate Students
Anitra Auster
Emily Bernstein
Amy Caudy
Kenneth Chang
Brian Chen
Jeffrey Christensen
Michelle Cilia
Laureen Connell
Ahmet Den li
Sujit Dike
Yi Chieh (Nancy) Du
Farida Emran
Lavina Faleiro
Eric Gillitzer
Eve-Ellen Govek
Tina Gumienny
Jill Hemish
Brian Hill
Daniel Hoeppner
Pin Hu
Ajit Janardhan
Ashkan Javaherian
Kendall Jensen
Flavio Kamenetz
Manpreet Katari
Edward Kim
Soyoung Kim
Ying Ying (Ingrid) Koh
Arlinda Lee
So Young Lee
Sungwoo Lee
Zheng Li
Shih-Chieh (Jack) Lin
Michele Mc Donough
Troy Messick
John Mignone
Stuart Milstein
Shirly Pinto
Julia Polyakova
Alex Rai
Emiliano Rial Verde
Patrick Reilly
Jose Rodriguez
Andrew Samuelson
Laura Schramm
Bjorn Schumacher
Yvette Seger
Setareh Sepehri
Hang Shi
Songhai Shi
Michael Stebbins
Javor Stolarov
Tomasz (Tomek) Swigut
Marcela Tello-Ruiz
Suzanne Tharin
Elizabeth Thomas
Niraj Tolia
Jiayuan (James) Tong
Beth Trumbull
Thomas Tubon
Thomas Volpe
Joseph West
Herman Wijnen
Joanna Wysocka
Xiaohong (Helena) Yang
Ming Ming Zhao
Jun Zhu
Tao (Lee) Zou
Research Programmers
John Healy
Marco Mangone
Aleksandar Poleksic
Ravi Sachidanandam
David Weissmann
Research Associates
Carmelita Bautista
Robert Gasperini
Lisa Manche
Linda Rodgers
Patricia Wendel
Lab Facility Managers
Diane Esposito
Timothy Mulligan
Spencer Teplin
Ming Wang
Regina Whitaker
Laboratory Manager
Martha Daddario
Scientific Administrators
Sadie Arana
Patricia Bird
'dee Mallardi
Carol Marcincuk
Barbara Matusik
Lorraine Mclnerny
Jane Reader
Carol Sekunda*
Judith Smith
Madeline Wisnewski
Research Assistants
Imran Abrahams
Hunter Maats
Laboratory Technicians
Joan Alexander
Esteban Araya
Juana Arroyo
Deborah Aufiero
Nicole A. Bailey
Joshua Baker
Jody Barditch
Jay Bikoff
Jennifer A. Bizgia
Sabrina Boettcher
Kimberly Bronson
Anthony Bug lino
Barry Burbach
Eileen Cahill
Jodi Coblentz
Maureen Cowan
Nancy Dawkins-Pisani
Joseph Di Leo
Margaret Falkowski
Eugenia Friedman
Scott Gossweiler
Lori Grady
Karen Greenwood
Inessa Hakker
Michiko Hirano
Tamara Howard
Emily N. Huang
Wei Jiang
Kristin Kirchoff
Robert Krimper
Kimberly La Vine
Hui Li
Andrew Lin
Jianping Liu
Stacy Lopez
Beicong Ma*
Christine Maurel
Mila McCurrach
Robert McGuirk
Jennifer Meth
Barbara Mish
Lidia Nascimento
Aigoul Nourjanova
Adam Oberlander
Andrew O'Shaughnessy
Ximena Opitz-Araya
Ronnie Packer
Kimberly Pennino
Raymond Preston
Michael Riggs
Milka Rodriguez
Simone Salghetti
David Sargent
Kristin Schutz
Lei-Hoon See
Ravi Shah
Monica Shekher
Nadim Shohdy
Joseph Simorowski
Patrick Smith
Lori Spiegel
John Sugram
Yu ling Sun*
Julie Thomas
Jennifer Troge
Philip Vahab
Klara Velinzon
Marie Danielle Vil
Jeanne Wiggins
Priscilla Wu
Mianjia Ye
Cristina Yordan
Zhuang Yuan
Li Zhang
Ying Zhang
Hong Zhou
Hui Zhou
Media Makers/
Laboratory Aides
June Blanchford
Patricia Brady
Jack Brodsky
Florinda Chaves
Rodney Chisum
Janice Douglas
*Employee of Howard Hughes Medical Institute.
390
Salvador Henriquez
Robin Kirchner
Lance Lefkowitz
Yang (Nancy) Liu
Vincent Meschan
Rulan Shen
Margaret Wallace
Denise Wurtz
Xiu-Xia Zhang
Research Administration
Maureen Bell
Melissa de Is Bastide
Watson School of
Biological Sciences
Lilian Gann
Janet Duffy
DEPARTMENTS
Accounting
Jennifer Blovsky
Karine Boyce
Guy Cozza
Mary Ellen Goldstein
Laura Guterman
Elizabeth Janow
Patricia Maroney
Alison McDermott
Carlos Mendez
Mary Ann Miceli
Elizabeth Panagot
Lari Russo
Patricia Urena
Noreen Vance
Barbara Wang
Art
Michael Ockler
James Duffy
Irwin Mend linger
Philip Renna
Banbury Center
Katya Davey
Eleanor Sidorenko
Beatrice To liver
Central Administration
Maureen Berejka
Barry Braunstein
Carol Dempster
Delia King
Roberta Salant
CSHL Press
Acquisition
Alexander Gann
Elizabeth Powers
Books: Editorial
Janet Argentine
Mary Cozza
Judith Cuddihy
Maryliz Dickerson
Joan Ebert
Kaaren Janssen
Nora Mclnerny
Inez Sialiano
Kaetrin Simpson
Journals: Editorial
Laurie Goodman
Margaret Calicchia
Kimberly Gavin
Emily Pei-hsin Huang
Valerie Pakaluk
Production
Denise Weiss
Patricia Barker
Dorothy Brown
Daniel de Bruin
Elaine Cantwell
Nadine Dumser
Cynthia Grimm
Ma la Mazzullo
Nora Ruth
Susan Schaefer
Peri Zeenkov
Fulfillment/Distribution
Guy Keyes
Kathleen Cirone
Gabriella Horvath
Jacqueline Matura
Richard Passmore
Sharon Story
Joanne Thomas
Thurman Thompson
Finance
Nancy Hodson
Jennifer Bloch
Marketing
Ingrid Benirschke
Advertising Sales
Marcie Ebenstein
Development
Richard Cosnotti
Lynn Cannon
Gordon Hargraves
Donna Harrington
Kimberly Sneed
Julie Sutherland
Vincent Torti
Cathie Wardell
Peter Wayne
DNA Learning Center
Joan Alexander
Scott Bronson
Shirley Chan
Matthew Christensen
Susan Conova
Judy Cumella-Korabik
Nancy Daidola
Susan Lauter
Patricia Maskiell
Amanda Mc Brien
Michele McDonough
Martha Mullally
Danielle Sixsmith
James Tong
Thomas Volpe
Chun-hua Yang
Facilities
Arthur Brings
Christopher Hubert
Jack Richards
Peter Stahl
Leslie Allen
Margaret Challis
Marlene Rubino
Frank Russo
Barbara Santos
Charles Schneider
Daniella Zullin
Carpentry and Painting
Peter Schwind
Edwin Bennett
Michael Demers
Paul Edwards
Romulo Estrella
Jeffrey Klaverweiden
John Meyer
Joseph Pirnak
Wilson Ramones
Benjamin Veneable
Harry Wozniak
Custodial/Housekeeping
Steven Tang
Dessie Carter
Ming-Kai Chan
Leo Franz
Aaron Hendrickson
Joseph Houser
Louis Hunter
Christina Lazar
Susanne MacPherson
Patricia McAdams
Janeth Mejia
Dora Merlin°
Guido Mosquera
Maria Mosquera
Mary Muno
Wayne Pay
Waide (Wayne) Redwood
Ronald Romani
Claudia Schmid
Danuta Slodkowska
Yew Teo
Curtis Williams
Electrical
Louis Jagoda
Jeffrey Goldblum
Environmental Health and
Safety
Paul Cannava
Randal Jones
John Pisciotta
Stephen Sallese
Equipment Design
Fabrication and Repair
Cliff Sutkevich
Robert Eifert
George Newell
James Robey
Grounds
Daniel Miller
Drew Comer
Paul Draser
Joseph Ellis
Lawrence Giordano
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Edward Haab
Allek Hendrickson
Christopher McEvoy
Jacob Milliken
John Murphy
Andrew Sauer
Stanley Schwarz
Martin Slodkowski
Harris Research Support
Facility
Lisa Bianco
Kelly Brings
Jodi Coblentz
Charlene De Poto
Halina Swidzinski
Ryszard Swidzinski
Mechanical Services
Robert Collins
Russell Allen
Greg Beal
William Bishop
Robert Dickerson
Lane Smith
John Sundman
Security
Robert Gensel
Frank Carberry
Randy Wilfong
Shipping and Receiving
Daniel Jusino
Kevin Donohue
Renee Le Strange
Joseph Marcel lo
Food Service
James Hope
Victor Ariza
Jaime Bonilla
Francis Bowdren
Guiditta Carino
William Carmona
Rose Ciurleo
Michael Corral
Joan Doxey
Julie Ehrlich
Barbara Gordon
Jennifer Gordon
Quintin Irizarry
Pierre Jean-Baptiste
Oscar Lastra
Jesus Magana
Thomas Mcllvaine
Maureen Morrow
Frederick Munter
Ronald Padden
Carlos Perez
Jorge Ramirez
Mauricio Rodriguez
Susana Roman
David Sarinick
Cathy van Deurs-Smith
Roger Vereen
Leslie Wenzel
Grants
Susan Schultz
Sharon Bense
Wendy Crowley
Maureen Davies
Carol DuPree
Patricia Kurfess
William Mahoney
Dee McKeon
Human Resources
Cheryl Sinclair
Marjorie Berko
Jennifer Donovan
Jan Eisenman
Kim Gronachan
Sandra Neuwald
Barbara Purcell
Merilyn Simkins
Zoe Stylianoudakis
Information Services
Gerald Latter
James Bense
John Diffiey
James Gergel
Derek Johnson
Matthew Labush
Robert Pace
Barbara Peters
Dmitri Primak
Salvatore Serafino
Russell Strine
David Trimboli
John Uhl
Lee Wilbur
Library
Ludmila Pollock
Paula Abisognio
Clare Bunce
Ellen de Bruin
Laura Hyman
Leigh Johnson
Wanda Stolen
Claudia Zago
Meetings/Courses
Edward Campodonico
William Dickerson
Donna Dykeman
Michael Glaessgen
Andrew Mendelsohn
Andrea Newell
James (Herb) Parsons
Jonathan Parsons
Katherine Ruffo lo
Mary Smith
Margaret Stellabotte
Andrea Stephenson
Diane Tighe
Nancy Weeks
Jenna Williams
Barbara Zane
Public Affairs
Deborah Barnes
Margot Bennett
Wendy Goldstein Helfman
Lynn Hardin
Peter Sherwood
Purchasing
Philip Lembo
Margaret Brock
Carol Brower
Lorraine Byers
Susan De Angelo
Bruce Fahlbusch
Patricia Hinton-Stenko
Christopher Oravitz
Susan Rose
Leonard Sposato
Technology Transfer
Barry Braunstein
Carol Dempster
Research Staff Departures
during 1999
Faculty
Ueli Grossniklaus
Peter Nest ler
Visiting Scientists
Toshiro Tskamoto
Postdoctoral Fellows
Christine Berthier
Hennes Buelow
Grace Chen
Douglas Conklin
John Connolly
Serge Desnoyers
Dennis Dong
Howard Fernhead
Andrew Fraser
Anton Gartner
Ilya loschikhes
Nobuhiro Kashige
Balazs Lendvai
Qiong Liu
Hong-Xiang Liu
Dehua Liu
Mireya Marin
Thomas Misteli*
Naoki Nakaya
Laurence Parnell
Jean-Christophe Poncer
Baskar Ramamurthy
Minoru Saito
Andrew Settles
Charles Spillane
Peiqing Sun
Jack Tabaska
Daan van Aalten
Jean-Philippe Vielle-Calzada
Jing (Jenny) Wang
Tomoki Yokochi
Shahid Zaman
Shao-Hui Zhang
Dong-Jing Zou
Graduate Students
Robert Babb
Hsu-Hsin (Grace) Chen
Tracy Kuhlman
Paul Mintz
James Moore
Ahmed Samatar
Tzu Ling Tseng
*Employ. of Howard Hughes Medical Institute.
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